data_2jrr_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2jrr _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 . . . . . 0 CA--C 1.539 0.545 0 CA-C-O 120.987 0.422 . . . . 0.0 111.753 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 57.2 m -75.52 127.53 33.3 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.305 179.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 85.2 mttt -141.18 123.41 15.68 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 120.993 0.425 . . . . 0.0 111.32 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.497 ' N ' HD11 ' A' ' 10' ' ' ILE . 2.8 mp -88.74 119.64 36.25 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.769 -178.042 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 15.0 t -105.97 154.69 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-O 121.028 0.442 . . . . 0.0 111.245 -178.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -80.93 -37.78 28.96 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 121.048 0.451 . . . . 0.0 110.727 -177.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -101.56 162.97 12.51 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.396 176.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 50.5 m -79.97 -40.89 27.06 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -177.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 18.5 ptt-85 -86.09 118.43 25.55 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 121.458 0.647 . . . . 0.0 110.813 177.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 39.5 t -111.47 125.02 68.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.988 -172.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.95 82.23 5.15 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 120.984 0.421 . . . . 0.0 111.341 176.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.514 ' SG ' ' SG ' ' A' ' 43' ' ' CYS . 41.9 t . . . . . 0 N--CA 1.468 0.45 0 CA-C-O 121.17 0.51 . . . . 0.0 111.47 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.459 ' O ' ' HD3' ' A' ' 29' ' ' ARG . 1.1 tmt_? . . . . . 0 N--CA 1.452 -0.356 0 CA-C-O 122.185 0.993 . . . . 0.0 109.006 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.1 m -131.21 131.88 63.4 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 114.652 -1.158 . . . . 0.0 111.703 178.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 49.1 m95 -105.81 114.92 29.36 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.355 -178.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.56 HD22 ' HG ' ' A' ' 43' ' ' CYS . 6.4 mp -107.76 133.01 52.77 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 120.837 0.351 . . . . 0.0 111.421 179.249 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 54.9 tp60 -90.03 119.88 30.76 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 121.144 0.497 . . . . 0.0 111.958 -178.1 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.496 HG21 ' HB2' ' A' ' 52' ' ' LEU . 73.1 mt -79.93 118.17 71.08 Favored Pre-proline 0 CA--C 1.54 0.589 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.999 175.102 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.68 ' HG2' HG22 ' A' ' 38' ' ' THR . 97.2 Cg_endo -83.05 121.6 3.18 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 122.325 2.016 . . . . 0.0 112.868 178.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -56.5 -16.77 6.5 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-O 121.306 0.574 . . . . 0.0 111.427 175.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -61.69 -29.17 69.92 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 115.61 -0.723 . . . . 0.0 112.026 177.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.68 HG22 ' HG2' ' A' ' 35' ' ' PRO . 12.9 t -131.16 -38.82 1.2 Allowed 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 120.679 0.276 . . . . 0.0 111.415 178.179 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 107.42 2.45 35.34 Favored Glycine 0 CA--C 1.53 0.98 0 N-CA-C 115.419 0.928 . . . . 0.0 115.419 171.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 68.1 p-90 -144.8 164.96 29.46 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 118.271 1.035 . . . . 0.0 112.972 -176.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.436 HG22 ' HB3' ' A' ' 32' ' ' LEU . 9.9 p -147.92 143.94 19.31 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.244 171.118 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -116.64 141.51 48.11 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 -177.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.56 ' HG ' HD22 ' A' ' 32' ' ' LEU . 60.5 m -110.68 109.28 57.92 Favored Pre-proline 0 N--CA 1.473 0.716 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.163 173.07 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -69.06 15.61 0.19 Allowed 'Trans proline' 0 CA--C 1.549 1.24 0 C-N-CA 123.079 2.519 . . . . 0.0 115.511 -167.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -96.13 -72.21 0.64 Allowed 'General case' 0 N--CA 1.473 0.698 0 O-C-N 121.925 -0.485 . . . . 0.0 110.919 177.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.408 ' SG ' ' O ' ' A' ' 46' ' ' CYS . 43.1 t -86.94 3.8 44.23 Favored 'General case' 0 N--CA 1.475 0.822 0 O-C-N 122.218 -0.301 . . . . 0.0 111.58 169.676 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 56.48 31.29 18.63 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 121.379 0.609 . . . . 0.0 112.0 -178.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 61.9 m -64.95 110.93 2.62 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.123 176.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 84.2 tttt -98.62 102.38 14.1 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 121.08 0.466 . . . . 0.0 110.659 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -87.33 116.62 25.54 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.465 -175.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.464 ' O ' ' HA ' ' A' ' 10' ' ' ILE . 77.8 t -96.9 139.53 19.34 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.07 177.194 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.496 ' HB2' HG21 ' A' ' 34' ' ' ILE . 51.7 tp -77.4 131.78 38.19 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 121.221 0.534 . . . . 0.0 111.667 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -53.43 110.38 0.55 Allowed 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -179.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 85.68 2.32 86.9 Favored Glycine 0 CA--C 1.527 0.787 0 C-N-CA 121.191 -0.528 . . . . 0.0 113.821 176.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 40.8 t -70.15 174.8 5.08 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.049 0.452 . . . . 0.0 111.776 179.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -67.69 -23.91 65.35 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 121.075 0.464 . . . . 0.0 111.075 179.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -74.18 -18.46 60.77 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 121.045 0.45 . . . . 0.0 110.893 172.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 32.9 t70 . . . . . 0 CA--C 1.545 0.772 0 CA-C-O 121.578 0.704 . . . . 0.0 110.148 177.354 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 . . . . . 0 N--CA 1.472 0.643 0 CA-C-O 121.364 0.602 . . . . 0.0 112.243 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 97.3 m -89.72 136.19 33.18 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.786 -179.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 45.1 tttp -127.65 116.75 20.78 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 120.636 0.255 . . . . 0.0 110.829 -175.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 44.5 mm -86.3 112.37 22.63 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-O 120.989 0.423 . . . . 0.0 111.199 -178.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 35.7 m -113.33 164.53 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -178.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -105.41 -6.3 19.65 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-O 121.057 0.456 . . . . 0.0 111.424 179.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 68.6 mmtt -120.04 144.37 47.59 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.094 0.473 . . . . 0.0 111.856 -179.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 34.7 m -72.83 -21.06 61.02 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.603 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 80.4 mtt-85 -102.4 111.75 24.17 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-O 121.241 0.543 . . . . 0.0 110.634 177.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 36.7 t -119.96 131.2 73.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.851 -175.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.432 ' HB3' ' CE2' ' A' ' 31' ' ' TRP . . . -74.91 139.57 43.17 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 121.122 0.487 . . . . 0.0 111.742 177.427 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 53.0 t . . . . . 0 C--N 1.327 -0.39 0 CA-C-O 121.146 0.498 . . . . 0.0 110.534 177.319 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 4.4 tmt_? . . . . . 0 CA--C 1.531 0.25 0 CA-C-O 121.941 0.876 . . . . 0.0 109.56 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 28.7 m -122.36 134.89 64.21 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 CA-C-N 114.846 -1.07 . . . . 0.0 111.486 178.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . 0.432 ' CE2' ' HB3' ' A' ' 17' ' ' ALA . 15.7 m95 -116.27 127.35 54.65 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 120.787 0.327 . . . . 0.0 111.114 179.679 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.7 mp -92.08 151.93 20.19 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 121.179 0.514 . . . . 0.0 111.544 -178.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 27.9 tp60 -110.2 108.98 19.31 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.019 -179.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.493 HG12 HG13 ' A' ' 41' ' ' VAL . 75.8 mt -71.62 122.3 86.81 Favored Pre-proline 0 CA--C 1.542 0.641 0 CA-C-N 116.634 -0.257 . . . . 0.0 111.481 179.336 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.473 ' HG2' ' OG1' ' A' ' 38' ' ' THR . 44.7 Cg_endo -86.31 127.11 2.83 Favored 'Trans proline' 0 CA--C 1.54 0.811 0 C-N-CA 122.95 2.434 . . . . 0.0 112.709 176.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -59.22 -21.97 60.34 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 121.43 0.633 . . . . 0.0 110.792 177.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -59.11 -31.7 69.16 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 115.234 -0.893 . . . . 0.0 111.742 178.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.473 ' OG1' ' HG2' ' A' ' 35' ' ' PRO . 44.8 p -113.92 -47.44 2.96 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.308 0.575 . . . . 0.0 110.975 178.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.493 ' HA3' ' H ' ' A' ' 57' ' ' ALA . . . 100.2 1.08 55.84 Favored Glycine 0 CA--C 1.525 0.676 0 CA-C-N 115.874 -0.603 . . . . 0.0 112.782 -178.198 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 58.5 p-90 -155.46 162.27 40.77 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.088 0.471 . . . . 0.0 111.388 -177.1 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.493 HG13 HG12 ' A' ' 34' ' ' ILE . 14.2 p -148.67 126.45 2.95 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 CA-C-O 120.992 0.425 . . . . 0.0 110.62 172.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.406 ' HA ' ' HA ' ' A' ' 49' ' ' LYS . 16.7 pt-20 -94.39 143.01 26.77 Favored 'General case' 0 CA--C 1.535 0.398 0 O-C-N 122.124 -0.36 . . . . 0.0 111.035 179.437 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 37.0 t -71.55 130.99 86.68 Favored Pre-proline 0 N--CA 1.468 0.435 0 N-CA-C 111.825 0.305 . . . . 0.0 111.825 179.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -76.59 0.46 9.51 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 122.406 2.07 . . . . 0.0 113.077 179.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -99.87 -87.64 0.36 Allowed 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 111.687 0.254 . . . . 0.0 111.687 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 42.0 t -169.78 22.27 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 111.827 0.306 . . . . 0.0 111.827 -179.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -87.75 -88.23 0.14 Allowed 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -173.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 73.7 m -155.31 179.19 9.4 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-O 121.596 0.712 . . . . 0.0 112.627 -177.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.406 ' HA ' ' HA ' ' A' ' 42' ' ' GLU . 40.3 ttmt -111.5 120.31 41.71 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.959 174.324 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 46.2 m-85 -103.27 116.48 32.53 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 111.922 0.342 . . . . 0.0 111.922 -170.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 85.9 t -105.08 135.47 42.96 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 CA-C-O 120.946 0.403 . . . . 0.0 111.513 178.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.424 ' HB2' HG21 ' A' ' 34' ' ' ILE . 53.0 tp -87.44 122.16 30.81 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 121.154 0.502 . . . . 0.0 111.711 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.43 ' HD3' ' N ' ' A' ' 54' ' ' GLY . 4.2 tmtm? -67.72 127.9 34.5 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.365 179.185 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.43 ' N ' ' HD3' ' A' ' 53' ' ' LYS . . . 87.52 12.62 66.76 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 121.391 -0.433 . . . . 0.0 112.886 -175.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.7 t -110.23 -173.4 2.24 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 122.552 -0.381 . . . . 0.0 111.34 178.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 61.6 tttp -57.1 -47.76 80.26 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -176.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.493 ' H ' ' HA3' ' A' ' 39' ' ' GLY . . . -73.99 -13.91 60.95 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 112.543 0.571 . . . . 0.0 112.543 -177.42 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 33.3 t70 . . . . . 0 CA--C 1.538 0.499 0 CA-C-O 121.529 0.681 . . . . 0.0 111.04 -179.756 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 . . . . . 0 CA--C 1.543 0.681 0 CA-C-O 122.317 1.056 . . . . 0.0 110.54 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 91.0 m -123.2 110.56 15.4 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.48 -1.236 . . . . 0.0 110.003 -177.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 5.7 tmtt? -102.6 115.4 30.51 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.787 0.327 . . . . 0.0 110.819 -172.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.478 HG23 ' HB2' ' A' ' 53' ' ' LYS . 2.5 mp -82.02 101.24 6.61 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.88 -177.533 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.407 HG23 HD13 ' A' ' 34' ' ' ILE . 35.7 m -102.67 167.93 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 CA-C-O 120.963 0.411 . . . . 0.0 111.874 -178.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -104.63 -20.61 13.6 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -176.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -130.33 165.0 23.42 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 121.019 0.438 . . . . 0.0 112.097 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.9 m -81.57 -37.89 26.98 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 112.67 0.619 . . . . 0.0 112.67 -174.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 28.9 tpt180 -87.27 105.23 17.09 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 122.117 -0.364 . . . . 0.0 110.642 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 58.9 t -131.05 135.03 60.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 N-CA-C 112.211 0.448 . . . . 0.0 112.211 -173.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -76.09 112.53 12.63 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.044 0.449 . . . . 0.0 110.237 172.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.677 ' HB2' HD13 ' A' ' 32' ' ' LEU . 58.3 m . . . . . 0 C--N 1.324 -0.535 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.22 -174.26 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 23.3 tpt180 . . . . . 0 N--CA 1.466 0.371 0 CA-C-O 121.667 0.746 . . . . 0.0 110.024 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 27.1 t -100.47 125.98 54.16 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.759 -173.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 61.2 m95 -105.53 115.66 30.63 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 121.026 0.441 . . . . 0.0 111.418 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.677 HD13 ' HB2' ' A' ' 18' ' ' CYS . 9.0 mp -98.04 172.2 7.77 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.307 0.575 . . . . 0.0 111.678 -179.452 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 58.1 tp60 -137.64 116.41 12.25 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.528 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.476 HG12 HG13 ' A' ' 41' ' ' VAL . 68.4 mt -68.56 120.21 73.84 Favored Pre-proline 0 CA--C 1.539 0.539 0 CA-C-N 116.686 -0.234 . . . . 0.0 111.209 177.141 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.565 ' HG2' ' OG1' ' A' ' 38' ' ' THR . 74.0 Cg_endo -75.21 110.98 3.21 Favored 'Trans proline' 0 CA--C 1.535 0.561 0 C-N-CA 122.412 2.075 . . . . 0.0 111.67 176.539 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -54.93 -21.56 12.07 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 116.079 -0.51 . . . . 0.0 112.242 -176.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -61.14 -46.95 88.45 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-O 120.665 0.269 . . . . 0.0 111.247 173.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.565 ' OG1' ' HG2' ' A' ' 35' ' ' PRO . 29.2 p -89.03 -50.21 6.3 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 120.841 0.353 . . . . 0.0 111.521 -177.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 103.45 1.82 47.2 Favored Glycine 0 CA--C 1.527 0.792 0 C-N-CA 121.202 -0.523 . . . . 0.0 112.71 -176.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 63.6 p-90 -152.63 158.99 43.22 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 120.951 0.405 . . . . 0.0 112.006 -177.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.476 HG13 HG12 ' A' ' 34' ' ' ILE . 14.9 p -145.17 126.67 8.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-O 120.926 0.394 . . . . 0.0 110.269 174.071 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.582 ' HA ' ' HA ' ' A' ' 49' ' ' LYS . 10.5 pt-20 -103.66 152.67 21.51 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.234 0.54 . . . . 0.0 112.416 -177.2 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 6.4 t -69.61 134.13 88.55 Favored Pre-proline 0 N--CA 1.471 0.608 0 CA-C-N 115.705 -0.68 . . . . 0.0 112.174 -176.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -78.46 -5.94 15.19 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 122.739 2.292 . . . . 0.0 112.767 178.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -108.96 -93.58 0.42 Allowed 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 -179.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 48.7 t -144.46 9.9 1.42 Allowed 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 112.948 0.722 . . . . 0.0 112.948 -169.101 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -90.14 -107.39 0.09 Allowed 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 112.959 0.726 . . . . 0.0 112.959 -172.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 72.0 m -152.33 -179.74 7.82 Favored 'General case' 0 N--CA 1.477 0.902 0 O-C-N 121.692 -0.63 . . . . 0.0 112.475 -174.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.582 ' HA ' ' HA ' ' A' ' 42' ' ' GLU . 36.8 ttpt -106.74 125.64 51.26 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.291 177.051 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 36.4 m-85 -99.77 113.24 25.6 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 120.763 0.316 . . . . 0.0 111.144 -175.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 99.9 t -99.04 131.6 45.97 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 CA-C-O 121.101 0.477 . . . . 0.0 111.898 179.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 59.9 tp -78.11 118.15 20.08 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.543 179.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.478 ' HB2' HG23 ' A' ' 10' ' ' ILE . 47.4 tttp -74.33 151.22 39.82 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 121.124 0.488 . . . . 0.0 111.203 178.528 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.79 14.6 81.86 Favored Glycine 0 CA--C 1.527 0.799 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.07 -174.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 48.3 t -116.5 -177.48 3.19 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.2 0.524 . . . . 0.0 111.532 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 50.6 mtpt -60.52 -34.76 74.58 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.639 -179.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -86.18 8.89 19.24 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 -178.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.4 t0 . . . . . 0 CA--C 1.545 0.784 0 CA-C-O 121.182 0.515 . . . . 0.0 111.859 -179.576 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 . . . . . 0 CA--C 1.535 0.388 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 23.3 m -98.01 125.81 43.13 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.017 176.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 24.4 tptp -121.8 110.72 16.25 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 120.816 0.341 . . . . 0.0 110.558 -178.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 55.5 mt -77.19 104.41 5.13 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-O 120.909 0.385 . . . . 0.0 111.236 -177.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 34.5 m -95.06 155.75 3.25 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-O 121.067 0.461 . . . . 0.0 111.439 179.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -82.19 -37.09 26.59 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.807 -175.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 46.5 mmtm -118.94 167.18 11.98 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 121.212 0.529 . . . . 0.0 112.273 -177.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 18.6 m -68.64 -34.65 76.1 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -174.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.452 ' HA ' ' O ' ' A' ' 32' ' ' LEU . 16.6 ptt180 -98.64 135.36 40.25 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.231 0.538 . . . . 0.0 111.668 -179.27 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 48.7 t -129.34 122.96 56.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.277 -178.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -74.78 94.03 2.69 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.12 0.486 . . . . 0.0 110.678 176.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.412 ' SG ' HD12 ' A' ' 32' ' ' LEU . 85.8 m . . . . . 0 N--CA 1.467 0.384 0 CA-C-O 120.93 0.395 . . . . 0.0 111.657 -176.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 21.8 tpt180 . . . . . 0 C--O 1.236 0.356 0 CA-C-O 121.814 0.816 . . . . 0.0 110.089 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 30.0 m -112.84 121.67 65.54 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 CA-C-N 115.062 -0.972 . . . . 0.0 112.395 -177.176 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 69.5 m95 -106.55 113.33 26.78 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.885 177.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.452 ' O ' ' HA ' ' A' ' 15' ' ' ARG . 8.1 mp -86.38 144.72 27.19 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 120.878 0.371 . . . . 0.0 110.977 179.14 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 54.2 tp60 -115.91 116.35 27.82 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.059 -177.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.415 HG12 HG13 ' A' ' 41' ' ' VAL . 61.9 mt -76.48 126.41 86.27 Favored Pre-proline 0 CA--C 1.539 0.535 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -179.065 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.538 ' HG2' ' OG1' ' A' ' 38' ' ' THR . 57.1 Cg_endo -86.78 132.45 3.43 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 122.87 2.38 . . . . 0.0 112.092 173.645 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -66.04 -25.62 67.14 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 121.941 -0.474 . . . . 0.0 111.492 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -54.51 -56.48 18.46 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.134 0.492 . . . . 0.0 111.37 177.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.538 ' OG1' ' HG2' ' A' ' 35' ' ' PRO . 52.4 p -76.27 -47.82 22.39 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.407 0.622 . . . . 0.0 110.055 174.473 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 99.09 1.5 57.06 Favored Glycine 0 CA--C 1.524 0.621 0 CA-C-N 115.504 -0.771 . . . . 0.0 112.672 -178.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.495 ' HB3' HG21 ' A' ' 51' ' ' VAL . 63.7 p-90 -159.3 166.83 30.38 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 122.56 0.344 . . . . 0.0 110.911 -176.026 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.415 HG13 HG12 ' A' ' 34' ' ' ILE . 12.2 p -135.37 132.69 52.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-O 121.112 0.482 . . . . 0.0 111.399 176.219 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -92.01 112.11 23.91 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 121.148 0.499 . . . . 0.0 110.818 176.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 41.0 t -71.28 110.56 7.65 Favored Pre-proline 0 N--CA 1.471 0.576 0 CA-C-N 116.187 -0.461 . . . . 0.0 112.086 -178.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -71.55 -11.24 27.95 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 122.632 2.221 . . . . 0.0 112.425 177.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 78.4 m-85 -84.56 -42.7 15.21 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 115.956 -0.566 . . . . 0.0 112.007 -176.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 84.5 m -131.92 8.08 4.42 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 -178.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 57.7 78.26 0.24 Allowed 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 176.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 91.2 m -152.46 147.31 26.1 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.944 177.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -99.63 106.47 18.43 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 120.651 0.262 . . . . 0.0 111.091 178.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -91.74 111.69 23.32 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.55 0.214 . . . . 0.0 110.615 178.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.495 HG21 ' HB3' ' A' ' 40' ' ' TRP . 97.9 t -97.51 135.61 31.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-O 121.023 0.439 . . . . 0.0 111.58 -179.623 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 59.0 tp -75.42 130.95 39.8 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 116.171 -0.468 . . . . 0.0 112.029 -178.182 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 51.7 tttm -58.91 102.5 0.12 Allowed 'General case' 0 CA--C 1.542 0.645 0 CA-C-O 121.114 0.483 . . . . 0.0 111.443 174.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 117.6 -7.06 15.92 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 121.362 -0.447 . . . . 0.0 112.538 -176.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 12.4 t -65.81 151.92 45.55 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 177.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.47 -7.39 47.12 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 120.905 0.383 . . . . 0.0 111.477 174.062 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -72.19 -27.33 62.49 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 121.174 0.511 . . . . 0.0 110.402 170.066 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.7 t70 . . . . . 0 CA--C 1.547 0.833 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.711 175.769 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 . . . . . 0 N--CA 1.465 0.298 0 CA-C-O 121.197 0.522 . . . . 0.0 110.639 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 66.5 m -98.39 141.78 30.83 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.786 -177.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 55.1 tptt -133.87 114.76 13.68 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.879 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 52.4 mt -88.64 105.34 15.63 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 CA-C-O 120.727 0.298 . . . . 0.0 111.013 -177.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.4 t -102.67 147.79 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-O 120.884 0.373 . . . . 0.0 111.271 -176.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -89.23 -4.46 58.19 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 121.075 0.464 . . . . 0.0 111.183 -178.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -131.89 152.25 51.17 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.051 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 21.1 m -80.39 -6.83 58.66 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 120.837 0.351 . . . . 0.0 111.611 179.076 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -95.16 114.64 26.46 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 120.942 0.401 . . . . 0.0 110.961 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 70.7 t -125.46 135.08 65.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 N-CA-C 113.056 0.762 . . . . 0.0 113.056 -171.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -104.37 110.3 22.49 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.525 173.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 66.2 m . . . . . 0 N--CA 1.474 0.761 0 C-N-CA 122.515 0.326 . . . . 0.0 111.28 179.231 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.446 -0.646 0 CA-C-O 122.35 1.071 . . . . 0.0 110.909 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 19.0 m -109.69 154.2 11.24 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.133 0 CA-C-N 113.97 -1.468 . . . . 0.0 111.453 -178.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 49.7 m95 -124.14 114.84 20.2 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 121.243 0.544 . . . . 0.0 112.136 -175.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.438 ' N ' HD11 ' A' ' 32' ' ' LEU . 6.1 mp -105.46 167.56 9.66 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.454 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 54.2 tp60 -130.25 113.51 14.51 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.336 179.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.541 HG21 ' HB2' ' A' ' 52' ' ' LEU . 76.2 mt -63.06 120.15 58.67 Favored Pre-proline 0 CA--C 1.541 0.597 0 CA-C-O 120.684 0.278 . . . . 0.0 111.397 -179.288 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.582 ' HG2' ' OG1' ' A' ' 38' ' ' THR . 83.5 Cg_endo -79.82 113.75 3.08 Favored 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 122.262 1.975 . . . . 0.0 112.022 177.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -60.89 -15.0 25.91 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 121.115 0.483 . . . . 0.0 111.542 -179.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -68.87 -29.51 67.83 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.568 174.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.582 ' OG1' ' HG2' ' A' ' 35' ' ' PRO . 34.6 p -103.25 -54.73 2.55 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 121.205 0.526 . . . . 0.0 110.445 175.151 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 113.13 -0.19 25.39 Favored Glycine 0 CA--C 1.526 0.727 0 CA-C-N 115.8 -0.636 . . . . 0.0 113.123 179.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 66.1 p-90 -166.45 162.44 16.91 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -177.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.529 HG13 HG12 ' A' ' 34' ' ' ILE . 11.3 p -153.77 133.55 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.346 174.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.464 ' HA ' ' HA ' ' A' ' 49' ' ' LYS . 0.5 OUTLIER -110.94 148.87 31.56 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.062 0.458 . . . . 0.0 111.866 -178.282 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.539 ' HB3' ' HB3' ' A' ' 47' ' ' ASP . 52.3 t -84.52 108.13 13.6 Favored Pre-proline 0 N--CA 1.466 0.364 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 171.018 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -65.06 -9.41 21.55 Favored 'Trans proline' 0 CA--C 1.54 0.794 0 C-N-CA 122.742 2.295 . . . . 0.0 113.476 -172.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -87.33 -89.9 0.12 Allowed 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 120.566 0.222 . . . . 0.0 111.575 -177.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 75.7 m -152.45 82.62 1.24 Allowed 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 120.956 0.408 . . . . 0.0 111.477 179.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.539 ' HB3' ' HB3' ' A' ' 43' ' ' CYS . 9.7 t70 -149.98 -90.22 0.07 Allowed 'General case' 0 CA--C 1.548 0.889 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.184 177.038 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 30.2 p 179.8 -176.92 0.34 Allowed 'General case' 0 N--CA 1.477 0.889 0 CA-C-O 121.106 0.479 . . . . 0.0 111.422 174.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.464 ' HA ' ' HA ' ' A' ' 42' ' ' GLU . 39.5 ttmt -106.54 120.27 41.48 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 123.036 0.534 . . . . 0.0 110.693 178.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -98.72 108.24 20.88 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.081 0.467 . . . . 0.0 111.868 -173.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 99.7 t -93.75 134.39 31.59 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.243 178.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.541 ' HB2' HG21 ' A' ' 34' ' ' ILE . 51.8 tp -79.18 120.7 24.07 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 121.304 0.573 . . . . 0.0 111.649 -178.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -77.4 118.18 19.61 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.948 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 88.38 55.48 2.19 Favored Glycine 0 CA--C 1.524 0.652 0 C-N-CA 121.035 -0.603 . . . . 0.0 111.64 -173.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 25.0 t -151.03 -150.99 0.37 Allowed 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 122.898 0.479 . . . . 0.0 110.985 -175.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -101.65 22.72 12.33 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 -177.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -129.51 -33.26 1.89 Allowed 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 121.415 0.626 . . . . 0.0 111.097 -175.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 . . . . . 0 CA--C 1.546 0.797 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.764 178.512 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 . . . . . 0 N--CA 1.472 0.673 0 CA-C-O 121.601 0.715 . . . . 0.0 110.574 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.429 ' HA ' ' O ' ' A' ' 49' ' ' LYS . 51.6 m -118.93 137.97 53.1 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 115.395 -0.821 . . . . 0.0 111.559 -172.351 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -134.92 129.9 35.03 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 120.766 0.317 . . . . 0.0 111.069 -176.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 59.9 mt -86.45 118.91 33.63 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 CA-C-O 121.079 0.466 . . . . 0.0 111.614 -179.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 35.3 m -109.52 163.41 6.62 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.964 176.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -92.17 -21.44 20.39 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -176.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -121.54 152.01 39.69 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 -176.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 48.7 m -70.28 -21.04 63.0 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 116.049 -0.523 . . . . 0.0 112.334 -178.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 80.7 mtp180 -87.6 111.83 21.66 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.148 0.499 . . . . 0.0 111.33 178.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.497 HG13 ' HG ' ' A' ' 18' ' ' CYS . 61.2 t -113.01 115.81 50.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.926 -177.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -95.16 115.01 26.87 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 120.695 0.283 . . . . 0.0 111.382 177.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.5 ' O ' HG13 ' A' ' 30' ' ' VAL . 82.8 m . . . . . 0 N--CA 1.47 0.544 0 CA-C-O 120.927 0.394 . . . . 0.0 111.306 179.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.424 ' O ' ' HD3' ' A' ' 29' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.45 -0.46 0 CA-C-O 122.444 1.116 . . . . 0.0 111.342 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.5 HG13 ' O ' ' A' ' 18' ' ' CYS . 11.5 p -132.02 132.98 61.22 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-N 114.153 -1.385 . . . . 0.0 109.488 166.632 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 59.8 m95 -100.09 132.5 45.41 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.24 0.543 . . . . 0.0 112.339 -176.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.421 ' N ' HD13 ' A' ' 32' ' ' LEU . 5.4 mp -115.67 160.89 19.45 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.904 177.13 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -119.55 124.78 47.24 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.496 178.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.491 HG21 ' HB2' ' A' ' 52' ' ' LEU . 73.7 mt -79.33 132.25 63.18 Favored Pre-proline 0 CA--C 1.545 0.768 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -178.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.547 ' HG2' ' OG1' ' A' ' 38' ' ' THR . 94.7 Cg_endo -81.95 117.33 2.9 Favored 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 122.609 2.206 . . . . 0.0 112.317 173.521 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -60.25 -33.82 72.82 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -176.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.489 ' O ' ' HE2' ' A' ' 56' ' ' LYS . 8.0 p-10 -62.23 -30.9 71.42 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 120.773 0.321 . . . . 0.0 111.846 -178.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.547 ' OG1' ' HG2' ' A' ' 35' ' ' PRO . 21.9 p -91.55 -48.89 6.6 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.377 0.608 . . . . 0.0 110.428 175.023 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 100.01 2.47 56.0 Favored Glycine 0 CA--C 1.524 0.614 0 CA-C-N 115.597 -0.729 . . . . 0.0 112.756 -177.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.404 ' HB3' HG23 ' A' ' 51' ' ' VAL . 65.2 p-90 -158.81 152.77 23.52 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 120.961 0.41 . . . . 0.0 111.867 -175.533 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.421 HG13 HG12 ' A' ' 34' ' ' ILE . 11.0 p -131.6 150.58 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.939 176.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -117.2 131.47 56.85 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 121.113 0.482 . . . . 0.0 111.154 178.164 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 49.5 t -82.67 110.49 22.63 Favored Pre-proline 0 N--CA 1.47 0.532 0 N-CA-C 111.911 0.337 . . . . 0.0 111.911 -179.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -58.94 -26.93 83.15 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 122.699 2.266 . . . . 0.0 113.319 -177.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -112.03 17.55 19.54 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 112.13 0.418 . . . . 0.0 112.13 -176.127 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.421 ' SG ' ' SG ' ' A' ' 48' ' ' CYS . 36.2 t -146.1 -7.17 0.56 Allowed 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 174.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 55.18 24.72 6.51 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 113.203 0.816 . . . . 0.0 113.203 178.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.421 ' SG ' ' SG ' ' A' ' 46' ' ' CYS . 81.3 m -102.92 138.02 40.35 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 120.812 0.339 . . . . 0.0 111.611 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.429 ' O ' ' HA ' ' A' ' 8' ' ' THR . 85.7 tttt -109.01 121.51 45.3 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 122.92 0.488 . . . . 0.0 111.149 -178.378 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -116.93 125.77 51.95 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 112.13 0.418 . . . . 0.0 112.13 -177.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.404 HG23 ' HB3' ' A' ' 40' ' ' TRP . 40.9 t -94.54 139.33 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.873 176.344 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.491 ' HB2' HG21 ' A' ' 34' ' ' ILE . 56.5 tp -87.13 119.12 27.03 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.407 177.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -67.67 118.59 11.15 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 121.076 0.465 . . . . 0.0 111.122 178.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 120.5 -28.51 6.21 Favored Glycine 0 CA--C 1.525 0.686 0 CA-C-N 115.992 -0.549 . . . . 0.0 112.29 -174.16 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 66.1 m -80.83 168.07 19.19 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 120.877 0.37 . . . . 0.0 111.252 178.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.489 ' HE2' ' O ' ' A' ' 37' ' ' ASP . 65.7 pttt -58.59 -25.03 62.18 Favored 'General case' 0 CA--C 1.543 0.673 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -177.206 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.72 -33.2 75.11 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.151 0.5 . . . . 0.0 111.23 176.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 32.7 t70 . . . . . 0 CA--C 1.543 0.687 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.206 177.904 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 . . . . . 0 N--CA 1.475 0.789 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 86.8 m -85.83 115.32 23.4 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.059 175.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 73.8 mttt -121.95 98.57 6.01 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 120.995 0.426 . . . . 0.0 110.882 176.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 57.8 mt -86.21 127.75 39.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.108 -179.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 28.5 m -125.56 163.45 26.71 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.546 -179.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -89.15 -19.79 25.05 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 120.76 0.314 . . . . 0.0 111.515 179.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 13.6 pttm -131.84 148.08 52.52 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 121.076 0.465 . . . . 0.0 111.615 -177.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 12.2 p -68.39 -30.79 69.79 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 114.572 1.323 . . . . 0.0 114.572 -168.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 94.4 mtt180 -75.41 104.3 5.92 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 118.53 0.604 . . . . 0.0 111.512 179.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 36.4 t -117.88 122.37 69.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.388 -178.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -81.4 109.66 16.1 Favored 'General case' 0 CA--C 1.535 0.4 0 O-C-N 122.252 -0.28 . . . . 0.0 111.116 175.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.731 ' SG ' ' HB ' ' A' ' 30' ' ' VAL . 22.8 p . . . . . 0 N--CA 1.47 0.559 0 CA-C-O 121.056 0.455 . . . . 0.0 110.936 179.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.46 ' HD3' ' HA ' ' A' ' 29' ' ' ARG . 2.8 tpp180 . . . . . 0 N--CA 1.445 -0.722 0 CA-C-O 122.461 1.124 . . . . 0.0 112.612 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.731 ' HB ' ' SG ' ' A' ' 18' ' ' CYS . 48.4 t -118.45 115.08 47.04 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.066 0 CA-C-N 114.107 -1.406 . . . . 0.0 110.565 177.544 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 83.3 m95 -91.41 103.91 16.49 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 120.948 0.404 . . . . 0.0 111.291 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.496 HD21 ' HD3' ' A' ' 44' ' ' PRO . 6.2 mp -83.62 131.07 34.99 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 121.021 0.439 . . . . 0.0 111.436 179.107 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 27.1 tp60 -93.89 105.32 17.35 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.334 176.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.498 HG12 HG13 ' A' ' 41' ' ' VAL . 73.5 mt -64.43 124.76 86.83 Favored Pre-proline 0 CA--C 1.542 0.638 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.661 -178.359 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.542 ' HG2' ' OG1' ' A' ' 38' ' ' THR . 76.9 Cg_endo -74.19 119.24 5.72 Favored 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 122.671 2.247 . . . . 0.0 112.211 179.567 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -64.63 -17.15 63.76 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-O 121.162 0.506 . . . . 0.0 111.582 -178.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -64.93 -44.07 90.72 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 120.916 0.389 . . . . 0.0 111.22 175.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.542 ' OG1' ' HG2' ' A' ' 35' ' ' PRO . 31.6 p -95.92 -54.3 3.38 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 121.08 0.467 . . . . 0.0 110.99 179.545 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 110.87 1.18 28.74 Favored Glycine 0 CA--C 1.524 0.605 0 CA-C-N 115.948 -0.569 . . . . 0.0 113.494 179.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 62.0 p-90 -153.79 160.15 42.15 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 116.941 0.37 . . . . 0.0 111.183 -177.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.498 HG13 HG12 ' A' ' 34' ' ' ILE . 13.4 p -141.15 141.49 30.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.648 176.053 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.39 154.93 16.96 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 121.305 0.574 . . . . 0.0 111.948 -179.135 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.445 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 43.8 t -73.05 123.12 89.22 Favored Pre-proline 0 CA--C 1.537 0.449 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.603 179.305 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.496 ' HD3' HD21 ' A' ' 32' ' ' LEU . 14.9 Cg_exo -69.03 -7.71 21.59 Favored 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 122.757 2.305 . . . . 0.0 113.095 -179.501 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -98.83 -46.9 5.49 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 120.924 0.392 . . . . 0.0 111.576 -178.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 25.1 t -120.08 -91.0 0.57 Allowed 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.514 -177.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -173.91 19.11 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 179.005 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.412 ' HB2' ' HB2' ' A' ' 43' ' ' CYS . 56.7 m -64.97 132.53 49.53 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 -177.33 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.747 ' HZ3' ' HB2' ' A' ' 49' ' ' LYS . 5.0 ttmp? -102.34 110.71 22.74 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 121.203 0.525 . . . . 0.0 111.572 -179.257 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 55.3 m-85 -94.76 104.35 16.26 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.447 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 56.7 t -92.13 137.3 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 CA-C-O 121.174 0.511 . . . . 0.0 112.372 -175.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 59.6 tp -98.91 130.05 45.28 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.508 178.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -64.77 143.9 57.62 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-O 120.845 0.355 . . . . 0.0 111.635 178.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 81.42 -13.89 31.95 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 121.367 -0.444 . . . . 0.0 114.081 175.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 59.9 p -84.2 179.99 7.35 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 120.935 0.398 . . . . 0.0 111.345 -178.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 62.0 mttm -63.5 -27.33 69.19 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 179.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -69.53 -27.45 65.18 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.301 0.572 . . . . 0.0 110.662 175.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 32.3 t70 . . . . . 0 CA--C 1.544 0.744 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.769 176.198 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 . . . . . 0 CA--C 1.541 0.604 0 CA-C-O 121.561 0.696 . . . . 0.0 112.667 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.449 ' OG1' ' NZ ' ' A' ' 49' ' ' LYS . 99.9 m -103.95 147.3 27.52 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.087 178.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -134.95 113.13 11.21 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 120.786 0.327 . . . . 0.0 110.684 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 53.2 mt -86.82 107.1 16.54 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-O 121.176 0.512 . . . . 0.0 111.005 -179.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.497 HG12 HG21 ' A' ' 16' ' ' VAL . 30.6 m -96.12 155.6 3.4 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-O 121.175 0.512 . . . . 0.0 112.149 -176.666 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -94.98 3.1 55.32 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.642 -176.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 62.7 pttt -135.07 155.2 51.15 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.016 179.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 59.0 m -75.87 -32.66 59.81 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -175.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.456 ' HB3' ' OE1' ' A' ' 33' ' ' GLN . 13.0 ptp180 -112.79 121.13 43.81 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 121.233 0.54 . . . . 0.0 111.469 -178.027 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.497 HG21 HG12 ' A' ' 11' ' ' VAL . 46.2 t -127.49 132.35 69.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.679 -177.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.473 ' HA ' ' O ' ' A' ' 30' ' ' VAL . . . -83.04 88.28 6.87 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 121.146 0.498 . . . . 0.0 110.718 176.065 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.451 ' SG ' ' HB3' ' A' ' 46' ' ' CYS . 43.7 t . . . . . 0 N--CA 1.471 0.614 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 -174.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 22.9 tpt180 . . . . . 0 N--CA 1.454 -0.248 0 CA-C-O 122.308 1.052 . . . . 0.0 111.426 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.473 ' O ' ' HA ' ' A' ' 17' ' ' ALA . 58.9 t -107.16 112.54 40.42 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 CA-C-N 114.196 -1.365 . . . . 0.0 111.322 -177.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 95.9 m95 -95.09 118.48 31.96 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.125 0.488 . . . . 0.0 111.919 -179.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.1 mp -94.58 111.65 23.41 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.31 173.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.456 ' OE1' ' HB3' ' A' ' 15' ' ' ARG . 59.4 tp60 -92.43 110.08 21.48 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.83 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.478 HG21 ' HB2' ' A' ' 52' ' ' LEU . 73.5 mt -75.77 119.12 75.68 Favored Pre-proline 0 CA--C 1.543 0.676 0 CA-C-O 120.9 0.381 . . . . 0.0 111.331 179.162 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -85.5 146.35 9.57 Favored 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 122.842 2.361 . . . . 0.0 113.178 -178.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -70.9 -10.12 59.03 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 120.864 0.364 . . . . 0.0 110.848 174.357 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -62.94 -40.58 98.09 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.352 0.596 . . . . 0.0 110.836 172.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 44.3 p -108.56 -54.04 2.56 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.624 -176.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 99.61 1.12 56.51 Favored Glycine 0 CA--C 1.525 0.694 0 CA-C-N 116.092 -0.504 . . . . 0.0 112.061 -174.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 64.5 p-90 -156.86 166.93 31.99 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 122.588 0.355 . . . . 0.0 110.966 -177.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 11.5 p -145.11 136.58 20.34 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-O 120.895 0.379 . . . . 0.0 110.921 174.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -91.76 133.43 35.62 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.006 0.431 . . . . 0.0 110.447 177.176 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.481 ' SG ' ' HB2' ' A' ' 45' ' ' TYR . 44.5 t -103.69 105.31 47.02 Favored Pre-proline 0 N--CA 1.467 0.413 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -178.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -73.54 -2.54 12.3 Favored 'Trans proline' 0 CA--C 1.542 0.923 0 C-N-CA 122.526 2.151 . . . . 0.0 112.351 174.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.481 ' HB2' ' SG ' ' A' ' 43' ' ' CYS . 60.7 m-85 -90.74 -42.14 10.86 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.548 179.099 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.451 ' HB3' ' SG ' ' A' ' 18' ' ' CYS . 53.1 t -118.53 1.87 11.74 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -175.329 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 59.43 51.44 6.62 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 112.802 0.668 . . . . 0.0 112.802 175.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 87.6 m -149.04 157.6 43.53 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 120.835 0.35 . . . . 0.0 111.505 177.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.6 ' HZ3' ' HB3' ' A' ' 49' ' ' LYS . 7.2 ttpm? -106.45 121.9 45.21 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 116.532 -0.303 . . . . 0.0 111.282 178.634 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 37.1 m-85 -99.62 119.41 38.04 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 120.663 0.268 . . . . 0.0 111.511 -179.093 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 97.3 t -101.87 139.99 21.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 CA-C-O 120.84 0.353 . . . . 0.0 111.491 177.103 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.478 ' HB2' HG21 ' A' ' 34' ' ' ILE . 60.9 tp -88.54 118.71 28.39 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 120.935 0.398 . . . . 0.0 111.919 -179.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -63.57 133.17 53.3 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.816 178.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 90.36 -8.18 80.24 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 121.159 -0.543 . . . . 0.0 113.546 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 45.5 t -77.52 179.94 6.21 Favored 'General case' 0 N--CA 1.472 0.667 0 O-C-N 122.361 -0.493 . . . . 0.0 111.035 178.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -66.85 -27.77 67.8 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.116 0.484 . . . . 0.0 111.157 179.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -76.41 -25.38 54.43 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.444 177.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 32.0 t70 . . . . . 0 CA--C 1.538 0.516 0 CA-C-O 121.42 0.628 . . . . 0.0 111.332 -178.756 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.464 ' HB3' ' SG ' ' A' ' 48' ' ' CYS . 86.4 tt0 . . . . . 0 CA--C 1.541 0.63 0 CA-C-O 120.945 0.402 . . . . 0.0 111.794 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 57.8 p -96.1 115.46 27.46 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 122.751 0.42 . . . . 0.0 111.771 178.177 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 65.2 mttm -99.37 100.43 11.49 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.018 0.437 . . . . 0.0 110.269 178.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.478 HG21 ' HB2' ' A' ' 53' ' ' LYS . 55.4 mt -82.19 100.47 6.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.546 -176.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 33.2 m -107.93 157.0 8.27 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 CA-C-O 121.108 0.48 . . . . 0.0 112.247 -176.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -99.74 25.31 7.34 Favored 'General case' 0 CA--C 1.548 0.896 0 CA-C-O 121.676 0.75 . . . . 0.0 110.5 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -144.1 131.48 20.91 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.071 -175.081 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 9.1 m -81.01 -26.71 36.24 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -178.106 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.438 ' HG2' ' OE1' ' A' ' 33' ' ' GLN . 89.2 mtt180 -100.7 92.38 5.07 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.17 0.509 . . . . 0.0 110.123 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 44.9 t -107.83 118.6 55.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-N 115.925 -0.579 . . . . 0.0 112.155 -171.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.408 ' HB3' ' CE2' ' A' ' 31' ' ' TRP . . . -84.93 100.5 11.66 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 120.751 0.31 . . . . 0.0 110.756 175.172 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.645 ' SG ' ' HB ' ' A' ' 30' ' ' VAL . 29.7 p . . . . . 0 N--CA 1.47 0.559 0 CA-C-O 121.063 0.459 . . . . 0.0 111.769 -175.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 2.4 tmt_? . . . . . 0 C--O 1.233 0.223 0 CA-C-O 121.806 0.813 . . . . 0.0 109.888 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.645 ' HB ' ' SG ' ' A' ' 18' ' ' CYS . 55.1 t -124.54 132.69 70.97 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.022 0 CA-C-N 114.558 -1.201 . . . . 0.0 110.784 179.208 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . 0.408 ' CE2' ' HB3' ' A' ' 17' ' ' ALA . 37.3 m95 -110.02 119.94 40.89 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-O 121.205 0.526 . . . . 0.0 112.26 -176.576 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.6 mp -100.4 163.43 12.38 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 121.303 0.573 . . . . 0.0 111.568 177.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.438 ' OE1' ' HG2' ' A' ' 15' ' ' ARG . 55.8 tp60 -131.27 114.21 14.77 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.768 -179.365 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.528 HG21 ' HB2' ' A' ' 52' ' ' LEU . 64.7 mt -69.96 121.21 82.11 Favored Pre-proline 0 CA--C 1.543 0.7 0 CA-C-O 120.863 0.363 . . . . 0.0 111.617 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.479 ' HG2' ' OG1' ' A' ' 38' ' ' THR . 65.3 Cg_endo -81.63 130.26 6.79 Favored 'Trans proline' 0 CA--C 1.544 0.976 0 C-N-CA 122.855 2.37 . . . . 0.0 113.351 -178.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 44.3 mm-40 -60.02 -18.14 44.04 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 175.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -67.92 -36.64 80.51 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 120.966 0.413 . . . . 0.0 111.49 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.479 ' OG1' ' HG2' ' A' ' 35' ' ' PRO . 43.7 p -108.36 -50.86 2.97 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.049 0.452 . . . . 0.0 111.701 -177.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 104.31 1.64 44.33 Favored Glycine 0 CA--C 1.527 0.826 0 C-N-CA 121.352 -0.452 . . . . 0.0 112.412 -174.125 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 65.3 p-90 -154.36 160.19 41.56 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 122.708 0.403 . . . . 0.0 111.418 -179.164 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.488 HG13 HG12 ' A' ' 34' ' ' ILE . 12.3 p -144.11 127.05 11.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 CA-C-O 120.9 0.381 . . . . 0.0 110.823 176.455 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -100.16 146.2 27.12 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 121.058 0.456 . . . . 0.0 111.745 -178.457 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.556 ' HB3' ' HB2' ' A' ' 47' ' ' ASP . 42.0 t -103.86 119.28 54.99 Favored Pre-proline 0 CA--C 1.536 0.415 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -65.57 -12.58 35.72 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 122.819 2.346 . . . . 0.0 112.836 178.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.542 ' HB2' ' SG ' ' A' ' 43' ' ' CYS . 95.3 m-85 -82.38 7.31 14.44 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.716 178.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.463 ' HB2' ' O ' ' A' ' 45' ' ' TYR . 76.4 m 83.2 31.24 0.08 Allowed 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.906 0.882 . . . . 0.0 112.48 175.715 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.556 ' HB2' ' HB3' ' A' ' 43' ' ' CYS . 24.4 m-20 -94.2 5.96 50.11 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 120.999 0.428 . . . . 0.0 111.005 169.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.464 ' SG ' ' HB3' ' A' ' 7' ' ' GLU . 78.4 m 66.72 -161.92 0.24 Allowed 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 175.065 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.725 ' HZ1' ' HB2' ' A' ' 49' ' ' LYS . 5.0 ttmp? -94.11 126.75 39.52 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -174.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -96.89 105.49 17.64 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 120.658 0.266 . . . . 0.0 110.87 176.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 98.7 t -91.28 132.0 36.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-O 120.798 0.333 . . . . 0.0 111.472 -179.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.528 ' HB2' HG21 ' A' ' 34' ' ' ILE . 48.6 tp -85.39 112.54 20.94 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 121.215 0.531 . . . . 0.0 111.503 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.478 ' HB2' HG21 ' A' ' 10' ' ' ILE . 10.1 tmtt? -58.35 138.74 56.27 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.468 176.095 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 67.32 42.32 90.33 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 121.153 -0.546 . . . . 0.0 112.68 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 35.2 t -143.15 -168.57 2.83 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 120.767 0.317 . . . . 0.0 111.327 -176.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -60.84 -26.13 67.14 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -178.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -94.86 -15.03 24.03 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 -179.154 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 22.9 t70 . . . . . 0 CA--C 1.541 0.631 0 CA-C-O 121.004 0.43 . . . . 0.0 111.614 -177.591 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 . . . . . 0 N--CA 1.467 0.414 0 CA-C-O 121.497 0.665 . . . . 0.0 111.439 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.441 HG21 HG21 ' A' ' 51' ' ' VAL . 38.7 m -84.38 104.94 14.82 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 114.725 -1.125 . . . . 0.0 110.788 -177.198 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 62.2 mttm -120.68 122.0 39.49 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 121.09 0.471 . . . . 0.0 111.198 -174.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.445 HD12 ' HB ' ' A' ' 51' ' ' VAL . 49.9 mm -82.89 121.87 36.55 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 CA-C-N 115.91 -0.586 . . . . 0.0 112.295 -173.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 29.5 m -130.08 149.85 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.194 178.063 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -90.42 -15.72 30.4 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 179.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -96.97 142.68 28.63 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.037 0.446 . . . . 0.0 111.695 -179.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 20.0 m -80.57 -23.06 40.18 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.576 179.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.442 ' HA ' ' O ' ' A' ' 32' ' ' LEU . 16.2 ptp180 -116.15 119.46 35.87 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 121.311 0.577 . . . . 0.0 111.178 176.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 51.4 t -118.3 142.34 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.501 -175.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -94.33 110.47 22.23 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 120.982 0.42 . . . . 0.0 111.34 178.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.502 ' SG ' HD12 ' A' ' 32' ' ' LEU . 78.3 m . . . . . 0 C--O 1.237 0.398 0 CA-C-O 120.865 0.364 . . . . 0.0 111.41 176.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.452 ' O ' ' HD3' ' A' ' 29' ' ' ARG . 0.4 OUTLIER . . . . . 0 N--CA 1.448 -0.541 0 CA-C-O 122.598 1.189 . . . . 0.0 110.228 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 60.7 t -120.28 129.85 75.04 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-N 113.919 -1.492 . . . . 0.0 110.988 178.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 74.4 m95 -104.09 124.22 48.67 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.063 0.459 . . . . 0.0 112.157 -178.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.502 HD12 ' SG ' ' A' ' 18' ' ' CYS . 7.2 mp -103.07 149.88 24.15 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.94 177.197 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 27.6 tp60 -120.32 109.02 14.87 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.812 -178.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.461 HG12 HG13 ' A' ' 41' ' ' VAL . 67.8 mt -60.45 129.46 89.2 Favored Pre-proline 0 CA--C 1.543 0.678 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.743 179.497 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.565 ' HG2' ' OG1' ' A' ' 38' ' ' THR . 45.7 Cg_endo -78.61 119.21 4.39 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 122.216 1.944 . . . . 0.0 111.52 173.018 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 22.2 mp0 -56.72 -40.33 75.51 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 -171.175 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -81.13 0.77 34.76 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 -173.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.565 ' OG1' ' HG2' ' A' ' 35' ' ' PRO . 22.6 p -107.06 -46.22 3.96 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.336 0.589 . . . . 0.0 109.823 171.139 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 100.3 0.92 55.75 Favored Glycine 0 CA--C 1.524 0.602 0 CA-C-N 115.558 -0.746 . . . . 0.0 113.212 178.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.418 ' HB3' HG23 ' A' ' 51' ' ' VAL . 67.5 p-90 -157.33 157.31 33.9 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.024 0.44 . . . . 0.0 112.118 -176.198 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.461 HG13 HG12 ' A' ' 34' ' ' ILE . 13.3 p -135.46 139.91 45.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.593 174.323 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -106.55 131.73 53.38 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.164 0.506 . . . . 0.0 111.083 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.44 ' HA ' HD22 ' A' ' 32' ' ' LEU . 47.5 t -86.23 122.04 72.44 Favored Pre-proline 0 CA--C 1.537 0.466 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.784 -177.419 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -74.71 -12.56 22.16 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 122.496 2.131 . . . . 0.0 112.84 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -99.42 -39.13 8.52 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 116.268 -0.424 . . . . 0.0 112.053 -178.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 46.3 t -116.8 2.62 12.88 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -177.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 54.25 25.86 6.24 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 174.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 71.0 m -95.48 144.71 25.75 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.296 177.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.454 ' HE3' ' HB2' ' A' ' 49' ' ' LYS . 34.9 ttmt -112.44 106.52 15.02 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-O 121.17 0.51 . . . . 0.0 111.215 -177.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 52.4 m-85 -91.24 111.16 22.53 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.51 -175.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.445 ' HB ' HD12 ' A' ' 10' ' ' ILE . 68.9 t -94.86 132.66 38.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-O 121.031 0.443 . . . . 0.0 111.279 177.735 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 41.8 tp -82.29 115.8 21.52 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 121.054 0.454 . . . . 0.0 112.12 -176.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.55 ' HE3' ' N ' ' A' ' 54' ' ' GLY . 0.1 OUTLIER -67.27 112.9 4.78 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 120.973 0.415 . . . . 0.0 110.042 178.582 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.55 ' N ' ' HE3' ' A' ' 53' ' ' LYS . . . 114.14 -4.51 23.78 Favored Glycine 0 CA--C 1.523 0.592 0 C-N-CA 121.323 -0.465 . . . . 0.0 112.591 -176.433 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 47.7 t -82.01 179.92 7.64 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 121.107 0.48 . . . . 0.0 111.629 177.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 19.4 ptmt -54.93 -43.71 73.58 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -177.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.41 -22.64 66.24 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.097 0.475 . . . . 0.0 112.056 -178.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 16.9 t70 . . . . . 0 CA--C 1.545 0.766 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.843 -178.29 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.433 ' CD ' ' H ' ' A' ' 8' ' ' THR . 0.2 OUTLIER . . . . . 0 CA--C 1.545 0.778 0 CA-C-O 120.79 0.329 . . . . 0.0 110.192 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.433 ' H ' ' CD ' ' A' ' 7' ' ' GLU . 77.2 m -70.9 123.52 22.2 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 121.102 0.477 . . . . 0.0 111.734 -179.609 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 23.2 tptp -121.35 101.82 7.88 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 120.873 0.368 . . . . 0.0 110.233 179.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 60.4 mt -83.43 99.89 6.48 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.065 -176.005 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 27.2 m -110.73 154.05 12.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 CA-C-O 121.009 0.433 . . . . 0.0 112.105 -175.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -87.5 14.99 7.16 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 120.787 0.327 . . . . 0.0 111.584 -178.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 58.0 pttt -132.83 143.94 49.88 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -174.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 54.0 m -87.92 -24.94 23.46 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 116.276 -0.42 . . . . 0.0 112.111 -178.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 75.2 mtt180 -108.71 110.19 21.54 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 121.179 0.514 . . . . 0.0 111.87 -179.146 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 50.3 t -114.01 147.21 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.064 -178.152 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.478 ' HA ' ' O ' ' A' ' 30' ' ' VAL . . . -91.18 106.71 18.7 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 121.348 0.594 . . . . 0.0 112.568 -177.361 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.66 ' SG ' HD23 ' A' ' 32' ' ' LEU . 95.9 m . . . . . 0 N--CA 1.472 0.642 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.633 178.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 6.1 tpt180 . . . . . 0 CA--C 1.53 0.196 0 CA-C-O 121.956 0.884 . . . . 0.0 110.504 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.478 ' O ' ' HA ' ' A' ' 17' ' ' ALA . 60.8 t -135.71 103.81 4.12 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 CA-C-N 114.669 -1.15 . . . . 0.0 110.421 -179.238 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 85.1 m95 -94.78 124.07 38.61 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -173.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.66 HD23 ' SG ' ' A' ' 18' ' ' CYS . 11.2 mp -105.45 131.57 52.7 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.019 0.438 . . . . 0.0 110.646 171.579 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 28.9 tp60 -92.88 115.1 27.81 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.836 -177.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.455 HG21 ' HB2' ' A' ' 52' ' ' LEU . 69.0 mt -66.79 118.1 51.49 Favored Pre-proline 0 CA--C 1.538 0.508 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.526 173.222 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.424 ' HG2' ' OG1' ' A' ' 38' ' ' THR . 97.6 Cg_endo -82.19 134.23 7.92 Favored 'Trans proline' 0 CA--C 1.538 0.704 0 C-N-CA 122.424 2.083 . . . . 0.0 113.045 179.445 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -58.4 -23.01 56.0 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 121.433 0.635 . . . . 0.0 110.599 174.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -62.4 -35.3 78.77 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 115.3 -0.864 . . . . 0.0 111.967 179.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.424 ' OG1' ' HG2' ' A' ' 35' ' ' PRO . 31.9 p -108.73 -48.73 3.26 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-O 121.03 0.443 . . . . 0.0 111.326 -179.058 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 101.08 -0.56 54.71 Favored Glycine 0 CA--C 1.527 0.807 0 CA-C-N 116.034 -0.53 . . . . 0.0 112.779 -177.005 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 67.5 p-90 -155.11 166.23 34.23 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 120.891 0.376 . . . . 0.0 111.821 -177.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 10.1 p -144.07 144.35 22.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 CA-C-N 116.528 -0.306 . . . . 0.0 110.912 175.459 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -105.13 141.36 36.81 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 120.834 0.349 . . . . 0.0 111.127 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.45 ' SG ' ' HB3' ' A' ' 46' ' ' CYS . 29.3 p -99.07 116.61 65.11 Favored Pre-proline 0 CA--C 1.539 0.52 0 O-C-N 122.305 -0.247 . . . . 0.0 110.935 175.043 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -70.37 16.93 0.24 Allowed 'Trans proline' 0 CA--C 1.544 0.981 0 C-N-CA 122.768 2.312 . . . . 0.0 113.642 -176.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 35.0 m-85 -117.26 -49.6 2.58 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 120.837 0.351 . . . . 0.0 111.418 176.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.45 ' HB3' ' SG ' ' A' ' 43' ' ' CYS . 13.2 t -105.13 -4.94 21.24 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -175.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 63.81 18.64 11.29 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 112.913 0.709 . . . . 0.0 112.913 177.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.442 ' SG ' ' SG ' ' A' ' 46' ' ' CYS . 34.7 m -79.8 135.27 36.44 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 120.84 0.352 . . . . 0.0 111.262 -179.748 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -99.62 95.42 6.95 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 120.915 0.388 . . . . 0.0 110.522 178.339 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -82.1 105.04 12.88 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.697 0.284 . . . . 0.0 111.263 -173.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 90.4 t -91.47 126.78 44.1 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.293 178.105 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.455 ' HB2' HG21 ' A' ' 34' ' ' ILE . 58.0 tp -73.32 112.53 9.46 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 121.175 0.512 . . . . 0.0 111.125 178.663 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 61.5 tttm -63.34 118.07 7.52 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.343 -178.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 102.25 -3.48 51.13 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 121.37 -0.443 . . . . 0.0 112.853 -174.176 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 35.2 t -90.82 -176.84 4.8 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 120.931 0.396 . . . . 0.0 111.544 178.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 54.9 mttm -72.24 -10.99 60.51 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 120.901 0.381 . . . . 0.0 111.968 -176.251 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -93.88 -0.94 55.45 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 120.967 0.413 . . . . 0.0 110.858 173.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 24.9 t70 . . . . . 0 CA--C 1.549 0.924 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.858 -178.175 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 . . . . . 0 C--O 1.238 0.474 0 CA-C-O 121.953 0.883 . . . . 0.0 111.34 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 96.2 m -126.51 148.9 49.64 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 114.752 -1.113 . . . . 0.0 110.731 -177.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.413 ' HD2' ' CE1' ' A' ' 50' ' ' TYR . 98.7 mttt -120.08 126.95 52.02 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 120.867 0.365 . . . . 0.0 110.735 -176.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.42 HG23 ' HB2' ' A' ' 53' ' ' LYS . 34.9 mm -91.83 98.84 8.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-O 121.023 0.439 . . . . 0.0 110.831 -179.179 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 34.7 m -99.15 158.0 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-O 121.407 0.623 . . . . 0.0 112.501 -174.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -91.72 -34.5 14.61 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.506 177.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -90.45 151.19 21.5 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.311 0.577 . . . . 0.0 112.479 -175.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 43.8 m -78.3 -27.51 47.31 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.331 173.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 71.7 mtp180 -90.42 107.2 19.0 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.618 175.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 55.1 t -113.97 118.59 58.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 120.999 0.428 . . . . 0.0 112.09 -175.423 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.13 103.09 7.85 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 121.057 0.456 . . . . 0.0 110.29 173.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.714 ' SG ' HD12 ' A' ' 32' ' ' LEU . 79.1 m . . . . . 0 N--CA 1.469 0.482 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -172.329 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 7.9 tpt180 . . . . . 0 C--O 1.236 0.387 0 CA-C-O 122.62 1.2 . . . . 0.0 111.981 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 19.9 m -104.7 114.62 44.79 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 CA-C-N 113.658 -1.61 . . . . 0.0 112.265 -177.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 96.7 m95 -101.82 124.42 47.42 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.717 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.714 HD12 ' SG ' ' A' ' 18' ' ' CYS . 9.3 mp -117.49 134.1 55.23 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 121.011 0.434 . . . . 0.0 110.945 174.248 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -93.73 116.42 28.9 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.263 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.493 HG12 HG13 ' A' ' 41' ' ' VAL . 77.7 mt -61.73 123.0 75.24 Favored Pre-proline 0 CA--C 1.542 0.637 0 CA-C-O 120.891 0.377 . . . . 0.0 111.849 179.18 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.558 ' HG2' ' OG1' ' A' ' 38' ' ' THR . 76.7 Cg_endo -81.23 140.16 12.13 Favored 'Trans proline' 0 CA--C 1.544 0.983 0 C-N-CA 122.803 2.335 . . . . 0.0 112.818 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -70.64 -28.92 65.19 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 121.01 0.433 . . . . 0.0 111.746 -179.34 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -61.61 -25.01 67.08 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 179.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.558 ' OG1' ' HG2' ' A' ' 35' ' ' PRO . 47.2 p -109.84 -54.0 2.61 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-O 121.286 0.565 . . . . 0.0 111.197 176.048 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 101.05 1.34 54.78 Favored Glycine 0 CA--C 1.524 0.648 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.003 -175.247 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 54.5 p-90 -152.87 162.92 40.7 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 121.077 0.465 . . . . 0.0 111.681 -176.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.493 HG13 HG12 ' A' ' 34' ' ' ILE . 8.4 p -142.67 118.71 5.53 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 CA-C-O 120.925 0.393 . . . . 0.0 110.773 173.707 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.521 ' HA ' ' HA ' ' A' ' 49' ' ' LYS . 9.4 pt-20 -100.0 106.61 18.41 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.529 0.68 . . . . 0.0 110.112 175.701 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.833 ' HB3' ' SG ' ' A' ' 46' ' ' CYS . 44.0 t -75.83 130.91 77.51 Favored Pre-proline 0 N--CA 1.466 0.371 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -167.13 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -69.58 -15.15 37.61 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 122.571 2.181 . . . . 0.0 112.569 175.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.514 ' HD2' ' SG ' ' A' ' 43' ' ' CYS . 90.1 m-85 -85.24 -43.2 13.98 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.601 179.542 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.833 ' SG ' ' HB3' ' A' ' 43' ' ' CYS . 27.1 p -97.04 -17.77 19.81 Favored 'General case' 0 N--CA 1.478 0.925 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 -178.695 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 10.1 t70 67.96 20.06 9.25 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-O 121.123 0.487 . . . . 0.0 111.147 179.19 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 53.6 t -121.43 154.73 36.16 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 120.916 0.389 . . . . 0.0 111.616 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.521 ' HA ' ' HA ' ' A' ' 42' ' ' GLU . 17.9 ttmm -98.51 134.45 41.45 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.385 -177.37 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.413 ' CE1' ' HD2' ' A' ' 9' ' ' LYS . 72.3 m-85 -115.08 113.29 23.83 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 122.17 -0.331 . . . . 0.0 111.244 178.358 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.403 HG13 ' HB3' ' A' ' 57' ' ' ALA . 49.7 t -97.51 128.44 48.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 CA-C-O 121.169 0.509 . . . . 0.0 111.737 175.703 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.464 ' HB2' HD11 ' A' ' 34' ' ' ILE . 51.6 tp -78.6 114.02 17.15 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.029 178.024 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.42 ' HB2' HG23 ' A' ' 10' ' ' ILE . 33.9 ttpt -63.48 121.65 14.35 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.329 -179.188 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 92.1 13.57 57.39 Favored Glycine 0 CA--C 1.531 1.047 0 CA-C-N 116.14 -0.482 . . . . 0.0 113.751 -177.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 34.5 p -107.29 -166.65 1.18 Allowed 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 117.296 0.548 . . . . 0.0 111.905 -178.499 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -63.31 -20.29 65.36 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 115.927 -0.578 . . . . 0.0 111.777 177.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.403 ' HB3' HG13 ' A' ' 51' ' ' VAL . . . -94.22 -1.2 54.46 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 179.526 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.6 t70 . . . . . 0 CA--C 1.543 0.694 0 CA-C-N 116.639 -0.255 . . . . 0.0 110.756 -176.686 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 . . . . . 0 N--CA 1.483 1.208 0 CA-C-O 121.582 0.706 . . . . 0.0 112.523 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 51.7 m -104.51 145.74 29.86 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 115.52 -0.764 . . . . 0.0 112.372 -171.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -129.14 114.19 16.02 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.262 176.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 55.0 mt -84.76 94.93 3.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 121.306 0.574 . . . . 0.0 110.761 -179.262 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 29.9 m -104.8 149.11 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-N 115.932 -0.576 . . . . 0.0 112.188 -174.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -75.67 -19.77 58.92 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.347 -177.204 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.438 ' NZ ' ' O ' ' A' ' 15' ' ' ARG . 13.2 ptmm? -112.08 143.04 43.75 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 116.204 -0.453 . . . . 0.0 112.171 -173.317 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.425 ' HB2' ' NE2' ' A' ' 33' ' ' GLN . 37.6 p -79.11 -38.58 35.85 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 112.724 0.639 . . . . 0.0 112.724 -178.609 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.438 ' O ' ' NZ ' ' A' ' 13' ' ' LYS . 8.9 mmt180 -78.69 127.72 32.48 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.362 0.601 . . . . 0.0 111.953 -178.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 95.3 t -143.21 124.18 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.765 -178.409 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.52 112.11 15.25 Favored 'General case' 0 CA--C 1.537 0.463 0 O-C-N 122.214 -0.303 . . . . 0.0 110.817 177.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 48.2 t . . . . . 0 N--CA 1.471 0.608 0 N-CA-C 112.516 0.561 . . . . 0.0 112.516 -178.825 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 10.1 tpt180 . . . . . 0 N--CA 1.464 0.227 0 CA-C-O 121.979 0.895 . . . . 0.0 110.831 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 89.9 t -137.78 117.77 15.77 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 CA-C-N 114.526 -1.216 . . . . 0.0 110.178 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 81.9 m95 -105.66 119.95 40.43 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 121.348 0.594 . . . . 0.0 112.254 -174.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.403 ' N ' HD13 ' A' ' 32' ' ' LEU . 6.9 mp -81.09 152.35 27.88 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.679 173.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.425 ' NE2' ' HB2' ' A' ' 14' ' ' SER . 25.0 tp60 -120.77 111.93 18.2 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.882 -178.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.478 HG21 ' HB2' ' A' ' 52' ' ' LEU . 61.0 mt -77.23 109.7 10.03 Favored Pre-proline 0 CA--C 1.541 0.608 0 CA-C-O 120.57 0.224 . . . . 0.0 110.397 173.431 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -86.47 156.24 9.27 Favored 'Trans proline' 0 CA--C 1.536 0.622 0 C-N-CA 122.793 2.329 . . . . 0.0 113.391 -176.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -73.79 -18.89 60.91 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.042 0.449 . . . . 0.0 110.271 174.372 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -58.02 -56.22 24.77 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-O 121.275 0.56 . . . . 0.0 110.927 174.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 44.6 p -90.48 -50.32 6.01 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.748 -179.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 99.48 1.55 56.63 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-N 116.141 -0.481 . . . . 0.0 112.415 -174.353 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.519 ' HB3' HG23 ' A' ' 51' ' ' VAL . 30.1 p-90 -158.55 170.86 21.25 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 122.656 0.382 . . . . 0.0 111.827 -177.036 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 11.2 p -141.93 144.92 24.79 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 CA-C-O 120.882 0.372 . . . . 0.0 111.039 175.289 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -104.38 137.94 41.53 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 120.875 0.369 . . . . 0.0 111.132 -178.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.666 ' SG ' ' HE2' ' A' ' 50' ' ' TYR . 68.6 m -95.13 109.59 45.48 Favored Pre-proline 0 N--CA 1.472 0.66 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.617 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -64.97 -12.03 32.6 Favored 'Trans proline' 0 CA--C 1.543 0.967 0 C-N-CA 122.495 2.13 . . . . 0.0 113.585 -178.144 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 -110.93 -62.63 1.51 Allowed 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 120.827 0.346 . . . . 0.0 111.716 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.597 ' SG ' ' SG ' ' A' ' 48' ' ' CYS . 42.8 t -73.08 -14.76 61.46 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -178.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 16.0 t70 71.96 -4.85 1.85 Allowed 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 123.342 0.657 . . . . 0.0 112.69 177.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.597 ' SG ' ' SG ' ' A' ' 46' ' ' CYS . 81.2 m -65.83 147.65 53.03 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.087 0.47 . . . . 0.0 112.198 178.035 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 59.8 tttm -118.45 104.31 10.58 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.419 178.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.666 ' HE2' ' SG ' ' A' ' 43' ' ' CYS . 97.3 m-85 -89.26 113.92 25.22 Favored 'General case' 0 N--CA 1.468 0.444 0 O-C-N 122.057 -0.402 . . . . 0.0 111.411 -174.109 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.519 HG23 ' HB3' ' A' ' 40' ' ' TRP . 80.1 t -95.69 136.56 26.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 CA-C-O 120.777 0.322 . . . . 0.0 111.435 176.014 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.517 ' HB3' ' HB3' ' A' ' 55' ' ' SER . 48.7 tp -71.97 120.03 16.99 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 121.29 0.567 . . . . 0.0 111.195 178.46 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -65.78 116.88 7.43 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.518 -179.003 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 91.27 14.97 56.63 Favored Glycine 0 CA--C 1.527 0.784 0 CA-C-N 116.195 -0.457 . . . . 0.0 113.054 -176.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.517 ' HB3' ' HB3' ' A' ' 52' ' ' LEU . 76.9 p -91.09 -177.93 5.04 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 121.379 0.609 . . . . 0.0 111.916 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -57.42 -37.79 73.31 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.771 173.152 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -78.69 -30.78 46.25 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -176.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 24.8 t70 . . . . . 0 CA--C 1.537 0.465 0 CA-C-O 120.936 0.398 . . . . 0.0 111.662 179.177 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 . . . . . 0 CA--C 1.539 0.55 0 CA-C-O 121.351 0.596 . . . . 0.0 111.956 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 67.9 p -90.38 142.99 27.18 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.126 -179.028 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.407 ' HD3' ' CD1' ' A' ' 50' ' ' TYR . 57.4 tttp -116.56 97.92 6.27 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 176.282 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.52 HG22 ' HB2' ' A' ' 53' ' ' LYS . 2.0 mp -77.03 124.0 34.63 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-O 121.153 0.502 . . . . 0.0 112.266 -172.846 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 30.2 m -136.35 162.4 35.7 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.003 177.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -102.17 -16.41 16.37 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 111.76 0.282 . . . . 0.0 111.76 176.569 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -106.81 142.31 36.64 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 121.125 0.488 . . . . 0.0 111.3 177.28 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 74.6 m -76.17 -6.47 51.44 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 -173.126 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 90.2 mtt180 -111.61 120.13 41.05 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 121.61 -0.681 . . . . 0.0 112.081 177.085 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 37.4 t -134.71 140.95 44.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.996 179.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -93.89 127.92 39.9 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 116.729 -0.214 . . . . 0.0 111.142 178.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.562 ' SG ' ' HB2' ' A' ' 47' ' ' ASP . 41.4 t . . . . . 0 N--CA 1.471 0.602 0 CA-C-O 120.873 0.368 . . . . 0.0 110.926 177.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 3.8 tmt_? . . . . . 0 CA--C 1.529 0.156 0 CA-C-O 121.85 0.833 . . . . 0.0 110.584 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.44 HG22 ' HB3' ' A' ' 18' ' ' CYS . 14.5 m -136.7 120.03 22.28 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.257 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.838 173.004 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 48.1 m95 -99.43 112.61 24.77 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.356 -178.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.422 ' N ' HD12 ' A' ' 32' ' ' LEU . 6.1 mp -90.26 132.1 35.71 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 121.118 0.485 . . . . 0.0 111.61 -179.392 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 27.3 tp60 -93.68 106.74 18.69 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.858 176.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.509 HG12 HG13 ' A' ' 41' ' ' VAL . 97.8 mt -60.73 125.35 82.68 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.026 176.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.545 ' HG2' ' OG1' ' A' ' 38' ' ' THR . 84.5 Cg_endo -76.96 105.34 2.06 Favored 'Trans proline' 0 CA--C 1.535 0.566 0 C-N-CA 122.261 1.974 . . . . 0.0 111.753 177.533 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -57.93 -19.13 27.81 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 121.299 0.571 . . . . 0.0 110.366 178.205 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -54.66 -43.53 72.47 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.503 172.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.545 ' OG1' ' HG2' ' A' ' 35' ' ' PRO . 44.1 p -97.49 -57.73 2.18 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.722 177.536 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 120.55 0.99 12.29 Favored Glycine 0 CA--C 1.529 0.926 0 CA-C-N 115.849 -0.614 . . . . 0.0 112.627 -177.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 63.9 p-90 -162.12 160.62 27.5 Favored 'General case' 0 N--CA 1.471 0.607 0 O-C-N 122.709 -0.289 . . . . 0.0 111.396 -176.248 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.509 HG13 HG12 ' A' ' 34' ' ' ILE . 11.6 p -148.4 129.91 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 CA-C-O 120.713 0.292 . . . . 0.0 110.807 173.75 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.409 ' HA ' ' HA ' ' A' ' 49' ' ' LYS . 9.6 pt-20 -90.89 140.02 30.21 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 120.913 0.387 . . . . 0.0 111.211 178.042 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 44.5 t -70.35 126.37 92.3 Favored Pre-proline 0 N--CA 1.47 0.569 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.774 -176.596 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.32 -26.16 29.92 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 122.785 2.323 . . . . 0.0 112.971 -179.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -78.36 -92.92 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 121.123 0.487 . . . . 0.0 111.016 177.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 48.0 t -172.41 81.38 0.05 Allowed 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.039 0.447 . . . . 0.0 110.305 -179.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.562 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 13.3 t70 -136.8 -95.72 0.22 Allowed 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.393 -178.06 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 90.7 m -153.62 -170.34 3.56 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 120.92 0.39 . . . . 0.0 110.674 177.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.409 ' HA ' ' HA ' ' A' ' 42' ' ' GLU . 34.8 ttpt -111.62 115.6 29.4 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 120.899 0.381 . . . . 0.0 110.632 175.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.407 ' CD1' ' HD3' ' A' ' 9' ' ' LYS . 43.4 m-85 -82.69 114.92 21.38 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.18 -171.218 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 80.9 t -109.38 123.74 65.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-O 121.314 0.578 . . . . 0.0 111.843 -176.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 46.0 tp -81.0 107.95 14.26 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.733 178.405 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.52 ' HB2' HG22 ' A' ' 10' ' ' ILE . 28.6 ttpp -65.15 147.45 53.45 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 120.907 0.384 . . . . 0.0 111.293 -179.593 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 85.95 7.89 80.07 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.446 -174.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 14.8 t -109.78 173.71 6.2 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 120.913 0.387 . . . . 0.0 111.499 179.143 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 23.5 pttm -62.81 -18.1 62.24 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-O 120.818 0.342 . . . . 0.0 111.241 175.542 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -74.0 -24.53 59.6 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.377 0.608 . . . . 0.0 110.804 174.296 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.5 t0 . . . . . 0 CA--C 1.538 0.514 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.436 175.855 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.544 0.736 0 CA-C-O 121.232 0.539 . . . . 0.0 111.246 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 87.4 m -100.02 124.57 45.53 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -172.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 44.7 mttp -122.59 109.03 13.8 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.877 177.299 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.565 HG21 ' HB2' ' A' ' 53' ' ' LYS . 15.7 mt -82.99 79.87 1.44 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-O 121.191 0.52 . . . . 0.0 109.706 177.477 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 4.7 t -92.45 148.69 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 CA-C-O 121.036 0.445 . . . . 0.0 111.571 -172.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -78.55 -20.76 49.91 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 120.847 0.356 . . . . 0.0 111.343 -175.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 7.0 ptpp? -108.92 148.62 30.4 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 120.895 0.379 . . . . 0.0 111.522 177.462 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.412 ' HA ' HD12 ' A' ' 34' ' ' ILE . 67.4 p -82.36 -44.01 16.7 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 112.894 0.701 . . . . 0.0 112.894 -177.198 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 49.2 mtt180 -78.59 90.54 4.54 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 121.417 0.627 . . . . 0.0 111.627 -176.052 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 47.8 t -110.53 120.65 61.83 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.29 -179.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -96.11 158.27 15.52 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 121.016 0.436 . . . . 0.0 111.867 179.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 51.4 t . . . . . 0 N--CA 1.467 0.385 0 CA-C-O 120.946 0.403 . . . . 0.0 111.401 178.247 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.408 ' HA ' ' HD3' ' A' ' 29' ' ' ARG . 3.4 tpp180 . . . . . 0 N--CA 1.441 -0.896 0 CA-C-O 121.879 0.847 . . . . 0.0 112.19 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 31.4 m -98.35 124.75 51.64 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 CA-C-N 114.6 -1.182 . . . . 0.0 111.563 178.382 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 50.4 m95 -104.68 112.82 26.05 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 120.898 0.38 . . . . 0.0 111.302 178.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.445 ' N ' HD13 ' A' ' 32' ' ' LEU . 5.8 mp -98.87 127.99 44.94 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 121.254 0.549 . . . . 0.0 112.083 -177.399 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 22.8 tp60 -104.11 108.42 19.77 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.738 176.186 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.528 HG21 ' HB2' ' A' ' 52' ' ' LEU . 80.0 mt -67.61 121.36 78.86 Favored Pre-proline 0 CA--C 1.538 0.482 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.846 176.415 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.649 ' HG2' HG23 ' A' ' 38' ' ' THR . 72.8 Cg_endo -76.8 103.67 1.79 Allowed 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 122.147 1.898 . . . . 0.0 112.116 178.329 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -48.81 -26.67 2.52 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.068 0.547 . . . . 0.0 112.186 179.017 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -51.19 -46.19 62.07 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-N 116.144 -0.48 . . . . 0.0 112.049 175.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.649 HG23 ' HG2' ' A' ' 35' ' ' PRO . 14.9 t -104.7 -32.92 8.66 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 111.871 0.323 . . . . 0.0 111.871 -179.562 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 103.98 2.67 45.61 Favored Glycine 0 CA--C 1.533 1.217 0 N-CA-C 114.92 0.728 . . . . 0.0 114.92 174.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.41 ' H ' HG22 ' A' ' 38' ' ' THR . 58.2 p-90 -156.52 163.45 39.38 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 117.942 0.871 . . . . 0.0 112.09 -175.423 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.501 HG13 HG12 ' A' ' 34' ' ' ILE . 6.3 p -150.21 165.88 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 N-CA-C 109.873 -0.418 . . . . 0.0 109.873 174.645 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -142.6 150.82 40.82 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.256 0.551 . . . . 0.0 111.648 176.139 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.634 ' SG ' ' N ' ' A' ' 47' ' ' ASP . 28.6 p -69.99 141.37 89.33 Favored Pre-proline 0 N--CA 1.468 0.468 0 CA-C-N 115.692 -0.686 . . . . 0.0 112.663 -172.747 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 43' ' ' CYS . 18.3 Cg_exo -67.55 -27.88 38.72 Favored 'Trans proline' 0 CA--C 1.542 0.894 0 C-N-CA 122.708 2.272 . . . . 0.0 113.25 177.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -94.51 -83.62 0.34 Allowed 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 -178.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 49.5 t -168.14 18.47 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.953 0 CA-C-O 120.797 0.332 . . . . 0.0 111.874 -177.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.634 ' N ' ' SG ' ' A' ' 43' ' ' CYS . 2.1 m-20 -66.6 -79.17 0.05 OUTLIER 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 116.292 -0.413 . . . . 0.0 112.075 -174.431 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.445 ' SG ' ' O ' ' A' ' 47' ' ' ASP . 72.0 m -161.62 171.25 18.31 Favored 'General case' 0 N--CA 1.479 1.011 0 CA-C-O 121.516 0.674 . . . . 0.0 112.607 -177.743 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 36.1 tttp -110.65 120.29 41.94 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.692 174.416 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -108.67 115.34 29.92 Favored 'General case' 0 N--CA 1.469 0.502 0 O-C-N 121.871 -0.518 . . . . 0.0 112.23 -170.167 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 94.9 t -96.42 137.9 23.07 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.09 176.26 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.528 ' HB2' HG21 ' A' ' 34' ' ' ILE . 36.7 tp -84.35 104.77 14.65 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 121.514 0.673 . . . . 0.0 111.92 -178.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.565 ' HB2' HG21 ' A' ' 10' ' ' ILE . 47.3 tttm -62.2 128.19 34.95 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.75 178.657 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 93.33 -5.48 74.66 Favored Glycine 0 CA--C 1.529 0.943 0 CA-C-N 116.034 -0.53 . . . . 0.0 113.409 -177.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 44.7 t -95.46 -175.61 3.52 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 122.468 -0.431 . . . . 0.0 111.441 178.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 15.3 ptmm? -62.27 -19.97 63.79 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 120.872 0.368 . . . . 0.0 111.489 178.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -82.31 -10.79 58.97 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 112.027 0.38 . . . . 0.0 112.027 177.302 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.7 t70 . . . . . 0 CA--C 1.54 0.568 0 CA-C-O 121.674 0.749 . . . . 0.0 110.376 177.915 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 . . . . . 0 CA--C 1.543 0.701 0 CA-C-O 120.866 0.365 . . . . 0.0 111.559 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 69.1 m -125.03 142.02 51.75 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 122.447 0.299 . . . . 0.0 111.388 -178.266 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 25.1 mtmm -137.01 126.91 25.76 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 120.932 0.396 . . . . 0.0 111.25 177.068 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.492 ' N ' HD13 ' A' ' 10' ' ' ILE . 2.6 mp -92.67 110.78 23.46 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.494 178.578 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 33.7 m -104.35 164.31 3.78 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-O 121.228 0.537 . . . . 0.0 111.802 -177.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -96.38 -23.62 16.54 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 116.16 -0.473 . . . . 0.0 112.066 -177.218 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -120.27 151.17 39.56 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-O 120.941 0.4 . . . . 0.0 111.475 -177.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 19.9 m -68.97 -26.63 65.14 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 113.607 0.966 . . . . 0.0 113.607 -171.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 4.5 tpt180 -101.77 119.89 39.5 Favored 'General case' 0 N--CA 1.473 0.688 0 O-C-N 121.494 -0.754 . . . . 0.0 111.605 -178.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 41.0 t -129.69 141.89 45.31 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 CA-C-O 120.813 0.339 . . . . 0.0 111.322 -178.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -92.39 116.1 28.68 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.875 0.369 . . . . 0.0 111.356 177.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.49 ' HB3' HG23 ' A' ' 30' ' ' VAL . 40.1 t . . . . . 0 N--CA 1.473 0.681 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.282 179.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.431 ' HD3' ' HA ' ' A' ' 29' ' ' ARG . 12.3 tpp180 . . . . . 0 N--CA 1.439 -0.993 0 CA-C-O 122.236 1.017 . . . . 0.0 112.733 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.49 HG23 ' HB3' ' A' ' 18' ' ' CYS . 17.4 m -119.08 116.38 50.81 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 CA-C-N 114.294 -1.321 . . . . 0.0 111.242 176.151 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 89.0 m95 -96.65 109.63 22.22 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.531 -178.633 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.7 mp -90.13 154.89 19.43 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 121.149 0.5 . . . . 0.0 111.276 177.219 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.444 HE21 ' HA ' ' A' ' 33' ' ' GLN . 0.0 OUTLIER -122.73 129.13 51.41 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.002 0.429 . . . . 0.0 111.368 178.754 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.495 HG12 HG13 ' A' ' 41' ' ' VAL . 55.0 mt -87.09 117.73 69.02 Favored Pre-proline 0 CA--C 1.537 0.447 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.146 177.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.501 ' HG2' ' OG1' ' A' ' 38' ' ' THR . 82.5 Cg_endo -79.76 123.34 5.24 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 122.179 1.919 . . . . 0.0 111.832 177.707 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.486 ' O ' ' HB2' ' A' ' 56' ' ' LYS . 13.0 pt-20 -56.23 -23.79 38.07 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 111.923 0.342 . . . . 0.0 111.923 -177.355 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -66.93 -35.62 80.39 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 178.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.501 ' OG1' ' HG2' ' A' ' 35' ' ' PRO . 39.9 p -92.29 -50.89 5.43 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 120.924 0.392 . . . . 0.0 110.775 178.723 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.496 ' HA2' ' OG ' ' A' ' 55' ' ' SER . . . 103.98 -0.03 44.91 Favored Glycine 0 CA--C 1.524 0.596 0 CA-C-N 116.073 -0.512 . . . . 0.0 112.841 -178.761 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.406 ' HA ' ' O ' ' A' ' 50' ' ' TYR . 67.7 p-90 -162.14 162.54 28.54 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 120.716 0.293 . . . . 0.0 111.327 -175.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.495 HG13 HG12 ' A' ' 34' ' ' ILE . 9.7 p -142.27 141.74 28.13 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-O 121.033 0.444 . . . . 0.0 110.73 173.479 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.464 ' O ' ' HD3' ' A' ' 44' ' ' PRO . 9.0 pt-20 -100.74 141.27 33.85 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 111.849 0.314 . . . . 0.0 111.849 -177.474 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.534 ' SG ' ' HB3' ' A' ' 47' ' ' ASP . 29.9 p -98.4 99.91 8.21 Favored Pre-proline 0 CA--C 1.54 0.56 0 CA-C-O 120.64 0.257 . . . . 0.0 110.419 170.449 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.464 ' HD3' ' O ' ' A' ' 42' ' ' GLU . 23.2 Cg_exo -65.77 -3.92 8.96 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 122.735 2.29 . . . . 0.0 113.13 -178.328 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -82.83 -76.15 0.28 Allowed 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 116.592 -0.276 . . . . 0.0 110.589 179.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 24.8 p 173.86 92.33 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.358 177.205 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.534 ' HB3' ' SG ' ' A' ' 43' ' ' CYS . 13.5 t70 -161.02 -83.03 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 116.717 -0.219 . . . . 0.0 110.969 173.538 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.502 ' N ' ' SG ' ' A' ' 43' ' ' CYS . 81.9 m -160.76 178.27 9.61 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 122.144 0.973 . . . . 0.0 113.135 -177.892 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 19.3 ttmm -102.48 113.58 27.05 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 114.484 -1.235 . . . . 0.0 108.754 168.384 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.449 ' HB2' HG13 ' A' ' 41' ' ' VAL . 67.7 m-85 -85.85 105.71 16.55 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 111.847 0.314 . . . . 0.0 111.847 -173.569 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 67.0 t -88.22 133.05 31.73 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 CA-C-O 120.767 0.317 . . . . 0.0 111.038 174.328 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.459 ' HB2' HG21 ' A' ' 34' ' ' ILE . 53.2 tp -98.77 131.75 44.66 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 121.359 0.6 . . . . 0.0 112.42 -175.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -68.05 141.25 56.23 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 115.811 -0.632 . . . . 0.0 111.144 176.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 70.8 10.64 68.06 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 121.271 -0.49 . . . . 0.0 113.68 179.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.496 ' OG ' ' HA2' ' A' ' 39' ' ' GLY . 29.4 t -97.57 -171.08 2.11 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 122.495 -0.415 . . . . 0.0 111.535 -179.356 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.486 ' HB2' ' O ' ' A' ' 36' ' ' GLU . 47.3 tptt -53.32 -43.97 68.05 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 120.944 0.402 . . . . 0.0 111.928 -177.744 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -82.26 2.39 32.17 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -175.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.0 t70 . . . . . 0 N--CA 1.471 0.58 0 CA-C-O 120.924 0.392 . . . . 0.0 111.659 -178.377 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.472 0.634 0 CA-C-O 121.506 0.669 . . . . 0.0 111.854 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 54.2 m -89.86 111.37 22.39 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.602 177.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 46.8 tptt -100.54 109.3 21.39 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.04 -172.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 58.3 mt -79.04 94.22 1.73 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 CA-C-O 121.141 0.496 . . . . 0.0 110.602 179.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.418 HG12 HG23 ' A' ' 16' ' ' VAL . 3.5 t -97.89 156.84 3.55 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 CA-C-O 121.127 0.489 . . . . 0.0 111.62 -175.763 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -96.43 -4.31 41.96 Favored 'General case' 0 CA--C 1.548 0.873 0 CA-C-O 121.01 0.433 . . . . 0.0 111.909 -178.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 50.9 mtmt -137.35 153.08 50.29 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 122.101 -0.374 . . . . 0.0 111.42 -176.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 77.7 p -79.06 -40.15 32.01 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.063 0.459 . . . . 0.0 111.265 177.438 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 78.2 mtm180 -75.35 94.82 3.1 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.96 176.294 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.483 HG12 ' CD1' ' A' ' 50' ' ' TYR . 47.4 t -111.35 137.86 42.17 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.34 -177.627 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -97.96 118.46 34.59 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 121.069 0.461 . . . . 0.0 111.755 -179.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 10.0 t . . . . . 0 N--CA 1.467 0.422 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.061 174.762 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.4 ' NE ' ' HE1' ' A' ' 31' ' ' TRP . 0.8 OUTLIER . . . . . 0 N--CA 1.446 -0.655 0 CA-C-O 122.769 1.271 . . . . 0.0 111.779 . . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 25.7 m -134.32 141.09 44.55 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 113.855 -1.521 . . . . 0.0 109.774 169.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . 0.4 ' HE1' ' NE ' ' A' ' 29' ' ' ARG . 75.7 m95 -107.25 123.55 48.46 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -171.433 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.471 ' N ' HD13 ' A' ' 32' ' ' LEU . 5.1 mp -103.44 158.65 16.2 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.615 178.052 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -123.77 109.53 13.78 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.935 0.398 . . . . 0.0 111.436 -179.002 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.471 HG12 HG13 ' A' ' 41' ' ' VAL . 64.6 mt -70.47 115.06 31.17 Favored Pre-proline 0 CA--C 1.542 0.656 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.47 178.439 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.419 ' HG2' ' OG1' ' A' ' 38' ' ' THR . 90.4 Cg_endo -80.11 145.47 17.38 Favored 'Trans proline' 0 CA--C 1.54 0.825 0 C-N-CA 122.517 2.145 . . . . 0.0 112.753 179.573 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 20.9 mp0 -62.95 -29.51 70.86 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 121.105 0.479 . . . . 0.0 111.035 179.437 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -58.43 -50.28 74.25 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.497 -0.774 . . . . 0.0 112.155 -178.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.419 ' OG1' ' HG2' ' A' ' 35' ' ' PRO . 50.2 p -90.34 -49.16 6.69 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.077 0.465 . . . . 0.0 111.324 -178.267 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 98.24 0.95 58.22 Favored Glycine 0 CA--C 1.523 0.562 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.399 -176.292 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.526 ' HB3' HG23 ' A' ' 51' ' ' VAL . 68.2 p-90 -156.79 164.13 38.44 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 121.148 0.499 . . . . 0.0 112.151 -176.605 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.471 HG13 HG12 ' A' ' 34' ' ' ILE . 14.5 p -142.85 137.09 27.15 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.676 174.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -98.83 148.03 24.33 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.155 0.502 . . . . 0.0 112.139 -177.319 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.66 ' SG ' ' HE2' ' A' ' 50' ' ' TYR . 74.0 m -98.25 119.31 62.11 Favored Pre-proline 0 CA--C 1.538 0.519 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.578 171.256 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -73.13 22.44 0.32 Allowed 'Trans proline' 0 CA--C 1.541 0.861 0 C-N-CA 122.902 2.402 . . . . 0.0 114.036 -173.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -114.94 -88.7 0.57 Allowed 'General case' 0 CA--C 1.538 0.517 0 O-C-N 122.084 -0.385 . . . . 0.0 111.073 177.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 57.5 m -160.57 18.98 0.14 Allowed 'General case' 0 N--CA 1.477 0.913 0 CA-C-O 120.856 0.36 . . . . 0.0 111.331 -177.161 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.414 ' O ' ' SG ' ' A' ' 48' ' ' CYS . 2.1 m-20 -81.74 -93.5 0.05 Allowed 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 112.276 0.473 . . . . 0.0 112.276 -173.34 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.414 ' SG ' ' O ' ' A' ' 47' ' ' ASP . 72.3 m -161.38 173.33 15.09 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.553 0.692 . . . . 0.0 112.043 -176.539 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.7 ttmp? -101.47 104.77 15.71 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.269 169.041 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.66 ' HE2' ' SG ' ' A' ' 43' ' ' CYS . 95.4 m-85 -81.85 103.16 11.32 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.926 0.393 . . . . 0.0 111.767 -173.745 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.526 HG23 ' HB3' ' A' ' 40' ' ' TRP . 88.0 t -94.28 123.19 46.29 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.928 178.712 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 51.4 tp -77.88 120.41 22.72 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 116.585 -0.28 . . . . 0.0 110.978 176.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 46.8 tttp -65.71 146.06 55.25 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 121.149 0.5 . . . . 0.0 111.954 -178.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 85.11 17.45 62.86 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 121.117 -0.563 . . . . 0.0 112.549 -175.452 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.5 m -118.36 172.14 7.66 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 122.481 0.312 . . . . 0.0 110.886 -179.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -56.31 -30.08 62.09 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -178.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -75.96 -26.91 57.27 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 121.006 0.431 . . . . 0.0 112.111 179.079 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 34.3 t70 . . . . . 0 CA--C 1.543 0.686 0 CA-C-O 121.549 0.69 . . . . 0.0 110.571 179.366 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 . . . . . 0 N--CA 1.472 0.632 0 CA-C-O 121.227 0.537 . . . . 0.0 112.069 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 69.5 m -89.18 119.65 29.86 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.292 174.141 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 55.9 tptt -109.82 106.91 16.69 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 120.656 0.265 . . . . 0.0 111.236 -173.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 56.2 mt -86.09 100.95 9.79 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-O 121.104 0.478 . . . . 0.0 111.351 -179.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 34.5 m -103.94 162.57 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 CA-C-O 120.951 0.405 . . . . 0.0 111.35 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -92.93 -32.46 14.55 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-O 120.887 0.375 . . . . 0.0 111.618 -178.317 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -108.16 143.31 37.11 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 120.729 0.299 . . . . 0.0 111.643 -179.277 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 41.2 t -63.01 -37.24 86.38 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 112.824 0.676 . . . . 0.0 112.824 -176.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 52.5 mtt85 -74.18 105.49 5.41 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.201 0.524 . . . . 0.0 111.892 178.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 48.0 t -100.95 106.17 18.97 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.966 176.592 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -80.82 101.03 9.12 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 120.936 0.398 . . . . 0.0 111.266 178.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 52.0 t . . . . . 0 CA--C 1.539 0.539 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -178.737 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.458 ' HD3' ' HA ' ' A' ' 29' ' ' ARG . 0.1 OUTLIER . . . . . 0 N--CA 1.441 -0.89 0 CA-C-O 122.24 1.019 . . . . 0.0 110.665 . . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 55.8 t -93.94 105.07 16.45 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 CA-C-N 114.134 -1.394 . . . . 0.0 111.17 -179.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 56.7 m95 -92.22 111.52 23.11 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.367 178.609 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.416 ' N ' HD11 ' A' ' 32' ' ' LEU . 5.6 mp -91.37 134.03 34.95 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 120.753 0.311 . . . . 0.0 111.003 177.612 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 14.6 tp60 -104.88 106.91 17.61 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 177.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.535 HG21 ' HB2' ' A' ' 52' ' ' LEU . 75.6 mt -63.46 117.42 34.16 Favored Pre-proline 0 CA--C 1.54 0.566 0 CA-C-O 120.602 0.239 . . . . 0.0 111.408 -179.702 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.537 ' HG2' ' OG1' ' A' ' 38' ' ' THR . 90.1 Cg_endo -80.1 127.78 7.01 Favored 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 122.611 2.207 . . . . 0.0 113.005 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -61.31 -21.94 64.44 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 120.981 0.42 . . . . 0.0 111.675 179.275 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -64.04 -35.12 79.68 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.884 178.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.537 ' OG1' ' HG2' ' A' ' 35' ' ' PRO . 36.0 p -106.04 -52.42 2.81 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-O 121.029 0.442 . . . . 0.0 111.605 -178.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 106.56 0.64 37.25 Favored Glycine 0 CA--C 1.526 0.762 0 CA-C-N 116.189 -0.46 . . . . 0.0 112.643 -176.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 67.7 p-90 -155.81 162.79 40.42 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 120.916 0.388 . . . . 0.0 111.595 -178.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.512 HG13 HG12 ' A' ' 34' ' ' ILE . 12.3 p -151.81 127.85 1.84 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.452 172.647 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.408 ' HA ' ' HA ' ' A' ' 49' ' ' LYS . 12.6 pt-20 -100.89 150.21 23.08 Favored 'General case' 0 CA--C 1.536 0.405 0 O-C-N 121.925 -0.485 . . . . 0.0 111.324 -179.357 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 42.6 t -97.16 107.41 37.94 Favored Pre-proline 0 N--CA 1.468 0.429 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.813 -177.417 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.4 ' HD3' ' O ' ' A' ' 42' ' ' GLU . 41.4 Cg_exo -58.55 -14.66 21.97 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 122.364 2.043 . . . . 0.0 113.035 177.467 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -105.03 -0.3 26.92 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.807 -178.386 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 42.5 t -143.9 -2.2 0.94 Allowed 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 112.416 0.525 . . . . 0.0 112.416 -179.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 61.7 m-20 70.95 -41.17 0.5 Allowed 'General case' 0 CA--C 1.548 0.876 0 N-CA-C 114.026 1.121 . . . . 0.0 114.026 178.125 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 77.3 m -58.69 145.68 39.2 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 -172.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.408 ' HA ' ' HA ' ' A' ' 42' ' ' GLU . 20.4 ttmm -107.46 123.25 48.13 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.989 -178.205 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 55.1 m-85 -100.53 114.61 28.39 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 -174.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.407 HG13 ' HB3' ' A' ' 57' ' ' ALA . 93.2 t -99.15 145.24 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 CA-C-O 120.819 0.342 . . . . 0.0 111.467 176.871 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.535 ' HB2' HG21 ' A' ' 34' ' ' ILE . 54.5 tp -94.1 126.09 39.12 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 120.907 0.384 . . . . 0.0 111.735 179.84 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.464 ' NZ ' ' HB3' ' A' ' 53' ' ' LYS . 0.9 OUTLIER -61.88 122.91 16.59 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.435 178.428 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 90.07 7.65 67.76 Favored Glycine 0 CA--C 1.524 0.649 0 C-N-CA 121.417 -0.421 . . . . 0.0 113.299 -178.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 34.6 t -100.72 -173.56 2.42 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 122.364 -0.492 . . . . 0.0 111.587 178.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 48.7 mmtm -54.31 -34.73 61.6 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 113.253 0.835 . . . . 0.0 113.253 -175.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.407 ' HB3' HG13 ' A' ' 51' ' ' VAL . . . -94.19 6.77 47.56 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -176.467 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.7 t70 . . . . . 0 CA--C 1.552 1.045 0 O-C-N 122.151 -0.343 . . . . 0.0 111.302 -178.301 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 . . . . . 0 N--CA 1.468 0.464 0 CA-C-O 121.073 0.463 . . . . 0.0 112.029 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 86.1 m -122.14 135.6 54.81 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.671 176.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 57.6 mtpt -137.23 137.92 39.59 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 122.342 0.257 . . . . 0.0 111.116 -173.566 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 57.3 mt -97.45 107.34 19.89 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-O 120.966 0.412 . . . . 0.0 111.417 -179.031 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 11.7 t -100.07 156.21 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.772 177.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -90.17 -7.8 52.75 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 -175.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 16.5 ptpt -130.53 152.21 50.16 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 121.073 0.463 . . . . 0.0 111.892 -176.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 23.0 m -83.63 9.53 11.34 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -174.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 75.0 mtp180 -128.19 116.97 20.72 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 121.007 0.432 . . . . 0.0 111.759 -178.417 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 39.9 t -131.64 152.65 37.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.396 -178.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.46 ' HA ' ' O ' ' A' ' 30' ' ' VAL . . . -81.53 154.1 26.44 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-O 121.278 0.561 . . . . 0.0 112.404 -179.59 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.521 ' HB2' HD12 ' A' ' 32' ' ' LEU . 43.1 t . . . . . 0 N--CA 1.476 0.859 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.773 -174.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 16.5 tpt180 . . . . . 0 N--CA 1.466 0.36 0 CA-C-O 122.01 0.909 . . . . 0.0 110.246 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.46 ' O ' ' HA ' ' A' ' 17' ' ' ALA . 61.2 t -128.11 132.24 68.65 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 CA-C-N 114.456 -1.247 . . . . 0.0 109.64 -178.595 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 84.2 m95 -115.58 136.15 53.36 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 -172.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.521 HD12 ' HB2' ' A' ' 18' ' ' CYS . 8.8 mp -113.53 144.53 42.69 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.633 172.138 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.443 HE21 ' HA ' ' A' ' 33' ' ' GLN . 0.0 OUTLIER -103.92 119.84 39.77 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.272 -179.258 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.575 HG12 HG13 ' A' ' 41' ' ' VAL . 50.7 mt -75.0 114.46 35.12 Favored Pre-proline 0 CA--C 1.54 0.566 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.956 177.432 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.547 ' HG2' ' OG1' ' A' ' 38' ' ' THR . 91.3 Cg_endo -77.92 132.34 11.71 Favored 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 122.475 2.117 . . . . 0.0 112.356 178.553 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -77.32 -7.72 56.49 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 120.836 0.351 . . . . 0.0 111.341 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -68.03 -56.01 10.48 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 121.028 0.442 . . . . 0.0 110.89 172.488 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.547 ' OG1' ' HG2' ' A' ' 35' ' ' PRO . 47.9 p -80.64 -43.26 20.75 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.157 177.874 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 103.07 -0.19 47.86 Favored Glycine 0 CA--C 1.524 0.617 0 CA-C-N 115.56 -0.745 . . . . 0.0 112.811 -178.279 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.513 ' HB3' HG22 ' A' ' 51' ' ' VAL . 65.9 p-90 -161.2 161.24 30.84 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 -176.288 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.575 HG13 HG12 ' A' ' 34' ' ' ILE . 9.8 p -146.76 133.39 13.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.231 169.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -111.39 140.45 45.97 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -174.604 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.511 ' HB3' ' SG ' ' A' ' 48' ' ' CYS . 43.8 t -74.41 112.87 19.1 Favored Pre-proline 0 CA--C 1.537 0.452 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.623 178.516 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -58.35 -14.39 20.07 Favored 'Trans proline' 0 CA--C 1.542 0.911 0 C-N-CA 122.695 2.263 . . . . 0.0 113.404 -178.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -87.18 -51.35 6.03 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.705 -177.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 52.4 t -103.27 -3.7 25.29 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -178.06 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 49.8 m-20 65.76 10.67 6.99 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.115 0.566 . . . . 0.0 112.373 179.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.511 ' SG ' ' HB3' ' A' ' 43' ' ' CYS . 6.4 p -73.85 116.85 14.94 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 121.145 0.498 . . . . 0.0 111.515 179.553 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 18.3 ttmm -91.88 113.12 25.3 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.79 -177.166 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -97.38 103.34 15.26 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 120.988 0.423 . . . . 0.0 111.921 -175.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.513 HG22 ' HB3' ' A' ' 40' ' ' TRP . 78.5 t -82.55 142.87 13.04 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.662 175.397 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.478 ' HB2' HG21 ' A' ' 34' ' ' ILE . 68.6 tp -89.41 124.93 34.91 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 120.91 0.386 . . . . 0.0 111.7 178.269 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 8.5 tmtm? -71.05 122.89 20.88 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 174.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 97.19 52.54 1.46 Allowed Glycine 0 CA--C 1.526 0.732 0 N-CA-C 111.749 -0.54 . . . . 0.0 111.749 -172.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.41 ' H ' ' HB3' ' A' ' 58' ' ' ASP . 51.6 p -155.31 -178.49 7.3 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.516 0.674 . . . . 0.0 111.75 -176.341 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 32.4 ttpt -67.68 -15.23 63.54 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-N 115.322 -0.854 . . . . 0.0 112.059 179.411 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -99.99 2.34 43.4 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 121.202 0.525 . . . . 0.0 111.667 176.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.41 ' HB3' ' H ' ' A' ' 55' ' ' SER . 16.4 t70 . . . . . 0 CA--C 1.547 0.846 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.73 -177.472 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 . . . . . 0 N--CA 1.475 0.777 0 CA-C-O 121.23 0.538 . . . . 0.0 112.313 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 80.1 m -99.45 107.3 19.47 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.926 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.567 ' HZ3' ' HB3' ' A' ' 9' ' ' LYS . 6.8 mtpm? -102.81 93.46 5.08 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.158 0.504 . . . . 0.0 110.372 -175.181 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.419 ' HA ' ' O ' ' A' ' 51' ' ' VAL . 62.3 mt -78.28 99.37 2.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.061 -178.666 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 35.6 m -105.67 160.24 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-N 115.753 -0.658 . . . . 0.0 112.062 -174.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -91.19 1.14 57.32 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 120.757 0.313 . . . . 0.0 111.65 178.293 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -115.62 153.39 31.36 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 120.826 0.346 . . . . 0.0 111.63 -176.15 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 42.8 m -89.35 -22.77 22.45 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 116.517 -0.311 . . . . 0.0 111.161 176.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 68.8 mtt180 -114.38 114.6 26.09 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 120.918 0.39 . . . . 0.0 111.372 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 47.2 t -124.28 138.16 54.78 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.657 -177.386 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.0 102.11 7.23 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 120.964 0.411 . . . . 0.0 111.641 178.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.489 ' SG ' ' HB2' ' A' ' 43' ' ' CYS . 51.5 t . . . . . 0 C--N 1.326 -0.426 0 CA-C-O 121.398 0.618 . . . . 0.0 111.629 177.652 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 1.1 mmm180 . . . . . 0 N--CA 1.44 -0.952 0 CA-C-O 123.093 1.425 . . . . 0.0 112.563 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.456 HG22 ' HB3' ' A' ' 18' ' ' CYS . 17.8 m -119.8 125.02 73.89 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 CA-C-N 112.494 -2.139 . . . . 0.0 110.959 -179.464 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 39.5 m95 -101.84 114.53 28.69 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.078 0.466 . . . . 0.0 111.182 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 10.5 mp -92.81 150.73 20.43 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.654 -179.354 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 50.8 tp60 -104.39 124.95 50.14 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.791 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.483 HG21 ' HB2' ' A' ' 52' ' ' LEU . 74.7 mt -84.21 114.47 54.76 Favored Pre-proline 0 CA--C 1.542 0.65 0 CA-C-N 116.642 -0.254 . . . . 0.0 110.381 172.391 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -84.92 143.23 9.26 Favored 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 122.704 2.269 . . . . 0.0 113.235 -177.268 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.426 ' O ' ' NZ ' ' A' ' 56' ' ' LYS . 16.4 mm-40 -69.5 -3.81 16.17 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 121.117 0.484 . . . . 0.0 111.066 171.88 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -65.18 -62.86 1.29 Allowed 'General case' 0 CA--C 1.543 0.683 0 CA-C-O 121.034 0.445 . . . . 0.0 110.158 169.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 82.0 p -91.79 -48.88 6.56 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 115.758 -0.655 . . . . 0.0 112.037 -179.006 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 100.68 1.51 55.3 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 121.309 -0.472 . . . . 0.0 112.718 -175.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 60.2 p-90 -156.53 164.78 37.81 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 122.559 0.344 . . . . 0.0 111.39 -176.495 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 13.6 p -146.93 152.0 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 174.201 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -124.18 147.51 47.95 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 113.059 0.763 . . . . 0.0 113.059 -175.016 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.489 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 18.0 t -101.53 105.24 39.32 Favored Pre-proline 0 N--CA 1.468 0.432 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.274 174.226 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -77.17 -0.33 10.49 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 122.457 2.105 . . . . 0.0 113.123 -177.02 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -90.05 -67.71 0.83 Allowed 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 116.636 -0.256 . . . . 0.0 111.507 -176.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 49.4 t -104.26 6.07 35.17 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 111.869 0.322 . . . . 0.0 111.869 178.101 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 26.6 m-20 69.06 101.35 0.06 Allowed 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 175.29 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 52.0 m -161.69 120.8 2.43 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.135 175.075 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -100.4 110.84 23.05 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 120.753 0.311 . . . . 0.0 110.812 177.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 27.9 m-85 -91.57 107.13 18.99 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 120.638 0.256 . . . . 0.0 110.456 -177.19 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.419 ' O ' ' HA ' ' A' ' 10' ' ' ILE . 90.5 t -100.4 131.4 48.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 CA-C-O 120.726 0.298 . . . . 0.0 111.741 179.646 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.483 ' HB2' HG21 ' A' ' 34' ' ' ILE . 68.0 tp -81.54 119.42 23.75 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.096 0.475 . . . . 0.0 111.934 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.413 ' HB2' HG21 ' A' ' 10' ' ' ILE . 88.0 tttt -69.0 108.23 3.45 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.868 177.103 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 119.87 -13.59 10.63 Favored Glycine 0 CA--C 1.527 0.801 0 C-N-CA 121.412 -0.423 . . . . 0.0 112.542 -175.571 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 59.6 p -81.29 -176.57 6.06 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 120.93 0.395 . . . . 0.0 111.147 178.398 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.426 ' NZ ' ' O ' ' A' ' 36' ' ' GLU . 33.7 mtmm -73.07 -20.19 61.01 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.655 -0.248 . . . . 0.0 111.612 179.073 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -71.6 -49.61 38.67 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.287 0.565 . . . . 0.0 111.321 -175.46 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.4 t70 . . . . . 0 CA--C 1.536 0.429 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.867 177.927 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.61 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.6 OUTLIER . . . . . 0 N--CA 1.493 1.676 0 CA-C-O 120.77 0.319 . . . . 0.0 111.47 . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.447 ' O ' HG13 ' A' ' 3' ' ' ILE . 40.4 p -76.62 -3.09 35.94 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -177.177 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.447 HG13 ' O ' ' A' ' 2' ' ' THR . 2.6 pp 47.34 13.26 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.91 0 C-N-CA 123.826 0.85 . . . . 0.0 112.996 -172.362 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.417 ' H ' ' C ' ' A' ' 2' ' ' THR . 23.2 mt-30 54.6 -165.08 0.1 Allowed 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 123.786 0.835 . . . . 0.0 112.725 177.545 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -150.58 88.39 4.63 Favored Pre-proline 0 N--CA 1.471 0.578 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -178.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -63.08 85.77 0.12 Allowed 'Trans proline' 0 CA--C 1.542 0.922 0 C-N-CA 122.4 2.067 . . . . 0.0 112.207 175.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -87.56 96.05 10.26 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.753 -177.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 57.2 m -75.52 127.53 33.3 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.305 179.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 85.2 mttt -141.18 123.41 15.68 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 120.993 0.425 . . . . 0.0 111.32 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.497 HD11 ' N ' ' A' ' 10' ' ' ILE . 2.8 mp -88.74 119.64 36.25 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.769 -178.042 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 15.0 t -105.97 154.69 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-O 121.028 0.442 . . . . 0.0 111.245 -178.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -80.93 -37.78 28.96 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 121.048 0.451 . . . . 0.0 110.727 -177.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -101.56 162.97 12.51 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.396 176.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 50.5 m -79.97 -40.89 27.06 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -177.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 18.5 ptt-85 -86.09 118.43 25.55 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 121.458 0.647 . . . . 0.0 110.813 177.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 39.5 t -111.47 125.02 68.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.988 -172.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.95 82.23 5.15 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 120.984 0.421 . . . . 0.0 111.341 176.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.536 ' SG ' ' N ' ' A' ' 19' ' ' ASP . 41.9 t -84.54 178.71 7.6 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.17 0.51 . . . . 0.0 111.47 -179.719 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.645 ' HB3' ' HA ' ' A' ' 27' ' ' HIS . 31.4 m-20 -132.96 -66.35 0.67 Allowed 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 -177.626 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 162.92 -146.33 11.64 Favored Glycine 0 CA--C 1.526 0.734 0 C-N-CA 120.456 -0.878 . . . . 0.0 113.441 -178.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.854 ' HA2' ' HB2' ' A' ' 46' ' ' CYS . . . -96.62 -105.44 2.25 Favored Glycine 0 N--CA 1.467 0.719 0 C-N-CA 121.337 -0.459 . . . . 0.0 112.687 179.616 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.9 mp0 -75.11 162.77 28.23 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 122.607 -0.349 . . . . 0.0 110.408 170.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -45.0 -49.7 9.16 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 121.634 -0.317 . . . . 0.0 113.774 176.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -79.78 -3.0 45.76 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -178.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 83.1 mt -113.84 49.3 1.0 Allowed 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.581 0.705 . . . . 0.0 110.724 -179.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 126.46 -138.54 10.75 Favored Glycine 0 CA--C 1.524 0.617 0 CA-C-N 115.347 -0.842 . . . . 0.0 112.636 174.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.645 ' HA ' ' HB3' ' A' ' 19' ' ' ASP . 7.3 m80 67.92 47.3 0.39 Allowed Pre-proline 0 CA--C 1.545 0.754 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 179.166 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.631 ' HD3' ' N ' ' A' ' 27' ' ' HIS . 42.9 Cg_endo -101.74 4.3 0.54 Allowed 'Trans proline' 0 CA--C 1.545 1.046 0 C-N-CA 122.884 2.389 . . . . 0.0 113.378 175.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.523 ' HB3' ' O ' ' A' ' 28' ' ' PRO . 1.1 tmt_? 77.06 99.13 0.07 Allowed 'General case' 0 C--N 1.346 0.421 0 CA-C-O 122.185 0.993 . . . . 0.0 109.006 -172.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.1 m -131.21 131.88 63.4 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 114.652 -1.158 . . . . 0.0 111.703 178.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 49.1 m95 -105.81 114.92 29.36 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.355 -178.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.56 HD22 ' HG ' ' A' ' 43' ' ' CYS . 6.4 mp -107.76 133.01 52.77 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 120.837 0.351 . . . . 0.0 111.421 179.249 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 54.9 tp60 -90.03 119.88 30.76 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 121.144 0.497 . . . . 0.0 111.958 -178.1 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.496 HG21 ' HB2' ' A' ' 52' ' ' LEU . 73.1 mt -79.93 118.17 71.08 Favored Pre-proline 0 CA--C 1.54 0.589 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.999 175.102 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.68 ' HG2' HG22 ' A' ' 38' ' ' THR . 97.2 Cg_endo -83.05 121.6 3.18 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 122.325 2.016 . . . . 0.0 112.868 178.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -56.5 -16.77 6.5 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-O 121.306 0.574 . . . . 0.0 111.427 175.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -61.69 -29.17 69.92 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 115.61 -0.723 . . . . 0.0 112.026 177.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.68 HG22 ' HG2' ' A' ' 35' ' ' PRO . 12.9 t -131.16 -38.82 1.2 Allowed 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 120.679 0.276 . . . . 0.0 111.415 178.179 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 107.42 2.45 35.34 Favored Glycine 0 CA--C 1.53 0.98 0 N-CA-C 115.419 0.928 . . . . 0.0 115.419 171.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 68.1 p-90 -144.8 164.96 29.46 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 118.271 1.035 . . . . 0.0 112.972 -176.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.436 HG22 ' HB3' ' A' ' 32' ' ' LEU . 9.9 p -147.92 143.94 19.31 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.244 171.118 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -116.64 141.51 48.11 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 -177.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.56 ' HG ' HD22 ' A' ' 32' ' ' LEU . 60.5 m -110.68 109.28 57.92 Favored Pre-proline 0 N--CA 1.473 0.716 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.163 173.07 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -69.06 15.61 0.19 Allowed 'Trans proline' 0 CA--C 1.549 1.24 0 C-N-CA 123.079 2.519 . . . . 0.0 115.511 -167.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -96.13 -72.21 0.64 Allowed 'General case' 0 N--CA 1.473 0.698 0 O-C-N 121.925 -0.485 . . . . 0.0 110.919 177.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.854 ' HB2' ' HA2' ' A' ' 21' ' ' GLY . 43.1 t -86.94 3.8 44.23 Favored 'General case' 0 N--CA 1.475 0.822 0 O-C-N 122.218 -0.301 . . . . 0.0 111.58 169.676 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 56.48 31.29 18.63 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 121.379 0.609 . . . . 0.0 112.0 -178.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 61.9 m -64.95 110.93 2.62 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.123 176.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 84.2 tttt -98.62 102.38 14.1 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 121.08 0.466 . . . . 0.0 110.659 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -87.33 116.62 25.54 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.465 -175.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.464 ' O ' ' HA ' ' A' ' 10' ' ' ILE . 77.8 t -96.9 139.53 19.34 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.07 177.194 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.496 ' HB2' HG21 ' A' ' 34' ' ' ILE . 51.7 tp -77.4 131.78 38.19 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 121.221 0.534 . . . . 0.0 111.667 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -53.43 110.38 0.55 Allowed 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -179.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 85.68 2.32 86.9 Favored Glycine 0 CA--C 1.527 0.787 0 C-N-CA 121.191 -0.528 . . . . 0.0 113.821 176.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 40.8 t -70.15 174.8 5.08 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.049 0.452 . . . . 0.0 111.776 179.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -67.69 -23.91 65.35 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 121.075 0.464 . . . . 0.0 111.075 179.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -74.18 -18.46 60.77 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 121.045 0.45 . . . . 0.0 110.893 172.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -101.06 29.67 4.52 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-O 121.578 0.704 . . . . 0.0 110.148 177.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -93.25 13.05 22.43 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.81 -178.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.455 ' N ' HD12 ' A' ' 60' ' ' LEU . 6.3 mp -83.19 -160.67 0.43 Allowed 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.447 177.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.424 ' HB2' ' O ' ' A' ' 60' ' ' LEU . 23.6 mm-40 69.3 -75.57 0.07 Allowed 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 120.921 0.391 . . . . 0.0 110.854 -177.273 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 17.9 p-80 -164.93 142.76 6.29 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 120.898 0.38 . . . . 0.0 111.072 -179.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 25.5 m170 -79.19 178.62 7.93 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 121.444 0.64 . . . . 0.0 112.545 -176.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 7.3 p80 -151.17 -52.28 0.13 Allowed 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.665 -179.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 86.5 t60 61.18 2.84 0.64 Allowed 'General case' 0 N--CA 1.48 1.025 0 N-CA-C 114.77 1.396 . . . . 0.0 114.77 167.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 33.3 p80 44.6 -164.19 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.256 0 CA-C-N 118.38 0.536 . . . . 0.0 111.553 -173.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 25.0 p-80 . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.647 -0.692 . . . . 0.0 111.098 174.63 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.0 mtt . . . . . 0 N--CA 1.488 1.425 0 CA-C-O 121.024 0.44 . . . . 0.0 110.885 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 67.9 p -115.9 153.56 31.33 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 121.051 0.453 . . . . 0.0 111.394 178.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 60.6 mt -95.54 -26.81 4.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-O 121.203 0.525 . . . . 0.0 109.921 171.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 66.51 -76.74 0.05 OUTLIER 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.024 -178.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 62.24 103.16 0.03 OUTLIER Pre-proline 0 N--CA 1.471 0.599 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 175.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -60.03 87.83 0.07 OUTLIER 'Trans proline' 0 CA--C 1.539 0.73 0 C-N-CA 122.267 1.978 . . . . 0.0 112.337 175.181 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -43.03 124.87 3.36 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.364 0.602 . . . . 0.0 112.243 178.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 97.3 m -89.72 136.19 33.18 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.786 -179.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 45.1 tttp -127.65 116.75 20.78 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 120.636 0.255 . . . . 0.0 110.829 -175.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 44.5 mm -86.3 112.37 22.63 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-O 120.989 0.423 . . . . 0.0 111.199 -178.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 35.7 m -113.33 164.53 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -178.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -105.41 -6.3 19.65 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-O 121.057 0.456 . . . . 0.0 111.424 179.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 68.6 mmtt -120.04 144.37 47.59 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.094 0.473 . . . . 0.0 111.856 -179.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 34.7 m -72.83 -21.06 61.02 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.603 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 80.4 mtt-85 -102.4 111.75 24.17 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-O 121.241 0.543 . . . . 0.0 110.634 177.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 36.7 t -119.96 131.2 73.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.851 -175.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.432 ' HB3' ' CE2' ' A' ' 31' ' ' TRP . . . -74.91 139.57 43.17 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 121.122 0.487 . . . . 0.0 111.742 177.427 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 53.0 t -127.46 71.36 1.34 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.146 0.498 . . . . 0.0 110.534 177.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -69.29 -75.21 0.11 Allowed 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.723 -178.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 161.79 -176.08 38.28 Favored Glycine 0 CA--C 1.521 0.466 0 C-N-CA 120.119 -1.039 . . . . 0.0 113.975 177.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -110.61 -102.16 2.68 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 112.244 -0.342 . . . . 0.0 112.244 178.002 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 44.2 mm-40 -67.06 167.37 12.02 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 116.778 0.289 . . . . 0.0 111.403 176.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -44.04 -54.79 5.95 Favored Glycine 0 CA--C 1.53 0.972 0 N-CA-C 114.267 0.467 . . . . 0.0 114.267 -179.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.74 -29.26 70.0 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 120.969 0.414 . . . . 0.0 112.009 179.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 85.6 mt -89.9 1.27 56.42 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.285 179.184 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -76.45 107.51 2.37 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 121.165 -0.54 . . . . 0.0 113.241 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 28.1 m80 -94.85 152.12 39.46 Favored Pre-proline 0 CA--C 1.544 0.725 0 O-C-N 122.623 -0.339 . . . . 0.0 110.192 177.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_exo -52.42 -69.79 0.06 OUTLIER 'Trans proline' 0 CA--C 1.544 0.981 0 C-N-CA 122.642 2.228 . . . . 0.0 114.199 -176.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 4.4 tmt_? 179.28 92.27 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.25 0 CA-C-O 121.941 0.876 . . . . 0.0 109.56 -179.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 28.7 m -122.36 134.89 64.21 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 CA-C-N 114.846 -1.07 . . . . 0.0 111.486 178.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . 0.432 ' CE2' ' HB3' ' A' ' 17' ' ' ALA . 15.7 m95 -116.27 127.35 54.65 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 120.787 0.327 . . . . 0.0 111.114 179.679 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.7 mp -92.08 151.93 20.19 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 121.179 0.514 . . . . 0.0 111.544 -178.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 27.9 tp60 -110.2 108.98 19.31 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.019 -179.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.493 HG12 HG13 ' A' ' 41' ' ' VAL . 75.8 mt -71.62 122.3 86.81 Favored Pre-proline 0 CA--C 1.542 0.641 0 CA-C-N 116.634 -0.257 . . . . 0.0 111.481 179.336 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.473 ' HG2' ' OG1' ' A' ' 38' ' ' THR . 44.7 Cg_endo -86.31 127.11 2.83 Favored 'Trans proline' 0 CA--C 1.54 0.811 0 C-N-CA 122.95 2.434 . . . . 0.0 112.709 176.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -59.22 -21.97 60.34 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 121.43 0.633 . . . . 0.0 110.792 177.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -59.11 -31.7 69.16 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 115.234 -0.893 . . . . 0.0 111.742 178.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.473 ' OG1' ' HG2' ' A' ' 35' ' ' PRO . 44.8 p -113.92 -47.44 2.96 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.308 0.575 . . . . 0.0 110.975 178.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.493 ' HA3' ' H ' ' A' ' 57' ' ' ALA . . . 100.2 1.08 55.84 Favored Glycine 0 CA--C 1.525 0.676 0 CA-C-N 115.874 -0.603 . . . . 0.0 112.782 -178.198 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 58.5 p-90 -155.46 162.27 40.77 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.088 0.471 . . . . 0.0 111.388 -177.1 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.493 HG13 HG12 ' A' ' 34' ' ' ILE . 14.2 p -148.67 126.45 2.95 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 CA-C-O 120.992 0.425 . . . . 0.0 110.62 172.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.406 ' HA ' ' HA ' ' A' ' 49' ' ' LYS . 16.7 pt-20 -94.39 143.01 26.77 Favored 'General case' 0 CA--C 1.535 0.398 0 O-C-N 122.124 -0.36 . . . . 0.0 111.035 179.437 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 37.0 t -71.55 130.99 86.68 Favored Pre-proline 0 N--CA 1.468 0.435 0 N-CA-C 111.825 0.305 . . . . 0.0 111.825 179.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -76.59 0.46 9.51 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 122.406 2.07 . . . . 0.0 113.077 179.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -99.87 -87.64 0.36 Allowed 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 111.687 0.254 . . . . 0.0 111.687 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 42.0 t -169.78 22.27 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 111.827 0.306 . . . . 0.0 111.827 -179.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -87.75 -88.23 0.14 Allowed 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -173.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 73.7 m -155.31 179.19 9.4 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-O 121.596 0.712 . . . . 0.0 112.627 -177.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.406 ' HA ' ' HA ' ' A' ' 42' ' ' GLU . 40.3 ttmt -111.5 120.31 41.71 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.959 174.324 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 46.2 m-85 -103.27 116.48 32.53 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 111.922 0.342 . . . . 0.0 111.922 -170.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 85.9 t -105.08 135.47 42.96 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 CA-C-O 120.946 0.403 . . . . 0.0 111.513 178.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.424 ' HB2' HG21 ' A' ' 34' ' ' ILE . 53.0 tp -87.44 122.16 30.81 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 121.154 0.502 . . . . 0.0 111.711 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.43 ' HD3' ' N ' ' A' ' 54' ' ' GLY . 4.2 tmtm? -67.72 127.9 34.5 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.365 179.185 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.43 ' N ' ' HD3' ' A' ' 53' ' ' LYS . . . 87.52 12.62 66.76 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 121.391 -0.433 . . . . 0.0 112.886 -175.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.7 t -110.23 -173.4 2.24 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 122.552 -0.381 . . . . 0.0 111.34 178.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 61.6 tttp -57.1 -47.76 80.26 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -176.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.493 ' H ' ' HA3' ' A' ' 39' ' ' GLY . . . -73.99 -13.91 60.95 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 112.543 0.571 . . . . 0.0 112.543 -177.42 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -72.28 84.98 1.07 Allowed 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 121.529 0.681 . . . . 0.0 111.04 -179.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -155.78 18.95 0.39 Allowed 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.777 176.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.6 pp -128.06 14.58 6.8 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -175.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -57.4 134.44 56.03 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 121.217 0.532 . . . . 0.0 111.739 -177.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 56.0 m80 -92.33 113.48 25.77 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.626 -177.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 54.6 m-70 -84.48 73.7 10.48 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 116.646 -0.252 . . . . 0.0 111.023 -178.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 33.9 m170 71.46 -47.86 0.67 Allowed 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.267 0.627 . . . . 0.0 112.119 -176.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 46.0 t-80 -49.59 124.67 9.91 Favored 'General case' 0 CA--C 1.539 0.558 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 -179.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 36.0 t60 -118.2 -50.86 2.45 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.478 176.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 85.2 t60 . . . . . 0 C--O 1.247 0.932 0 CA-C-O 118.977 -0.535 . . . . 0.0 111.408 176.356 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.7 tpt . . . . . 0 N--CA 1.489 1.499 0 N-CA-C 111.961 0.356 . . . . 0.0 111.961 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.46 ' C ' ' H ' ' A' ' 4' ' ' GLN . 3.1 m -128.68 14.29 6.46 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-O 121.003 0.43 . . . . 0.0 111.216 -178.035 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 58.3 mt 70.08 -22.9 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 123.056 0.543 . . . . 0.0 112.055 -176.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.46 ' H ' ' C ' ' A' ' 2' ' ' THR . 23.8 mt-30 63.68 16.03 9.41 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.112 0.565 . . . . 0.0 111.17 -175.281 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -153.45 52.23 0.8 Allowed Pre-proline 0 CA--C 1.544 0.732 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.411 178.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -65.91 91.23 0.25 Allowed 'Trans proline' 0 C--N 1.355 0.906 0 C-N-CA 122.296 1.997 . . . . 0.0 112.167 -177.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 62.94 17.67 10.23 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-O 122.317 1.056 . . . . 0.0 110.54 -177.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 91.0 m -123.2 110.56 15.4 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.48 -1.236 . . . . 0.0 110.003 -177.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 5.7 tmtt? -102.6 115.4 30.51 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.787 0.327 . . . . 0.0 110.819 -172.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.478 HG23 ' HB2' ' A' ' 53' ' ' LYS . 2.5 mp -82.02 101.24 6.61 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.88 -177.533 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.407 HG23 HD13 ' A' ' 34' ' ' ILE . 35.7 m -102.67 167.93 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 CA-C-O 120.963 0.411 . . . . 0.0 111.874 -178.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -104.63 -20.61 13.6 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -176.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -130.33 165.0 23.42 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 121.019 0.438 . . . . 0.0 112.097 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.9 m -81.57 -37.89 26.98 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 112.67 0.619 . . . . 0.0 112.67 -174.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 28.9 tpt180 -87.27 105.23 17.09 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 122.117 -0.364 . . . . 0.0 110.642 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 58.9 t -131.05 135.03 60.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 N-CA-C 112.211 0.448 . . . . 0.0 112.211 -173.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -76.09 112.53 12.63 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.044 0.449 . . . . 0.0 110.237 172.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.677 ' HB2' HD13 ' A' ' 32' ' ' LEU . 58.3 m -119.46 -164.93 1.1 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.22 -174.26 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.636 ' HB3' ' CD2' ' A' ' 27' ' ' HIS . 2.4 m-20 65.73 4.58 2.94 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 175.142 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 161.08 174.36 30.83 Favored Glycine 0 CA--C 1.527 0.794 0 C-N-CA 120.281 -0.961 . . . . 0.0 113.517 175.031 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 173.72 14.8 0.02 OUTLIER Glycine 0 CA--C 1.534 1.24 0 C-N-CA 120.55 -0.833 . . . . 0.0 114.58 177.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -98.98 -152.76 0.42 Allowed 'General case' 0 CA--C 1.548 0.883 0 CA-C-N 117.693 0.746 . . . . 0.0 111.539 -178.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -43.54 -48.64 7.19 Favored Glycine 0 CA--C 1.533 1.183 0 N-CA-C 114.991 0.757 . . . . 0.0 114.991 -176.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -105.35 20.77 18.32 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 122.219 -0.577 . . . . 0.0 111.043 177.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.595 HD13 ' HD3' ' A' ' 29' ' ' ARG . 91.1 mt 59.31 23.64 12.09 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 115.663 -0.699 . . . . 0.0 112.052 -178.497 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 65.07 -101.34 0.54 Allowed Glycine 0 CA--C 1.523 0.534 0 C-N-CA 121.248 -0.501 . . . . 0.0 112.02 -176.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.636 ' CD2' ' HB3' ' A' ' 19' ' ' ASP . 0.2 OUTLIER -92.81 133.81 28.58 Favored Pre-proline 0 CA--C 1.537 0.45 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 169.982 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.515 ' O ' ' HB2' ' A' ' 29' ' ' ARG . 20.4 Cg_exo -17.49 -57.71 0.02 OUTLIER 'Trans proline' 0 CA--C 1.545 1.033 0 C-N-CA 124.979 3.786 . . . . 0.0 115.816 -165.516 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.595 ' HD3' HD13 ' A' ' 25' ' ' LEU . 23.3 tpt180 172.2 88.98 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.667 0.746 . . . . 0.0 110.024 172.354 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 27.1 t -100.47 125.98 54.16 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.759 -173.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 61.2 m95 -105.53 115.66 30.63 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 121.026 0.441 . . . . 0.0 111.418 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.677 HD13 ' HB2' ' A' ' 18' ' ' CYS . 9.0 mp -98.04 172.2 7.77 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.307 0.575 . . . . 0.0 111.678 -179.452 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 58.1 tp60 -137.64 116.41 12.25 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.528 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.476 HG12 HG13 ' A' ' 41' ' ' VAL . 68.4 mt -68.56 120.21 73.84 Favored Pre-proline 0 CA--C 1.539 0.539 0 CA-C-N 116.686 -0.234 . . . . 0.0 111.209 177.141 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.565 ' HG2' ' OG1' ' A' ' 38' ' ' THR . 74.0 Cg_endo -75.21 110.98 3.21 Favored 'Trans proline' 0 CA--C 1.535 0.561 0 C-N-CA 122.412 2.075 . . . . 0.0 111.67 176.539 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -54.93 -21.56 12.07 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 116.079 -0.51 . . . . 0.0 112.242 -176.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -61.14 -46.95 88.45 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-O 120.665 0.269 . . . . 0.0 111.247 173.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.565 ' OG1' ' HG2' ' A' ' 35' ' ' PRO . 29.2 p -89.03 -50.21 6.3 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 120.841 0.353 . . . . 0.0 111.521 -177.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 103.45 1.82 47.2 Favored Glycine 0 CA--C 1.527 0.792 0 C-N-CA 121.202 -0.523 . . . . 0.0 112.71 -176.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 63.6 p-90 -152.63 158.99 43.22 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 120.951 0.405 . . . . 0.0 112.006 -177.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.476 HG13 HG12 ' A' ' 34' ' ' ILE . 14.9 p -145.17 126.67 8.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-O 120.926 0.394 . . . . 0.0 110.269 174.071 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.582 ' HA ' ' HA ' ' A' ' 49' ' ' LYS . 10.5 pt-20 -103.66 152.67 21.51 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.234 0.54 . . . . 0.0 112.416 -177.2 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 6.4 t -69.61 134.13 88.55 Favored Pre-proline 0 N--CA 1.471 0.608 0 CA-C-N 115.705 -0.68 . . . . 0.0 112.174 -176.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -78.46 -5.94 15.19 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 122.739 2.292 . . . . 0.0 112.767 178.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -108.96 -93.58 0.42 Allowed 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 -179.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 48.7 t -144.46 9.9 1.42 Allowed 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 112.948 0.722 . . . . 0.0 112.948 -169.101 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -90.14 -107.39 0.09 Allowed 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 112.959 0.726 . . . . 0.0 112.959 -172.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 72.0 m -152.33 -179.74 7.82 Favored 'General case' 0 N--CA 1.477 0.902 0 O-C-N 121.692 -0.63 . . . . 0.0 112.475 -174.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.582 ' HA ' ' HA ' ' A' ' 42' ' ' GLU . 36.8 ttpt -106.74 125.64 51.26 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.291 177.051 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 36.4 m-85 -99.77 113.24 25.6 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 120.763 0.316 . . . . 0.0 111.144 -175.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 99.9 t -99.04 131.6 45.97 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 CA-C-O 121.101 0.477 . . . . 0.0 111.898 179.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 59.9 tp -78.11 118.15 20.08 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.543 179.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.478 ' HB2' HG23 ' A' ' 10' ' ' ILE . 47.4 tttp -74.33 151.22 39.82 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 121.124 0.488 . . . . 0.0 111.203 178.528 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.79 14.6 81.86 Favored Glycine 0 CA--C 1.527 0.799 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.07 -174.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 48.3 t -116.5 -177.48 3.19 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.2 0.524 . . . . 0.0 111.532 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 50.6 mtpt -60.52 -34.76 74.58 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.639 -179.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -86.18 8.89 19.24 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 -178.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -89.81 3.23 53.54 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-O 121.182 0.515 . . . . 0.0 111.859 -179.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -143.31 87.2 1.94 Allowed 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 121.442 0.639 . . . . 0.0 111.187 178.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.464 ' N ' HD13 ' A' ' 60' ' ' LEU . 5.2 mp -85.37 17.94 2.91 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.867 -178.539 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -90.37 149.01 22.47 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.193 0.52 . . . . 0.0 111.757 -179.081 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 76.2 t60 -90.26 -38.51 13.37 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.978 171.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 32.5 t-80 -171.91 100.05 0.17 Allowed 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.789 -0.642 . . . . 0.0 111.296 178.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 79.5 t60 -156.18 -80.91 0.07 Allowed 'General case' 0 CA--C 1.537 0.463 0 O-C-N 122.415 -0.178 . . . . 0.0 110.937 176.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 54.4 t-80 -124.51 74.98 1.36 Allowed 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 121.322 0.582 . . . . 0.0 111.792 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 34.1 m170 -88.2 -14.99 37.18 Favored 'General case' 0 CA--C 1.54 0.562 0 O-C-N 122.157 -0.339 . . . . 0.0 110.805 173.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 19.7 t-80 . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.676 -0.678 . . . . 0.0 111.113 177.028 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.402 ' HG3' ' H ' ' A' ' 3' ' ' ILE . 26.5 ptt? . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 112.176 0.436 . . . . 0.0 112.176 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.409 HG22 ' O ' ' A' ' 2' ' ' THR . 5.6 m 58.94 10.7 1.63 Allowed 'General case' 0 N--CA 1.482 1.129 0 CA-C-O 121.123 0.487 . . . . 0.0 112.206 179.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.482 ' O ' HG22 ' A' ' 3' ' ' ILE . 36.1 mt 61.87 8.14 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.024 0 C-N-CA 123.036 0.535 . . . . 0.0 111.609 -176.011 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 62.83 -71.61 0.05 Allowed 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.243 0.617 . . . . 0.0 111.868 -176.307 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 66.57 82.62 0.2 Allowed Pre-proline 0 CA--C 1.542 0.64 0 C-N-CA 123.472 0.709 . . . . 0.0 112.684 179.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.84 69.88 2.9 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 122.286 1.991 . . . . 0.0 111.554 173.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -67.24 117.9 9.9 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 115.868 -0.605 . . . . 0.0 112.409 -173.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 23.3 m -98.01 125.81 43.13 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.017 176.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 24.4 tptp -121.8 110.72 16.25 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 120.816 0.341 . . . . 0.0 110.558 -178.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 55.5 mt -77.19 104.41 5.13 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-O 120.909 0.385 . . . . 0.0 111.236 -177.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 34.5 m -95.06 155.75 3.25 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-O 121.067 0.461 . . . . 0.0 111.439 179.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -82.19 -37.09 26.59 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.807 -175.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 46.5 mmtm -118.94 167.18 11.98 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 121.212 0.529 . . . . 0.0 112.273 -177.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 18.6 m -68.64 -34.65 76.1 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -174.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.452 ' HA ' ' O ' ' A' ' 32' ' ' LEU . 16.6 ptt180 -98.64 135.36 40.25 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.231 0.538 . . . . 0.0 111.668 -179.27 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 48.7 t -129.34 122.96 56.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.277 -178.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -74.78 94.03 2.69 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.12 0.486 . . . . 0.0 110.678 176.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.412 ' SG ' HD12 ' A' ' 32' ' ' LEU . 85.8 m -92.24 60.46 3.7 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.93 0.395 . . . . 0.0 111.657 -176.026 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -55.4 -62.67 1.52 Allowed 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.048 177.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.435 ' HA2' ' SG ' ' A' ' 46' ' ' CYS . . . 162.56 -158.28 30.4 Favored Glycine 0 CA--C 1.523 0.546 0 C-N-CA 121.155 -0.545 . . . . 0.0 112.738 178.701 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -80.31 -105.89 0.28 Allowed Glycine 0 CA--C 1.526 0.734 0 C-N-CA 121.093 -0.575 . . . . 0.0 112.476 177.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -64.72 156.57 29.99 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 122.515 -0.403 . . . . 0.0 110.868 174.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -43.79 -54.6 5.81 Favored Glycine 0 CA--C 1.534 1.243 0 N-CA-C 114.148 0.419 . . . . 0.0 114.148 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -66.56 -22.79 66.15 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 69.6 mt -87.14 0.74 54.82 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 120.887 0.375 . . . . 0.0 111.401 -179.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -82.31 162.63 42.23 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 121.168 -0.539 . . . . 0.0 113.833 -178.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.455 ' HB3' ' HD2' ' A' ' 28' ' ' PRO . 61.4 m80 -99.53 165.06 15.42 Favored Pre-proline 0 CA--C 1.545 0.771 0 C-N-CA 122.901 0.48 . . . . 0.0 110.084 178.144 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.455 ' HD2' ' HB3' ' A' ' 27' ' ' HIS . 59.7 Cg_exo -38.85 -65.3 0.17 Allowed 'Trans proline' 0 C--N 1.357 1.002 0 C-N-CA 123.205 2.603 . . . . 0.0 114.329 -178.245 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.435 ' HB2' ' O ' ' A' ' 28' ' ' PRO . 21.8 tpt180 174.48 89.94 0.0 OUTLIER 'General case' 0 C--O 1.236 0.356 0 CA-C-O 121.814 0.816 . . . . 0.0 110.089 177.531 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 30.0 m -112.84 121.67 65.54 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 CA-C-N 115.062 -0.972 . . . . 0.0 112.395 -177.176 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 69.5 m95 -106.55 113.33 26.78 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.885 177.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.452 ' O ' ' HA ' ' A' ' 15' ' ' ARG . 8.1 mp -86.38 144.72 27.19 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 120.878 0.371 . . . . 0.0 110.977 179.14 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 54.2 tp60 -115.91 116.35 27.82 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.059 -177.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.415 HG12 HG13 ' A' ' 41' ' ' VAL . 61.9 mt -76.48 126.41 86.27 Favored Pre-proline 0 CA--C 1.539 0.535 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -179.065 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.538 ' HG2' ' OG1' ' A' ' 38' ' ' THR . 57.1 Cg_endo -86.78 132.45 3.43 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 122.87 2.38 . . . . 0.0 112.092 173.645 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -66.04 -25.62 67.14 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 121.941 -0.474 . . . . 0.0 111.492 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -54.51 -56.48 18.46 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.134 0.492 . . . . 0.0 111.37 177.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.538 ' OG1' ' HG2' ' A' ' 35' ' ' PRO . 52.4 p -76.27 -47.82 22.39 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.407 0.622 . . . . 0.0 110.055 174.473 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 99.09 1.5 57.06 Favored Glycine 0 CA--C 1.524 0.621 0 CA-C-N 115.504 -0.771 . . . . 0.0 112.672 -178.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.495 ' HB3' HG21 ' A' ' 51' ' ' VAL . 63.7 p-90 -159.3 166.83 30.38 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 122.56 0.344 . . . . 0.0 110.911 -176.026 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.415 HG13 HG12 ' A' ' 34' ' ' ILE . 12.2 p -135.37 132.69 52.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-O 121.112 0.482 . . . . 0.0 111.399 176.219 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -92.01 112.11 23.91 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 121.148 0.499 . . . . 0.0 110.818 176.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 41.0 t -71.28 110.56 7.65 Favored Pre-proline 0 N--CA 1.471 0.576 0 CA-C-N 116.187 -0.461 . . . . 0.0 112.086 -178.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -71.55 -11.24 27.95 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 122.632 2.221 . . . . 0.0 112.425 177.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.441 ' HB3' ' CE1' ' A' ' 27' ' ' HIS . 78.4 m-85 -84.56 -42.7 15.21 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 115.956 -0.566 . . . . 0.0 112.007 -176.323 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.435 ' SG ' ' HA2' ' A' ' 20' ' ' GLY . 84.5 m -131.92 8.08 4.42 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 -178.013 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 57.7 78.26 0.24 Allowed 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 176.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 91.2 m -152.46 147.31 26.1 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.944 177.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -99.63 106.47 18.43 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 120.651 0.262 . . . . 0.0 111.091 178.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -91.74 111.69 23.32 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.55 0.214 . . . . 0.0 110.615 178.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.495 HG21 ' HB3' ' A' ' 40' ' ' TRP . 97.9 t -97.51 135.61 31.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-O 121.023 0.439 . . . . 0.0 111.58 -179.623 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 59.0 tp -75.42 130.95 39.8 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 116.171 -0.468 . . . . 0.0 112.029 -178.182 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 51.7 tttm -58.91 102.5 0.12 Allowed 'General case' 0 CA--C 1.542 0.645 0 CA-C-O 121.114 0.483 . . . . 0.0 111.443 174.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 117.6 -7.06 15.92 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 121.362 -0.447 . . . . 0.0 112.538 -176.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 12.4 t -65.81 151.92 45.55 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 177.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.47 -7.39 47.12 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 120.905 0.383 . . . . 0.0 111.477 174.062 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -72.19 -27.33 62.49 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 121.174 0.511 . . . . 0.0 110.402 170.066 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -85.43 -177.73 6.53 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.711 175.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 59.42 79.42 0.23 Allowed 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.333 0.587 . . . . 0.0 111.314 -179.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.508 ' N ' HD11 ' A' ' 60' ' ' LEU . 5.1 mp -79.35 3.08 19.3 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.903 -174.21 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -75.97 99.14 4.46 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-O 120.785 0.326 . . . . 0.0 110.139 178.195 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -95.98 9.29 41.21 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 -173.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 79.1 t60 -71.63 -15.34 62.24 Favored 'General case' 0 N--CA 1.471 0.599 0 O-C-N 121.602 -0.686 . . . . 0.0 110.028 173.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 45.2 m80 -69.56 96.36 0.92 Allowed 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.058 173.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 57.1 m-70 -88.15 -63.13 1.35 Allowed 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 121.031 0.443 . . . . 0.0 110.542 176.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 28.8 p80 -125.34 22.01 7.84 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 121.278 0.561 . . . . 0.0 110.571 179.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 75.0 t60 . . . . . 0 C--O 1.251 1.164 0 CA-C-O 118.201 -0.904 . . . . 0.0 110.338 -179.299 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.569 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.434 0 CA-C-O 120.707 0.289 . . . . 0.0 111.305 . . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.441 ' C ' ' H ' ' A' ' 4' ' ' GLN . 27.7 m -109.86 159.56 17.11 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 120.748 0.309 . . . . 0.0 111.002 -178.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.405 ' O ' HG12 ' A' ' 3' ' ' ILE . 15.2 tt -69.94 13.96 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.208 0 CA-C-O 121.163 0.506 . . . . 0.0 112.282 177.402 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.441 ' H ' ' C ' ' A' ' 2' ' ' THR . 22.3 tm0? 63.25 92.76 0.06 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.739 0.815 . . . . 0.0 111.959 -179.203 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.411 ' N ' ' HD3' ' A' ' 6' ' ' PRO . . . -172.96 62.94 0.29 Allowed Pre-proline 0 CA--C 1.539 0.527 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.411 177.364 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.411 ' HD3' ' N ' ' A' ' 5' ' ' ALA . 5.5 Cg_exo -79.58 29.98 0.48 Allowed 'Trans proline' 0 CA--C 1.537 0.654 0 C-N-CA 123.25 2.633 . . . . 0.0 113.455 -175.018 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -75.35 75.79 2.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.197 0.522 . . . . 0.0 110.639 -179.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 66.5 m -98.39 141.78 30.83 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.786 -177.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 55.1 tptt -133.87 114.76 13.68 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.879 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 52.4 mt -88.64 105.34 15.63 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 CA-C-O 120.727 0.298 . . . . 0.0 111.013 -177.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 2.4 t -102.67 147.79 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-O 120.884 0.373 . . . . 0.0 111.271 -176.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -89.23 -4.46 58.19 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 121.075 0.464 . . . . 0.0 111.183 -178.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -131.89 152.25 51.17 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.051 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 21.1 m -80.39 -6.83 58.66 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 120.837 0.351 . . . . 0.0 111.611 179.076 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -95.16 114.64 26.46 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 120.942 0.401 . . . . 0.0 110.961 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 70.7 t -125.46 135.08 65.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 N-CA-C 113.056 0.762 . . . . 0.0 113.056 -171.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -104.37 110.3 22.49 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.525 173.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 66.2 m -107.85 177.66 4.75 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 122.515 0.326 . . . . 0.0 111.28 179.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.645 ' HB3' ' HA ' ' A' ' 27' ' ' HIS . 8.2 m-20 -127.06 66.0 1.29 Allowed 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 121.563 0.697 . . . . 0.0 112.621 178.236 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -174.22 120.05 0.77 Allowed Glycine 0 CA--C 1.527 0.82 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.343 176.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 149.37 -51.99 0.53 Allowed Glycine 0 CA--C 1.533 1.198 0 C-N-CA 119.827 -1.178 . . . . 0.0 115.78 177.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 78.7 mt-10 -94.93 169.19 10.31 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 113.191 0.811 . . . . 0.0 113.191 -170.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 40.58 -97.5 0.01 OUTLIER Glycine 0 CA--C 1.534 1.227 0 CA-C-N 115.523 -0.762 . . . . 0.0 114.582 -173.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -89.13 17.17 6.16 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 117.132 0.466 . . . . 0.0 111.507 178.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.6 pp 50.41 5.62 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 125.457 1.503 . . . . 0.0 114.14 -178.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -125.98 101.95 0.63 Allowed Glycine 0 CA--C 1.526 0.745 0 C-N-CA 121.021 -0.609 . . . . 0.0 113.654 -175.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.645 ' HA ' ' HB3' ' A' ' 19' ' ' ASP . 13.3 m-70 56.29 52.15 6.62 Favored Pre-proline 0 CA--C 1.548 0.9 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 176.382 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.568 ' HD3' ' N ' ' A' ' 27' ' ' HIS . 44.0 Cg_endo -102.76 13.37 0.33 Allowed 'Trans proline' 0 CA--C 1.545 1.059 0 C-N-CA 123.362 2.708 . . . . 0.0 113.405 177.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 64.25 86.93 0.12 Allowed 'General case' 0 N--CA 1.446 -0.646 0 CA-C-O 122.35 1.071 . . . . 0.0 110.909 -177.423 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 19.0 m -109.69 154.2 11.24 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.133 0 CA-C-N 113.97 -1.468 . . . . 0.0 111.453 -178.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 49.7 m95 -124.14 114.84 20.2 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 121.243 0.544 . . . . 0.0 112.136 -175.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.438 ' N ' HD11 ' A' ' 32' ' ' LEU . 6.1 mp -105.46 167.56 9.66 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.454 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 54.2 tp60 -130.25 113.51 14.51 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.336 179.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.541 HG21 ' HB2' ' A' ' 52' ' ' LEU . 76.2 mt -63.06 120.15 58.67 Favored Pre-proline 0 CA--C 1.541 0.597 0 CA-C-O 120.684 0.278 . . . . 0.0 111.397 -179.288 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.582 ' HG2' ' OG1' ' A' ' 38' ' ' THR . 83.5 Cg_endo -79.82 113.75 3.08 Favored 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 122.262 1.975 . . . . 0.0 112.022 177.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -60.89 -15.0 25.91 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 121.115 0.483 . . . . 0.0 111.542 -179.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -68.87 -29.51 67.83 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.568 174.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.582 ' OG1' ' HG2' ' A' ' 35' ' ' PRO . 34.6 p -103.25 -54.73 2.55 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 121.205 0.526 . . . . 0.0 110.445 175.151 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 113.13 -0.19 25.39 Favored Glycine 0 CA--C 1.526 0.727 0 CA-C-N 115.8 -0.636 . . . . 0.0 113.123 179.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 66.1 p-90 -166.45 162.44 16.91 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -177.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.529 HG13 HG12 ' A' ' 34' ' ' ILE . 11.3 p -153.77 133.55 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.346 174.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.464 ' HA ' ' HA ' ' A' ' 49' ' ' LYS . 0.5 OUTLIER -110.94 148.87 31.56 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.062 0.458 . . . . 0.0 111.866 -178.282 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.539 ' HB3' ' HB3' ' A' ' 47' ' ' ASP . 52.3 t -84.52 108.13 13.6 Favored Pre-proline 0 N--CA 1.466 0.364 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 171.018 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -65.06 -9.41 21.55 Favored 'Trans proline' 0 CA--C 1.54 0.794 0 C-N-CA 122.742 2.295 . . . . 0.0 113.476 -172.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -87.33 -89.9 0.12 Allowed 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 120.566 0.222 . . . . 0.0 111.575 -177.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 75.7 m -152.45 82.62 1.24 Allowed 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 120.956 0.408 . . . . 0.0 111.477 179.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.539 ' HB3' ' HB3' ' A' ' 43' ' ' CYS . 9.7 t70 -149.98 -90.22 0.07 Allowed 'General case' 0 CA--C 1.548 0.889 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.184 177.038 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 30.2 p 179.8 -176.92 0.34 Allowed 'General case' 0 N--CA 1.477 0.889 0 CA-C-O 121.106 0.479 . . . . 0.0 111.422 174.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.464 ' HA ' ' HA ' ' A' ' 42' ' ' GLU . 39.5 ttmt -106.54 120.27 41.48 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 123.036 0.534 . . . . 0.0 110.693 178.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -98.72 108.24 20.88 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.081 0.467 . . . . 0.0 111.868 -173.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 99.7 t -93.75 134.39 31.59 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.243 178.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.541 ' HB2' HG21 ' A' ' 34' ' ' ILE . 51.8 tp -79.18 120.7 24.07 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 121.304 0.573 . . . . 0.0 111.649 -178.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -77.4 118.18 19.61 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.948 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 88.38 55.48 2.19 Favored Glycine 0 CA--C 1.524 0.652 0 C-N-CA 121.035 -0.603 . . . . 0.0 111.64 -173.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 25.0 t -151.03 -150.99 0.37 Allowed 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 122.898 0.479 . . . . 0.0 110.985 -175.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -101.65 22.72 12.33 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 -177.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -129.51 -33.26 1.89 Allowed 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 121.415 0.626 . . . . 0.0 111.097 -175.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -74.94 68.7 1.82 Allowed 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.764 178.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -99.14 29.74 3.76 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.517 -179.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.444 ' N ' HD13 ' A' ' 60' ' ' LEU . 6.1 mp -76.3 80.08 3.06 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 121.019 0.438 . . . . 0.0 111.842 -177.586 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -84.63 93.31 8.36 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 121.395 0.616 . . . . 0.0 110.873 176.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 88.6 m-70 -139.17 97.7 3.36 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.982 177.028 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 71.0 t60 -70.61 84.77 0.62 Allowed 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 121.192 0.52 . . . . 0.0 110.127 174.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.408 ' O ' ' N ' ' A' ' 66' ' ' HIS . 2.6 t-160 -69.73 151.58 45.65 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.252 179.625 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . 0.487 ' O ' ' HB2' ' A' ' 66' ' ' HIS . 17.0 t60 -66.59 72.47 0.08 Allowed 'General case' 0 CA--C 1.545 0.754 0 CA-C-O 121.01 0.434 . . . . 0.0 111.297 -177.317 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.487 ' HB2' ' O ' ' A' ' 65' ' ' HIS . 41.0 t-80 161.19 -32.05 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.066 0.946 . . . . 0.0 110.173 -173.582 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 39.6 t-80 . . . . . 0 C--O 1.25 1.098 0 CA-C-O 118.916 -0.564 . . . . 0.0 111.876 -175.598 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.3 ptm . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 23.5 p -74.11 131.37 41.24 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.444 ' O ' ' HD2' ' A' ' 6' ' ' PRO . 25.1 pt -73.06 66.54 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 CA-C-O 121.979 0.895 . . . . 0.0 109.133 168.023 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -81.31 20.44 0.85 Allowed 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 115.243 -0.89 . . . . 0.0 113.249 -169.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -74.69 -47.22 5.29 Favored Pre-proline 0 CA--C 1.547 0.843 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 179.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.444 ' HD2' ' O ' ' A' ' 3' ' ' ILE . 83.6 Cg_exo -46.69 99.2 0.03 OUTLIER 'Trans proline' 0 C--N 1.36 1.16 0 C-N-CA 122.879 2.386 . . . . 0.0 114.526 -177.296 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -90.4 21.7 3.76 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 121.601 0.715 . . . . 0.0 110.574 173.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.429 ' HA ' ' O ' ' A' ' 49' ' ' LYS . 51.6 m -118.93 137.97 53.1 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 115.395 -0.821 . . . . 0.0 111.559 -172.351 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -134.92 129.9 35.03 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 120.766 0.317 . . . . 0.0 111.069 -176.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 59.9 mt -86.45 118.91 33.63 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 CA-C-O 121.079 0.466 . . . . 0.0 111.614 -179.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 35.3 m -109.52 163.41 6.62 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.964 176.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -92.17 -21.44 20.39 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -176.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -121.54 152.01 39.69 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 -176.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 48.7 m -70.28 -21.04 63.0 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 116.049 -0.523 . . . . 0.0 112.334 -178.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 80.7 mtp180 -87.6 111.83 21.66 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.148 0.499 . . . . 0.0 111.33 178.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.497 HG13 ' HG ' ' A' ' 18' ' ' CYS . 61.2 t -113.01 115.81 50.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.926 -177.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -95.16 115.01 26.87 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 120.695 0.283 . . . . 0.0 111.382 177.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.5 ' O ' HG13 ' A' ' 30' ' ' VAL . 82.8 m -113.95 127.86 56.15 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 120.927 0.394 . . . . 0.0 111.306 179.34 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.525 ' HA ' ' H ' ' A' ' 29' ' ' ARG . 4.6 m-20 -85.9 -76.65 0.33 Allowed 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 120.946 0.403 . . . . 0.0 111.232 178.384 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.452 ' HA3' ' O ' ' A' ' 25' ' ' LEU . . . 162.31 -145.54 10.86 Favored Glycine 0 CA--C 1.52 0.393 0 C-N-CA 120.05 -1.071 . . . . 0.0 113.879 179.286 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 128.85 16.56 1.98 Allowed Glycine 0 CA--C 1.528 0.846 0 CA-C-N 115.329 -0.436 . . . . 0.0 112.114 -175.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 66.2 mm-40 -83.53 -169.25 2.46 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 122.46 0.304 . . . . 0.0 111.213 175.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -44.4 -53.14 7.01 Favored Glycine 0 CA--C 1.533 1.202 0 N-CA-C 114.138 0.415 . . . . 0.0 114.138 179.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.411 ' C ' ' H ' ' A' ' 26' ' ' GLY . . . -98.44 20.36 12.84 Favored 'General case' 0 N--CA 1.473 0.706 0 O-C-N 122.359 -0.495 . . . . 0.0 111.706 177.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.452 ' O ' ' HA3' ' A' ' 20' ' ' GLY . 57.4 mt 71.85 -19.71 0.26 Allowed 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.943 0.897 . . . . 0.0 112.601 -179.609 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.411 ' H ' ' C ' ' A' ' 24' ' ' ALA . . . 91.92 -107.88 3.55 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 120.916 -0.659 . . . . 0.0 114.256 175.56 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 2.6 p80 -159.57 104.54 1.48 Allowed Pre-proline 0 N--CA 1.475 0.783 0 O-C-N 122.46 -0.435 . . . . 0.0 111.954 -168.172 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.486 ' O ' ' HB3' ' A' ' 29' ' ' ARG . 39.2 Cg_exo -56.22 93.54 0.05 OUTLIER 'Trans proline' 0 CA--C 1.54 0.789 0 C-N-CA 122.391 2.061 . . . . 0.0 113.132 -178.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.525 ' H ' ' HA ' ' A' ' 19' ' ' ASP . 0.0 OUTLIER 81.72 102.69 0.06 Allowed 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 122.444 1.116 . . . . 0.0 111.342 175.072 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.5 HG13 ' O ' ' A' ' 18' ' ' CYS . 11.5 p -132.02 132.98 61.22 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-N 114.153 -1.385 . . . . 0.0 109.488 166.632 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 59.8 m95 -100.09 132.5 45.41 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.24 0.543 . . . . 0.0 112.339 -176.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.421 ' N ' HD13 ' A' ' 32' ' ' LEU . 5.4 mp -115.67 160.89 19.45 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.904 177.13 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -119.55 124.78 47.24 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.496 178.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.491 HG21 ' HB2' ' A' ' 52' ' ' LEU . 73.7 mt -79.33 132.25 63.18 Favored Pre-proline 0 CA--C 1.545 0.768 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -178.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.547 ' HG2' ' OG1' ' A' ' 38' ' ' THR . 94.7 Cg_endo -81.95 117.33 2.9 Favored 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 122.609 2.206 . . . . 0.0 112.317 173.521 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -60.25 -33.82 72.82 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -176.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.489 ' O ' ' HE2' ' A' ' 56' ' ' LYS . 8.0 p-10 -62.23 -30.9 71.42 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 120.773 0.321 . . . . 0.0 111.846 -178.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.547 ' OG1' ' HG2' ' A' ' 35' ' ' PRO . 21.9 p -91.55 -48.89 6.6 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.377 0.608 . . . . 0.0 110.428 175.023 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 100.01 2.47 56.0 Favored Glycine 0 CA--C 1.524 0.614 0 CA-C-N 115.597 -0.729 . . . . 0.0 112.756 -177.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.404 ' HB3' HG23 ' A' ' 51' ' ' VAL . 65.2 p-90 -158.81 152.77 23.52 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 120.961 0.41 . . . . 0.0 111.867 -175.533 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.421 HG13 HG12 ' A' ' 34' ' ' ILE . 11.0 p -131.6 150.58 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.939 176.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -117.2 131.47 56.85 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 121.113 0.482 . . . . 0.0 111.154 178.164 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 49.5 t -82.67 110.49 22.63 Favored Pre-proline 0 N--CA 1.47 0.532 0 N-CA-C 111.911 0.337 . . . . 0.0 111.911 -179.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -58.94 -26.93 83.15 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 122.699 2.266 . . . . 0.0 113.319 -177.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -112.03 17.55 19.54 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 112.13 0.418 . . . . 0.0 112.13 -176.127 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.421 ' SG ' ' SG ' ' A' ' 48' ' ' CYS . 36.2 t -146.1 -7.17 0.56 Allowed 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 174.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 55.18 24.72 6.51 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 113.203 0.816 . . . . 0.0 113.203 178.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.421 ' SG ' ' SG ' ' A' ' 46' ' ' CYS . 81.3 m -102.92 138.02 40.35 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 120.812 0.339 . . . . 0.0 111.611 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.429 ' O ' ' HA ' ' A' ' 8' ' ' THR . 85.7 tttt -109.01 121.51 45.3 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 122.92 0.488 . . . . 0.0 111.149 -178.378 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -116.93 125.77 51.95 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 112.13 0.418 . . . . 0.0 112.13 -177.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.404 HG23 ' HB3' ' A' ' 40' ' ' TRP . 40.9 t -94.54 139.33 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.873 176.344 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.491 ' HB2' HG21 ' A' ' 34' ' ' ILE . 56.5 tp -87.13 119.12 27.03 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.407 177.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -67.67 118.59 11.15 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 121.076 0.465 . . . . 0.0 111.122 178.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 120.5 -28.51 6.21 Favored Glycine 0 CA--C 1.525 0.686 0 CA-C-N 115.992 -0.549 . . . . 0.0 112.29 -174.16 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 66.1 m -80.83 168.07 19.19 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 120.877 0.37 . . . . 0.0 111.252 178.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.489 ' HE2' ' O ' ' A' ' 37' ' ' ASP . 65.7 pttt -58.59 -25.03 62.18 Favored 'General case' 0 CA--C 1.543 0.673 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -177.206 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.72 -33.2 75.11 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.151 0.5 . . . . 0.0 111.23 176.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -77.28 -5.91 51.19 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.206 177.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.39 36.05 0.24 Allowed 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -177.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.9 pp -62.34 165.43 6.01 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 122.182 -0.324 . . . . 0.0 110.965 174.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 49.1 121.16 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.436 0 CA-C-O 121.999 0.904 . . . . 0.0 113.127 -175.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 52.0 t-80 -82.57 40.35 0.66 Allowed 'General case' 0 CA--C 1.546 0.816 0 O-C-N 121.232 -0.917 . . . . 0.0 110.615 176.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 39.3 t-80 -95.6 10.47 36.6 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.731 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 69.1 m80 71.03 134.58 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.626 0.77 . . . . 0.0 111.754 -177.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 43.7 m-70 -101.25 179.4 4.37 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 121.489 0.661 . . . . 0.0 112.509 -176.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 28.3 m170 -71.05 93.38 1.02 Allowed 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.989 -178.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 22.3 p-80 . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.719 -0.658 . . . . 0.0 112.112 -177.275 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.0 ptp . . . . . 0 N--CA 1.489 1.517 0 CA-C-O 120.921 0.391 . . . . 0.0 112.023 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 2.0 m -119.04 9.12 11.74 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.549 174.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.449 ' O ' ' HG2' ' A' ' 4' ' ' GLN . 49.0 mm 72.92 -40.16 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 123.345 0.658 . . . . 0.0 111.527 -173.783 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.449 ' HG2' ' O ' ' A' ' 3' ' ' ILE . 9.3 pt20 53.31 26.07 4.96 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.278 1.031 . . . . 0.0 113.07 171.749 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -117.09 82.96 14.49 Favored Pre-proline 0 CA--C 1.54 0.571 0 CA-C-O 120.775 0.321 . . . . 0.0 111.103 177.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.486 ' O ' ' HA ' ' A' ' 48' ' ' CYS . 62.6 Cg_endo -86.92 31.05 0.45 Allowed 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 123.076 2.518 . . . . 0.0 114.023 -173.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 51.11 103.83 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 178.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 86.8 m -85.83 115.32 23.4 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.059 175.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 73.8 mttt -121.95 98.57 6.01 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 120.995 0.426 . . . . 0.0 110.882 176.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 57.8 mt -86.21 127.75 39.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.108 -179.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 28.5 m -125.56 163.45 26.71 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.546 -179.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -89.15 -19.79 25.05 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 120.76 0.314 . . . . 0.0 111.515 179.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 13.6 pttm -131.84 148.08 52.52 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 121.076 0.465 . . . . 0.0 111.615 -177.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 12.2 p -68.39 -30.79 69.79 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 114.572 1.323 . . . . 0.0 114.572 -168.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 94.4 mtt180 -75.41 104.3 5.92 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 118.53 0.604 . . . . 0.0 111.512 179.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 36.4 t -117.88 122.37 69.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.388 -178.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -81.4 109.66 16.1 Favored 'General case' 0 CA--C 1.535 0.4 0 O-C-N 122.252 -0.28 . . . . 0.0 111.116 175.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.731 ' SG ' ' HB ' ' A' ' 30' ' ' VAL . 22.8 p -66.07 104.28 1.12 Allowed 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 121.056 0.455 . . . . 0.0 110.936 179.664 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -66.28 -84.99 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 115.989 -0.55 . . . . 0.0 112.469 -177.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.528 ' HA3' ' HA2' ' A' ' 26' ' ' GLY . . . 161.14 175.11 31.81 Favored Glycine 0 CA--C 1.524 0.65 0 C-N-CA 120.351 -0.928 . . . . 0.0 113.806 178.101 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -73.43 -70.6 1.21 Allowed Glycine 0 CA--C 1.523 0.564 0 C-N-CA 121.026 -0.606 . . . . 0.0 112.075 175.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -166.25 128.57 1.91 Allowed 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 122.343 0.257 . . . . 0.0 111.082 178.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 39.79 -96.06 0.01 OUTLIER Glycine 0 CA--C 1.531 1.064 0 N-CA-C 115.015 0.766 . . . . 0.0 115.015 179.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -60.39 -28.59 68.35 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.112 0.482 . . . . 0.0 112.196 -177.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 85.9 mt -95.65 23.0 6.5 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-O 120.983 0.42 . . . . 0.0 111.702 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.528 ' HA2' ' HA3' ' A' ' 20' ' ' GLY . . . -80.64 176.0 54.75 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 121.377 -0.44 . . . . 0.0 112.578 175.798 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 10.1 m-70 -127.87 140.35 37.92 Favored Pre-proline 0 N--CA 1.472 0.666 0 O-C-N 121.948 -0.736 . . . . 0.0 111.069 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -76.16 52.35 3.46 Favored 'Trans proline' 0 CA--C 1.546 1.103 0 C-N-CA 122.893 2.395 . . . . 0.0 113.981 -175.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.46 ' HD3' ' HA ' ' A' ' 29' ' ' ARG . 2.8 tpp180 59.74 85.75 0.1 Allowed 'General case' 0 N--CA 1.445 -0.722 0 CA-C-O 122.461 1.124 . . . . 0.0 112.612 176.534 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.731 ' HB ' ' SG ' ' A' ' 18' ' ' CYS . 48.4 t -118.45 115.08 47.04 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.066 0 CA-C-N 114.107 -1.406 . . . . 0.0 110.565 177.544 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 83.3 m95 -91.41 103.91 16.49 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 120.948 0.404 . . . . 0.0 111.291 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.496 HD21 ' HD3' ' A' ' 44' ' ' PRO . 6.2 mp -83.62 131.07 34.99 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 121.021 0.439 . . . . 0.0 111.436 179.107 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 27.1 tp60 -93.89 105.32 17.35 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.334 176.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.498 HG12 HG13 ' A' ' 41' ' ' VAL . 73.5 mt -64.43 124.76 86.83 Favored Pre-proline 0 CA--C 1.542 0.638 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.661 -178.359 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.542 ' HG2' ' OG1' ' A' ' 38' ' ' THR . 76.9 Cg_endo -74.19 119.24 5.72 Favored 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 122.671 2.247 . . . . 0.0 112.211 179.567 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -64.63 -17.15 63.76 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-O 121.162 0.506 . . . . 0.0 111.582 -178.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -64.93 -44.07 90.72 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 120.916 0.389 . . . . 0.0 111.22 175.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.542 ' OG1' ' HG2' ' A' ' 35' ' ' PRO . 31.6 p -95.92 -54.3 3.38 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 121.08 0.467 . . . . 0.0 110.99 179.545 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 110.87 1.18 28.74 Favored Glycine 0 CA--C 1.524 0.605 0 CA-C-N 115.948 -0.569 . . . . 0.0 113.494 179.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 62.0 p-90 -153.79 160.15 42.15 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 116.941 0.37 . . . . 0.0 111.183 -177.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.498 HG13 HG12 ' A' ' 34' ' ' ILE . 13.4 p -141.15 141.49 30.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.648 176.053 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.39 154.93 16.96 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 121.305 0.574 . . . . 0.0 111.948 -179.135 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.445 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 43.8 t -73.05 123.12 89.22 Favored Pre-proline 0 CA--C 1.537 0.449 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.603 179.305 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.496 ' HD3' HD21 ' A' ' 32' ' ' LEU . 14.9 Cg_exo -69.03 -7.71 21.59 Favored 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 122.757 2.305 . . . . 0.0 113.095 -179.501 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -98.83 -46.9 5.49 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 120.924 0.392 . . . . 0.0 111.576 -178.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 25.1 t -120.08 -91.0 0.57 Allowed 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.514 -177.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -173.91 19.11 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 179.005 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.486 ' HA ' ' O ' ' A' ' 6' ' ' PRO . 56.7 m -64.97 132.53 49.53 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 -177.33 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.747 ' HZ3' ' HB2' ' A' ' 49' ' ' LYS . 5.0 ttmp? -102.34 110.71 22.74 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 121.203 0.525 . . . . 0.0 111.572 -179.257 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 55.3 m-85 -94.76 104.35 16.26 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.447 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 56.7 t -92.13 137.3 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 CA-C-O 121.174 0.511 . . . . 0.0 112.372 -175.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 59.6 tp -98.91 130.05 45.28 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.508 178.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -64.77 143.9 57.62 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-O 120.845 0.355 . . . . 0.0 111.635 178.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 81.42 -13.89 31.95 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 121.367 -0.444 . . . . 0.0 114.081 175.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 59.9 p -84.2 179.99 7.35 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 120.935 0.398 . . . . 0.0 111.345 -178.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 62.0 mttm -63.5 -27.33 69.19 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 179.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -69.53 -27.45 65.18 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.301 0.572 . . . . 0.0 110.662 175.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -90.89 -21.91 21.17 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.769 176.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -86.49 -22.17 26.58 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 3.5 pp -74.85 170.58 15.62 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 111.857 0.317 . . . . 0.0 111.857 179.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 68.79 -59.95 0.45 Allowed 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.245 0.618 . . . . 0.0 111.472 -177.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 26.8 t60 -67.9 100.1 0.92 Allowed 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 172.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 13.6 p-80 -53.96 115.41 2.01 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-O 120.759 0.314 . . . . 0.0 111.122 -176.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 32.0 t60 -62.29 -17.19 57.95 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -172.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . 0.533 ' O ' ' HB3' ' A' ' 66' ' ' HIS . 30.0 m-70 -53.11 128.79 28.91 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 120.93 -0.308 . . . . 0.0 111.025 175.14 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.533 ' HB3' ' O ' ' A' ' 65' ' ' HIS . 82.6 t60 81.92 91.89 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.549 -165.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 78.0 t60 . . . . . 0 C--O 1.252 1.232 0 CA-C-O 118.165 -0.921 . . . . 0.0 112.603 -178.773 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.3 ptm . . . . . 0 N--CA 1.49 1.526 0 CA-C-O 120.754 0.311 . . . . 0.0 111.685 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.444 ' C ' ' H ' ' A' ' 4' ' ' GLN . 75.2 p -127.03 -58.08 1.3 Allowed 'General case' 0 N--CA 1.475 0.808 0 O-C-N 122.04 -0.413 . . . . 0.0 111.624 176.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 63.7 mt 72.92 -22.73 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.849 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.944 -177.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.444 ' H ' ' C ' ' A' ' 2' ' ' THR . 83.4 mm-40 64.36 6.86 3.25 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.109 0.564 . . . . 0.0 111.875 -176.607 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -159.85 56.69 0.89 Allowed Pre-proline 0 CA--C 1.541 0.629 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.947 179.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -80.9 39.2 0.83 Allowed 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 122.738 2.292 . . . . 0.0 113.067 -175.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -66.62 134.94 53.34 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-O 121.561 0.696 . . . . 0.0 112.667 -174.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.449 ' OG1' ' NZ ' ' A' ' 49' ' ' LYS . 99.9 m -103.95 147.3 27.52 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.087 178.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -134.95 113.13 11.21 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 120.786 0.327 . . . . 0.0 110.684 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 53.2 mt -86.82 107.1 16.54 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-O 121.176 0.512 . . . . 0.0 111.005 -179.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.497 HG12 HG21 ' A' ' 16' ' ' VAL . 30.6 m -96.12 155.6 3.4 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-O 121.175 0.512 . . . . 0.0 112.149 -176.666 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -94.98 3.1 55.32 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.642 -176.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 62.7 pttt -135.07 155.2 51.15 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.016 179.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 59.0 m -75.87 -32.66 59.81 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -175.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.456 ' HB3' ' OE1' ' A' ' 33' ' ' GLN . 13.0 ptp180 -112.79 121.13 43.81 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 121.233 0.54 . . . . 0.0 111.469 -178.027 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.497 HG21 HG12 ' A' ' 11' ' ' VAL . 46.2 t -127.49 132.35 69.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.679 -177.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.473 ' HA ' ' O ' ' A' ' 30' ' ' VAL . . . -83.04 88.28 6.87 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 121.146 0.498 . . . . 0.0 110.718 176.065 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.451 ' SG ' ' HB3' ' A' ' 46' ' ' CYS . 43.7 t -72.24 104.03 3.55 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 -174.137 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 38.0 t70 54.04 22.14 3.3 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-O 122.093 0.949 . . . . 0.0 111.777 177.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -123.41 111.77 1.75 Allowed Glycine 0 CA--C 1.522 0.471 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.584 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 65.78 27.13 72.43 Favored Glycine 0 CA--C 1.53 1.025 0 C-N-CA 121.048 -0.596 . . . . 0.0 113.006 -174.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -112.04 -149.91 0.45 Allowed 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 122.709 0.404 . . . . 0.0 110.738 179.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -43.31 -47.0 6.84 Favored Glycine 0 CA--C 1.534 1.236 0 N-CA-C 114.537 0.575 . . . . 0.0 114.537 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -97.52 -3.22 40.25 Favored 'General case' 0 N--CA 1.472 0.656 0 O-C-N 122.356 -0.496 . . . . 0.0 112.034 179.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.0 pp 43.22 26.87 0.1 Allowed 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.507 1.123 . . . . 0.0 113.863 176.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -55.9 -68.02 1.91 Allowed Glycine 0 CA--C 1.526 0.759 0 N-CA-C 114.375 0.51 . . . . 0.0 114.375 -175.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.421 ' CE1' ' HB3' ' A' ' 45' ' ' TYR . 8.1 m80 -77.26 156.37 81.6 Favored Pre-proline 0 N--CA 1.472 0.649 0 O-C-N 122.374 -0.486 . . . . 0.0 110.974 -178.194 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -72.7 48.57 1.36 Allowed 'Trans proline' 0 CA--C 1.544 1.007 0 C-N-CA 123.142 2.562 . . . . 0.0 113.497 179.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 22.9 tpt180 67.37 85.97 0.14 Allowed 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 122.308 1.052 . . . . 0.0 111.426 179.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.473 ' O ' ' HA ' ' A' ' 17' ' ' ALA . 58.9 t -107.16 112.54 40.42 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 CA-C-N 114.196 -1.365 . . . . 0.0 111.322 -177.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 95.9 m95 -95.09 118.48 31.96 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.125 0.488 . . . . 0.0 111.919 -179.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.1 mp -94.58 111.65 23.41 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.31 173.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.456 ' OE1' ' HB3' ' A' ' 15' ' ' ARG . 59.4 tp60 -92.43 110.08 21.48 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.83 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.478 HG21 ' HB2' ' A' ' 52' ' ' LEU . 73.5 mt -75.77 119.12 75.68 Favored Pre-proline 0 CA--C 1.543 0.676 0 CA-C-O 120.9 0.381 . . . . 0.0 111.331 179.162 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -85.5 146.35 9.57 Favored 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 122.842 2.361 . . . . 0.0 113.178 -178.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -70.9 -10.12 59.03 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 120.864 0.364 . . . . 0.0 110.848 174.357 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -62.94 -40.58 98.09 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.352 0.596 . . . . 0.0 110.836 172.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 44.3 p -108.56 -54.04 2.56 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.624 -176.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 99.61 1.12 56.51 Favored Glycine 0 CA--C 1.525 0.694 0 CA-C-N 116.092 -0.504 . . . . 0.0 112.061 -174.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 64.5 p-90 -156.86 166.93 31.99 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 122.588 0.355 . . . . 0.0 110.966 -177.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 11.5 p -145.11 136.58 20.34 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-O 120.895 0.379 . . . . 0.0 110.921 174.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -91.76 133.43 35.62 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.006 0.431 . . . . 0.0 110.447 177.176 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.481 ' SG ' ' HB2' ' A' ' 45' ' ' TYR . 44.5 t -103.69 105.31 47.02 Favored Pre-proline 0 N--CA 1.467 0.413 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -178.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -73.54 -2.54 12.3 Favored 'Trans proline' 0 CA--C 1.542 0.923 0 C-N-CA 122.526 2.151 . . . . 0.0 112.351 174.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.481 ' HB2' ' SG ' ' A' ' 43' ' ' CYS . 60.7 m-85 -90.74 -42.14 10.86 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.548 179.099 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.451 ' HB3' ' SG ' ' A' ' 18' ' ' CYS . 53.1 t -118.53 1.87 11.74 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -175.329 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 59.43 51.44 6.62 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 112.802 0.668 . . . . 0.0 112.802 175.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 87.6 m -149.04 157.6 43.53 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 120.835 0.35 . . . . 0.0 111.505 177.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.6 ' HZ3' ' HB3' ' A' ' 49' ' ' LYS . 7.2 ttpm? -106.45 121.9 45.21 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 116.532 -0.303 . . . . 0.0 111.282 178.634 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 37.1 m-85 -99.62 119.41 38.04 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 120.663 0.268 . . . . 0.0 111.511 -179.093 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 97.3 t -101.87 139.99 21.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 CA-C-O 120.84 0.353 . . . . 0.0 111.491 177.103 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.478 ' HB2' HG21 ' A' ' 34' ' ' ILE . 60.9 tp -88.54 118.71 28.39 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 120.935 0.398 . . . . 0.0 111.919 -179.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -63.57 133.17 53.3 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.816 178.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 90.36 -8.18 80.24 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 121.159 -0.543 . . . . 0.0 113.546 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 45.5 t -77.52 179.94 6.21 Favored 'General case' 0 N--CA 1.472 0.667 0 O-C-N 122.361 -0.493 . . . . 0.0 111.035 178.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -66.85 -27.77 67.8 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.116 0.484 . . . . 0.0 111.157 179.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -76.41 -25.38 54.43 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.444 177.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -110.94 86.96 2.42 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 121.42 0.628 . . . . 0.0 111.332 -178.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -102.67 -18.5 15.18 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.827 175.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 3.1 pp -67.49 -6.14 18.27 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 -177.274 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 54.1 tp10 -88.79 -73.44 0.5 Allowed 'General case' 0 CA--C 1.538 0.499 0 O-C-N 121.87 -0.519 . . . . 0.0 111.663 176.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 29.5 t60 -84.45 -20.0 32.47 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -177.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 28.3 t60 69.34 -15.12 0.29 Allowed 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 113.399 0.889 . . . . 0.0 113.399 176.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 -140.93 171.25 14.33 Favored 'General case' 0 N--CA 1.474 0.746 0 O-C-N 121.964 -0.46 . . . . 0.0 110.977 178.09 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 11.1 m170 -106.57 153.63 22.06 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 120.805 0.336 . . . . 0.0 110.94 175.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 38.7 m80 -78.13 -36.66 47.55 Favored 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 168.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 48.5 t-80 . . . . . 0 C--O 1.257 1.463 0 CA-C-N 114.971 -1.013 . . . . 0.0 110.454 172.897 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 70.7 mtm . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 120.982 0.42 . . . . 0.0 111.21 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 68.6 p -96.39 158.95 15.2 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.074 0.464 . . . . 0.0 111.713 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.408 ' O ' ' HG2' ' A' ' 4' ' ' GLN . 35.0 pt -75.22 9.19 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.303 173.651 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.408 ' HG2' ' O ' ' A' ' 3' ' ' ILE . 9.5 pt20 49.08 19.75 0.32 Allowed 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.85 1.26 . . . . 0.0 113.221 179.729 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -131.41 96.21 22.07 Favored Pre-proline 0 CA--C 1.542 0.642 0 CA-C-O 120.795 0.331 . . . . 0.0 111.482 179.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -88.04 32.77 0.4 Allowed 'Trans proline' 0 CA--C 1.541 0.859 0 C-N-CA 122.892 2.395 . . . . 0.0 113.124 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.464 ' HB3' ' SG ' ' A' ' 48' ' ' CYS . 86.4 tt0 -65.47 115.22 5.48 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 120.945 0.402 . . . . 0.0 111.794 -177.431 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 57.8 p -96.1 115.46 27.46 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 122.751 0.42 . . . . 0.0 111.771 178.177 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 65.2 mttm -99.37 100.43 11.49 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.018 0.437 . . . . 0.0 110.269 178.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.478 HG21 ' HB2' ' A' ' 53' ' ' LYS . 55.4 mt -82.19 100.47 6.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.546 -176.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 33.2 m -107.93 157.0 8.27 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 CA-C-O 121.108 0.48 . . . . 0.0 112.247 -176.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -99.74 25.31 7.34 Favored 'General case' 0 CA--C 1.548 0.896 0 CA-C-O 121.676 0.75 . . . . 0.0 110.5 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -144.1 131.48 20.91 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.071 -175.081 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 9.1 m -81.01 -26.71 36.24 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -178.106 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.438 ' HG2' ' OE1' ' A' ' 33' ' ' GLN . 89.2 mtt180 -100.7 92.38 5.07 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.17 0.509 . . . . 0.0 110.123 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 44.9 t -107.83 118.6 55.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-N 115.925 -0.579 . . . . 0.0 112.155 -171.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.408 ' HB3' ' CE2' ' A' ' 31' ' ' TRP . . . -84.93 100.5 11.66 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 120.751 0.31 . . . . 0.0 110.756 175.172 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.645 ' SG ' ' HB ' ' A' ' 30' ' ' VAL . 29.7 p -71.58 117.49 13.21 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 121.063 0.459 . . . . 0.0 111.769 -175.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -89.94 -75.3 0.46 Allowed 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.27 176.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 172.65 -164.68 36.94 Favored Glycine 0 CA--C 1.519 0.342 0 C-N-CA 120.579 -0.82 . . . . 0.0 113.088 -179.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -145.94 -86.45 0.07 OUTLIER Glycine 0 CA--C 1.522 0.507 0 C-N-CA 121.224 -0.512 . . . . 0.0 112.474 -179.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -72.32 163.32 28.17 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 120.666 0.269 . . . . 0.0 111.17 175.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -43.97 -54.08 6.18 Favored Glycine 0 CA--C 1.533 1.192 0 N-CA-C 114.6 0.6 . . . . 0.0 114.6 -176.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -77.51 -10.35 59.43 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 -178.035 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 64.1 mt -98.48 19.08 15.15 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 112.462 0.542 . . . . 0.0 112.462 -175.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -80.1 138.81 20.48 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 121.01 -0.614 . . . . 0.0 113.005 176.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 32.2 m80 -126.89 145.3 53.24 Favored Pre-proline 0 N--CA 1.472 0.67 0 O-C-N 122.444 -0.444 . . . . 0.0 110.579 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_exo -57.85 -58.15 0.92 Allowed 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 122.706 2.271 . . . . 0.0 114.183 -175.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 2.4 tmt_? 177.27 93.18 0.01 OUTLIER 'General case' 0 C--O 1.233 0.223 0 CA-C-O 121.806 0.813 . . . . 0.0 109.888 -171.391 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.645 ' HB ' ' SG ' ' A' ' 18' ' ' CYS . 55.1 t -124.54 132.69 70.97 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.022 0 CA-C-N 114.558 -1.201 . . . . 0.0 110.784 179.208 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . 0.408 ' CE2' ' HB3' ' A' ' 17' ' ' ALA . 37.3 m95 -110.02 119.94 40.89 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-O 121.205 0.526 . . . . 0.0 112.26 -176.576 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.6 mp -100.4 163.43 12.38 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 121.303 0.573 . . . . 0.0 111.568 177.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.438 ' OE1' ' HG2' ' A' ' 15' ' ' ARG . 55.8 tp60 -131.27 114.21 14.77 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.768 -179.365 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.528 HG21 ' HB2' ' A' ' 52' ' ' LEU . 64.7 mt -69.96 121.21 82.11 Favored Pre-proline 0 CA--C 1.543 0.7 0 CA-C-O 120.863 0.363 . . . . 0.0 111.617 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.479 ' HG2' ' OG1' ' A' ' 38' ' ' THR . 65.3 Cg_endo -81.63 130.26 6.79 Favored 'Trans proline' 0 CA--C 1.544 0.976 0 C-N-CA 122.855 2.37 . . . . 0.0 113.351 -178.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 44.3 mm-40 -60.02 -18.14 44.04 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 175.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -67.92 -36.64 80.51 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 120.966 0.413 . . . . 0.0 111.49 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.479 ' OG1' ' HG2' ' A' ' 35' ' ' PRO . 43.7 p -108.36 -50.86 2.97 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.049 0.452 . . . . 0.0 111.701 -177.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 104.31 1.64 44.33 Favored Glycine 0 CA--C 1.527 0.826 0 C-N-CA 121.352 -0.452 . . . . 0.0 112.412 -174.125 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 65.3 p-90 -154.36 160.19 41.56 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 122.708 0.403 . . . . 0.0 111.418 -179.164 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.488 HG13 HG12 ' A' ' 34' ' ' ILE . 12.3 p -144.11 127.05 11.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 CA-C-O 120.9 0.381 . . . . 0.0 110.823 176.455 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -100.16 146.2 27.12 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 121.058 0.456 . . . . 0.0 111.745 -178.457 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.556 ' HB3' ' HB2' ' A' ' 47' ' ' ASP . 42.0 t -103.86 119.28 54.99 Favored Pre-proline 0 CA--C 1.536 0.415 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -65.57 -12.58 35.72 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 122.819 2.346 . . . . 0.0 112.836 178.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.542 ' HB2' ' SG ' ' A' ' 43' ' ' CYS . 95.3 m-85 -82.38 7.31 14.44 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.716 178.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.463 ' HB2' ' O ' ' A' ' 45' ' ' TYR . 76.4 m 83.2 31.24 0.08 Allowed 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.906 0.882 . . . . 0.0 112.48 175.715 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.556 ' HB2' ' HB3' ' A' ' 43' ' ' CYS . 24.4 m-20 -94.2 5.96 50.11 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 120.999 0.428 . . . . 0.0 111.005 169.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.464 ' SG ' ' HB3' ' A' ' 7' ' ' GLU . 78.4 m 66.72 -161.92 0.24 Allowed 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 175.065 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.725 ' HZ1' ' HB2' ' A' ' 49' ' ' LYS . 5.0 ttmp? -94.11 126.75 39.52 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -174.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -96.89 105.49 17.64 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 120.658 0.266 . . . . 0.0 110.87 176.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 98.7 t -91.28 132.0 36.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-O 120.798 0.333 . . . . 0.0 111.472 -179.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.528 ' HB2' HG21 ' A' ' 34' ' ' ILE . 48.6 tp -85.39 112.54 20.94 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 121.215 0.531 . . . . 0.0 111.503 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.478 ' HB2' HG21 ' A' ' 10' ' ' ILE . 10.1 tmtt? -58.35 138.74 56.27 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.468 176.095 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 67.32 42.32 90.33 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 121.153 -0.546 . . . . 0.0 112.68 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 35.2 t -143.15 -168.57 2.83 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 120.767 0.317 . . . . 0.0 111.327 -176.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -60.84 -26.13 67.14 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -178.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -94.86 -15.03 24.03 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 -179.154 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -141.79 115.07 8.84 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 121.004 0.43 . . . . 0.0 111.614 -177.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -133.33 -58.7 0.88 Allowed 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 120.976 0.417 . . . . 0.0 110.264 176.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 96.7 mt -121.85 -68.46 0.89 Allowed 'General case' 0 CA--C 1.539 0.519 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.47 175.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 52.64 -147.53 0.46 Allowed 'General case' 0 N--CA 1.474 0.748 0 CA-C-O 120.869 0.366 . . . . 0.0 111.605 173.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 57.7 m-70 -94.08 16.94 13.37 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 121.202 0.525 . . . . 0.0 110.443 171.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -64.59 98.22 0.25 Allowed 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.629 -178.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 34.3 p-80 -106.18 127.22 53.06 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 120.827 0.346 . . . . 0.0 111.869 -175.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 26.8 p80 -81.77 29.27 0.39 Allowed 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 116.623 -0.262 . . . . 0.0 111.621 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 14.7 t-80 66.72 123.95 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.136 0.574 . . . . 0.0 112.14 -174.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 10.8 p80 . . . . . 0 C--O 1.252 1.219 0 CA-C-O 118.774 -0.631 . . . . 0.0 111.662 176.029 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.0 mmt . . . . . 0 N--CA 1.493 1.701 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 72.6 p -96.0 137.45 35.05 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -179.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -80.75 -20.32 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 CA-C-O 120.86 0.362 . . . . 0.0 110.976 172.276 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 65.45 101.19 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.625 0.77 . . . . 0.0 112.505 178.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -110.83 93.55 17.45 Favored Pre-proline 0 N--CA 1.469 0.479 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.98 176.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -66.59 86.81 0.28 Allowed 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 122.725 2.284 . . . . 0.0 112.745 -179.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -73.14 -23.45 60.47 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.497 0.665 . . . . 0.0 111.439 177.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.441 HG21 HG21 ' A' ' 51' ' ' VAL . 38.7 m -84.38 104.94 14.82 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 114.725 -1.125 . . . . 0.0 110.788 -177.198 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 62.2 mttm -120.68 122.0 39.49 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 121.09 0.471 . . . . 0.0 111.198 -174.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.445 HD12 ' HB ' ' A' ' 51' ' ' VAL . 49.9 mm -82.89 121.87 36.55 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 CA-C-N 115.91 -0.586 . . . . 0.0 112.295 -173.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 29.5 m -130.08 149.85 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.194 178.063 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -90.42 -15.72 30.4 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 179.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -96.97 142.68 28.63 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.037 0.446 . . . . 0.0 111.695 -179.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 20.0 m -80.57 -23.06 40.18 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.576 179.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.442 ' HA ' ' O ' ' A' ' 32' ' ' LEU . 16.2 ptp180 -116.15 119.46 35.87 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 121.311 0.577 . . . . 0.0 111.178 176.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 51.4 t -118.3 142.34 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.501 -175.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -94.33 110.47 22.23 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 120.982 0.42 . . . . 0.0 111.34 178.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.502 ' SG ' HD12 ' A' ' 32' ' ' LEU . 78.3 m -86.8 95.69 9.93 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 120.865 0.364 . . . . 0.0 111.41 176.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -83.49 -80.07 0.19 Allowed 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.606 174.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.628 ' HA3' ' HA2' ' A' ' 26' ' ' GLY . . . 161.04 -179.74 36.31 Favored Glycine 0 CA--C 1.523 0.571 0 C-N-CA 120.828 -0.701 . . . . 0.0 113.435 178.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -84.07 -100.78 0.59 Allowed Glycine 0 CA--C 1.526 0.771 0 C-N-CA 121.133 -0.556 . . . . 0.0 112.272 175.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 13.5 mp0 -76.59 165.53 24.65 Favored 'General case' 0 CA--C 1.541 0.622 0 O-C-N 122.596 -0.355 . . . . 0.0 110.416 172.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -43.83 -49.39 7.54 Favored Glycine 0 CA--C 1.533 1.182 0 N-CA-C 114.228 0.451 . . . . 0.0 114.228 -179.115 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.22 -31.93 72.53 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 121.041 0.448 . . . . 0.0 111.829 179.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 86.0 mt -90.37 0.26 57.34 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.865 0.364 . . . . 0.0 111.429 179.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.628 ' HA2' ' HA3' ' A' ' 20' ' ' GLY . . . -78.7 165.48 51.33 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 121.442 -0.409 . . . . 0.0 113.352 179.502 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 77.4 m80 -138.63 157.55 71.84 Favored Pre-proline 0 CA--C 1.538 0.499 0 O-C-N 122.606 -0.35 . . . . 0.0 110.524 -179.23 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.479 ' O ' ' HB3' ' A' ' 29' ' ' ARG . 70.7 Cg_endo -72.2 31.5 0.27 Allowed 'Trans proline' 0 CA--C 1.544 1.019 0 C-N-CA 122.437 2.092 . . . . 0.0 114.191 -176.381 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.479 ' HB3' ' O ' ' A' ' 28' ' ' PRO . 0.4 OUTLIER 76.69 98.07 0.07 Allowed 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 122.598 1.189 . . . . 0.0 110.228 175.44 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 60.7 t -120.28 129.85 75.04 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-N 113.919 -1.492 . . . . 0.0 110.988 178.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 74.4 m95 -104.09 124.22 48.67 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.063 0.459 . . . . 0.0 112.157 -178.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.502 HD12 ' SG ' ' A' ' 18' ' ' CYS . 7.2 mp -103.07 149.88 24.15 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.94 177.197 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 27.6 tp60 -120.32 109.02 14.87 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.812 -178.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.461 HG12 HG13 ' A' ' 41' ' ' VAL . 67.8 mt -60.45 129.46 89.2 Favored Pre-proline 0 CA--C 1.543 0.678 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.743 179.497 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.565 ' HG2' ' OG1' ' A' ' 38' ' ' THR . 45.7 Cg_endo -78.61 119.21 4.39 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 122.216 1.944 . . . . 0.0 111.52 173.018 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 22.2 mp0 -56.72 -40.33 75.51 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 -171.175 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -81.13 0.77 34.76 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 -173.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.565 ' OG1' ' HG2' ' A' ' 35' ' ' PRO . 22.6 p -107.06 -46.22 3.96 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.336 0.589 . . . . 0.0 109.823 171.139 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 100.3 0.92 55.75 Favored Glycine 0 CA--C 1.524 0.602 0 CA-C-N 115.558 -0.746 . . . . 0.0 113.212 178.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.418 ' HB3' HG23 ' A' ' 51' ' ' VAL . 67.5 p-90 -157.33 157.31 33.9 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.024 0.44 . . . . 0.0 112.118 -176.198 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.461 HG13 HG12 ' A' ' 34' ' ' ILE . 13.3 p -135.46 139.91 45.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.593 174.323 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -106.55 131.73 53.38 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.164 0.506 . . . . 0.0 111.083 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.44 ' HA ' HD22 ' A' ' 32' ' ' LEU . 47.5 t -86.23 122.04 72.44 Favored Pre-proline 0 CA--C 1.537 0.466 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.784 -177.419 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -74.71 -12.56 22.16 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 122.496 2.131 . . . . 0.0 112.84 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -99.42 -39.13 8.52 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 116.268 -0.424 . . . . 0.0 112.053 -178.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 46.3 t -116.8 2.62 12.88 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -177.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 54.25 25.86 6.24 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 174.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 71.0 m -95.48 144.71 25.75 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.296 177.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.454 ' HE3' ' HB2' ' A' ' 49' ' ' LYS . 34.9 ttmt -112.44 106.52 15.02 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-O 121.17 0.51 . . . . 0.0 111.215 -177.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 52.4 m-85 -91.24 111.16 22.53 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.51 -175.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.445 ' HB ' HD12 ' A' ' 10' ' ' ILE . 68.9 t -94.86 132.66 38.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-O 121.031 0.443 . . . . 0.0 111.279 177.735 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 41.8 tp -82.29 115.8 21.52 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 121.054 0.454 . . . . 0.0 112.12 -176.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.55 ' HE3' ' N ' ' A' ' 54' ' ' GLY . 0.1 OUTLIER -67.27 112.9 4.78 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 120.973 0.415 . . . . 0.0 110.042 178.582 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.55 ' N ' ' HE3' ' A' ' 53' ' ' LYS . . . 114.14 -4.51 23.78 Favored Glycine 0 CA--C 1.523 0.592 0 C-N-CA 121.323 -0.465 . . . . 0.0 112.591 -176.433 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 47.7 t -82.01 179.92 7.64 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 121.107 0.48 . . . . 0.0 111.629 177.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 19.4 ptmt -54.93 -43.71 73.58 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -177.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.41 -22.64 66.24 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.097 0.475 . . . . 0.0 112.056 -178.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -79.97 -19.43 47.91 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.843 -178.29 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -80.92 58.72 3.5 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 121.277 0.56 . . . . 0.0 112.373 -174.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.6 pp -69.14 175.56 3.75 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 116.153 -0.476 . . . . 0.0 112.059 177.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -85.54 122.77 30.15 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-O 121.615 0.721 . . . . 0.0 112.734 -175.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 55.4 t60 -169.38 85.58 0.14 Allowed 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 115.253 -0.885 . . . . 0.0 108.974 173.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 23.8 p80 -142.87 177.31 8.43 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 113.512 0.93 . . . . 0.0 113.512 -167.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 6.5 p-80 -143.46 170.88 14.97 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 114.787 -1.097 . . . . 0.0 110.003 176.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 18.1 m80 -69.12 90.52 0.47 Allowed 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 121.17 0.51 . . . . 0.0 111.793 179.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 26.2 t-80 -95.03 -21.27 18.68 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.342 0.591 . . . . 0.0 109.625 172.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 53.9 m-70 . . . . . 0 C--O 1.251 1.164 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.398 174.862 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.593 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.0 OUTLIER . . . . . 0 N--CA 1.488 1.475 0 CA-C-O 120.725 0.297 . . . . 0.0 111.63 . . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.697 HG23 ' H ' ' A' ' 4' ' ' GLN . 6.6 m -123.96 136.3 54.22 Favored 'General case' 0 N--CA 1.475 0.806 0 O-C-N 122.172 -0.33 . . . . 0.0 111.138 177.656 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 10.2 tp -64.73 -20.66 27.76 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 CA-C-O 121.488 0.661 . . . . 0.0 110.576 174.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.697 ' H ' HG23 ' A' ' 2' ' ' THR . 53.1 mt-30 70.84 -84.59 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 115.068 -0.969 . . . . 0.0 112.047 177.612 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 51.79 58.22 15.9 Favored Pre-proline 0 CA--C 1.546 0.825 0 CA-C-O 120.922 0.391 . . . . 0.0 111.861 -174.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -83.1 37.97 0.7 Allowed 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 122.928 2.419 . . . . 0.0 113.305 -174.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.433 ' CD ' ' H ' ' A' ' 8' ' ' THR . 0.2 OUTLIER -124.05 -159.62 0.88 Allowed 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.192 -177.805 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.433 ' H ' ' CD ' ' A' ' 7' ' ' GLU . 77.2 m -70.9 123.52 22.2 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 121.102 0.477 . . . . 0.0 111.734 -179.609 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 23.2 tptp -121.35 101.82 7.88 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 120.873 0.368 . . . . 0.0 110.233 179.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 60.4 mt -83.43 99.89 6.48 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.065 -176.005 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 27.2 m -110.73 154.05 12.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 CA-C-O 121.009 0.433 . . . . 0.0 112.105 -175.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -87.5 14.99 7.16 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 120.787 0.327 . . . . 0.0 111.584 -178.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 58.0 pttt -132.83 143.94 49.88 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -174.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 54.0 m -87.92 -24.94 23.46 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 116.276 -0.42 . . . . 0.0 112.111 -178.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 75.2 mtt180 -108.71 110.19 21.54 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 121.179 0.514 . . . . 0.0 111.87 -179.146 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 50.3 t -114.01 147.21 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.064 -178.152 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.478 ' HA ' ' O ' ' A' ' 30' ' ' VAL . . . -91.18 106.71 18.7 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 121.348 0.594 . . . . 0.0 112.568 -177.361 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.66 ' SG ' HD23 ' A' ' 32' ' ' LEU . 95.9 m -85.39 -158.38 0.37 Allowed 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.633 178.72 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 9.9 t70 66.92 89.51 0.1 Allowed 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 121.21 0.528 . . . . 0.0 110.717 -175.212 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.62 ' HA2' ' O ' ' A' ' 25' ' ' LEU . . . -146.31 144.4 12.74 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 121.143 -0.551 . . . . 0.0 113.532 -178.681 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 154.63 -27.33 0.67 Allowed Glycine 0 CA--C 1.531 1.093 0 C-N-CA 120.763 -0.732 . . . . 0.0 114.463 176.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.49 ' HG2' ' N ' ' A' ' 23' ' ' GLY . 32.9 tt0 -151.69 168.43 25.04 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 117.071 0.436 . . . . 0.0 110.945 -174.71 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.49 ' N ' ' HG2' ' A' ' 22' ' ' GLU . . . -44.52 -57.37 5.15 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 121.632 -0.318 . . . . 0.0 113.748 176.086 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.54 -23.65 66.92 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 121.015 0.436 . . . . 0.0 111.89 177.422 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.62 ' O ' ' HA2' ' A' ' 20' ' ' GLY . 89.5 mt -103.88 25.86 9.36 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.975 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -82.68 51.82 4.6 Favored Glycine 0 CA--C 1.527 0.807 0 C-N-CA 120.892 -0.671 . . . . 0.0 113.668 -176.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 88.3 m-70 50.0 63.85 9.42 Favored Pre-proline 0 N--CA 1.475 0.78 0 C-N-CA 123.168 0.587 . . . . 0.0 112.404 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -59.21 -62.35 0.18 Allowed 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 122.721 2.281 . . . . 0.0 112.618 178.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 6.1 tpt180 -179.42 85.38 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.196 0 CA-C-O 121.956 0.884 . . . . 0.0 110.504 177.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.478 ' O ' ' HA ' ' A' ' 17' ' ' ALA . 60.8 t -135.71 103.81 4.12 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 CA-C-N 114.669 -1.15 . . . . 0.0 110.421 -179.238 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 85.1 m95 -94.78 124.07 38.61 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -173.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.66 HD23 ' SG ' ' A' ' 18' ' ' CYS . 11.2 mp -105.45 131.57 52.7 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.019 0.438 . . . . 0.0 110.646 171.579 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 28.9 tp60 -92.88 115.1 27.81 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.836 -177.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.455 HG21 ' HB2' ' A' ' 52' ' ' LEU . 69.0 mt -66.79 118.1 51.49 Favored Pre-proline 0 CA--C 1.538 0.508 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.526 173.222 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.424 ' HG2' ' OG1' ' A' ' 38' ' ' THR . 97.6 Cg_endo -82.19 134.23 7.92 Favored 'Trans proline' 0 CA--C 1.538 0.704 0 C-N-CA 122.424 2.083 . . . . 0.0 113.045 179.445 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -58.4 -23.01 56.0 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 121.433 0.635 . . . . 0.0 110.599 174.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -62.4 -35.3 78.77 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 115.3 -0.864 . . . . 0.0 111.967 179.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.424 ' OG1' ' HG2' ' A' ' 35' ' ' PRO . 31.9 p -108.73 -48.73 3.26 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-O 121.03 0.443 . . . . 0.0 111.326 -179.058 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 101.08 -0.56 54.71 Favored Glycine 0 CA--C 1.527 0.807 0 CA-C-N 116.034 -0.53 . . . . 0.0 112.779 -177.005 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 67.5 p-90 -155.11 166.23 34.23 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 120.891 0.376 . . . . 0.0 111.821 -177.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 10.1 p -144.07 144.35 22.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 CA-C-N 116.528 -0.306 . . . . 0.0 110.912 175.459 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -105.13 141.36 36.81 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 120.834 0.349 . . . . 0.0 111.127 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.45 ' SG ' ' HB3' ' A' ' 46' ' ' CYS . 29.3 p -99.07 116.61 65.11 Favored Pre-proline 0 CA--C 1.539 0.52 0 O-C-N 122.305 -0.247 . . . . 0.0 110.935 175.043 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -70.37 16.93 0.24 Allowed 'Trans proline' 0 CA--C 1.544 0.981 0 C-N-CA 122.768 2.312 . . . . 0.0 113.642 -176.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 35.0 m-85 -117.26 -49.6 2.58 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 120.837 0.351 . . . . 0.0 111.418 176.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.45 ' HB3' ' SG ' ' A' ' 43' ' ' CYS . 13.2 t -105.13 -4.94 21.24 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -175.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 63.81 18.64 11.29 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 112.913 0.709 . . . . 0.0 112.913 177.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.442 ' SG ' ' SG ' ' A' ' 46' ' ' CYS . 34.7 m -79.8 135.27 36.44 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 120.84 0.352 . . . . 0.0 111.262 -179.748 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -99.62 95.42 6.95 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 120.915 0.388 . . . . 0.0 110.522 178.339 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -82.1 105.04 12.88 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.697 0.284 . . . . 0.0 111.263 -173.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 90.4 t -91.47 126.78 44.1 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.293 178.105 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.455 ' HB2' HG21 ' A' ' 34' ' ' ILE . 58.0 tp -73.32 112.53 9.46 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 121.175 0.512 . . . . 0.0 111.125 178.663 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 61.5 tttm -63.34 118.07 7.52 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.343 -178.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 102.25 -3.48 51.13 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 121.37 -0.443 . . . . 0.0 112.853 -174.176 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 35.2 t -90.82 -176.84 4.8 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 120.931 0.396 . . . . 0.0 111.544 178.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 54.9 mttm -72.24 -10.99 60.51 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 120.901 0.381 . . . . 0.0 111.968 -176.251 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -93.88 -0.94 55.45 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 120.967 0.413 . . . . 0.0 110.858 173.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.5 ' CG ' ' H ' ' A' ' 59' ' ' ALA . 24.9 t70 -126.91 -162.76 1.18 Allowed 'General case' 0 CA--C 1.549 0.924 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.858 -178.175 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.5 ' H ' ' CG ' ' A' ' 58' ' ' ASP . . . 71.83 45.11 0.44 Allowed 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.568 0.699 . . . . 0.0 110.958 -179.408 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 5.4 mp -69.75 -20.84 63.49 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.527 -179.342 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.459 ' HB3' ' HB3' ' A' ' 64' ' ' HIS . 44.1 mt-10 -75.52 57.58 0.96 Allowed 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 121.095 0.474 . . . . 0.0 110.695 174.037 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 54.7 t-80 -65.26 -25.26 67.58 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 121.289 0.566 . . . . 0.0 110.081 -176.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 41.2 p-80 -81.87 -24.56 35.68 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 115.505 -0.771 . . . . 0.0 111.951 177.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.459 ' HB3' ' HB3' ' A' ' 61' ' ' GLU . 23.2 t-80 -114.93 104.94 12.42 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 120.772 0.32 . . . . 0.0 111.114 -174.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 26.4 m80 -98.01 -46.19 5.98 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 111.968 0.358 . . . . 0.0 111.968 -175.433 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 42.1 t-80 -70.08 98.81 1.37 Allowed 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 120.885 0.374 . . . . 0.0 110.728 175.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 12.0 p80 . . . . . 0 C--O 1.254 1.334 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -176.098 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.525 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.635 0 N-CA-C 111.811 0.3 . . . . 0.0 111.811 . . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 39.6 p -80.52 151.01 29.4 Favored 'General case' 0 N--CA 1.47 0.553 0 O-C-N 122.255 -0.278 . . . . 0.0 110.706 172.337 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.414 ' N ' HD12 ' A' ' 3' ' ' ILE . 2.0 mp -62.22 -25.22 37.02 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-O 121.014 0.435 . . . . 0.0 110.548 177.281 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 67.2 mm-40 59.74 80.39 0.2 Allowed 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 115.729 -0.669 . . . . 0.0 112.064 179.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.539 ' HB2' ' HD3' ' A' ' 6' ' ' PRO . . . -169.63 -52.49 0.0 OUTLIER Pre-proline 0 CA--C 1.547 0.859 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.988 178.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.539 ' HD3' ' HB2' ' A' ' 5' ' ' ALA . 55.1 Cg_endo -90.59 28.12 0.42 Allowed 'Trans proline' 0 C--N 1.357 1.022 0 C-N-CA 122.147 1.898 . . . . 0.0 112.994 179.522 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -92.99 87.62 5.83 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-O 121.953 0.883 . . . . 0.0 111.34 -176.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 96.2 m -126.51 148.9 49.64 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 114.752 -1.113 . . . . 0.0 110.731 -177.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.413 ' HD2' ' CE1' ' A' ' 50' ' ' TYR . 98.7 mttt -120.08 126.95 52.02 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 120.867 0.365 . . . . 0.0 110.735 -176.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.42 HG23 ' HB2' ' A' ' 53' ' ' LYS . 34.9 mm -91.83 98.84 8.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-O 121.023 0.439 . . . . 0.0 110.831 -179.179 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 34.7 m -99.15 158.0 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-O 121.407 0.623 . . . . 0.0 112.501 -174.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -91.72 -34.5 14.61 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.506 177.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -90.45 151.19 21.5 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.311 0.577 . . . . 0.0 112.479 -175.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 43.8 m -78.3 -27.51 47.31 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.331 173.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 71.7 mtp180 -90.42 107.2 19.0 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.618 175.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 55.1 t -113.97 118.59 58.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 120.999 0.428 . . . . 0.0 112.09 -175.423 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.13 103.09 7.85 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 121.057 0.456 . . . . 0.0 110.29 173.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.714 ' SG ' HD12 ' A' ' 32' ' ' LEU . 79.1 m -70.69 84.13 0.63 Allowed 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -172.329 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 40.37 66.3 0.64 Allowed 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 121.673 0.749 . . . . 0.0 112.532 176.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -157.04 151.9 23.24 Favored Glycine 0 CA--C 1.525 0.716 0 C-N-CA 119.804 -1.188 . . . . 0.0 114.59 -176.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' A' ' 27' ' ' HIS . . . -164.16 -132.47 1.35 Allowed Glycine 0 CA--C 1.524 0.601 0 N-CA-C 111.191 -0.764 . . . . 0.0 111.191 177.778 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -88.65 118.81 28.58 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 122.277 -0.543 . . . . 0.0 111.523 174.55 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 39.76 -94.96 0.01 OUTLIER Glycine 0 CA--C 1.534 1.28 0 N-CA-C 115.512 0.965 . . . . 0.0 115.512 178.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.2 -17.84 63.93 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 -173.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 86.0 mt -78.04 -2.91 39.51 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 -179.333 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 128.6 -130.0 6.39 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 121.481 -0.39 . . . . 0.0 112.866 178.255 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.417 ' O ' ' N ' ' A' ' 21' ' ' GLY . 6.3 m80 -84.94 156.56 60.77 Favored Pre-proline 0 N--CA 1.477 0.908 0 O-C-N 122.443 -0.445 . . . . 0.0 109.973 178.282 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -63.83 64.64 0.21 Allowed 'Trans proline' 0 CA--C 1.551 1.337 0 C-N-CA 122.894 2.396 . . . . 0.0 114.472 -178.547 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 7.9 tpt180 49.61 81.53 0.06 Allowed 'General case' 0 C--O 1.236 0.387 0 CA-C-O 122.62 1.2 . . . . 0.0 111.981 179.012 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 19.9 m -104.7 114.62 44.79 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 CA-C-N 113.658 -1.61 . . . . 0.0 112.265 -177.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 96.7 m95 -101.82 124.42 47.42 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.717 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.714 HD12 ' SG ' ' A' ' 18' ' ' CYS . 9.3 mp -117.49 134.1 55.23 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 121.011 0.434 . . . . 0.0 110.945 174.248 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -93.73 116.42 28.9 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.263 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.493 HG12 HG13 ' A' ' 41' ' ' VAL . 77.7 mt -61.73 123.0 75.24 Favored Pre-proline 0 CA--C 1.542 0.637 0 CA-C-O 120.891 0.377 . . . . 0.0 111.849 179.18 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.558 ' HG2' ' OG1' ' A' ' 38' ' ' THR . 76.7 Cg_endo -81.23 140.16 12.13 Favored 'Trans proline' 0 CA--C 1.544 0.983 0 C-N-CA 122.803 2.335 . . . . 0.0 112.818 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -70.64 -28.92 65.19 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 121.01 0.433 . . . . 0.0 111.746 -179.34 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -61.61 -25.01 67.08 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 179.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.558 ' OG1' ' HG2' ' A' ' 35' ' ' PRO . 47.2 p -109.84 -54.0 2.61 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-O 121.286 0.565 . . . . 0.0 111.197 176.048 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 101.05 1.34 54.78 Favored Glycine 0 CA--C 1.524 0.648 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.003 -175.247 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 54.5 p-90 -152.87 162.92 40.7 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 121.077 0.465 . . . . 0.0 111.681 -176.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.493 HG13 HG12 ' A' ' 34' ' ' ILE . 8.4 p -142.67 118.71 5.53 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 CA-C-O 120.925 0.393 . . . . 0.0 110.773 173.707 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.521 ' HA ' ' HA ' ' A' ' 49' ' ' LYS . 9.4 pt-20 -100.0 106.61 18.41 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.529 0.68 . . . . 0.0 110.112 175.701 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.833 ' HB3' ' SG ' ' A' ' 46' ' ' CYS . 44.0 t -75.83 130.91 77.51 Favored Pre-proline 0 N--CA 1.466 0.371 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -167.13 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -69.58 -15.15 37.61 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 122.571 2.181 . . . . 0.0 112.569 175.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.514 ' HD2' ' SG ' ' A' ' 43' ' ' CYS . 90.1 m-85 -85.24 -43.2 13.98 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.601 179.542 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.833 ' SG ' ' HB3' ' A' ' 43' ' ' CYS . 27.1 p -97.04 -17.77 19.81 Favored 'General case' 0 N--CA 1.478 0.925 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 -178.695 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 10.1 t70 67.96 20.06 9.25 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-O 121.123 0.487 . . . . 0.0 111.147 179.19 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 53.6 t -121.43 154.73 36.16 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 120.916 0.389 . . . . 0.0 111.616 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.521 ' HA ' ' HA ' ' A' ' 42' ' ' GLU . 17.9 ttmm -98.51 134.45 41.45 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.385 -177.37 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.413 ' CE1' ' HD2' ' A' ' 9' ' ' LYS . 72.3 m-85 -115.08 113.29 23.83 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 122.17 -0.331 . . . . 0.0 111.244 178.358 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.403 HG13 ' HB3' ' A' ' 57' ' ' ALA . 49.7 t -97.51 128.44 48.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 CA-C-O 121.169 0.509 . . . . 0.0 111.737 175.703 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.464 ' HB2' HD11 ' A' ' 34' ' ' ILE . 51.6 tp -78.6 114.02 17.15 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.029 178.024 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.42 ' HB2' HG23 ' A' ' 10' ' ' ILE . 33.9 ttpt -63.48 121.65 14.35 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.329 -179.188 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 92.1 13.57 57.39 Favored Glycine 0 CA--C 1.531 1.047 0 CA-C-N 116.14 -0.482 . . . . 0.0 113.751 -177.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 34.5 p -107.29 -166.65 1.18 Allowed 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 117.296 0.548 . . . . 0.0 111.905 -178.499 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -63.31 -20.29 65.36 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 115.927 -0.578 . . . . 0.0 111.777 177.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.403 ' HB3' HG13 ' A' ' 51' ' ' VAL . . . -94.22 -1.2 54.46 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 179.526 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -130.12 172.82 11.35 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 116.639 -0.255 . . . . 0.0 110.756 -176.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 63.22 77.51 0.32 Allowed 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 121.262 0.553 . . . . 0.0 111.11 -176.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 78.0 mt -65.8 -62.62 1.4 Allowed 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.571 -176.272 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.1 -25.66 63.61 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.846 178.38 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 39.0 t-80 74.21 20.81 2.6 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.431 0.692 . . . . 0.0 112.437 167.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 35.3 t-80 -80.46 -13.44 59.11 Favored 'General case' 0 CA--C 1.539 0.541 0 O-C-N 121.789 -0.569 . . . . 0.0 110.252 176.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 11.1 t-160 -79.65 92.96 5.43 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 170.211 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 21.6 p80 -86.41 143.73 27.66 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 -167.327 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 11.0 p80 -175.45 124.29 0.23 Allowed 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.131 172.058 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 40.7 m170 . . . . . 0 C--O 1.251 1.146 0 CA-C-O 118.678 -0.677 . . . . 0.0 111.432 178.623 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.7 mtm . . . . . 0 N--CA 1.494 1.756 0 CA-C-O 120.908 0.385 . . . . 0.0 111.18 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.424 ' C ' ' H ' ' A' ' 4' ' ' GLN . 2.9 m -78.62 24.93 0.27 Allowed 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -172.511 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.404 HG22 ' O ' ' A' ' 3' ' ' ILE . 44.5 mm 66.31 -5.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 CA-C-O 121.092 0.472 . . . . 0.0 111.399 -176.714 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.424 ' H ' ' C ' ' A' ' 2' ' ' THR . 1.9 mp0 57.67 22.07 7.95 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.077 0.551 . . . . 0.0 111.918 -178.036 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -138.01 88.79 15.27 Favored Pre-proline 0 CA--C 1.534 0.34 0 CA-C-O 120.858 0.361 . . . . 0.0 111.917 -179.003 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -67.77 97.34 0.46 Allowed 'Trans proline' 0 CA--C 1.535 0.528 0 C-N-CA 122.308 2.005 . . . . 0.0 110.648 171.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -23.13 103.75 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 124.07 0.948 . . . . 0.0 112.523 -179.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 51.7 m -104.51 145.74 29.86 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 115.52 -0.764 . . . . 0.0 112.372 -171.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -129.14 114.19 16.02 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.262 176.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 55.0 mt -84.76 94.93 3.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 121.306 0.574 . . . . 0.0 110.761 -179.262 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 29.9 m -104.8 149.11 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-N 115.932 -0.576 . . . . 0.0 112.188 -174.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -75.67 -19.77 58.92 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.347 -177.204 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.438 ' NZ ' ' O ' ' A' ' 15' ' ' ARG . 13.2 ptmm? -112.08 143.04 43.75 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 116.204 -0.453 . . . . 0.0 112.171 -173.317 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.425 ' HB2' ' NE2' ' A' ' 33' ' ' GLN . 37.6 p -79.11 -38.58 35.85 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 112.724 0.639 . . . . 0.0 112.724 -178.609 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.438 ' O ' ' NZ ' ' A' ' 13' ' ' LYS . 8.9 mmt180 -78.69 127.72 32.48 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.362 0.601 . . . . 0.0 111.953 -178.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 95.3 t -143.21 124.18 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.765 -178.409 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.52 112.11 15.25 Favored 'General case' 0 CA--C 1.537 0.463 0 O-C-N 122.214 -0.303 . . . . 0.0 110.817 177.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 48.2 t -147.13 98.77 3.07 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 112.516 0.561 . . . . 0.0 112.516 -178.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.519 ' HB2' ' HB ' ' A' ' 30' ' ' VAL . 35.1 t70 -143.49 64.98 1.33 Allowed 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.744 0.783 . . . . 0.0 110.167 174.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 160.88 -172.99 37.3 Favored Glycine 0 CA--C 1.519 0.34 0 CA-C-N 115.846 -0.615 . . . . 0.0 112.043 -179.067 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -61.87 -42.58 99.76 Favored Glycine 0 CA--C 1.526 0.727 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.373 177.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -164.67 177.3 8.13 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 122.92 0.488 . . . . 0.0 109.966 176.38 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -45.41 -50.68 10.06 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 121.468 -0.396 . . . . 0.0 113.898 176.278 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -83.36 -2.2 55.18 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.161 0.505 . . . . 0.0 111.942 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.0 tt -125.69 56.04 1.41 Allowed 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 125.69 -140.37 12.16 Favored Glycine 0 CA--C 1.524 0.627 0 CA-C-N 115.341 -0.845 . . . . 0.0 112.598 178.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 1.6 m80 64.16 56.67 1.66 Allowed Pre-proline 0 CA--C 1.548 0.895 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 174.516 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.441 ' O ' ' HB2' ' A' ' 29' ' ' ARG . 19.4 Cg_endo -58.04 -58.2 0.87 Allowed 'Trans proline' 0 C--N 1.358 1.046 0 C-N-CA 122.212 1.941 . . . . 0.0 111.993 176.481 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.441 ' HB2' ' O ' ' A' ' 28' ' ' PRO . 10.1 tpt180 178.43 85.41 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 121.979 0.895 . . . . 0.0 110.831 170.558 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.519 ' HB ' ' HB2' ' A' ' 19' ' ' ASP . 89.9 t -137.78 117.77 15.77 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 CA-C-N 114.526 -1.216 . . . . 0.0 110.178 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 81.9 m95 -105.66 119.95 40.43 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 121.348 0.594 . . . . 0.0 112.254 -174.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.403 ' N ' HD13 ' A' ' 32' ' ' LEU . 6.9 mp -81.09 152.35 27.88 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.679 173.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.425 ' NE2' ' HB2' ' A' ' 14' ' ' SER . 25.0 tp60 -120.77 111.93 18.2 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.882 -178.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.478 HG21 ' HB2' ' A' ' 52' ' ' LEU . 61.0 mt -77.23 109.7 10.03 Favored Pre-proline 0 CA--C 1.541 0.608 0 CA-C-O 120.57 0.224 . . . . 0.0 110.397 173.431 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -86.47 156.24 9.27 Favored 'Trans proline' 0 CA--C 1.536 0.622 0 C-N-CA 122.793 2.329 . . . . 0.0 113.391 -176.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -73.79 -18.89 60.91 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.042 0.449 . . . . 0.0 110.271 174.372 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -58.02 -56.22 24.77 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-O 121.275 0.56 . . . . 0.0 110.927 174.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 44.6 p -90.48 -50.32 6.01 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.748 -179.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 99.48 1.55 56.63 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-N 116.141 -0.481 . . . . 0.0 112.415 -174.353 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.519 ' HB3' HG23 ' A' ' 51' ' ' VAL . 30.1 p-90 -158.55 170.86 21.25 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 122.656 0.382 . . . . 0.0 111.827 -177.036 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 11.2 p -141.93 144.92 24.79 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 CA-C-O 120.882 0.372 . . . . 0.0 111.039 175.289 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -104.38 137.94 41.53 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 120.875 0.369 . . . . 0.0 111.132 -178.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.666 ' SG ' ' HE2' ' A' ' 50' ' ' TYR . 68.6 m -95.13 109.59 45.48 Favored Pre-proline 0 N--CA 1.472 0.66 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.617 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -64.97 -12.03 32.6 Favored 'Trans proline' 0 CA--C 1.543 0.967 0 C-N-CA 122.495 2.13 . . . . 0.0 113.585 -178.144 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 -110.93 -62.63 1.51 Allowed 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 120.827 0.346 . . . . 0.0 111.716 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.597 ' SG ' ' SG ' ' A' ' 48' ' ' CYS . 42.8 t -73.08 -14.76 61.46 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -178.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 16.0 t70 71.96 -4.85 1.85 Allowed 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 123.342 0.657 . . . . 0.0 112.69 177.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.597 ' SG ' ' SG ' ' A' ' 46' ' ' CYS . 81.2 m -65.83 147.65 53.03 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.087 0.47 . . . . 0.0 112.198 178.035 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 59.8 tttm -118.45 104.31 10.58 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.419 178.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.666 ' HE2' ' SG ' ' A' ' 43' ' ' CYS . 97.3 m-85 -89.26 113.92 25.22 Favored 'General case' 0 N--CA 1.468 0.444 0 O-C-N 122.057 -0.402 . . . . 0.0 111.411 -174.109 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.519 HG23 ' HB3' ' A' ' 40' ' ' TRP . 80.1 t -95.69 136.56 26.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 CA-C-O 120.777 0.322 . . . . 0.0 111.435 176.014 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.517 ' HB3' ' HB3' ' A' ' 55' ' ' SER . 48.7 tp -71.97 120.03 16.99 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 121.29 0.567 . . . . 0.0 111.195 178.46 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -65.78 116.88 7.43 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.518 -179.003 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 91.27 14.97 56.63 Favored Glycine 0 CA--C 1.527 0.784 0 CA-C-N 116.195 -0.457 . . . . 0.0 113.054 -176.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.517 ' HB3' ' HB3' ' A' ' 52' ' ' LEU . 76.9 p -91.09 -177.93 5.04 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 121.379 0.609 . . . . 0.0 111.916 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -57.42 -37.79 73.31 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.771 173.152 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -78.69 -30.78 46.25 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -176.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -82.24 -41.92 19.6 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 120.936 0.398 . . . . 0.0 111.662 179.177 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -79.6 -60.54 2.31 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -178.086 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 94.6 mt 61.85 101.0 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 122.602 0.361 . . . . 0.0 111.747 -176.032 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 53.9 mm-40 69.07 159.73 0.18 Allowed 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 121.659 0.742 . . . . 0.0 112.729 -179.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 19.1 p80 -147.22 123.22 10.73 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.901 -179.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 52.8 m80 -125.95 132.2 52.13 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -176.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 33.3 p80 -166.8 127.39 1.59 Allowed 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.825 171.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 38.6 m80 -75.81 118.24 18.4 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.309 -177.098 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 58.5 m80 67.87 -163.39 0.21 Allowed 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 122.778 0.431 . . . . 0.0 111.263 -175.5 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 10.6 p80 . . . . . 0 C--O 1.249 1.048 0 CA-C-O 119.116 -0.468 . . . . 0.0 111.95 -179.416 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.6 mmt . . . . . 0 N--CA 1.492 1.661 0 N-CA-C 111.753 0.279 . . . . 0.0 111.753 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.464 ' O ' ' HB ' ' A' ' 3' ' ' ILE . 7.0 m -85.17 -2.3 57.86 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -174.378 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.464 ' HB ' ' O ' ' A' ' 2' ' ' THR . 1.9 mp 74.4 -20.06 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 122.894 0.478 . . . . 0.0 111.892 -178.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.424 ' H ' ' C ' ' A' ' 2' ' ' THR . 47.8 mt-30 73.97 -52.33 0.69 Allowed 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.715 0.806 . . . . 0.0 112.706 177.035 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 60.16 69.77 1.14 Allowed Pre-proline 0 N--CA 1.473 0.697 0 CA-C-O 121.122 0.487 . . . . 0.0 111.983 -179.265 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_exo -71.72 90.35 0.72 Allowed 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 122.711 2.274 . . . . 0.0 112.688 -179.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -64.6 144.32 57.29 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 121.351 0.596 . . . . 0.0 111.956 178.346 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 67.9 p -90.38 142.99 27.18 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.126 -179.028 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.407 ' HD3' ' CD1' ' A' ' 50' ' ' TYR . 57.4 tttp -116.56 97.92 6.27 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 176.282 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.52 HG22 ' HB2' ' A' ' 53' ' ' LYS . 2.0 mp -77.03 124.0 34.63 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-O 121.153 0.502 . . . . 0.0 112.266 -172.846 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 30.2 m -136.35 162.4 35.7 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.003 177.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -102.17 -16.41 16.37 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 111.76 0.282 . . . . 0.0 111.76 176.569 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -106.81 142.31 36.64 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 121.125 0.488 . . . . 0.0 111.3 177.28 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 74.6 m -76.17 -6.47 51.44 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 -173.126 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 90.2 mtt180 -111.61 120.13 41.05 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 121.61 -0.681 . . . . 0.0 112.081 177.085 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 37.4 t -134.71 140.95 44.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.996 179.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -93.89 127.92 39.9 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 116.729 -0.214 . . . . 0.0 111.142 178.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.562 ' SG ' ' HB2' ' A' ' 47' ' ' ASP . 41.4 t -63.7 98.7 0.19 Allowed 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 120.873 0.368 . . . . 0.0 110.926 177.0 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -69.64 -52.4 26.17 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 -174.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -159.96 -145.38 4.25 Favored Glycine 0 C--O 1.223 -0.56 0 C-N-CA 119.851 -1.166 . . . . 0.0 114.998 -172.095 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 89.73 -5.03 83.77 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 121.377 -0.439 . . . . 0.0 113.19 -176.18 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.639 ' HB2' ' NE2' ' A' ' 27' ' ' HIS . 10.1 tp10 -95.39 122.36 38.02 Favored 'General case' 0 N--CA 1.469 0.485 0 O-C-N 122.457 -0.437 . . . . 0.0 110.982 -179.187 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 39.69 -90.86 0.01 OUTLIER Glycine 0 CA--C 1.531 1.078 0 O-C-N 123.379 0.424 . . . . 0.0 113.839 -178.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -80.84 31.23 0.31 Allowed 'General case' 0 CA--C 1.544 0.726 0 O-C-N 122.605 -0.35 . . . . 0.0 111.191 174.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.8 pp 48.81 39.55 14.32 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 124.675 1.19 . . . . 0.0 113.638 -179.377 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.415 ' O ' ' HB3' ' A' ' 22' ' ' GLU . . . -132.52 152.59 20.3 Favored Glycine 0 CA--C 1.534 1.261 0 C-N-CA 120.859 -0.686 . . . . 0.0 114.264 178.755 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.639 ' NE2' ' HB2' ' A' ' 22' ' ' GLU . 24.2 m80 -139.06 155.13 72.89 Favored Pre-proline 0 N--CA 1.479 0.977 0 C-N-CA 122.894 0.478 . . . . 0.0 110.988 174.055 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -69.1 -72.8 0.02 OUTLIER 'Trans proline' 0 CA--C 1.545 1.044 0 C-N-CA 122.605 2.203 . . . . 0.0 114.411 -179.431 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 3.8 tmt_? -179.08 94.64 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.156 0 CA-C-O 121.85 0.833 . . . . 0.0 110.584 -174.005 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.44 HG22 ' HB3' ' A' ' 18' ' ' CYS . 14.5 m -136.7 120.03 22.28 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.257 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.838 173.004 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 48.1 m95 -99.43 112.61 24.77 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.356 -178.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.422 ' N ' HD12 ' A' ' 32' ' ' LEU . 6.1 mp -90.26 132.1 35.71 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 121.118 0.485 . . . . 0.0 111.61 -179.392 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 27.3 tp60 -93.68 106.74 18.69 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.858 176.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.509 HG12 HG13 ' A' ' 41' ' ' VAL . 97.8 mt -60.73 125.35 82.68 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.026 176.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.545 ' HG2' ' OG1' ' A' ' 38' ' ' THR . 84.5 Cg_endo -76.96 105.34 2.06 Favored 'Trans proline' 0 CA--C 1.535 0.566 0 C-N-CA 122.261 1.974 . . . . 0.0 111.753 177.533 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -57.93 -19.13 27.81 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 121.299 0.571 . . . . 0.0 110.366 178.205 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -54.66 -43.53 72.47 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.503 172.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.545 ' OG1' ' HG2' ' A' ' 35' ' ' PRO . 44.1 p -97.49 -57.73 2.18 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.722 177.536 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 120.55 0.99 12.29 Favored Glycine 0 CA--C 1.529 0.926 0 CA-C-N 115.849 -0.614 . . . . 0.0 112.627 -177.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 63.9 p-90 -162.12 160.62 27.5 Favored 'General case' 0 N--CA 1.471 0.607 0 O-C-N 122.709 -0.289 . . . . 0.0 111.396 -176.248 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.509 HG13 HG12 ' A' ' 34' ' ' ILE . 11.6 p -148.4 129.91 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 CA-C-O 120.713 0.292 . . . . 0.0 110.807 173.75 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.409 ' HA ' ' HA ' ' A' ' 49' ' ' LYS . 9.6 pt-20 -90.89 140.02 30.21 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 120.913 0.387 . . . . 0.0 111.211 178.042 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 44.5 t -70.35 126.37 92.3 Favored Pre-proline 0 N--CA 1.47 0.569 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.774 -176.596 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.32 -26.16 29.92 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 122.785 2.323 . . . . 0.0 112.971 -179.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -78.36 -92.92 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 121.123 0.487 . . . . 0.0 111.016 177.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 48.0 t -172.41 81.38 0.05 Allowed 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.039 0.447 . . . . 0.0 110.305 -179.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.562 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 13.3 t70 -136.8 -95.72 0.22 Allowed 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.393 -178.06 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 90.7 m -153.62 -170.34 3.56 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 120.92 0.39 . . . . 0.0 110.674 177.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.409 ' HA ' ' HA ' ' A' ' 42' ' ' GLU . 34.8 ttpt -111.62 115.6 29.4 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 120.899 0.381 . . . . 0.0 110.632 175.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.407 ' CD1' ' HD3' ' A' ' 9' ' ' LYS . 43.4 m-85 -82.69 114.92 21.38 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.18 -171.218 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 80.9 t -109.38 123.74 65.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-O 121.314 0.578 . . . . 0.0 111.843 -176.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 46.0 tp -81.0 107.95 14.26 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.733 178.405 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.52 ' HB2' HG22 ' A' ' 10' ' ' ILE . 28.6 ttpp -65.15 147.45 53.45 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 120.907 0.384 . . . . 0.0 111.293 -179.593 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 85.95 7.89 80.07 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.446 -174.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 14.8 t -109.78 173.71 6.2 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 120.913 0.387 . . . . 0.0 111.499 179.143 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 23.5 pttm -62.81 -18.1 62.24 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-O 120.818 0.342 . . . . 0.0 111.241 175.542 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -74.0 -24.53 59.6 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.377 0.608 . . . . 0.0 110.804 174.296 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -95.56 -21.44 18.27 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.436 175.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.539 ' O ' ' HB2' ' A' ' 62' ' ' HIS . . . 71.08 102.59 0.06 Allowed 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.708 -176.503 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 83.8 mt -46.77 149.6 0.82 Allowed 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 -175.189 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 25.3 mm-40 73.42 -82.5 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.852 -170.25 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . 0.539 ' HB2' ' O ' ' A' ' 59' ' ' ALA . 8.9 t-160 52.1 28.63 5.56 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-O 120.889 0.376 . . . . 0.0 111.84 175.771 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 47.5 t-80 62.79 26.01 15.38 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 122.986 0.514 . . . . 0.0 112.235 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 33.7 m-70 -74.67 -3.92 34.19 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 121.922 -0.486 . . . . 0.0 111.665 177.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 57.3 t-80 -68.08 112.1 4.85 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 121.036 0.446 . . . . 0.0 111.575 178.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 78.9 m80 -85.19 165.69 17.18 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.436 179.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 53.6 t-80 . . . . . 0 C--O 1.252 1.218 0 CA-C-O 118.934 -0.555 . . . . 0.0 111.722 -175.419 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.446 ' C ' ' SD ' ' A' ' 1' ' ' MET . 0.9 OUTLIER . . . . . 0 N--CA 1.487 1.414 0 CA-C-O 120.696 0.284 . . . . 0.0 111.05 . . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 66.8 p -128.77 148.24 50.84 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 120.957 0.408 . . . . 0.0 111.249 176.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 62.1 mt -75.47 -23.2 16.69 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-O 121.045 0.45 . . . . 0.0 110.625 174.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 64.12 -86.1 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.262 -178.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 46.63 79.28 0.35 Allowed Pre-proline 0 CA--C 1.544 0.737 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 177.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.468 ' HD2' ' HD2' ' A' ' 49' ' ' LYS . 22.8 Cg_exo -64.92 76.72 0.21 Allowed 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 122.584 2.189 . . . . 0.0 112.481 176.574 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 55.66 103.27 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.255 0.622 . . . . 0.0 111.246 -175.069 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 87.4 m -100.02 124.57 45.53 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -172.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 44.7 mttp -122.59 109.03 13.8 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.877 177.299 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.565 HG21 ' HB2' ' A' ' 53' ' ' LYS . 15.7 mt -82.99 79.87 1.44 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-O 121.191 0.52 . . . . 0.0 109.706 177.477 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 4.7 t -92.45 148.69 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 CA-C-O 121.036 0.445 . . . . 0.0 111.571 -172.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -78.55 -20.76 49.91 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 120.847 0.356 . . . . 0.0 111.343 -175.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 7.0 ptpp? -108.92 148.62 30.4 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 120.895 0.379 . . . . 0.0 111.522 177.462 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.412 ' HA ' HD12 ' A' ' 34' ' ' ILE . 67.4 p -82.36 -44.01 16.7 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 112.894 0.701 . . . . 0.0 112.894 -177.198 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 49.2 mtt180 -78.59 90.54 4.54 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 121.417 0.627 . . . . 0.0 111.627 -176.052 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 47.8 t -110.53 120.65 61.83 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.29 -179.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -96.11 158.27 15.52 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 121.016 0.436 . . . . 0.0 111.867 179.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 51.4 t -149.42 140.9 23.33 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 120.946 0.403 . . . . 0.0 111.401 178.247 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -94.44 -59.58 1.91 Allowed 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.09 174.321 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 162.64 -146.44 11.86 Favored Glycine 0 CA--C 1.524 0.62 0 C-N-CA 120.858 -0.687 . . . . 0.0 113.216 177.355 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -133.82 -90.26 0.39 Allowed Glycine 0 CA--C 1.525 0.669 0 C-N-CA 121.429 -0.415 . . . . 0.0 112.782 -179.125 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -71.36 156.56 39.36 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 122.564 -0.374 . . . . 0.0 111.032 177.238 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -44.47 -46.27 8.61 Favored Glycine 0 CA--C 1.532 1.108 0 N-CA-C 113.671 0.229 . . . . 0.0 113.671 178.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -74.29 -24.09 59.19 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 178.362 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 83.7 mt -93.43 17.38 11.53 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 120.908 0.385 . . . . 0.0 111.777 -177.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -78.07 104.42 2.01 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 121.15 -0.547 . . . . 0.0 112.895 178.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 25.7 m170 -78.39 148.66 74.33 Favored Pre-proline 0 CA--C 1.542 0.662 0 O-C-N 122.63 -0.335 . . . . 0.0 110.533 178.16 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -72.08 49.34 1.3 Allowed 'Trans proline' 0 CA--C 1.549 1.27 0 C-N-CA 123.091 2.527 . . . . 0.0 114.112 -177.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.408 ' HA ' ' HD3' ' A' ' 29' ' ' ARG . 3.4 tpp180 64.13 90.72 0.08 Allowed 'General case' 0 N--CA 1.441 -0.896 0 CA-C-O 121.879 0.847 . . . . 0.0 112.19 176.514 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 31.4 m -98.35 124.75 51.64 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 CA-C-N 114.6 -1.182 . . . . 0.0 111.563 178.382 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 50.4 m95 -104.68 112.82 26.05 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 120.898 0.38 . . . . 0.0 111.302 178.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.445 ' N ' HD13 ' A' ' 32' ' ' LEU . 5.8 mp -98.87 127.99 44.94 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 121.254 0.549 . . . . 0.0 112.083 -177.399 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 22.8 tp60 -104.11 108.42 19.77 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.738 176.186 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.528 HG21 ' HB2' ' A' ' 52' ' ' LEU . 80.0 mt -67.61 121.36 78.86 Favored Pre-proline 0 CA--C 1.538 0.482 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.846 176.415 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.649 ' HG2' HG23 ' A' ' 38' ' ' THR . 72.8 Cg_endo -76.8 103.67 1.79 Allowed 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 122.147 1.898 . . . . 0.0 112.116 178.329 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -48.81 -26.67 2.52 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.068 0.547 . . . . 0.0 112.186 179.017 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -51.19 -46.19 62.07 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-N 116.144 -0.48 . . . . 0.0 112.049 175.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.649 HG23 ' HG2' ' A' ' 35' ' ' PRO . 14.9 t -104.7 -32.92 8.66 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 111.871 0.323 . . . . 0.0 111.871 -179.562 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 103.98 2.67 45.61 Favored Glycine 0 CA--C 1.533 1.217 0 N-CA-C 114.92 0.728 . . . . 0.0 114.92 174.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.41 ' H ' HG22 ' A' ' 38' ' ' THR . 58.2 p-90 -156.52 163.45 39.38 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 117.942 0.871 . . . . 0.0 112.09 -175.423 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.501 HG13 HG12 ' A' ' 34' ' ' ILE . 6.3 p -150.21 165.88 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 N-CA-C 109.873 -0.418 . . . . 0.0 109.873 174.645 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -142.6 150.82 40.82 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.256 0.551 . . . . 0.0 111.648 176.139 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.634 ' SG ' ' N ' ' A' ' 47' ' ' ASP . 28.6 p -69.99 141.37 89.33 Favored Pre-proline 0 N--CA 1.468 0.468 0 CA-C-N 115.692 -0.686 . . . . 0.0 112.663 -172.747 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 43' ' ' CYS . 18.3 Cg_exo -67.55 -27.88 38.72 Favored 'Trans proline' 0 CA--C 1.542 0.894 0 C-N-CA 122.708 2.272 . . . . 0.0 113.25 177.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -94.51 -83.62 0.34 Allowed 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 -178.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 49.5 t -168.14 18.47 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.953 0 CA-C-O 120.797 0.332 . . . . 0.0 111.874 -177.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.634 ' N ' ' SG ' ' A' ' 43' ' ' CYS . 2.1 m-20 -66.6 -79.17 0.05 OUTLIER 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 116.292 -0.413 . . . . 0.0 112.075 -174.431 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.445 ' SG ' ' O ' ' A' ' 47' ' ' ASP . 72.0 m -161.62 171.25 18.31 Favored 'General case' 0 N--CA 1.479 1.011 0 CA-C-O 121.516 0.674 . . . . 0.0 112.607 -177.743 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.468 ' HD2' ' HD2' ' A' ' 6' ' ' PRO . 36.1 tttp -110.65 120.29 41.94 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.692 174.416 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -108.67 115.34 29.92 Favored 'General case' 0 N--CA 1.469 0.502 0 O-C-N 121.871 -0.518 . . . . 0.0 112.23 -170.167 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 94.9 t -96.42 137.9 23.07 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.09 176.26 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.528 ' HB2' HG21 ' A' ' 34' ' ' ILE . 36.7 tp -84.35 104.77 14.65 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 121.514 0.673 . . . . 0.0 111.92 -178.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.565 ' HB2' HG21 ' A' ' 10' ' ' ILE . 47.3 tttm -62.2 128.19 34.95 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.75 178.657 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 93.33 -5.48 74.66 Favored Glycine 0 CA--C 1.529 0.943 0 CA-C-N 116.034 -0.53 . . . . 0.0 113.409 -177.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 44.7 t -95.46 -175.61 3.52 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 122.468 -0.431 . . . . 0.0 111.441 178.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 15.3 ptmm? -62.27 -19.97 63.79 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 120.872 0.368 . . . . 0.0 111.489 178.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -82.31 -10.79 58.97 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 112.027 0.38 . . . . 0.0 112.027 177.302 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -73.56 75.48 1.47 Allowed 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 121.674 0.749 . . . . 0.0 110.376 177.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -139.64 13.41 2.52 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.593 -179.232 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.44 HD22 ' N ' ' A' ' 60' ' ' LEU . 2.8 mm? -76.71 70.14 3.17 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.447 0.642 . . . . 0.0 110.608 178.599 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -141.79 86.27 1.98 Allowed 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.136 -178.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 40.2 p-80 -78.01 -13.88 59.72 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.049 0.452 . . . . 0.0 110.61 178.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 40.1 t-80 -171.19 -45.8 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.426 177.293 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 40.4 m-70 -106.92 124.65 49.93 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.36 176.282 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 5.1 t-160 -99.22 114.59 27.47 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 175.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 22.2 p80 -154.11 178.72 9.66 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 120.974 0.416 . . . . 0.0 112.113 -176.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 41.9 t60 . . . . . 0 C--O 1.249 1.077 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.822 170.934 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.3 mtt . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 120.887 0.375 . . . . 0.0 111.508 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 72.8 p -84.74 131.09 34.6 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 120.978 0.418 . . . . 0.0 111.678 179.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 33.6 pt -74.64 -17.94 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-O 120.699 0.285 . . . . 0.0 111.33 177.368 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 69.4 mt-30 68.69 141.59 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.377 0.671 . . . . 0.0 112.157 -179.612 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 61.61 73.91 0.54 Allowed Pre-proline 0 CA--C 1.544 0.719 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 176.383 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -77.81 65.73 8.19 Favored 'Trans proline' 0 CA--C 1.545 1.034 0 C-N-CA 122.514 2.143 . . . . 0.0 112.541 177.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -66.85 155.14 39.11 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.559 -179.23 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 69.1 m -125.03 142.02 51.75 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 122.447 0.299 . . . . 0.0 111.388 -178.266 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 25.1 mtmm -137.01 126.91 25.76 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 120.932 0.396 . . . . 0.0 111.25 177.068 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.492 ' N ' HD13 ' A' ' 10' ' ' ILE . 2.6 mp -92.67 110.78 23.46 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.494 178.578 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 33.7 m -104.35 164.31 3.78 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-O 121.228 0.537 . . . . 0.0 111.802 -177.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -96.38 -23.62 16.54 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 116.16 -0.473 . . . . 0.0 112.066 -177.218 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -120.27 151.17 39.56 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-O 120.941 0.4 . . . . 0.0 111.475 -177.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 19.9 m -68.97 -26.63 65.14 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 113.607 0.966 . . . . 0.0 113.607 -171.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 4.5 tpt180 -101.77 119.89 39.5 Favored 'General case' 0 N--CA 1.473 0.688 0 O-C-N 121.494 -0.754 . . . . 0.0 111.605 -178.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 41.0 t -129.69 141.89 45.31 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 CA-C-O 120.813 0.339 . . . . 0.0 111.322 -178.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -92.39 116.1 28.68 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.875 0.369 . . . . 0.0 111.356 177.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.49 ' HB3' HG23 ' A' ' 30' ' ' VAL . 40.1 t -80.26 91.45 5.62 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.282 179.411 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -69.7 -76.48 0.1 Allowed 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.55 -176.317 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 161.55 -157.71 29.42 Favored Glycine 0 CA--C 1.526 0.721 0 C-N-CA 120.058 -1.068 . . . . 0.0 114.164 179.018 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -104.0 -74.08 0.97 Allowed Glycine 0 CA--C 1.524 0.651 0 CA-C-O 121.097 0.276 . . . . 0.0 112.794 -179.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -103.97 165.74 10.85 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 122.506 0.322 . . . . 0.0 111.006 176.184 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -44.09 -56.87 5.09 Favored Glycine 0 CA--C 1.53 1.002 0 N-CA-C 114.096 0.398 . . . . 0.0 114.096 179.048 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.75 -15.56 62.18 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 120.941 0.401 . . . . 0.0 112.037 -179.334 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 90.1 mt -97.22 12.91 31.22 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.53 179.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -81.71 143.85 23.74 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 121.387 -0.435 . . . . 0.0 113.201 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.408 ' NE2' ' SG ' ' A' ' 46' ' ' CYS . 20.2 m80 -91.57 147.28 34.89 Favored Pre-proline 0 CA--C 1.539 0.533 0 O-C-N 122.655 -0.32 . . . . 0.0 111.108 -176.153 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -73.51 62.03 4.43 Favored 'Trans proline' 0 CA--C 1.545 1.026 0 C-N-CA 122.709 2.273 . . . . 0.0 113.639 -178.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.431 ' HD3' ' HA ' ' A' ' 29' ' ' ARG . 12.3 tpp180 58.6 88.07 0.07 Allowed 'General case' 0 N--CA 1.439 -0.993 0 CA-C-O 122.236 1.017 . . . . 0.0 112.733 176.063 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.49 HG23 ' HB3' ' A' ' 18' ' ' CYS . 17.4 m -119.08 116.38 50.81 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 CA-C-N 114.294 -1.321 . . . . 0.0 111.242 176.151 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 89.0 m95 -96.65 109.63 22.22 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.531 -178.633 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.7 mp -90.13 154.89 19.43 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 121.149 0.5 . . . . 0.0 111.276 177.219 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.444 HE21 ' HA ' ' A' ' 33' ' ' GLN . 0.0 OUTLIER -122.73 129.13 51.41 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.002 0.429 . . . . 0.0 111.368 178.754 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.495 HG12 HG13 ' A' ' 41' ' ' VAL . 55.0 mt -87.09 117.73 69.02 Favored Pre-proline 0 CA--C 1.537 0.447 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.146 177.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.501 ' HG2' ' OG1' ' A' ' 38' ' ' THR . 82.5 Cg_endo -79.76 123.34 5.24 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 122.179 1.919 . . . . 0.0 111.832 177.707 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.486 ' O ' ' HB2' ' A' ' 56' ' ' LYS . 13.0 pt-20 -56.23 -23.79 38.07 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 111.923 0.342 . . . . 0.0 111.923 -177.355 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -66.93 -35.62 80.39 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 178.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.501 ' OG1' ' HG2' ' A' ' 35' ' ' PRO . 39.9 p -92.29 -50.89 5.43 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 120.924 0.392 . . . . 0.0 110.775 178.723 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.496 ' HA2' ' OG ' ' A' ' 55' ' ' SER . . . 103.98 -0.03 44.91 Favored Glycine 0 CA--C 1.524 0.596 0 CA-C-N 116.073 -0.512 . . . . 0.0 112.841 -178.761 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.406 ' HA ' ' O ' ' A' ' 50' ' ' TYR . 67.7 p-90 -162.14 162.54 28.54 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 120.716 0.293 . . . . 0.0 111.327 -175.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.495 HG13 HG12 ' A' ' 34' ' ' ILE . 9.7 p -142.27 141.74 28.13 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-O 121.033 0.444 . . . . 0.0 110.73 173.479 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.464 ' O ' ' HD3' ' A' ' 44' ' ' PRO . 9.0 pt-20 -100.74 141.27 33.85 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 111.849 0.314 . . . . 0.0 111.849 -177.474 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.534 ' SG ' ' HB3' ' A' ' 47' ' ' ASP . 29.9 p -98.4 99.91 8.21 Favored Pre-proline 0 CA--C 1.54 0.56 0 CA-C-O 120.64 0.257 . . . . 0.0 110.419 170.449 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.464 ' HD3' ' O ' ' A' ' 42' ' ' GLU . 23.2 Cg_exo -65.77 -3.92 8.96 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 122.735 2.29 . . . . 0.0 113.13 -178.328 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -82.83 -76.15 0.28 Allowed 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 116.592 -0.276 . . . . 0.0 110.589 179.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.408 ' SG ' ' NE2' ' A' ' 27' ' ' HIS . 24.8 p 173.86 92.33 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.358 177.205 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.534 ' HB3' ' SG ' ' A' ' 43' ' ' CYS . 13.5 t70 -161.02 -83.03 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 116.717 -0.219 . . . . 0.0 110.969 173.538 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.502 ' N ' ' SG ' ' A' ' 43' ' ' CYS . 81.9 m -160.76 178.27 9.61 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 122.144 0.973 . . . . 0.0 113.135 -177.892 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 19.3 ttmm -102.48 113.58 27.05 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 114.484 -1.235 . . . . 0.0 108.754 168.384 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.449 ' HB2' HG13 ' A' ' 41' ' ' VAL . 67.7 m-85 -85.85 105.71 16.55 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 111.847 0.314 . . . . 0.0 111.847 -173.569 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 67.0 t -88.22 133.05 31.73 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 CA-C-O 120.767 0.317 . . . . 0.0 111.038 174.328 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.459 ' HB2' HG21 ' A' ' 34' ' ' ILE . 53.2 tp -98.77 131.75 44.66 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 121.359 0.6 . . . . 0.0 112.42 -175.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -68.05 141.25 56.23 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 115.811 -0.632 . . . . 0.0 111.144 176.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 70.8 10.64 68.06 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 121.271 -0.49 . . . . 0.0 113.68 179.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.496 ' OG ' ' HA2' ' A' ' 39' ' ' GLY . 29.4 t -97.57 -171.08 2.11 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 122.495 -0.415 . . . . 0.0 111.535 -179.356 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.486 ' HB2' ' O ' ' A' ' 36' ' ' GLU . 47.3 tptt -53.32 -43.97 68.05 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 120.944 0.402 . . . . 0.0 111.928 -177.744 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -82.26 2.39 32.17 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -175.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -77.02 -36.55 56.17 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 120.924 0.392 . . . . 0.0 111.659 -178.377 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -80.35 50.35 1.26 Allowed 'General case' 0 CA--C 1.543 0.676 0 CA-C-O 121.031 0.443 . . . . 0.0 112.021 -178.53 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.409 ' O ' HD11 ' A' ' 60' ' ' LEU . 2.7 pp -76.98 155.58 32.55 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.936 179.604 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 53.77 34.7 19.68 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-O 121.083 0.468 . . . . 0.0 112.235 178.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 45.8 t60 -76.95 11.83 1.61 Allowed 'General case' 0 CA--C 1.547 0.852 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.579 -178.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 15.0 t-80 66.04 18.38 11.01 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 122.696 0.398 . . . . 0.0 111.786 176.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 33.4 t60 -98.31 123.97 42.7 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 120.658 0.266 . . . . 0.0 111.024 -179.183 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 23.2 m170 -78.82 171.92 14.49 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 121.676 0.751 . . . . 0.0 112.44 179.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 29.6 p80 -147.86 19.0 1.14 Allowed 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.738 177.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 25.2 t60 . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.666 -0.683 . . . . 0.0 110.699 -177.605 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.3 mmt . . . . . 0 N--CA 1.489 1.503 0 CA-C-O 120.845 0.355 . . . . 0.0 111.329 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 21.4 p -72.55 161.45 30.77 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 121.028 0.442 . . . . 0.0 111.942 177.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 45.7 mt -72.15 -8.83 12.11 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 CA-C-O 121.479 0.657 . . . . 0.0 110.714 177.148 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 70.61 10.07 7.03 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 115.357 -0.838 . . . . 0.0 112.853 176.173 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -127.81 74.47 78.53 Favored Pre-proline 0 N--CA 1.47 0.558 0 CA-C-O 121.018 0.437 . . . . 0.0 111.621 178.089 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -96.22 94.67 0.09 OUTLIER 'Trans proline' 0 CA--C 1.542 0.923 0 C-N-CA 123.377 2.718 . . . . 0.0 113.009 177.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.44 6.02 25.03 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 121.506 0.669 . . . . 0.0 111.854 177.737 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 54.2 m -89.86 111.37 22.39 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.602 177.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 46.8 tptt -100.54 109.3 21.39 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.04 -172.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 58.3 mt -79.04 94.22 1.73 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 CA-C-O 121.141 0.496 . . . . 0.0 110.602 179.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.418 HG12 HG23 ' A' ' 16' ' ' VAL . 3.5 t -97.89 156.84 3.55 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 CA-C-O 121.127 0.489 . . . . 0.0 111.62 -175.763 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -96.43 -4.31 41.96 Favored 'General case' 0 CA--C 1.548 0.873 0 CA-C-O 121.01 0.433 . . . . 0.0 111.909 -178.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 50.9 mtmt -137.35 153.08 50.29 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 122.101 -0.374 . . . . 0.0 111.42 -176.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 77.7 p -79.06 -40.15 32.01 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.063 0.459 . . . . 0.0 111.265 177.438 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 78.2 mtm180 -75.35 94.82 3.1 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.96 176.294 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.483 HG12 ' CD1' ' A' ' 50' ' ' TYR . 47.4 t -111.35 137.86 42.17 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.34 -177.627 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -97.96 118.46 34.59 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 121.069 0.461 . . . . 0.0 111.755 -179.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 10.0 t -66.78 124.92 24.26 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.061 174.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -98.7 -73.49 0.62 Allowed 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 120.875 0.369 . . . . 0.0 110.989 178.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.435 ' HA3' ' HA2' ' A' ' 26' ' ' GLY . . . 160.08 -178.25 36.22 Favored Glycine 0 CA--C 1.525 0.665 0 C-N-CA 120.693 -0.765 . . . . 0.0 113.103 177.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -91.02 -93.33 1.29 Allowed Glycine 0 CA--C 1.525 0.715 0 N-CA-C 111.364 -0.695 . . . . 0.0 111.364 172.17 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -87.58 166.28 14.84 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 168.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -45.41 -50.63 10.1 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 120.975 -0.631 . . . . 0.0 112.927 172.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.42 -15.29 60.32 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 178.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 93.6 mt -111.51 18.95 18.64 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.053 0.454 . . . . 0.0 110.488 176.438 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.435 ' HA2' ' HA3' ' A' ' 20' ' ' GLY . . . -75.95 122.89 6.75 Favored Glycine 0 CA--C 1.526 0.736 0 CA-C-N 115.956 -0.566 . . . . 0.0 113.52 -177.073 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 27.6 m80 -92.42 120.9 67.26 Favored Pre-proline 0 CA--C 1.543 0.679 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 178.143 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -74.05 53.55 2.94 Favored 'Trans proline' 0 CA--C 1.546 1.09 0 C-N-CA 122.975 2.45 . . . . 0.0 115.116 -168.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.4 ' NE ' ' HE1' ' A' ' 31' ' ' TRP . 0.8 OUTLIER 75.16 99.13 0.07 Allowed 'General case' 0 N--CA 1.446 -0.655 0 CA-C-O 122.769 1.271 . . . . 0.0 111.779 169.726 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 25.7 m -134.32 141.09 44.55 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 113.855 -1.521 . . . . 0.0 109.774 169.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . 0.4 ' HE1' ' NE ' ' A' ' 29' ' ' ARG . 75.7 m95 -107.25 123.55 48.46 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -171.433 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.471 ' N ' HD13 ' A' ' 32' ' ' LEU . 5.1 mp -103.44 158.65 16.2 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.615 178.052 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -123.77 109.53 13.78 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.935 0.398 . . . . 0.0 111.436 -179.002 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.471 HG12 HG13 ' A' ' 41' ' ' VAL . 64.6 mt -70.47 115.06 31.17 Favored Pre-proline 0 CA--C 1.542 0.656 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.47 178.439 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.419 ' HG2' ' OG1' ' A' ' 38' ' ' THR . 90.4 Cg_endo -80.11 145.47 17.38 Favored 'Trans proline' 0 CA--C 1.54 0.825 0 C-N-CA 122.517 2.145 . . . . 0.0 112.753 179.573 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 20.9 mp0 -62.95 -29.51 70.86 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 121.105 0.479 . . . . 0.0 111.035 179.437 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -58.43 -50.28 74.25 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.497 -0.774 . . . . 0.0 112.155 -178.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.419 ' OG1' ' HG2' ' A' ' 35' ' ' PRO . 50.2 p -90.34 -49.16 6.69 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.077 0.465 . . . . 0.0 111.324 -178.267 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 98.24 0.95 58.22 Favored Glycine 0 CA--C 1.523 0.562 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.399 -176.292 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.526 ' HB3' HG23 ' A' ' 51' ' ' VAL . 68.2 p-90 -156.79 164.13 38.44 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 121.148 0.499 . . . . 0.0 112.151 -176.605 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.471 HG13 HG12 ' A' ' 34' ' ' ILE . 14.5 p -142.85 137.09 27.15 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.676 174.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -98.83 148.03 24.33 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.155 0.502 . . . . 0.0 112.139 -177.319 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.66 ' SG ' ' HE2' ' A' ' 50' ' ' TYR . 74.0 m -98.25 119.31 62.11 Favored Pre-proline 0 CA--C 1.538 0.519 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.578 171.256 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -73.13 22.44 0.32 Allowed 'Trans proline' 0 CA--C 1.541 0.861 0 C-N-CA 122.902 2.402 . . . . 0.0 114.036 -173.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -114.94 -88.7 0.57 Allowed 'General case' 0 CA--C 1.538 0.517 0 O-C-N 122.084 -0.385 . . . . 0.0 111.073 177.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 57.5 m -160.57 18.98 0.14 Allowed 'General case' 0 N--CA 1.477 0.913 0 CA-C-O 120.856 0.36 . . . . 0.0 111.331 -177.161 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.414 ' O ' ' SG ' ' A' ' 48' ' ' CYS . 2.1 m-20 -81.74 -93.5 0.05 Allowed 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 112.276 0.473 . . . . 0.0 112.276 -173.34 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.414 ' SG ' ' O ' ' A' ' 47' ' ' ASP . 72.3 m -161.38 173.33 15.09 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.553 0.692 . . . . 0.0 112.043 -176.539 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.7 ttmp? -101.47 104.77 15.71 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.269 169.041 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.66 ' HE2' ' SG ' ' A' ' 43' ' ' CYS . 95.4 m-85 -81.85 103.16 11.32 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.926 0.393 . . . . 0.0 111.767 -173.745 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.526 HG23 ' HB3' ' A' ' 40' ' ' TRP . 88.0 t -94.28 123.19 46.29 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.928 178.712 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 51.4 tp -77.88 120.41 22.72 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 116.585 -0.28 . . . . 0.0 110.978 176.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 46.8 tttp -65.71 146.06 55.25 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 121.149 0.5 . . . . 0.0 111.954 -178.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 85.11 17.45 62.86 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 121.117 -0.563 . . . . 0.0 112.549 -175.452 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.5 m -118.36 172.14 7.66 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 122.481 0.312 . . . . 0.0 110.886 -179.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -56.31 -30.08 62.09 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -178.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -75.96 -26.91 57.27 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 121.006 0.431 . . . . 0.0 112.111 179.079 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -77.69 72.48 4.23 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-O 121.549 0.69 . . . . 0.0 110.571 179.366 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -153.69 -17.86 0.14 Allowed 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -179.352 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.405 ' N ' HD12 ' A' ' 60' ' ' LEU . 7.0 mp -60.64 -73.72 0.09 Allowed 'General case' 0 CA--C 1.54 0.585 0 O-C-N 122.084 -0.385 . . . . 0.0 111.925 -178.285 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -96.42 116.35 28.91 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 120.806 0.336 . . . . 0.0 111.163 -178.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 1.7 p80 -167.95 134.25 2.03 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 120.901 0.381 . . . . 0.0 111.5 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 2.5 p-80 -138.63 -179.61 5.92 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.993 175.356 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 32.5 m170 -50.39 108.66 0.24 Allowed 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.218 0.532 . . . . 0.0 112.346 -175.361 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 37.5 m80 63.71 -88.88 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.965 177.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 85.7 m-70 -148.73 -35.14 0.2 Allowed 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 112.902 0.704 . . . . 0.0 112.902 -178.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 31.2 m170 . . . . . 0 C--O 1.251 1.169 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 -176.076 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.1 ptp . . . . . 0 N--CA 1.489 1.517 0 CA-C-O 121.02 0.438 . . . . 0.0 111.429 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 20.8 p -87.09 179.75 6.61 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.478 171.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 33.5 pt -68.81 -24.29 28.53 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-O 121.542 0.687 . . . . 0.0 109.738 169.461 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 22.5 mt-30 61.94 2.05 0.72 Allowed 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 114.938 -1.028 . . . . 0.0 113.66 174.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -59.47 106.6 0.76 Allowed Pre-proline 0 CA--C 1.542 0.66 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 -176.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -91.77 30.81 0.32 Allowed 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 123.259 2.64 . . . . 0.0 113.011 -179.537 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -94.17 25.38 3.8 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 121.227 0.537 . . . . 0.0 112.069 -176.486 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 69.5 m -89.18 119.65 29.86 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.292 174.141 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 55.9 tptt -109.82 106.91 16.69 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 120.656 0.265 . . . . 0.0 111.236 -173.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 56.2 mt -86.09 100.95 9.79 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-O 121.104 0.478 . . . . 0.0 111.351 -179.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 34.5 m -103.94 162.57 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 CA-C-O 120.951 0.405 . . . . 0.0 111.35 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -92.93 -32.46 14.55 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-O 120.887 0.375 . . . . 0.0 111.618 -178.317 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -108.16 143.31 37.11 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 120.729 0.299 . . . . 0.0 111.643 -179.277 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 41.2 t -63.01 -37.24 86.38 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 112.824 0.676 . . . . 0.0 112.824 -176.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 52.5 mtt85 -74.18 105.49 5.41 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.201 0.524 . . . . 0.0 111.892 178.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 48.0 t -100.95 106.17 18.97 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.966 176.592 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -80.82 101.03 9.12 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 120.936 0.398 . . . . 0.0 111.266 178.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 52.0 t -96.74 104.75 16.78 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -178.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -77.3 -58.86 3.04 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 121.534 0.683 . . . . 0.0 110.369 172.176 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 162.35 172.19 29.47 Favored Glycine 0 CA--C 1.523 0.573 0 C-N-CA 121.074 -0.584 . . . . 0.0 113.065 176.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -106.41 -80.74 1.35 Allowed Glycine 0 CA--C 1.524 0.618 0 N-CA-C 111.65 -0.58 . . . . 0.0 111.65 175.562 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 23.6 mm-40 -99.61 169.56 9.19 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 122.26 0.224 . . . . 0.0 110.397 172.129 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -44.51 -46.93 8.8 Favored Glycine 0 CA--C 1.535 1.317 0 N-CA-C 114.142 0.417 . . . . 0.0 114.142 178.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.21 -24.97 68.12 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -179.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 91.4 mt -106.49 16.4 24.71 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 120.689 0.28 . . . . 0.0 111.655 -179.442 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -85.07 138.24 16.42 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 120.978 -0.63 . . . . 0.0 113.044 179.447 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -154.58 152.62 26.34 Favored Pre-proline 0 N--CA 1.472 0.653 0 O-C-N 122.583 -0.363 . . . . 0.0 111.125 179.629 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_exo -38.88 -67.28 0.11 Allowed 'Trans proline' 0 C--N 1.354 0.846 0 C-N-CA 123.587 2.858 . . . . 0.0 114.587 -175.507 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.458 ' HD3' ' HA ' ' A' ' 29' ' ' ARG . 0.1 OUTLIER -177.78 91.57 0.03 OUTLIER 'General case' 0 N--CA 1.441 -0.89 0 CA-C-O 122.24 1.019 . . . . 0.0 110.665 -178.12 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 55.8 t -93.94 105.07 16.45 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 CA-C-N 114.134 -1.394 . . . . 0.0 111.17 -179.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 56.7 m95 -92.22 111.52 23.11 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.367 178.609 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.416 ' N ' HD11 ' A' ' 32' ' ' LEU . 5.6 mp -91.37 134.03 34.95 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 120.753 0.311 . . . . 0.0 111.003 177.612 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 14.6 tp60 -104.88 106.91 17.61 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 177.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.535 HG21 ' HB2' ' A' ' 52' ' ' LEU . 75.6 mt -63.46 117.42 34.16 Favored Pre-proline 0 CA--C 1.54 0.566 0 CA-C-O 120.602 0.239 . . . . 0.0 111.408 -179.702 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.537 ' HG2' ' OG1' ' A' ' 38' ' ' THR . 90.1 Cg_endo -80.1 127.78 7.01 Favored 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 122.611 2.207 . . . . 0.0 113.005 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -61.31 -21.94 64.44 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 120.981 0.42 . . . . 0.0 111.675 179.275 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -64.04 -35.12 79.68 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.884 178.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.537 ' OG1' ' HG2' ' A' ' 35' ' ' PRO . 36.0 p -106.04 -52.42 2.81 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-O 121.029 0.442 . . . . 0.0 111.605 -178.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 106.56 0.64 37.25 Favored Glycine 0 CA--C 1.526 0.762 0 CA-C-N 116.189 -0.46 . . . . 0.0 112.643 -176.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 67.7 p-90 -155.81 162.79 40.42 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 120.916 0.388 . . . . 0.0 111.595 -178.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.512 HG13 HG12 ' A' ' 34' ' ' ILE . 12.3 p -151.81 127.85 1.84 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.452 172.647 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.408 ' HA ' ' HA ' ' A' ' 49' ' ' LYS . 12.6 pt-20 -100.89 150.21 23.08 Favored 'General case' 0 CA--C 1.536 0.405 0 O-C-N 121.925 -0.485 . . . . 0.0 111.324 -179.357 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 42.6 t -97.16 107.41 37.94 Favored Pre-proline 0 N--CA 1.468 0.429 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.813 -177.417 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.4 ' HD3' ' O ' ' A' ' 42' ' ' GLU . 41.4 Cg_exo -58.55 -14.66 21.97 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 122.364 2.043 . . . . 0.0 113.035 177.467 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -105.03 -0.3 26.92 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.807 -178.386 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 42.5 t -143.9 -2.2 0.94 Allowed 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 112.416 0.525 . . . . 0.0 112.416 -179.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 61.7 m-20 70.95 -41.17 0.5 Allowed 'General case' 0 CA--C 1.548 0.876 0 N-CA-C 114.026 1.121 . . . . 0.0 114.026 178.125 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 77.3 m -58.69 145.68 39.2 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 -172.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.408 ' HA ' ' HA ' ' A' ' 42' ' ' GLU . 20.4 ttmm -107.46 123.25 48.13 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.989 -178.205 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 55.1 m-85 -100.53 114.61 28.39 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 -174.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.407 HG13 ' HB3' ' A' ' 57' ' ' ALA . 93.2 t -99.15 145.24 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 CA-C-O 120.819 0.342 . . . . 0.0 111.467 176.871 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.535 ' HB2' HG21 ' A' ' 34' ' ' ILE . 54.5 tp -94.1 126.09 39.12 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 120.907 0.384 . . . . 0.0 111.735 179.84 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.464 ' NZ ' ' HB3' ' A' ' 53' ' ' LYS . 0.9 OUTLIER -61.88 122.91 16.59 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.435 178.428 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 90.07 7.65 67.76 Favored Glycine 0 CA--C 1.524 0.649 0 C-N-CA 121.417 -0.421 . . . . 0.0 113.299 -178.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 34.6 t -100.72 -173.56 2.42 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 122.364 -0.492 . . . . 0.0 111.587 178.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 48.7 mmtm -54.31 -34.73 61.6 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 113.253 0.835 . . . . 0.0 113.253 -175.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.407 ' HB3' HG13 ' A' ' 51' ' ' VAL . . . -94.19 6.77 47.56 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -176.467 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.418 ' CG ' ' H ' ' A' ' 59' ' ' ALA . 30.7 t70 -117.48 -136.31 0.35 Allowed 'General case' 0 CA--C 1.552 1.045 0 O-C-N 122.151 -0.343 . . . . 0.0 111.302 -178.301 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.418 ' H ' ' CG ' ' A' ' 58' ' ' ASP . . . 64.31 17.15 10.59 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-O 121.15 0.5 . . . . 0.0 111.559 -173.78 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.6 pp -89.31 10.09 23.61 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 -177.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -65.78 90.51 0.12 Allowed 'General case' 0 CA--C 1.541 0.621 0 CA-C-O 121.281 0.562 . . . . 0.0 111.794 -178.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 71.7 m80 -97.66 -31.74 12.13 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.957 175.136 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 44.6 t60 -175.69 -35.06 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.93 174.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 33.8 m170 -63.98 92.58 0.08 Allowed 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 120.973 0.416 . . . . 0.0 110.912 175.373 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 8.1 t60 -172.09 -24.04 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.015 -178.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 11.9 p80 -150.92 149.88 30.17 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.345 179.293 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 60.8 t-80 . . . . . 0 C--O 1.249 1.076 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 176.829 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.9 ttt . . . . . 0 N--CA 1.489 1.522 0 CA-C-O 121.005 0.431 . . . . 0.0 110.697 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 5.2 m -108.14 -2.2 19.68 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -173.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.441 ' O ' HD12 ' A' ' 3' ' ' ILE . 2.1 pp 37.22 70.65 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-O 122.052 0.929 . . . . 0.0 111.833 -165.253 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -45.82 106.09 0.07 Allowed 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 114.697 -1.138 . . . . 0.0 112.033 -175.119 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.468 ' HB3' ' HD3' ' A' ' 6' ' ' PRO . . . -165.72 -53.85 0.01 OUTLIER Pre-proline 0 CA--C 1.547 0.834 0 CA-C-N 116.017 -0.538 . . . . 0.0 112.222 -176.607 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.468 ' HD3' ' HB3' ' A' ' 5' ' ' ALA . 68.9 Cg_endo -81.48 37.11 0.66 Allowed 'Trans proline' 0 C--N 1.358 1.073 0 C-N-CA 122.278 1.985 . . . . 0.0 113.085 -179.706 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -91.72 31.72 1.18 Allowed 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.073 0.463 . . . . 0.0 112.029 -174.265 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 86.1 m -122.14 135.6 54.81 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.671 176.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 57.6 mtpt -137.23 137.92 39.59 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 122.342 0.257 . . . . 0.0 111.116 -173.566 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 57.3 mt -97.45 107.34 19.89 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-O 120.966 0.412 . . . . 0.0 111.417 -179.031 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 11.7 t -100.07 156.21 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.772 177.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -90.17 -7.8 52.75 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 -175.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 16.5 ptpt -130.53 152.21 50.16 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 121.073 0.463 . . . . 0.0 111.892 -176.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 23.0 m -83.63 9.53 11.34 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -174.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 75.0 mtp180 -128.19 116.97 20.72 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 121.007 0.432 . . . . 0.0 111.759 -178.417 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 39.9 t -131.64 152.65 37.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.396 -178.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.46 ' HA ' ' O ' ' A' ' 30' ' ' VAL . . . -81.53 154.1 26.44 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-O 121.278 0.561 . . . . 0.0 112.404 -179.59 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.573 ' SG ' ' N ' ' A' ' 19' ' ' ASP . 43.1 t -136.53 -166.92 1.97 Allowed 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.773 -174.743 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.573 ' N ' ' SG ' ' A' ' 18' ' ' CYS . 15.7 t70 62.97 84.89 0.14 Allowed 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.586 0.754 . . . . 0.0 112.031 178.394 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.473 ' HA3' ' O ' ' A' ' 25' ' ' LEU . . . 160.05 160.45 10.56 Favored Glycine 0 CA--C 1.525 0.685 0 C-N-CA 121.336 -0.459 . . . . 0.0 112.217 177.609 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 167.43 35.86 0.02 OUTLIER Glycine 0 CA--C 1.531 1.045 0 C-N-CA 120.05 -1.071 . . . . 0.0 114.821 177.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -158.48 145.14 17.39 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 117.493 0.646 . . . . 0.0 110.989 174.328 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 41.04 -96.07 0.01 OUTLIER Glycine 0 CA--C 1.532 1.118 0 N-CA-C 114.293 0.477 . . . . 0.0 114.293 -174.006 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -78.45 2.26 19.48 Favored 'General case' 0 N--CA 1.473 0.675 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -178.244 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.473 ' O ' ' HA3' ' A' ' 20' ' ' GLY . 86.9 mt 64.85 13.78 8.76 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.393 0.677 . . . . 0.0 112.763 178.019 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 55.39 -118.13 9.84 Favored Glycine 0 CA--C 1.532 1.136 0 N-CA-C 113.979 0.352 . . . . 0.0 113.979 177.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 12.5 m-70 66.24 83.1 0.19 Allowed Pre-proline 0 N--CA 1.473 0.722 0 C-N-CA 123.523 0.729 . . . . 0.0 112.765 176.655 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.46 ' O ' ' HB2' ' A' ' 29' ' ' ARG . 57.3 Cg_endo -74.77 -62.36 0.04 OUTLIER 'Trans proline' 0 CA--C 1.542 0.888 0 C-N-CA 122.157 1.905 . . . . 0.0 111.594 172.412 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.46 ' HB2' ' O ' ' A' ' 28' ' ' PRO . 16.5 tpt180 176.84 83.89 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 122.01 0.909 . . . . 0.0 110.246 169.687 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.46 ' O ' ' HA ' ' A' ' 17' ' ' ALA . 61.2 t -128.11 132.24 68.65 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 CA-C-N 114.456 -1.247 . . . . 0.0 109.64 -178.595 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 84.2 m95 -115.58 136.15 53.36 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 -172.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.521 HD12 ' HB2' ' A' ' 18' ' ' CYS . 8.8 mp -113.53 144.53 42.69 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.633 172.138 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.443 HE21 ' HA ' ' A' ' 33' ' ' GLN . 0.0 OUTLIER -103.92 119.84 39.77 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.272 -179.258 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.575 HG12 HG13 ' A' ' 41' ' ' VAL . 50.7 mt -75.0 114.46 35.12 Favored Pre-proline 0 CA--C 1.54 0.566 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.956 177.432 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.547 ' HG2' ' OG1' ' A' ' 38' ' ' THR . 91.3 Cg_endo -77.92 132.34 11.71 Favored 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 122.475 2.117 . . . . 0.0 112.356 178.553 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -77.32 -7.72 56.49 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 120.836 0.351 . . . . 0.0 111.341 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -68.03 -56.01 10.48 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 121.028 0.442 . . . . 0.0 110.89 172.488 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.547 ' OG1' ' HG2' ' A' ' 35' ' ' PRO . 47.9 p -80.64 -43.26 20.75 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.157 177.874 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 103.07 -0.19 47.86 Favored Glycine 0 CA--C 1.524 0.617 0 CA-C-N 115.56 -0.745 . . . . 0.0 112.811 -178.279 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.513 ' HB3' HG22 ' A' ' 51' ' ' VAL . 65.9 p-90 -161.2 161.24 30.84 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 -176.288 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.575 HG13 HG12 ' A' ' 34' ' ' ILE . 9.8 p -146.76 133.39 13.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.231 169.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -111.39 140.45 45.97 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -174.604 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.511 ' HB3' ' SG ' ' A' ' 48' ' ' CYS . 43.8 t -74.41 112.87 19.1 Favored Pre-proline 0 CA--C 1.537 0.452 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.623 178.516 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -58.35 -14.39 20.07 Favored 'Trans proline' 0 CA--C 1.542 0.911 0 C-N-CA 122.695 2.263 . . . . 0.0 113.404 -178.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -87.18 -51.35 6.03 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.705 -177.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 52.4 t -103.27 -3.7 25.29 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -178.06 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 49.8 m-20 65.76 10.67 6.99 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.115 0.566 . . . . 0.0 112.373 179.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.511 ' SG ' ' HB3' ' A' ' 43' ' ' CYS . 6.4 p -73.85 116.85 14.94 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 121.145 0.498 . . . . 0.0 111.515 179.553 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 18.3 ttmm -91.88 113.12 25.3 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.79 -177.166 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -97.38 103.34 15.26 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 120.988 0.423 . . . . 0.0 111.921 -175.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.513 HG22 ' HB3' ' A' ' 40' ' ' TRP . 78.5 t -82.55 142.87 13.04 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.662 175.397 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.478 ' HB2' HG21 ' A' ' 34' ' ' ILE . 68.6 tp -89.41 124.93 34.91 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 120.91 0.386 . . . . 0.0 111.7 178.269 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 8.5 tmtm? -71.05 122.89 20.88 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 174.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 97.19 52.54 1.46 Allowed Glycine 0 CA--C 1.526 0.732 0 N-CA-C 111.749 -0.54 . . . . 0.0 111.749 -172.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.41 ' H ' ' HB3' ' A' ' 58' ' ' ASP . 51.6 p -155.31 -178.49 7.3 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.516 0.674 . . . . 0.0 111.75 -176.341 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 32.4 ttpt -67.68 -15.23 63.54 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-N 115.322 -0.854 . . . . 0.0 112.059 179.411 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -99.99 2.34 43.4 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 121.202 0.525 . . . . 0.0 111.667 176.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.41 ' HB3' ' H ' ' A' ' 55' ' ' SER . 16.4 t70 -119.17 176.24 5.41 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.73 -177.472 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 69.96 86.01 0.13 Allowed 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.472 0.653 . . . . 0.0 110.986 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.511 ' N ' HD13 ' A' ' 60' ' ' LEU . 5.3 mp -87.15 82.51 7.66 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.499 -174.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -62.38 -8.82 6.62 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-O 121.271 0.557 . . . . 0.0 111.836 179.199 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 30.5 p-80 -100.99 22.92 11.46 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.237 178.42 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 66.1 m-70 -140.27 145.17 36.97 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 120.899 0.38 . . . . 0.0 111.709 174.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 4.4 t60 63.25 -76.81 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 123.294 0.637 . . . . 0.0 112.462 174.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 57.4 t-80 -171.9 133.49 0.73 Allowed 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 122.54 0.336 . . . . 0.0 110.612 -179.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 7.1 p-80 -107.64 159.23 16.62 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 120.931 0.396 . . . . 0.0 111.476 179.488 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 6.5 p80 . . . . . 0 C--O 1.253 1.265 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.818 177.22 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.497 ' C ' ' SD ' ' A' ' 1' ' ' MET . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 120.765 0.316 . . . . 0.0 111.139 . . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 69.9 p -67.61 144.07 55.73 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 121.253 0.549 . . . . 0.0 112.477 -177.061 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 33.2 pt -93.68 -0.31 10.29 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.167 177.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 70.83 -70.57 0.15 Allowed 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.598 0.759 . . . . 0.0 111.693 -178.459 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.417 ' N ' ' HD3' ' A' ' 6' ' ' PRO . . . 55.09 62.36 7.86 Favored Pre-proline 0 N--CA 1.471 0.621 0 CA-C-O 121.088 0.47 . . . . 0.0 111.958 -176.364 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.417 ' HD3' ' N ' ' A' ' 5' ' ' ALA . 13.9 Cg_exo -68.61 94.8 0.45 Allowed 'Trans proline' 0 C--N 1.352 0.745 0 C-N-CA 122.3 2.0 . . . . 0.0 112.258 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -41.08 105.62 0.05 OUTLIER 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.313 178.224 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 80.1 m -99.45 107.3 19.47 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.926 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.567 ' HZ3' ' HB3' ' A' ' 9' ' ' LYS . 6.8 mtpm? -102.81 93.46 5.08 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.158 0.504 . . . . 0.0 110.372 -175.181 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.419 ' HA ' ' O ' ' A' ' 51' ' ' VAL . 62.3 mt -78.28 99.37 2.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.061 -178.666 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 35.6 m -105.67 160.24 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-N 115.753 -0.658 . . . . 0.0 112.062 -174.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -91.19 1.14 57.32 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 120.757 0.313 . . . . 0.0 111.65 178.293 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -115.62 153.39 31.36 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 120.826 0.346 . . . . 0.0 111.63 -176.15 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 42.8 m -89.35 -22.77 22.45 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 116.517 -0.311 . . . . 0.0 111.161 176.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 68.8 mtt180 -114.38 114.6 26.09 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 120.918 0.39 . . . . 0.0 111.372 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 47.2 t -124.28 138.16 54.78 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.657 -177.386 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.0 102.11 7.23 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 120.964 0.411 . . . . 0.0 111.641 178.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.531 ' SG ' ' N ' ' A' ' 19' ' ' ASP . 51.5 t -78.77 173.78 12.13 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.398 0.618 . . . . 0.0 111.629 177.652 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.531 ' N ' ' SG ' ' A' ' 18' ' ' CYS . 0.7 OUTLIER -107.91 -4.6 17.8 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 115.553 -0.748 . . . . 0.0 112.886 -174.883 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.402 ' O ' HG21 ' A' ' 30' ' ' VAL . . . -124.14 138.4 11.29 Favored Glycine 0 CA--C 1.527 0.792 0 C-N-CA 120.059 -1.067 . . . . 0.0 114.125 -176.466 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -134.29 -42.84 0.13 Allowed Glycine 0 CA--C 1.527 0.814 0 C-N-CA 121.529 -0.367 . . . . 0.0 112.573 179.024 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.715 ' HB3' ' HB2' ' A' ' 25' ' ' LEU . 40.4 tt0 -169.32 159.09 8.54 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.373 0.669 . . . . 0.0 109.986 177.659 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -44.4 -55.79 5.78 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 121.655 -0.307 . . . . 0.0 113.64 176.148 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -85.5 -6.21 59.21 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 178.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.715 ' HB2' ' HB3' ' A' ' 22' ' ' GLU . 98.5 mt -115.6 48.9 1.14 Allowed 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.393 0.616 . . . . 0.0 109.925 177.687 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -71.29 128.96 16.79 Favored Glycine 0 CA--C 1.526 0.779 0 CA-C-N 115.758 -0.656 . . . . 0.0 113.633 -179.346 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.5 ' NE2' ' HB2' ' A' ' 19' ' ' ASP . 8.4 m80 52.43 60.43 13.12 Favored Pre-proline 0 CA--C 1.546 0.825 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 177.671 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.467 ' HG2' HG13 ' A' ' 30' ' ' VAL . 30.2 Cg_endo -102.03 18.11 0.25 Allowed 'Trans proline' 0 CA--C 1.542 0.916 0 C-N-CA 123.431 2.754 . . . . 0.0 113.711 179.471 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 1.1 mmm180 60.79 88.78 0.08 Allowed 'General case' 0 N--CA 1.44 -0.952 0 CA-C-O 123.093 1.425 . . . . 0.0 112.563 -174.589 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.467 HG13 ' HG2' ' A' ' 28' ' ' PRO . 17.8 m -119.8 125.02 73.89 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 CA-C-N 112.494 -2.139 . . . . 0.0 110.959 -179.464 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 39.5 m95 -101.84 114.53 28.69 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.078 0.466 . . . . 0.0 111.182 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 10.5 mp -92.81 150.73 20.43 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.654 -179.354 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 50.8 tp60 -104.39 124.95 50.14 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.791 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.483 HG21 ' HB2' ' A' ' 52' ' ' LEU . 74.7 mt -84.21 114.47 54.76 Favored Pre-proline 0 CA--C 1.542 0.65 0 CA-C-N 116.642 -0.254 . . . . 0.0 110.381 172.391 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -84.92 143.23 9.26 Favored 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 122.704 2.269 . . . . 0.0 113.235 -177.268 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.426 ' O ' ' NZ ' ' A' ' 56' ' ' LYS . 16.4 mm-40 -69.5 -3.81 16.17 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 121.117 0.484 . . . . 0.0 111.066 171.88 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -65.18 -62.86 1.29 Allowed 'General case' 0 CA--C 1.543 0.683 0 CA-C-O 121.034 0.445 . . . . 0.0 110.158 169.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 82.0 p -91.79 -48.88 6.56 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 115.758 -0.655 . . . . 0.0 112.037 -179.006 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 100.68 1.51 55.3 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 121.309 -0.472 . . . . 0.0 112.718 -175.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 60.2 p-90 -156.53 164.78 37.81 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 122.559 0.344 . . . . 0.0 111.39 -176.495 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 13.6 p -146.93 152.0 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 174.201 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -124.18 147.51 47.95 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 113.059 0.763 . . . . 0.0 113.059 -175.016 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.489 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 18.0 t -101.53 105.24 39.32 Favored Pre-proline 0 N--CA 1.468 0.432 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.274 174.226 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -77.17 -0.33 10.49 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 122.457 2.105 . . . . 0.0 113.123 -177.02 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -90.05 -67.71 0.83 Allowed 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 116.636 -0.256 . . . . 0.0 111.507 -176.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 49.4 t -104.26 6.07 35.17 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 111.869 0.322 . . . . 0.0 111.869 178.101 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 26.6 m-20 69.06 101.35 0.06 Allowed 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 175.29 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 52.0 m -161.69 120.8 2.43 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.135 175.075 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -100.4 110.84 23.05 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 120.753 0.311 . . . . 0.0 110.812 177.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 27.9 m-85 -91.57 107.13 18.99 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 120.638 0.256 . . . . 0.0 110.456 -177.19 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.419 ' O ' ' HA ' ' A' ' 10' ' ' ILE . 90.5 t -100.4 131.4 48.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 CA-C-O 120.726 0.298 . . . . 0.0 111.741 179.646 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.483 ' HB2' HG21 ' A' ' 34' ' ' ILE . 68.0 tp -81.54 119.42 23.75 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.096 0.475 . . . . 0.0 111.934 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.413 ' HB2' HG21 ' A' ' 10' ' ' ILE . 88.0 tttt -69.0 108.23 3.45 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.868 177.103 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 119.87 -13.59 10.63 Favored Glycine 0 CA--C 1.527 0.801 0 C-N-CA 121.412 -0.423 . . . . 0.0 112.542 -175.571 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 59.6 p -81.29 -176.57 6.06 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 120.93 0.395 . . . . 0.0 111.147 178.398 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.426 ' NZ ' ' O ' ' A' ' 36' ' ' GLU . 33.7 mtmm -73.07 -20.19 61.01 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.655 -0.248 . . . . 0.0 111.612 179.073 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -71.6 -49.61 38.67 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.287 0.565 . . . . 0.0 111.321 -175.46 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -75.91 -30.45 58.78 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.867 177.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.436 ' C ' ' H ' ' A' ' 61' ' ' GLU . . . -67.78 -47.52 68.93 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 179.438 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 88.8 mt 69.7 -29.5 0.18 Allowed 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.137 0.575 . . . . 0.0 112.263 -175.323 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.436 ' H ' ' C ' ' A' ' 59' ' ' ALA . 13.8 mt-10 -83.43 17.29 2.2 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 122.956 0.502 . . . . 0.0 111.288 173.763 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 34.8 p80 44.09 36.91 1.61 Allowed 'General case' 0 N--CA 1.476 0.832 0 CA-C-O 121.866 0.841 . . . . 0.0 110.547 -165.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 15.4 t60 79.04 -33.45 0.15 Allowed 'General case' 0 CA--C 1.548 0.876 0 CA-C-N 114.148 -1.387 . . . . 0.0 112.319 178.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 37.7 t60 69.2 143.77 0.05 OUTLIER 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 170.17 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 33.9 m170 -61.43 102.65 0.25 Allowed 'General case' 0 N--CA 1.477 0.883 0 O-C-N 122.006 -0.434 . . . . 0.0 111.606 177.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -96.38 -8.57 32.1 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 120.935 0.397 . . . . 0.0 111.429 174.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 79.5 m80 . . . . . 0 C--O 1.248 0.999 0 CA-C-O 118.522 -0.752 . . . . 0.0 111.201 176.139 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 . . . . . 0 CA--C 1.539 0.545 0 CA-C-O 120.987 0.422 . . . . 0.0 111.753 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 57.2 m -75.52 127.53 33.3 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.305 179.502 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 85.2 mttt -141.18 123.41 15.68 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 120.993 0.425 . . . . 0.0 111.32 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.522 HD12 ' N ' ' A' ' 10' ' ' ILE . 2.8 mp -88.74 119.64 36.25 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.769 -178.042 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 15.0 t -105.97 154.69 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-O 121.028 0.442 . . . . 0.0 111.245 -178.319 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -80.93 -37.78 28.96 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 121.048 0.451 . . . . 0.0 110.727 -177.165 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -101.56 162.97 12.51 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.396 176.629 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 50.5 m -79.97 -40.89 27.06 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -177.254 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 18.5 ptt-85 -86.09 118.43 25.55 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 121.458 0.647 . . . . 0.0 110.813 177.299 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 39.5 t -111.47 125.02 68.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.988 -172.815 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.95 82.23 5.15 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 120.984 0.421 . . . . 0.0 111.341 176.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.577 ' HG ' ' HG ' ' A' ' 43' ' ' CYS . 41.9 t . . . . . 0 N--CA 1.468 0.45 0 CA-C-O 121.17 0.51 . . . . 0.0 111.47 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.472 ' O ' ' HD3' ' A' ' 29' ' ' ARG . 1.1 tmt_? . . . . . 0 N--CA 1.452 -0.356 0 CA-C-O 122.185 0.993 . . . . 0.0 109.006 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.1 m -131.21 131.88 63.4 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 114.652 -1.158 . . . . 0.0 111.703 178.046 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 49.1 m95 -105.81 114.92 29.36 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.355 -178.077 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.461 ' HB3' HG21 ' A' ' 41' ' ' VAL . 6.4 mp -107.76 133.01 52.77 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 120.837 0.351 . . . . 0.0 111.421 179.249 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 54.9 tp60 -90.03 119.88 30.76 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 121.144 0.497 . . . . 0.0 111.958 -178.1 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.562 HG21 ' HB2' ' A' ' 52' ' ' LEU . 73.1 mt -79.93 118.17 71.08 Favored Pre-proline 0 CA--C 1.54 0.589 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.999 175.102 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.692 ' HG2' HG22 ' A' ' 38' ' ' THR . 97.2 Cg_endo -83.05 121.6 3.18 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 122.325 2.016 . . . . 0.0 112.868 178.811 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -56.5 -16.77 6.5 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-O 121.306 0.574 . . . . 0.0 111.427 175.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -61.69 -29.17 69.92 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 115.61 -0.723 . . . . 0.0 112.026 177.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.692 HG22 ' HG2' ' A' ' 35' ' ' PRO . 12.9 t -131.16 -38.82 1.2 Allowed 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 120.679 0.276 . . . . 0.0 111.415 178.179 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 107.42 2.45 35.34 Favored Glycine 0 CA--C 1.53 0.98 0 N-CA-C 115.419 0.928 . . . . 0.0 115.419 171.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.447 ' H ' HG23 ' A' ' 38' ' ' THR . 68.1 p-90 -144.8 164.96 29.46 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 118.271 1.035 . . . . 0.0 112.972 -176.022 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.461 HG21 ' HB3' ' A' ' 32' ' ' LEU . 9.9 p -147.92 143.94 19.31 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.244 171.118 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -116.64 141.51 48.11 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 -177.107 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.577 ' HG ' ' HG ' ' A' ' 18' ' ' CYS . 60.5 m -110.68 109.28 57.92 Favored Pre-proline 0 N--CA 1.473 0.716 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.163 173.07 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -69.06 15.61 0.19 Allowed 'Trans proline' 0 CA--C 1.549 1.24 0 C-N-CA 123.079 2.519 . . . . 0.0 115.511 -167.181 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -96.13 -72.21 0.64 Allowed 'General case' 0 N--CA 1.473 0.698 0 O-C-N 121.925 -0.485 . . . . 0.0 110.919 177.024 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.406 ' O ' ' SG ' ' A' ' 46' ' ' CYS . 43.1 t -86.94 3.8 44.23 Favored 'General case' 0 N--CA 1.475 0.822 0 O-C-N 122.218 -0.301 . . . . 0.0 111.58 169.676 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 56.48 31.29 18.63 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 121.379 0.609 . . . . 0.0 112.0 -178.57 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 61.9 m -64.95 110.93 2.62 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.123 176.588 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 84.2 tttt -98.62 102.38 14.1 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 121.08 0.466 . . . . 0.0 110.659 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -87.33 116.62 25.54 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.465 -175.611 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.465 ' O ' ' HA ' ' A' ' 10' ' ' ILE . 77.8 t -96.9 139.53 19.34 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.07 177.194 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.562 ' HB2' HG21 ' A' ' 34' ' ' ILE . 51.7 tp -77.4 131.78 38.19 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 121.221 0.534 . . . . 0.0 111.667 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -53.43 110.38 0.55 Allowed 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -179.022 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 85.68 2.32 86.9 Favored Glycine 0 CA--C 1.527 0.787 0 C-N-CA 121.191 -0.528 . . . . 0.0 113.821 176.442 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.412 ' HB2' ' HB3' ' A' ' 52' ' ' LEU . 40.8 t -70.15 174.8 5.08 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.049 0.452 . . . . 0.0 111.776 179.387 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -67.69 -23.91 65.35 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 121.075 0.464 . . . . 0.0 111.075 179.485 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -74.18 -18.46 60.77 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 121.045 0.45 . . . . 0.0 110.893 172.565 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 32.9 t70 . . . . . 0 CA--C 1.545 0.772 0 CA-C-O 121.578 0.704 . . . . 0.0 110.148 177.354 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 . . . . . 0 N--CA 1.472 0.643 0 CA-C-O 121.364 0.602 . . . . 0.0 112.243 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 97.3 m -89.72 136.19 33.18 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.786 -179.107 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 45.1 tttp -127.65 116.75 20.78 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 120.636 0.255 . . . . 0.0 110.829 -175.587 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 44.5 mm -86.3 112.37 22.63 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-O 120.989 0.423 . . . . 0.0 111.199 -178.387 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 35.7 m -113.33 164.53 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -178.141 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -105.41 -6.3 19.65 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-O 121.057 0.456 . . . . 0.0 111.424 179.722 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 68.6 mmtt -120.04 144.37 47.59 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.094 0.473 . . . . 0.0 111.856 -179.015 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 34.7 m -72.83 -21.06 61.02 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.603 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 80.4 mtt-85 -102.4 111.75 24.17 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-O 121.241 0.543 . . . . 0.0 110.634 177.049 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 36.7 t -119.96 131.2 73.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.851 -175.521 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.501 ' HB2' ' CE2' ' A' ' 31' ' ' TRP . . . -74.91 139.57 43.17 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 121.122 0.487 . . . . 0.0 111.742 177.427 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 53.0 t . . . . . 0 C--N 1.327 -0.39 0 CA-C-O 121.146 0.498 . . . . 0.0 110.534 177.319 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 4.4 tmt_? . . . . . 0 CA--C 1.531 0.25 0 CA-C-O 121.941 0.876 . . . . 0.0 109.56 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 28.7 m -122.36 134.89 64.21 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 CA-C-N 114.846 -1.07 . . . . 0.0 111.486 178.82 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.501 ' CE2' ' HB2' ' A' ' 17' ' ' ALA . 15.7 m95 -116.27 127.35 54.65 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 120.787 0.327 . . . . 0.0 111.114 179.679 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.7 mp -92.08 151.93 20.19 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 121.179 0.514 . . . . 0.0 111.544 -178.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -110.2 108.98 19.31 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.019 -179.258 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.556 HG12 HG12 ' A' ' 41' ' ' VAL . 75.8 mt -71.62 122.3 86.81 Favored Pre-proline 0 CA--C 1.542 0.641 0 CA-C-N 116.634 -0.257 . . . . 0.0 111.481 179.336 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.488 ' HG2' ' OG1' ' A' ' 38' ' ' THR . 44.7 Cg_endo -86.31 127.11 2.83 Favored 'Trans proline' 0 CA--C 1.54 0.811 0 C-N-CA 122.95 2.434 . . . . 0.0 112.709 176.878 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -59.22 -21.97 60.34 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 121.43 0.633 . . . . 0.0 110.792 177.288 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -59.11 -31.7 69.16 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 115.234 -0.893 . . . . 0.0 111.742 178.017 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.488 ' OG1' ' HG2' ' A' ' 35' ' ' PRO . 44.8 p -113.92 -47.44 2.96 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.308 0.575 . . . . 0.0 110.975 178.695 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.547 ' HA3' ' H ' ' A' ' 57' ' ' ALA . . . 100.2 1.08 55.84 Favored Glycine 0 CA--C 1.525 0.676 0 CA-C-N 115.874 -0.603 . . . . 0.0 112.782 -178.198 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 58.5 p-90 -155.46 162.27 40.77 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.088 0.471 . . . . 0.0 111.388 -177.1 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.556 HG12 HG12 ' A' ' 34' ' ' ILE . 14.2 p -148.67 126.45 2.95 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 CA-C-O 120.992 0.425 . . . . 0.0 110.62 172.966 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.422 ' HA ' ' HA ' ' A' ' 49' ' ' LYS . 16.7 pt-20 -94.39 143.01 26.77 Favored 'General case' 0 CA--C 1.535 0.398 0 O-C-N 122.124 -0.36 . . . . 0.0 111.035 179.437 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 37.0 t -71.55 130.99 86.68 Favored Pre-proline 0 N--CA 1.468 0.435 0 N-CA-C 111.825 0.305 . . . . 0.0 111.825 179.308 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -76.59 0.46 9.51 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 122.406 2.07 . . . . 0.0 113.077 179.351 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -99.87 -87.64 0.36 Allowed 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 111.687 0.254 . . . . 0.0 111.687 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 42.0 t -169.78 22.27 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 111.827 0.306 . . . . 0.0 111.827 -179.103 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -87.75 -88.23 0.14 Allowed 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -173.42 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 73.7 m -155.31 179.19 9.4 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-O 121.596 0.712 . . . . 0.0 112.627 -177.33 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.422 ' HA ' ' HA ' ' A' ' 42' ' ' GLU . 40.3 ttmt -111.5 120.31 41.71 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.959 174.324 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 46.2 m-85 -103.27 116.48 32.53 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 111.922 0.342 . . . . 0.0 111.922 -170.165 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 85.9 t -105.08 135.47 42.96 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 CA-C-O 120.946 0.403 . . . . 0.0 111.513 178.531 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.438 ' HB2' HG21 ' A' ' 34' ' ' ILE . 53.0 tp -87.44 122.16 30.81 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 121.154 0.502 . . . . 0.0 111.711 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.442 ' HD3' ' N ' ' A' ' 54' ' ' GLY . 4.2 tmtm? -67.72 127.9 34.5 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.365 179.185 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.442 ' N ' ' HD3' ' A' ' 53' ' ' LYS . . . 87.52 12.62 66.76 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 121.391 -0.433 . . . . 0.0 112.886 -175.839 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.7 t -110.23 -173.4 2.24 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 122.552 -0.381 . . . . 0.0 111.34 178.521 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 61.6 tttp -57.1 -47.76 80.26 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -176.407 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.547 ' H ' ' HA3' ' A' ' 39' ' ' GLY . . . -73.99 -13.91 60.95 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 112.543 0.571 . . . . 0.0 112.543 -177.42 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 33.3 t70 . . . . . 0 CA--C 1.538 0.499 0 CA-C-O 121.529 0.681 . . . . 0.0 111.04 -179.756 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 . . . . . 0 CA--C 1.543 0.681 0 CA-C-O 122.317 1.056 . . . . 0.0 110.54 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 91.0 m -123.2 110.56 15.4 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.48 -1.236 . . . . 0.0 110.003 -177.188 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 5.7 tmtt? -102.6 115.4 30.51 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.787 0.327 . . . . 0.0 110.819 -172.545 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.513 HD12 ' N ' ' A' ' 10' ' ' ILE . 2.5 mp -82.02 101.24 6.61 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.88 -177.533 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.41 HG21 HD11 ' A' ' 34' ' ' ILE . 35.7 m -102.67 167.93 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 CA-C-O 120.963 0.411 . . . . 0.0 111.874 -178.788 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -104.63 -20.61 13.6 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -176.361 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -130.33 165.0 23.42 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 121.019 0.438 . . . . 0.0 112.097 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.9 m -81.57 -37.89 26.98 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 112.67 0.619 . . . . 0.0 112.67 -174.719 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 28.9 tpt180 -87.27 105.23 17.09 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 122.117 -0.364 . . . . 0.0 110.642 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 58.9 t -131.05 135.03 60.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 N-CA-C 112.211 0.448 . . . . 0.0 112.211 -173.28 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -76.09 112.53 12.63 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.044 0.449 . . . . 0.0 110.237 172.46 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.679 ' HB2' HD13 ' A' ' 32' ' ' LEU . 58.3 m . . . . . 0 C--N 1.324 -0.535 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.22 -174.26 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 23.3 tpt180 . . . . . 0 N--CA 1.466 0.371 0 CA-C-O 121.667 0.746 . . . . 0.0 110.024 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 27.1 t -100.47 125.98 54.16 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.759 -173.62 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 61.2 m95 -105.53 115.66 30.63 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 121.026 0.441 . . . . 0.0 111.418 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.679 HD13 ' HB2' ' A' ' 18' ' ' CYS . 9.0 mp -98.04 172.2 7.77 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.307 0.575 . . . . 0.0 111.678 -179.452 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 58.1 tp60 -137.64 116.41 12.25 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.528 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.546 HG12 HG12 ' A' ' 41' ' ' VAL . 68.4 mt -68.56 120.21 73.84 Favored Pre-proline 0 CA--C 1.539 0.539 0 CA-C-N 116.686 -0.234 . . . . 0.0 111.209 177.141 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.576 ' HG2' ' OG1' ' A' ' 38' ' ' THR . 74.0 Cg_endo -75.21 110.98 3.21 Favored 'Trans proline' 0 CA--C 1.535 0.561 0 C-N-CA 122.412 2.075 . . . . 0.0 111.67 176.539 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -54.93 -21.56 12.07 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 116.079 -0.51 . . . . 0.0 112.242 -176.554 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -61.14 -46.95 88.45 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-O 120.665 0.269 . . . . 0.0 111.247 173.439 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.576 ' OG1' ' HG2' ' A' ' 35' ' ' PRO . 29.2 p -89.03 -50.21 6.3 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 120.841 0.353 . . . . 0.0 111.521 -177.947 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 103.45 1.82 47.2 Favored Glycine 0 CA--C 1.527 0.792 0 C-N-CA 121.202 -0.523 . . . . 0.0 112.71 -176.585 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 63.6 p-90 -152.63 158.99 43.22 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 120.951 0.405 . . . . 0.0 112.006 -177.491 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.546 HG12 HG12 ' A' ' 34' ' ' ILE . 14.9 p -145.17 126.67 8.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-O 120.926 0.394 . . . . 0.0 110.269 174.071 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.588 ' HA ' ' HA ' ' A' ' 49' ' ' LYS . 10.5 pt-20 -103.66 152.67 21.51 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.234 0.54 . . . . 0.0 112.416 -177.2 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 6.4 t -69.61 134.13 88.55 Favored Pre-proline 0 N--CA 1.471 0.608 0 CA-C-N 115.705 -0.68 . . . . 0.0 112.174 -176.916 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -78.46 -5.94 15.19 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 122.739 2.292 . . . . 0.0 112.767 178.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -108.96 -93.58 0.42 Allowed 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 -179.707 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 48.7 t -144.46 9.9 1.42 Allowed 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 112.948 0.722 . . . . 0.0 112.948 -169.101 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -90.14 -107.39 0.09 Allowed 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 112.959 0.726 . . . . 0.0 112.959 -172.217 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 72.0 m -152.33 -179.74 7.82 Favored 'General case' 0 N--CA 1.477 0.902 0 O-C-N 121.692 -0.63 . . . . 0.0 112.475 -174.484 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.588 ' HA ' ' HA ' ' A' ' 42' ' ' GLU . 36.8 ttpt -106.74 125.64 51.26 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.291 177.051 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 36.4 m-85 -99.77 113.24 25.6 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 120.763 0.316 . . . . 0.0 111.144 -175.143 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 99.9 t -99.04 131.6 45.97 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 CA-C-O 121.101 0.477 . . . . 0.0 111.898 179.34 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 59.9 tp -78.11 118.15 20.08 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.543 179.544 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.484 ' HB2' HG23 ' A' ' 10' ' ' ILE . 47.4 tttp -74.33 151.22 39.82 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 121.124 0.488 . . . . 0.0 111.203 178.528 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.79 14.6 81.86 Favored Glycine 0 CA--C 1.527 0.799 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.07 -174.397 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 48.3 t -116.5 -177.48 3.19 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.2 0.524 . . . . 0.0 111.532 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 50.6 mtpt -60.52 -34.76 74.58 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.639 -179.368 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -86.18 8.89 19.24 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 -178.42 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.4 t0 . . . . . 0 CA--C 1.545 0.784 0 CA-C-O 121.182 0.515 . . . . 0.0 111.859 -179.576 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 . . . . . 0 CA--C 1.535 0.388 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 23.3 m -98.01 125.81 43.13 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.017 176.284 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 24.4 tptp -121.8 110.72 16.25 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 120.816 0.341 . . . . 0.0 110.558 -178.258 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 55.5 mt -77.19 104.41 5.13 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-O 120.909 0.385 . . . . 0.0 111.236 -177.512 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 34.5 m -95.06 155.75 3.25 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-O 121.067 0.461 . . . . 0.0 111.439 179.482 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -82.19 -37.09 26.59 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.807 -175.133 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 46.5 mmtm -118.94 167.18 11.98 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 121.212 0.529 . . . . 0.0 112.273 -177.458 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 18.6 m -68.64 -34.65 76.1 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -174.816 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.457 ' HA ' ' O ' ' A' ' 32' ' ' LEU . 16.6 ptt180 -98.64 135.36 40.25 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.231 0.538 . . . . 0.0 111.668 -179.27 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 48.7 t -129.34 122.96 56.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.277 -178.473 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -74.78 94.03 2.69 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.12 0.486 . . . . 0.0 110.678 176.409 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.423 ' SG ' HD13 ' A' ' 32' ' ' LEU . 85.8 m . . . . . 0 N--CA 1.467 0.384 0 CA-C-O 120.93 0.395 . . . . 0.0 111.657 -176.026 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 21.8 tpt180 . . . . . 0 C--O 1.236 0.356 0 CA-C-O 121.814 0.816 . . . . 0.0 110.089 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 30.0 m -112.84 121.67 65.54 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 CA-C-N 115.062 -0.972 . . . . 0.0 112.395 -177.176 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 69.5 m95 -106.55 113.33 26.78 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.885 177.31 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.457 ' O ' ' HA ' ' A' ' 15' ' ' ARG . 8.1 mp -86.38 144.72 27.19 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 120.878 0.371 . . . . 0.0 110.977 179.14 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 54.2 tp60 -115.91 116.35 27.82 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.059 -177.267 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.434 HG12 HG12 ' A' ' 41' ' ' VAL . 61.9 mt -76.48 126.41 86.27 Favored Pre-proline 0 CA--C 1.539 0.535 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -179.065 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.555 ' HG2' ' OG1' ' A' ' 38' ' ' THR . 57.1 Cg_endo -86.78 132.45 3.43 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 122.87 2.38 . . . . 0.0 112.092 173.645 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -66.04 -25.62 67.14 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 121.941 -0.474 . . . . 0.0 111.492 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -54.51 -56.48 18.46 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.134 0.492 . . . . 0.0 111.37 177.631 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.555 ' OG1' ' HG2' ' A' ' 35' ' ' PRO . 52.4 p -76.27 -47.82 22.39 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.407 0.622 . . . . 0.0 110.055 174.473 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 99.09 1.5 57.06 Favored Glycine 0 CA--C 1.524 0.621 0 CA-C-N 115.504 -0.771 . . . . 0.0 112.672 -178.747 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.528 ' HB3' HG22 ' A' ' 51' ' ' VAL . 63.7 p-90 -159.3 166.83 30.38 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 122.56 0.344 . . . . 0.0 110.911 -176.026 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.434 HG12 HG12 ' A' ' 34' ' ' ILE . 12.2 p -135.37 132.69 52.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-O 121.112 0.482 . . . . 0.0 111.399 176.219 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -92.01 112.11 23.91 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 121.148 0.499 . . . . 0.0 110.818 176.771 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 41.0 t -71.28 110.56 7.65 Favored Pre-proline 0 N--CA 1.471 0.576 0 CA-C-N 116.187 -0.461 . . . . 0.0 112.086 -178.132 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -71.55 -11.24 27.95 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 122.632 2.221 . . . . 0.0 112.425 177.464 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 78.4 m-85 -84.56 -42.7 15.21 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 115.956 -0.566 . . . . 0.0 112.007 -176.323 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 84.5 m -131.92 8.08 4.42 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 -178.013 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 57.7 78.26 0.24 Allowed 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 176.014 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 91.2 m -152.46 147.31 26.1 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.944 177.857 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -99.63 106.47 18.43 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 120.651 0.262 . . . . 0.0 111.091 178.55 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -91.74 111.69 23.32 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.55 0.214 . . . . 0.0 110.615 178.454 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.528 HG22 ' HB3' ' A' ' 40' ' ' TRP . 97.9 t -97.51 135.61 31.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-O 121.023 0.439 . . . . 0.0 111.58 -179.623 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.408 ' HB2' HG21 ' A' ' 34' ' ' ILE . 59.0 tp -75.42 130.95 39.8 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 116.171 -0.468 . . . . 0.0 112.029 -178.182 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 51.7 tttm -58.91 102.5 0.12 Allowed 'General case' 0 CA--C 1.542 0.645 0 CA-C-O 121.114 0.483 . . . . 0.0 111.443 174.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 117.6 -7.06 15.92 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 121.362 -0.447 . . . . 0.0 112.538 -176.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 12.4 t -65.81 151.92 45.55 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 177.27 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.47 -7.39 47.12 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 120.905 0.383 . . . . 0.0 111.477 174.062 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -72.19 -27.33 62.49 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 121.174 0.511 . . . . 0.0 110.402 170.066 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.7 t70 . . . . . 0 CA--C 1.547 0.833 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.711 175.769 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 . . . . . 0 N--CA 1.465 0.298 0 CA-C-O 121.197 0.522 . . . . 0.0 110.639 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 66.5 m -98.39 141.78 30.83 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.786 -177.279 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 55.1 tptt -133.87 114.76 13.68 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.879 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 52.4 mt -88.64 105.34 15.63 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 CA-C-O 120.727 0.298 . . . . 0.0 111.013 -177.575 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.461 HG12 ' H ' ' A' ' 13' ' ' LYS . 2.4 t -102.67 147.79 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-O 120.884 0.373 . . . . 0.0 111.271 -176.877 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -89.23 -4.46 58.19 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 121.075 0.464 . . . . 0.0 111.183 -178.606 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.461 ' H ' HG12 ' A' ' 11' ' ' VAL . 67.5 mttm -131.89 152.25 51.17 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.051 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 21.1 m -80.39 -6.83 58.66 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 120.837 0.351 . . . . 0.0 111.611 179.076 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -95.16 114.64 26.46 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 120.942 0.401 . . . . 0.0 110.961 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 70.7 t -125.46 135.08 65.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 N-CA-C 113.056 0.762 . . . . 0.0 113.056 -171.718 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -104.37 110.3 22.49 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.525 173.817 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 66.2 m . . . . . 0 N--CA 1.474 0.761 0 C-N-CA 122.515 0.326 . . . . 0.0 111.28 179.231 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.446 -0.646 0 CA-C-O 122.35 1.071 . . . . 0.0 110.909 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 19.0 m -109.69 154.2 11.24 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.133 0 CA-C-N 113.97 -1.468 . . . . 0.0 111.453 -178.551 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 49.7 m95 -124.14 114.84 20.2 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 121.243 0.544 . . . . 0.0 112.136 -175.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.45 ' N ' HD12 ' A' ' 32' ' ' LEU . 6.1 mp -105.46 167.56 9.66 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.454 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 54.2 tp60 -130.25 113.51 14.51 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.336 179.103 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.595 HG21 ' HB2' ' A' ' 52' ' ' LEU . 76.2 mt -63.06 120.15 58.67 Favored Pre-proline 0 CA--C 1.541 0.597 0 CA-C-O 120.684 0.278 . . . . 0.0 111.397 -179.288 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.596 ' HG2' ' OG1' ' A' ' 38' ' ' THR . 83.5 Cg_endo -79.82 113.75 3.08 Favored 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 122.262 1.975 . . . . 0.0 112.022 177.82 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -60.89 -15.0 25.91 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 121.115 0.483 . . . . 0.0 111.542 -179.073 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -68.87 -29.51 67.83 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.568 174.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.596 ' OG1' ' HG2' ' A' ' 35' ' ' PRO . 34.6 p -103.25 -54.73 2.55 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 121.205 0.526 . . . . 0.0 110.445 175.151 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 113.13 -0.19 25.39 Favored Glycine 0 CA--C 1.526 0.727 0 CA-C-N 115.8 -0.636 . . . . 0.0 113.123 179.245 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 66.1 p-90 -166.45 162.44 16.91 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -177.341 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.565 HG12 HG12 ' A' ' 34' ' ' ILE . 11.3 p -153.77 133.55 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.346 174.846 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.47 ' HA ' ' HA ' ' A' ' 49' ' ' LYS . 0.5 OUTLIER -110.94 148.87 31.56 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.062 0.458 . . . . 0.0 111.866 -178.282 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.564 ' HB3' ' HB3' ' A' ' 47' ' ' ASP . 52.3 t -84.52 108.13 13.6 Favored Pre-proline 0 N--CA 1.466 0.364 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 171.018 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -65.06 -9.41 21.55 Favored 'Trans proline' 0 CA--C 1.54 0.794 0 C-N-CA 122.742 2.295 . . . . 0.0 113.476 -172.724 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -87.33 -89.9 0.12 Allowed 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 120.566 0.222 . . . . 0.0 111.575 -177.706 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 75.7 m -152.45 82.62 1.24 Allowed 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 120.956 0.408 . . . . 0.0 111.477 179.554 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.564 ' HB3' ' HB3' ' A' ' 43' ' ' CYS . 9.7 t70 -149.98 -90.22 0.07 Allowed 'General case' 0 CA--C 1.548 0.889 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.184 177.038 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 30.2 p 179.8 -176.92 0.34 Allowed 'General case' 0 N--CA 1.477 0.889 0 CA-C-O 121.106 0.479 . . . . 0.0 111.422 174.872 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.47 ' HA ' ' HA ' ' A' ' 42' ' ' GLU . 39.5 ttmt -106.54 120.27 41.48 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 123.036 0.534 . . . . 0.0 110.693 178.66 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -98.72 108.24 20.88 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.081 0.467 . . . . 0.0 111.868 -173.528 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 99.7 t -93.75 134.39 31.59 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.243 178.411 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.595 ' HB2' HG21 ' A' ' 34' ' ' ILE . 51.8 tp -79.18 120.7 24.07 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 121.304 0.573 . . . . 0.0 111.649 -178.8 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -77.4 118.18 19.61 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.948 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 88.38 55.48 2.19 Favored Glycine 0 CA--C 1.524 0.652 0 C-N-CA 121.035 -0.603 . . . . 0.0 111.64 -173.665 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 25.0 t -151.03 -150.99 0.37 Allowed 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 122.898 0.479 . . . . 0.0 110.985 -175.383 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -101.65 22.72 12.33 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 -177.65 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -129.51 -33.26 1.89 Allowed 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 121.415 0.626 . . . . 0.0 111.097 -175.556 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 . . . . . 0 CA--C 1.546 0.797 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.764 178.512 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 . . . . . 0 N--CA 1.472 0.673 0 CA-C-O 121.601 0.715 . . . . 0.0 110.574 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.435 ' HA ' ' O ' ' A' ' 49' ' ' LYS . 51.6 m -118.93 137.97 53.1 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 115.395 -0.821 . . . . 0.0 111.559 -172.351 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -134.92 129.9 35.03 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 120.766 0.317 . . . . 0.0 111.069 -176.627 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 59.9 mt -86.45 118.91 33.63 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 CA-C-O 121.079 0.466 . . . . 0.0 111.614 -179.203 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 35.3 m -109.52 163.41 6.62 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.964 176.503 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -92.17 -21.44 20.39 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -176.201 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -121.54 152.01 39.69 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 -176.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 48.7 m -70.28 -21.04 63.0 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 116.049 -0.523 . . . . 0.0 112.334 -178.315 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 80.7 mtp180 -87.6 111.83 21.66 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.148 0.499 . . . . 0.0 111.33 178.72 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 61.2 t -113.01 115.81 50.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.926 -177.817 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -95.16 115.01 26.87 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 120.695 0.283 . . . . 0.0 111.382 177.456 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.51 ' O ' HG12 ' A' ' 30' ' ' VAL . 82.8 m . . . . . 0 N--CA 1.47 0.544 0 CA-C-O 120.927 0.394 . . . . 0.0 111.306 179.34 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.437 ' O ' ' HD3' ' A' ' 29' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.45 -0.46 0 CA-C-O 122.444 1.116 . . . . 0.0 111.342 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.51 HG12 ' O ' ' A' ' 18' ' ' CYS . 11.5 p -132.02 132.98 61.22 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-N 114.153 -1.385 . . . . 0.0 109.488 166.632 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 59.8 m95 -100.09 132.5 45.41 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.24 0.543 . . . . 0.0 112.339 -176.084 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.429 ' N ' HD12 ' A' ' 32' ' ' LEU . 5.4 mp -115.67 160.89 19.45 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.904 177.13 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 61.6 tp60 -119.55 124.78 47.24 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.496 178.263 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.521 HG21 ' HB2' ' A' ' 52' ' ' LEU . 73.7 mt -79.33 132.25 63.18 Favored Pre-proline 0 CA--C 1.545 0.768 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -178.939 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.559 ' HG2' ' OG1' ' A' ' 38' ' ' THR . 94.7 Cg_endo -81.95 117.33 2.9 Favored 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 122.609 2.206 . . . . 0.0 112.317 173.521 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -60.25 -33.82 72.82 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -176.107 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.489 ' O ' ' HE2' ' A' ' 56' ' ' LYS . 8.0 p-10 -62.23 -30.9 71.42 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 120.773 0.321 . . . . 0.0 111.846 -178.769 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.559 ' OG1' ' HG2' ' A' ' 35' ' ' PRO . 21.9 p -91.55 -48.89 6.6 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.377 0.608 . . . . 0.0 110.428 175.023 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 100.01 2.47 56.0 Favored Glycine 0 CA--C 1.524 0.614 0 CA-C-N 115.597 -0.729 . . . . 0.0 112.756 -177.483 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.441 ' HB3' HG22 ' A' ' 51' ' ' VAL . 65.2 p-90 -158.81 152.77 23.52 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 120.961 0.41 . . . . 0.0 111.867 -175.533 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.483 HG12 HG12 ' A' ' 34' ' ' ILE . 11.0 p -131.6 150.58 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.939 176.861 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -117.2 131.47 56.85 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 121.113 0.482 . . . . 0.0 111.154 178.164 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.417 ' SG ' ' HB3' ' A' ' 46' ' ' CYS . 49.5 t -82.67 110.49 22.63 Favored Pre-proline 0 N--CA 1.47 0.532 0 N-CA-C 111.911 0.337 . . . . 0.0 111.911 -179.176 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -58.94 -26.93 83.15 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 122.699 2.266 . . . . 0.0 113.319 -177.405 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -112.03 17.55 19.54 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 112.13 0.418 . . . . 0.0 112.13 -176.127 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.421 ' SG ' ' SG ' ' A' ' 48' ' ' CYS . 36.2 t -146.1 -7.17 0.56 Allowed 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 174.857 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 55.18 24.72 6.51 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 113.203 0.816 . . . . 0.0 113.203 178.033 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.421 ' SG ' ' SG ' ' A' ' 46' ' ' CYS . 81.3 m -102.92 138.02 40.35 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 120.812 0.339 . . . . 0.0 111.611 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.435 ' O ' ' HA ' ' A' ' 8' ' ' THR . 85.7 tttt -109.01 121.51 45.3 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 122.92 0.488 . . . . 0.0 111.149 -178.378 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -116.93 125.77 51.95 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 112.13 0.418 . . . . 0.0 112.13 -177.002 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.441 HG22 ' HB3' ' A' ' 40' ' ' TRP . 40.9 t -94.54 139.33 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.873 176.344 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.521 ' HB2' HG21 ' A' ' 34' ' ' ILE . 56.5 tp -87.13 119.12 27.03 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.407 177.702 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -67.67 118.59 11.15 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 121.076 0.465 . . . . 0.0 111.122 178.73 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 120.5 -28.51 6.21 Favored Glycine 0 CA--C 1.525 0.686 0 CA-C-N 115.992 -0.549 . . . . 0.0 112.29 -174.16 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 66.1 m -80.83 168.07 19.19 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 120.877 0.37 . . . . 0.0 111.252 178.45 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.489 ' HE2' ' O ' ' A' ' 37' ' ' ASP . 65.7 pttt -58.59 -25.03 62.18 Favored 'General case' 0 CA--C 1.543 0.673 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -177.206 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.72 -33.2 75.11 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.151 0.5 . . . . 0.0 111.23 176.54 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 32.7 t70 . . . . . 0 CA--C 1.543 0.687 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.206 177.904 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 . . . . . 0 N--CA 1.475 0.789 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 86.8 m -85.83 115.32 23.4 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.059 175.659 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 73.8 mttt -121.95 98.57 6.01 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 120.995 0.426 . . . . 0.0 110.882 176.86 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 57.8 mt -86.21 127.75 39.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.108 -179.268 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 28.5 m -125.56 163.45 26.71 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.546 -179.357 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -89.15 -19.79 25.05 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 120.76 0.314 . . . . 0.0 111.515 179.374 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 13.6 pttm -131.84 148.08 52.52 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 121.076 0.465 . . . . 0.0 111.615 -177.892 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 12.2 p -68.39 -30.79 69.79 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 114.572 1.323 . . . . 0.0 114.572 -168.498 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 94.4 mtt180 -75.41 104.3 5.92 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 118.53 0.604 . . . . 0.0 111.512 179.065 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 36.4 t -117.88 122.37 69.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.388 -178.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -81.4 109.66 16.1 Favored 'General case' 0 CA--C 1.535 0.4 0 O-C-N 122.252 -0.28 . . . . 0.0 111.116 175.75 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.74 ' SG ' ' HB ' ' A' ' 30' ' ' VAL . 22.8 p . . . . . 0 N--CA 1.47 0.559 0 CA-C-O 121.056 0.455 . . . . 0.0 110.936 179.664 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.455 ' HD3' ' HA ' ' A' ' 29' ' ' ARG . 2.8 tpp180 . . . . . 0 N--CA 1.445 -0.722 0 CA-C-O 122.461 1.124 . . . . 0.0 112.612 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.74 ' HB ' ' SG ' ' A' ' 18' ' ' CYS . 48.4 t -118.45 115.08 47.04 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.066 0 CA-C-N 114.107 -1.406 . . . . 0.0 110.565 177.544 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 83.3 m95 -91.41 103.91 16.49 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 120.948 0.404 . . . . 0.0 111.291 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.539 HD21 ' HD3' ' A' ' 44' ' ' PRO . 6.2 mp -83.62 131.07 34.99 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 121.021 0.439 . . . . 0.0 111.436 179.107 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -93.89 105.32 17.35 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.334 176.18 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.556 HG12 HG12 ' A' ' 41' ' ' VAL . 73.5 mt -64.43 124.76 86.83 Favored Pre-proline 0 CA--C 1.542 0.638 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.661 -178.359 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.565 ' HG2' ' OG1' ' A' ' 38' ' ' THR . 76.9 Cg_endo -74.19 119.24 5.72 Favored 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 122.671 2.247 . . . . 0.0 112.211 179.567 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -64.63 -17.15 63.76 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-O 121.162 0.506 . . . . 0.0 111.582 -178.021 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -64.93 -44.07 90.72 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 120.916 0.389 . . . . 0.0 111.22 175.585 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.565 ' OG1' ' HG2' ' A' ' 35' ' ' PRO . 31.6 p -95.92 -54.3 3.38 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 121.08 0.467 . . . . 0.0 110.99 179.545 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 110.87 1.18 28.74 Favored Glycine 0 CA--C 1.524 0.605 0 CA-C-N 115.948 -0.569 . . . . 0.0 113.494 179.006 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 62.0 p-90 -153.79 160.15 42.15 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 116.941 0.37 . . . . 0.0 111.183 -177.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.556 HG12 HG12 ' A' ' 34' ' ' ILE . 13.4 p -141.15 141.49 30.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.648 176.053 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.39 154.93 16.96 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 121.305 0.574 . . . . 0.0 111.948 -179.135 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.464 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 43.8 t -73.05 123.12 89.22 Favored Pre-proline 0 CA--C 1.537 0.449 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.603 179.305 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.539 ' HD3' HD21 ' A' ' 32' ' ' LEU . 14.9 Cg_exo -69.03 -7.71 21.59 Favored 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 122.757 2.305 . . . . 0.0 113.095 -179.501 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -98.83 -46.9 5.49 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 120.924 0.392 . . . . 0.0 111.576 -178.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 25.1 t -120.08 -91.0 0.57 Allowed 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.514 -177.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -173.91 19.11 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 179.005 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.422 ' HB2' ' HB2' ' A' ' 43' ' ' CYS . 56.7 m -64.97 132.53 49.53 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 -177.33 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.452 ' NZ ' ' HB2' ' A' ' 49' ' ' LYS . 5.0 ttmp? -102.34 110.71 22.74 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 121.203 0.525 . . . . 0.0 111.572 -179.257 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 55.3 m-85 -94.76 104.35 16.26 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.447 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 56.7 t -92.13 137.3 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 CA-C-O 121.174 0.511 . . . . 0.0 112.372 -175.694 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 59.6 tp -98.91 130.05 45.28 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.508 178.774 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -64.77 143.9 57.62 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-O 120.845 0.355 . . . . 0.0 111.635 178.256 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 81.42 -13.89 31.95 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 121.367 -0.444 . . . . 0.0 114.081 175.59 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 59.9 p -84.2 179.99 7.35 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 120.935 0.398 . . . . 0.0 111.345 -178.545 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 62.0 mttm -63.5 -27.33 69.19 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 179.555 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -69.53 -27.45 65.18 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.301 0.572 . . . . 0.0 110.662 175.814 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 32.3 t70 . . . . . 0 CA--C 1.544 0.744 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.769 176.198 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 . . . . . 0 CA--C 1.541 0.604 0 CA-C-O 121.561 0.696 . . . . 0.0 112.667 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.42 ' OG1' ' NZ ' ' A' ' 49' ' ' LYS . 99.9 m -103.95 147.3 27.52 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.087 178.852 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -134.95 113.13 11.21 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 120.786 0.327 . . . . 0.0 110.684 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 53.2 mt -86.82 107.1 16.54 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-O 121.176 0.512 . . . . 0.0 111.005 -179.463 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.512 HG11 HG21 ' A' ' 16' ' ' VAL . 30.6 m -96.12 155.6 3.4 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-O 121.175 0.512 . . . . 0.0 112.149 -176.666 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -94.98 3.1 55.32 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.642 -176.843 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 62.7 pttt -135.07 155.2 51.15 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.016 179.435 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 59.0 m -75.87 -32.66 59.81 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -175.67 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.468 ' HB3' ' OE1' ' A' ' 33' ' ' GLN . 13.0 ptp180 -112.79 121.13 43.81 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 121.233 0.54 . . . . 0.0 111.469 -178.027 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.512 HG21 HG11 ' A' ' 11' ' ' VAL . 46.2 t -127.49 132.35 69.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.679 -177.695 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.486 ' HA ' ' O ' ' A' ' 30' ' ' VAL . . . -83.04 88.28 6.87 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 121.146 0.498 . . . . 0.0 110.718 176.065 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.462 ' SG ' ' HB3' ' A' ' 46' ' ' CYS . 43.7 t . . . . . 0 N--CA 1.471 0.614 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 -174.137 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 22.9 tpt180 . . . . . 0 N--CA 1.454 -0.248 0 CA-C-O 122.308 1.052 . . . . 0.0 111.426 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.486 ' O ' ' HA ' ' A' ' 17' ' ' ALA . 58.9 t -107.16 112.54 40.42 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 CA-C-N 114.196 -1.365 . . . . 0.0 111.322 -177.811 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 95.9 m95 -95.09 118.48 31.96 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.125 0.488 . . . . 0.0 111.919 -179.417 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.407 ' N ' HD12 ' A' ' 32' ' ' LEU . 7.1 mp -94.58 111.65 23.41 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.31 173.634 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.468 ' OE1' ' HB3' ' A' ' 15' ' ' ARG . 59.4 tp60 -92.43 110.08 21.48 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.83 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.517 HG21 ' HB2' ' A' ' 52' ' ' LEU . 73.5 mt -75.77 119.12 75.68 Favored Pre-proline 0 CA--C 1.543 0.676 0 CA-C-O 120.9 0.381 . . . . 0.0 111.331 179.162 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -85.5 146.35 9.57 Favored 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 122.842 2.361 . . . . 0.0 113.178 -178.916 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -70.9 -10.12 59.03 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 120.864 0.364 . . . . 0.0 110.848 174.357 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -62.94 -40.58 98.09 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.352 0.596 . . . . 0.0 110.836 172.49 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 44.3 p -108.56 -54.04 2.56 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.624 -176.443 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 99.61 1.12 56.51 Favored Glycine 0 CA--C 1.525 0.694 0 CA-C-N 116.092 -0.504 . . . . 0.0 112.061 -174.878 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 64.5 p-90 -156.86 166.93 31.99 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 122.588 0.355 . . . . 0.0 110.966 -177.308 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.415 HG12 HG12 ' A' ' 34' ' ' ILE . 11.5 p -145.11 136.58 20.34 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-O 120.895 0.379 . . . . 0.0 110.921 174.688 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -91.76 133.43 35.62 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.006 0.431 . . . . 0.0 110.447 177.176 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.48 ' SG ' ' HB2' ' A' ' 45' ' ' TYR . 44.5 t -103.69 105.31 47.02 Favored Pre-proline 0 N--CA 1.467 0.413 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -178.704 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -73.54 -2.54 12.3 Favored 'Trans proline' 0 CA--C 1.542 0.923 0 C-N-CA 122.526 2.151 . . . . 0.0 112.351 174.299 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.48 ' HB2' ' SG ' ' A' ' 43' ' ' CYS . 60.7 m-85 -90.74 -42.14 10.86 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.548 179.099 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.462 ' HB3' ' SG ' ' A' ' 18' ' ' CYS . 53.1 t -118.53 1.87 11.74 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -175.329 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 59.43 51.44 6.62 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 112.802 0.668 . . . . 0.0 112.802 175.234 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 87.6 m -149.04 157.6 43.53 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 120.835 0.35 . . . . 0.0 111.505 177.657 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.42 ' NZ ' ' OG1' ' A' ' 8' ' ' THR . 7.2 ttpm? -106.45 121.9 45.21 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 116.532 -0.303 . . . . 0.0 111.282 178.634 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 37.1 m-85 -99.62 119.41 38.04 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 120.663 0.268 . . . . 0.0 111.511 -179.093 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 97.3 t -101.87 139.99 21.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 CA-C-O 120.84 0.353 . . . . 0.0 111.491 177.103 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.517 ' HB2' HG21 ' A' ' 34' ' ' ILE . 60.9 tp -88.54 118.71 28.39 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 120.935 0.398 . . . . 0.0 111.919 -179.695 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.422 ' HE3' ' HB2' ' A' ' 53' ' ' LYS . 38.2 ttmt -63.57 133.17 53.3 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.816 178.978 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 90.36 -8.18 80.24 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 121.159 -0.543 . . . . 0.0 113.546 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 45.5 t -77.52 179.94 6.21 Favored 'General case' 0 N--CA 1.472 0.667 0 O-C-N 122.361 -0.493 . . . . 0.0 111.035 178.662 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -66.85 -27.77 67.8 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.116 0.484 . . . . 0.0 111.157 179.285 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -76.41 -25.38 54.43 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.444 177.707 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 32.0 t70 . . . . . 0 CA--C 1.538 0.516 0 CA-C-O 121.42 0.628 . . . . 0.0 111.332 -178.756 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.48 ' HB3' ' SG ' ' A' ' 48' ' ' CYS . 86.4 tt0 . . . . . 0 CA--C 1.541 0.63 0 CA-C-O 120.945 0.402 . . . . 0.0 111.794 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 57.8 p -96.1 115.46 27.46 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 122.751 0.42 . . . . 0.0 111.771 178.177 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 65.2 mttm -99.37 100.43 11.49 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.018 0.437 . . . . 0.0 110.269 178.12 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.484 HG22 ' HB2' ' A' ' 53' ' ' LYS . 55.4 mt -82.19 100.47 6.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.546 -176.846 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 33.2 m -107.93 157.0 8.27 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 CA-C-O 121.108 0.48 . . . . 0.0 112.247 -176.312 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -99.74 25.31 7.34 Favored 'General case' 0 CA--C 1.548 0.896 0 CA-C-O 121.676 0.75 . . . . 0.0 110.5 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -144.1 131.48 20.91 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.071 -175.081 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.416 ' HA ' HD12 ' A' ' 34' ' ' ILE . 9.1 m -81.01 -26.71 36.24 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -178.106 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.451 ' HG2' ' OE1' ' A' ' 33' ' ' GLN . 89.2 mtt180 -100.7 92.38 5.07 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.17 0.509 . . . . 0.0 110.123 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 44.9 t -107.83 118.6 55.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-N 115.925 -0.579 . . . . 0.0 112.155 -171.235 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.449 ' HB2' ' CE2' ' A' ' 31' ' ' TRP . . . -84.93 100.5 11.66 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 120.751 0.31 . . . . 0.0 110.756 175.172 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.656 ' SG ' ' HB ' ' A' ' 30' ' ' VAL . 29.7 p . . . . . 0 N--CA 1.47 0.559 0 CA-C-O 121.063 0.459 . . . . 0.0 111.769 -175.76 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 2.4 tmt_? . . . . . 0 C--O 1.233 0.223 0 CA-C-O 121.806 0.813 . . . . 0.0 109.888 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.656 ' HB ' ' SG ' ' A' ' 18' ' ' CYS . 55.1 t -124.54 132.69 70.97 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.022 0 CA-C-N 114.558 -1.201 . . . . 0.0 110.784 179.208 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.449 ' CE2' ' HB2' ' A' ' 17' ' ' ALA . 37.3 m95 -110.02 119.94 40.89 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-O 121.205 0.526 . . . . 0.0 112.26 -176.576 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.6 mp -100.4 163.43 12.38 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 121.303 0.573 . . . . 0.0 111.568 177.221 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.451 ' OE1' ' HG2' ' A' ' 15' ' ' ARG . 55.8 tp60 -131.27 114.21 14.77 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.768 -179.365 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.564 HG21 ' HB2' ' A' ' 52' ' ' LEU . 64.7 mt -69.96 121.21 82.11 Favored Pre-proline 0 CA--C 1.543 0.7 0 CA-C-O 120.863 0.363 . . . . 0.0 111.617 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.497 ' HG2' ' OG1' ' A' ' 38' ' ' THR . 65.3 Cg_endo -81.63 130.26 6.79 Favored 'Trans proline' 0 CA--C 1.544 0.976 0 C-N-CA 122.855 2.37 . . . . 0.0 113.351 -178.883 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 44.3 mm-40 -60.02 -18.14 44.04 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 175.724 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -67.92 -36.64 80.51 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 120.966 0.413 . . . . 0.0 111.49 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.497 ' OG1' ' HG2' ' A' ' 35' ' ' PRO . 43.7 p -108.36 -50.86 2.97 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.049 0.452 . . . . 0.0 111.701 -177.879 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 104.31 1.64 44.33 Favored Glycine 0 CA--C 1.527 0.826 0 C-N-CA 121.352 -0.452 . . . . 0.0 112.412 -174.125 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 65.3 p-90 -154.36 160.19 41.56 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 122.708 0.403 . . . . 0.0 111.418 -179.164 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.547 HG12 HG12 ' A' ' 34' ' ' ILE . 12.3 p -144.11 127.05 11.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 CA-C-O 120.9 0.381 . . . . 0.0 110.823 176.455 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.406 ' HG3' ' H ' ' A' ' 42' ' ' GLU . 0.4 OUTLIER -100.16 146.2 27.12 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 121.058 0.456 . . . . 0.0 111.745 -178.457 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.566 ' HB3' ' HB2' ' A' ' 47' ' ' ASP . 42.0 t -103.86 119.28 54.99 Favored Pre-proline 0 CA--C 1.536 0.415 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -65.57 -12.58 35.72 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 122.819 2.346 . . . . 0.0 112.836 178.504 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.54 ' HB2' ' SG ' ' A' ' 43' ' ' CYS . 95.3 m-85 -82.38 7.31 14.44 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.716 178.84 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.461 ' HB2' ' O ' ' A' ' 45' ' ' TYR . 76.4 m 83.2 31.24 0.08 Allowed 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.906 0.882 . . . . 0.0 112.48 175.715 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.566 ' HB2' ' HB3' ' A' ' 43' ' ' CYS . 24.4 m-20 -94.2 5.96 50.11 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 120.999 0.428 . . . . 0.0 111.005 169.887 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.48 ' SG ' ' HB3' ' A' ' 7' ' ' GLU . 78.4 m 66.72 -161.92 0.24 Allowed 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 175.065 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.42 ' NZ ' ' HB2' ' A' ' 49' ' ' LYS . 5.0 ttmp? -94.11 126.75 39.52 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -174.835 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -96.89 105.49 17.64 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 120.658 0.266 . . . . 0.0 110.87 176.8 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 98.7 t -91.28 132.0 36.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-O 120.798 0.333 . . . . 0.0 111.472 -179.646 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.564 ' HB2' HG21 ' A' ' 34' ' ' ILE . 48.6 tp -85.39 112.54 20.94 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 121.215 0.531 . . . . 0.0 111.503 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.484 ' HB2' HG22 ' A' ' 10' ' ' ILE . 10.1 tmtt? -58.35 138.74 56.27 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.468 176.095 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 67.32 42.32 90.33 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 121.153 -0.546 . . . . 0.0 112.68 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 35.2 t -143.15 -168.57 2.83 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 120.767 0.317 . . . . 0.0 111.327 -176.325 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -60.84 -26.13 67.14 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -178.269 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -94.86 -15.03 24.03 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 -179.154 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 22.9 t70 . . . . . 0 CA--C 1.541 0.631 0 CA-C-O 121.004 0.43 . . . . 0.0 111.614 -177.591 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 . . . . . 0 N--CA 1.467 0.414 0 CA-C-O 121.497 0.665 . . . . 0.0 111.439 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.461 HG23 HG21 ' A' ' 51' ' ' VAL . 38.7 m -84.38 104.94 14.82 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 114.725 -1.125 . . . . 0.0 110.788 -177.198 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 62.2 mttm -120.68 122.0 39.49 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 121.09 0.471 . . . . 0.0 111.198 -174.324 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.458 HD13 ' HB ' ' A' ' 51' ' ' VAL . 49.9 mm -82.89 121.87 36.55 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 CA-C-N 115.91 -0.586 . . . . 0.0 112.295 -173.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 29.5 m -130.08 149.85 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.194 178.063 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -90.42 -15.72 30.4 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 179.778 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -96.97 142.68 28.63 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.037 0.446 . . . . 0.0 111.695 -179.481 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 20.0 m -80.57 -23.06 40.18 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.576 179.741 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.457 ' HA ' ' O ' ' A' ' 32' ' ' LEU . 16.2 ptp180 -116.15 119.46 35.87 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 121.311 0.577 . . . . 0.0 111.178 176.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 51.4 t -118.3 142.34 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.501 -175.331 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -94.33 110.47 22.23 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 120.982 0.42 . . . . 0.0 111.34 178.257 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.52 ' SG ' HD13 ' A' ' 32' ' ' LEU . 78.3 m . . . . . 0 C--O 1.237 0.398 0 CA-C-O 120.865 0.364 . . . . 0.0 111.41 176.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.455 ' O ' ' HD3' ' A' ' 29' ' ' ARG . 0.4 OUTLIER . . . . . 0 N--CA 1.448 -0.541 0 CA-C-O 122.598 1.189 . . . . 0.0 110.228 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 60.7 t -120.28 129.85 75.04 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-N 113.919 -1.492 . . . . 0.0 110.988 178.633 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 74.4 m95 -104.09 124.22 48.67 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.063 0.459 . . . . 0.0 112.157 -178.621 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.52 HD13 ' SG ' ' A' ' 18' ' ' CYS . 7.2 mp -103.07 149.88 24.15 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.94 177.197 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 27.6 tp60 -120.32 109.02 14.87 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.812 -178.356 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.516 HG12 HG12 ' A' ' 41' ' ' VAL . 67.8 mt -60.45 129.46 89.2 Favored Pre-proline 0 CA--C 1.543 0.678 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.743 179.497 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.563 ' HG2' ' OG1' ' A' ' 38' ' ' THR . 45.7 Cg_endo -78.61 119.21 4.39 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 122.216 1.944 . . . . 0.0 111.52 173.018 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 22.2 mp0 -56.72 -40.33 75.51 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 -171.175 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -81.13 0.77 34.76 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 -173.499 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.563 ' OG1' ' HG2' ' A' ' 35' ' ' PRO . 22.6 p -107.06 -46.22 3.96 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.336 0.589 . . . . 0.0 109.823 171.139 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 100.3 0.92 55.75 Favored Glycine 0 CA--C 1.524 0.602 0 CA-C-N 115.558 -0.746 . . . . 0.0 113.212 178.165 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.445 ' HB3' HG22 ' A' ' 51' ' ' VAL . 67.5 p-90 -157.33 157.31 33.9 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.024 0.44 . . . . 0.0 112.118 -176.198 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.516 HG12 HG12 ' A' ' 34' ' ' ILE . 13.3 p -135.46 139.91 45.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.593 174.323 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -106.55 131.73 53.38 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.164 0.506 . . . . 0.0 111.083 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.432 ' HA ' HD21 ' A' ' 32' ' ' LEU . 47.5 t -86.23 122.04 72.44 Favored Pre-proline 0 CA--C 1.537 0.466 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.784 -177.419 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -74.71 -12.56 22.16 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 122.496 2.131 . . . . 0.0 112.84 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -99.42 -39.13 8.52 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 116.268 -0.424 . . . . 0.0 112.053 -178.291 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.425 ' HG ' ' HG ' ' A' ' 48' ' ' CYS . 46.3 t -116.8 2.62 12.88 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -177.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 54.25 25.86 6.24 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 174.835 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.425 ' HG ' ' HG ' ' A' ' 46' ' ' CYS . 71.0 m -95.48 144.71 25.75 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.296 177.546 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.452 ' HE3' ' HB2' ' A' ' 49' ' ' LYS . 34.9 ttmt -112.44 106.52 15.02 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-O 121.17 0.51 . . . . 0.0 111.215 -177.898 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 52.4 m-85 -91.24 111.16 22.53 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.51 -175.503 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.461 HG21 HG23 ' A' ' 8' ' ' THR . 68.9 t -94.86 132.66 38.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-O 121.031 0.443 . . . . 0.0 111.279 177.735 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 41.8 tp -82.29 115.8 21.52 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 121.054 0.454 . . . . 0.0 112.12 -176.626 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.559 ' HE3' ' N ' ' A' ' 54' ' ' GLY . 0.1 OUTLIER -67.27 112.9 4.78 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 120.973 0.415 . . . . 0.0 110.042 178.582 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.559 ' N ' ' HE3' ' A' ' 53' ' ' LYS . . . 114.14 -4.51 23.78 Favored Glycine 0 CA--C 1.523 0.592 0 C-N-CA 121.323 -0.465 . . . . 0.0 112.591 -176.433 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 47.7 t -82.01 179.92 7.64 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 121.107 0.48 . . . . 0.0 111.629 177.552 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 19.4 ptmt -54.93 -43.71 73.58 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -177.28 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.41 -22.64 66.24 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.097 0.475 . . . . 0.0 112.056 -178.736 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 16.9 t70 . . . . . 0 CA--C 1.545 0.766 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.843 -178.29 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.455 ' CD ' ' H ' ' A' ' 8' ' ' THR . 0.2 OUTLIER . . . . . 0 CA--C 1.545 0.778 0 CA-C-O 120.79 0.329 . . . . 0.0 110.192 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.455 ' H ' ' CD ' ' A' ' 7' ' ' GLU . 77.2 m -70.9 123.52 22.2 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 121.102 0.477 . . . . 0.0 111.734 -179.609 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 23.2 tptp -121.35 101.82 7.88 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 120.873 0.368 . . . . 0.0 110.233 179.447 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 60.4 mt -83.43 99.89 6.48 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.065 -176.005 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 27.2 m -110.73 154.05 12.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 CA-C-O 121.009 0.433 . . . . 0.0 112.105 -175.778 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -87.5 14.99 7.16 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 120.787 0.327 . . . . 0.0 111.584 -178.516 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 58.0 pttt -132.83 143.94 49.88 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -174.898 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 54.0 m -87.92 -24.94 23.46 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 116.276 -0.42 . . . . 0.0 112.111 -178.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 75.2 mtt180 -108.71 110.19 21.54 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 121.179 0.514 . . . . 0.0 111.87 -179.146 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 50.3 t -114.01 147.21 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.064 -178.152 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.494 ' HA ' ' O ' ' A' ' 30' ' ' VAL . . . -91.18 106.71 18.7 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 121.348 0.594 . . . . 0.0 112.568 -177.361 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.682 ' SG ' HD22 ' A' ' 32' ' ' LEU . 95.9 m . . . . . 0 N--CA 1.472 0.642 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.633 178.72 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 6.1 tpt180 . . . . . 0 CA--C 1.53 0.196 0 CA-C-O 121.956 0.884 . . . . 0.0 110.504 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.494 ' O ' ' HA ' ' A' ' 17' ' ' ALA . 60.8 t -135.71 103.81 4.12 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 CA-C-N 114.669 -1.15 . . . . 0.0 110.421 -179.238 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 85.1 m95 -94.78 124.07 38.61 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -173.66 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.682 HD22 ' SG ' ' A' ' 18' ' ' CYS . 11.2 mp -105.45 131.57 52.7 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.019 0.438 . . . . 0.0 110.646 171.579 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -92.88 115.1 27.81 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.836 -177.438 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.495 HG21 ' HB2' ' A' ' 52' ' ' LEU . 69.0 mt -66.79 118.1 51.49 Favored Pre-proline 0 CA--C 1.538 0.508 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.526 173.222 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.437 ' HG2' ' OG1' ' A' ' 38' ' ' THR . 97.6 Cg_endo -82.19 134.23 7.92 Favored 'Trans proline' 0 CA--C 1.538 0.704 0 C-N-CA 122.424 2.083 . . . . 0.0 113.045 179.445 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -58.4 -23.01 56.0 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 121.433 0.635 . . . . 0.0 110.599 174.64 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -62.4 -35.3 78.77 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 115.3 -0.864 . . . . 0.0 111.967 179.59 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.437 ' OG1' ' HG2' ' A' ' 35' ' ' PRO . 31.9 p -108.73 -48.73 3.26 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-O 121.03 0.443 . . . . 0.0 111.326 -179.058 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 101.08 -0.56 54.71 Favored Glycine 0 CA--C 1.527 0.807 0 CA-C-N 116.034 -0.53 . . . . 0.0 112.779 -177.005 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 67.5 p-90 -155.11 166.23 34.23 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 120.891 0.376 . . . . 0.0 111.821 -177.889 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.432 HG12 HG12 ' A' ' 34' ' ' ILE . 10.1 p -144.07 144.35 22.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 CA-C-N 116.528 -0.306 . . . . 0.0 110.912 175.459 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -105.13 141.36 36.81 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 120.834 0.349 . . . . 0.0 111.127 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.468 ' SG ' ' HB3' ' A' ' 46' ' ' CYS . 29.3 p -99.07 116.61 65.11 Favored Pre-proline 0 CA--C 1.539 0.52 0 O-C-N 122.305 -0.247 . . . . 0.0 110.935 175.043 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -70.37 16.93 0.24 Allowed 'Trans proline' 0 CA--C 1.544 0.981 0 C-N-CA 122.768 2.312 . . . . 0.0 113.642 -176.925 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 35.0 m-85 -117.26 -49.6 2.58 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 120.837 0.351 . . . . 0.0 111.418 176.404 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.468 ' HB3' ' SG ' ' A' ' 43' ' ' CYS . 13.2 t -105.13 -4.94 21.24 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -175.944 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 63.81 18.64 11.29 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 112.913 0.709 . . . . 0.0 112.913 177.768 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.442 ' SG ' ' SG ' ' A' ' 46' ' ' CYS . 34.7 m -79.8 135.27 36.44 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 120.84 0.352 . . . . 0.0 111.262 -179.748 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -99.62 95.42 6.95 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 120.915 0.388 . . . . 0.0 110.522 178.339 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.406 ' CZ ' ' HB2' ' A' ' 48' ' ' CYS . 76.0 m-85 -82.1 105.04 12.88 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.697 0.284 . . . . 0.0 111.263 -173.837 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 90.4 t -91.47 126.78 44.1 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.293 178.105 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.495 ' HB2' HG21 ' A' ' 34' ' ' ILE . 58.0 tp -73.32 112.53 9.46 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 121.175 0.512 . . . . 0.0 111.125 178.663 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 61.5 tttm -63.34 118.07 7.52 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.343 -178.829 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 102.25 -3.48 51.13 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 121.37 -0.443 . . . . 0.0 112.853 -174.176 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 35.2 t -90.82 -176.84 4.8 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 120.931 0.396 . . . . 0.0 111.544 178.899 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 54.9 mttm -72.24 -10.99 60.51 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 120.901 0.381 . . . . 0.0 111.968 -176.251 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -93.88 -0.94 55.45 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 120.967 0.413 . . . . 0.0 110.858 173.632 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 24.9 t70 . . . . . 0 CA--C 1.549 0.924 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.858 -178.175 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 . . . . . 0 C--O 1.238 0.474 0 CA-C-O 121.953 0.883 . . . . 0.0 111.34 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 96.2 m -126.51 148.9 49.64 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 114.752 -1.113 . . . . 0.0 110.731 -177.573 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.429 ' HD2' ' CE1' ' A' ' 50' ' ' TYR . 98.7 mttt -120.08 126.95 52.02 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 120.867 0.365 . . . . 0.0 110.735 -176.874 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.428 HG22 ' HB2' ' A' ' 53' ' ' LYS . 34.9 mm -91.83 98.84 8.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-O 121.023 0.439 . . . . 0.0 110.831 -179.179 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 34.7 m -99.15 158.0 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-O 121.407 0.623 . . . . 0.0 112.501 -174.11 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -91.72 -34.5 14.61 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.506 177.693 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -90.45 151.19 21.5 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.311 0.577 . . . . 0.0 112.479 -175.9 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 43.8 m -78.3 -27.51 47.31 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.331 173.48 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 71.7 mtp180 -90.42 107.2 19.0 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.618 175.175 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 55.1 t -113.97 118.59 58.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 120.999 0.428 . . . . 0.0 112.09 -175.423 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.13 103.09 7.85 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 121.057 0.456 . . . . 0.0 110.29 173.892 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.727 ' SG ' HD13 ' A' ' 32' ' ' LEU . 79.1 m . . . . . 0 N--CA 1.469 0.482 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -172.329 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 7.9 tpt180 . . . . . 0 C--O 1.236 0.387 0 CA-C-O 122.62 1.2 . . . . 0.0 111.981 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 19.9 m -104.7 114.62 44.79 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 CA-C-N 113.658 -1.61 . . . . 0.0 112.265 -177.608 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 96.7 m95 -101.82 124.42 47.42 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.717 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.727 HD13 ' SG ' ' A' ' 18' ' ' CYS . 9.3 mp -117.49 134.1 55.23 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 121.011 0.434 . . . . 0.0 110.945 174.248 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -93.73 116.42 28.9 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.263 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.557 HG12 HG12 ' A' ' 41' ' ' VAL . 77.7 mt -61.73 123.0 75.24 Favored Pre-proline 0 CA--C 1.542 0.637 0 CA-C-O 120.891 0.377 . . . . 0.0 111.849 179.18 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.579 ' HG2' ' OG1' ' A' ' 38' ' ' THR . 76.7 Cg_endo -81.23 140.16 12.13 Favored 'Trans proline' 0 CA--C 1.544 0.983 0 C-N-CA 122.803 2.335 . . . . 0.0 112.818 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -70.64 -28.92 65.19 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 121.01 0.433 . . . . 0.0 111.746 -179.34 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -61.61 -25.01 67.08 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 179.562 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.579 ' OG1' ' HG2' ' A' ' 35' ' ' PRO . 47.2 p -109.84 -54.0 2.61 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-O 121.286 0.565 . . . . 0.0 111.197 176.048 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 101.05 1.34 54.78 Favored Glycine 0 CA--C 1.524 0.648 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.003 -175.247 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 54.5 p-90 -152.87 162.92 40.7 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 121.077 0.465 . . . . 0.0 111.681 -176.825 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.557 HG12 HG12 ' A' ' 34' ' ' ILE . 8.4 p -142.67 118.71 5.53 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 CA-C-O 120.925 0.393 . . . . 0.0 110.773 173.707 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.544 ' HA ' ' HA ' ' A' ' 49' ' ' LYS . 9.4 pt-20 -100.0 106.61 18.41 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.529 0.68 . . . . 0.0 110.112 175.701 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.843 ' HB3' ' SG ' ' A' ' 46' ' ' CYS . 44.0 t -75.83 130.91 77.51 Favored Pre-proline 0 N--CA 1.466 0.371 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -167.13 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -69.58 -15.15 37.61 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 122.571 2.181 . . . . 0.0 112.569 175.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.512 ' HD2' ' SG ' ' A' ' 43' ' ' CYS . 90.1 m-85 -85.24 -43.2 13.98 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.601 179.542 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.843 ' SG ' ' HB3' ' A' ' 43' ' ' CYS . 27.1 p -97.04 -17.77 19.81 Favored 'General case' 0 N--CA 1.478 0.925 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 -178.695 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 10.1 t70 67.96 20.06 9.25 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-O 121.123 0.487 . . . . 0.0 111.147 179.19 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 53.6 t -121.43 154.73 36.16 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 120.916 0.389 . . . . 0.0 111.616 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.544 ' HA ' ' HA ' ' A' ' 42' ' ' GLU . 17.9 ttmm -98.51 134.45 41.45 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.385 -177.37 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.429 ' CE1' ' HD2' ' A' ' 9' ' ' LYS . 72.3 m-85 -115.08 113.29 23.83 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 122.17 -0.331 . . . . 0.0 111.244 178.358 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 49.7 t -97.51 128.44 48.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 CA-C-O 121.169 0.509 . . . . 0.0 111.737 175.703 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.448 ' HB2' HD13 ' A' ' 34' ' ' ILE . 51.6 tp -78.6 114.02 17.15 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.029 178.024 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.428 ' HB2' HG22 ' A' ' 10' ' ' ILE . 33.9 ttpt -63.48 121.65 14.35 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.329 -179.188 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 92.1 13.57 57.39 Favored Glycine 0 CA--C 1.531 1.047 0 CA-C-N 116.14 -0.482 . . . . 0.0 113.751 -177.619 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 34.5 p -107.29 -166.65 1.18 Allowed 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 117.296 0.548 . . . . 0.0 111.905 -178.499 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -63.31 -20.29 65.36 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 115.927 -0.578 . . . . 0.0 111.777 177.682 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -94.22 -1.2 54.46 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 179.526 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.6 t70 . . . . . 0 CA--C 1.543 0.694 0 CA-C-N 116.639 -0.255 . . . . 0.0 110.756 -176.686 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 . . . . . 0 N--CA 1.483 1.208 0 CA-C-O 121.582 0.706 . . . . 0.0 112.523 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.412 HG23 HG23 ' A' ' 51' ' ' VAL . 51.7 m -104.51 145.74 29.86 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 115.52 -0.764 . . . . 0.0 112.372 -171.47 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -129.14 114.19 16.02 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.262 176.437 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 55.0 mt -84.76 94.93 3.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 121.306 0.574 . . . . 0.0 110.761 -179.262 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 29.9 m -104.8 149.11 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-N 115.932 -0.576 . . . . 0.0 112.188 -174.394 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -75.67 -19.77 58.92 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.347 -177.204 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.438 ' NZ ' ' O ' ' A' ' 15' ' ' ARG . 13.2 ptmm? -112.08 143.04 43.75 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 116.204 -0.453 . . . . 0.0 112.171 -173.317 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.422 ' HB2' ' NE2' ' A' ' 33' ' ' GLN . 37.6 p -79.11 -38.58 35.85 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 112.724 0.639 . . . . 0.0 112.724 -178.609 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.438 ' O ' ' NZ ' ' A' ' 13' ' ' LYS . 8.9 mmt180 -78.69 127.72 32.48 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.362 0.601 . . . . 0.0 111.953 -178.94 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 95.3 t -143.21 124.18 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.765 -178.409 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.52 112.11 15.25 Favored 'General case' 0 CA--C 1.537 0.463 0 O-C-N 122.214 -0.303 . . . . 0.0 110.817 177.757 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 48.2 t . . . . . 0 N--CA 1.471 0.608 0 N-CA-C 112.516 0.561 . . . . 0.0 112.516 -178.825 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.408 ' HD2' ' HA ' ' A' ' 29' ' ' ARG . 10.1 tpt180 . . . . . 0 N--CA 1.464 0.227 0 CA-C-O 121.979 0.895 . . . . 0.0 110.831 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 89.9 t -137.78 117.77 15.77 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 CA-C-N 114.526 -1.216 . . . . 0.0 110.178 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 81.9 m95 -105.66 119.95 40.43 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 121.348 0.594 . . . . 0.0 112.254 -174.569 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.418 ' N ' HD12 ' A' ' 32' ' ' LEU . 6.9 mp -81.09 152.35 27.88 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.679 173.94 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.422 ' NE2' ' HB2' ' A' ' 14' ' ' SER . 25.0 tp60 -120.77 111.93 18.2 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.882 -178.887 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.529 HG21 ' HB2' ' A' ' 52' ' ' LEU . 61.0 mt -77.23 109.7 10.03 Favored Pre-proline 0 CA--C 1.541 0.608 0 CA-C-O 120.57 0.224 . . . . 0.0 110.397 173.431 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -86.47 156.24 9.27 Favored 'Trans proline' 0 CA--C 1.536 0.622 0 C-N-CA 122.793 2.329 . . . . 0.0 113.391 -176.871 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -73.79 -18.89 60.91 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.042 0.449 . . . . 0.0 110.271 174.372 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -58.02 -56.22 24.77 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-O 121.275 0.56 . . . . 0.0 110.927 174.895 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 44.6 p -90.48 -50.32 6.01 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.748 -179.66 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 99.48 1.55 56.63 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-N 116.141 -0.481 . . . . 0.0 112.415 -174.353 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.561 ' HB3' HG22 ' A' ' 51' ' ' VAL . 30.1 p-90 -158.55 170.86 21.25 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 122.656 0.382 . . . . 0.0 111.827 -177.036 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 11.2 p -141.93 144.92 24.79 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 CA-C-O 120.882 0.372 . . . . 0.0 111.039 175.289 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -104.38 137.94 41.53 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 120.875 0.369 . . . . 0.0 111.132 -178.987 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.665 ' SG ' ' HE2' ' A' ' 50' ' ' TYR . 68.6 m -95.13 109.59 45.48 Favored Pre-proline 0 N--CA 1.472 0.66 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.617 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -64.97 -12.03 32.6 Favored 'Trans proline' 0 CA--C 1.543 0.967 0 C-N-CA 122.495 2.13 . . . . 0.0 113.585 -178.144 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 -110.93 -62.63 1.51 Allowed 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 120.827 0.346 . . . . 0.0 111.716 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.504 ' SG ' ' SG ' ' A' ' 48' ' ' CYS . 42.8 t -73.08 -14.76 61.46 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -178.985 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 16.0 t70 71.96 -4.85 1.85 Allowed 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 123.342 0.657 . . . . 0.0 112.69 177.258 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.504 ' SG ' ' SG ' ' A' ' 46' ' ' CYS . 81.2 m -65.83 147.65 53.03 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.087 0.47 . . . . 0.0 112.198 178.035 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 59.8 tttm -118.45 104.31 10.58 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.419 178.258 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.665 ' HE2' ' SG ' ' A' ' 43' ' ' CYS . 97.3 m-85 -89.26 113.92 25.22 Favored 'General case' 0 N--CA 1.468 0.444 0 O-C-N 122.057 -0.402 . . . . 0.0 111.411 -174.109 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.561 HG22 ' HB3' ' A' ' 40' ' ' TRP . 80.1 t -95.69 136.56 26.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 CA-C-O 120.777 0.322 . . . . 0.0 111.435 176.014 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.529 ' HB2' HG21 ' A' ' 34' ' ' ILE . 48.7 tp -71.97 120.03 16.99 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 121.29 0.567 . . . . 0.0 111.195 178.46 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -65.78 116.88 7.43 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.518 -179.003 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 91.27 14.97 56.63 Favored Glycine 0 CA--C 1.527 0.784 0 CA-C-N 116.195 -0.457 . . . . 0.0 113.054 -176.03 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.515 ' HB3' ' HB3' ' A' ' 52' ' ' LEU . 76.9 p -91.09 -177.93 5.04 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 121.379 0.609 . . . . 0.0 111.916 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -57.42 -37.79 73.31 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.771 173.152 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -78.69 -30.78 46.25 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -176.551 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 24.8 t70 . . . . . 0 CA--C 1.537 0.465 0 CA-C-O 120.936 0.398 . . . . 0.0 111.662 179.177 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 . . . . . 0 CA--C 1.539 0.55 0 CA-C-O 121.351 0.596 . . . . 0.0 111.956 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 67.9 p -90.38 142.99 27.18 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.126 -179.028 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.419 ' HD3' ' CD1' ' A' ' 50' ' ' TYR . 57.4 tttp -116.56 97.92 6.27 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 176.282 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.545 HG23 ' HB2' ' A' ' 53' ' ' LYS . 2.0 mp -77.03 124.0 34.63 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-O 121.153 0.502 . . . . 0.0 112.266 -172.846 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 30.2 m -136.35 162.4 35.7 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.003 177.0 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -102.17 -16.41 16.37 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 111.76 0.282 . . . . 0.0 111.76 176.569 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -106.81 142.31 36.64 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 121.125 0.488 . . . . 0.0 111.3 177.28 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 74.6 m -76.17 -6.47 51.44 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 -173.126 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 90.2 mtt180 -111.61 120.13 41.05 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 121.61 -0.681 . . . . 0.0 112.081 177.085 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 37.4 t -134.71 140.95 44.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.996 179.711 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -93.89 127.92 39.9 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 116.729 -0.214 . . . . 0.0 111.142 178.433 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.568 ' SG ' ' HB2' ' A' ' 47' ' ' ASP . 41.4 t . . . . . 0 N--CA 1.471 0.602 0 CA-C-O 120.873 0.368 . . . . 0.0 110.926 177.0 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 3.8 tmt_? . . . . . 0 CA--C 1.529 0.156 0 CA-C-O 121.85 0.833 . . . . 0.0 110.584 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.459 HG23 ' HB3' ' A' ' 18' ' ' CYS . 14.5 m -136.7 120.03 22.28 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.257 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.838 173.004 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 48.1 m95 -99.43 112.61 24.77 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.356 -178.527 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.438 ' N ' HD12 ' A' ' 32' ' ' LEU . 6.1 mp -90.26 132.1 35.71 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 121.118 0.485 . . . . 0.0 111.61 -179.392 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 27.3 tp60 -93.68 106.74 18.69 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.858 176.959 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.563 HG12 HG12 ' A' ' 41' ' ' VAL . 97.8 mt -60.73 125.35 82.68 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.026 176.878 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.567 ' HG2' ' OG1' ' A' ' 38' ' ' THR . 84.5 Cg_endo -76.96 105.34 2.06 Favored 'Trans proline' 0 CA--C 1.535 0.566 0 C-N-CA 122.261 1.974 . . . . 0.0 111.753 177.533 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -57.93 -19.13 27.81 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 121.299 0.571 . . . . 0.0 110.366 178.205 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -54.66 -43.53 72.47 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.503 172.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.567 ' OG1' ' HG2' ' A' ' 35' ' ' PRO . 44.1 p -97.49 -57.73 2.18 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.722 177.536 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 120.55 0.99 12.29 Favored Glycine 0 CA--C 1.529 0.926 0 CA-C-N 115.849 -0.614 . . . . 0.0 112.627 -177.676 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 63.9 p-90 -162.12 160.62 27.5 Favored 'General case' 0 N--CA 1.471 0.607 0 O-C-N 122.709 -0.289 . . . . 0.0 111.396 -176.248 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.563 HG12 HG12 ' A' ' 34' ' ' ILE . 11.6 p -148.4 129.91 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 CA-C-O 120.713 0.292 . . . . 0.0 110.807 173.75 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.416 ' HA ' ' HA ' ' A' ' 49' ' ' LYS . 9.6 pt-20 -90.89 140.02 30.21 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 120.913 0.387 . . . . 0.0 111.211 178.042 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 44.5 t -70.35 126.37 92.3 Favored Pre-proline 0 N--CA 1.47 0.569 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.774 -176.596 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.32 -26.16 29.92 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 122.785 2.323 . . . . 0.0 112.971 -179.653 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -78.36 -92.92 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 121.123 0.487 . . . . 0.0 111.016 177.675 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 48.0 t -172.41 81.38 0.05 Allowed 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.039 0.447 . . . . 0.0 110.305 -179.412 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.568 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 13.3 t70 -136.8 -95.72 0.22 Allowed 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.393 -178.06 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 90.7 m -153.62 -170.34 3.56 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 120.92 0.39 . . . . 0.0 110.674 177.823 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.416 ' HA ' ' HA ' ' A' ' 42' ' ' GLU . 34.8 ttpt -111.62 115.6 29.4 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 120.899 0.381 . . . . 0.0 110.632 175.886 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.419 ' CD1' ' HD3' ' A' ' 9' ' ' LYS . 43.4 m-85 -82.69 114.92 21.38 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.18 -171.218 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 80.9 t -109.38 123.74 65.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-O 121.314 0.578 . . . . 0.0 111.843 -176.668 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 46.0 tp -81.0 107.95 14.26 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.733 178.405 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.545 ' HB2' HG23 ' A' ' 10' ' ' ILE . 28.6 ttpp -65.15 147.45 53.45 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 120.907 0.384 . . . . 0.0 111.293 -179.593 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 85.95 7.89 80.07 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.446 -174.63 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 14.8 t -109.78 173.71 6.2 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 120.913 0.387 . . . . 0.0 111.499 179.143 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 23.5 pttm -62.81 -18.1 62.24 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-O 120.818 0.342 . . . . 0.0 111.241 175.542 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -74.0 -24.53 59.6 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.377 0.608 . . . . 0.0 110.804 174.296 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.5 t0 . . . . . 0 CA--C 1.538 0.514 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.436 175.855 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.544 0.736 0 CA-C-O 121.232 0.539 . . . . 0.0 111.246 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 87.4 m -100.02 124.57 45.53 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -172.526 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 44.7 mttp -122.59 109.03 13.8 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.877 177.299 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.57 HG22 ' HB2' ' A' ' 53' ' ' LYS . 15.7 mt -82.99 79.87 1.44 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-O 121.191 0.52 . . . . 0.0 109.706 177.477 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.443 HG12 ' H ' ' A' ' 13' ' ' LYS . 4.7 t -92.45 148.69 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 CA-C-O 121.036 0.445 . . . . 0.0 111.571 -172.784 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -78.55 -20.76 49.91 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 120.847 0.356 . . . . 0.0 111.343 -175.662 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.443 ' H ' HG12 ' A' ' 11' ' ' VAL . 7.0 ptpp? -108.92 148.62 30.4 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 120.895 0.379 . . . . 0.0 111.522 177.462 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.441 ' HA ' HD12 ' A' ' 34' ' ' ILE . 67.4 p -82.36 -44.01 16.7 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 112.894 0.701 . . . . 0.0 112.894 -177.198 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 49.2 mtt180 -78.59 90.54 4.54 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 121.417 0.627 . . . . 0.0 111.627 -176.052 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 47.8 t -110.53 120.65 61.83 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.29 -179.69 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -96.11 158.27 15.52 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 121.016 0.436 . . . . 0.0 111.867 179.41 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 51.4 t . . . . . 0 N--CA 1.467 0.385 0 CA-C-O 120.946 0.403 . . . . 0.0 111.401 178.247 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.406 ' HA ' ' HD3' ' A' ' 29' ' ' ARG . 3.4 tpp180 . . . . . 0 N--CA 1.441 -0.896 0 CA-C-O 121.879 0.847 . . . . 0.0 112.19 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 31.4 m -98.35 124.75 51.64 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 CA-C-N 114.6 -1.182 . . . . 0.0 111.563 178.382 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 50.4 m95 -104.68 112.82 26.05 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 120.898 0.38 . . . . 0.0 111.302 178.5 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.443 ' N ' HD12 ' A' ' 32' ' ' LEU . 5.8 mp -98.87 127.99 44.94 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 121.254 0.549 . . . . 0.0 112.083 -177.399 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -104.11 108.42 19.77 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.738 176.186 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.581 HG21 ' HB2' ' A' ' 52' ' ' LEU . 80.0 mt -67.61 121.36 78.86 Favored Pre-proline 0 CA--C 1.538 0.482 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.846 176.415 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.676 ' HG2' HG22 ' A' ' 38' ' ' THR . 72.8 Cg_endo -76.8 103.67 1.79 Allowed 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 122.147 1.898 . . . . 0.0 112.116 178.329 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -48.81 -26.67 2.52 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.068 0.547 . . . . 0.0 112.186 179.017 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -51.19 -46.19 62.07 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-N 116.144 -0.48 . . . . 0.0 112.049 175.639 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.676 HG22 ' HG2' ' A' ' 35' ' ' PRO . 14.9 t -104.7 -32.92 8.66 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 111.871 0.323 . . . . 0.0 111.871 -179.562 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 103.98 2.67 45.61 Favored Glycine 0 CA--C 1.533 1.217 0 N-CA-C 114.92 0.728 . . . . 0.0 114.92 174.931 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.492 ' H ' HG23 ' A' ' 38' ' ' THR . 58.2 p-90 -156.52 163.45 39.38 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 117.942 0.871 . . . . 0.0 112.09 -175.423 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.575 HG12 HG12 ' A' ' 34' ' ' ILE . 6.3 p -150.21 165.88 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 N-CA-C 109.873 -0.418 . . . . 0.0 109.873 174.645 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -142.6 150.82 40.82 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.256 0.551 . . . . 0.0 111.648 176.139 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.634 ' SG ' ' N ' ' A' ' 47' ' ' ASP . 28.6 p -69.99 141.37 89.33 Favored Pre-proline 0 N--CA 1.468 0.468 0 CA-C-N 115.692 -0.686 . . . . 0.0 112.663 -172.747 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 43' ' ' CYS . 18.3 Cg_exo -67.55 -27.88 38.72 Favored 'Trans proline' 0 CA--C 1.542 0.894 0 C-N-CA 122.708 2.272 . . . . 0.0 113.25 177.904 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -94.51 -83.62 0.34 Allowed 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 -178.688 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 49.5 t -168.14 18.47 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.953 0 CA-C-O 120.797 0.332 . . . . 0.0 111.874 -177.683 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.634 ' N ' ' SG ' ' A' ' 43' ' ' CYS . 2.1 m-20 -66.6 -79.17 0.05 OUTLIER 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 116.292 -0.413 . . . . 0.0 112.075 -174.431 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.435 ' SG ' ' O ' ' A' ' 47' ' ' ASP . 72.0 m -161.62 171.25 18.31 Favored 'General case' 0 N--CA 1.479 1.011 0 CA-C-O 121.516 0.674 . . . . 0.0 112.607 -177.743 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 36.1 tttp -110.65 120.29 41.94 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.692 174.416 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -108.67 115.34 29.92 Favored 'General case' 0 N--CA 1.469 0.502 0 O-C-N 121.871 -0.518 . . . . 0.0 112.23 -170.167 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 94.9 t -96.42 137.9 23.07 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.09 176.26 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.581 ' HB2' HG21 ' A' ' 34' ' ' ILE . 36.7 tp -84.35 104.77 14.65 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 121.514 0.673 . . . . 0.0 111.92 -178.942 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.57 ' HB2' HG22 ' A' ' 10' ' ' ILE . 47.3 tttm -62.2 128.19 34.95 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.75 178.657 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 93.33 -5.48 74.66 Favored Glycine 0 CA--C 1.529 0.943 0 CA-C-N 116.034 -0.53 . . . . 0.0 113.409 -177.348 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 44.7 t -95.46 -175.61 3.52 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 122.468 -0.431 . . . . 0.0 111.441 178.745 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 15.3 ptmm? -62.27 -19.97 63.79 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 120.872 0.368 . . . . 0.0 111.489 178.969 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -82.31 -10.79 58.97 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 112.027 0.38 . . . . 0.0 112.027 177.302 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.7 t70 . . . . . 0 CA--C 1.54 0.568 0 CA-C-O 121.674 0.749 . . . . 0.0 110.376 177.915 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 . . . . . 0 CA--C 1.543 0.701 0 CA-C-O 120.866 0.365 . . . . 0.0 111.559 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 69.1 m -125.03 142.02 51.75 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 122.447 0.299 . . . . 0.0 111.388 -178.266 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 25.1 mtmm -137.01 126.91 25.76 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 120.932 0.396 . . . . 0.0 111.25 177.068 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.525 HD12 ' N ' ' A' ' 10' ' ' ILE . 2.6 mp -92.67 110.78 23.46 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.494 178.578 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 33.7 m -104.35 164.31 3.78 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-O 121.228 0.537 . . . . 0.0 111.802 -177.888 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -96.38 -23.62 16.54 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 116.16 -0.473 . . . . 0.0 112.066 -177.218 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -120.27 151.17 39.56 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-O 120.941 0.4 . . . . 0.0 111.475 -177.771 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 19.9 m -68.97 -26.63 65.14 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 113.607 0.966 . . . . 0.0 113.607 -171.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 4.5 tpt180 -101.77 119.89 39.5 Favored 'General case' 0 N--CA 1.473 0.688 0 O-C-N 121.494 -0.754 . . . . 0.0 111.605 -178.558 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 41.0 t -129.69 141.89 45.31 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 CA-C-O 120.813 0.339 . . . . 0.0 111.322 -178.779 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -92.39 116.1 28.68 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.875 0.369 . . . . 0.0 111.356 177.548 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.506 ' HB3' HG23 ' A' ' 30' ' ' VAL . 40.1 t . . . . . 0 N--CA 1.473 0.681 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.282 179.411 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.424 ' HD3' ' HA ' ' A' ' 29' ' ' ARG . 12.3 tpp180 . . . . . 0 N--CA 1.439 -0.993 0 CA-C-O 122.236 1.017 . . . . 0.0 112.733 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.506 HG23 ' HB3' ' A' ' 18' ' ' CYS . 17.4 m -119.08 116.38 50.81 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 CA-C-N 114.294 -1.321 . . . . 0.0 111.242 176.151 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 89.0 m95 -96.65 109.63 22.22 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.531 -178.633 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.7 mp -90.13 154.89 19.43 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 121.149 0.5 . . . . 0.0 111.276 177.219 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 6.5 tp60 -122.73 129.13 51.41 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.002 0.429 . . . . 0.0 111.368 178.754 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.586 HG12 HG12 ' A' ' 41' ' ' VAL . 55.0 mt -87.09 117.73 69.02 Favored Pre-proline 0 CA--C 1.537 0.447 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.146 177.907 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.509 ' HG2' ' OG1' ' A' ' 38' ' ' THR . 82.5 Cg_endo -79.76 123.34 5.24 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 122.179 1.919 . . . . 0.0 111.832 177.707 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.503 ' O ' ' HB2' ' A' ' 56' ' ' LYS . 13.0 pt-20 -56.23 -23.79 38.07 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 111.923 0.342 . . . . 0.0 111.923 -177.355 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -66.93 -35.62 80.39 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 178.935 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.509 ' OG1' ' HG2' ' A' ' 35' ' ' PRO . 39.9 p -92.29 -50.89 5.43 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 120.924 0.392 . . . . 0.0 110.775 178.723 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.511 ' HA2' ' OG ' ' A' ' 55' ' ' SER . . . 103.98 -0.03 44.91 Favored Glycine 0 CA--C 1.524 0.596 0 CA-C-N 116.073 -0.512 . . . . 0.0 112.841 -178.761 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.412 ' HA ' ' O ' ' A' ' 50' ' ' TYR . 67.7 p-90 -162.14 162.54 28.54 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 120.716 0.293 . . . . 0.0 111.327 -175.933 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.586 HG12 HG12 ' A' ' 34' ' ' ILE . 9.7 p -142.27 141.74 28.13 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-O 121.033 0.444 . . . . 0.0 110.73 173.479 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.47 ' O ' ' HD3' ' A' ' 44' ' ' PRO . 9.0 pt-20 -100.74 141.27 33.85 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 111.849 0.314 . . . . 0.0 111.849 -177.474 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.542 ' SG ' ' HB3' ' A' ' 47' ' ' ASP . 29.9 p -98.4 99.91 8.21 Favored Pre-proline 0 CA--C 1.54 0.56 0 CA-C-O 120.64 0.257 . . . . 0.0 110.419 170.449 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.47 ' HD3' ' O ' ' A' ' 42' ' ' GLU . 23.2 Cg_exo -65.77 -3.92 8.96 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 122.735 2.29 . . . . 0.0 113.13 -178.328 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -82.83 -76.15 0.28 Allowed 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 116.592 -0.276 . . . . 0.0 110.589 179.522 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 24.8 p 173.86 92.33 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.358 177.205 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.542 ' HB3' ' SG ' ' A' ' 43' ' ' CYS . 13.5 t70 -161.02 -83.03 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 116.717 -0.219 . . . . 0.0 110.969 173.538 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.502 ' N ' ' SG ' ' A' ' 43' ' ' CYS . 81.9 m -160.76 178.27 9.61 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 122.144 0.973 . . . . 0.0 113.135 -177.892 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 19.3 ttmm -102.48 113.58 27.05 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 114.484 -1.235 . . . . 0.0 108.754 168.384 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.419 ' HB2' HG12 ' A' ' 41' ' ' VAL . 67.7 m-85 -85.85 105.71 16.55 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 111.847 0.314 . . . . 0.0 111.847 -173.569 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 67.0 t -88.22 133.05 31.73 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 CA-C-O 120.767 0.317 . . . . 0.0 111.038 174.328 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.504 ' HB2' HG21 ' A' ' 34' ' ' ILE . 53.2 tp -98.77 131.75 44.66 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 121.359 0.6 . . . . 0.0 112.42 -175.916 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -68.05 141.25 56.23 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 115.811 -0.632 . . . . 0.0 111.144 176.625 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 70.8 10.64 68.06 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 121.271 -0.49 . . . . 0.0 113.68 179.712 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.511 ' OG ' ' HA2' ' A' ' 39' ' ' GLY . 29.4 t -97.57 -171.08 2.11 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 122.495 -0.415 . . . . 0.0 111.535 -179.356 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.503 ' HB2' ' O ' ' A' ' 36' ' ' GLU . 47.3 tptt -53.32 -43.97 68.05 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 120.944 0.402 . . . . 0.0 111.928 -177.744 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -82.26 2.39 32.17 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -175.888 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.0 t70 . . . . . 0 N--CA 1.471 0.58 0 CA-C-O 120.924 0.392 . . . . 0.0 111.659 -178.377 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.472 0.634 0 CA-C-O 121.506 0.669 . . . . 0.0 111.854 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 54.2 m -89.86 111.37 22.39 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.602 177.836 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 46.8 tptt -100.54 109.3 21.39 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.04 -172.644 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 58.3 mt -79.04 94.22 1.73 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 CA-C-O 121.141 0.496 . . . . 0.0 110.602 179.462 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.51 HG12 ' H ' ' A' ' 13' ' ' LYS . 3.5 t -97.89 156.84 3.55 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 CA-C-O 121.127 0.489 . . . . 0.0 111.62 -175.763 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -96.43 -4.31 41.96 Favored 'General case' 0 CA--C 1.548 0.873 0 CA-C-O 121.01 0.433 . . . . 0.0 111.909 -178.945 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.51 ' H ' HG12 ' A' ' 11' ' ' VAL . 50.9 mtmt -137.35 153.08 50.29 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 122.101 -0.374 . . . . 0.0 111.42 -176.753 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 77.7 p -79.06 -40.15 32.01 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.063 0.459 . . . . 0.0 111.265 177.438 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 78.2 mtm180 -75.35 94.82 3.1 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.96 176.294 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.495 HG11 ' CD1' ' A' ' 50' ' ' TYR . 47.4 t -111.35 137.86 42.17 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.34 -177.627 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -97.96 118.46 34.59 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 121.069 0.461 . . . . 0.0 111.755 -179.728 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 10.0 t . . . . . 0 N--CA 1.467 0.422 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.061 174.762 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.425 ' NE ' ' HE1' ' A' ' 31' ' ' TRP . 0.8 OUTLIER . . . . . 0 N--CA 1.446 -0.655 0 CA-C-O 122.769 1.271 . . . . 0.0 111.779 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 25.7 m -134.32 141.09 44.55 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 113.855 -1.521 . . . . 0.0 109.774 169.818 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.425 ' HE1' ' NE ' ' A' ' 29' ' ' ARG . 75.7 m95 -107.25 123.55 48.46 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -171.433 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.487 ' N ' HD12 ' A' ' 32' ' ' LEU . 5.1 mp -103.44 158.65 16.2 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.615 178.052 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 42.0 tp60 -123.77 109.53 13.78 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.935 0.398 . . . . 0.0 111.436 -179.002 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.501 HG12 HG12 ' A' ' 41' ' ' VAL . 64.6 mt -70.47 115.06 31.17 Favored Pre-proline 0 CA--C 1.542 0.656 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.47 178.439 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.432 ' HG2' ' OG1' ' A' ' 38' ' ' THR . 90.4 Cg_endo -80.11 145.47 17.38 Favored 'Trans proline' 0 CA--C 1.54 0.825 0 C-N-CA 122.517 2.145 . . . . 0.0 112.753 179.573 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.402 ' H ' ' CD ' ' A' ' 36' ' ' GLU . 20.9 mp0 -62.95 -29.51 70.86 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 121.105 0.479 . . . . 0.0 111.035 179.437 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -58.43 -50.28 74.25 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.497 -0.774 . . . . 0.0 112.155 -178.899 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.432 ' OG1' ' HG2' ' A' ' 35' ' ' PRO . 50.2 p -90.34 -49.16 6.69 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.077 0.465 . . . . 0.0 111.324 -178.267 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 98.24 0.95 58.22 Favored Glycine 0 CA--C 1.523 0.562 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.399 -176.292 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.557 ' HB3' HG22 ' A' ' 51' ' ' VAL . 68.2 p-90 -156.79 164.13 38.44 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 121.148 0.499 . . . . 0.0 112.151 -176.605 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.501 HG12 HG12 ' A' ' 34' ' ' ILE . 14.5 p -142.85 137.09 27.15 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.676 174.996 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -98.83 148.03 24.33 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.155 0.502 . . . . 0.0 112.139 -177.319 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.662 ' SG ' ' HE2' ' A' ' 50' ' ' TYR . 74.0 m -98.25 119.31 62.11 Favored Pre-proline 0 CA--C 1.538 0.519 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.578 171.256 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -73.13 22.44 0.32 Allowed 'Trans proline' 0 CA--C 1.541 0.861 0 C-N-CA 122.902 2.402 . . . . 0.0 114.036 -173.619 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -114.94 -88.7 0.57 Allowed 'General case' 0 CA--C 1.538 0.517 0 O-C-N 122.084 -0.385 . . . . 0.0 111.073 177.612 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 57.5 m -160.57 18.98 0.14 Allowed 'General case' 0 N--CA 1.477 0.913 0 CA-C-O 120.856 0.36 . . . . 0.0 111.331 -177.161 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.41 ' O ' ' SG ' ' A' ' 48' ' ' CYS . 2.1 m-20 -81.74 -93.5 0.05 Allowed 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 112.276 0.473 . . . . 0.0 112.276 -173.34 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.41 ' SG ' ' O ' ' A' ' 47' ' ' ASP . 72.3 m -161.38 173.33 15.09 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.553 0.692 . . . . 0.0 112.043 -176.539 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.7 ttmp? -101.47 104.77 15.71 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.269 169.041 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.662 ' HE2' ' SG ' ' A' ' 43' ' ' CYS . 95.4 m-85 -81.85 103.16 11.32 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.926 0.393 . . . . 0.0 111.767 -173.745 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.557 HG22 ' HB3' ' A' ' 40' ' ' TRP . 88.0 t -94.28 123.19 46.29 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.928 178.712 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 51.4 tp -77.88 120.41 22.72 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 116.585 -0.28 . . . . 0.0 110.978 176.893 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 46.8 tttp -65.71 146.06 55.25 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 121.149 0.5 . . . . 0.0 111.954 -178.567 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 85.11 17.45 62.86 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 121.117 -0.563 . . . . 0.0 112.549 -175.452 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.5 m -118.36 172.14 7.66 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 122.481 0.312 . . . . 0.0 110.886 -179.809 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -56.31 -30.08 62.09 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -178.753 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -75.96 -26.91 57.27 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 121.006 0.431 . . . . 0.0 112.111 179.079 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 34.3 t70 . . . . . 0 CA--C 1.543 0.686 0 CA-C-O 121.549 0.69 . . . . 0.0 110.571 179.366 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 . . . . . 0 N--CA 1.472 0.632 0 CA-C-O 121.227 0.537 . . . . 0.0 112.069 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 69.5 m -89.18 119.65 29.86 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.292 174.141 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 55.9 tptt -109.82 106.91 16.69 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 120.656 0.265 . . . . 0.0 111.236 -173.473 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 56.2 mt -86.09 100.95 9.79 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-O 121.104 0.478 . . . . 0.0 111.351 -179.771 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 34.5 m -103.94 162.57 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 CA-C-O 120.951 0.405 . . . . 0.0 111.35 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -92.93 -32.46 14.55 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-O 120.887 0.375 . . . . 0.0 111.618 -178.317 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -108.16 143.31 37.11 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 120.729 0.299 . . . . 0.0 111.643 -179.277 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 41.2 t -63.01 -37.24 86.38 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 112.824 0.676 . . . . 0.0 112.824 -176.234 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 52.5 mtt85 -74.18 105.49 5.41 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.201 0.524 . . . . 0.0 111.892 178.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 48.0 t -100.95 106.17 18.97 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.966 176.592 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -80.82 101.03 9.12 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 120.936 0.398 . . . . 0.0 111.266 178.689 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 52.0 t . . . . . 0 CA--C 1.539 0.539 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -178.737 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.48 ' HD3' ' HA ' ' A' ' 29' ' ' ARG . 0.1 OUTLIER . . . . . 0 N--CA 1.441 -0.89 0 CA-C-O 122.24 1.019 . . . . 0.0 110.665 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 55.8 t -93.94 105.07 16.45 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 CA-C-N 114.134 -1.394 . . . . 0.0 111.17 -179.771 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 56.7 m95 -92.22 111.52 23.11 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.367 178.609 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.413 ' N ' HD12 ' A' ' 32' ' ' LEU . 5.6 mp -91.37 134.03 34.95 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 120.753 0.311 . . . . 0.0 111.003 177.612 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.5 tp-100 -104.88 106.91 17.61 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 177.64 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.586 HG12 HG12 ' A' ' 41' ' ' VAL . 75.6 mt -63.46 117.42 34.16 Favored Pre-proline 0 CA--C 1.54 0.566 0 CA-C-O 120.602 0.239 . . . . 0.0 111.408 -179.702 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.555 ' HG2' ' OG1' ' A' ' 38' ' ' THR . 90.1 Cg_endo -80.1 127.78 7.01 Favored 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 122.611 2.207 . . . . 0.0 113.005 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -61.31 -21.94 64.44 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 120.981 0.42 . . . . 0.0 111.675 179.275 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -64.04 -35.12 79.68 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.884 178.0 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.555 ' OG1' ' HG2' ' A' ' 35' ' ' PRO . 36.0 p -106.04 -52.42 2.81 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-O 121.029 0.442 . . . . 0.0 111.605 -178.93 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 106.56 0.64 37.25 Favored Glycine 0 CA--C 1.526 0.762 0 CA-C-N 116.189 -0.46 . . . . 0.0 112.643 -176.813 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 67.7 p-90 -155.81 162.79 40.42 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 120.916 0.388 . . . . 0.0 111.595 -178.438 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.586 HG12 HG12 ' A' ' 34' ' ' ILE . 12.3 p -151.81 127.85 1.84 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.452 172.647 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.417 ' HA ' ' HA ' ' A' ' 49' ' ' LYS . 12.6 pt-20 -100.89 150.21 23.08 Favored 'General case' 0 CA--C 1.536 0.405 0 O-C-N 121.925 -0.485 . . . . 0.0 111.324 -179.357 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 42.6 t -97.16 107.41 37.94 Favored Pre-proline 0 N--CA 1.468 0.429 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.813 -177.417 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.412 ' HD3' ' O ' ' A' ' 42' ' ' GLU . 41.4 Cg_exo -58.55 -14.66 21.97 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 122.364 2.043 . . . . 0.0 113.035 177.467 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -105.03 -0.3 26.92 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.807 -178.386 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 42.5 t -143.9 -2.2 0.94 Allowed 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 112.416 0.525 . . . . 0.0 112.416 -179.781 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 61.7 m-20 70.95 -41.17 0.5 Allowed 'General case' 0 CA--C 1.548 0.876 0 N-CA-C 114.026 1.121 . . . . 0.0 114.026 178.125 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 77.3 m -58.69 145.68 39.2 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 -172.491 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.417 ' HA ' ' HA ' ' A' ' 42' ' ' GLU . 20.4 ttmm -107.46 123.25 48.13 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.989 -178.205 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 55.1 m-85 -100.53 114.61 28.39 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 -174.778 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.405 HG13 ' HB3' ' A' ' 57' ' ' ALA . 93.2 t -99.15 145.24 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 CA-C-O 120.819 0.342 . . . . 0.0 111.467 176.871 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.563 ' HB2' HG21 ' A' ' 34' ' ' ILE . 54.5 tp -94.1 126.09 39.12 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 120.907 0.384 . . . . 0.0 111.735 179.84 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.457 ' NZ ' ' HB3' ' A' ' 53' ' ' LYS . 0.9 OUTLIER -61.88 122.91 16.59 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.435 178.428 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 90.07 7.65 67.76 Favored Glycine 0 CA--C 1.524 0.649 0 C-N-CA 121.417 -0.421 . . . . 0.0 113.299 -178.768 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 34.6 t -100.72 -173.56 2.42 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 122.364 -0.492 . . . . 0.0 111.587 178.657 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 48.7 mmtm -54.31 -34.73 61.6 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 113.253 0.835 . . . . 0.0 113.253 -175.728 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.405 ' HB3' HG13 ' A' ' 51' ' ' VAL . . . -94.19 6.77 47.56 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -176.467 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.7 t70 . . . . . 0 CA--C 1.552 1.045 0 O-C-N 122.151 -0.343 . . . . 0.0 111.302 -178.301 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 . . . . . 0 N--CA 1.468 0.464 0 CA-C-O 121.073 0.463 . . . . 0.0 112.029 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 86.1 m -122.14 135.6 54.81 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.671 176.948 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 57.6 mtpt -137.23 137.92 39.59 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 122.342 0.257 . . . . 0.0 111.116 -173.566 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 57.3 mt -97.45 107.34 19.89 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-O 120.966 0.412 . . . . 0.0 111.417 -179.031 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.44 HG12 ' H ' ' A' ' 13' ' ' LYS . 11.7 t -100.07 156.21 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.772 177.928 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -90.17 -7.8 52.75 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 -175.679 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.44 ' H ' HG12 ' A' ' 11' ' ' VAL . 16.5 ptpt -130.53 152.21 50.16 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 121.073 0.463 . . . . 0.0 111.892 -176.98 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 23.0 m -83.63 9.53 11.34 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -174.586 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 75.0 mtp180 -128.19 116.97 20.72 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 121.007 0.432 . . . . 0.0 111.759 -178.417 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 39.9 t -131.64 152.65 37.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.396 -178.619 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.472 ' HA ' ' O ' ' A' ' 30' ' ' VAL . . . -81.53 154.1 26.44 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-O 121.278 0.561 . . . . 0.0 112.404 -179.59 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.568 ' HB2' HD13 ' A' ' 32' ' ' LEU . 43.1 t . . . . . 0 N--CA 1.476 0.859 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.773 -174.743 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 16.5 tpt180 . . . . . 0 N--CA 1.466 0.36 0 CA-C-O 122.01 0.909 . . . . 0.0 110.246 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.472 ' O ' ' HA ' ' A' ' 17' ' ' ALA . 61.2 t -128.11 132.24 68.65 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 CA-C-N 114.456 -1.247 . . . . 0.0 109.64 -178.595 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 84.2 m95 -115.58 136.15 53.36 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 -172.991 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.568 HD13 ' HB2' ' A' ' 18' ' ' CYS . 8.8 mp -113.53 144.53 42.69 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.633 172.138 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 6.5 tp60 -103.92 119.84 39.77 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.272 -179.258 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.661 HG12 HG12 ' A' ' 41' ' ' VAL . 50.7 mt -75.0 114.46 35.12 Favored Pre-proline 0 CA--C 1.54 0.566 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.956 177.432 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.565 ' HG2' ' OG1' ' A' ' 38' ' ' THR . 91.3 Cg_endo -77.92 132.34 11.71 Favored 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 122.475 2.117 . . . . 0.0 112.356 178.553 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -77.32 -7.72 56.49 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 120.836 0.351 . . . . 0.0 111.341 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -68.03 -56.01 10.48 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 121.028 0.442 . . . . 0.0 110.89 172.488 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.565 ' OG1' ' HG2' ' A' ' 35' ' ' PRO . 47.9 p -80.64 -43.26 20.75 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.157 177.874 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 103.07 -0.19 47.86 Favored Glycine 0 CA--C 1.524 0.617 0 CA-C-N 115.56 -0.745 . . . . 0.0 112.811 -178.279 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.542 ' HB3' HG22 ' A' ' 51' ' ' VAL . 65.9 p-90 -161.2 161.24 30.84 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 -176.288 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.661 HG12 HG12 ' A' ' 34' ' ' ILE . 9.8 p -146.76 133.39 13.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.231 169.929 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -111.39 140.45 45.97 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -174.604 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.528 ' HB3' ' SG ' ' A' ' 48' ' ' CYS . 43.8 t -74.41 112.87 19.1 Favored Pre-proline 0 CA--C 1.537 0.452 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.623 178.516 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -58.35 -14.39 20.07 Favored 'Trans proline' 0 CA--C 1.542 0.911 0 C-N-CA 122.695 2.263 . . . . 0.0 113.404 -178.645 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -87.18 -51.35 6.03 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.705 -177.733 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 52.4 t -103.27 -3.7 25.29 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -178.06 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 49.8 m-20 65.76 10.67 6.99 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.115 0.566 . . . . 0.0 112.373 179.739 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.528 ' SG ' ' HB3' ' A' ' 43' ' ' CYS . 6.4 p -73.85 116.85 14.94 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 121.145 0.498 . . . . 0.0 111.515 179.553 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 18.3 ttmm -91.88 113.12 25.3 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.79 -177.166 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -97.38 103.34 15.26 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 120.988 0.423 . . . . 0.0 111.921 -175.713 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.542 HG22 ' HB3' ' A' ' 40' ' ' TRP . 78.5 t -82.55 142.87 13.04 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.662 175.397 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.512 ' HB2' HG21 ' A' ' 34' ' ' ILE . 68.6 tp -89.41 124.93 34.91 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 120.91 0.386 . . . . 0.0 111.7 178.269 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 8.5 tmtm? -71.05 122.89 20.88 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 174.991 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 97.19 52.54 1.46 Allowed Glycine 0 CA--C 1.526 0.732 0 N-CA-C 111.749 -0.54 . . . . 0.0 111.749 -172.067 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.479 ' H ' ' HB3' ' A' ' 58' ' ' ASP . 51.6 p -155.31 -178.49 7.3 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.516 0.674 . . . . 0.0 111.75 -176.341 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 32.4 ttpt -67.68 -15.23 63.54 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-N 115.322 -0.854 . . . . 0.0 112.059 179.411 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -99.99 2.34 43.4 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 121.202 0.525 . . . . 0.0 111.667 176.736 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.479 ' HB3' ' H ' ' A' ' 55' ' ' SER . 16.4 t70 . . . . . 0 CA--C 1.547 0.846 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.73 -177.472 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 . . . . . 0 N--CA 1.475 0.777 0 CA-C-O 121.23 0.538 . . . . 0.0 112.313 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 80.1 m -99.45 107.3 19.47 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.926 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 6.8 mtpm? -102.81 93.46 5.08 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.158 0.504 . . . . 0.0 110.372 -175.181 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.429 ' HA ' ' O ' ' A' ' 51' ' ' VAL . 62.3 mt -78.28 99.37 2.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.061 -178.666 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 35.6 m -105.67 160.24 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-N 115.753 -0.658 . . . . 0.0 112.062 -174.906 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -91.19 1.14 57.32 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 120.757 0.313 . . . . 0.0 111.65 178.293 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -115.62 153.39 31.36 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 120.826 0.346 . . . . 0.0 111.63 -176.15 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 42.8 m -89.35 -22.77 22.45 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 116.517 -0.311 . . . . 0.0 111.161 176.676 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 68.8 mtt180 -114.38 114.6 26.09 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 120.918 0.39 . . . . 0.0 111.372 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 47.2 t -124.28 138.16 54.78 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.657 -177.386 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.0 102.11 7.23 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 120.964 0.411 . . . . 0.0 111.641 178.452 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.478 ' SG ' ' HB2' ' A' ' 43' ' ' CYS . 51.5 t . . . . . 0 C--N 1.326 -0.426 0 CA-C-O 121.398 0.618 . . . . 0.0 111.629 177.652 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 1.1 mmm180 . . . . . 0 N--CA 1.44 -0.952 0 CA-C-O 123.093 1.425 . . . . 0.0 112.563 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.476 HG23 ' HB3' ' A' ' 18' ' ' CYS . 17.8 m -119.8 125.02 73.89 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 CA-C-N 112.494 -2.139 . . . . 0.0 110.959 -179.464 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 39.5 m95 -101.84 114.53 28.69 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.078 0.466 . . . . 0.0 111.182 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 10.5 mp -92.81 150.73 20.43 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.654 -179.354 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 50.8 tp60 -104.39 124.95 50.14 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.791 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.526 HG21 ' HB2' ' A' ' 52' ' ' LEU . 74.7 mt -84.21 114.47 54.76 Favored Pre-proline 0 CA--C 1.542 0.65 0 CA-C-N 116.642 -0.254 . . . . 0.0 110.381 172.391 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -84.92 143.23 9.26 Favored 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 122.704 2.269 . . . . 0.0 113.235 -177.268 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.426 ' O ' ' NZ ' ' A' ' 56' ' ' LYS . 16.4 mm-40 -69.5 -3.81 16.17 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 121.117 0.484 . . . . 0.0 111.066 171.88 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -65.18 -62.86 1.29 Allowed 'General case' 0 CA--C 1.543 0.683 0 CA-C-O 121.034 0.445 . . . . 0.0 110.158 169.553 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 82.0 p -91.79 -48.88 6.56 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 115.758 -0.655 . . . . 0.0 112.037 -179.006 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 100.68 1.51 55.3 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 121.309 -0.472 . . . . 0.0 112.718 -175.993 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 60.2 p-90 -156.53 164.78 37.81 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 122.559 0.344 . . . . 0.0 111.39 -176.495 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 13.6 p -146.93 152.0 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 174.201 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -124.18 147.51 47.95 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 113.059 0.763 . . . . 0.0 113.059 -175.016 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.478 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 18.0 t -101.53 105.24 39.32 Favored Pre-proline 0 N--CA 1.468 0.432 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.274 174.226 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -77.17 -0.33 10.49 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 122.457 2.105 . . . . 0.0 113.123 -177.02 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -90.05 -67.71 0.83 Allowed 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 116.636 -0.256 . . . . 0.0 111.507 -176.923 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 49.4 t -104.26 6.07 35.17 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 111.869 0.322 . . . . 0.0 111.869 178.101 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 26.6 m-20 69.06 101.35 0.06 Allowed 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 175.29 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 52.0 m -161.69 120.8 2.43 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.135 175.075 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -100.4 110.84 23.05 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 120.753 0.311 . . . . 0.0 110.812 177.8 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 27.9 m-85 -91.57 107.13 18.99 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 120.638 0.256 . . . . 0.0 110.456 -177.19 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.429 ' O ' ' HA ' ' A' ' 10' ' ' ILE . 90.5 t -100.4 131.4 48.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 CA-C-O 120.726 0.298 . . . . 0.0 111.741 179.646 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.526 ' HB2' HG21 ' A' ' 34' ' ' ILE . 68.0 tp -81.54 119.42 23.75 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.096 0.475 . . . . 0.0 111.934 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.42 ' HB2' HG22 ' A' ' 10' ' ' ILE . 88.0 tttt -69.0 108.23 3.45 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.868 177.103 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 119.87 -13.59 10.63 Favored Glycine 0 CA--C 1.527 0.801 0 C-N-CA 121.412 -0.423 . . . . 0.0 112.542 -175.571 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 59.6 p -81.29 -176.57 6.06 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 120.93 0.395 . . . . 0.0 111.147 178.398 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.426 ' NZ ' ' O ' ' A' ' 36' ' ' GLU . 33.7 mtmm -73.07 -20.19 61.01 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.655 -0.248 . . . . 0.0 111.612 179.073 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -71.6 -49.61 38.67 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.287 0.565 . . . . 0.0 111.321 -175.46 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.4 t70 . . . . . 0 CA--C 1.536 0.429 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.867 177.927 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.608 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.6 OUTLIER . . . . . 0 N--CA 1.493 1.676 0 CA-C-O 120.77 0.319 . . . . 0.0 111.47 . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.445 ' O ' HG13 ' A' ' 3' ' ' ILE . 40.4 p -76.62 -3.09 35.94 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -177.177 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.445 HG13 ' O ' ' A' ' 2' ' ' THR . 2.6 pp 47.34 13.26 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.91 0 C-N-CA 123.826 0.85 . . . . 0.0 112.996 -172.362 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 71.2 mt-30 54.6 -165.08 0.1 Allowed 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 123.786 0.835 . . . . 0.0 112.725 177.545 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -150.58 88.39 4.63 Favored Pre-proline 0 N--CA 1.471 0.578 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -178.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -63.08 85.77 0.12 Allowed 'Trans proline' 0 CA--C 1.542 0.922 0 C-N-CA 122.4 2.067 . . . . 0.0 112.207 175.282 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -87.56 96.05 10.26 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.753 -177.331 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 57.2 m -75.52 127.53 33.3 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.305 179.502 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 85.2 mttt -141.18 123.41 15.68 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 120.993 0.425 . . . . 0.0 111.32 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.522 ' N ' HD12 ' A' ' 10' ' ' ILE . 2.8 mp -88.74 119.64 36.25 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.769 -178.042 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 15.0 t -105.97 154.69 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-O 121.028 0.442 . . . . 0.0 111.245 -178.319 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -80.93 -37.78 28.96 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 121.048 0.451 . . . . 0.0 110.727 -177.165 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -101.56 162.97 12.51 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.396 176.629 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 50.5 m -79.97 -40.89 27.06 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -177.254 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 18.5 ptt-85 -86.09 118.43 25.55 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 121.458 0.647 . . . . 0.0 110.813 177.299 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 39.5 t -111.47 125.02 68.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.988 -172.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.95 82.23 5.15 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 120.984 0.421 . . . . 0.0 111.341 176.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.577 ' HG ' ' HG ' ' A' ' 43' ' ' CYS . 41.9 t -84.54 178.71 7.6 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.17 0.51 . . . . 0.0 111.47 -179.719 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.633 ' HB3' ' HA ' ' A' ' 27' ' ' HIS . 31.4 m-20 -132.96 -66.35 0.67 Allowed 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 -177.626 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 162.92 -146.33 11.64 Favored Glycine 0 CA--C 1.526 0.734 0 C-N-CA 120.456 -0.878 . . . . 0.0 113.441 -178.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.891 ' HA2' ' HB2' ' A' ' 46' ' ' CYS . . . -96.62 -105.44 2.25 Favored Glycine 0 N--CA 1.467 0.719 0 C-N-CA 121.337 -0.459 . . . . 0.0 112.687 179.616 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.9 mp0 -75.11 162.77 28.23 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 122.607 -0.349 . . . . 0.0 110.408 170.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -45.0 -49.7 9.16 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 121.634 -0.317 . . . . 0.0 113.774 176.15 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -79.78 -3.0 45.76 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -178.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 83.1 mt -113.84 49.3 1.0 Allowed 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.581 0.705 . . . . 0.0 110.724 -179.242 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 126.46 -138.54 10.75 Favored Glycine 0 CA--C 1.524 0.617 0 CA-C-N 115.347 -0.842 . . . . 0.0 112.636 174.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.638 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 17.0 m-70 67.92 47.3 0.39 Allowed Pre-proline 0 CA--C 1.545 0.754 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 179.166 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.638 ' HD3' ' N ' ' A' ' 27' ' ' HIS . 42.9 Cg_endo -101.74 4.3 0.54 Allowed 'Trans proline' 0 CA--C 1.545 1.046 0 C-N-CA 122.884 2.389 . . . . 0.0 113.378 175.9 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.532 ' HB3' ' O ' ' A' ' 28' ' ' PRO . 1.1 tmt_? 77.06 99.13 0.07 Allowed 'General case' 0 C--N 1.346 0.421 0 CA-C-O 122.185 0.993 . . . . 0.0 109.006 -172.834 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.1 m -131.21 131.88 63.4 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 114.652 -1.158 . . . . 0.0 111.703 178.046 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 49.1 m95 -105.81 114.92 29.36 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.355 -178.077 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.461 ' HB3' HG21 ' A' ' 41' ' ' VAL . 6.4 mp -107.76 133.01 52.77 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 120.837 0.351 . . . . 0.0 111.421 179.249 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 54.9 tp60 -90.03 119.88 30.76 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 121.144 0.497 . . . . 0.0 111.958 -178.1 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.562 HG21 ' HB2' ' A' ' 52' ' ' LEU . 73.1 mt -79.93 118.17 71.08 Favored Pre-proline 0 CA--C 1.54 0.589 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.999 175.102 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.692 ' HG2' HG22 ' A' ' 38' ' ' THR . 97.2 Cg_endo -83.05 121.6 3.18 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 122.325 2.016 . . . . 0.0 112.868 178.811 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -56.5 -16.77 6.5 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-O 121.306 0.574 . . . . 0.0 111.427 175.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -61.69 -29.17 69.92 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 115.61 -0.723 . . . . 0.0 112.026 177.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.692 HG22 ' HG2' ' A' ' 35' ' ' PRO . 12.9 t -131.16 -38.82 1.2 Allowed 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 120.679 0.276 . . . . 0.0 111.415 178.179 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 107.42 2.45 35.34 Favored Glycine 0 CA--C 1.53 0.98 0 N-CA-C 115.419 0.928 . . . . 0.0 115.419 171.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.447 ' H ' HG23 ' A' ' 38' ' ' THR . 68.1 p-90 -144.8 164.96 29.46 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 118.271 1.035 . . . . 0.0 112.972 -176.022 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.461 HG21 ' HB3' ' A' ' 32' ' ' LEU . 9.9 p -147.92 143.94 19.31 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.244 171.118 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -116.64 141.51 48.11 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 -177.107 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.577 ' HG ' ' HG ' ' A' ' 18' ' ' CYS . 60.5 m -110.68 109.28 57.92 Favored Pre-proline 0 N--CA 1.473 0.716 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.163 173.07 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -69.06 15.61 0.19 Allowed 'Trans proline' 0 CA--C 1.549 1.24 0 C-N-CA 123.079 2.519 . . . . 0.0 115.511 -167.181 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -96.13 -72.21 0.64 Allowed 'General case' 0 N--CA 1.473 0.698 0 O-C-N 121.925 -0.485 . . . . 0.0 110.919 177.024 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.891 ' HB2' ' HA2' ' A' ' 21' ' ' GLY . 43.1 t -86.94 3.8 44.23 Favored 'General case' 0 N--CA 1.475 0.822 0 O-C-N 122.218 -0.301 . . . . 0.0 111.58 169.676 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 56.48 31.29 18.63 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 121.379 0.609 . . . . 0.0 112.0 -178.57 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 61.9 m -64.95 110.93 2.62 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.123 176.588 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 84.2 tttt -98.62 102.38 14.1 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 121.08 0.466 . . . . 0.0 110.659 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -87.33 116.62 25.54 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.465 -175.611 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.465 ' O ' ' HA ' ' A' ' 10' ' ' ILE . 77.8 t -96.9 139.53 19.34 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.07 177.194 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.562 ' HB2' HG21 ' A' ' 34' ' ' ILE . 51.7 tp -77.4 131.78 38.19 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 121.221 0.534 . . . . 0.0 111.667 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -53.43 110.38 0.55 Allowed 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -179.022 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 85.68 2.32 86.9 Favored Glycine 0 CA--C 1.527 0.787 0 C-N-CA 121.191 -0.528 . . . . 0.0 113.821 176.442 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.412 ' HB2' ' HB3' ' A' ' 52' ' ' LEU . 40.8 t -70.15 174.8 5.08 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.049 0.452 . . . . 0.0 111.776 179.387 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -67.69 -23.91 65.35 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 121.075 0.464 . . . . 0.0 111.075 179.485 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -74.18 -18.46 60.77 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 121.045 0.45 . . . . 0.0 110.893 172.565 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -101.06 29.67 4.52 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-O 121.578 0.704 . . . . 0.0 110.148 177.354 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -93.25 13.05 22.43 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.81 -178.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.457 ' N ' HD12 ' A' ' 60' ' ' LEU . 6.3 mp -83.19 -160.67 0.43 Allowed 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.447 177.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.421 ' HB2' ' O ' ' A' ' 60' ' ' LEU . 23.6 mm-40 69.3 -75.57 0.07 Allowed 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 120.921 0.391 . . . . 0.0 110.854 -177.273 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 17.9 p-80 -164.93 142.76 6.29 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 120.898 0.38 . . . . 0.0 111.072 -179.48 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 25.5 m170 -79.19 178.62 7.93 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 121.444 0.64 . . . . 0.0 112.545 -176.096 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 7.3 p80 -151.17 -52.28 0.13 Allowed 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.665 -179.416 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 86.5 t60 61.18 2.84 0.64 Allowed 'General case' 0 N--CA 1.48 1.025 0 N-CA-C 114.77 1.396 . . . . 0.0 114.77 167.535 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 33.3 p80 44.6 -164.19 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.256 0 CA-C-N 118.38 0.536 . . . . 0.0 111.553 -173.032 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 25.0 p-80 . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.647 -0.692 . . . . 0.0 111.098 174.63 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.0 mtt . . . . . 0 N--CA 1.488 1.425 0 CA-C-O 121.024 0.44 . . . . 0.0 110.885 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 67.9 p -115.9 153.56 31.33 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 121.051 0.453 . . . . 0.0 111.394 178.801 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 60.6 mt -95.54 -26.81 4.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-O 121.203 0.525 . . . . 0.0 109.921 171.407 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 66.51 -76.74 0.05 OUTLIER 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.024 -178.562 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 62.24 103.16 0.03 OUTLIER Pre-proline 0 N--CA 1.471 0.599 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 175.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -60.03 87.83 0.07 OUTLIER 'Trans proline' 0 CA--C 1.539 0.73 0 C-N-CA 122.267 1.978 . . . . 0.0 112.337 175.181 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -43.03 124.87 3.36 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.364 0.602 . . . . 0.0 112.243 178.771 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 97.3 m -89.72 136.19 33.18 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.786 -179.107 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 45.1 tttp -127.65 116.75 20.78 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 120.636 0.255 . . . . 0.0 110.829 -175.587 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 44.5 mm -86.3 112.37 22.63 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-O 120.989 0.423 . . . . 0.0 111.199 -178.387 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 35.7 m -113.33 164.53 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -178.141 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -105.41 -6.3 19.65 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-O 121.057 0.456 . . . . 0.0 111.424 179.722 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 68.6 mmtt -120.04 144.37 47.59 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.094 0.473 . . . . 0.0 111.856 -179.015 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 34.7 m -72.83 -21.06 61.02 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.603 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 80.4 mtt-85 -102.4 111.75 24.17 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-O 121.241 0.543 . . . . 0.0 110.634 177.049 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 36.7 t -119.96 131.2 73.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.851 -175.521 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.501 ' HB2' ' CE2' ' A' ' 31' ' ' TRP . . . -74.91 139.57 43.17 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 121.122 0.487 . . . . 0.0 111.742 177.427 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 53.0 t -127.46 71.36 1.34 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.146 0.498 . . . . 0.0 110.534 177.319 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -69.29 -75.21 0.11 Allowed 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.723 -178.281 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 161.79 -176.08 38.28 Favored Glycine 0 CA--C 1.521 0.466 0 C-N-CA 120.119 -1.039 . . . . 0.0 113.975 177.671 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -110.61 -102.16 2.68 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 112.244 -0.342 . . . . 0.0 112.244 178.002 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 44.2 mm-40 -67.06 167.37 12.02 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 116.778 0.289 . . . . 0.0 111.403 176.503 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -44.04 -54.79 5.95 Favored Glycine 0 CA--C 1.53 0.972 0 N-CA-C 114.267 0.467 . . . . 0.0 114.267 -179.513 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.74 -29.26 70.0 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 120.969 0.414 . . . . 0.0 112.009 179.63 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 85.6 mt -89.9 1.27 56.42 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.285 179.184 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -76.45 107.51 2.37 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 121.165 -0.54 . . . . 0.0 113.241 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 28.1 m80 -94.85 152.12 39.46 Favored Pre-proline 0 CA--C 1.544 0.725 0 O-C-N 122.623 -0.339 . . . . 0.0 110.192 177.705 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_exo -52.42 -69.79 0.06 OUTLIER 'Trans proline' 0 CA--C 1.544 0.981 0 C-N-CA 122.642 2.228 . . . . 0.0 114.199 -176.011 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 4.4 tmt_? 179.28 92.27 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.25 0 CA-C-O 121.941 0.876 . . . . 0.0 109.56 -179.319 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 28.7 m -122.36 134.89 64.21 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 CA-C-N 114.846 -1.07 . . . . 0.0 111.486 178.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.501 ' CE2' ' HB2' ' A' ' 17' ' ' ALA . 15.7 m95 -116.27 127.35 54.65 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 120.787 0.327 . . . . 0.0 111.114 179.679 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.7 mp -92.08 151.93 20.19 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 121.179 0.514 . . . . 0.0 111.544 -178.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -110.2 108.98 19.31 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.019 -179.258 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.556 HG12 HG12 ' A' ' 41' ' ' VAL . 75.8 mt -71.62 122.3 86.81 Favored Pre-proline 0 CA--C 1.542 0.641 0 CA-C-N 116.634 -0.257 . . . . 0.0 111.481 179.336 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.488 ' HG2' ' OG1' ' A' ' 38' ' ' THR . 44.7 Cg_endo -86.31 127.11 2.83 Favored 'Trans proline' 0 CA--C 1.54 0.811 0 C-N-CA 122.95 2.434 . . . . 0.0 112.709 176.878 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -59.22 -21.97 60.34 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 121.43 0.633 . . . . 0.0 110.792 177.288 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -59.11 -31.7 69.16 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 115.234 -0.893 . . . . 0.0 111.742 178.017 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.488 ' OG1' ' HG2' ' A' ' 35' ' ' PRO . 44.8 p -113.92 -47.44 2.96 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.308 0.575 . . . . 0.0 110.975 178.695 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.547 ' HA3' ' H ' ' A' ' 57' ' ' ALA . . . 100.2 1.08 55.84 Favored Glycine 0 CA--C 1.525 0.676 0 CA-C-N 115.874 -0.603 . . . . 0.0 112.782 -178.198 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 58.5 p-90 -155.46 162.27 40.77 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.088 0.471 . . . . 0.0 111.388 -177.1 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.556 HG12 HG12 ' A' ' 34' ' ' ILE . 14.2 p -148.67 126.45 2.95 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 CA-C-O 120.992 0.425 . . . . 0.0 110.62 172.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.422 ' HA ' ' HA ' ' A' ' 49' ' ' LYS . 16.7 pt-20 -94.39 143.01 26.77 Favored 'General case' 0 CA--C 1.535 0.398 0 O-C-N 122.124 -0.36 . . . . 0.0 111.035 179.437 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 37.0 t -71.55 130.99 86.68 Favored Pre-proline 0 N--CA 1.468 0.435 0 N-CA-C 111.825 0.305 . . . . 0.0 111.825 179.308 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -76.59 0.46 9.51 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 122.406 2.07 . . . . 0.0 113.077 179.351 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -99.87 -87.64 0.36 Allowed 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 111.687 0.254 . . . . 0.0 111.687 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 42.0 t -169.78 22.27 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 111.827 0.306 . . . . 0.0 111.827 -179.103 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -87.75 -88.23 0.14 Allowed 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -173.42 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 73.7 m -155.31 179.19 9.4 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-O 121.596 0.712 . . . . 0.0 112.627 -177.33 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.422 ' HA ' ' HA ' ' A' ' 42' ' ' GLU . 40.3 ttmt -111.5 120.31 41.71 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.959 174.324 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 46.2 m-85 -103.27 116.48 32.53 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 111.922 0.342 . . . . 0.0 111.922 -170.165 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 85.9 t -105.08 135.47 42.96 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 CA-C-O 120.946 0.403 . . . . 0.0 111.513 178.531 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.438 ' HB2' HG21 ' A' ' 34' ' ' ILE . 53.0 tp -87.44 122.16 30.81 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 121.154 0.502 . . . . 0.0 111.711 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.442 ' HD3' ' N ' ' A' ' 54' ' ' GLY . 4.2 tmtm? -67.72 127.9 34.5 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.365 179.185 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.442 ' N ' ' HD3' ' A' ' 53' ' ' LYS . . . 87.52 12.62 66.76 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 121.391 -0.433 . . . . 0.0 112.886 -175.839 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.7 t -110.23 -173.4 2.24 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 122.552 -0.381 . . . . 0.0 111.34 178.521 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 61.6 tttp -57.1 -47.76 80.26 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -176.407 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.547 ' H ' ' HA3' ' A' ' 39' ' ' GLY . . . -73.99 -13.91 60.95 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 112.543 0.571 . . . . 0.0 112.543 -177.42 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -72.28 84.98 1.07 Allowed 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 121.529 0.681 . . . . 0.0 111.04 -179.756 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -155.78 18.95 0.39 Allowed 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.777 176.139 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.6 pp -128.06 14.58 6.8 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -175.468 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -57.4 134.44 56.03 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 121.217 0.532 . . . . 0.0 111.739 -177.293 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 56.0 m80 -92.33 113.48 25.77 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.626 -177.457 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 54.6 m-70 -84.48 73.7 10.48 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 116.646 -0.252 . . . . 0.0 111.023 -178.621 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 33.9 m170 71.46 -47.86 0.67 Allowed 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.267 0.627 . . . . 0.0 112.119 -176.386 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 46.0 t-80 -49.59 124.67 9.91 Favored 'General case' 0 CA--C 1.539 0.558 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 -179.307 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 36.0 t60 -118.2 -50.86 2.45 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.478 176.289 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 85.2 t60 . . . . . 0 C--O 1.247 0.932 0 CA-C-O 118.977 -0.535 . . . . 0.0 111.408 176.356 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.7 tpt . . . . . 0 N--CA 1.489 1.499 0 N-CA-C 111.961 0.356 . . . . 0.0 111.961 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.441 ' C ' ' H ' ' A' ' 4' ' ' GLN . 3.1 m -128.68 14.29 6.46 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-O 121.003 0.43 . . . . 0.0 111.216 -178.035 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 58.3 mt 70.08 -22.9 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 123.056 0.543 . . . . 0.0 112.055 -176.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.441 ' H ' ' C ' ' A' ' 2' ' ' THR . 75.0 mt-30 63.68 16.03 9.41 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.112 0.565 . . . . 0.0 111.17 -175.281 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -153.45 52.23 0.8 Allowed Pre-proline 0 CA--C 1.544 0.732 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.411 178.517 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -65.91 91.23 0.25 Allowed 'Trans proline' 0 C--N 1.355 0.906 0 C-N-CA 122.296 1.997 . . . . 0.0 112.167 -177.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 62.94 17.67 10.23 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-O 122.317 1.056 . . . . 0.0 110.54 -177.854 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 91.0 m -123.2 110.56 15.4 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.48 -1.236 . . . . 0.0 110.003 -177.188 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 5.7 tmtt? -102.6 115.4 30.51 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.787 0.327 . . . . 0.0 110.819 -172.545 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.513 HD12 ' N ' ' A' ' 10' ' ' ILE . 2.5 mp -82.02 101.24 6.61 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.88 -177.533 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.41 HG21 HD11 ' A' ' 34' ' ' ILE . 35.7 m -102.67 167.93 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 CA-C-O 120.963 0.411 . . . . 0.0 111.874 -178.788 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -104.63 -20.61 13.6 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -176.361 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -130.33 165.0 23.42 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 121.019 0.438 . . . . 0.0 112.097 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.9 m -81.57 -37.89 26.98 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 112.67 0.619 . . . . 0.0 112.67 -174.719 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 28.9 tpt180 -87.27 105.23 17.09 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 122.117 -0.364 . . . . 0.0 110.642 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 58.9 t -131.05 135.03 60.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 N-CA-C 112.211 0.448 . . . . 0.0 112.211 -173.28 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -76.09 112.53 12.63 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.044 0.449 . . . . 0.0 110.237 172.46 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.679 ' HB2' HD13 ' A' ' 32' ' ' LEU . 58.3 m -119.46 -164.93 1.1 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.22 -174.26 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.635 ' HB3' ' CD2' ' A' ' 27' ' ' HIS . 2.4 m-20 65.73 4.58 2.94 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 175.142 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 161.08 174.36 30.83 Favored Glycine 0 CA--C 1.527 0.794 0 C-N-CA 120.281 -0.961 . . . . 0.0 113.517 175.031 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 173.72 14.8 0.02 OUTLIER Glycine 0 CA--C 1.534 1.24 0 C-N-CA 120.55 -0.833 . . . . 0.0 114.58 177.434 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -98.98 -152.76 0.42 Allowed 'General case' 0 CA--C 1.548 0.883 0 CA-C-N 117.693 0.746 . . . . 0.0 111.539 -178.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -43.54 -48.64 7.19 Favored Glycine 0 CA--C 1.533 1.183 0 N-CA-C 114.991 0.757 . . . . 0.0 114.991 -176.551 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -105.35 20.77 18.32 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 122.219 -0.577 . . . . 0.0 111.043 177.853 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.61 HD13 ' HD3' ' A' ' 29' ' ' ARG . 91.1 mt 59.31 23.64 12.09 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 115.663 -0.699 . . . . 0.0 112.052 -178.497 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 65.07 -101.34 0.54 Allowed Glycine 0 CA--C 1.523 0.534 0 C-N-CA 121.248 -0.501 . . . . 0.0 112.02 -176.822 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.635 ' CD2' ' HB3' ' A' ' 19' ' ' ASP . 0.2 OUTLIER -92.81 133.81 28.58 Favored Pre-proline 0 CA--C 1.537 0.45 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 169.982 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.516 ' O ' ' HB2' ' A' ' 29' ' ' ARG . 20.4 Cg_exo -17.49 -57.71 0.02 OUTLIER 'Trans proline' 0 CA--C 1.545 1.033 0 C-N-CA 124.979 3.786 . . . . 0.0 115.816 -165.516 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.61 ' HD3' HD13 ' A' ' 25' ' ' LEU . 23.3 tpt180 172.2 88.98 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.667 0.746 . . . . 0.0 110.024 172.354 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.404 ' HB ' ' HB2' ' A' ' 19' ' ' ASP . 27.1 t -100.47 125.98 54.16 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.759 -173.62 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 61.2 m95 -105.53 115.66 30.63 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 121.026 0.441 . . . . 0.0 111.418 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.679 HD13 ' HB2' ' A' ' 18' ' ' CYS . 9.0 mp -98.04 172.2 7.77 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.307 0.575 . . . . 0.0 111.678 -179.452 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 58.1 tp60 -137.64 116.41 12.25 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.528 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.546 HG12 HG12 ' A' ' 41' ' ' VAL . 68.4 mt -68.56 120.21 73.84 Favored Pre-proline 0 CA--C 1.539 0.539 0 CA-C-N 116.686 -0.234 . . . . 0.0 111.209 177.141 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.576 ' HG2' ' OG1' ' A' ' 38' ' ' THR . 74.0 Cg_endo -75.21 110.98 3.21 Favored 'Trans proline' 0 CA--C 1.535 0.561 0 C-N-CA 122.412 2.075 . . . . 0.0 111.67 176.539 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -54.93 -21.56 12.07 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 116.079 -0.51 . . . . 0.0 112.242 -176.554 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -61.14 -46.95 88.45 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-O 120.665 0.269 . . . . 0.0 111.247 173.439 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.576 ' OG1' ' HG2' ' A' ' 35' ' ' PRO . 29.2 p -89.03 -50.21 6.3 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 120.841 0.353 . . . . 0.0 111.521 -177.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 103.45 1.82 47.2 Favored Glycine 0 CA--C 1.527 0.792 0 C-N-CA 121.202 -0.523 . . . . 0.0 112.71 -176.585 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 63.6 p-90 -152.63 158.99 43.22 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 120.951 0.405 . . . . 0.0 112.006 -177.491 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.546 HG12 HG12 ' A' ' 34' ' ' ILE . 14.9 p -145.17 126.67 8.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-O 120.926 0.394 . . . . 0.0 110.269 174.071 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.588 ' HA ' ' HA ' ' A' ' 49' ' ' LYS . 10.5 pt-20 -103.66 152.67 21.51 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.234 0.54 . . . . 0.0 112.416 -177.2 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 6.4 t -69.61 134.13 88.55 Favored Pre-proline 0 N--CA 1.471 0.608 0 CA-C-N 115.705 -0.68 . . . . 0.0 112.174 -176.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -78.46 -5.94 15.19 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 122.739 2.292 . . . . 0.0 112.767 178.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -108.96 -93.58 0.42 Allowed 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 -179.707 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 48.7 t -144.46 9.9 1.42 Allowed 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 112.948 0.722 . . . . 0.0 112.948 -169.101 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -90.14 -107.39 0.09 Allowed 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 112.959 0.726 . . . . 0.0 112.959 -172.217 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 72.0 m -152.33 -179.74 7.82 Favored 'General case' 0 N--CA 1.477 0.902 0 O-C-N 121.692 -0.63 . . . . 0.0 112.475 -174.484 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.588 ' HA ' ' HA ' ' A' ' 42' ' ' GLU . 36.8 ttpt -106.74 125.64 51.26 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.291 177.051 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 36.4 m-85 -99.77 113.24 25.6 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 120.763 0.316 . . . . 0.0 111.144 -175.143 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 99.9 t -99.04 131.6 45.97 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 CA-C-O 121.101 0.477 . . . . 0.0 111.898 179.34 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 59.9 tp -78.11 118.15 20.08 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.543 179.544 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.484 ' HB2' HG23 ' A' ' 10' ' ' ILE . 47.4 tttp -74.33 151.22 39.82 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 121.124 0.488 . . . . 0.0 111.203 178.528 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.79 14.6 81.86 Favored Glycine 0 CA--C 1.527 0.799 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.07 -174.397 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 48.3 t -116.5 -177.48 3.19 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.2 0.524 . . . . 0.0 111.532 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 50.6 mtpt -60.52 -34.76 74.58 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.639 -179.368 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -86.18 8.89 19.24 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 -178.42 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -89.81 3.23 53.54 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-O 121.182 0.515 . . . . 0.0 111.859 -179.576 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -143.31 87.2 1.94 Allowed 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 121.442 0.639 . . . . 0.0 111.187 178.458 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.466 ' N ' HD12 ' A' ' 60' ' ' LEU . 5.2 mp -85.37 17.94 2.91 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.867 -178.539 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -90.37 149.01 22.47 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.193 0.52 . . . . 0.0 111.757 -179.081 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 76.2 t60 -90.26 -38.51 13.37 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.978 171.621 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 32.5 t-80 -171.91 100.05 0.17 Allowed 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.789 -0.642 . . . . 0.0 111.296 178.029 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 79.5 t60 -156.18 -80.91 0.07 Allowed 'General case' 0 CA--C 1.537 0.463 0 O-C-N 122.415 -0.178 . . . . 0.0 110.937 176.156 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 54.4 t-80 -124.51 74.98 1.36 Allowed 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 121.322 0.582 . . . . 0.0 111.792 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 34.1 m170 -88.2 -14.99 37.18 Favored 'General case' 0 CA--C 1.54 0.562 0 O-C-N 122.157 -0.339 . . . . 0.0 110.805 173.504 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 19.7 t-80 . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.676 -0.678 . . . . 0.0 111.113 177.028 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.456 ' HG3' ' H ' ' A' ' 3' ' ' ILE . 26.5 ptt? . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 112.176 0.436 . . . . 0.0 112.176 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.419 HG22 ' O ' ' A' ' 2' ' ' THR . 5.6 m 58.94 10.7 1.63 Allowed 'General case' 0 N--CA 1.482 1.129 0 CA-C-O 121.123 0.487 . . . . 0.0 112.206 179.0 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.499 ' O ' HG22 ' A' ' 3' ' ' ILE . 36.1 mt 61.87 8.14 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.024 0 C-N-CA 123.036 0.535 . . . . 0.0 111.609 -176.011 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 62.83 -71.61 0.05 Allowed 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.243 0.617 . . . . 0.0 111.868 -176.307 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 66.57 82.62 0.2 Allowed Pre-proline 0 CA--C 1.542 0.64 0 C-N-CA 123.472 0.709 . . . . 0.0 112.684 179.013 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.84 69.88 2.9 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 122.286 1.991 . . . . 0.0 111.554 173.816 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -67.24 117.9 9.9 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 115.868 -0.605 . . . . 0.0 112.409 -173.768 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 23.3 m -98.01 125.81 43.13 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.017 176.284 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 24.4 tptp -121.8 110.72 16.25 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 120.816 0.341 . . . . 0.0 110.558 -178.258 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 55.5 mt -77.19 104.41 5.13 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-O 120.909 0.385 . . . . 0.0 111.236 -177.512 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 34.5 m -95.06 155.75 3.25 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-O 121.067 0.461 . . . . 0.0 111.439 179.482 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -82.19 -37.09 26.59 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.807 -175.133 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 46.5 mmtm -118.94 167.18 11.98 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 121.212 0.529 . . . . 0.0 112.273 -177.458 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 18.6 m -68.64 -34.65 76.1 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -174.816 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.457 ' HA ' ' O ' ' A' ' 32' ' ' LEU . 16.6 ptt180 -98.64 135.36 40.25 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.231 0.538 . . . . 0.0 111.668 -179.27 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 48.7 t -129.34 122.96 56.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.277 -178.473 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -74.78 94.03 2.69 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.12 0.486 . . . . 0.0 110.678 176.409 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.423 ' SG ' HD13 ' A' ' 32' ' ' LEU . 85.8 m -92.24 60.46 3.7 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.93 0.395 . . . . 0.0 111.657 -176.026 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -55.4 -62.67 1.52 Allowed 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.048 177.222 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.451 ' HA2' ' SG ' ' A' ' 46' ' ' CYS . . . 162.56 -158.28 30.4 Favored Glycine 0 CA--C 1.523 0.546 0 C-N-CA 121.155 -0.545 . . . . 0.0 112.738 178.701 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -80.31 -105.89 0.28 Allowed Glycine 0 CA--C 1.526 0.734 0 C-N-CA 121.093 -0.575 . . . . 0.0 112.476 177.686 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -64.72 156.57 29.99 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 122.515 -0.403 . . . . 0.0 110.868 174.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -43.79 -54.6 5.81 Favored Glycine 0 CA--C 1.534 1.243 0 N-CA-C 114.148 0.419 . . . . 0.0 114.148 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -66.56 -22.79 66.15 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 69.6 mt -87.14 0.74 54.82 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 120.887 0.375 . . . . 0.0 111.401 -179.275 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -82.31 162.63 42.23 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 121.168 -0.539 . . . . 0.0 113.833 -178.173 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.471 ' HB3' ' HD2' ' A' ' 28' ' ' PRO . 61.4 m80 -99.53 165.06 15.42 Favored Pre-proline 0 CA--C 1.545 0.771 0 C-N-CA 122.901 0.48 . . . . 0.0 110.084 178.144 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.471 ' HD2' ' HB3' ' A' ' 27' ' ' HIS . 59.7 Cg_exo -38.85 -65.3 0.17 Allowed 'Trans proline' 0 C--N 1.357 1.002 0 C-N-CA 123.205 2.603 . . . . 0.0 114.329 -178.245 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.438 ' HB2' ' O ' ' A' ' 28' ' ' PRO . 21.8 tpt180 174.48 89.94 0.0 OUTLIER 'General case' 0 C--O 1.236 0.356 0 CA-C-O 121.814 0.816 . . . . 0.0 110.089 177.531 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 30.0 m -112.84 121.67 65.54 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 CA-C-N 115.062 -0.972 . . . . 0.0 112.395 -177.176 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 69.5 m95 -106.55 113.33 26.78 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.885 177.31 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.457 ' O ' ' HA ' ' A' ' 15' ' ' ARG . 8.1 mp -86.38 144.72 27.19 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 120.878 0.371 . . . . 0.0 110.977 179.14 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 54.2 tp60 -115.91 116.35 27.82 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.059 -177.267 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.434 HG12 HG12 ' A' ' 41' ' ' VAL . 61.9 mt -76.48 126.41 86.27 Favored Pre-proline 0 CA--C 1.539 0.535 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -179.065 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.555 ' HG2' ' OG1' ' A' ' 38' ' ' THR . 57.1 Cg_endo -86.78 132.45 3.43 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 122.87 2.38 . . . . 0.0 112.092 173.645 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -66.04 -25.62 67.14 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 121.941 -0.474 . . . . 0.0 111.492 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -54.51 -56.48 18.46 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.134 0.492 . . . . 0.0 111.37 177.631 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.555 ' OG1' ' HG2' ' A' ' 35' ' ' PRO . 52.4 p -76.27 -47.82 22.39 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.407 0.622 . . . . 0.0 110.055 174.473 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 99.09 1.5 57.06 Favored Glycine 0 CA--C 1.524 0.621 0 CA-C-N 115.504 -0.771 . . . . 0.0 112.672 -178.747 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.528 ' HB3' HG22 ' A' ' 51' ' ' VAL . 63.7 p-90 -159.3 166.83 30.38 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 122.56 0.344 . . . . 0.0 110.911 -176.026 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.434 HG12 HG12 ' A' ' 34' ' ' ILE . 12.2 p -135.37 132.69 52.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-O 121.112 0.482 . . . . 0.0 111.399 176.219 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -92.01 112.11 23.91 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 121.148 0.499 . . . . 0.0 110.818 176.771 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 41.0 t -71.28 110.56 7.65 Favored Pre-proline 0 N--CA 1.471 0.576 0 CA-C-N 116.187 -0.461 . . . . 0.0 112.086 -178.132 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -71.55 -11.24 27.95 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 122.632 2.221 . . . . 0.0 112.425 177.464 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.451 ' HB3' ' CE1' ' A' ' 27' ' ' HIS . 78.4 m-85 -84.56 -42.7 15.21 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 115.956 -0.566 . . . . 0.0 112.007 -176.323 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.451 ' SG ' ' HA2' ' A' ' 20' ' ' GLY . 84.5 m -131.92 8.08 4.42 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 -178.013 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 57.7 78.26 0.24 Allowed 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 176.014 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 91.2 m -152.46 147.31 26.1 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.944 177.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -99.63 106.47 18.43 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 120.651 0.262 . . . . 0.0 111.091 178.55 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -91.74 111.69 23.32 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.55 0.214 . . . . 0.0 110.615 178.454 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.528 HG22 ' HB3' ' A' ' 40' ' ' TRP . 97.9 t -97.51 135.61 31.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-O 121.023 0.439 . . . . 0.0 111.58 -179.623 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.408 ' HB2' HG21 ' A' ' 34' ' ' ILE . 59.0 tp -75.42 130.95 39.8 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 116.171 -0.468 . . . . 0.0 112.029 -178.182 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 51.7 tttm -58.91 102.5 0.12 Allowed 'General case' 0 CA--C 1.542 0.645 0 CA-C-O 121.114 0.483 . . . . 0.0 111.443 174.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 117.6 -7.06 15.92 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 121.362 -0.447 . . . . 0.0 112.538 -176.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 12.4 t -65.81 151.92 45.55 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 177.27 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.47 -7.39 47.12 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 120.905 0.383 . . . . 0.0 111.477 174.062 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -72.19 -27.33 62.49 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 121.174 0.511 . . . . 0.0 110.402 170.066 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -85.43 -177.73 6.53 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.711 175.769 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 59.42 79.42 0.23 Allowed 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.333 0.587 . . . . 0.0 111.314 -179.492 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.5 ' N ' HD12 ' A' ' 60' ' ' LEU . 5.1 mp -79.35 3.08 19.3 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.903 -174.21 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -75.97 99.14 4.46 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-O 120.785 0.326 . . . . 0.0 110.139 178.195 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -95.98 9.29 41.21 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 -173.242 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 79.1 t60 -71.63 -15.34 62.24 Favored 'General case' 0 N--CA 1.471 0.599 0 O-C-N 121.602 -0.686 . . . . 0.0 110.028 173.309 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 45.2 m80 -69.56 96.36 0.92 Allowed 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.058 173.503 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 71.8 m80 -88.15 -63.13 1.35 Allowed 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 121.031 0.443 . . . . 0.0 110.542 176.127 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 28.8 p80 -125.34 22.01 7.84 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 121.278 0.561 . . . . 0.0 110.571 179.053 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 75.0 t60 . . . . . 0 C--O 1.251 1.164 0 CA-C-O 118.201 -0.904 . . . . 0.0 110.338 -179.299 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.55 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.434 0 CA-C-O 120.707 0.289 . . . . 0.0 111.305 . . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.431 HG22 ' N ' ' A' ' 3' ' ' ILE . 27.7 m -109.86 159.56 17.11 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 120.748 0.309 . . . . 0.0 111.002 -178.642 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.431 ' N ' HG22 ' A' ' 2' ' ' THR . 15.2 tt -69.94 13.96 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.208 0 CA-C-O 121.163 0.506 . . . . 0.0 112.282 177.402 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.418 ' H ' ' C ' ' A' ' 2' ' ' THR . 22.3 tm0? 63.25 92.76 0.06 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.739 0.815 . . . . 0.0 111.959 -179.203 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.404 ' N ' ' HD3' ' A' ' 6' ' ' PRO . . . -172.96 62.94 0.29 Allowed Pre-proline 0 CA--C 1.539 0.527 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.411 177.364 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.404 ' HD3' ' N ' ' A' ' 5' ' ' ALA . 5.5 Cg_exo -79.58 29.98 0.48 Allowed 'Trans proline' 0 CA--C 1.537 0.654 0 C-N-CA 123.25 2.633 . . . . 0.0 113.455 -175.018 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -75.35 75.79 2.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.197 0.522 . . . . 0.0 110.639 -179.495 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 66.5 m -98.39 141.78 30.83 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.786 -177.279 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 55.1 tptt -133.87 114.76 13.68 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.879 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 52.4 mt -88.64 105.34 15.63 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 CA-C-O 120.727 0.298 . . . . 0.0 111.013 -177.575 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.461 HG12 ' H ' ' A' ' 13' ' ' LYS . 2.4 t -102.67 147.79 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-O 120.884 0.373 . . . . 0.0 111.271 -176.877 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -89.23 -4.46 58.19 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 121.075 0.464 . . . . 0.0 111.183 -178.606 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.461 ' H ' HG12 ' A' ' 11' ' ' VAL . 67.5 mttm -131.89 152.25 51.17 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.051 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 21.1 m -80.39 -6.83 58.66 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 120.837 0.351 . . . . 0.0 111.611 179.076 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -95.16 114.64 26.46 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 120.942 0.401 . . . . 0.0 110.961 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 70.7 t -125.46 135.08 65.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 N-CA-C 113.056 0.762 . . . . 0.0 113.056 -171.718 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -104.37 110.3 22.49 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.525 173.817 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 66.2 m -107.85 177.66 4.75 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 122.515 0.326 . . . . 0.0 111.28 179.231 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.618 ' HB3' ' HA ' ' A' ' 27' ' ' HIS . 8.2 m-20 -127.06 66.0 1.29 Allowed 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 121.563 0.697 . . . . 0.0 112.621 178.236 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -174.22 120.05 0.77 Allowed Glycine 0 CA--C 1.527 0.82 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.343 176.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 149.37 -51.99 0.53 Allowed Glycine 0 CA--C 1.533 1.198 0 C-N-CA 119.827 -1.178 . . . . 0.0 115.78 177.701 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.418 ' HG3' HG12 ' A' ' 30' ' ' VAL . 78.7 mt-10 -94.93 169.19 10.31 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 113.191 0.811 . . . . 0.0 113.191 -170.597 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 40.58 -97.5 0.01 OUTLIER Glycine 0 CA--C 1.534 1.227 0 CA-C-N 115.523 -0.762 . . . . 0.0 114.582 -173.699 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -89.13 17.17 6.16 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 117.132 0.466 . . . . 0.0 111.507 178.438 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.6 pp 50.41 5.62 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 125.457 1.503 . . . . 0.0 114.14 -178.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -125.98 101.95 0.63 Allowed Glycine 0 CA--C 1.526 0.745 0 C-N-CA 121.021 -0.609 . . . . 0.0 113.654 -175.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.618 ' HA ' ' HB3' ' A' ' 19' ' ' ASP . 13.3 m-70 56.29 52.15 6.62 Favored Pre-proline 0 CA--C 1.548 0.9 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 176.382 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.582 ' HD3' ' N ' ' A' ' 27' ' ' HIS . 44.0 Cg_endo -102.76 13.37 0.33 Allowed 'Trans proline' 0 CA--C 1.545 1.059 0 C-N-CA 123.362 2.708 . . . . 0.0 113.405 177.757 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 64.25 86.93 0.12 Allowed 'General case' 0 N--CA 1.446 -0.646 0 CA-C-O 122.35 1.071 . . . . 0.0 110.909 -177.423 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.418 HG12 ' HG3' ' A' ' 22' ' ' GLU . 19.0 m -109.69 154.2 11.24 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.133 0 CA-C-N 113.97 -1.468 . . . . 0.0 111.453 -178.551 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 49.7 m95 -124.14 114.84 20.2 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 121.243 0.544 . . . . 0.0 112.136 -175.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.45 ' N ' HD12 ' A' ' 32' ' ' LEU . 6.1 mp -105.46 167.56 9.66 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.454 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 54.2 tp60 -130.25 113.51 14.51 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.336 179.103 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.595 HG21 ' HB2' ' A' ' 52' ' ' LEU . 76.2 mt -63.06 120.15 58.67 Favored Pre-proline 0 CA--C 1.541 0.597 0 CA-C-O 120.684 0.278 . . . . 0.0 111.397 -179.288 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.596 ' HG2' ' OG1' ' A' ' 38' ' ' THR . 83.5 Cg_endo -79.82 113.75 3.08 Favored 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 122.262 1.975 . . . . 0.0 112.022 177.82 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -60.89 -15.0 25.91 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 121.115 0.483 . . . . 0.0 111.542 -179.073 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -68.87 -29.51 67.83 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.568 174.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.596 ' OG1' ' HG2' ' A' ' 35' ' ' PRO . 34.6 p -103.25 -54.73 2.55 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 121.205 0.526 . . . . 0.0 110.445 175.151 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 113.13 -0.19 25.39 Favored Glycine 0 CA--C 1.526 0.727 0 CA-C-N 115.8 -0.636 . . . . 0.0 113.123 179.245 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 66.1 p-90 -166.45 162.44 16.91 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -177.341 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.565 HG12 HG12 ' A' ' 34' ' ' ILE . 11.3 p -153.77 133.55 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.346 174.846 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.47 ' HA ' ' HA ' ' A' ' 49' ' ' LYS . 0.5 OUTLIER -110.94 148.87 31.56 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.062 0.458 . . . . 0.0 111.866 -178.282 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.564 ' HB3' ' HB3' ' A' ' 47' ' ' ASP . 52.3 t -84.52 108.13 13.6 Favored Pre-proline 0 N--CA 1.466 0.364 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 171.018 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -65.06 -9.41 21.55 Favored 'Trans proline' 0 CA--C 1.54 0.794 0 C-N-CA 122.742 2.295 . . . . 0.0 113.476 -172.724 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -87.33 -89.9 0.12 Allowed 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 120.566 0.222 . . . . 0.0 111.575 -177.706 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 75.7 m -152.45 82.62 1.24 Allowed 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 120.956 0.408 . . . . 0.0 111.477 179.554 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.564 ' HB3' ' HB3' ' A' ' 43' ' ' CYS . 9.7 t70 -149.98 -90.22 0.07 Allowed 'General case' 0 CA--C 1.548 0.889 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.184 177.038 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 30.2 p 179.8 -176.92 0.34 Allowed 'General case' 0 N--CA 1.477 0.889 0 CA-C-O 121.106 0.479 . . . . 0.0 111.422 174.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.47 ' HA ' ' HA ' ' A' ' 42' ' ' GLU . 39.5 ttmt -106.54 120.27 41.48 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 123.036 0.534 . . . . 0.0 110.693 178.66 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -98.72 108.24 20.88 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.081 0.467 . . . . 0.0 111.868 -173.528 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 99.7 t -93.75 134.39 31.59 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.243 178.411 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.595 ' HB2' HG21 ' A' ' 34' ' ' ILE . 51.8 tp -79.18 120.7 24.07 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 121.304 0.573 . . . . 0.0 111.649 -178.8 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -77.4 118.18 19.61 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.948 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 88.38 55.48 2.19 Favored Glycine 0 CA--C 1.524 0.652 0 C-N-CA 121.035 -0.603 . . . . 0.0 111.64 -173.665 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 25.0 t -151.03 -150.99 0.37 Allowed 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 122.898 0.479 . . . . 0.0 110.985 -175.383 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -101.65 22.72 12.33 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 -177.65 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -129.51 -33.26 1.89 Allowed 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 121.415 0.626 . . . . 0.0 111.097 -175.556 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -74.94 68.7 1.82 Allowed 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.764 178.512 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -99.14 29.74 3.76 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.517 -179.613 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.456 ' N ' HD12 ' A' ' 60' ' ' LEU . 6.1 mp -76.3 80.08 3.06 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 121.019 0.438 . . . . 0.0 111.842 -177.586 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -84.63 93.31 8.36 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 121.395 0.616 . . . . 0.0 110.873 176.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 88.6 m-70 -139.17 97.7 3.36 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.982 177.028 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 71.0 t60 -70.61 84.77 0.62 Allowed 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 121.192 0.52 . . . . 0.0 110.127 174.746 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.408 ' O ' ' N ' ' A' ' 66' ' ' HIS . 2.6 t-160 -69.73 151.58 45.65 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.252 179.625 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' HIS . . . . . 0.507 ' O ' ' HB2' ' A' ' 66' ' ' HIS . 17.0 t60 -66.59 72.47 0.08 Allowed 'General case' 0 CA--C 1.545 0.754 0 CA-C-O 121.01 0.434 . . . . 0.0 111.297 -177.317 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.507 ' HB2' ' O ' ' A' ' 65' ' ' HIS . 41.0 t-80 161.19 -32.05 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.066 0.946 . . . . 0.0 110.173 -173.582 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 39.6 t-80 . . . . . 0 C--O 1.25 1.098 0 CA-C-O 118.916 -0.564 . . . . 0.0 111.876 -175.598 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.3 ptm . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 23.5 p -74.11 131.37 41.24 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.472 ' O ' ' HD2' ' A' ' 6' ' ' PRO . 25.1 pt -73.06 66.54 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 CA-C-O 121.979 0.895 . . . . 0.0 109.133 168.023 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -81.31 20.44 0.85 Allowed 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 115.243 -0.89 . . . . 0.0 113.249 -169.354 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.401 ' HB3' ' HD3' ' A' ' 6' ' ' PRO . . . -74.69 -47.22 5.29 Favored Pre-proline 0 CA--C 1.547 0.843 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 179.649 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.472 ' HD2' ' O ' ' A' ' 3' ' ' ILE . 83.6 Cg_exo -46.69 99.2 0.03 OUTLIER 'Trans proline' 0 C--N 1.36 1.16 0 C-N-CA 122.879 2.386 . . . . 0.0 114.526 -177.296 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -90.4 21.7 3.76 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 121.601 0.715 . . . . 0.0 110.574 173.435 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.435 ' HA ' ' O ' ' A' ' 49' ' ' LYS . 51.6 m -118.93 137.97 53.1 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 115.395 -0.821 . . . . 0.0 111.559 -172.351 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -134.92 129.9 35.03 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 120.766 0.317 . . . . 0.0 111.069 -176.627 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 59.9 mt -86.45 118.91 33.63 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 CA-C-O 121.079 0.466 . . . . 0.0 111.614 -179.203 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 35.3 m -109.52 163.41 6.62 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.964 176.503 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -92.17 -21.44 20.39 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -176.201 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -121.54 152.01 39.69 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 -176.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 48.7 m -70.28 -21.04 63.0 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 116.049 -0.523 . . . . 0.0 112.334 -178.315 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 80.7 mtp180 -87.6 111.83 21.66 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.148 0.499 . . . . 0.0 111.33 178.72 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 61.2 t -113.01 115.81 50.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.926 -177.817 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -95.16 115.01 26.87 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 120.695 0.283 . . . . 0.0 111.382 177.456 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.51 ' O ' HG12 ' A' ' 30' ' ' VAL . 82.8 m -113.95 127.86 56.15 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 120.927 0.394 . . . . 0.0 111.306 179.34 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.598 ' HA ' ' H ' ' A' ' 29' ' ' ARG . 4.6 m-20 -85.9 -76.65 0.33 Allowed 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 120.946 0.403 . . . . 0.0 111.232 178.384 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.456 ' HA3' ' O ' ' A' ' 25' ' ' LEU . . . 162.31 -145.54 10.86 Favored Glycine 0 CA--C 1.52 0.393 0 C-N-CA 120.05 -1.071 . . . . 0.0 113.879 179.286 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 128.85 16.56 1.98 Allowed Glycine 0 CA--C 1.528 0.846 0 CA-C-N 115.329 -0.436 . . . . 0.0 112.114 -175.169 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 66.2 mm-40 -83.53 -169.25 2.46 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 122.46 0.304 . . . . 0.0 111.213 175.607 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -44.4 -53.14 7.01 Favored Glycine 0 CA--C 1.533 1.202 0 N-CA-C 114.138 0.415 . . . . 0.0 114.138 179.146 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -98.44 20.36 12.84 Favored 'General case' 0 N--CA 1.473 0.706 0 O-C-N 122.359 -0.495 . . . . 0.0 111.706 177.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.456 ' O ' ' HA3' ' A' ' 20' ' ' GLY . 57.4 mt 71.85 -19.71 0.26 Allowed 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.943 0.897 . . . . 0.0 112.601 -179.609 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 91.92 -107.88 3.55 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 120.916 -0.659 . . . . 0.0 114.256 175.56 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 2.6 p80 -159.57 104.54 1.48 Allowed Pre-proline 0 N--CA 1.475 0.783 0 O-C-N 122.46 -0.435 . . . . 0.0 111.954 -168.172 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.495 ' O ' ' HB3' ' A' ' 29' ' ' ARG . 39.2 Cg_exo -56.22 93.54 0.05 OUTLIER 'Trans proline' 0 CA--C 1.54 0.789 0 C-N-CA 122.391 2.061 . . . . 0.0 113.132 -178.914 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.598 ' H ' ' HA ' ' A' ' 19' ' ' ASP . 0.0 OUTLIER 81.72 102.69 0.06 Allowed 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 122.444 1.116 . . . . 0.0 111.342 175.072 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.51 HG12 ' O ' ' A' ' 18' ' ' CYS . 11.5 p -132.02 132.98 61.22 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-N 114.153 -1.385 . . . . 0.0 109.488 166.632 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 59.8 m95 -100.09 132.5 45.41 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.24 0.543 . . . . 0.0 112.339 -176.084 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.429 ' N ' HD12 ' A' ' 32' ' ' LEU . 5.4 mp -115.67 160.89 19.45 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.904 177.13 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 61.6 tp60 -119.55 124.78 47.24 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.496 178.263 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.521 HG21 ' HB2' ' A' ' 52' ' ' LEU . 73.7 mt -79.33 132.25 63.18 Favored Pre-proline 0 CA--C 1.545 0.768 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -178.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.559 ' HG2' ' OG1' ' A' ' 38' ' ' THR . 94.7 Cg_endo -81.95 117.33 2.9 Favored 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 122.609 2.206 . . . . 0.0 112.317 173.521 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -60.25 -33.82 72.82 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -176.107 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.489 ' O ' ' HE2' ' A' ' 56' ' ' LYS . 8.0 p-10 -62.23 -30.9 71.42 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 120.773 0.321 . . . . 0.0 111.846 -178.769 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.559 ' OG1' ' HG2' ' A' ' 35' ' ' PRO . 21.9 p -91.55 -48.89 6.6 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.377 0.608 . . . . 0.0 110.428 175.023 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 100.01 2.47 56.0 Favored Glycine 0 CA--C 1.524 0.614 0 CA-C-N 115.597 -0.729 . . . . 0.0 112.756 -177.483 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.441 ' HB3' HG22 ' A' ' 51' ' ' VAL . 65.2 p-90 -158.81 152.77 23.52 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 120.961 0.41 . . . . 0.0 111.867 -175.533 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.483 HG12 HG12 ' A' ' 34' ' ' ILE . 11.0 p -131.6 150.58 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.939 176.861 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -117.2 131.47 56.85 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 121.113 0.482 . . . . 0.0 111.154 178.164 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.417 ' SG ' ' HB3' ' A' ' 46' ' ' CYS . 49.5 t -82.67 110.49 22.63 Favored Pre-proline 0 N--CA 1.47 0.532 0 N-CA-C 111.911 0.337 . . . . 0.0 111.911 -179.176 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -58.94 -26.93 83.15 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 122.699 2.266 . . . . 0.0 113.319 -177.405 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -112.03 17.55 19.54 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 112.13 0.418 . . . . 0.0 112.13 -176.127 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.421 ' SG ' ' SG ' ' A' ' 48' ' ' CYS . 36.2 t -146.1 -7.17 0.56 Allowed 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 174.857 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 55.18 24.72 6.51 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 113.203 0.816 . . . . 0.0 113.203 178.033 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.421 ' SG ' ' SG ' ' A' ' 46' ' ' CYS . 81.3 m -102.92 138.02 40.35 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 120.812 0.339 . . . . 0.0 111.611 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.435 ' O ' ' HA ' ' A' ' 8' ' ' THR . 85.7 tttt -109.01 121.51 45.3 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 122.92 0.488 . . . . 0.0 111.149 -178.378 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -116.93 125.77 51.95 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 112.13 0.418 . . . . 0.0 112.13 -177.002 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.441 HG22 ' HB3' ' A' ' 40' ' ' TRP . 40.9 t -94.54 139.33 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.873 176.344 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.521 ' HB2' HG21 ' A' ' 34' ' ' ILE . 56.5 tp -87.13 119.12 27.03 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.407 177.702 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -67.67 118.59 11.15 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 121.076 0.465 . . . . 0.0 111.122 178.73 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 120.5 -28.51 6.21 Favored Glycine 0 CA--C 1.525 0.686 0 CA-C-N 115.992 -0.549 . . . . 0.0 112.29 -174.16 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 66.1 m -80.83 168.07 19.19 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 120.877 0.37 . . . . 0.0 111.252 178.45 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.489 ' HE2' ' O ' ' A' ' 37' ' ' ASP . 65.7 pttt -58.59 -25.03 62.18 Favored 'General case' 0 CA--C 1.543 0.673 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -177.206 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.72 -33.2 75.11 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.151 0.5 . . . . 0.0 111.23 176.54 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -77.28 -5.91 51.19 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.206 177.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.39 36.05 0.24 Allowed 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -177.357 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.9 pp -62.34 165.43 6.01 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 122.182 -0.324 . . . . 0.0 110.965 174.684 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 49.1 121.16 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.436 0 CA-C-O 121.999 0.904 . . . . 0.0 113.127 -175.471 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 52.0 t-80 -82.57 40.35 0.66 Allowed 'General case' 0 CA--C 1.546 0.816 0 O-C-N 121.232 -0.917 . . . . 0.0 110.615 176.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 39.3 t-80 -95.6 10.47 36.6 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.731 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 69.1 m80 71.03 134.58 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.626 0.77 . . . . 0.0 111.754 -177.602 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 43.7 m-70 -101.25 179.4 4.37 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 121.489 0.661 . . . . 0.0 112.509 -176.728 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 28.3 m170 -71.05 93.38 1.02 Allowed 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.989 -178.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 22.3 p-80 . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.719 -0.658 . . . . 0.0 112.112 -177.275 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.0 ptp . . . . . 0 N--CA 1.489 1.517 0 CA-C-O 120.921 0.391 . . . . 0.0 112.023 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 2.0 m -119.04 9.12 11.74 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.549 174.5 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.464 ' O ' ' HG2' ' A' ' 4' ' ' GLN . 49.0 mm 72.92 -40.16 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 123.345 0.658 . . . . 0.0 111.527 -173.783 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.464 ' HG2' ' O ' ' A' ' 3' ' ' ILE . 9.3 pt20 53.31 26.07 4.96 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.278 1.031 . . . . 0.0 113.07 171.749 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -117.09 82.96 14.49 Favored Pre-proline 0 CA--C 1.54 0.571 0 CA-C-O 120.775 0.321 . . . . 0.0 111.103 177.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.503 ' O ' ' HA ' ' A' ' 48' ' ' CYS . 62.6 Cg_endo -86.92 31.05 0.45 Allowed 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 123.076 2.518 . . . . 0.0 114.023 -173.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 51.11 103.83 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 178.343 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 86.8 m -85.83 115.32 23.4 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.059 175.659 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 73.8 mttt -121.95 98.57 6.01 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 120.995 0.426 . . . . 0.0 110.882 176.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 57.8 mt -86.21 127.75 39.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.108 -179.268 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 28.5 m -125.56 163.45 26.71 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.546 -179.357 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -89.15 -19.79 25.05 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 120.76 0.314 . . . . 0.0 111.515 179.374 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 13.6 pttm -131.84 148.08 52.52 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 121.076 0.465 . . . . 0.0 111.615 -177.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 12.2 p -68.39 -30.79 69.79 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 114.572 1.323 . . . . 0.0 114.572 -168.498 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 94.4 mtt180 -75.41 104.3 5.92 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 118.53 0.604 . . . . 0.0 111.512 179.065 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 36.4 t -117.88 122.37 69.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.388 -178.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -81.4 109.66 16.1 Favored 'General case' 0 CA--C 1.535 0.4 0 O-C-N 122.252 -0.28 . . . . 0.0 111.116 175.75 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.74 ' SG ' ' HB ' ' A' ' 30' ' ' VAL . 22.8 p -66.07 104.28 1.12 Allowed 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 121.056 0.455 . . . . 0.0 110.936 179.664 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -66.28 -84.99 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 115.989 -0.55 . . . . 0.0 112.469 -177.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.544 ' HA3' ' HA2' ' A' ' 26' ' ' GLY . . . 161.14 175.11 31.81 Favored Glycine 0 CA--C 1.524 0.65 0 C-N-CA 120.351 -0.928 . . . . 0.0 113.806 178.101 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -73.43 -70.6 1.21 Allowed Glycine 0 CA--C 1.523 0.564 0 C-N-CA 121.026 -0.606 . . . . 0.0 112.075 175.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -166.25 128.57 1.91 Allowed 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 122.343 0.257 . . . . 0.0 111.082 178.608 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 39.79 -96.06 0.01 OUTLIER Glycine 0 CA--C 1.531 1.064 0 N-CA-C 115.015 0.766 . . . . 0.0 115.015 179.271 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -60.39 -28.59 68.35 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.112 0.482 . . . . 0.0 112.196 -177.694 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 85.9 mt -95.65 23.0 6.5 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-O 120.983 0.42 . . . . 0.0 111.702 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.544 ' HA2' ' HA3' ' A' ' 20' ' ' GLY . . . -80.64 176.0 54.75 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 121.377 -0.44 . . . . 0.0 112.578 175.798 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 10.1 m-70 -127.87 140.35 37.92 Favored Pre-proline 0 N--CA 1.472 0.666 0 O-C-N 121.948 -0.736 . . . . 0.0 111.069 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -76.16 52.35 3.46 Favored 'Trans proline' 0 CA--C 1.546 1.103 0 C-N-CA 122.893 2.395 . . . . 0.0 113.981 -175.382 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.455 ' HD3' ' HA ' ' A' ' 29' ' ' ARG . 2.8 tpp180 59.74 85.75 0.1 Allowed 'General case' 0 N--CA 1.445 -0.722 0 CA-C-O 122.461 1.124 . . . . 0.0 112.612 176.534 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.74 ' HB ' ' SG ' ' A' ' 18' ' ' CYS . 48.4 t -118.45 115.08 47.04 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.066 0 CA-C-N 114.107 -1.406 . . . . 0.0 110.565 177.544 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 83.3 m95 -91.41 103.91 16.49 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 120.948 0.404 . . . . 0.0 111.291 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.539 HD21 ' HD3' ' A' ' 44' ' ' PRO . 6.2 mp -83.62 131.07 34.99 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 121.021 0.439 . . . . 0.0 111.436 179.107 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -93.89 105.32 17.35 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.334 176.18 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.556 HG12 HG12 ' A' ' 41' ' ' VAL . 73.5 mt -64.43 124.76 86.83 Favored Pre-proline 0 CA--C 1.542 0.638 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.661 -178.359 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.565 ' HG2' ' OG1' ' A' ' 38' ' ' THR . 76.9 Cg_endo -74.19 119.24 5.72 Favored 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 122.671 2.247 . . . . 0.0 112.211 179.567 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -64.63 -17.15 63.76 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-O 121.162 0.506 . . . . 0.0 111.582 -178.021 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -64.93 -44.07 90.72 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 120.916 0.389 . . . . 0.0 111.22 175.585 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.565 ' OG1' ' HG2' ' A' ' 35' ' ' PRO . 31.6 p -95.92 -54.3 3.38 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 121.08 0.467 . . . . 0.0 110.99 179.545 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 110.87 1.18 28.74 Favored Glycine 0 CA--C 1.524 0.605 0 CA-C-N 115.948 -0.569 . . . . 0.0 113.494 179.006 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 62.0 p-90 -153.79 160.15 42.15 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 116.941 0.37 . . . . 0.0 111.183 -177.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.556 HG12 HG12 ' A' ' 34' ' ' ILE . 13.4 p -141.15 141.49 30.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.648 176.053 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.39 154.93 16.96 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 121.305 0.574 . . . . 0.0 111.948 -179.135 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.464 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 43.8 t -73.05 123.12 89.22 Favored Pre-proline 0 CA--C 1.537 0.449 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.603 179.305 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.539 ' HD3' HD21 ' A' ' 32' ' ' LEU . 14.9 Cg_exo -69.03 -7.71 21.59 Favored 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 122.757 2.305 . . . . 0.0 113.095 -179.501 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -98.83 -46.9 5.49 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 120.924 0.392 . . . . 0.0 111.576 -178.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 25.1 t -120.08 -91.0 0.57 Allowed 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.514 -177.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -173.91 19.11 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 179.005 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.503 ' HA ' ' O ' ' A' ' 6' ' ' PRO . 56.7 m -64.97 132.53 49.53 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 -177.33 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.452 ' NZ ' ' HB2' ' A' ' 49' ' ' LYS . 5.0 ttmp? -102.34 110.71 22.74 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 121.203 0.525 . . . . 0.0 111.572 -179.257 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 55.3 m-85 -94.76 104.35 16.26 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.447 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 56.7 t -92.13 137.3 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 CA-C-O 121.174 0.511 . . . . 0.0 112.372 -175.694 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 59.6 tp -98.91 130.05 45.28 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.508 178.774 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -64.77 143.9 57.62 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-O 120.845 0.355 . . . . 0.0 111.635 178.256 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 81.42 -13.89 31.95 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 121.367 -0.444 . . . . 0.0 114.081 175.59 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 59.9 p -84.2 179.99 7.35 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 120.935 0.398 . . . . 0.0 111.345 -178.545 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 62.0 mttm -63.5 -27.33 69.19 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 179.555 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -69.53 -27.45 65.18 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.301 0.572 . . . . 0.0 110.662 175.814 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -90.89 -21.91 21.17 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.769 176.198 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -86.49 -22.17 26.58 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 3.5 pp -74.85 170.58 15.62 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 111.857 0.317 . . . . 0.0 111.857 179.613 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 68.79 -59.95 0.45 Allowed 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.245 0.618 . . . . 0.0 111.472 -177.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 26.8 t60 -67.9 100.1 0.92 Allowed 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 172.559 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 13.6 p-80 -53.96 115.41 2.01 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-O 120.759 0.314 . . . . 0.0 111.122 -176.599 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 32.0 t60 -62.29 -17.19 57.95 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -172.277 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' HIS . . . . . 0.552 ' O ' ' HB3' ' A' ' 66' ' ' HIS . 30.0 m-70 -53.11 128.79 28.91 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 120.93 -0.308 . . . . 0.0 111.025 175.14 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.552 ' HB3' ' O ' ' A' ' 65' ' ' HIS . 82.6 t60 81.92 91.89 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.549 -165.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 78.0 t60 . . . . . 0 C--O 1.252 1.232 0 CA-C-O 118.165 -0.921 . . . . 0.0 112.603 -178.773 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.3 ptm . . . . . 0 N--CA 1.49 1.526 0 CA-C-O 120.754 0.311 . . . . 0.0 111.685 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.413 ' C ' ' H ' ' A' ' 4' ' ' GLN . 75.2 p -127.03 -58.08 1.3 Allowed 'General case' 0 N--CA 1.475 0.808 0 O-C-N 122.04 -0.413 . . . . 0.0 111.624 176.92 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 63.7 mt 72.92 -22.73 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.849 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.944 -177.617 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.413 ' H ' ' C ' ' A' ' 2' ' ' THR . 83.4 mm-40 64.36 6.86 3.25 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.109 0.564 . . . . 0.0 111.875 -176.607 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -159.85 56.69 0.89 Allowed Pre-proline 0 CA--C 1.541 0.629 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.947 179.244 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -80.9 39.2 0.83 Allowed 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 122.738 2.292 . . . . 0.0 113.067 -175.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -66.62 134.94 53.34 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-O 121.561 0.696 . . . . 0.0 112.667 -174.671 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.42 ' OG1' ' NZ ' ' A' ' 49' ' ' LYS . 99.9 m -103.95 147.3 27.52 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.087 178.852 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -134.95 113.13 11.21 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 120.786 0.327 . . . . 0.0 110.684 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 53.2 mt -86.82 107.1 16.54 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-O 121.176 0.512 . . . . 0.0 111.005 -179.463 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.512 HG11 HG21 ' A' ' 16' ' ' VAL . 30.6 m -96.12 155.6 3.4 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-O 121.175 0.512 . . . . 0.0 112.149 -176.666 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -94.98 3.1 55.32 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.642 -176.843 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 62.7 pttt -135.07 155.2 51.15 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.016 179.435 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 59.0 m -75.87 -32.66 59.81 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -175.67 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.468 ' HB3' ' OE1' ' A' ' 33' ' ' GLN . 13.0 ptp180 -112.79 121.13 43.81 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 121.233 0.54 . . . . 0.0 111.469 -178.027 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.512 HG21 HG11 ' A' ' 11' ' ' VAL . 46.2 t -127.49 132.35 69.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.679 -177.695 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.486 ' HA ' ' O ' ' A' ' 30' ' ' VAL . . . -83.04 88.28 6.87 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 121.146 0.498 . . . . 0.0 110.718 176.065 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.462 ' SG ' ' HB3' ' A' ' 46' ' ' CYS . 43.7 t -72.24 104.03 3.55 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 -174.137 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 38.0 t70 54.04 22.14 3.3 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-O 122.093 0.949 . . . . 0.0 111.777 177.024 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -123.41 111.77 1.75 Allowed Glycine 0 CA--C 1.522 0.471 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.584 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 65.78 27.13 72.43 Favored Glycine 0 CA--C 1.53 1.025 0 C-N-CA 121.048 -0.596 . . . . 0.0 113.006 -174.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -112.04 -149.91 0.45 Allowed 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 122.709 0.404 . . . . 0.0 110.738 179.385 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -43.31 -47.0 6.84 Favored Glycine 0 CA--C 1.534 1.236 0 N-CA-C 114.537 0.575 . . . . 0.0 114.537 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -97.52 -3.22 40.25 Favored 'General case' 0 N--CA 1.472 0.656 0 O-C-N 122.356 -0.496 . . . . 0.0 112.034 179.19 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.0 pp 43.22 26.87 0.1 Allowed 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.507 1.123 . . . . 0.0 113.863 176.494 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -55.9 -68.02 1.91 Allowed Glycine 0 CA--C 1.526 0.759 0 N-CA-C 114.375 0.51 . . . . 0.0 114.375 -175.613 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.436 ' CE1' ' HB3' ' A' ' 45' ' ' TYR . 8.1 m80 -77.26 156.37 81.6 Favored Pre-proline 0 N--CA 1.472 0.649 0 O-C-N 122.374 -0.486 . . . . 0.0 110.974 -178.194 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -72.7 48.57 1.36 Allowed 'Trans proline' 0 CA--C 1.544 1.007 0 C-N-CA 123.142 2.562 . . . . 0.0 113.497 179.526 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 22.9 tpt180 67.37 85.97 0.14 Allowed 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 122.308 1.052 . . . . 0.0 111.426 179.252 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.486 ' O ' ' HA ' ' A' ' 17' ' ' ALA . 58.9 t -107.16 112.54 40.42 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 CA-C-N 114.196 -1.365 . . . . 0.0 111.322 -177.811 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 95.9 m95 -95.09 118.48 31.96 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.125 0.488 . . . . 0.0 111.919 -179.417 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.407 ' N ' HD12 ' A' ' 32' ' ' LEU . 7.1 mp -94.58 111.65 23.41 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.31 173.634 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.468 ' OE1' ' HB3' ' A' ' 15' ' ' ARG . 59.4 tp60 -92.43 110.08 21.48 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.83 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.517 HG21 ' HB2' ' A' ' 52' ' ' LEU . 73.5 mt -75.77 119.12 75.68 Favored Pre-proline 0 CA--C 1.543 0.676 0 CA-C-O 120.9 0.381 . . . . 0.0 111.331 179.162 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -85.5 146.35 9.57 Favored 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 122.842 2.361 . . . . 0.0 113.178 -178.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -70.9 -10.12 59.03 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 120.864 0.364 . . . . 0.0 110.848 174.357 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -62.94 -40.58 98.09 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.352 0.596 . . . . 0.0 110.836 172.49 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 44.3 p -108.56 -54.04 2.56 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.624 -176.443 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 99.61 1.12 56.51 Favored Glycine 0 CA--C 1.525 0.694 0 CA-C-N 116.092 -0.504 . . . . 0.0 112.061 -174.878 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 64.5 p-90 -156.86 166.93 31.99 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 122.588 0.355 . . . . 0.0 110.966 -177.308 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.415 HG12 HG12 ' A' ' 34' ' ' ILE . 11.5 p -145.11 136.58 20.34 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-O 120.895 0.379 . . . . 0.0 110.921 174.688 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -91.76 133.43 35.62 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.006 0.431 . . . . 0.0 110.447 177.176 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.48 ' SG ' ' HB2' ' A' ' 45' ' ' TYR . 44.5 t -103.69 105.31 47.02 Favored Pre-proline 0 N--CA 1.467 0.413 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -178.704 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -73.54 -2.54 12.3 Favored 'Trans proline' 0 CA--C 1.542 0.923 0 C-N-CA 122.526 2.151 . . . . 0.0 112.351 174.299 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.48 ' HB2' ' SG ' ' A' ' 43' ' ' CYS . 60.7 m-85 -90.74 -42.14 10.86 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.548 179.099 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.462 ' HB3' ' SG ' ' A' ' 18' ' ' CYS . 53.1 t -118.53 1.87 11.74 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -175.329 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 59.43 51.44 6.62 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 112.802 0.668 . . . . 0.0 112.802 175.234 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 87.6 m -149.04 157.6 43.53 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 120.835 0.35 . . . . 0.0 111.505 177.657 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.42 ' NZ ' ' OG1' ' A' ' 8' ' ' THR . 7.2 ttpm? -106.45 121.9 45.21 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 116.532 -0.303 . . . . 0.0 111.282 178.634 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 37.1 m-85 -99.62 119.41 38.04 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 120.663 0.268 . . . . 0.0 111.511 -179.093 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 97.3 t -101.87 139.99 21.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 CA-C-O 120.84 0.353 . . . . 0.0 111.491 177.103 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.517 ' HB2' HG21 ' A' ' 34' ' ' ILE . 60.9 tp -88.54 118.71 28.39 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 120.935 0.398 . . . . 0.0 111.919 -179.695 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.422 ' HE3' ' HB2' ' A' ' 53' ' ' LYS . 38.2 ttmt -63.57 133.17 53.3 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.816 178.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 90.36 -8.18 80.24 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 121.159 -0.543 . . . . 0.0 113.546 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 45.5 t -77.52 179.94 6.21 Favored 'General case' 0 N--CA 1.472 0.667 0 O-C-N 122.361 -0.493 . . . . 0.0 111.035 178.662 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -66.85 -27.77 67.8 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.116 0.484 . . . . 0.0 111.157 179.285 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -76.41 -25.38 54.43 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.444 177.707 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -110.94 86.96 2.42 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 121.42 0.628 . . . . 0.0 111.332 -178.756 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -102.67 -18.5 15.18 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.827 175.393 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 3.1 pp -67.49 -6.14 18.27 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 -177.274 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 54.1 tp10 -88.79 -73.44 0.5 Allowed 'General case' 0 CA--C 1.538 0.499 0 O-C-N 121.87 -0.519 . . . . 0.0 111.663 176.817 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 29.5 t60 -84.45 -20.0 32.47 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -177.553 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 35.0 t-80 69.34 -15.12 0.29 Allowed 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 113.399 0.889 . . . . 0.0 113.399 176.538 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 -140.93 171.25 14.33 Favored 'General case' 0 N--CA 1.474 0.746 0 O-C-N 121.964 -0.46 . . . . 0.0 110.977 178.09 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 11.1 m170 -106.57 153.63 22.06 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 120.805 0.336 . . . . 0.0 110.94 175.691 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 38.7 m80 -78.13 -36.66 47.55 Favored 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 168.285 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 48.5 t-80 . . . . . 0 C--O 1.257 1.463 0 CA-C-N 114.971 -1.013 . . . . 0.0 110.454 172.897 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 70.7 mtm . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 120.982 0.42 . . . . 0.0 111.21 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 68.6 p -96.39 158.95 15.2 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.074 0.464 . . . . 0.0 111.713 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.425 ' O ' ' HG2' ' A' ' 4' ' ' GLN . 35.0 pt -75.22 9.19 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.303 173.651 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.425 ' HG2' ' O ' ' A' ' 3' ' ' ILE . 9.5 pt20 49.08 19.75 0.32 Allowed 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.85 1.26 . . . . 0.0 113.221 179.729 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -131.41 96.21 22.07 Favored Pre-proline 0 CA--C 1.542 0.642 0 CA-C-O 120.795 0.331 . . . . 0.0 111.482 179.354 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -88.04 32.77 0.4 Allowed 'Trans proline' 0 CA--C 1.541 0.859 0 C-N-CA 122.892 2.395 . . . . 0.0 113.124 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.48 ' HB3' ' SG ' ' A' ' 48' ' ' CYS . 86.4 tt0 -65.47 115.22 5.48 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 120.945 0.402 . . . . 0.0 111.794 -177.431 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 57.8 p -96.1 115.46 27.46 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 122.751 0.42 . . . . 0.0 111.771 178.177 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 65.2 mttm -99.37 100.43 11.49 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.018 0.437 . . . . 0.0 110.269 178.12 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.484 HG22 ' HB2' ' A' ' 53' ' ' LYS . 55.4 mt -82.19 100.47 6.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.546 -176.846 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 33.2 m -107.93 157.0 8.27 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 CA-C-O 121.108 0.48 . . . . 0.0 112.247 -176.312 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -99.74 25.31 7.34 Favored 'General case' 0 CA--C 1.548 0.896 0 CA-C-O 121.676 0.75 . . . . 0.0 110.5 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -144.1 131.48 20.91 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.071 -175.081 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.416 ' HA ' HD12 ' A' ' 34' ' ' ILE . 9.1 m -81.01 -26.71 36.24 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -178.106 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.451 ' HG2' ' OE1' ' A' ' 33' ' ' GLN . 89.2 mtt180 -100.7 92.38 5.07 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.17 0.509 . . . . 0.0 110.123 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 44.9 t -107.83 118.6 55.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-N 115.925 -0.579 . . . . 0.0 112.155 -171.235 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.449 ' HB2' ' CE2' ' A' ' 31' ' ' TRP . . . -84.93 100.5 11.66 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 120.751 0.31 . . . . 0.0 110.756 175.172 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.656 ' SG ' ' HB ' ' A' ' 30' ' ' VAL . 29.7 p -71.58 117.49 13.21 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 121.063 0.459 . . . . 0.0 111.769 -175.76 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -89.94 -75.3 0.46 Allowed 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.27 176.582 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 172.65 -164.68 36.94 Favored Glycine 0 CA--C 1.519 0.342 0 C-N-CA 120.579 -0.82 . . . . 0.0 113.088 -179.23 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -145.94 -86.45 0.07 OUTLIER Glycine 0 CA--C 1.522 0.507 0 C-N-CA 121.224 -0.512 . . . . 0.0 112.474 -179.656 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -72.32 163.32 28.17 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 120.666 0.269 . . . . 0.0 111.17 175.508 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -43.97 -54.08 6.18 Favored Glycine 0 CA--C 1.533 1.192 0 N-CA-C 114.6 0.6 . . . . 0.0 114.6 -176.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -77.51 -10.35 59.43 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 -178.035 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 64.1 mt -98.48 19.08 15.15 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 112.462 0.542 . . . . 0.0 112.462 -175.866 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -80.1 138.81 20.48 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 121.01 -0.614 . . . . 0.0 113.005 176.18 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 32.2 m80 -126.89 145.3 53.24 Favored Pre-proline 0 N--CA 1.472 0.67 0 O-C-N 122.444 -0.444 . . . . 0.0 110.579 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_exo -57.85 -58.15 0.92 Allowed 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 122.706 2.271 . . . . 0.0 114.183 -175.464 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 2.4 tmt_? 177.27 93.18 0.01 OUTLIER 'General case' 0 C--O 1.233 0.223 0 CA-C-O 121.806 0.813 . . . . 0.0 109.888 -171.391 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.656 ' HB ' ' SG ' ' A' ' 18' ' ' CYS . 55.1 t -124.54 132.69 70.97 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.022 0 CA-C-N 114.558 -1.201 . . . . 0.0 110.784 179.208 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.449 ' CE2' ' HB2' ' A' ' 17' ' ' ALA . 37.3 m95 -110.02 119.94 40.89 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-O 121.205 0.526 . . . . 0.0 112.26 -176.576 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.6 mp -100.4 163.43 12.38 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 121.303 0.573 . . . . 0.0 111.568 177.221 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.451 ' OE1' ' HG2' ' A' ' 15' ' ' ARG . 55.8 tp60 -131.27 114.21 14.77 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.768 -179.365 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.564 HG21 ' HB2' ' A' ' 52' ' ' LEU . 64.7 mt -69.96 121.21 82.11 Favored Pre-proline 0 CA--C 1.543 0.7 0 CA-C-O 120.863 0.363 . . . . 0.0 111.617 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.497 ' HG2' ' OG1' ' A' ' 38' ' ' THR . 65.3 Cg_endo -81.63 130.26 6.79 Favored 'Trans proline' 0 CA--C 1.544 0.976 0 C-N-CA 122.855 2.37 . . . . 0.0 113.351 -178.883 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 44.3 mm-40 -60.02 -18.14 44.04 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 175.724 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -67.92 -36.64 80.51 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 120.966 0.413 . . . . 0.0 111.49 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.497 ' OG1' ' HG2' ' A' ' 35' ' ' PRO . 43.7 p -108.36 -50.86 2.97 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.049 0.452 . . . . 0.0 111.701 -177.879 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 104.31 1.64 44.33 Favored Glycine 0 CA--C 1.527 0.826 0 C-N-CA 121.352 -0.452 . . . . 0.0 112.412 -174.125 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 65.3 p-90 -154.36 160.19 41.56 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 122.708 0.403 . . . . 0.0 111.418 -179.164 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.547 HG12 HG12 ' A' ' 34' ' ' ILE . 12.3 p -144.11 127.05 11.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 CA-C-O 120.9 0.381 . . . . 0.0 110.823 176.455 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.406 ' HG3' ' H ' ' A' ' 42' ' ' GLU . 0.4 OUTLIER -100.16 146.2 27.12 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 121.058 0.456 . . . . 0.0 111.745 -178.457 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.566 ' HB3' ' HB2' ' A' ' 47' ' ' ASP . 42.0 t -103.86 119.28 54.99 Favored Pre-proline 0 CA--C 1.536 0.415 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -65.57 -12.58 35.72 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 122.819 2.346 . . . . 0.0 112.836 178.504 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.54 ' HB2' ' SG ' ' A' ' 43' ' ' CYS . 95.3 m-85 -82.38 7.31 14.44 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.716 178.84 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.461 ' HB2' ' O ' ' A' ' 45' ' ' TYR . 76.4 m 83.2 31.24 0.08 Allowed 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.906 0.882 . . . . 0.0 112.48 175.715 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.566 ' HB2' ' HB3' ' A' ' 43' ' ' CYS . 24.4 m-20 -94.2 5.96 50.11 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 120.999 0.428 . . . . 0.0 111.005 169.887 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.48 ' SG ' ' HB3' ' A' ' 7' ' ' GLU . 78.4 m 66.72 -161.92 0.24 Allowed 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 175.065 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.42 ' NZ ' ' HB2' ' A' ' 49' ' ' LYS . 5.0 ttmp? -94.11 126.75 39.52 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -174.835 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -96.89 105.49 17.64 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 120.658 0.266 . . . . 0.0 110.87 176.8 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 98.7 t -91.28 132.0 36.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-O 120.798 0.333 . . . . 0.0 111.472 -179.646 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.564 ' HB2' HG21 ' A' ' 34' ' ' ILE . 48.6 tp -85.39 112.54 20.94 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 121.215 0.531 . . . . 0.0 111.503 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.484 ' HB2' HG22 ' A' ' 10' ' ' ILE . 10.1 tmtt? -58.35 138.74 56.27 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.468 176.095 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 67.32 42.32 90.33 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 121.153 -0.546 . . . . 0.0 112.68 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 35.2 t -143.15 -168.57 2.83 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 120.767 0.317 . . . . 0.0 111.327 -176.325 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -60.84 -26.13 67.14 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -178.269 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -94.86 -15.03 24.03 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 -179.154 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -141.79 115.07 8.84 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 121.004 0.43 . . . . 0.0 111.614 -177.591 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -133.33 -58.7 0.88 Allowed 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 120.976 0.417 . . . . 0.0 110.264 176.646 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 96.7 mt -121.85 -68.46 0.89 Allowed 'General case' 0 CA--C 1.539 0.519 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.47 175.069 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 52.64 -147.53 0.46 Allowed 'General case' 0 N--CA 1.474 0.748 0 CA-C-O 120.869 0.366 . . . . 0.0 111.605 173.271 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 57.7 m-70 -94.08 16.94 13.37 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 121.202 0.525 . . . . 0.0 110.443 171.061 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -64.59 98.22 0.25 Allowed 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.629 -178.398 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 34.3 p-80 -106.18 127.22 53.06 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 120.827 0.346 . . . . 0.0 111.869 -175.338 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 26.8 p80 -81.77 29.27 0.39 Allowed 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 116.623 -0.262 . . . . 0.0 111.621 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 14.7 t-80 66.72 123.95 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.136 0.574 . . . . 0.0 112.14 -174.641 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 10.8 p80 . . . . . 0 C--O 1.252 1.219 0 CA-C-O 118.774 -0.631 . . . . 0.0 111.662 176.029 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.0 mmt . . . . . 0 N--CA 1.493 1.701 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 72.6 p -96.0 137.45 35.05 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -179.24 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.542 HD13 ' H ' ' A' ' 3' ' ' ILE . 0.2 OUTLIER -80.75 -20.32 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 CA-C-O 120.86 0.362 . . . . 0.0 110.976 172.276 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 65.45 101.19 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.625 0.77 . . . . 0.0 112.505 178.131 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -110.83 93.55 17.45 Favored Pre-proline 0 N--CA 1.469 0.479 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.98 176.395 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -66.59 86.81 0.28 Allowed 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 122.725 2.284 . . . . 0.0 112.745 -179.456 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -73.14 -23.45 60.47 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.497 0.665 . . . . 0.0 111.439 177.823 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.461 HG23 HG21 ' A' ' 51' ' ' VAL . 38.7 m -84.38 104.94 14.82 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 114.725 -1.125 . . . . 0.0 110.788 -177.198 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 62.2 mttm -120.68 122.0 39.49 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 121.09 0.471 . . . . 0.0 111.198 -174.324 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.458 HD13 ' HB ' ' A' ' 51' ' ' VAL . 49.9 mm -82.89 121.87 36.55 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 CA-C-N 115.91 -0.586 . . . . 0.0 112.295 -173.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 29.5 m -130.08 149.85 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.194 178.063 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -90.42 -15.72 30.4 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 179.778 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -96.97 142.68 28.63 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.037 0.446 . . . . 0.0 111.695 -179.481 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 20.0 m -80.57 -23.06 40.18 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.576 179.741 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.457 ' HA ' ' O ' ' A' ' 32' ' ' LEU . 16.2 ptp180 -116.15 119.46 35.87 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 121.311 0.577 . . . . 0.0 111.178 176.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 51.4 t -118.3 142.34 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.501 -175.331 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -94.33 110.47 22.23 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 120.982 0.42 . . . . 0.0 111.34 178.257 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.52 ' SG ' HD13 ' A' ' 32' ' ' LEU . 78.3 m -86.8 95.69 9.93 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 120.865 0.364 . . . . 0.0 111.41 176.921 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -83.49 -80.07 0.19 Allowed 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.606 174.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.632 ' HA3' ' HA2' ' A' ' 26' ' ' GLY . . . 161.04 -179.74 36.31 Favored Glycine 0 CA--C 1.523 0.571 0 C-N-CA 120.828 -0.701 . . . . 0.0 113.435 178.0 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -84.07 -100.78 0.59 Allowed Glycine 0 CA--C 1.526 0.771 0 C-N-CA 121.133 -0.556 . . . . 0.0 112.272 175.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 13.5 mp0 -76.59 165.53 24.65 Favored 'General case' 0 CA--C 1.541 0.622 0 O-C-N 122.596 -0.355 . . . . 0.0 110.416 172.583 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -43.83 -49.39 7.54 Favored Glycine 0 CA--C 1.533 1.182 0 N-CA-C 114.228 0.451 . . . . 0.0 114.228 -179.115 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.22 -31.93 72.53 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 121.041 0.448 . . . . 0.0 111.829 179.073 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 86.0 mt -90.37 0.26 57.34 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.865 0.364 . . . . 0.0 111.429 179.414 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.632 ' HA2' ' HA3' ' A' ' 20' ' ' GLY . . . -78.7 165.48 51.33 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 121.442 -0.409 . . . . 0.0 113.352 179.502 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 77.4 m80 -138.63 157.55 71.84 Favored Pre-proline 0 CA--C 1.538 0.499 0 O-C-N 122.606 -0.35 . . . . 0.0 110.524 -179.23 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.485 ' O ' ' HB3' ' A' ' 29' ' ' ARG . 70.7 Cg_endo -72.2 31.5 0.27 Allowed 'Trans proline' 0 CA--C 1.544 1.019 0 C-N-CA 122.437 2.092 . . . . 0.0 114.191 -176.381 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.485 ' HB3' ' O ' ' A' ' 28' ' ' PRO . 0.4 OUTLIER 76.69 98.07 0.07 Allowed 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 122.598 1.189 . . . . 0.0 110.228 175.44 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 60.7 t -120.28 129.85 75.04 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-N 113.919 -1.492 . . . . 0.0 110.988 178.633 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 74.4 m95 -104.09 124.22 48.67 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.063 0.459 . . . . 0.0 112.157 -178.621 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.52 HD13 ' SG ' ' A' ' 18' ' ' CYS . 7.2 mp -103.07 149.88 24.15 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.94 177.197 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 27.6 tp60 -120.32 109.02 14.87 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.812 -178.356 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.516 HG12 HG12 ' A' ' 41' ' ' VAL . 67.8 mt -60.45 129.46 89.2 Favored Pre-proline 0 CA--C 1.543 0.678 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.743 179.497 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.563 ' HG2' ' OG1' ' A' ' 38' ' ' THR . 45.7 Cg_endo -78.61 119.21 4.39 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 122.216 1.944 . . . . 0.0 111.52 173.018 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 22.2 mp0 -56.72 -40.33 75.51 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 -171.175 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -81.13 0.77 34.76 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 -173.499 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.563 ' OG1' ' HG2' ' A' ' 35' ' ' PRO . 22.6 p -107.06 -46.22 3.96 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.336 0.589 . . . . 0.0 109.823 171.139 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 100.3 0.92 55.75 Favored Glycine 0 CA--C 1.524 0.602 0 CA-C-N 115.558 -0.746 . . . . 0.0 113.212 178.165 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.445 ' HB3' HG22 ' A' ' 51' ' ' VAL . 67.5 p-90 -157.33 157.31 33.9 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.024 0.44 . . . . 0.0 112.118 -176.198 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.516 HG12 HG12 ' A' ' 34' ' ' ILE . 13.3 p -135.46 139.91 45.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.593 174.323 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -106.55 131.73 53.38 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.164 0.506 . . . . 0.0 111.083 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.432 ' HA ' HD21 ' A' ' 32' ' ' LEU . 47.5 t -86.23 122.04 72.44 Favored Pre-proline 0 CA--C 1.537 0.466 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.784 -177.419 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -74.71 -12.56 22.16 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 122.496 2.131 . . . . 0.0 112.84 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -99.42 -39.13 8.52 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 116.268 -0.424 . . . . 0.0 112.053 -178.291 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.425 ' HG ' ' HG ' ' A' ' 48' ' ' CYS . 46.3 t -116.8 2.62 12.88 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -177.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 54.25 25.86 6.24 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 174.835 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.425 ' HG ' ' HG ' ' A' ' 46' ' ' CYS . 71.0 m -95.48 144.71 25.75 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.296 177.546 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.452 ' HE3' ' HB2' ' A' ' 49' ' ' LYS . 34.9 ttmt -112.44 106.52 15.02 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-O 121.17 0.51 . . . . 0.0 111.215 -177.898 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 52.4 m-85 -91.24 111.16 22.53 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.51 -175.503 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.461 HG21 HG23 ' A' ' 8' ' ' THR . 68.9 t -94.86 132.66 38.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-O 121.031 0.443 . . . . 0.0 111.279 177.735 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 41.8 tp -82.29 115.8 21.52 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 121.054 0.454 . . . . 0.0 112.12 -176.626 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.559 ' HE3' ' N ' ' A' ' 54' ' ' GLY . 0.1 OUTLIER -67.27 112.9 4.78 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 120.973 0.415 . . . . 0.0 110.042 178.582 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.559 ' N ' ' HE3' ' A' ' 53' ' ' LYS . . . 114.14 -4.51 23.78 Favored Glycine 0 CA--C 1.523 0.592 0 C-N-CA 121.323 -0.465 . . . . 0.0 112.591 -176.433 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 47.7 t -82.01 179.92 7.64 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 121.107 0.48 . . . . 0.0 111.629 177.552 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 19.4 ptmt -54.93 -43.71 73.58 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -177.28 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.41 -22.64 66.24 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.097 0.475 . . . . 0.0 112.056 -178.736 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -79.97 -19.43 47.91 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.843 -178.29 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -80.92 58.72 3.5 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 121.277 0.56 . . . . 0.0 112.373 -174.642 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.6 pp -69.14 175.56 3.75 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 116.153 -0.476 . . . . 0.0 112.059 177.355 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -85.54 122.77 30.15 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-O 121.615 0.721 . . . . 0.0 112.734 -175.718 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 55.4 t60 -169.38 85.58 0.14 Allowed 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 115.253 -0.885 . . . . 0.0 108.974 173.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 23.8 p80 -142.87 177.31 8.43 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 113.512 0.93 . . . . 0.0 113.512 -167.505 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 6.5 p-80 -143.46 170.88 14.97 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 114.787 -1.097 . . . . 0.0 110.003 176.63 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 18.1 m80 -69.12 90.52 0.47 Allowed 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 121.17 0.51 . . . . 0.0 111.793 179.422 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 26.2 t-80 -95.03 -21.27 18.68 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.342 0.591 . . . . 0.0 109.625 172.603 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 53.9 m-70 . . . . . 0 C--O 1.251 1.164 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.398 174.862 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.593 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.0 OUTLIER . . . . . 0 N--CA 1.488 1.475 0 CA-C-O 120.725 0.297 . . . . 0.0 111.63 . . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.77 HG22 ' H ' ' A' ' 4' ' ' GLN . 6.6 m -123.96 136.3 54.22 Favored 'General case' 0 N--CA 1.475 0.806 0 O-C-N 122.172 -0.33 . . . . 0.0 111.138 177.656 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 10.2 tp -64.73 -20.66 27.76 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 CA-C-O 121.488 0.661 . . . . 0.0 110.576 174.76 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.77 ' H ' HG22 ' A' ' 2' ' ' THR . 53.1 mt-30 70.84 -84.59 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 115.068 -0.969 . . . . 0.0 112.047 177.612 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 51.79 58.22 15.9 Favored Pre-proline 0 CA--C 1.546 0.825 0 CA-C-O 120.922 0.391 . . . . 0.0 111.861 -174.635 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -83.1 37.97 0.7 Allowed 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 122.928 2.419 . . . . 0.0 113.305 -174.8 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.455 ' CD ' ' H ' ' A' ' 8' ' ' THR . 0.2 OUTLIER -124.05 -159.62 0.88 Allowed 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.192 -177.805 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.455 ' H ' ' CD ' ' A' ' 7' ' ' GLU . 77.2 m -70.9 123.52 22.2 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 121.102 0.477 . . . . 0.0 111.734 -179.609 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 23.2 tptp -121.35 101.82 7.88 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 120.873 0.368 . . . . 0.0 110.233 179.447 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 60.4 mt -83.43 99.89 6.48 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.065 -176.005 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 27.2 m -110.73 154.05 12.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 CA-C-O 121.009 0.433 . . . . 0.0 112.105 -175.778 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -87.5 14.99 7.16 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 120.787 0.327 . . . . 0.0 111.584 -178.516 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 58.0 pttt -132.83 143.94 49.88 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -174.898 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 54.0 m -87.92 -24.94 23.46 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 116.276 -0.42 . . . . 0.0 112.111 -178.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 75.2 mtt180 -108.71 110.19 21.54 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 121.179 0.514 . . . . 0.0 111.87 -179.146 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 50.3 t -114.01 147.21 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.064 -178.152 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.494 ' HA ' ' O ' ' A' ' 30' ' ' VAL . . . -91.18 106.71 18.7 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 121.348 0.594 . . . . 0.0 112.568 -177.361 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.682 ' SG ' HD22 ' A' ' 32' ' ' LEU . 95.9 m -85.39 -158.38 0.37 Allowed 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.633 178.72 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 9.9 t70 66.92 89.51 0.1 Allowed 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 121.21 0.528 . . . . 0.0 110.717 -175.212 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.625 ' HA2' ' O ' ' A' ' 25' ' ' LEU . . . -146.31 144.4 12.74 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 121.143 -0.551 . . . . 0.0 113.532 -178.681 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 154.63 -27.33 0.67 Allowed Glycine 0 CA--C 1.531 1.093 0 C-N-CA 120.763 -0.732 . . . . 0.0 114.463 176.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.501 ' HG2' ' N ' ' A' ' 23' ' ' GLY . 32.9 tt0 -151.69 168.43 25.04 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 117.071 0.436 . . . . 0.0 110.945 -174.71 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.501 ' N ' ' HG2' ' A' ' 22' ' ' GLU . . . -44.52 -57.37 5.15 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 121.632 -0.318 . . . . 0.0 113.748 176.086 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.54 -23.65 66.92 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 121.015 0.436 . . . . 0.0 111.89 177.422 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.625 ' O ' ' HA2' ' A' ' 20' ' ' GLY . 89.5 mt -103.88 25.86 9.36 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.975 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -82.68 51.82 4.6 Favored Glycine 0 CA--C 1.527 0.807 0 C-N-CA 120.892 -0.671 . . . . 0.0 113.668 -176.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 88.3 m-70 50.0 63.85 9.42 Favored Pre-proline 0 N--CA 1.475 0.78 0 C-N-CA 123.168 0.587 . . . . 0.0 112.404 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -59.21 -62.35 0.18 Allowed 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 122.721 2.281 . . . . 0.0 112.618 178.803 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 6.1 tpt180 -179.42 85.38 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.196 0 CA-C-O 121.956 0.884 . . . . 0.0 110.504 177.778 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.494 ' O ' ' HA ' ' A' ' 17' ' ' ALA . 60.8 t -135.71 103.81 4.12 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 CA-C-N 114.669 -1.15 . . . . 0.0 110.421 -179.238 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 85.1 m95 -94.78 124.07 38.61 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -173.66 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.682 HD22 ' SG ' ' A' ' 18' ' ' CYS . 11.2 mp -105.45 131.57 52.7 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.019 0.438 . . . . 0.0 110.646 171.579 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -92.88 115.1 27.81 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.836 -177.438 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.495 HG21 ' HB2' ' A' ' 52' ' ' LEU . 69.0 mt -66.79 118.1 51.49 Favored Pre-proline 0 CA--C 1.538 0.508 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.526 173.222 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.437 ' HG2' ' OG1' ' A' ' 38' ' ' THR . 97.6 Cg_endo -82.19 134.23 7.92 Favored 'Trans proline' 0 CA--C 1.538 0.704 0 C-N-CA 122.424 2.083 . . . . 0.0 113.045 179.445 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -58.4 -23.01 56.0 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 121.433 0.635 . . . . 0.0 110.599 174.64 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -62.4 -35.3 78.77 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 115.3 -0.864 . . . . 0.0 111.967 179.59 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.437 ' OG1' ' HG2' ' A' ' 35' ' ' PRO . 31.9 p -108.73 -48.73 3.26 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-O 121.03 0.443 . . . . 0.0 111.326 -179.058 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 101.08 -0.56 54.71 Favored Glycine 0 CA--C 1.527 0.807 0 CA-C-N 116.034 -0.53 . . . . 0.0 112.779 -177.005 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 67.5 p-90 -155.11 166.23 34.23 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 120.891 0.376 . . . . 0.0 111.821 -177.889 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.432 HG12 HG12 ' A' ' 34' ' ' ILE . 10.1 p -144.07 144.35 22.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 CA-C-N 116.528 -0.306 . . . . 0.0 110.912 175.459 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -105.13 141.36 36.81 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 120.834 0.349 . . . . 0.0 111.127 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.468 ' SG ' ' HB3' ' A' ' 46' ' ' CYS . 29.3 p -99.07 116.61 65.11 Favored Pre-proline 0 CA--C 1.539 0.52 0 O-C-N 122.305 -0.247 . . . . 0.0 110.935 175.043 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -70.37 16.93 0.24 Allowed 'Trans proline' 0 CA--C 1.544 0.981 0 C-N-CA 122.768 2.312 . . . . 0.0 113.642 -176.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 35.0 m-85 -117.26 -49.6 2.58 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 120.837 0.351 . . . . 0.0 111.418 176.404 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.468 ' HB3' ' SG ' ' A' ' 43' ' ' CYS . 13.2 t -105.13 -4.94 21.24 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -175.944 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 63.81 18.64 11.29 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 112.913 0.709 . . . . 0.0 112.913 177.768 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.442 ' SG ' ' SG ' ' A' ' 46' ' ' CYS . 34.7 m -79.8 135.27 36.44 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 120.84 0.352 . . . . 0.0 111.262 -179.748 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -99.62 95.42 6.95 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 120.915 0.388 . . . . 0.0 110.522 178.339 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.406 ' CZ ' ' HB2' ' A' ' 48' ' ' CYS . 76.0 m-85 -82.1 105.04 12.88 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.697 0.284 . . . . 0.0 111.263 -173.837 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 90.4 t -91.47 126.78 44.1 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.293 178.105 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.495 ' HB2' HG21 ' A' ' 34' ' ' ILE . 58.0 tp -73.32 112.53 9.46 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 121.175 0.512 . . . . 0.0 111.125 178.663 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 61.5 tttm -63.34 118.07 7.52 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.343 -178.829 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 102.25 -3.48 51.13 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 121.37 -0.443 . . . . 0.0 112.853 -174.176 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 35.2 t -90.82 -176.84 4.8 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 120.931 0.396 . . . . 0.0 111.544 178.899 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 54.9 mttm -72.24 -10.99 60.51 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 120.901 0.381 . . . . 0.0 111.968 -176.251 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -93.88 -0.94 55.45 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 120.967 0.413 . . . . 0.0 110.858 173.632 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.477 ' CG ' ' H ' ' A' ' 59' ' ' ALA . 24.9 t70 -126.91 -162.76 1.18 Allowed 'General case' 0 CA--C 1.549 0.924 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.858 -178.175 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.477 ' H ' ' CG ' ' A' ' 58' ' ' ASP . . . 71.83 45.11 0.44 Allowed 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.568 0.699 . . . . 0.0 110.958 -179.408 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.459 ' H ' HD12 ' A' ' 60' ' ' LEU . 5.4 mp -69.75 -20.84 63.49 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.527 -179.342 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.472 ' HB3' ' HB3' ' A' ' 64' ' ' HIS . 44.1 mt-10 -75.52 57.58 0.96 Allowed 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 121.095 0.474 . . . . 0.0 110.695 174.037 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 54.7 t-80 -65.26 -25.26 67.58 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 121.289 0.566 . . . . 0.0 110.081 -176.266 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 41.2 p-80 -81.87 -24.56 35.68 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 115.505 -0.771 . . . . 0.0 111.951 177.175 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.472 ' HB3' ' HB3' ' A' ' 61' ' ' GLU . 23.2 t-80 -114.93 104.94 12.42 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 120.772 0.32 . . . . 0.0 111.114 -174.809 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 26.4 m80 -98.01 -46.19 5.98 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 111.968 0.358 . . . . 0.0 111.968 -175.433 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 42.1 t-80 -70.08 98.81 1.37 Allowed 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 120.885 0.374 . . . . 0.0 110.728 175.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 12.0 p80 . . . . . 0 C--O 1.254 1.334 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -176.098 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.525 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.635 0 N-CA-C 111.811 0.3 . . . . 0.0 111.811 . . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 39.6 p -80.52 151.01 29.4 Favored 'General case' 0 N--CA 1.47 0.553 0 O-C-N 122.255 -0.278 . . . . 0.0 110.706 172.337 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.424 ' N ' HD12 ' A' ' 3' ' ' ILE . 2.0 mp -62.22 -25.22 37.02 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-O 121.014 0.435 . . . . 0.0 110.548 177.281 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 67.2 mm-40 59.74 80.39 0.2 Allowed 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 115.729 -0.669 . . . . 0.0 112.064 179.517 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.551 ' HB3' ' HD3' ' A' ' 6' ' ' PRO . . . -169.63 -52.49 0.0 OUTLIER Pre-proline 0 CA--C 1.547 0.859 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.988 178.844 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.551 ' HD3' ' HB3' ' A' ' 5' ' ' ALA . 55.1 Cg_endo -90.59 28.12 0.42 Allowed 'Trans proline' 0 C--N 1.357 1.022 0 C-N-CA 122.147 1.898 . . . . 0.0 112.994 179.522 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -92.99 87.62 5.83 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-O 121.953 0.883 . . . . 0.0 111.34 -176.564 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 96.2 m -126.51 148.9 49.64 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 114.752 -1.113 . . . . 0.0 110.731 -177.573 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.429 ' HD2' ' CE1' ' A' ' 50' ' ' TYR . 98.7 mttt -120.08 126.95 52.02 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 120.867 0.365 . . . . 0.0 110.735 -176.874 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.428 HG22 ' HB2' ' A' ' 53' ' ' LYS . 34.9 mm -91.83 98.84 8.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-O 121.023 0.439 . . . . 0.0 110.831 -179.179 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 34.7 m -99.15 158.0 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-O 121.407 0.623 . . . . 0.0 112.501 -174.11 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -91.72 -34.5 14.61 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.506 177.693 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -90.45 151.19 21.5 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.311 0.577 . . . . 0.0 112.479 -175.9 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 43.8 m -78.3 -27.51 47.31 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.331 173.48 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 71.7 mtp180 -90.42 107.2 19.0 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.618 175.175 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 55.1 t -113.97 118.59 58.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 120.999 0.428 . . . . 0.0 112.09 -175.423 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.13 103.09 7.85 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 121.057 0.456 . . . . 0.0 110.29 173.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.727 ' SG ' HD13 ' A' ' 32' ' ' LEU . 79.1 m -70.69 84.13 0.63 Allowed 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -172.329 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 40.37 66.3 0.64 Allowed 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 121.673 0.749 . . . . 0.0 112.532 176.827 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -157.04 151.9 23.24 Favored Glycine 0 CA--C 1.525 0.716 0 C-N-CA 119.804 -1.188 . . . . 0.0 114.59 -176.557 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' A' ' 27' ' ' HIS . . . -164.16 -132.47 1.35 Allowed Glycine 0 CA--C 1.524 0.601 0 N-CA-C 111.191 -0.764 . . . . 0.0 111.191 177.778 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.436 ' H ' HD12 ' A' ' 25' ' ' LEU . 32.8 mt-10 -88.65 118.81 28.58 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 122.277 -0.543 . . . . 0.0 111.523 174.55 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 39.76 -94.96 0.01 OUTLIER Glycine 0 CA--C 1.534 1.28 0 N-CA-C 115.512 0.965 . . . . 0.0 115.512 178.514 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.2 -17.84 63.93 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 -173.544 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.436 HD12 ' H ' ' A' ' 22' ' ' GLU . 86.0 mt -78.04 -2.91 39.51 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 -179.333 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 128.6 -130.0 6.39 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 121.481 -0.39 . . . . 0.0 112.866 178.255 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.417 ' O ' ' N ' ' A' ' 21' ' ' GLY . 6.3 m80 -84.94 156.56 60.77 Favored Pre-proline 0 N--CA 1.477 0.908 0 O-C-N 122.443 -0.445 . . . . 0.0 109.973 178.282 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -63.83 64.64 0.21 Allowed 'Trans proline' 0 CA--C 1.551 1.337 0 C-N-CA 122.894 2.396 . . . . 0.0 114.472 -178.547 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 7.9 tpt180 49.61 81.53 0.06 Allowed 'General case' 0 C--O 1.236 0.387 0 CA-C-O 122.62 1.2 . . . . 0.0 111.981 179.012 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 19.9 m -104.7 114.62 44.79 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 CA-C-N 113.658 -1.61 . . . . 0.0 112.265 -177.608 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 96.7 m95 -101.82 124.42 47.42 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.717 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.727 HD13 ' SG ' ' A' ' 18' ' ' CYS . 9.3 mp -117.49 134.1 55.23 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 121.011 0.434 . . . . 0.0 110.945 174.248 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -93.73 116.42 28.9 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.263 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.557 HG12 HG12 ' A' ' 41' ' ' VAL . 77.7 mt -61.73 123.0 75.24 Favored Pre-proline 0 CA--C 1.542 0.637 0 CA-C-O 120.891 0.377 . . . . 0.0 111.849 179.18 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.579 ' HG2' ' OG1' ' A' ' 38' ' ' THR . 76.7 Cg_endo -81.23 140.16 12.13 Favored 'Trans proline' 0 CA--C 1.544 0.983 0 C-N-CA 122.803 2.335 . . . . 0.0 112.818 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -70.64 -28.92 65.19 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 121.01 0.433 . . . . 0.0 111.746 -179.34 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -61.61 -25.01 67.08 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 179.562 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.579 ' OG1' ' HG2' ' A' ' 35' ' ' PRO . 47.2 p -109.84 -54.0 2.61 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-O 121.286 0.565 . . . . 0.0 111.197 176.048 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 101.05 1.34 54.78 Favored Glycine 0 CA--C 1.524 0.648 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.003 -175.247 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 54.5 p-90 -152.87 162.92 40.7 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 121.077 0.465 . . . . 0.0 111.681 -176.825 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.557 HG12 HG12 ' A' ' 34' ' ' ILE . 8.4 p -142.67 118.71 5.53 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 CA-C-O 120.925 0.393 . . . . 0.0 110.773 173.707 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.544 ' HA ' ' HA ' ' A' ' 49' ' ' LYS . 9.4 pt-20 -100.0 106.61 18.41 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.529 0.68 . . . . 0.0 110.112 175.701 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.843 ' HB3' ' SG ' ' A' ' 46' ' ' CYS . 44.0 t -75.83 130.91 77.51 Favored Pre-proline 0 N--CA 1.466 0.371 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -167.13 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -69.58 -15.15 37.61 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 122.571 2.181 . . . . 0.0 112.569 175.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.512 ' HD2' ' SG ' ' A' ' 43' ' ' CYS . 90.1 m-85 -85.24 -43.2 13.98 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.601 179.542 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.843 ' SG ' ' HB3' ' A' ' 43' ' ' CYS . 27.1 p -97.04 -17.77 19.81 Favored 'General case' 0 N--CA 1.478 0.925 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 -178.695 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 10.1 t70 67.96 20.06 9.25 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-O 121.123 0.487 . . . . 0.0 111.147 179.19 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 53.6 t -121.43 154.73 36.16 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 120.916 0.389 . . . . 0.0 111.616 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.544 ' HA ' ' HA ' ' A' ' 42' ' ' GLU . 17.9 ttmm -98.51 134.45 41.45 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.385 -177.37 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.429 ' CE1' ' HD2' ' A' ' 9' ' ' LYS . 72.3 m-85 -115.08 113.29 23.83 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 122.17 -0.331 . . . . 0.0 111.244 178.358 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 49.7 t -97.51 128.44 48.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 CA-C-O 121.169 0.509 . . . . 0.0 111.737 175.703 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.448 ' HB2' HD13 ' A' ' 34' ' ' ILE . 51.6 tp -78.6 114.02 17.15 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.029 178.024 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.428 ' HB2' HG22 ' A' ' 10' ' ' ILE . 33.9 ttpt -63.48 121.65 14.35 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.329 -179.188 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 92.1 13.57 57.39 Favored Glycine 0 CA--C 1.531 1.047 0 CA-C-N 116.14 -0.482 . . . . 0.0 113.751 -177.619 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 34.5 p -107.29 -166.65 1.18 Allowed 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 117.296 0.548 . . . . 0.0 111.905 -178.499 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -63.31 -20.29 65.36 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 115.927 -0.578 . . . . 0.0 111.777 177.682 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -94.22 -1.2 54.46 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 179.526 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -130.12 172.82 11.35 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 116.639 -0.255 . . . . 0.0 110.756 -176.686 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 63.22 77.51 0.32 Allowed 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 121.262 0.553 . . . . 0.0 111.11 -176.47 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 78.0 mt -65.8 -62.62 1.4 Allowed 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.571 -176.272 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.1 -25.66 63.61 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.846 178.38 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 39.0 t-80 74.21 20.81 2.6 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.431 0.692 . . . . 0.0 112.437 167.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 35.3 t-80 -80.46 -13.44 59.11 Favored 'General case' 0 CA--C 1.539 0.541 0 O-C-N 121.789 -0.569 . . . . 0.0 110.252 176.565 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 11.1 t-160 -79.65 92.96 5.43 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 170.211 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 21.6 p80 -86.41 143.73 27.66 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 -167.327 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 11.0 p80 -175.45 124.29 0.23 Allowed 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.131 172.058 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 40.7 m170 . . . . . 0 C--O 1.251 1.146 0 CA-C-O 118.678 -0.677 . . . . 0.0 111.432 178.623 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.7 mtm . . . . . 0 N--CA 1.494 1.756 0 CA-C-O 120.908 0.385 . . . . 0.0 111.18 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 2.9 m -78.62 24.93 0.27 Allowed 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -172.511 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.407 HG22 ' O ' ' A' ' 3' ' ' ILE . 44.5 mm 66.31 -5.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 CA-C-O 121.092 0.472 . . . . 0.0 111.399 -176.714 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 57.67 22.07 7.95 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.077 0.551 . . . . 0.0 111.918 -178.036 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -138.01 88.79 15.27 Favored Pre-proline 0 CA--C 1.534 0.34 0 CA-C-O 120.858 0.361 . . . . 0.0 111.917 -179.003 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -67.77 97.34 0.46 Allowed 'Trans proline' 0 CA--C 1.535 0.528 0 C-N-CA 122.308 2.005 . . . . 0.0 110.648 171.121 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -23.13 103.75 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 124.07 0.948 . . . . 0.0 112.523 -179.456 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.412 HG23 HG23 ' A' ' 51' ' ' VAL . 51.7 m -104.51 145.74 29.86 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 115.52 -0.764 . . . . 0.0 112.372 -171.47 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -129.14 114.19 16.02 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.262 176.437 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 55.0 mt -84.76 94.93 3.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 121.306 0.574 . . . . 0.0 110.761 -179.262 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 29.9 m -104.8 149.11 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-N 115.932 -0.576 . . . . 0.0 112.188 -174.394 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -75.67 -19.77 58.92 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.347 -177.204 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.438 ' NZ ' ' O ' ' A' ' 15' ' ' ARG . 13.2 ptmm? -112.08 143.04 43.75 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 116.204 -0.453 . . . . 0.0 112.171 -173.317 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.422 ' HB2' ' NE2' ' A' ' 33' ' ' GLN . 37.6 p -79.11 -38.58 35.85 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 112.724 0.639 . . . . 0.0 112.724 -178.609 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.438 ' O ' ' NZ ' ' A' ' 13' ' ' LYS . 8.9 mmt180 -78.69 127.72 32.48 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.362 0.601 . . . . 0.0 111.953 -178.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 95.3 t -143.21 124.18 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.765 -178.409 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.52 112.11 15.25 Favored 'General case' 0 CA--C 1.537 0.463 0 O-C-N 122.214 -0.303 . . . . 0.0 110.817 177.757 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 48.2 t -147.13 98.77 3.07 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 112.516 0.561 . . . . 0.0 112.516 -178.825 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.54 ' HB2' ' HB ' ' A' ' 30' ' ' VAL . 35.1 t70 -143.49 64.98 1.33 Allowed 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.744 0.783 . . . . 0.0 110.167 174.957 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 160.88 -172.99 37.3 Favored Glycine 0 CA--C 1.519 0.34 0 CA-C-N 115.846 -0.615 . . . . 0.0 112.043 -179.067 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -61.87 -42.58 99.76 Favored Glycine 0 CA--C 1.526 0.727 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.373 177.384 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -164.67 177.3 8.13 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 122.92 0.488 . . . . 0.0 109.966 176.38 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -45.41 -50.68 10.06 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 121.468 -0.396 . . . . 0.0 113.898 176.278 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -83.36 -2.2 55.18 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.161 0.505 . . . . 0.0 111.942 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.0 tt -125.69 56.04 1.41 Allowed 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.631 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 125.69 -140.37 12.16 Favored Glycine 0 CA--C 1.524 0.627 0 CA-C-N 115.341 -0.845 . . . . 0.0 112.598 178.307 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 1.6 m80 64.16 56.67 1.66 Allowed Pre-proline 0 CA--C 1.548 0.895 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 174.516 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.438 ' O ' ' HB2' ' A' ' 29' ' ' ARG . 19.4 Cg_endo -58.04 -58.2 0.87 Allowed 'Trans proline' 0 C--N 1.358 1.046 0 C-N-CA 122.212 1.941 . . . . 0.0 111.993 176.481 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.438 ' HB2' ' O ' ' A' ' 28' ' ' PRO . 10.1 tpt180 178.43 85.41 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 121.979 0.895 . . . . 0.0 110.831 170.558 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.54 ' HB ' ' HB2' ' A' ' 19' ' ' ASP . 89.9 t -137.78 117.77 15.77 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 CA-C-N 114.526 -1.216 . . . . 0.0 110.178 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 81.9 m95 -105.66 119.95 40.43 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 121.348 0.594 . . . . 0.0 112.254 -174.569 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.418 ' N ' HD12 ' A' ' 32' ' ' LEU . 6.9 mp -81.09 152.35 27.88 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.679 173.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.422 ' NE2' ' HB2' ' A' ' 14' ' ' SER . 25.0 tp60 -120.77 111.93 18.2 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.882 -178.887 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.529 HG21 ' HB2' ' A' ' 52' ' ' LEU . 61.0 mt -77.23 109.7 10.03 Favored Pre-proline 0 CA--C 1.541 0.608 0 CA-C-O 120.57 0.224 . . . . 0.0 110.397 173.431 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -86.47 156.24 9.27 Favored 'Trans proline' 0 CA--C 1.536 0.622 0 C-N-CA 122.793 2.329 . . . . 0.0 113.391 -176.871 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -73.79 -18.89 60.91 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.042 0.449 . . . . 0.0 110.271 174.372 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -58.02 -56.22 24.77 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-O 121.275 0.56 . . . . 0.0 110.927 174.895 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 44.6 p -90.48 -50.32 6.01 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.748 -179.66 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 99.48 1.55 56.63 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-N 116.141 -0.481 . . . . 0.0 112.415 -174.353 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.561 ' HB3' HG22 ' A' ' 51' ' ' VAL . 30.1 p-90 -158.55 170.86 21.25 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 122.656 0.382 . . . . 0.0 111.827 -177.036 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 11.2 p -141.93 144.92 24.79 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 CA-C-O 120.882 0.372 . . . . 0.0 111.039 175.289 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -104.38 137.94 41.53 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 120.875 0.369 . . . . 0.0 111.132 -178.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.665 ' SG ' ' HE2' ' A' ' 50' ' ' TYR . 68.6 m -95.13 109.59 45.48 Favored Pre-proline 0 N--CA 1.472 0.66 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.617 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -64.97 -12.03 32.6 Favored 'Trans proline' 0 CA--C 1.543 0.967 0 C-N-CA 122.495 2.13 . . . . 0.0 113.585 -178.144 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 -110.93 -62.63 1.51 Allowed 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 120.827 0.346 . . . . 0.0 111.716 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.504 ' SG ' ' SG ' ' A' ' 48' ' ' CYS . 42.8 t -73.08 -14.76 61.46 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -178.985 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 16.0 t70 71.96 -4.85 1.85 Allowed 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 123.342 0.657 . . . . 0.0 112.69 177.258 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.504 ' SG ' ' SG ' ' A' ' 46' ' ' CYS . 81.2 m -65.83 147.65 53.03 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.087 0.47 . . . . 0.0 112.198 178.035 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 59.8 tttm -118.45 104.31 10.58 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.419 178.258 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.665 ' HE2' ' SG ' ' A' ' 43' ' ' CYS . 97.3 m-85 -89.26 113.92 25.22 Favored 'General case' 0 N--CA 1.468 0.444 0 O-C-N 122.057 -0.402 . . . . 0.0 111.411 -174.109 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.561 HG22 ' HB3' ' A' ' 40' ' ' TRP . 80.1 t -95.69 136.56 26.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 CA-C-O 120.777 0.322 . . . . 0.0 111.435 176.014 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.529 ' HB2' HG21 ' A' ' 34' ' ' ILE . 48.7 tp -71.97 120.03 16.99 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 121.29 0.567 . . . . 0.0 111.195 178.46 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -65.78 116.88 7.43 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.518 -179.003 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 91.27 14.97 56.63 Favored Glycine 0 CA--C 1.527 0.784 0 CA-C-N 116.195 -0.457 . . . . 0.0 113.054 -176.03 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.515 ' HB3' ' HB3' ' A' ' 52' ' ' LEU . 76.9 p -91.09 -177.93 5.04 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 121.379 0.609 . . . . 0.0 111.916 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -57.42 -37.79 73.31 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.771 173.152 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -78.69 -30.78 46.25 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -176.551 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -82.24 -41.92 19.6 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 120.936 0.398 . . . . 0.0 111.662 179.177 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -79.6 -60.54 2.31 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -178.086 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 94.6 mt 61.85 101.0 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 122.602 0.361 . . . . 0.0 111.747 -176.032 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 53.9 mm-40 69.07 159.73 0.18 Allowed 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 121.659 0.742 . . . . 0.0 112.729 -179.788 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 19.1 p80 -147.22 123.22 10.73 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.901 -179.72 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 52.8 m80 -125.95 132.2 52.13 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -176.434 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 33.3 p80 -166.8 127.39 1.59 Allowed 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.825 171.387 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 38.6 m80 -75.81 118.24 18.4 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.309 -177.098 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 58.5 m80 67.87 -163.39 0.21 Allowed 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 122.778 0.431 . . . . 0.0 111.263 -175.5 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 10.6 p80 . . . . . 0 C--O 1.249 1.048 0 CA-C-O 119.116 -0.468 . . . . 0.0 111.95 -179.416 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.6 mmt . . . . . 0 N--CA 1.492 1.661 0 N-CA-C 111.753 0.279 . . . . 0.0 111.753 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.486 ' O ' ' HB ' ' A' ' 3' ' ' ILE . 7.0 m -85.17 -2.3 57.86 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -174.378 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.486 ' HB ' ' O ' ' A' ' 2' ' ' THR . 1.9 mp 74.4 -20.06 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 122.894 0.478 . . . . 0.0 111.892 -178.866 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 73.97 -52.33 0.69 Allowed 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.715 0.806 . . . . 0.0 112.706 177.035 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 60.16 69.77 1.14 Allowed Pre-proline 0 N--CA 1.473 0.697 0 CA-C-O 121.122 0.487 . . . . 0.0 111.983 -179.265 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_exo -71.72 90.35 0.72 Allowed 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 122.711 2.274 . . . . 0.0 112.688 -179.665 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -64.6 144.32 57.29 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 121.351 0.596 . . . . 0.0 111.956 178.346 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 67.9 p -90.38 142.99 27.18 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.126 -179.028 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.419 ' HD3' ' CD1' ' A' ' 50' ' ' TYR . 57.4 tttp -116.56 97.92 6.27 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 176.282 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.545 HG23 ' HB2' ' A' ' 53' ' ' LYS . 2.0 mp -77.03 124.0 34.63 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-O 121.153 0.502 . . . . 0.0 112.266 -172.846 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 30.2 m -136.35 162.4 35.7 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.003 177.0 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -102.17 -16.41 16.37 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 111.76 0.282 . . . . 0.0 111.76 176.569 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -106.81 142.31 36.64 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 121.125 0.488 . . . . 0.0 111.3 177.28 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 74.6 m -76.17 -6.47 51.44 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 -173.126 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 90.2 mtt180 -111.61 120.13 41.05 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 121.61 -0.681 . . . . 0.0 112.081 177.085 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 37.4 t -134.71 140.95 44.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.996 179.711 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -93.89 127.92 39.9 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 116.729 -0.214 . . . . 0.0 111.142 178.433 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.568 ' SG ' ' HB2' ' A' ' 47' ' ' ASP . 41.4 t -63.7 98.7 0.19 Allowed 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 120.873 0.368 . . . . 0.0 110.926 177.0 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -69.64 -52.4 26.17 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 -174.824 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -159.96 -145.38 4.25 Favored Glycine 0 C--O 1.223 -0.56 0 C-N-CA 119.851 -1.166 . . . . 0.0 114.998 -172.095 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 89.73 -5.03 83.77 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 121.377 -0.439 . . . . 0.0 113.19 -176.18 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.645 ' HB2' ' NE2' ' A' ' 27' ' ' HIS . 10.1 tp10 -95.39 122.36 38.02 Favored 'General case' 0 N--CA 1.469 0.485 0 O-C-N 122.457 -0.437 . . . . 0.0 110.982 -179.187 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 39.69 -90.86 0.01 OUTLIER Glycine 0 CA--C 1.531 1.078 0 O-C-N 123.379 0.424 . . . . 0.0 113.839 -178.406 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -80.84 31.23 0.31 Allowed 'General case' 0 CA--C 1.544 0.726 0 O-C-N 122.605 -0.35 . . . . 0.0 111.191 174.775 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.8 pp 48.81 39.55 14.32 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 124.675 1.19 . . . . 0.0 113.638 -179.377 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.431 ' O ' ' HB3' ' A' ' 22' ' ' GLU . . . -132.52 152.59 20.3 Favored Glycine 0 CA--C 1.534 1.261 0 C-N-CA 120.859 -0.686 . . . . 0.0 114.264 178.755 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.645 ' NE2' ' HB2' ' A' ' 22' ' ' GLU . 24.2 m80 -139.06 155.13 72.89 Favored Pre-proline 0 N--CA 1.479 0.977 0 C-N-CA 122.894 0.478 . . . . 0.0 110.988 174.055 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -69.1 -72.8 0.02 OUTLIER 'Trans proline' 0 CA--C 1.545 1.044 0 C-N-CA 122.605 2.203 . . . . 0.0 114.411 -179.431 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 3.8 tmt_? -179.08 94.64 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.156 0 CA-C-O 121.85 0.833 . . . . 0.0 110.584 -174.005 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.459 HG23 ' HB3' ' A' ' 18' ' ' CYS . 14.5 m -136.7 120.03 22.28 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.257 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.838 173.004 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 48.1 m95 -99.43 112.61 24.77 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.356 -178.527 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.438 ' N ' HD12 ' A' ' 32' ' ' LEU . 6.1 mp -90.26 132.1 35.71 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 121.118 0.485 . . . . 0.0 111.61 -179.392 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 27.3 tp60 -93.68 106.74 18.69 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.858 176.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.563 HG12 HG12 ' A' ' 41' ' ' VAL . 97.8 mt -60.73 125.35 82.68 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.026 176.878 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.567 ' HG2' ' OG1' ' A' ' 38' ' ' THR . 84.5 Cg_endo -76.96 105.34 2.06 Favored 'Trans proline' 0 CA--C 1.535 0.566 0 C-N-CA 122.261 1.974 . . . . 0.0 111.753 177.533 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -57.93 -19.13 27.81 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 121.299 0.571 . . . . 0.0 110.366 178.205 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -54.66 -43.53 72.47 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.503 172.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.567 ' OG1' ' HG2' ' A' ' 35' ' ' PRO . 44.1 p -97.49 -57.73 2.18 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.722 177.536 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 120.55 0.99 12.29 Favored Glycine 0 CA--C 1.529 0.926 0 CA-C-N 115.849 -0.614 . . . . 0.0 112.627 -177.676 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 63.9 p-90 -162.12 160.62 27.5 Favored 'General case' 0 N--CA 1.471 0.607 0 O-C-N 122.709 -0.289 . . . . 0.0 111.396 -176.248 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.563 HG12 HG12 ' A' ' 34' ' ' ILE . 11.6 p -148.4 129.91 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 CA-C-O 120.713 0.292 . . . . 0.0 110.807 173.75 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.416 ' HA ' ' HA ' ' A' ' 49' ' ' LYS . 9.6 pt-20 -90.89 140.02 30.21 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 120.913 0.387 . . . . 0.0 111.211 178.042 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 44.5 t -70.35 126.37 92.3 Favored Pre-proline 0 N--CA 1.47 0.569 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.774 -176.596 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.32 -26.16 29.92 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 122.785 2.323 . . . . 0.0 112.971 -179.653 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -78.36 -92.92 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 121.123 0.487 . . . . 0.0 111.016 177.675 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 48.0 t -172.41 81.38 0.05 Allowed 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.039 0.447 . . . . 0.0 110.305 -179.412 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.568 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 13.3 t70 -136.8 -95.72 0.22 Allowed 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.393 -178.06 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 90.7 m -153.62 -170.34 3.56 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 120.92 0.39 . . . . 0.0 110.674 177.823 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.416 ' HA ' ' HA ' ' A' ' 42' ' ' GLU . 34.8 ttpt -111.62 115.6 29.4 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 120.899 0.381 . . . . 0.0 110.632 175.886 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.419 ' CD1' ' HD3' ' A' ' 9' ' ' LYS . 43.4 m-85 -82.69 114.92 21.38 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.18 -171.218 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 80.9 t -109.38 123.74 65.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-O 121.314 0.578 . . . . 0.0 111.843 -176.668 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 46.0 tp -81.0 107.95 14.26 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.733 178.405 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.545 ' HB2' HG23 ' A' ' 10' ' ' ILE . 28.6 ttpp -65.15 147.45 53.45 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 120.907 0.384 . . . . 0.0 111.293 -179.593 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 85.95 7.89 80.07 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.446 -174.63 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 14.8 t -109.78 173.71 6.2 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 120.913 0.387 . . . . 0.0 111.499 179.143 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 23.5 pttm -62.81 -18.1 62.24 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-O 120.818 0.342 . . . . 0.0 111.241 175.542 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -74.0 -24.53 59.6 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.377 0.608 . . . . 0.0 110.804 174.296 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -95.56 -21.44 18.27 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.436 175.855 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.555 ' O ' ' HB2' ' A' ' 62' ' ' HIS . . . 71.08 102.59 0.06 Allowed 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.708 -176.503 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 83.8 mt -46.77 149.6 0.82 Allowed 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 -175.189 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 25.3 mm-40 73.42 -82.5 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.852 -170.25 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' HIS . . . . . 0.555 ' HB2' ' O ' ' A' ' 59' ' ' ALA . 8.9 t-160 52.1 28.63 5.56 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-O 120.889 0.376 . . . . 0.0 111.84 175.771 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 47.5 t-80 62.79 26.01 15.38 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 122.986 0.514 . . . . 0.0 112.235 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 33.7 m-70 -74.67 -3.92 34.19 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 121.922 -0.486 . . . . 0.0 111.665 177.833 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 57.3 t-80 -68.08 112.1 4.85 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 121.036 0.446 . . . . 0.0 111.575 178.615 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 78.9 m80 -85.19 165.69 17.18 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.436 179.239 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 53.6 t-80 . . . . . 0 C--O 1.252 1.218 0 CA-C-O 118.934 -0.555 . . . . 0.0 111.722 -175.419 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.446 ' C ' ' SD ' ' A' ' 1' ' ' MET . 0.9 OUTLIER . . . . . 0 N--CA 1.487 1.414 0 CA-C-O 120.696 0.284 . . . . 0.0 111.05 . . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 66.8 p -128.77 148.24 50.84 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 120.957 0.408 . . . . 0.0 111.249 176.589 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 62.1 mt -75.47 -23.2 16.69 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-O 121.045 0.45 . . . . 0.0 110.625 174.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 64.12 -86.1 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.262 -178.385 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 46.63 79.28 0.35 Allowed Pre-proline 0 CA--C 1.544 0.737 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 177.86 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.499 ' HD2' ' HD2' ' A' ' 49' ' ' LYS . 22.8 Cg_exo -64.92 76.72 0.21 Allowed 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 122.584 2.189 . . . . 0.0 112.481 176.574 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 55.66 103.27 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.255 0.622 . . . . 0.0 111.246 -175.069 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 87.4 m -100.02 124.57 45.53 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -172.526 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 44.7 mttp -122.59 109.03 13.8 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.877 177.299 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.57 HG22 ' HB2' ' A' ' 53' ' ' LYS . 15.7 mt -82.99 79.87 1.44 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-O 121.191 0.52 . . . . 0.0 109.706 177.477 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.443 HG12 ' H ' ' A' ' 13' ' ' LYS . 4.7 t -92.45 148.69 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 CA-C-O 121.036 0.445 . . . . 0.0 111.571 -172.784 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -78.55 -20.76 49.91 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 120.847 0.356 . . . . 0.0 111.343 -175.662 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.443 ' H ' HG12 ' A' ' 11' ' ' VAL . 7.0 ptpp? -108.92 148.62 30.4 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 120.895 0.379 . . . . 0.0 111.522 177.462 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.441 ' HA ' HD12 ' A' ' 34' ' ' ILE . 67.4 p -82.36 -44.01 16.7 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 112.894 0.701 . . . . 0.0 112.894 -177.198 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 49.2 mtt180 -78.59 90.54 4.54 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 121.417 0.627 . . . . 0.0 111.627 -176.052 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 47.8 t -110.53 120.65 61.83 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.29 -179.69 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -96.11 158.27 15.52 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 121.016 0.436 . . . . 0.0 111.867 179.41 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 51.4 t -149.42 140.9 23.33 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 120.946 0.403 . . . . 0.0 111.401 178.247 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -94.44 -59.58 1.91 Allowed 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.09 174.321 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 162.64 -146.44 11.86 Favored Glycine 0 CA--C 1.524 0.62 0 C-N-CA 120.858 -0.687 . . . . 0.0 113.216 177.355 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -133.82 -90.26 0.39 Allowed Glycine 0 CA--C 1.525 0.669 0 C-N-CA 121.429 -0.415 . . . . 0.0 112.782 -179.125 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -71.36 156.56 39.36 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 122.564 -0.374 . . . . 0.0 111.032 177.238 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -44.47 -46.27 8.61 Favored Glycine 0 CA--C 1.532 1.108 0 N-CA-C 113.671 0.229 . . . . 0.0 113.671 178.655 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -74.29 -24.09 59.19 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 178.362 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 83.7 mt -93.43 17.38 11.53 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 120.908 0.385 . . . . 0.0 111.777 -177.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -78.07 104.42 2.01 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 121.15 -0.547 . . . . 0.0 112.895 178.341 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.408 ' HA ' ' HD3' ' A' ' 28' ' ' PRO . 25.7 m170 -78.39 148.66 74.33 Favored Pre-proline 0 CA--C 1.542 0.662 0 O-C-N 122.63 -0.335 . . . . 0.0 110.533 178.16 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 27' ' ' HIS . 12.2 Cg_exo -72.08 49.34 1.3 Allowed 'Trans proline' 0 CA--C 1.549 1.27 0 C-N-CA 123.091 2.527 . . . . 0.0 114.112 -177.591 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.406 ' HA ' ' HD3' ' A' ' 29' ' ' ARG . 3.4 tpp180 64.13 90.72 0.08 Allowed 'General case' 0 N--CA 1.441 -0.896 0 CA-C-O 121.879 0.847 . . . . 0.0 112.19 176.514 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 31.4 m -98.35 124.75 51.64 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 CA-C-N 114.6 -1.182 . . . . 0.0 111.563 178.382 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 50.4 m95 -104.68 112.82 26.05 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 120.898 0.38 . . . . 0.0 111.302 178.5 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.443 ' N ' HD12 ' A' ' 32' ' ' LEU . 5.8 mp -98.87 127.99 44.94 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 121.254 0.549 . . . . 0.0 112.083 -177.399 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -104.11 108.42 19.77 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.738 176.186 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.581 HG21 ' HB2' ' A' ' 52' ' ' LEU . 80.0 mt -67.61 121.36 78.86 Favored Pre-proline 0 CA--C 1.538 0.482 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.846 176.415 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.676 ' HG2' HG22 ' A' ' 38' ' ' THR . 72.8 Cg_endo -76.8 103.67 1.79 Allowed 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 122.147 1.898 . . . . 0.0 112.116 178.329 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -48.81 -26.67 2.52 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.068 0.547 . . . . 0.0 112.186 179.017 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -51.19 -46.19 62.07 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-N 116.144 -0.48 . . . . 0.0 112.049 175.639 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.676 HG22 ' HG2' ' A' ' 35' ' ' PRO . 14.9 t -104.7 -32.92 8.66 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 111.871 0.323 . . . . 0.0 111.871 -179.562 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 103.98 2.67 45.61 Favored Glycine 0 CA--C 1.533 1.217 0 N-CA-C 114.92 0.728 . . . . 0.0 114.92 174.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.492 ' H ' HG23 ' A' ' 38' ' ' THR . 58.2 p-90 -156.52 163.45 39.38 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 117.942 0.871 . . . . 0.0 112.09 -175.423 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.575 HG12 HG12 ' A' ' 34' ' ' ILE . 6.3 p -150.21 165.88 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 N-CA-C 109.873 -0.418 . . . . 0.0 109.873 174.645 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -142.6 150.82 40.82 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.256 0.551 . . . . 0.0 111.648 176.139 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.634 ' SG ' ' N ' ' A' ' 47' ' ' ASP . 28.6 p -69.99 141.37 89.33 Favored Pre-proline 0 N--CA 1.468 0.468 0 CA-C-N 115.692 -0.686 . . . . 0.0 112.663 -172.747 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 43' ' ' CYS . 18.3 Cg_exo -67.55 -27.88 38.72 Favored 'Trans proline' 0 CA--C 1.542 0.894 0 C-N-CA 122.708 2.272 . . . . 0.0 113.25 177.904 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -94.51 -83.62 0.34 Allowed 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 -178.688 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 49.5 t -168.14 18.47 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.953 0 CA-C-O 120.797 0.332 . . . . 0.0 111.874 -177.683 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.634 ' N ' ' SG ' ' A' ' 43' ' ' CYS . 2.1 m-20 -66.6 -79.17 0.05 OUTLIER 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 116.292 -0.413 . . . . 0.0 112.075 -174.431 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.435 ' SG ' ' O ' ' A' ' 47' ' ' ASP . 72.0 m -161.62 171.25 18.31 Favored 'General case' 0 N--CA 1.479 1.011 0 CA-C-O 121.516 0.674 . . . . 0.0 112.607 -177.743 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.499 ' HD2' ' HD2' ' A' ' 6' ' ' PRO . 36.1 tttp -110.65 120.29 41.94 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.692 174.416 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -108.67 115.34 29.92 Favored 'General case' 0 N--CA 1.469 0.502 0 O-C-N 121.871 -0.518 . . . . 0.0 112.23 -170.167 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 94.9 t -96.42 137.9 23.07 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.09 176.26 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.581 ' HB2' HG21 ' A' ' 34' ' ' ILE . 36.7 tp -84.35 104.77 14.65 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 121.514 0.673 . . . . 0.0 111.92 -178.942 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.57 ' HB2' HG22 ' A' ' 10' ' ' ILE . 47.3 tttm -62.2 128.19 34.95 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.75 178.657 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 93.33 -5.48 74.66 Favored Glycine 0 CA--C 1.529 0.943 0 CA-C-N 116.034 -0.53 . . . . 0.0 113.409 -177.348 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 44.7 t -95.46 -175.61 3.52 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 122.468 -0.431 . . . . 0.0 111.441 178.745 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 15.3 ptmm? -62.27 -19.97 63.79 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 120.872 0.368 . . . . 0.0 111.489 178.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -82.31 -10.79 58.97 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 112.027 0.38 . . . . 0.0 112.027 177.302 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -73.56 75.48 1.47 Allowed 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 121.674 0.749 . . . . 0.0 110.376 177.915 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -139.64 13.41 2.52 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.593 -179.232 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.443 HD22 ' N ' ' A' ' 60' ' ' LEU . 2.8 mm? -76.71 70.14 3.17 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.447 0.642 . . . . 0.0 110.608 178.599 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -141.79 86.27 1.98 Allowed 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.136 -178.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 40.2 p-80 -78.01 -13.88 59.72 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.049 0.452 . . . . 0.0 110.61 178.599 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 40.1 t-80 -171.19 -45.8 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.426 177.293 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 40.4 m-70 -106.92 124.65 49.93 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.36 176.282 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 5.1 t-160 -99.22 114.59 27.47 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 175.8 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 22.2 p80 -154.11 178.72 9.66 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 120.974 0.416 . . . . 0.0 112.113 -176.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 41.9 t60 . . . . . 0 C--O 1.249 1.077 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.822 170.934 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.3 mtt . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 120.887 0.375 . . . . 0.0 111.508 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 72.8 p -84.74 131.09 34.6 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 120.978 0.418 . . . . 0.0 111.678 179.583 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 33.6 pt -74.64 -17.94 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-O 120.699 0.285 . . . . 0.0 111.33 177.368 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 69.4 mt-30 68.69 141.59 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.377 0.671 . . . . 0.0 112.157 -179.612 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 61.61 73.91 0.54 Allowed Pre-proline 0 CA--C 1.544 0.719 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 176.383 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -77.81 65.73 8.19 Favored 'Trans proline' 0 CA--C 1.545 1.034 0 C-N-CA 122.514 2.143 . . . . 0.0 112.541 177.836 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -66.85 155.14 39.11 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.559 -179.23 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 69.1 m -125.03 142.02 51.75 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 122.447 0.299 . . . . 0.0 111.388 -178.266 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 25.1 mtmm -137.01 126.91 25.76 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 120.932 0.396 . . . . 0.0 111.25 177.068 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.525 HD12 ' N ' ' A' ' 10' ' ' ILE . 2.6 mp -92.67 110.78 23.46 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.494 178.578 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 33.7 m -104.35 164.31 3.78 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-O 121.228 0.537 . . . . 0.0 111.802 -177.888 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -96.38 -23.62 16.54 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 116.16 -0.473 . . . . 0.0 112.066 -177.218 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -120.27 151.17 39.56 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-O 120.941 0.4 . . . . 0.0 111.475 -177.771 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 19.9 m -68.97 -26.63 65.14 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 113.607 0.966 . . . . 0.0 113.607 -171.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 4.5 tpt180 -101.77 119.89 39.5 Favored 'General case' 0 N--CA 1.473 0.688 0 O-C-N 121.494 -0.754 . . . . 0.0 111.605 -178.558 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 41.0 t -129.69 141.89 45.31 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 CA-C-O 120.813 0.339 . . . . 0.0 111.322 -178.779 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -92.39 116.1 28.68 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.875 0.369 . . . . 0.0 111.356 177.548 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.506 ' HB3' HG23 ' A' ' 30' ' ' VAL . 40.1 t -80.26 91.45 5.62 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.282 179.411 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -69.7 -76.48 0.1 Allowed 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.55 -176.317 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 161.55 -157.71 29.42 Favored Glycine 0 CA--C 1.526 0.721 0 C-N-CA 120.058 -1.068 . . . . 0.0 114.164 179.018 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -104.0 -74.08 0.97 Allowed Glycine 0 CA--C 1.524 0.651 0 CA-C-O 121.097 0.276 . . . . 0.0 112.794 -179.697 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.465 ' H ' ' HB2' ' A' ' 25' ' ' LEU . 68.6 mm-40 -103.97 165.74 10.85 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 122.506 0.322 . . . . 0.0 111.006 176.184 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -44.09 -56.87 5.09 Favored Glycine 0 CA--C 1.53 1.002 0 N-CA-C 114.096 0.398 . . . . 0.0 114.096 179.048 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.75 -15.56 62.18 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 120.941 0.401 . . . . 0.0 112.037 -179.334 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.465 ' HB2' ' H ' ' A' ' 22' ' ' GLU . 90.1 mt -97.22 12.91 31.22 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.53 179.591 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -81.71 143.85 23.74 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 121.387 -0.435 . . . . 0.0 113.201 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 20.2 m80 -91.57 147.28 34.89 Favored Pre-proline 0 CA--C 1.539 0.533 0 O-C-N 122.655 -0.32 . . . . 0.0 111.108 -176.153 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -73.51 62.03 4.43 Favored 'Trans proline' 0 CA--C 1.545 1.026 0 C-N-CA 122.709 2.273 . . . . 0.0 113.639 -178.831 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.424 ' HD3' ' HA ' ' A' ' 29' ' ' ARG . 12.3 tpp180 58.6 88.07 0.07 Allowed 'General case' 0 N--CA 1.439 -0.993 0 CA-C-O 122.236 1.017 . . . . 0.0 112.733 176.063 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.506 HG23 ' HB3' ' A' ' 18' ' ' CYS . 17.4 m -119.08 116.38 50.81 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 CA-C-N 114.294 -1.321 . . . . 0.0 111.242 176.151 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 89.0 m95 -96.65 109.63 22.22 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.531 -178.633 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.7 mp -90.13 154.89 19.43 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 121.149 0.5 . . . . 0.0 111.276 177.219 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 6.5 tp60 -122.73 129.13 51.41 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.002 0.429 . . . . 0.0 111.368 178.754 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.586 HG12 HG12 ' A' ' 41' ' ' VAL . 55.0 mt -87.09 117.73 69.02 Favored Pre-proline 0 CA--C 1.537 0.447 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.146 177.907 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.509 ' HG2' ' OG1' ' A' ' 38' ' ' THR . 82.5 Cg_endo -79.76 123.34 5.24 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 122.179 1.919 . . . . 0.0 111.832 177.707 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.503 ' O ' ' HB2' ' A' ' 56' ' ' LYS . 13.0 pt-20 -56.23 -23.79 38.07 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 111.923 0.342 . . . . 0.0 111.923 -177.355 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -66.93 -35.62 80.39 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 178.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.509 ' OG1' ' HG2' ' A' ' 35' ' ' PRO . 39.9 p -92.29 -50.89 5.43 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 120.924 0.392 . . . . 0.0 110.775 178.723 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.511 ' HA2' ' OG ' ' A' ' 55' ' ' SER . . . 103.98 -0.03 44.91 Favored Glycine 0 CA--C 1.524 0.596 0 CA-C-N 116.073 -0.512 . . . . 0.0 112.841 -178.761 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.412 ' HA ' ' O ' ' A' ' 50' ' ' TYR . 67.7 p-90 -162.14 162.54 28.54 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 120.716 0.293 . . . . 0.0 111.327 -175.933 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.586 HG12 HG12 ' A' ' 34' ' ' ILE . 9.7 p -142.27 141.74 28.13 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-O 121.033 0.444 . . . . 0.0 110.73 173.479 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.47 ' O ' ' HD3' ' A' ' 44' ' ' PRO . 9.0 pt-20 -100.74 141.27 33.85 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 111.849 0.314 . . . . 0.0 111.849 -177.474 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.542 ' SG ' ' HB3' ' A' ' 47' ' ' ASP . 29.9 p -98.4 99.91 8.21 Favored Pre-proline 0 CA--C 1.54 0.56 0 CA-C-O 120.64 0.257 . . . . 0.0 110.419 170.449 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.47 ' HD3' ' O ' ' A' ' 42' ' ' GLU . 23.2 Cg_exo -65.77 -3.92 8.96 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 122.735 2.29 . . . . 0.0 113.13 -178.328 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -82.83 -76.15 0.28 Allowed 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 116.592 -0.276 . . . . 0.0 110.589 179.522 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 24.8 p 173.86 92.33 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.358 177.205 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.542 ' HB3' ' SG ' ' A' ' 43' ' ' CYS . 13.5 t70 -161.02 -83.03 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 116.717 -0.219 . . . . 0.0 110.969 173.538 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.502 ' N ' ' SG ' ' A' ' 43' ' ' CYS . 81.9 m -160.76 178.27 9.61 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 122.144 0.973 . . . . 0.0 113.135 -177.892 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 19.3 ttmm -102.48 113.58 27.05 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 114.484 -1.235 . . . . 0.0 108.754 168.384 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.419 ' HB2' HG12 ' A' ' 41' ' ' VAL . 67.7 m-85 -85.85 105.71 16.55 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 111.847 0.314 . . . . 0.0 111.847 -173.569 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 67.0 t -88.22 133.05 31.73 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 CA-C-O 120.767 0.317 . . . . 0.0 111.038 174.328 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.504 ' HB2' HG21 ' A' ' 34' ' ' ILE . 53.2 tp -98.77 131.75 44.66 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 121.359 0.6 . . . . 0.0 112.42 -175.916 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -68.05 141.25 56.23 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 115.811 -0.632 . . . . 0.0 111.144 176.625 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 70.8 10.64 68.06 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 121.271 -0.49 . . . . 0.0 113.68 179.712 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.511 ' OG ' ' HA2' ' A' ' 39' ' ' GLY . 29.4 t -97.57 -171.08 2.11 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 122.495 -0.415 . . . . 0.0 111.535 -179.356 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.503 ' HB2' ' O ' ' A' ' 36' ' ' GLU . 47.3 tptt -53.32 -43.97 68.05 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 120.944 0.402 . . . . 0.0 111.928 -177.744 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -82.26 2.39 32.17 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -175.888 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -77.02 -36.55 56.17 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 120.924 0.392 . . . . 0.0 111.659 -178.377 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -80.35 50.35 1.26 Allowed 'General case' 0 CA--C 1.543 0.676 0 CA-C-O 121.031 0.443 . . . . 0.0 112.021 -178.53 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.424 HD12 ' O ' ' A' ' 60' ' ' LEU . 2.7 pp -76.98 155.58 32.55 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.936 179.604 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 53.77 34.7 19.68 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-O 121.083 0.468 . . . . 0.0 112.235 178.781 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 45.8 t60 -76.95 11.83 1.61 Allowed 'General case' 0 CA--C 1.547 0.852 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.579 -178.468 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 15.0 t-80 66.04 18.38 11.01 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 122.696 0.398 . . . . 0.0 111.786 176.769 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 33.4 t60 -98.31 123.97 42.7 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 120.658 0.266 . . . . 0.0 111.024 -179.183 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 23.2 m170 -78.82 171.92 14.49 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 121.676 0.751 . . . . 0.0 112.44 179.696 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 29.6 p80 -147.86 19.0 1.14 Allowed 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.738 177.887 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 25.2 t60 . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.666 -0.683 . . . . 0.0 110.699 -177.605 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.3 mmt . . . . . 0 N--CA 1.489 1.503 0 CA-C-O 120.845 0.355 . . . . 0.0 111.329 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 21.4 p -72.55 161.45 30.77 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 121.028 0.442 . . . . 0.0 111.942 177.53 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 45.7 mt -72.15 -8.83 12.11 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 CA-C-O 121.479 0.657 . . . . 0.0 110.714 177.148 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 70.61 10.07 7.03 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 115.357 -0.838 . . . . 0.0 112.853 176.173 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -127.81 74.47 78.53 Favored Pre-proline 0 N--CA 1.47 0.558 0 CA-C-O 121.018 0.437 . . . . 0.0 111.621 178.089 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -96.22 94.67 0.09 OUTLIER 'Trans proline' 0 CA--C 1.542 0.923 0 C-N-CA 123.377 2.718 . . . . 0.0 113.009 177.784 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.44 6.02 25.03 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 121.506 0.669 . . . . 0.0 111.854 177.737 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 54.2 m -89.86 111.37 22.39 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.602 177.836 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 46.8 tptt -100.54 109.3 21.39 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.04 -172.644 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 58.3 mt -79.04 94.22 1.73 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 CA-C-O 121.141 0.496 . . . . 0.0 110.602 179.462 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.51 HG12 ' H ' ' A' ' 13' ' ' LYS . 3.5 t -97.89 156.84 3.55 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 CA-C-O 121.127 0.489 . . . . 0.0 111.62 -175.763 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -96.43 -4.31 41.96 Favored 'General case' 0 CA--C 1.548 0.873 0 CA-C-O 121.01 0.433 . . . . 0.0 111.909 -178.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.51 ' H ' HG12 ' A' ' 11' ' ' VAL . 50.9 mtmt -137.35 153.08 50.29 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 122.101 -0.374 . . . . 0.0 111.42 -176.753 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 77.7 p -79.06 -40.15 32.01 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.063 0.459 . . . . 0.0 111.265 177.438 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 78.2 mtm180 -75.35 94.82 3.1 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.96 176.294 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.495 HG11 ' CD1' ' A' ' 50' ' ' TYR . 47.4 t -111.35 137.86 42.17 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.34 -177.627 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -97.96 118.46 34.59 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 121.069 0.461 . . . . 0.0 111.755 -179.728 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 10.0 t -66.78 124.92 24.26 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.061 174.762 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -98.7 -73.49 0.62 Allowed 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 120.875 0.369 . . . . 0.0 110.989 178.487 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.455 ' HA3' ' HA2' ' A' ' 26' ' ' GLY . . . 160.08 -178.25 36.22 Favored Glycine 0 CA--C 1.525 0.665 0 C-N-CA 120.693 -0.765 . . . . 0.0 113.103 177.898 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -91.02 -93.33 1.29 Allowed Glycine 0 CA--C 1.525 0.715 0 N-CA-C 111.364 -0.695 . . . . 0.0 111.364 172.17 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -87.58 166.28 14.84 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 168.723 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -45.41 -50.63 10.1 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 120.975 -0.631 . . . . 0.0 112.927 172.41 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.42 -15.29 60.32 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 178.357 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 93.6 mt -111.51 18.95 18.64 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.053 0.454 . . . . 0.0 110.488 176.438 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.455 ' HA2' ' HA3' ' A' ' 20' ' ' GLY . . . -75.95 122.89 6.75 Favored Glycine 0 CA--C 1.526 0.736 0 CA-C-N 115.956 -0.566 . . . . 0.0 113.52 -177.073 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 27.6 m80 -92.42 120.9 67.26 Favored Pre-proline 0 CA--C 1.543 0.679 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 178.143 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -74.05 53.55 2.94 Favored 'Trans proline' 0 CA--C 1.546 1.09 0 C-N-CA 122.975 2.45 . . . . 0.0 115.116 -168.715 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.425 ' NE ' ' HE1' ' A' ' 31' ' ' TRP . 0.8 OUTLIER 75.16 99.13 0.07 Allowed 'General case' 0 N--CA 1.446 -0.655 0 CA-C-O 122.769 1.271 . . . . 0.0 111.779 169.726 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 25.7 m -134.32 141.09 44.55 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 113.855 -1.521 . . . . 0.0 109.774 169.818 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.425 ' HE1' ' NE ' ' A' ' 29' ' ' ARG . 75.7 m95 -107.25 123.55 48.46 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -171.433 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.487 ' N ' HD12 ' A' ' 32' ' ' LEU . 5.1 mp -103.44 158.65 16.2 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.615 178.052 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 42.0 tp60 -123.77 109.53 13.78 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.935 0.398 . . . . 0.0 111.436 -179.002 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.501 HG12 HG12 ' A' ' 41' ' ' VAL . 64.6 mt -70.47 115.06 31.17 Favored Pre-proline 0 CA--C 1.542 0.656 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.47 178.439 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.432 ' HG2' ' OG1' ' A' ' 38' ' ' THR . 90.4 Cg_endo -80.11 145.47 17.38 Favored 'Trans proline' 0 CA--C 1.54 0.825 0 C-N-CA 122.517 2.145 . . . . 0.0 112.753 179.573 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.402 ' H ' ' CD ' ' A' ' 36' ' ' GLU . 20.9 mp0 -62.95 -29.51 70.86 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 121.105 0.479 . . . . 0.0 111.035 179.437 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -58.43 -50.28 74.25 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.497 -0.774 . . . . 0.0 112.155 -178.899 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.432 ' OG1' ' HG2' ' A' ' 35' ' ' PRO . 50.2 p -90.34 -49.16 6.69 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.077 0.465 . . . . 0.0 111.324 -178.267 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 98.24 0.95 58.22 Favored Glycine 0 CA--C 1.523 0.562 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.399 -176.292 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.557 ' HB3' HG22 ' A' ' 51' ' ' VAL . 68.2 p-90 -156.79 164.13 38.44 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 121.148 0.499 . . . . 0.0 112.151 -176.605 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.501 HG12 HG12 ' A' ' 34' ' ' ILE . 14.5 p -142.85 137.09 27.15 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.676 174.996 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -98.83 148.03 24.33 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.155 0.502 . . . . 0.0 112.139 -177.319 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.662 ' SG ' ' HE2' ' A' ' 50' ' ' TYR . 74.0 m -98.25 119.31 62.11 Favored Pre-proline 0 CA--C 1.538 0.519 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.578 171.256 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -73.13 22.44 0.32 Allowed 'Trans proline' 0 CA--C 1.541 0.861 0 C-N-CA 122.902 2.402 . . . . 0.0 114.036 -173.619 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -114.94 -88.7 0.57 Allowed 'General case' 0 CA--C 1.538 0.517 0 O-C-N 122.084 -0.385 . . . . 0.0 111.073 177.612 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 57.5 m -160.57 18.98 0.14 Allowed 'General case' 0 N--CA 1.477 0.913 0 CA-C-O 120.856 0.36 . . . . 0.0 111.331 -177.161 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.41 ' O ' ' SG ' ' A' ' 48' ' ' CYS . 2.1 m-20 -81.74 -93.5 0.05 Allowed 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 112.276 0.473 . . . . 0.0 112.276 -173.34 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.41 ' SG ' ' O ' ' A' ' 47' ' ' ASP . 72.3 m -161.38 173.33 15.09 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.553 0.692 . . . . 0.0 112.043 -176.539 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.7 ttmp? -101.47 104.77 15.71 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.269 169.041 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.662 ' HE2' ' SG ' ' A' ' 43' ' ' CYS . 95.4 m-85 -81.85 103.16 11.32 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.926 0.393 . . . . 0.0 111.767 -173.745 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.557 HG22 ' HB3' ' A' ' 40' ' ' TRP . 88.0 t -94.28 123.19 46.29 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.928 178.712 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 51.4 tp -77.88 120.41 22.72 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 116.585 -0.28 . . . . 0.0 110.978 176.893 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 46.8 tttp -65.71 146.06 55.25 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 121.149 0.5 . . . . 0.0 111.954 -178.567 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 85.11 17.45 62.86 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 121.117 -0.563 . . . . 0.0 112.549 -175.452 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.5 m -118.36 172.14 7.66 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 122.481 0.312 . . . . 0.0 110.886 -179.809 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -56.31 -30.08 62.09 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -178.753 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -75.96 -26.91 57.27 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 121.006 0.431 . . . . 0.0 112.111 179.079 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -77.69 72.48 4.23 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-O 121.549 0.69 . . . . 0.0 110.571 179.366 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -153.69 -17.86 0.14 Allowed 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -179.352 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.403 ' N ' HD12 ' A' ' 60' ' ' LEU . 7.0 mp -60.64 -73.72 0.09 Allowed 'General case' 0 CA--C 1.54 0.585 0 O-C-N 122.084 -0.385 . . . . 0.0 111.925 -178.285 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -96.42 116.35 28.91 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 120.806 0.336 . . . . 0.0 111.163 -178.774 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 1.7 p80 -167.95 134.25 2.03 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 120.901 0.381 . . . . 0.0 111.5 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 2.5 p-80 -138.63 -179.61 5.92 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.993 175.356 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 32.5 m170 -50.39 108.66 0.24 Allowed 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.218 0.532 . . . . 0.0 112.346 -175.361 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 37.5 m80 63.71 -88.88 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.965 177.781 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 85.7 m-70 -148.73 -35.14 0.2 Allowed 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 112.902 0.704 . . . . 0.0 112.902 -178.877 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 31.2 m170 . . . . . 0 C--O 1.251 1.169 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 -176.076 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.1 ptp . . . . . 0 N--CA 1.489 1.517 0 CA-C-O 121.02 0.438 . . . . 0.0 111.429 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 20.8 p -87.09 179.75 6.61 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.478 171.709 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 33.5 pt -68.81 -24.29 28.53 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-O 121.542 0.687 . . . . 0.0 109.738 169.461 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 61.94 2.05 0.72 Allowed 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 114.938 -1.028 . . . . 0.0 113.66 174.246 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -59.47 106.6 0.76 Allowed Pre-proline 0 CA--C 1.542 0.66 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 -176.547 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -91.77 30.81 0.32 Allowed 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 123.259 2.64 . . . . 0.0 113.011 -179.537 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -94.17 25.38 3.8 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 121.227 0.537 . . . . 0.0 112.069 -176.486 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 69.5 m -89.18 119.65 29.86 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.292 174.141 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 55.9 tptt -109.82 106.91 16.69 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 120.656 0.265 . . . . 0.0 111.236 -173.473 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 56.2 mt -86.09 100.95 9.79 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-O 121.104 0.478 . . . . 0.0 111.351 -179.771 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 34.5 m -103.94 162.57 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 CA-C-O 120.951 0.405 . . . . 0.0 111.35 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -92.93 -32.46 14.55 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-O 120.887 0.375 . . . . 0.0 111.618 -178.317 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -108.16 143.31 37.11 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 120.729 0.299 . . . . 0.0 111.643 -179.277 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 41.2 t -63.01 -37.24 86.38 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 112.824 0.676 . . . . 0.0 112.824 -176.234 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 52.5 mtt85 -74.18 105.49 5.41 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.201 0.524 . . . . 0.0 111.892 178.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 48.0 t -100.95 106.17 18.97 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.966 176.592 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -80.82 101.03 9.12 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 120.936 0.398 . . . . 0.0 111.266 178.689 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 52.0 t -96.74 104.75 16.78 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -178.737 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -77.3 -58.86 3.04 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 121.534 0.683 . . . . 0.0 110.369 172.176 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 162.35 172.19 29.47 Favored Glycine 0 CA--C 1.523 0.573 0 C-N-CA 121.074 -0.584 . . . . 0.0 113.065 176.891 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -106.41 -80.74 1.35 Allowed Glycine 0 CA--C 1.524 0.618 0 N-CA-C 111.65 -0.58 . . . . 0.0 111.65 175.562 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 23.6 mm-40 -99.61 169.56 9.19 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 122.26 0.224 . . . . 0.0 110.397 172.129 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -44.51 -46.93 8.8 Favored Glycine 0 CA--C 1.535 1.317 0 N-CA-C 114.142 0.417 . . . . 0.0 114.142 178.653 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.21 -24.97 68.12 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -179.639 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 91.4 mt -106.49 16.4 24.71 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 120.689 0.28 . . . . 0.0 111.655 -179.442 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -85.07 138.24 16.42 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 120.978 -0.63 . . . . 0.0 113.044 179.447 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -154.58 152.62 26.34 Favored Pre-proline 0 N--CA 1.472 0.653 0 O-C-N 122.583 -0.363 . . . . 0.0 111.125 179.629 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_exo -38.88 -67.28 0.11 Allowed 'Trans proline' 0 C--N 1.354 0.846 0 C-N-CA 123.587 2.858 . . . . 0.0 114.587 -175.507 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.48 ' HD3' ' HA ' ' A' ' 29' ' ' ARG . 0.1 OUTLIER -177.78 91.57 0.03 OUTLIER 'General case' 0 N--CA 1.441 -0.89 0 CA-C-O 122.24 1.019 . . . . 0.0 110.665 -178.12 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 55.8 t -93.94 105.07 16.45 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 CA-C-N 114.134 -1.394 . . . . 0.0 111.17 -179.771 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 56.7 m95 -92.22 111.52 23.11 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.367 178.609 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.413 ' N ' HD12 ' A' ' 32' ' ' LEU . 5.6 mp -91.37 134.03 34.95 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 120.753 0.311 . . . . 0.0 111.003 177.612 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.5 tp-100 -104.88 106.91 17.61 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 177.64 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.586 HG12 HG12 ' A' ' 41' ' ' VAL . 75.6 mt -63.46 117.42 34.16 Favored Pre-proline 0 CA--C 1.54 0.566 0 CA-C-O 120.602 0.239 . . . . 0.0 111.408 -179.702 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.555 ' HG2' ' OG1' ' A' ' 38' ' ' THR . 90.1 Cg_endo -80.1 127.78 7.01 Favored 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 122.611 2.207 . . . . 0.0 113.005 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -61.31 -21.94 64.44 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 120.981 0.42 . . . . 0.0 111.675 179.275 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -64.04 -35.12 79.68 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.884 178.0 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.555 ' OG1' ' HG2' ' A' ' 35' ' ' PRO . 36.0 p -106.04 -52.42 2.81 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-O 121.029 0.442 . . . . 0.0 111.605 -178.93 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 106.56 0.64 37.25 Favored Glycine 0 CA--C 1.526 0.762 0 CA-C-N 116.189 -0.46 . . . . 0.0 112.643 -176.813 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 67.7 p-90 -155.81 162.79 40.42 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 120.916 0.388 . . . . 0.0 111.595 -178.438 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.586 HG12 HG12 ' A' ' 34' ' ' ILE . 12.3 p -151.81 127.85 1.84 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.452 172.647 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.417 ' HA ' ' HA ' ' A' ' 49' ' ' LYS . 12.6 pt-20 -100.89 150.21 23.08 Favored 'General case' 0 CA--C 1.536 0.405 0 O-C-N 121.925 -0.485 . . . . 0.0 111.324 -179.357 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 42.6 t -97.16 107.41 37.94 Favored Pre-proline 0 N--CA 1.468 0.429 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.813 -177.417 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.412 ' HD3' ' O ' ' A' ' 42' ' ' GLU . 41.4 Cg_exo -58.55 -14.66 21.97 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 122.364 2.043 . . . . 0.0 113.035 177.467 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -105.03 -0.3 26.92 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.807 -178.386 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 42.5 t -143.9 -2.2 0.94 Allowed 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 112.416 0.525 . . . . 0.0 112.416 -179.781 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 61.7 m-20 70.95 -41.17 0.5 Allowed 'General case' 0 CA--C 1.548 0.876 0 N-CA-C 114.026 1.121 . . . . 0.0 114.026 178.125 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 77.3 m -58.69 145.68 39.2 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 -172.491 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.417 ' HA ' ' HA ' ' A' ' 42' ' ' GLU . 20.4 ttmm -107.46 123.25 48.13 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.989 -178.205 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 55.1 m-85 -100.53 114.61 28.39 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 -174.778 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.405 HG13 ' HB3' ' A' ' 57' ' ' ALA . 93.2 t -99.15 145.24 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 CA-C-O 120.819 0.342 . . . . 0.0 111.467 176.871 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.563 ' HB2' HG21 ' A' ' 34' ' ' ILE . 54.5 tp -94.1 126.09 39.12 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 120.907 0.384 . . . . 0.0 111.735 179.84 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.457 ' NZ ' ' HB3' ' A' ' 53' ' ' LYS . 0.9 OUTLIER -61.88 122.91 16.59 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.435 178.428 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 90.07 7.65 67.76 Favored Glycine 0 CA--C 1.524 0.649 0 C-N-CA 121.417 -0.421 . . . . 0.0 113.299 -178.768 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 34.6 t -100.72 -173.56 2.42 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 122.364 -0.492 . . . . 0.0 111.587 178.657 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 48.7 mmtm -54.31 -34.73 61.6 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 113.253 0.835 . . . . 0.0 113.253 -175.728 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.405 ' HB3' HG13 ' A' ' 51' ' ' VAL . . . -94.19 6.77 47.56 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -176.467 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -117.48 -136.31 0.35 Allowed 'General case' 0 CA--C 1.552 1.045 0 O-C-N 122.151 -0.343 . . . . 0.0 111.302 -178.301 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 64.31 17.15 10.59 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-O 121.15 0.5 . . . . 0.0 111.559 -173.78 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.6 pp -89.31 10.09 23.61 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 -177.887 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -65.78 90.51 0.12 Allowed 'General case' 0 CA--C 1.541 0.621 0 CA-C-O 121.281 0.562 . . . . 0.0 111.794 -178.574 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 71.7 m80 -97.66 -31.74 12.13 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.957 175.136 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 44.6 t60 -175.69 -35.06 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.93 174.626 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 33.8 m170 -63.98 92.58 0.08 Allowed 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 120.973 0.416 . . . . 0.0 110.912 175.373 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 8.1 t60 -172.09 -24.04 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.015 -178.8 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 11.9 p80 -150.92 149.88 30.17 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.345 179.293 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 60.8 t-80 . . . . . 0 C--O 1.249 1.076 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 176.829 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.9 ttt . . . . . 0 N--CA 1.489 1.522 0 CA-C-O 121.005 0.431 . . . . 0.0 110.697 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 5.2 m -108.14 -2.2 19.68 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -173.82 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.47 ' O ' HD12 ' A' ' 3' ' ' ILE . 2.1 pp 37.22 70.65 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-O 122.052 0.929 . . . . 0.0 111.833 -165.253 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -45.82 106.09 0.07 Allowed 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 114.697 -1.138 . . . . 0.0 112.033 -175.119 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.476 ' HB3' ' HD3' ' A' ' 6' ' ' PRO . . . -165.72 -53.85 0.01 OUTLIER Pre-proline 0 CA--C 1.547 0.834 0 CA-C-N 116.017 -0.538 . . . . 0.0 112.222 -176.607 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.476 ' HD3' ' HB3' ' A' ' 5' ' ' ALA . 68.9 Cg_endo -81.48 37.11 0.66 Allowed 'Trans proline' 0 C--N 1.358 1.073 0 C-N-CA 122.278 1.985 . . . . 0.0 113.085 -179.706 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -91.72 31.72 1.18 Allowed 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.073 0.463 . . . . 0.0 112.029 -174.265 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 86.1 m -122.14 135.6 54.81 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.671 176.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 57.6 mtpt -137.23 137.92 39.59 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 122.342 0.257 . . . . 0.0 111.116 -173.566 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 57.3 mt -97.45 107.34 19.89 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-O 120.966 0.412 . . . . 0.0 111.417 -179.031 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.44 HG12 ' H ' ' A' ' 13' ' ' LYS . 11.7 t -100.07 156.21 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.772 177.928 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -90.17 -7.8 52.75 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 -175.679 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.44 ' H ' HG12 ' A' ' 11' ' ' VAL . 16.5 ptpt -130.53 152.21 50.16 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 121.073 0.463 . . . . 0.0 111.892 -176.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 23.0 m -83.63 9.53 11.34 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -174.586 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 75.0 mtp180 -128.19 116.97 20.72 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 121.007 0.432 . . . . 0.0 111.759 -178.417 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 39.9 t -131.64 152.65 37.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.396 -178.619 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.472 ' HA ' ' O ' ' A' ' 30' ' ' VAL . . . -81.53 154.1 26.44 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-O 121.278 0.561 . . . . 0.0 112.404 -179.59 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.573 ' SG ' ' N ' ' A' ' 19' ' ' ASP . 43.1 t -136.53 -166.92 1.97 Allowed 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.773 -174.743 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.573 ' N ' ' SG ' ' A' ' 18' ' ' CYS . 15.7 t70 62.97 84.89 0.14 Allowed 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.586 0.754 . . . . 0.0 112.031 178.394 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.482 ' HA3' ' O ' ' A' ' 25' ' ' LEU . . . 160.05 160.45 10.56 Favored Glycine 0 CA--C 1.525 0.685 0 C-N-CA 121.336 -0.459 . . . . 0.0 112.217 177.609 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 167.43 35.86 0.02 OUTLIER Glycine 0 CA--C 1.531 1.045 0 C-N-CA 120.05 -1.071 . . . . 0.0 114.821 177.687 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -158.48 145.14 17.39 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 117.493 0.646 . . . . 0.0 110.989 174.328 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 41.04 -96.07 0.01 OUTLIER Glycine 0 CA--C 1.532 1.118 0 N-CA-C 114.293 0.477 . . . . 0.0 114.293 -174.006 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -78.45 2.26 19.48 Favored 'General case' 0 N--CA 1.473 0.675 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -178.244 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.482 ' O ' ' HA3' ' A' ' 20' ' ' GLY . 86.9 mt 64.85 13.78 8.76 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.393 0.677 . . . . 0.0 112.763 178.019 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 55.39 -118.13 9.84 Favored Glycine 0 CA--C 1.532 1.136 0 N-CA-C 113.979 0.352 . . . . 0.0 113.979 177.766 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 12.5 m-70 66.24 83.1 0.19 Allowed Pre-proline 0 N--CA 1.473 0.722 0 C-N-CA 123.523 0.729 . . . . 0.0 112.765 176.655 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.459 ' O ' ' HB2' ' A' ' 29' ' ' ARG . 57.3 Cg_endo -74.77 -62.36 0.04 OUTLIER 'Trans proline' 0 CA--C 1.542 0.888 0 C-N-CA 122.157 1.905 . . . . 0.0 111.594 172.412 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.459 ' HB2' ' O ' ' A' ' 28' ' ' PRO . 16.5 tpt180 176.84 83.89 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 122.01 0.909 . . . . 0.0 110.246 169.687 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.472 ' O ' ' HA ' ' A' ' 17' ' ' ALA . 61.2 t -128.11 132.24 68.65 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 CA-C-N 114.456 -1.247 . . . . 0.0 109.64 -178.595 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 84.2 m95 -115.58 136.15 53.36 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 -172.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.568 HD13 ' HB2' ' A' ' 18' ' ' CYS . 8.8 mp -113.53 144.53 42.69 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.633 172.138 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 6.5 tp60 -103.92 119.84 39.77 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.272 -179.258 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.661 HG12 HG12 ' A' ' 41' ' ' VAL . 50.7 mt -75.0 114.46 35.12 Favored Pre-proline 0 CA--C 1.54 0.566 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.956 177.432 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.565 ' HG2' ' OG1' ' A' ' 38' ' ' THR . 91.3 Cg_endo -77.92 132.34 11.71 Favored 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 122.475 2.117 . . . . 0.0 112.356 178.553 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -77.32 -7.72 56.49 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 120.836 0.351 . . . . 0.0 111.341 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -68.03 -56.01 10.48 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 121.028 0.442 . . . . 0.0 110.89 172.488 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.565 ' OG1' ' HG2' ' A' ' 35' ' ' PRO . 47.9 p -80.64 -43.26 20.75 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.157 177.874 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 103.07 -0.19 47.86 Favored Glycine 0 CA--C 1.524 0.617 0 CA-C-N 115.56 -0.745 . . . . 0.0 112.811 -178.279 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.542 ' HB3' HG22 ' A' ' 51' ' ' VAL . 65.9 p-90 -161.2 161.24 30.84 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 -176.288 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.661 HG12 HG12 ' A' ' 34' ' ' ILE . 9.8 p -146.76 133.39 13.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.231 169.929 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -111.39 140.45 45.97 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -174.604 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.528 ' HB3' ' SG ' ' A' ' 48' ' ' CYS . 43.8 t -74.41 112.87 19.1 Favored Pre-proline 0 CA--C 1.537 0.452 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.623 178.516 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -58.35 -14.39 20.07 Favored 'Trans proline' 0 CA--C 1.542 0.911 0 C-N-CA 122.695 2.263 . . . . 0.0 113.404 -178.645 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -87.18 -51.35 6.03 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.705 -177.733 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 52.4 t -103.27 -3.7 25.29 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -178.06 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 49.8 m-20 65.76 10.67 6.99 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.115 0.566 . . . . 0.0 112.373 179.739 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.528 ' SG ' ' HB3' ' A' ' 43' ' ' CYS . 6.4 p -73.85 116.85 14.94 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 121.145 0.498 . . . . 0.0 111.515 179.553 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 18.3 ttmm -91.88 113.12 25.3 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.79 -177.166 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -97.38 103.34 15.26 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 120.988 0.423 . . . . 0.0 111.921 -175.713 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.542 HG22 ' HB3' ' A' ' 40' ' ' TRP . 78.5 t -82.55 142.87 13.04 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.662 175.397 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.512 ' HB2' HG21 ' A' ' 34' ' ' ILE . 68.6 tp -89.41 124.93 34.91 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 120.91 0.386 . . . . 0.0 111.7 178.269 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 8.5 tmtm? -71.05 122.89 20.88 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 174.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 97.19 52.54 1.46 Allowed Glycine 0 CA--C 1.526 0.732 0 N-CA-C 111.749 -0.54 . . . . 0.0 111.749 -172.067 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.479 ' H ' ' HB3' ' A' ' 58' ' ' ASP . 51.6 p -155.31 -178.49 7.3 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.516 0.674 . . . . 0.0 111.75 -176.341 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 32.4 ttpt -67.68 -15.23 63.54 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-N 115.322 -0.854 . . . . 0.0 112.059 179.411 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -99.99 2.34 43.4 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 121.202 0.525 . . . . 0.0 111.667 176.736 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.479 ' HB3' ' H ' ' A' ' 55' ' ' SER . 16.4 t70 -119.17 176.24 5.41 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.73 -177.472 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 69.96 86.01 0.13 Allowed 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.472 0.653 . . . . 0.0 110.986 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.487 ' N ' HD12 ' A' ' 60' ' ' LEU . 5.3 mp -87.15 82.51 7.66 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.499 -174.914 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -62.38 -8.82 6.62 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-O 121.271 0.557 . . . . 0.0 111.836 179.199 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 30.5 p-80 -100.99 22.92 11.46 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.237 178.42 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 48.5 m80 -140.27 145.17 36.97 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 120.899 0.38 . . . . 0.0 111.709 174.881 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 4.4 t60 63.25 -76.81 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 123.294 0.637 . . . . 0.0 112.462 174.79 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 57.4 t-80 -171.9 133.49 0.73 Allowed 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 122.54 0.336 . . . . 0.0 110.612 -179.797 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 7.1 p-80 -107.64 159.23 16.62 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 120.931 0.396 . . . . 0.0 111.476 179.488 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 6.5 p80 . . . . . 0 C--O 1.253 1.265 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.818 177.22 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.497 ' C ' ' SD ' ' A' ' 1' ' ' MET . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 120.765 0.316 . . . . 0.0 111.139 . . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 69.9 p -67.61 144.07 55.73 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 121.253 0.549 . . . . 0.0 112.477 -177.061 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 33.2 pt -93.68 -0.31 10.29 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.167 177.855 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 91.6 mt-30 70.83 -70.57 0.15 Allowed 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.598 0.759 . . . . 0.0 111.693 -178.459 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.413 ' N ' ' HD3' ' A' ' 6' ' ' PRO . . . 55.09 62.36 7.86 Favored Pre-proline 0 N--CA 1.471 0.621 0 CA-C-O 121.088 0.47 . . . . 0.0 111.958 -176.364 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.413 ' HD3' ' N ' ' A' ' 5' ' ' ALA . 13.9 Cg_exo -68.61 94.8 0.45 Allowed 'Trans proline' 0 C--N 1.352 0.745 0 C-N-CA 122.3 2.0 . . . . 0.0 112.258 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -41.08 105.62 0.05 OUTLIER 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.313 178.224 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 80.1 m -99.45 107.3 19.47 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.926 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 6.8 mtpm? -102.81 93.46 5.08 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.158 0.504 . . . . 0.0 110.372 -175.181 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.429 ' HA ' ' O ' ' A' ' 51' ' ' VAL . 62.3 mt -78.28 99.37 2.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.061 -178.666 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 35.6 m -105.67 160.24 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-N 115.753 -0.658 . . . . 0.0 112.062 -174.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -91.19 1.14 57.32 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 120.757 0.313 . . . . 0.0 111.65 178.293 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -115.62 153.39 31.36 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 120.826 0.346 . . . . 0.0 111.63 -176.15 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 42.8 m -89.35 -22.77 22.45 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 116.517 -0.311 . . . . 0.0 111.161 176.676 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 68.8 mtt180 -114.38 114.6 26.09 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 120.918 0.39 . . . . 0.0 111.372 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 47.2 t -124.28 138.16 54.78 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.657 -177.386 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.0 102.11 7.23 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 120.964 0.411 . . . . 0.0 111.641 178.452 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.531 ' SG ' ' N ' ' A' ' 19' ' ' ASP . 51.5 t -78.77 173.78 12.13 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.398 0.618 . . . . 0.0 111.629 177.652 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.531 ' N ' ' SG ' ' A' ' 18' ' ' CYS . 0.7 OUTLIER -107.91 -4.6 17.8 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 115.553 -0.748 . . . . 0.0 112.886 -174.883 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.416 ' O ' HG21 ' A' ' 30' ' ' VAL . . . -124.14 138.4 11.29 Favored Glycine 0 CA--C 1.527 0.792 0 C-N-CA 120.059 -1.067 . . . . 0.0 114.125 -176.466 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -134.29 -42.84 0.13 Allowed Glycine 0 CA--C 1.527 0.814 0 C-N-CA 121.529 -0.367 . . . . 0.0 112.573 179.024 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.723 ' HB3' ' HB2' ' A' ' 25' ' ' LEU . 40.4 tt0 -169.32 159.09 8.54 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.373 0.669 . . . . 0.0 109.986 177.659 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -44.4 -55.79 5.78 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 121.655 -0.307 . . . . 0.0 113.64 176.148 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -85.5 -6.21 59.21 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 178.629 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.723 ' HB2' ' HB3' ' A' ' 22' ' ' GLU . 98.5 mt -115.6 48.9 1.14 Allowed 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.393 0.616 . . . . 0.0 109.925 177.687 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -71.29 128.96 16.79 Favored Glycine 0 CA--C 1.526 0.779 0 CA-C-N 115.758 -0.656 . . . . 0.0 113.633 -179.346 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.515 ' NE2' ' HB2' ' A' ' 19' ' ' ASP . 8.4 m80 52.43 60.43 13.12 Favored Pre-proline 0 CA--C 1.546 0.825 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 177.671 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.475 ' HG2' HG13 ' A' ' 30' ' ' VAL . 30.2 Cg_endo -102.03 18.11 0.25 Allowed 'Trans proline' 0 CA--C 1.542 0.916 0 C-N-CA 123.431 2.754 . . . . 0.0 113.711 179.471 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 1.1 mmm180 60.79 88.78 0.08 Allowed 'General case' 0 N--CA 1.44 -0.952 0 CA-C-O 123.093 1.425 . . . . 0.0 112.563 -174.589 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.476 HG23 ' HB3' ' A' ' 18' ' ' CYS . 17.8 m -119.8 125.02 73.89 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 CA-C-N 112.494 -2.139 . . . . 0.0 110.959 -179.464 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 39.5 m95 -101.84 114.53 28.69 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.078 0.466 . . . . 0.0 111.182 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 10.5 mp -92.81 150.73 20.43 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.654 -179.354 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 50.8 tp60 -104.39 124.95 50.14 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.791 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.526 HG21 ' HB2' ' A' ' 52' ' ' LEU . 74.7 mt -84.21 114.47 54.76 Favored Pre-proline 0 CA--C 1.542 0.65 0 CA-C-N 116.642 -0.254 . . . . 0.0 110.381 172.391 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -84.92 143.23 9.26 Favored 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 122.704 2.269 . . . . 0.0 113.235 -177.268 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.426 ' O ' ' NZ ' ' A' ' 56' ' ' LYS . 16.4 mm-40 -69.5 -3.81 16.17 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 121.117 0.484 . . . . 0.0 111.066 171.88 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -65.18 -62.86 1.29 Allowed 'General case' 0 CA--C 1.543 0.683 0 CA-C-O 121.034 0.445 . . . . 0.0 110.158 169.553 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 82.0 p -91.79 -48.88 6.56 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 115.758 -0.655 . . . . 0.0 112.037 -179.006 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 100.68 1.51 55.3 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 121.309 -0.472 . . . . 0.0 112.718 -175.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 60.2 p-90 -156.53 164.78 37.81 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 122.559 0.344 . . . . 0.0 111.39 -176.495 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 13.6 p -146.93 152.0 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 174.201 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -124.18 147.51 47.95 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 113.059 0.763 . . . . 0.0 113.059 -175.016 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.478 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 18.0 t -101.53 105.24 39.32 Favored Pre-proline 0 N--CA 1.468 0.432 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.274 174.226 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -77.17 -0.33 10.49 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 122.457 2.105 . . . . 0.0 113.123 -177.02 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -90.05 -67.71 0.83 Allowed 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 116.636 -0.256 . . . . 0.0 111.507 -176.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 49.4 t -104.26 6.07 35.17 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 111.869 0.322 . . . . 0.0 111.869 178.101 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 26.6 m-20 69.06 101.35 0.06 Allowed 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 175.29 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 52.0 m -161.69 120.8 2.43 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.135 175.075 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -100.4 110.84 23.05 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 120.753 0.311 . . . . 0.0 110.812 177.8 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 27.9 m-85 -91.57 107.13 18.99 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 120.638 0.256 . . . . 0.0 110.456 -177.19 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.429 ' O ' ' HA ' ' A' ' 10' ' ' ILE . 90.5 t -100.4 131.4 48.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 CA-C-O 120.726 0.298 . . . . 0.0 111.741 179.646 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.526 ' HB2' HG21 ' A' ' 34' ' ' ILE . 68.0 tp -81.54 119.42 23.75 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.096 0.475 . . . . 0.0 111.934 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.42 ' HB2' HG22 ' A' ' 10' ' ' ILE . 88.0 tttt -69.0 108.23 3.45 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.868 177.103 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 119.87 -13.59 10.63 Favored Glycine 0 CA--C 1.527 0.801 0 C-N-CA 121.412 -0.423 . . . . 0.0 112.542 -175.571 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 59.6 p -81.29 -176.57 6.06 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 120.93 0.395 . . . . 0.0 111.147 178.398 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.426 ' NZ ' ' O ' ' A' ' 36' ' ' GLU . 33.7 mtmm -73.07 -20.19 61.01 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.655 -0.248 . . . . 0.0 111.612 179.073 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -71.6 -49.61 38.67 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.287 0.565 . . . . 0.0 111.321 -175.46 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -75.91 -30.45 58.78 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.867 177.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.42 ' C ' ' H ' ' A' ' 61' ' ' GLU . . . -67.78 -47.52 68.93 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 179.438 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 88.8 mt 69.7 -29.5 0.18 Allowed 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.137 0.575 . . . . 0.0 112.263 -175.323 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.42 ' H ' ' C ' ' A' ' 59' ' ' ALA . 13.8 mt-10 -83.43 17.29 2.2 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 122.956 0.502 . . . . 0.0 111.288 173.763 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 34.8 p80 44.09 36.91 1.61 Allowed 'General case' 0 N--CA 1.476 0.832 0 CA-C-O 121.866 0.841 . . . . 0.0 110.547 -165.769 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 15.4 t60 79.04 -33.45 0.15 Allowed 'General case' 0 CA--C 1.548 0.876 0 CA-C-N 114.148 -1.387 . . . . 0.0 112.319 178.798 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 37.7 t60 69.2 143.77 0.05 OUTLIER 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 170.17 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 33.9 m170 -61.43 102.65 0.25 Allowed 'General case' 0 N--CA 1.477 0.883 0 O-C-N 122.006 -0.434 . . . . 0.0 111.606 177.581 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -96.38 -8.57 32.1 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 120.935 0.397 . . . . 0.0 111.429 174.39 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 79.5 m80 . . . . . 0 C--O 1.248 0.999 0 CA-C-O 118.522 -0.752 . . . . 0.0 111.201 176.139 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 . . . . . 0 CA--C 1.539 0.545 0 CA-C-O 120.987 0.422 . . . . 0.0 111.753 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 57.2 m -75.52 127.53 33.3 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.305 179.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 85.2 mttt -141.18 123.41 15.68 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 120.993 0.425 . . . . 0.0 111.32 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.522 ' N ' HD12 ' A' ' 10' ' ' ILE . 2.8 mp -88.74 119.64 36.25 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.769 -178.042 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 15.0 t -105.97 154.69 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-O 121.028 0.442 . . . . 0.0 111.245 -178.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -80.93 -37.78 28.96 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 121.048 0.451 . . . . 0.0 110.727 -177.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -101.56 162.97 12.51 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.396 176.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 50.5 m -79.97 -40.89 27.06 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -177.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 18.5 ptt-85 -86.09 118.43 25.55 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 121.458 0.647 . . . . 0.0 110.813 177.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 39.5 t -111.47 125.02 68.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.988 -172.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.95 82.23 5.15 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 120.984 0.421 . . . . 0.0 111.341 176.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.577 ' HG ' ' HG ' ' A' ' 43' ' ' CYS . 41.9 t . . . . . 0 N--CA 1.468 0.45 0 CA-C-O 121.17 0.51 . . . . 0.0 111.47 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.472 ' O ' ' HD3' ' A' ' 29' ' ' ARG . 1.1 tmt_? . . . . . 0 N--CA 1.452 -0.356 0 CA-C-O 122.185 0.993 . . . . 0.0 109.006 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.1 m -131.21 131.88 63.4 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 114.652 -1.158 . . . . 0.0 111.703 178.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 49.1 m95 -105.81 114.92 29.36 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.355 -178.077 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.461 ' HB3' HG21 ' A' ' 41' ' ' VAL . 6.4 mp -107.76 133.01 52.77 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 120.837 0.351 . . . . 0.0 111.421 179.249 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 54.9 tp60 -90.03 119.88 30.76 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 121.144 0.497 . . . . 0.0 111.958 -178.1 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.562 HG21 ' HB2' ' A' ' 52' ' ' LEU . 73.1 mt -79.93 118.17 71.08 Favored Pre-proline 0 CA--C 1.54 0.589 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.999 175.102 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.692 ' HG2' HG22 ' A' ' 38' ' ' THR . 97.2 Cg_endo -83.05 121.6 3.18 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 122.325 2.016 . . . . 0.0 112.868 178.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -56.5 -16.77 6.5 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-O 121.306 0.574 . . . . 0.0 111.427 175.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -61.69 -29.17 69.92 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 115.61 -0.723 . . . . 0.0 112.026 177.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.692 HG22 ' HG2' ' A' ' 35' ' ' PRO . 12.9 t -131.16 -38.82 1.2 Allowed 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 120.679 0.276 . . . . 0.0 111.415 178.179 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 107.42 2.45 35.34 Favored Glycine 0 CA--C 1.53 0.98 0 N-CA-C 115.419 0.928 . . . . 0.0 115.419 171.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.447 ' H ' HG23 ' A' ' 38' ' ' THR . 68.1 p-90 -144.8 164.96 29.46 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 118.271 1.035 . . . . 0.0 112.972 -176.022 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.461 HG21 ' HB3' ' A' ' 32' ' ' LEU . 9.9 p -147.92 143.94 19.31 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.244 171.118 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -116.64 141.51 48.11 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 -177.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.577 ' HG ' ' HG ' ' A' ' 18' ' ' CYS . 60.5 m -110.68 109.28 57.92 Favored Pre-proline 0 N--CA 1.473 0.716 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.163 173.07 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -69.06 15.61 0.19 Allowed 'Trans proline' 0 CA--C 1.549 1.24 0 C-N-CA 123.079 2.519 . . . . 0.0 115.511 -167.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -96.13 -72.21 0.64 Allowed 'General case' 0 N--CA 1.473 0.698 0 O-C-N 121.925 -0.485 . . . . 0.0 110.919 177.024 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.406 ' O ' ' SG ' ' A' ' 46' ' ' CYS . 43.1 t -86.94 3.8 44.23 Favored 'General case' 0 N--CA 1.475 0.822 0 O-C-N 122.218 -0.301 . . . . 0.0 111.58 169.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 56.48 31.29 18.63 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 121.379 0.609 . . . . 0.0 112.0 -178.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 61.9 m -64.95 110.93 2.62 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.123 176.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 84.2 tttt -98.62 102.38 14.1 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 121.08 0.466 . . . . 0.0 110.659 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -87.33 116.62 25.54 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.465 -175.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.465 ' O ' ' HA ' ' A' ' 10' ' ' ILE . 77.8 t -96.9 139.53 19.34 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.07 177.194 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.562 ' HB2' HG21 ' A' ' 34' ' ' ILE . 51.7 tp -77.4 131.78 38.19 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 121.221 0.534 . . . . 0.0 111.667 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -53.43 110.38 0.55 Allowed 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -179.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 85.68 2.32 86.9 Favored Glycine 0 CA--C 1.527 0.787 0 C-N-CA 121.191 -0.528 . . . . 0.0 113.821 176.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.412 ' HB2' ' HB3' ' A' ' 52' ' ' LEU . 40.8 t -70.15 174.8 5.08 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.049 0.452 . . . . 0.0 111.776 179.387 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -67.69 -23.91 65.35 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 121.075 0.464 . . . . 0.0 111.075 179.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -74.18 -18.46 60.77 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 121.045 0.45 . . . . 0.0 110.893 172.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 32.9 t70 . . . . . 0 CA--C 1.545 0.772 0 CA-C-O 121.578 0.704 . . . . 0.0 110.148 177.354 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 . . . . . 0 N--CA 1.472 0.643 0 CA-C-O 121.364 0.602 . . . . 0.0 112.243 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 97.3 m -89.72 136.19 33.18 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.786 -179.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 45.1 tttp -127.65 116.75 20.78 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 120.636 0.255 . . . . 0.0 110.829 -175.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 44.5 mm -86.3 112.37 22.63 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-O 120.989 0.423 . . . . 0.0 111.199 -178.387 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 35.7 m -113.33 164.53 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -178.141 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -105.41 -6.3 19.65 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-O 121.057 0.456 . . . . 0.0 111.424 179.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 68.6 mmtt -120.04 144.37 47.59 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.094 0.473 . . . . 0.0 111.856 -179.015 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 34.7 m -72.83 -21.06 61.02 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.603 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 80.4 mtt-85 -102.4 111.75 24.17 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-O 121.241 0.543 . . . . 0.0 110.634 177.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 36.7 t -119.96 131.2 73.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.851 -175.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.501 ' HB2' ' CE2' ' A' ' 31' ' ' TRP . . . -74.91 139.57 43.17 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 121.122 0.487 . . . . 0.0 111.742 177.427 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 53.0 t . . . . . 0 C--N 1.327 -0.39 0 CA-C-O 121.146 0.498 . . . . 0.0 110.534 177.319 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 4.4 tmt_? . . . . . 0 CA--C 1.531 0.25 0 CA-C-O 121.941 0.876 . . . . 0.0 109.56 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 28.7 m -122.36 134.89 64.21 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 CA-C-N 114.846 -1.07 . . . . 0.0 111.486 178.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.501 ' CE2' ' HB2' ' A' ' 17' ' ' ALA . 15.7 m95 -116.27 127.35 54.65 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 120.787 0.327 . . . . 0.0 111.114 179.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.7 mp -92.08 151.93 20.19 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 121.179 0.514 . . . . 0.0 111.544 -178.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 27.9 tp60 -110.2 108.98 19.31 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.019 -179.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.556 HG12 HG12 ' A' ' 41' ' ' VAL . 75.8 mt -71.62 122.3 86.81 Favored Pre-proline 0 CA--C 1.542 0.641 0 CA-C-N 116.634 -0.257 . . . . 0.0 111.481 179.336 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.488 ' HG2' ' OG1' ' A' ' 38' ' ' THR . 44.7 Cg_endo -86.31 127.11 2.83 Favored 'Trans proline' 0 CA--C 1.54 0.811 0 C-N-CA 122.95 2.434 . . . . 0.0 112.709 176.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -59.22 -21.97 60.34 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 121.43 0.633 . . . . 0.0 110.792 177.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -59.11 -31.7 69.16 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 115.234 -0.893 . . . . 0.0 111.742 178.017 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.488 ' OG1' ' HG2' ' A' ' 35' ' ' PRO . 44.8 p -113.92 -47.44 2.96 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.308 0.575 . . . . 0.0 110.975 178.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.547 ' HA3' ' H ' ' A' ' 57' ' ' ALA . . . 100.2 1.08 55.84 Favored Glycine 0 CA--C 1.525 0.676 0 CA-C-N 115.874 -0.603 . . . . 0.0 112.782 -178.198 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 58.5 p-90 -155.46 162.27 40.77 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.088 0.471 . . . . 0.0 111.388 -177.1 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.556 HG12 HG12 ' A' ' 34' ' ' ILE . 14.2 p -148.67 126.45 2.95 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 CA-C-O 120.992 0.425 . . . . 0.0 110.62 172.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.422 ' HA ' ' HA ' ' A' ' 49' ' ' LYS . 16.7 pt-20 -94.39 143.01 26.77 Favored 'General case' 0 CA--C 1.535 0.398 0 O-C-N 122.124 -0.36 . . . . 0.0 111.035 179.437 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 37.0 t -71.55 130.99 86.68 Favored Pre-proline 0 N--CA 1.468 0.435 0 N-CA-C 111.825 0.305 . . . . 0.0 111.825 179.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -76.59 0.46 9.51 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 122.406 2.07 . . . . 0.0 113.077 179.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -99.87 -87.64 0.36 Allowed 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 111.687 0.254 . . . . 0.0 111.687 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 42.0 t -169.78 22.27 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 111.827 0.306 . . . . 0.0 111.827 -179.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -87.75 -88.23 0.14 Allowed 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -173.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 73.7 m -155.31 179.19 9.4 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-O 121.596 0.712 . . . . 0.0 112.627 -177.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.422 ' HA ' ' HA ' ' A' ' 42' ' ' GLU . 40.3 ttmt -111.5 120.31 41.71 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.959 174.324 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 46.2 m-85 -103.27 116.48 32.53 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 111.922 0.342 . . . . 0.0 111.922 -170.165 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 85.9 t -105.08 135.47 42.96 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 CA-C-O 120.946 0.403 . . . . 0.0 111.513 178.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.438 ' HB2' HG21 ' A' ' 34' ' ' ILE . 53.0 tp -87.44 122.16 30.81 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 121.154 0.502 . . . . 0.0 111.711 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.442 ' HD3' ' N ' ' A' ' 54' ' ' GLY . 4.2 tmtm? -67.72 127.9 34.5 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.365 179.185 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.442 ' N ' ' HD3' ' A' ' 53' ' ' LYS . . . 87.52 12.62 66.76 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 121.391 -0.433 . . . . 0.0 112.886 -175.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.7 t -110.23 -173.4 2.24 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 122.552 -0.381 . . . . 0.0 111.34 178.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 61.6 tttp -57.1 -47.76 80.26 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -176.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.547 ' H ' ' HA3' ' A' ' 39' ' ' GLY . . . -73.99 -13.91 60.95 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 112.543 0.571 . . . . 0.0 112.543 -177.42 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 33.3 t70 . . . . . 0 CA--C 1.538 0.499 0 CA-C-O 121.529 0.681 . . . . 0.0 111.04 -179.756 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 . . . . . 0 CA--C 1.543 0.681 0 CA-C-O 122.317 1.056 . . . . 0.0 110.54 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 91.0 m -123.2 110.56 15.4 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.48 -1.236 . . . . 0.0 110.003 -177.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 5.7 tmtt? -102.6 115.4 30.51 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.787 0.327 . . . . 0.0 110.819 -172.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.513 ' N ' HD12 ' A' ' 10' ' ' ILE . 2.5 mp -82.02 101.24 6.61 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.88 -177.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.41 HG21 HD11 ' A' ' 34' ' ' ILE . 35.7 m -102.67 167.93 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 CA-C-O 120.963 0.411 . . . . 0.0 111.874 -178.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -104.63 -20.61 13.6 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -176.361 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -130.33 165.0 23.42 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 121.019 0.438 . . . . 0.0 112.097 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.9 m -81.57 -37.89 26.98 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 112.67 0.619 . . . . 0.0 112.67 -174.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 28.9 tpt180 -87.27 105.23 17.09 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 122.117 -0.364 . . . . 0.0 110.642 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 58.9 t -131.05 135.03 60.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 N-CA-C 112.211 0.448 . . . . 0.0 112.211 -173.28 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -76.09 112.53 12.63 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.044 0.449 . . . . 0.0 110.237 172.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.679 ' HB2' HD13 ' A' ' 32' ' ' LEU . 58.3 m . . . . . 0 C--N 1.324 -0.535 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.22 -174.26 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 23.3 tpt180 . . . . . 0 N--CA 1.466 0.371 0 CA-C-O 121.667 0.746 . . . . 0.0 110.024 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 27.1 t -100.47 125.98 54.16 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.759 -173.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 61.2 m95 -105.53 115.66 30.63 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 121.026 0.441 . . . . 0.0 111.418 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.679 HD13 ' HB2' ' A' ' 18' ' ' CYS . 9.0 mp -98.04 172.2 7.77 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.307 0.575 . . . . 0.0 111.678 -179.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 58.1 tp60 -137.64 116.41 12.25 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.528 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.546 HG12 HG12 ' A' ' 41' ' ' VAL . 68.4 mt -68.56 120.21 73.84 Favored Pre-proline 0 CA--C 1.539 0.539 0 CA-C-N 116.686 -0.234 . . . . 0.0 111.209 177.141 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.576 ' HG2' ' OG1' ' A' ' 38' ' ' THR . 74.0 Cg_endo -75.21 110.98 3.21 Favored 'Trans proline' 0 CA--C 1.535 0.561 0 C-N-CA 122.412 2.075 . . . . 0.0 111.67 176.539 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -54.93 -21.56 12.07 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 116.079 -0.51 . . . . 0.0 112.242 -176.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -61.14 -46.95 88.45 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-O 120.665 0.269 . . . . 0.0 111.247 173.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.576 ' OG1' ' HG2' ' A' ' 35' ' ' PRO . 29.2 p -89.03 -50.21 6.3 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 120.841 0.353 . . . . 0.0 111.521 -177.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 103.45 1.82 47.2 Favored Glycine 0 CA--C 1.527 0.792 0 C-N-CA 121.202 -0.523 . . . . 0.0 112.71 -176.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 63.6 p-90 -152.63 158.99 43.22 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 120.951 0.405 . . . . 0.0 112.006 -177.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.546 HG12 HG12 ' A' ' 34' ' ' ILE . 14.9 p -145.17 126.67 8.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-O 120.926 0.394 . . . . 0.0 110.269 174.071 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.588 ' HA ' ' HA ' ' A' ' 49' ' ' LYS . 10.5 pt-20 -103.66 152.67 21.51 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.234 0.54 . . . . 0.0 112.416 -177.2 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 6.4 t -69.61 134.13 88.55 Favored Pre-proline 0 N--CA 1.471 0.608 0 CA-C-N 115.705 -0.68 . . . . 0.0 112.174 -176.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -78.46 -5.94 15.19 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 122.739 2.292 . . . . 0.0 112.767 178.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -108.96 -93.58 0.42 Allowed 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 -179.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 48.7 t -144.46 9.9 1.42 Allowed 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 112.948 0.722 . . . . 0.0 112.948 -169.101 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -90.14 -107.39 0.09 Allowed 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 112.959 0.726 . . . . 0.0 112.959 -172.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 72.0 m -152.33 -179.74 7.82 Favored 'General case' 0 N--CA 1.477 0.902 0 O-C-N 121.692 -0.63 . . . . 0.0 112.475 -174.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.588 ' HA ' ' HA ' ' A' ' 42' ' ' GLU . 36.8 ttpt -106.74 125.64 51.26 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.291 177.051 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 36.4 m-85 -99.77 113.24 25.6 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 120.763 0.316 . . . . 0.0 111.144 -175.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 99.9 t -99.04 131.6 45.97 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 CA-C-O 121.101 0.477 . . . . 0.0 111.898 179.34 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 59.9 tp -78.11 118.15 20.08 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.543 179.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.484 ' HB2' HG23 ' A' ' 10' ' ' ILE . 47.4 tttp -74.33 151.22 39.82 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 121.124 0.488 . . . . 0.0 111.203 178.528 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.79 14.6 81.86 Favored Glycine 0 CA--C 1.527 0.799 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.07 -174.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 48.3 t -116.5 -177.48 3.19 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.2 0.524 . . . . 0.0 111.532 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 50.6 mtpt -60.52 -34.76 74.58 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.639 -179.368 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -86.18 8.89 19.24 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 -178.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.4 t0 . . . . . 0 CA--C 1.545 0.784 0 CA-C-O 121.182 0.515 . . . . 0.0 111.859 -179.576 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 . . . . . 0 CA--C 1.535 0.388 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 23.3 m -98.01 125.81 43.13 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.017 176.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 24.4 tptp -121.8 110.72 16.25 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 120.816 0.341 . . . . 0.0 110.558 -178.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 55.5 mt -77.19 104.41 5.13 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-O 120.909 0.385 . . . . 0.0 111.236 -177.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 34.5 m -95.06 155.75 3.25 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-O 121.067 0.461 . . . . 0.0 111.439 179.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -82.19 -37.09 26.59 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.807 -175.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 46.5 mmtm -118.94 167.18 11.98 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 121.212 0.529 . . . . 0.0 112.273 -177.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 18.6 m -68.64 -34.65 76.1 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -174.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.457 ' HA ' ' O ' ' A' ' 32' ' ' LEU . 16.6 ptt180 -98.64 135.36 40.25 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.231 0.538 . . . . 0.0 111.668 -179.27 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 48.7 t -129.34 122.96 56.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.277 -178.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -74.78 94.03 2.69 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.12 0.486 . . . . 0.0 110.678 176.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.423 ' SG ' HD13 ' A' ' 32' ' ' LEU . 85.8 m . . . . . 0 N--CA 1.467 0.384 0 CA-C-O 120.93 0.395 . . . . 0.0 111.657 -176.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 21.8 tpt180 . . . . . 0 C--O 1.236 0.356 0 CA-C-O 121.814 0.816 . . . . 0.0 110.089 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 30.0 m -112.84 121.67 65.54 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 CA-C-N 115.062 -0.972 . . . . 0.0 112.395 -177.176 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 69.5 m95 -106.55 113.33 26.78 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.885 177.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.457 ' O ' ' HA ' ' A' ' 15' ' ' ARG . 8.1 mp -86.38 144.72 27.19 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 120.878 0.371 . . . . 0.0 110.977 179.14 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 54.2 tp60 -115.91 116.35 27.82 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.059 -177.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.434 HG12 HG12 ' A' ' 41' ' ' VAL . 61.9 mt -76.48 126.41 86.27 Favored Pre-proline 0 CA--C 1.539 0.535 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -179.065 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.555 ' HG2' ' OG1' ' A' ' 38' ' ' THR . 57.1 Cg_endo -86.78 132.45 3.43 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 122.87 2.38 . . . . 0.0 112.092 173.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -66.04 -25.62 67.14 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 121.941 -0.474 . . . . 0.0 111.492 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -54.51 -56.48 18.46 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.134 0.492 . . . . 0.0 111.37 177.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.555 ' OG1' ' HG2' ' A' ' 35' ' ' PRO . 52.4 p -76.27 -47.82 22.39 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.407 0.622 . . . . 0.0 110.055 174.473 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 99.09 1.5 57.06 Favored Glycine 0 CA--C 1.524 0.621 0 CA-C-N 115.504 -0.771 . . . . 0.0 112.672 -178.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.528 ' HB3' HG22 ' A' ' 51' ' ' VAL . 63.7 p-90 -159.3 166.83 30.38 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 122.56 0.344 . . . . 0.0 110.911 -176.026 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.434 HG12 HG12 ' A' ' 34' ' ' ILE . 12.2 p -135.37 132.69 52.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-O 121.112 0.482 . . . . 0.0 111.399 176.219 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -92.01 112.11 23.91 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 121.148 0.499 . . . . 0.0 110.818 176.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 41.0 t -71.28 110.56 7.65 Favored Pre-proline 0 N--CA 1.471 0.576 0 CA-C-N 116.187 -0.461 . . . . 0.0 112.086 -178.132 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -71.55 -11.24 27.95 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 122.632 2.221 . . . . 0.0 112.425 177.464 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 78.4 m-85 -84.56 -42.7 15.21 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 115.956 -0.566 . . . . 0.0 112.007 -176.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 84.5 m -131.92 8.08 4.42 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 -178.013 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 57.7 78.26 0.24 Allowed 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 176.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 91.2 m -152.46 147.31 26.1 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.944 177.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -99.63 106.47 18.43 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 120.651 0.262 . . . . 0.0 111.091 178.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -91.74 111.69 23.32 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.55 0.214 . . . . 0.0 110.615 178.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.528 HG22 ' HB3' ' A' ' 40' ' ' TRP . 97.9 t -97.51 135.61 31.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-O 121.023 0.439 . . . . 0.0 111.58 -179.623 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.408 ' HB2' HG21 ' A' ' 34' ' ' ILE . 59.0 tp -75.42 130.95 39.8 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 116.171 -0.468 . . . . 0.0 112.029 -178.182 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 51.7 tttm -58.91 102.5 0.12 Allowed 'General case' 0 CA--C 1.542 0.645 0 CA-C-O 121.114 0.483 . . . . 0.0 111.443 174.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 117.6 -7.06 15.92 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 121.362 -0.447 . . . . 0.0 112.538 -176.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 12.4 t -65.81 151.92 45.55 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 177.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.47 -7.39 47.12 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 120.905 0.383 . . . . 0.0 111.477 174.062 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -72.19 -27.33 62.49 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 121.174 0.511 . . . . 0.0 110.402 170.066 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.7 t70 . . . . . 0 CA--C 1.547 0.833 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.711 175.769 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 . . . . . 0 N--CA 1.465 0.298 0 CA-C-O 121.197 0.522 . . . . 0.0 110.639 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 66.5 m -98.39 141.78 30.83 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.786 -177.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 55.1 tptt -133.87 114.76 13.68 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.879 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 52.4 mt -88.64 105.34 15.63 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 CA-C-O 120.727 0.298 . . . . 0.0 111.013 -177.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.461 HG12 ' H ' ' A' ' 13' ' ' LYS . 2.4 t -102.67 147.79 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-O 120.884 0.373 . . . . 0.0 111.271 -176.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -89.23 -4.46 58.19 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 121.075 0.464 . . . . 0.0 111.183 -178.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.461 ' H ' HG12 ' A' ' 11' ' ' VAL . 67.5 mttm -131.89 152.25 51.17 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.051 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 21.1 m -80.39 -6.83 58.66 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 120.837 0.351 . . . . 0.0 111.611 179.076 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -95.16 114.64 26.46 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 120.942 0.401 . . . . 0.0 110.961 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 70.7 t -125.46 135.08 65.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 N-CA-C 113.056 0.762 . . . . 0.0 113.056 -171.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -104.37 110.3 22.49 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.525 173.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 66.2 m . . . . . 0 N--CA 1.474 0.761 0 C-N-CA 122.515 0.326 . . . . 0.0 111.28 179.231 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.446 -0.646 0 CA-C-O 122.35 1.071 . . . . 0.0 110.909 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 19.0 m -109.69 154.2 11.24 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.133 0 CA-C-N 113.97 -1.468 . . . . 0.0 111.453 -178.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 49.7 m95 -124.14 114.84 20.2 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 121.243 0.544 . . . . 0.0 112.136 -175.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.45 ' N ' HD12 ' A' ' 32' ' ' LEU . 6.1 mp -105.46 167.56 9.66 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.454 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 54.2 tp60 -130.25 113.51 14.51 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.336 179.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.595 HG21 ' HB2' ' A' ' 52' ' ' LEU . 76.2 mt -63.06 120.15 58.67 Favored Pre-proline 0 CA--C 1.541 0.597 0 CA-C-O 120.684 0.278 . . . . 0.0 111.397 -179.288 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.596 ' HG2' ' OG1' ' A' ' 38' ' ' THR . 83.5 Cg_endo -79.82 113.75 3.08 Favored 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 122.262 1.975 . . . . 0.0 112.022 177.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -60.89 -15.0 25.91 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 121.115 0.483 . . . . 0.0 111.542 -179.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -68.87 -29.51 67.83 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.568 174.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.596 ' OG1' ' HG2' ' A' ' 35' ' ' PRO . 34.6 p -103.25 -54.73 2.55 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 121.205 0.526 . . . . 0.0 110.445 175.151 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 113.13 -0.19 25.39 Favored Glycine 0 CA--C 1.526 0.727 0 CA-C-N 115.8 -0.636 . . . . 0.0 113.123 179.245 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 66.1 p-90 -166.45 162.44 16.91 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -177.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.565 HG12 HG12 ' A' ' 34' ' ' ILE . 11.3 p -153.77 133.55 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.346 174.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.47 ' HA ' ' HA ' ' A' ' 49' ' ' LYS . 0.5 OUTLIER -110.94 148.87 31.56 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.062 0.458 . . . . 0.0 111.866 -178.282 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.564 ' HB3' ' HB3' ' A' ' 47' ' ' ASP . 52.3 t -84.52 108.13 13.6 Favored Pre-proline 0 N--CA 1.466 0.364 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 171.018 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -65.06 -9.41 21.55 Favored 'Trans proline' 0 CA--C 1.54 0.794 0 C-N-CA 122.742 2.295 . . . . 0.0 113.476 -172.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -87.33 -89.9 0.12 Allowed 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 120.566 0.222 . . . . 0.0 111.575 -177.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 75.7 m -152.45 82.62 1.24 Allowed 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 120.956 0.408 . . . . 0.0 111.477 179.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.564 ' HB3' ' HB3' ' A' ' 43' ' ' CYS . 9.7 t70 -149.98 -90.22 0.07 Allowed 'General case' 0 CA--C 1.548 0.889 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.184 177.038 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 30.2 p 179.8 -176.92 0.34 Allowed 'General case' 0 N--CA 1.477 0.889 0 CA-C-O 121.106 0.479 . . . . 0.0 111.422 174.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.47 ' HA ' ' HA ' ' A' ' 42' ' ' GLU . 39.5 ttmt -106.54 120.27 41.48 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 123.036 0.534 . . . . 0.0 110.693 178.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -98.72 108.24 20.88 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.081 0.467 . . . . 0.0 111.868 -173.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 99.7 t -93.75 134.39 31.59 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.243 178.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.595 ' HB2' HG21 ' A' ' 34' ' ' ILE . 51.8 tp -79.18 120.7 24.07 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 121.304 0.573 . . . . 0.0 111.649 -178.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -77.4 118.18 19.61 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.948 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 88.38 55.48 2.19 Favored Glycine 0 CA--C 1.524 0.652 0 C-N-CA 121.035 -0.603 . . . . 0.0 111.64 -173.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 25.0 t -151.03 -150.99 0.37 Allowed 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 122.898 0.479 . . . . 0.0 110.985 -175.383 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -101.65 22.72 12.33 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 -177.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -129.51 -33.26 1.89 Allowed 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 121.415 0.626 . . . . 0.0 111.097 -175.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 . . . . . 0 CA--C 1.546 0.797 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.764 178.512 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 . . . . . 0 N--CA 1.472 0.673 0 CA-C-O 121.601 0.715 . . . . 0.0 110.574 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.435 ' HA ' ' O ' ' A' ' 49' ' ' LYS . 51.6 m -118.93 137.97 53.1 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 115.395 -0.821 . . . . 0.0 111.559 -172.351 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -134.92 129.9 35.03 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 120.766 0.317 . . . . 0.0 111.069 -176.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 59.9 mt -86.45 118.91 33.63 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 CA-C-O 121.079 0.466 . . . . 0.0 111.614 -179.203 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 35.3 m -109.52 163.41 6.62 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.964 176.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -92.17 -21.44 20.39 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -176.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -121.54 152.01 39.69 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 -176.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 48.7 m -70.28 -21.04 63.0 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 116.049 -0.523 . . . . 0.0 112.334 -178.315 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 80.7 mtp180 -87.6 111.83 21.66 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.148 0.499 . . . . 0.0 111.33 178.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 61.2 t -113.01 115.81 50.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.926 -177.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -95.16 115.01 26.87 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 120.695 0.283 . . . . 0.0 111.382 177.456 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.51 ' O ' HG12 ' A' ' 30' ' ' VAL . 82.8 m . . . . . 0 N--CA 1.47 0.544 0 CA-C-O 120.927 0.394 . . . . 0.0 111.306 179.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.437 ' O ' ' HD3' ' A' ' 29' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.45 -0.46 0 CA-C-O 122.444 1.116 . . . . 0.0 111.342 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.51 HG12 ' O ' ' A' ' 18' ' ' CYS . 11.5 p -132.02 132.98 61.22 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-N 114.153 -1.385 . . . . 0.0 109.488 166.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 59.8 m95 -100.09 132.5 45.41 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.24 0.543 . . . . 0.0 112.339 -176.084 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.429 ' N ' HD12 ' A' ' 32' ' ' LEU . 5.4 mp -115.67 160.89 19.45 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.904 177.13 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -119.55 124.78 47.24 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.496 178.263 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.521 HG21 ' HB2' ' A' ' 52' ' ' LEU . 73.7 mt -79.33 132.25 63.18 Favored Pre-proline 0 CA--C 1.545 0.768 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -178.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.559 ' HG2' ' OG1' ' A' ' 38' ' ' THR . 94.7 Cg_endo -81.95 117.33 2.9 Favored 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 122.609 2.206 . . . . 0.0 112.317 173.521 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -60.25 -33.82 72.82 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -176.107 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.489 ' O ' ' HE2' ' A' ' 56' ' ' LYS . 8.0 p-10 -62.23 -30.9 71.42 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 120.773 0.321 . . . . 0.0 111.846 -178.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.559 ' OG1' ' HG2' ' A' ' 35' ' ' PRO . 21.9 p -91.55 -48.89 6.6 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.377 0.608 . . . . 0.0 110.428 175.023 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 100.01 2.47 56.0 Favored Glycine 0 CA--C 1.524 0.614 0 CA-C-N 115.597 -0.729 . . . . 0.0 112.756 -177.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.441 ' HB3' HG22 ' A' ' 51' ' ' VAL . 65.2 p-90 -158.81 152.77 23.52 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 120.961 0.41 . . . . 0.0 111.867 -175.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.483 HG12 HG12 ' A' ' 34' ' ' ILE . 11.0 p -131.6 150.58 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.939 176.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -117.2 131.47 56.85 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 121.113 0.482 . . . . 0.0 111.154 178.164 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.417 ' SG ' ' HB3' ' A' ' 46' ' ' CYS . 49.5 t -82.67 110.49 22.63 Favored Pre-proline 0 N--CA 1.47 0.532 0 N-CA-C 111.911 0.337 . . . . 0.0 111.911 -179.176 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -58.94 -26.93 83.15 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 122.699 2.266 . . . . 0.0 113.319 -177.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -112.03 17.55 19.54 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 112.13 0.418 . . . . 0.0 112.13 -176.127 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.421 ' SG ' ' SG ' ' A' ' 48' ' ' CYS . 36.2 t -146.1 -7.17 0.56 Allowed 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 174.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 55.18 24.72 6.51 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 113.203 0.816 . . . . 0.0 113.203 178.033 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.421 ' SG ' ' SG ' ' A' ' 46' ' ' CYS . 81.3 m -102.92 138.02 40.35 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 120.812 0.339 . . . . 0.0 111.611 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.435 ' O ' ' HA ' ' A' ' 8' ' ' THR . 85.7 tttt -109.01 121.51 45.3 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 122.92 0.488 . . . . 0.0 111.149 -178.378 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -116.93 125.77 51.95 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 112.13 0.418 . . . . 0.0 112.13 -177.002 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.441 HG22 ' HB3' ' A' ' 40' ' ' TRP . 40.9 t -94.54 139.33 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.873 176.344 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.521 ' HB2' HG21 ' A' ' 34' ' ' ILE . 56.5 tp -87.13 119.12 27.03 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.407 177.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -67.67 118.59 11.15 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 121.076 0.465 . . . . 0.0 111.122 178.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 120.5 -28.51 6.21 Favored Glycine 0 CA--C 1.525 0.686 0 CA-C-N 115.992 -0.549 . . . . 0.0 112.29 -174.16 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 66.1 m -80.83 168.07 19.19 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 120.877 0.37 . . . . 0.0 111.252 178.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.489 ' HE2' ' O ' ' A' ' 37' ' ' ASP . 65.7 pttt -58.59 -25.03 62.18 Favored 'General case' 0 CA--C 1.543 0.673 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -177.206 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.72 -33.2 75.11 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.151 0.5 . . . . 0.0 111.23 176.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 32.7 t70 . . . . . 0 CA--C 1.543 0.687 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.206 177.904 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 . . . . . 0 N--CA 1.475 0.789 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 86.8 m -85.83 115.32 23.4 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.059 175.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 73.8 mttt -121.95 98.57 6.01 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 120.995 0.426 . . . . 0.0 110.882 176.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 57.8 mt -86.21 127.75 39.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.108 -179.268 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 28.5 m -125.56 163.45 26.71 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.546 -179.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -89.15 -19.79 25.05 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 120.76 0.314 . . . . 0.0 111.515 179.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 13.6 pttm -131.84 148.08 52.52 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 121.076 0.465 . . . . 0.0 111.615 -177.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 12.2 p -68.39 -30.79 69.79 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 114.572 1.323 . . . . 0.0 114.572 -168.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 94.4 mtt180 -75.41 104.3 5.92 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 118.53 0.604 . . . . 0.0 111.512 179.065 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 36.4 t -117.88 122.37 69.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.388 -178.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -81.4 109.66 16.1 Favored 'General case' 0 CA--C 1.535 0.4 0 O-C-N 122.252 -0.28 . . . . 0.0 111.116 175.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.74 ' SG ' ' HB ' ' A' ' 30' ' ' VAL . 22.8 p . . . . . 0 N--CA 1.47 0.559 0 CA-C-O 121.056 0.455 . . . . 0.0 110.936 179.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.455 ' HA ' ' HD3' ' A' ' 29' ' ' ARG . 2.8 tpp180 . . . . . 0 N--CA 1.445 -0.722 0 CA-C-O 122.461 1.124 . . . . 0.0 112.612 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.74 ' HB ' ' SG ' ' A' ' 18' ' ' CYS . 48.4 t -118.45 115.08 47.04 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.066 0 CA-C-N 114.107 -1.406 . . . . 0.0 110.565 177.544 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 83.3 m95 -91.41 103.91 16.49 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 120.948 0.404 . . . . 0.0 111.291 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.539 HD21 ' HD3' ' A' ' 44' ' ' PRO . 6.2 mp -83.62 131.07 34.99 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 121.021 0.439 . . . . 0.0 111.436 179.107 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 27.1 tp60 -93.89 105.32 17.35 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.334 176.18 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.556 HG12 HG12 ' A' ' 41' ' ' VAL . 73.5 mt -64.43 124.76 86.83 Favored Pre-proline 0 CA--C 1.542 0.638 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.661 -178.359 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.565 ' HG2' ' OG1' ' A' ' 38' ' ' THR . 76.9 Cg_endo -74.19 119.24 5.72 Favored 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 122.671 2.247 . . . . 0.0 112.211 179.567 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -64.63 -17.15 63.76 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-O 121.162 0.506 . . . . 0.0 111.582 -178.021 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -64.93 -44.07 90.72 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 120.916 0.389 . . . . 0.0 111.22 175.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.565 ' OG1' ' HG2' ' A' ' 35' ' ' PRO . 31.6 p -95.92 -54.3 3.38 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 121.08 0.467 . . . . 0.0 110.99 179.545 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 110.87 1.18 28.74 Favored Glycine 0 CA--C 1.524 0.605 0 CA-C-N 115.948 -0.569 . . . . 0.0 113.494 179.006 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 62.0 p-90 -153.79 160.15 42.15 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 116.941 0.37 . . . . 0.0 111.183 -177.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.556 HG12 HG12 ' A' ' 34' ' ' ILE . 13.4 p -141.15 141.49 30.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.648 176.053 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.39 154.93 16.96 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 121.305 0.574 . . . . 0.0 111.948 -179.135 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.464 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 43.8 t -73.05 123.12 89.22 Favored Pre-proline 0 CA--C 1.537 0.449 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.603 179.305 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.539 ' HD3' HD21 ' A' ' 32' ' ' LEU . 14.9 Cg_exo -69.03 -7.71 21.59 Favored 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 122.757 2.305 . . . . 0.0 113.095 -179.501 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -98.83 -46.9 5.49 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 120.924 0.392 . . . . 0.0 111.576 -178.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 25.1 t -120.08 -91.0 0.57 Allowed 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.514 -177.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -173.91 19.11 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 179.005 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.422 ' HB2' ' HB2' ' A' ' 43' ' ' CYS . 56.7 m -64.97 132.53 49.53 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 -177.33 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.452 ' NZ ' ' HB2' ' A' ' 49' ' ' LYS . 5.0 ttmp? -102.34 110.71 22.74 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 121.203 0.525 . . . . 0.0 111.572 -179.257 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 55.3 m-85 -94.76 104.35 16.26 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.447 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 56.7 t -92.13 137.3 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 CA-C-O 121.174 0.511 . . . . 0.0 112.372 -175.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 59.6 tp -98.91 130.05 45.28 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.508 178.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -64.77 143.9 57.62 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-O 120.845 0.355 . . . . 0.0 111.635 178.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 81.42 -13.89 31.95 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 121.367 -0.444 . . . . 0.0 114.081 175.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 59.9 p -84.2 179.99 7.35 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 120.935 0.398 . . . . 0.0 111.345 -178.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 62.0 mttm -63.5 -27.33 69.19 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 179.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -69.53 -27.45 65.18 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.301 0.572 . . . . 0.0 110.662 175.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 32.3 t70 . . . . . 0 CA--C 1.544 0.744 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.769 176.198 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 . . . . . 0 CA--C 1.541 0.604 0 CA-C-O 121.561 0.696 . . . . 0.0 112.667 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.42 ' OG1' ' NZ ' ' A' ' 49' ' ' LYS . 99.9 m -103.95 147.3 27.52 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.087 178.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -134.95 113.13 11.21 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 120.786 0.327 . . . . 0.0 110.684 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 53.2 mt -86.82 107.1 16.54 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-O 121.176 0.512 . . . . 0.0 111.005 -179.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.512 HG11 HG21 ' A' ' 16' ' ' VAL . 30.6 m -96.12 155.6 3.4 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-O 121.175 0.512 . . . . 0.0 112.149 -176.666 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -94.98 3.1 55.32 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.642 -176.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 62.7 pttt -135.07 155.2 51.15 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.016 179.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 59.0 m -75.87 -32.66 59.81 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -175.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.468 ' HB3' ' OE1' ' A' ' 33' ' ' GLN . 13.0 ptp180 -112.79 121.13 43.81 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 121.233 0.54 . . . . 0.0 111.469 -178.027 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.512 HG21 HG11 ' A' ' 11' ' ' VAL . 46.2 t -127.49 132.35 69.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.679 -177.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.486 ' HA ' ' O ' ' A' ' 30' ' ' VAL . . . -83.04 88.28 6.87 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 121.146 0.498 . . . . 0.0 110.718 176.065 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.462 ' SG ' ' HB3' ' A' ' 46' ' ' CYS . 43.7 t . . . . . 0 N--CA 1.471 0.614 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 -174.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 22.9 tpt180 . . . . . 0 N--CA 1.454 -0.248 0 CA-C-O 122.308 1.052 . . . . 0.0 111.426 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.486 ' O ' ' HA ' ' A' ' 17' ' ' ALA . 58.9 t -107.16 112.54 40.42 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 CA-C-N 114.196 -1.365 . . . . 0.0 111.322 -177.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 95.9 m95 -95.09 118.48 31.96 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.125 0.488 . . . . 0.0 111.919 -179.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.407 ' N ' HD12 ' A' ' 32' ' ' LEU . 7.1 mp -94.58 111.65 23.41 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.31 173.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.468 ' OE1' ' HB3' ' A' ' 15' ' ' ARG . 59.4 tp60 -92.43 110.08 21.48 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.83 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.517 HG21 ' HB2' ' A' ' 52' ' ' LEU . 73.5 mt -75.77 119.12 75.68 Favored Pre-proline 0 CA--C 1.543 0.676 0 CA-C-O 120.9 0.381 . . . . 0.0 111.331 179.162 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -85.5 146.35 9.57 Favored 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 122.842 2.361 . . . . 0.0 113.178 -178.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -70.9 -10.12 59.03 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 120.864 0.364 . . . . 0.0 110.848 174.357 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -62.94 -40.58 98.09 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.352 0.596 . . . . 0.0 110.836 172.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 44.3 p -108.56 -54.04 2.56 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.624 -176.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 99.61 1.12 56.51 Favored Glycine 0 CA--C 1.525 0.694 0 CA-C-N 116.092 -0.504 . . . . 0.0 112.061 -174.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 64.5 p-90 -156.86 166.93 31.99 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 122.588 0.355 . . . . 0.0 110.966 -177.308 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.415 HG12 HG12 ' A' ' 34' ' ' ILE . 11.5 p -145.11 136.58 20.34 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-O 120.895 0.379 . . . . 0.0 110.921 174.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -91.76 133.43 35.62 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.006 0.431 . . . . 0.0 110.447 177.176 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.48 ' SG ' ' HB2' ' A' ' 45' ' ' TYR . 44.5 t -103.69 105.31 47.02 Favored Pre-proline 0 N--CA 1.467 0.413 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -178.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -73.54 -2.54 12.3 Favored 'Trans proline' 0 CA--C 1.542 0.923 0 C-N-CA 122.526 2.151 . . . . 0.0 112.351 174.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.48 ' HB2' ' SG ' ' A' ' 43' ' ' CYS . 60.7 m-85 -90.74 -42.14 10.86 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.548 179.099 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.462 ' HB3' ' SG ' ' A' ' 18' ' ' CYS . 53.1 t -118.53 1.87 11.74 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -175.329 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 59.43 51.44 6.62 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 112.802 0.668 . . . . 0.0 112.802 175.234 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 87.6 m -149.04 157.6 43.53 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 120.835 0.35 . . . . 0.0 111.505 177.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.42 ' NZ ' ' OG1' ' A' ' 8' ' ' THR . 7.2 ttpm? -106.45 121.9 45.21 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 116.532 -0.303 . . . . 0.0 111.282 178.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 37.1 m-85 -99.62 119.41 38.04 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 120.663 0.268 . . . . 0.0 111.511 -179.093 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 97.3 t -101.87 139.99 21.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 CA-C-O 120.84 0.353 . . . . 0.0 111.491 177.103 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.517 ' HB2' HG21 ' A' ' 34' ' ' ILE . 60.9 tp -88.54 118.71 28.39 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 120.935 0.398 . . . . 0.0 111.919 -179.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.422 ' HE3' ' HB2' ' A' ' 53' ' ' LYS . 38.2 ttmt -63.57 133.17 53.3 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.816 178.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 90.36 -8.18 80.24 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 121.159 -0.543 . . . . 0.0 113.546 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 45.5 t -77.52 179.94 6.21 Favored 'General case' 0 N--CA 1.472 0.667 0 O-C-N 122.361 -0.493 . . . . 0.0 111.035 178.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -66.85 -27.77 67.8 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.116 0.484 . . . . 0.0 111.157 179.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -76.41 -25.38 54.43 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.444 177.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 32.0 t70 . . . . . 0 CA--C 1.538 0.516 0 CA-C-O 121.42 0.628 . . . . 0.0 111.332 -178.756 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.48 ' HB3' ' SG ' ' A' ' 48' ' ' CYS . 86.4 tt0 . . . . . 0 CA--C 1.541 0.63 0 CA-C-O 120.945 0.402 . . . . 0.0 111.794 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 57.8 p -96.1 115.46 27.46 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 122.751 0.42 . . . . 0.0 111.771 178.177 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 65.2 mttm -99.37 100.43 11.49 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.018 0.437 . . . . 0.0 110.269 178.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.484 HG22 ' HB2' ' A' ' 53' ' ' LYS . 55.4 mt -82.19 100.47 6.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.546 -176.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 33.2 m -107.93 157.0 8.27 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 CA-C-O 121.108 0.48 . . . . 0.0 112.247 -176.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -99.74 25.31 7.34 Favored 'General case' 0 CA--C 1.548 0.896 0 CA-C-O 121.676 0.75 . . . . 0.0 110.5 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -144.1 131.48 20.91 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.071 -175.081 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.416 ' HA ' HD12 ' A' ' 34' ' ' ILE . 9.1 m -81.01 -26.71 36.24 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -178.106 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.451 ' HG2' ' OE1' ' A' ' 33' ' ' GLN . 89.2 mtt180 -100.7 92.38 5.07 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.17 0.509 . . . . 0.0 110.123 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 44.9 t -107.83 118.6 55.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-N 115.925 -0.579 . . . . 0.0 112.155 -171.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.449 ' HB2' ' CE2' ' A' ' 31' ' ' TRP . . . -84.93 100.5 11.66 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 120.751 0.31 . . . . 0.0 110.756 175.172 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.656 ' SG ' ' HB ' ' A' ' 30' ' ' VAL . 29.7 p . . . . . 0 N--CA 1.47 0.559 0 CA-C-O 121.063 0.459 . . . . 0.0 111.769 -175.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 2.4 tmt_? . . . . . 0 C--O 1.233 0.223 0 CA-C-O 121.806 0.813 . . . . 0.0 109.888 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.656 ' HB ' ' SG ' ' A' ' 18' ' ' CYS . 55.1 t -124.54 132.69 70.97 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.022 0 CA-C-N 114.558 -1.201 . . . . 0.0 110.784 179.208 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.449 ' CE2' ' HB2' ' A' ' 17' ' ' ALA . 37.3 m95 -110.02 119.94 40.89 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-O 121.205 0.526 . . . . 0.0 112.26 -176.576 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.6 mp -100.4 163.43 12.38 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 121.303 0.573 . . . . 0.0 111.568 177.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.451 ' OE1' ' HG2' ' A' ' 15' ' ' ARG . 55.8 tp60 -131.27 114.21 14.77 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.768 -179.365 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.564 HG21 ' HB2' ' A' ' 52' ' ' LEU . 64.7 mt -69.96 121.21 82.11 Favored Pre-proline 0 CA--C 1.543 0.7 0 CA-C-O 120.863 0.363 . . . . 0.0 111.617 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.497 ' HG2' ' OG1' ' A' ' 38' ' ' THR . 65.3 Cg_endo -81.63 130.26 6.79 Favored 'Trans proline' 0 CA--C 1.544 0.976 0 C-N-CA 122.855 2.37 . . . . 0.0 113.351 -178.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 44.3 mm-40 -60.02 -18.14 44.04 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 175.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -67.92 -36.64 80.51 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 120.966 0.413 . . . . 0.0 111.49 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.497 ' OG1' ' HG2' ' A' ' 35' ' ' PRO . 43.7 p -108.36 -50.86 2.97 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.049 0.452 . . . . 0.0 111.701 -177.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 104.31 1.64 44.33 Favored Glycine 0 CA--C 1.527 0.826 0 C-N-CA 121.352 -0.452 . . . . 0.0 112.412 -174.125 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 65.3 p-90 -154.36 160.19 41.56 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 122.708 0.403 . . . . 0.0 111.418 -179.164 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.547 HG12 HG12 ' A' ' 34' ' ' ILE . 12.3 p -144.11 127.05 11.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 CA-C-O 120.9 0.381 . . . . 0.0 110.823 176.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.406 ' HG3' ' H ' ' A' ' 42' ' ' GLU . 0.4 OUTLIER -100.16 146.2 27.12 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 121.058 0.456 . . . . 0.0 111.745 -178.457 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.566 ' HB3' ' HB2' ' A' ' 47' ' ' ASP . 42.0 t -103.86 119.28 54.99 Favored Pre-proline 0 CA--C 1.536 0.415 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -65.57 -12.58 35.72 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 122.819 2.346 . . . . 0.0 112.836 178.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.54 ' HB2' ' SG ' ' A' ' 43' ' ' CYS . 95.3 m-85 -82.38 7.31 14.44 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.716 178.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.461 ' HB2' ' O ' ' A' ' 45' ' ' TYR . 76.4 m 83.2 31.24 0.08 Allowed 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.906 0.882 . . . . 0.0 112.48 175.715 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.566 ' HB2' ' HB3' ' A' ' 43' ' ' CYS . 24.4 m-20 -94.2 5.96 50.11 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 120.999 0.428 . . . . 0.0 111.005 169.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.48 ' SG ' ' HB3' ' A' ' 7' ' ' GLU . 78.4 m 66.72 -161.92 0.24 Allowed 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 175.065 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.42 ' NZ ' ' HB2' ' A' ' 49' ' ' LYS . 5.0 ttmp? -94.11 126.75 39.52 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -174.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -96.89 105.49 17.64 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 120.658 0.266 . . . . 0.0 110.87 176.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 98.7 t -91.28 132.0 36.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-O 120.798 0.333 . . . . 0.0 111.472 -179.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.564 ' HB2' HG21 ' A' ' 34' ' ' ILE . 48.6 tp -85.39 112.54 20.94 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 121.215 0.531 . . . . 0.0 111.503 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.484 ' HB2' HG22 ' A' ' 10' ' ' ILE . 10.1 tmtt? -58.35 138.74 56.27 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.468 176.095 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 67.32 42.32 90.33 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 121.153 -0.546 . . . . 0.0 112.68 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 35.2 t -143.15 -168.57 2.83 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 120.767 0.317 . . . . 0.0 111.327 -176.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -60.84 -26.13 67.14 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -178.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -94.86 -15.03 24.03 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 -179.154 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 22.9 t70 . . . . . 0 CA--C 1.541 0.631 0 CA-C-O 121.004 0.43 . . . . 0.0 111.614 -177.591 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 . . . . . 0 N--CA 1.467 0.414 0 CA-C-O 121.497 0.665 . . . . 0.0 111.439 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.461 HG23 HG21 ' A' ' 51' ' ' VAL . 38.7 m -84.38 104.94 14.82 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 114.725 -1.125 . . . . 0.0 110.788 -177.198 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 62.2 mttm -120.68 122.0 39.49 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 121.09 0.471 . . . . 0.0 111.198 -174.324 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.458 HD13 ' HB ' ' A' ' 51' ' ' VAL . 49.9 mm -82.89 121.87 36.55 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 CA-C-N 115.91 -0.586 . . . . 0.0 112.295 -173.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 29.5 m -130.08 149.85 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.194 178.063 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -90.42 -15.72 30.4 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 179.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -96.97 142.68 28.63 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.037 0.446 . . . . 0.0 111.695 -179.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 20.0 m -80.57 -23.06 40.18 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.576 179.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.457 ' HA ' ' O ' ' A' ' 32' ' ' LEU . 16.2 ptp180 -116.15 119.46 35.87 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 121.311 0.577 . . . . 0.0 111.178 176.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 51.4 t -118.3 142.34 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.501 -175.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -94.33 110.47 22.23 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 120.982 0.42 . . . . 0.0 111.34 178.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.52 ' SG ' HD13 ' A' ' 32' ' ' LEU . 78.3 m . . . . . 0 C--O 1.237 0.398 0 CA-C-O 120.865 0.364 . . . . 0.0 111.41 176.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.455 ' O ' ' HD3' ' A' ' 29' ' ' ARG . 0.4 OUTLIER . . . . . 0 N--CA 1.448 -0.541 0 CA-C-O 122.598 1.189 . . . . 0.0 110.228 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 60.7 t -120.28 129.85 75.04 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-N 113.919 -1.492 . . . . 0.0 110.988 178.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 74.4 m95 -104.09 124.22 48.67 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.063 0.459 . . . . 0.0 112.157 -178.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.52 HD13 ' SG ' ' A' ' 18' ' ' CYS . 7.2 mp -103.07 149.88 24.15 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.94 177.197 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 27.6 tp60 -120.32 109.02 14.87 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.812 -178.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.516 HG12 HG12 ' A' ' 41' ' ' VAL . 67.8 mt -60.45 129.46 89.2 Favored Pre-proline 0 CA--C 1.543 0.678 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.743 179.497 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.563 ' HG2' ' OG1' ' A' ' 38' ' ' THR . 45.7 Cg_endo -78.61 119.21 4.39 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 122.216 1.944 . . . . 0.0 111.52 173.018 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 22.2 mp0 -56.72 -40.33 75.51 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 -171.175 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -81.13 0.77 34.76 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 -173.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.563 ' OG1' ' HG2' ' A' ' 35' ' ' PRO . 22.6 p -107.06 -46.22 3.96 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.336 0.589 . . . . 0.0 109.823 171.139 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 100.3 0.92 55.75 Favored Glycine 0 CA--C 1.524 0.602 0 CA-C-N 115.558 -0.746 . . . . 0.0 113.212 178.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.445 ' HB3' HG22 ' A' ' 51' ' ' VAL . 67.5 p-90 -157.33 157.31 33.9 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.024 0.44 . . . . 0.0 112.118 -176.198 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.516 HG12 HG12 ' A' ' 34' ' ' ILE . 13.3 p -135.46 139.91 45.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.593 174.323 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -106.55 131.73 53.38 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.164 0.506 . . . . 0.0 111.083 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.432 ' HA ' HD21 ' A' ' 32' ' ' LEU . 47.5 t -86.23 122.04 72.44 Favored Pre-proline 0 CA--C 1.537 0.466 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.784 -177.419 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -74.71 -12.56 22.16 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 122.496 2.131 . . . . 0.0 112.84 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -99.42 -39.13 8.52 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 116.268 -0.424 . . . . 0.0 112.053 -178.291 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.425 ' HG ' ' HG ' ' A' ' 48' ' ' CYS . 46.3 t -116.8 2.62 12.88 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -177.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 54.25 25.86 6.24 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 174.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.425 ' HG ' ' HG ' ' A' ' 46' ' ' CYS . 71.0 m -95.48 144.71 25.75 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.296 177.546 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.452 ' HE3' ' HB2' ' A' ' 49' ' ' LYS . 34.9 ttmt -112.44 106.52 15.02 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-O 121.17 0.51 . . . . 0.0 111.215 -177.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 52.4 m-85 -91.24 111.16 22.53 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.51 -175.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.461 HG21 HG23 ' A' ' 8' ' ' THR . 68.9 t -94.86 132.66 38.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-O 121.031 0.443 . . . . 0.0 111.279 177.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 41.8 tp -82.29 115.8 21.52 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 121.054 0.454 . . . . 0.0 112.12 -176.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.559 ' HE3' ' N ' ' A' ' 54' ' ' GLY . 0.1 OUTLIER -67.27 112.9 4.78 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 120.973 0.415 . . . . 0.0 110.042 178.582 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.559 ' N ' ' HE3' ' A' ' 53' ' ' LYS . . . 114.14 -4.51 23.78 Favored Glycine 0 CA--C 1.523 0.592 0 C-N-CA 121.323 -0.465 . . . . 0.0 112.591 -176.433 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 47.7 t -82.01 179.92 7.64 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 121.107 0.48 . . . . 0.0 111.629 177.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 19.4 ptmt -54.93 -43.71 73.58 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -177.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.41 -22.64 66.24 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.097 0.475 . . . . 0.0 112.056 -178.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 16.9 t70 . . . . . 0 CA--C 1.545 0.766 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.843 -178.29 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.455 ' CD ' ' H ' ' A' ' 8' ' ' THR . 0.2 OUTLIER . . . . . 0 CA--C 1.545 0.778 0 CA-C-O 120.79 0.329 . . . . 0.0 110.192 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.455 ' H ' ' CD ' ' A' ' 7' ' ' GLU . 77.2 m -70.9 123.52 22.2 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 121.102 0.477 . . . . 0.0 111.734 -179.609 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 23.2 tptp -121.35 101.82 7.88 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 120.873 0.368 . . . . 0.0 110.233 179.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 60.4 mt -83.43 99.89 6.48 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.065 -176.005 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 27.2 m -110.73 154.05 12.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 CA-C-O 121.009 0.433 . . . . 0.0 112.105 -175.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -87.5 14.99 7.16 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 120.787 0.327 . . . . 0.0 111.584 -178.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 58.0 pttt -132.83 143.94 49.88 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -174.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.425 ' HB3' HE22 ' A' ' 33' ' ' GLN . 54.0 m -87.92 -24.94 23.46 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 116.276 -0.42 . . . . 0.0 112.111 -178.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 75.2 mtt180 -108.71 110.19 21.54 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 121.179 0.514 . . . . 0.0 111.87 -179.146 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 50.3 t -114.01 147.21 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.064 -178.152 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.494 ' HA ' ' O ' ' A' ' 30' ' ' VAL . . . -91.18 106.71 18.7 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 121.348 0.594 . . . . 0.0 112.568 -177.361 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.682 ' SG ' HD22 ' A' ' 32' ' ' LEU . 95.9 m . . . . . 0 N--CA 1.472 0.642 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.633 178.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 6.1 tpt180 . . . . . 0 CA--C 1.53 0.196 0 CA-C-O 121.956 0.884 . . . . 0.0 110.504 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.494 ' O ' ' HA ' ' A' ' 17' ' ' ALA . 60.8 t -135.71 103.81 4.12 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 CA-C-N 114.669 -1.15 . . . . 0.0 110.421 -179.238 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 85.1 m95 -94.78 124.07 38.61 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -173.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.682 HD22 ' SG ' ' A' ' 18' ' ' CYS . 11.2 mp -105.45 131.57 52.7 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.019 0.438 . . . . 0.0 110.646 171.579 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.425 HE22 ' HB3' ' A' ' 14' ' ' SER . 28.9 tp60 -92.88 115.1 27.81 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.836 -177.438 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.495 HG21 ' HB2' ' A' ' 52' ' ' LEU . 69.0 mt -66.79 118.1 51.49 Favored Pre-proline 0 CA--C 1.538 0.508 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.526 173.222 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.437 ' HG2' ' OG1' ' A' ' 38' ' ' THR . 97.6 Cg_endo -82.19 134.23 7.92 Favored 'Trans proline' 0 CA--C 1.538 0.704 0 C-N-CA 122.424 2.083 . . . . 0.0 113.045 179.445 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -58.4 -23.01 56.0 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 121.433 0.635 . . . . 0.0 110.599 174.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -62.4 -35.3 78.77 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 115.3 -0.864 . . . . 0.0 111.967 179.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.437 ' OG1' ' HG2' ' A' ' 35' ' ' PRO . 31.9 p -108.73 -48.73 3.26 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-O 121.03 0.443 . . . . 0.0 111.326 -179.058 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 101.08 -0.56 54.71 Favored Glycine 0 CA--C 1.527 0.807 0 CA-C-N 116.034 -0.53 . . . . 0.0 112.779 -177.005 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 67.5 p-90 -155.11 166.23 34.23 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 120.891 0.376 . . . . 0.0 111.821 -177.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.432 HG12 HG12 ' A' ' 34' ' ' ILE . 10.1 p -144.07 144.35 22.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 CA-C-N 116.528 -0.306 . . . . 0.0 110.912 175.459 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -105.13 141.36 36.81 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 120.834 0.349 . . . . 0.0 111.127 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.468 ' SG ' ' HB3' ' A' ' 46' ' ' CYS . 29.3 p -99.07 116.61 65.11 Favored Pre-proline 0 CA--C 1.539 0.52 0 O-C-N 122.305 -0.247 . . . . 0.0 110.935 175.043 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -70.37 16.93 0.24 Allowed 'Trans proline' 0 CA--C 1.544 0.981 0 C-N-CA 122.768 2.312 . . . . 0.0 113.642 -176.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 35.0 m-85 -117.26 -49.6 2.58 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 120.837 0.351 . . . . 0.0 111.418 176.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.468 ' HB3' ' SG ' ' A' ' 43' ' ' CYS . 13.2 t -105.13 -4.94 21.24 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -175.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 63.81 18.64 11.29 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 112.913 0.709 . . . . 0.0 112.913 177.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.442 ' SG ' ' SG ' ' A' ' 46' ' ' CYS . 34.7 m -79.8 135.27 36.44 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 120.84 0.352 . . . . 0.0 111.262 -179.748 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -99.62 95.42 6.95 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 120.915 0.388 . . . . 0.0 110.522 178.339 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.406 ' CZ ' ' HB2' ' A' ' 48' ' ' CYS . 76.0 m-85 -82.1 105.04 12.88 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.697 0.284 . . . . 0.0 111.263 -173.837 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 90.4 t -91.47 126.78 44.1 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.293 178.105 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.495 ' HB2' HG21 ' A' ' 34' ' ' ILE . 58.0 tp -73.32 112.53 9.46 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 121.175 0.512 . . . . 0.0 111.125 178.663 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 61.5 tttm -63.34 118.07 7.52 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.343 -178.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 102.25 -3.48 51.13 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 121.37 -0.443 . . . . 0.0 112.853 -174.176 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 35.2 t -90.82 -176.84 4.8 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 120.931 0.396 . . . . 0.0 111.544 178.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 54.9 mttm -72.24 -10.99 60.51 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 120.901 0.381 . . . . 0.0 111.968 -176.251 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -93.88 -0.94 55.45 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 120.967 0.413 . . . . 0.0 110.858 173.632 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 24.9 t70 . . . . . 0 CA--C 1.549 0.924 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.858 -178.175 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 . . . . . 0 C--O 1.238 0.474 0 CA-C-O 121.953 0.883 . . . . 0.0 111.34 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 96.2 m -126.51 148.9 49.64 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 114.752 -1.113 . . . . 0.0 110.731 -177.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.429 ' HD2' ' CE1' ' A' ' 50' ' ' TYR . 98.7 mttt -120.08 126.95 52.02 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 120.867 0.365 . . . . 0.0 110.735 -176.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.428 HG22 ' HB2' ' A' ' 53' ' ' LYS . 34.9 mm -91.83 98.84 8.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-O 121.023 0.439 . . . . 0.0 110.831 -179.179 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 34.7 m -99.15 158.0 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-O 121.407 0.623 . . . . 0.0 112.501 -174.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -91.72 -34.5 14.61 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.506 177.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -90.45 151.19 21.5 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.311 0.577 . . . . 0.0 112.479 -175.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 43.8 m -78.3 -27.51 47.31 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.331 173.48 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 71.7 mtp180 -90.42 107.2 19.0 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.618 175.175 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 55.1 t -113.97 118.59 58.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 120.999 0.428 . . . . 0.0 112.09 -175.423 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.13 103.09 7.85 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 121.057 0.456 . . . . 0.0 110.29 173.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.727 ' SG ' HD13 ' A' ' 32' ' ' LEU . 79.1 m . . . . . 0 N--CA 1.469 0.482 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -172.329 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 7.9 tpt180 . . . . . 0 C--O 1.236 0.387 0 CA-C-O 122.62 1.2 . . . . 0.0 111.981 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 19.9 m -104.7 114.62 44.79 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 CA-C-N 113.658 -1.61 . . . . 0.0 112.265 -177.608 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 96.7 m95 -101.82 124.42 47.42 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.717 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.727 HD13 ' SG ' ' A' ' 18' ' ' CYS . 9.3 mp -117.49 134.1 55.23 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 121.011 0.434 . . . . 0.0 110.945 174.248 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -93.73 116.42 28.9 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.263 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.557 HG12 HG12 ' A' ' 41' ' ' VAL . 77.7 mt -61.73 123.0 75.24 Favored Pre-proline 0 CA--C 1.542 0.637 0 CA-C-O 120.891 0.377 . . . . 0.0 111.849 179.18 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.579 ' HG2' ' OG1' ' A' ' 38' ' ' THR . 76.7 Cg_endo -81.23 140.16 12.13 Favored 'Trans proline' 0 CA--C 1.544 0.983 0 C-N-CA 122.803 2.335 . . . . 0.0 112.818 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -70.64 -28.92 65.19 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 121.01 0.433 . . . . 0.0 111.746 -179.34 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -61.61 -25.01 67.08 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 179.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.579 ' OG1' ' HG2' ' A' ' 35' ' ' PRO . 47.2 p -109.84 -54.0 2.61 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-O 121.286 0.565 . . . . 0.0 111.197 176.048 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 101.05 1.34 54.78 Favored Glycine 0 CA--C 1.524 0.648 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.003 -175.247 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 54.5 p-90 -152.87 162.92 40.7 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 121.077 0.465 . . . . 0.0 111.681 -176.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.557 HG12 HG12 ' A' ' 34' ' ' ILE . 8.4 p -142.67 118.71 5.53 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 CA-C-O 120.925 0.393 . . . . 0.0 110.773 173.707 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.544 ' HA ' ' HA ' ' A' ' 49' ' ' LYS . 9.4 pt-20 -100.0 106.61 18.41 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.529 0.68 . . . . 0.0 110.112 175.701 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.843 ' HB3' ' SG ' ' A' ' 46' ' ' CYS . 44.0 t -75.83 130.91 77.51 Favored Pre-proline 0 N--CA 1.466 0.371 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -167.13 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -69.58 -15.15 37.61 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 122.571 2.181 . . . . 0.0 112.569 175.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.512 ' HD2' ' SG ' ' A' ' 43' ' ' CYS . 90.1 m-85 -85.24 -43.2 13.98 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.601 179.542 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.843 ' SG ' ' HB3' ' A' ' 43' ' ' CYS . 27.1 p -97.04 -17.77 19.81 Favored 'General case' 0 N--CA 1.478 0.925 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 -178.695 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 10.1 t70 67.96 20.06 9.25 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-O 121.123 0.487 . . . . 0.0 111.147 179.19 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 53.6 t -121.43 154.73 36.16 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 120.916 0.389 . . . . 0.0 111.616 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.544 ' HA ' ' HA ' ' A' ' 42' ' ' GLU . 17.9 ttmm -98.51 134.45 41.45 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.385 -177.37 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.429 ' CE1' ' HD2' ' A' ' 9' ' ' LYS . 72.3 m-85 -115.08 113.29 23.83 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 122.17 -0.331 . . . . 0.0 111.244 178.358 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 49.7 t -97.51 128.44 48.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 CA-C-O 121.169 0.509 . . . . 0.0 111.737 175.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.448 ' HB2' HD13 ' A' ' 34' ' ' ILE . 51.6 tp -78.6 114.02 17.15 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.029 178.024 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.428 ' HB2' HG22 ' A' ' 10' ' ' ILE . 33.9 ttpt -63.48 121.65 14.35 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.329 -179.188 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 92.1 13.57 57.39 Favored Glycine 0 CA--C 1.531 1.047 0 CA-C-N 116.14 -0.482 . . . . 0.0 113.751 -177.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 34.5 p -107.29 -166.65 1.18 Allowed 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 117.296 0.548 . . . . 0.0 111.905 -178.499 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -63.31 -20.29 65.36 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 115.927 -0.578 . . . . 0.0 111.777 177.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -94.22 -1.2 54.46 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 179.526 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.6 t70 . . . . . 0 CA--C 1.543 0.694 0 CA-C-N 116.639 -0.255 . . . . 0.0 110.756 -176.686 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 . . . . . 0 N--CA 1.483 1.208 0 CA-C-O 121.582 0.706 . . . . 0.0 112.523 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.412 HG23 HG23 ' A' ' 51' ' ' VAL . 51.7 m -104.51 145.74 29.86 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 115.52 -0.764 . . . . 0.0 112.372 -171.47 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -129.14 114.19 16.02 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.262 176.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 55.0 mt -84.76 94.93 3.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 121.306 0.574 . . . . 0.0 110.761 -179.262 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 29.9 m -104.8 149.11 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-N 115.932 -0.576 . . . . 0.0 112.188 -174.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -75.67 -19.77 58.92 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.347 -177.204 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.438 ' NZ ' ' O ' ' A' ' 15' ' ' ARG . 13.2 ptmm? -112.08 143.04 43.75 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 116.204 -0.453 . . . . 0.0 112.171 -173.317 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.422 ' HB2' ' NE2' ' A' ' 33' ' ' GLN . 37.6 p -79.11 -38.58 35.85 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 112.724 0.639 . . . . 0.0 112.724 -178.609 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.438 ' O ' ' NZ ' ' A' ' 13' ' ' LYS . 8.9 mmt180 -78.69 127.72 32.48 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.362 0.601 . . . . 0.0 111.953 -178.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 95.3 t -143.21 124.18 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.765 -178.409 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.52 112.11 15.25 Favored 'General case' 0 CA--C 1.537 0.463 0 O-C-N 122.214 -0.303 . . . . 0.0 110.817 177.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 48.2 t . . . . . 0 N--CA 1.471 0.608 0 N-CA-C 112.516 0.561 . . . . 0.0 112.516 -178.825 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.408 ' HD2' ' HA ' ' A' ' 29' ' ' ARG . 10.1 tpt180 . . . . . 0 N--CA 1.464 0.227 0 CA-C-O 121.979 0.895 . . . . 0.0 110.831 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 89.9 t -137.78 117.77 15.77 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 CA-C-N 114.526 -1.216 . . . . 0.0 110.178 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 81.9 m95 -105.66 119.95 40.43 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 121.348 0.594 . . . . 0.0 112.254 -174.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.418 ' N ' HD12 ' A' ' 32' ' ' LEU . 6.9 mp -81.09 152.35 27.88 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.679 173.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.422 ' NE2' ' HB2' ' A' ' 14' ' ' SER . 25.0 tp60 -120.77 111.93 18.2 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.882 -178.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.529 HG21 ' HB2' ' A' ' 52' ' ' LEU . 61.0 mt -77.23 109.7 10.03 Favored Pre-proline 0 CA--C 1.541 0.608 0 CA-C-O 120.57 0.224 . . . . 0.0 110.397 173.431 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -86.47 156.24 9.27 Favored 'Trans proline' 0 CA--C 1.536 0.622 0 C-N-CA 122.793 2.329 . . . . 0.0 113.391 -176.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -73.79 -18.89 60.91 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.042 0.449 . . . . 0.0 110.271 174.372 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -58.02 -56.22 24.77 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-O 121.275 0.56 . . . . 0.0 110.927 174.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 44.6 p -90.48 -50.32 6.01 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.748 -179.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 99.48 1.55 56.63 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-N 116.141 -0.481 . . . . 0.0 112.415 -174.353 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.561 ' HB3' HG22 ' A' ' 51' ' ' VAL . 30.1 p-90 -158.55 170.86 21.25 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 122.656 0.382 . . . . 0.0 111.827 -177.036 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 11.2 p -141.93 144.92 24.79 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 CA-C-O 120.882 0.372 . . . . 0.0 111.039 175.289 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -104.38 137.94 41.53 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 120.875 0.369 . . . . 0.0 111.132 -178.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.665 ' SG ' ' HE2' ' A' ' 50' ' ' TYR . 68.6 m -95.13 109.59 45.48 Favored Pre-proline 0 N--CA 1.472 0.66 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.617 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -64.97 -12.03 32.6 Favored 'Trans proline' 0 CA--C 1.543 0.967 0 C-N-CA 122.495 2.13 . . . . 0.0 113.585 -178.144 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 -110.93 -62.63 1.51 Allowed 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 120.827 0.346 . . . . 0.0 111.716 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.504 ' SG ' ' SG ' ' A' ' 48' ' ' CYS . 42.8 t -73.08 -14.76 61.46 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -178.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 16.0 t70 71.96 -4.85 1.85 Allowed 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 123.342 0.657 . . . . 0.0 112.69 177.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.504 ' SG ' ' SG ' ' A' ' 46' ' ' CYS . 81.2 m -65.83 147.65 53.03 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.087 0.47 . . . . 0.0 112.198 178.035 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 59.8 tttm -118.45 104.31 10.58 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.419 178.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.665 ' HE2' ' SG ' ' A' ' 43' ' ' CYS . 97.3 m-85 -89.26 113.92 25.22 Favored 'General case' 0 N--CA 1.468 0.444 0 O-C-N 122.057 -0.402 . . . . 0.0 111.411 -174.109 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.561 HG22 ' HB3' ' A' ' 40' ' ' TRP . 80.1 t -95.69 136.56 26.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 CA-C-O 120.777 0.322 . . . . 0.0 111.435 176.014 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.529 ' HB2' HG21 ' A' ' 34' ' ' ILE . 48.7 tp -71.97 120.03 16.99 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 121.29 0.567 . . . . 0.0 111.195 178.46 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -65.78 116.88 7.43 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.518 -179.003 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 91.27 14.97 56.63 Favored Glycine 0 CA--C 1.527 0.784 0 CA-C-N 116.195 -0.457 . . . . 0.0 113.054 -176.03 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.515 ' HB3' ' HB3' ' A' ' 52' ' ' LEU . 76.9 p -91.09 -177.93 5.04 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 121.379 0.609 . . . . 0.0 111.916 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -57.42 -37.79 73.31 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.771 173.152 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -78.69 -30.78 46.25 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -176.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 24.8 t70 . . . . . 0 CA--C 1.537 0.465 0 CA-C-O 120.936 0.398 . . . . 0.0 111.662 179.177 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 . . . . . 0 CA--C 1.539 0.55 0 CA-C-O 121.351 0.596 . . . . 0.0 111.956 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 67.9 p -90.38 142.99 27.18 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.126 -179.028 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.419 ' HD3' ' CD1' ' A' ' 50' ' ' TYR . 57.4 tttp -116.56 97.92 6.27 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 176.282 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.545 HG23 ' HB2' ' A' ' 53' ' ' LYS . 2.0 mp -77.03 124.0 34.63 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-O 121.153 0.502 . . . . 0.0 112.266 -172.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 30.2 m -136.35 162.4 35.7 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.003 177.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -102.17 -16.41 16.37 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 111.76 0.282 . . . . 0.0 111.76 176.569 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -106.81 142.31 36.64 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 121.125 0.488 . . . . 0.0 111.3 177.28 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 74.6 m -76.17 -6.47 51.44 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 -173.126 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 90.2 mtt180 -111.61 120.13 41.05 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 121.61 -0.681 . . . . 0.0 112.081 177.085 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 37.4 t -134.71 140.95 44.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.996 179.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -93.89 127.92 39.9 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 116.729 -0.214 . . . . 0.0 111.142 178.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.568 ' SG ' ' HB2' ' A' ' 47' ' ' ASP . 41.4 t . . . . . 0 N--CA 1.471 0.602 0 CA-C-O 120.873 0.368 . . . . 0.0 110.926 177.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 3.8 tmt_? . . . . . 0 CA--C 1.529 0.156 0 CA-C-O 121.85 0.833 . . . . 0.0 110.584 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.459 HG23 ' HB3' ' A' ' 18' ' ' CYS . 14.5 m -136.7 120.03 22.28 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.257 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.838 173.004 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 48.1 m95 -99.43 112.61 24.77 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.356 -178.527 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.438 ' N ' HD12 ' A' ' 32' ' ' LEU . 6.1 mp -90.26 132.1 35.71 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 121.118 0.485 . . . . 0.0 111.61 -179.392 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 27.3 tp60 -93.68 106.74 18.69 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.858 176.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.563 HG12 HG12 ' A' ' 41' ' ' VAL . 97.8 mt -60.73 125.35 82.68 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.026 176.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.567 ' HG2' ' OG1' ' A' ' 38' ' ' THR . 84.5 Cg_endo -76.96 105.34 2.06 Favored 'Trans proline' 0 CA--C 1.535 0.566 0 C-N-CA 122.261 1.974 . . . . 0.0 111.753 177.533 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -57.93 -19.13 27.81 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 121.299 0.571 . . . . 0.0 110.366 178.205 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -54.66 -43.53 72.47 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.503 172.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.567 ' OG1' ' HG2' ' A' ' 35' ' ' PRO . 44.1 p -97.49 -57.73 2.18 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.722 177.536 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 120.55 0.99 12.29 Favored Glycine 0 CA--C 1.529 0.926 0 CA-C-N 115.849 -0.614 . . . . 0.0 112.627 -177.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 63.9 p-90 -162.12 160.62 27.5 Favored 'General case' 0 N--CA 1.471 0.607 0 O-C-N 122.709 -0.289 . . . . 0.0 111.396 -176.248 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.563 HG12 HG12 ' A' ' 34' ' ' ILE . 11.6 p -148.4 129.91 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 CA-C-O 120.713 0.292 . . . . 0.0 110.807 173.75 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.416 ' HA ' ' HA ' ' A' ' 49' ' ' LYS . 9.6 pt-20 -90.89 140.02 30.21 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 120.913 0.387 . . . . 0.0 111.211 178.042 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 44.5 t -70.35 126.37 92.3 Favored Pre-proline 0 N--CA 1.47 0.569 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.774 -176.596 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.32 -26.16 29.92 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 122.785 2.323 . . . . 0.0 112.971 -179.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -78.36 -92.92 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 121.123 0.487 . . . . 0.0 111.016 177.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 48.0 t -172.41 81.38 0.05 Allowed 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.039 0.447 . . . . 0.0 110.305 -179.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.568 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 13.3 t70 -136.8 -95.72 0.22 Allowed 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.393 -178.06 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 90.7 m -153.62 -170.34 3.56 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 120.92 0.39 . . . . 0.0 110.674 177.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.416 ' HA ' ' HA ' ' A' ' 42' ' ' GLU . 34.8 ttpt -111.62 115.6 29.4 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 120.899 0.381 . . . . 0.0 110.632 175.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.419 ' CD1' ' HD3' ' A' ' 9' ' ' LYS . 43.4 m-85 -82.69 114.92 21.38 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.18 -171.218 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 80.9 t -109.38 123.74 65.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-O 121.314 0.578 . . . . 0.0 111.843 -176.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 46.0 tp -81.0 107.95 14.26 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.733 178.405 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.545 ' HB2' HG23 ' A' ' 10' ' ' ILE . 28.6 ttpp -65.15 147.45 53.45 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 120.907 0.384 . . . . 0.0 111.293 -179.593 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 85.95 7.89 80.07 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.446 -174.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 14.8 t -109.78 173.71 6.2 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 120.913 0.387 . . . . 0.0 111.499 179.143 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 23.5 pttm -62.81 -18.1 62.24 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-O 120.818 0.342 . . . . 0.0 111.241 175.542 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -74.0 -24.53 59.6 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.377 0.608 . . . . 0.0 110.804 174.296 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.5 t0 . . . . . 0 CA--C 1.538 0.514 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.436 175.855 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.544 0.736 0 CA-C-O 121.232 0.539 . . . . 0.0 111.246 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 87.4 m -100.02 124.57 45.53 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -172.526 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 44.7 mttp -122.59 109.03 13.8 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.877 177.299 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.57 HG22 ' HB2' ' A' ' 53' ' ' LYS . 15.7 mt -82.99 79.87 1.44 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-O 121.191 0.52 . . . . 0.0 109.706 177.477 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.443 HG12 ' H ' ' A' ' 13' ' ' LYS . 4.7 t -92.45 148.69 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 CA-C-O 121.036 0.445 . . . . 0.0 111.571 -172.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -78.55 -20.76 49.91 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 120.847 0.356 . . . . 0.0 111.343 -175.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.443 ' H ' HG12 ' A' ' 11' ' ' VAL . 7.0 ptpp? -108.92 148.62 30.4 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 120.895 0.379 . . . . 0.0 111.522 177.462 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.441 ' HA ' HD12 ' A' ' 34' ' ' ILE . 67.4 p -82.36 -44.01 16.7 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 112.894 0.701 . . . . 0.0 112.894 -177.198 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 49.2 mtt180 -78.59 90.54 4.54 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 121.417 0.627 . . . . 0.0 111.627 -176.052 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 47.8 t -110.53 120.65 61.83 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.29 -179.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -96.11 158.27 15.52 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 121.016 0.436 . . . . 0.0 111.867 179.41 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 51.4 t . . . . . 0 N--CA 1.467 0.385 0 CA-C-O 120.946 0.403 . . . . 0.0 111.401 178.247 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.406 ' HA ' ' HD3' ' A' ' 29' ' ' ARG . 3.4 tpp180 . . . . . 0 N--CA 1.441 -0.896 0 CA-C-O 121.879 0.847 . . . . 0.0 112.19 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 31.4 m -98.35 124.75 51.64 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 CA-C-N 114.6 -1.182 . . . . 0.0 111.563 178.382 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 50.4 m95 -104.68 112.82 26.05 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 120.898 0.38 . . . . 0.0 111.302 178.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.443 ' N ' HD12 ' A' ' 32' ' ' LEU . 5.8 mp -98.87 127.99 44.94 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 121.254 0.549 . . . . 0.0 112.083 -177.399 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 22.8 tp60 -104.11 108.42 19.77 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.738 176.186 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.581 HG21 ' HB2' ' A' ' 52' ' ' LEU . 80.0 mt -67.61 121.36 78.86 Favored Pre-proline 0 CA--C 1.538 0.482 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.846 176.415 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.676 ' HG2' HG22 ' A' ' 38' ' ' THR . 72.8 Cg_endo -76.8 103.67 1.79 Allowed 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 122.147 1.898 . . . . 0.0 112.116 178.329 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -48.81 -26.67 2.52 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.068 0.547 . . . . 0.0 112.186 179.017 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -51.19 -46.19 62.07 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-N 116.144 -0.48 . . . . 0.0 112.049 175.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.676 HG22 ' HG2' ' A' ' 35' ' ' PRO . 14.9 t -104.7 -32.92 8.66 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 111.871 0.323 . . . . 0.0 111.871 -179.562 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 103.98 2.67 45.61 Favored Glycine 0 CA--C 1.533 1.217 0 N-CA-C 114.92 0.728 . . . . 0.0 114.92 174.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.492 ' H ' HG23 ' A' ' 38' ' ' THR . 58.2 p-90 -156.52 163.45 39.38 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 117.942 0.871 . . . . 0.0 112.09 -175.423 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.575 HG12 HG12 ' A' ' 34' ' ' ILE . 6.3 p -150.21 165.88 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 N-CA-C 109.873 -0.418 . . . . 0.0 109.873 174.645 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -142.6 150.82 40.82 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.256 0.551 . . . . 0.0 111.648 176.139 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.634 ' SG ' ' N ' ' A' ' 47' ' ' ASP . 28.6 p -69.99 141.37 89.33 Favored Pre-proline 0 N--CA 1.468 0.468 0 CA-C-N 115.692 -0.686 . . . . 0.0 112.663 -172.747 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 43' ' ' CYS . 18.3 Cg_exo -67.55 -27.88 38.72 Favored 'Trans proline' 0 CA--C 1.542 0.894 0 C-N-CA 122.708 2.272 . . . . 0.0 113.25 177.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -94.51 -83.62 0.34 Allowed 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 -178.688 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 49.5 t -168.14 18.47 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.953 0 CA-C-O 120.797 0.332 . . . . 0.0 111.874 -177.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.634 ' N ' ' SG ' ' A' ' 43' ' ' CYS . 2.1 m-20 -66.6 -79.17 0.05 OUTLIER 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 116.292 -0.413 . . . . 0.0 112.075 -174.431 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.435 ' SG ' ' O ' ' A' ' 47' ' ' ASP . 72.0 m -161.62 171.25 18.31 Favored 'General case' 0 N--CA 1.479 1.011 0 CA-C-O 121.516 0.674 . . . . 0.0 112.607 -177.743 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 36.1 tttp -110.65 120.29 41.94 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.692 174.416 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -108.67 115.34 29.92 Favored 'General case' 0 N--CA 1.469 0.502 0 O-C-N 121.871 -0.518 . . . . 0.0 112.23 -170.167 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 94.9 t -96.42 137.9 23.07 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.09 176.26 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.581 ' HB2' HG21 ' A' ' 34' ' ' ILE . 36.7 tp -84.35 104.77 14.65 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 121.514 0.673 . . . . 0.0 111.92 -178.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.57 ' HB2' HG22 ' A' ' 10' ' ' ILE . 47.3 tttm -62.2 128.19 34.95 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.75 178.657 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 93.33 -5.48 74.66 Favored Glycine 0 CA--C 1.529 0.943 0 CA-C-N 116.034 -0.53 . . . . 0.0 113.409 -177.348 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 44.7 t -95.46 -175.61 3.52 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 122.468 -0.431 . . . . 0.0 111.441 178.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 15.3 ptmm? -62.27 -19.97 63.79 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 120.872 0.368 . . . . 0.0 111.489 178.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -82.31 -10.79 58.97 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 112.027 0.38 . . . . 0.0 112.027 177.302 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.7 t70 . . . . . 0 CA--C 1.54 0.568 0 CA-C-O 121.674 0.749 . . . . 0.0 110.376 177.915 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 . . . . . 0 CA--C 1.543 0.701 0 CA-C-O 120.866 0.365 . . . . 0.0 111.559 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 69.1 m -125.03 142.02 51.75 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 122.447 0.299 . . . . 0.0 111.388 -178.266 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 25.1 mtmm -137.01 126.91 25.76 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 120.932 0.396 . . . . 0.0 111.25 177.068 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.525 ' N ' HD12 ' A' ' 10' ' ' ILE . 2.6 mp -92.67 110.78 23.46 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.494 178.578 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 33.7 m -104.35 164.31 3.78 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-O 121.228 0.537 . . . . 0.0 111.802 -177.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -96.38 -23.62 16.54 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 116.16 -0.473 . . . . 0.0 112.066 -177.218 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -120.27 151.17 39.56 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-O 120.941 0.4 . . . . 0.0 111.475 -177.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 19.9 m -68.97 -26.63 65.14 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 113.607 0.966 . . . . 0.0 113.607 -171.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 4.5 tpt180 -101.77 119.89 39.5 Favored 'General case' 0 N--CA 1.473 0.688 0 O-C-N 121.494 -0.754 . . . . 0.0 111.605 -178.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 41.0 t -129.69 141.89 45.31 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 CA-C-O 120.813 0.339 . . . . 0.0 111.322 -178.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -92.39 116.1 28.68 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.875 0.369 . . . . 0.0 111.356 177.548 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.506 ' HB3' HG23 ' A' ' 30' ' ' VAL . 40.1 t . . . . . 0 N--CA 1.473 0.681 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.282 179.411 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.424 ' HA ' ' HD3' ' A' ' 29' ' ' ARG . 12.3 tpp180 . . . . . 0 N--CA 1.439 -0.993 0 CA-C-O 122.236 1.017 . . . . 0.0 112.733 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.506 HG23 ' HB3' ' A' ' 18' ' ' CYS . 17.4 m -119.08 116.38 50.81 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 CA-C-N 114.294 -1.321 . . . . 0.0 111.242 176.151 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 89.0 m95 -96.65 109.63 22.22 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.531 -178.633 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.7 mp -90.13 154.89 19.43 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 121.149 0.5 . . . . 0.0 111.276 177.219 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.487 ' HA ' HE21 ' A' ' 33' ' ' GLN . 0.0 OUTLIER -122.73 129.13 51.41 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.002 0.429 . . . . 0.0 111.368 178.754 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.586 HG12 HG12 ' A' ' 41' ' ' VAL . 55.0 mt -87.09 117.73 69.02 Favored Pre-proline 0 CA--C 1.537 0.447 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.146 177.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.509 ' HG2' ' OG1' ' A' ' 38' ' ' THR . 82.5 Cg_endo -79.76 123.34 5.24 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 122.179 1.919 . . . . 0.0 111.832 177.707 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.503 ' O ' ' HB2' ' A' ' 56' ' ' LYS . 13.0 pt-20 -56.23 -23.79 38.07 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 111.923 0.342 . . . . 0.0 111.923 -177.355 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -66.93 -35.62 80.39 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 178.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.509 ' OG1' ' HG2' ' A' ' 35' ' ' PRO . 39.9 p -92.29 -50.89 5.43 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 120.924 0.392 . . . . 0.0 110.775 178.723 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.511 ' HA2' ' OG ' ' A' ' 55' ' ' SER . . . 103.98 -0.03 44.91 Favored Glycine 0 CA--C 1.524 0.596 0 CA-C-N 116.073 -0.512 . . . . 0.0 112.841 -178.761 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.412 ' HA ' ' O ' ' A' ' 50' ' ' TYR . 67.7 p-90 -162.14 162.54 28.54 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 120.716 0.293 . . . . 0.0 111.327 -175.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.586 HG12 HG12 ' A' ' 34' ' ' ILE . 9.7 p -142.27 141.74 28.13 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-O 121.033 0.444 . . . . 0.0 110.73 173.479 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.47 ' O ' ' HD3' ' A' ' 44' ' ' PRO . 9.0 pt-20 -100.74 141.27 33.85 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 111.849 0.314 . . . . 0.0 111.849 -177.474 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.542 ' SG ' ' HB3' ' A' ' 47' ' ' ASP . 29.9 p -98.4 99.91 8.21 Favored Pre-proline 0 CA--C 1.54 0.56 0 CA-C-O 120.64 0.257 . . . . 0.0 110.419 170.449 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.47 ' HD3' ' O ' ' A' ' 42' ' ' GLU . 23.2 Cg_exo -65.77 -3.92 8.96 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 122.735 2.29 . . . . 0.0 113.13 -178.328 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -82.83 -76.15 0.28 Allowed 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 116.592 -0.276 . . . . 0.0 110.589 179.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 24.8 p 173.86 92.33 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.358 177.205 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.542 ' HB3' ' SG ' ' A' ' 43' ' ' CYS . 13.5 t70 -161.02 -83.03 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 116.717 -0.219 . . . . 0.0 110.969 173.538 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.502 ' N ' ' SG ' ' A' ' 43' ' ' CYS . 81.9 m -160.76 178.27 9.61 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 122.144 0.973 . . . . 0.0 113.135 -177.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 19.3 ttmm -102.48 113.58 27.05 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 114.484 -1.235 . . . . 0.0 108.754 168.384 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.419 ' HB2' HG12 ' A' ' 41' ' ' VAL . 67.7 m-85 -85.85 105.71 16.55 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 111.847 0.314 . . . . 0.0 111.847 -173.569 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 67.0 t -88.22 133.05 31.73 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 CA-C-O 120.767 0.317 . . . . 0.0 111.038 174.328 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.504 ' HB2' HG21 ' A' ' 34' ' ' ILE . 53.2 tp -98.77 131.75 44.66 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 121.359 0.6 . . . . 0.0 112.42 -175.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -68.05 141.25 56.23 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 115.811 -0.632 . . . . 0.0 111.144 176.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 70.8 10.64 68.06 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 121.271 -0.49 . . . . 0.0 113.68 179.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.511 ' OG ' ' HA2' ' A' ' 39' ' ' GLY . 29.4 t -97.57 -171.08 2.11 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 122.495 -0.415 . . . . 0.0 111.535 -179.356 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.503 ' HB2' ' O ' ' A' ' 36' ' ' GLU . 47.3 tptt -53.32 -43.97 68.05 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 120.944 0.402 . . . . 0.0 111.928 -177.744 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -82.26 2.39 32.17 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -175.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.0 t70 . . . . . 0 N--CA 1.471 0.58 0 CA-C-O 120.924 0.392 . . . . 0.0 111.659 -178.377 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.472 0.634 0 CA-C-O 121.506 0.669 . . . . 0.0 111.854 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 54.2 m -89.86 111.37 22.39 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.602 177.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 46.8 tptt -100.54 109.3 21.39 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.04 -172.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 58.3 mt -79.04 94.22 1.73 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 CA-C-O 121.141 0.496 . . . . 0.0 110.602 179.462 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.51 HG12 ' H ' ' A' ' 13' ' ' LYS . 3.5 t -97.89 156.84 3.55 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 CA-C-O 121.127 0.489 . . . . 0.0 111.62 -175.763 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -96.43 -4.31 41.96 Favored 'General case' 0 CA--C 1.548 0.873 0 CA-C-O 121.01 0.433 . . . . 0.0 111.909 -178.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.51 ' H ' HG12 ' A' ' 11' ' ' VAL . 50.9 mtmt -137.35 153.08 50.29 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 122.101 -0.374 . . . . 0.0 111.42 -176.753 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 77.7 p -79.06 -40.15 32.01 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.063 0.459 . . . . 0.0 111.265 177.438 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 78.2 mtm180 -75.35 94.82 3.1 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.96 176.294 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.495 HG11 ' CD1' ' A' ' 50' ' ' TYR . 47.4 t -111.35 137.86 42.17 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.34 -177.627 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -97.96 118.46 34.59 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 121.069 0.461 . . . . 0.0 111.755 -179.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 10.0 t . . . . . 0 N--CA 1.467 0.422 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.061 174.762 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.425 ' NE ' ' HE1' ' A' ' 31' ' ' TRP . 0.8 OUTLIER . . . . . 0 N--CA 1.446 -0.655 0 CA-C-O 122.769 1.271 . . . . 0.0 111.779 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 25.7 m -134.32 141.09 44.55 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 113.855 -1.521 . . . . 0.0 109.774 169.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.425 ' HE1' ' NE ' ' A' ' 29' ' ' ARG . 75.7 m95 -107.25 123.55 48.46 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -171.433 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.487 ' N ' HD12 ' A' ' 32' ' ' LEU . 5.1 mp -103.44 158.65 16.2 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.615 178.052 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -123.77 109.53 13.78 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.935 0.398 . . . . 0.0 111.436 -179.002 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.501 HG12 HG12 ' A' ' 41' ' ' VAL . 64.6 mt -70.47 115.06 31.17 Favored Pre-proline 0 CA--C 1.542 0.656 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.47 178.439 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.432 ' HG2' ' OG1' ' A' ' 38' ' ' THR . 90.4 Cg_endo -80.11 145.47 17.38 Favored 'Trans proline' 0 CA--C 1.54 0.825 0 C-N-CA 122.517 2.145 . . . . 0.0 112.753 179.573 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.402 ' H ' ' CD ' ' A' ' 36' ' ' GLU . 20.9 mp0 -62.95 -29.51 70.86 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 121.105 0.479 . . . . 0.0 111.035 179.437 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -58.43 -50.28 74.25 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.497 -0.774 . . . . 0.0 112.155 -178.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.432 ' OG1' ' HG2' ' A' ' 35' ' ' PRO . 50.2 p -90.34 -49.16 6.69 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.077 0.465 . . . . 0.0 111.324 -178.267 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 98.24 0.95 58.22 Favored Glycine 0 CA--C 1.523 0.562 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.399 -176.292 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.557 ' HB3' HG22 ' A' ' 51' ' ' VAL . 68.2 p-90 -156.79 164.13 38.44 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 121.148 0.499 . . . . 0.0 112.151 -176.605 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.501 HG12 HG12 ' A' ' 34' ' ' ILE . 14.5 p -142.85 137.09 27.15 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.676 174.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -98.83 148.03 24.33 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.155 0.502 . . . . 0.0 112.139 -177.319 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.662 ' SG ' ' HE2' ' A' ' 50' ' ' TYR . 74.0 m -98.25 119.31 62.11 Favored Pre-proline 0 CA--C 1.538 0.519 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.578 171.256 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -73.13 22.44 0.32 Allowed 'Trans proline' 0 CA--C 1.541 0.861 0 C-N-CA 122.902 2.402 . . . . 0.0 114.036 -173.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -114.94 -88.7 0.57 Allowed 'General case' 0 CA--C 1.538 0.517 0 O-C-N 122.084 -0.385 . . . . 0.0 111.073 177.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 57.5 m -160.57 18.98 0.14 Allowed 'General case' 0 N--CA 1.477 0.913 0 CA-C-O 120.856 0.36 . . . . 0.0 111.331 -177.161 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.41 ' O ' ' SG ' ' A' ' 48' ' ' CYS . 2.1 m-20 -81.74 -93.5 0.05 Allowed 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 112.276 0.473 . . . . 0.0 112.276 -173.34 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.41 ' SG ' ' O ' ' A' ' 47' ' ' ASP . 72.3 m -161.38 173.33 15.09 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.553 0.692 . . . . 0.0 112.043 -176.539 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.7 ttmp? -101.47 104.77 15.71 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.269 169.041 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.662 ' HE2' ' SG ' ' A' ' 43' ' ' CYS . 95.4 m-85 -81.85 103.16 11.32 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.926 0.393 . . . . 0.0 111.767 -173.745 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.557 HG22 ' HB3' ' A' ' 40' ' ' TRP . 88.0 t -94.28 123.19 46.29 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.928 178.712 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 51.4 tp -77.88 120.41 22.72 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 116.585 -0.28 . . . . 0.0 110.978 176.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 46.8 tttp -65.71 146.06 55.25 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 121.149 0.5 . . . . 0.0 111.954 -178.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 85.11 17.45 62.86 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 121.117 -0.563 . . . . 0.0 112.549 -175.452 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.5 m -118.36 172.14 7.66 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 122.481 0.312 . . . . 0.0 110.886 -179.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -56.31 -30.08 62.09 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -178.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -75.96 -26.91 57.27 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 121.006 0.431 . . . . 0.0 112.111 179.079 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 34.3 t70 . . . . . 0 CA--C 1.543 0.686 0 CA-C-O 121.549 0.69 . . . . 0.0 110.571 179.366 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 . . . . . 0 N--CA 1.472 0.632 0 CA-C-O 121.227 0.537 . . . . 0.0 112.069 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 69.5 m -89.18 119.65 29.86 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.292 174.141 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 55.9 tptt -109.82 106.91 16.69 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 120.656 0.265 . . . . 0.0 111.236 -173.473 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 56.2 mt -86.09 100.95 9.79 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-O 121.104 0.478 . . . . 0.0 111.351 -179.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 34.5 m -103.94 162.57 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 CA-C-O 120.951 0.405 . . . . 0.0 111.35 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -92.93 -32.46 14.55 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-O 120.887 0.375 . . . . 0.0 111.618 -178.317 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -108.16 143.31 37.11 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 120.729 0.299 . . . . 0.0 111.643 -179.277 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 41.2 t -63.01 -37.24 86.38 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 112.824 0.676 . . . . 0.0 112.824 -176.234 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 52.5 mtt85 -74.18 105.49 5.41 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.201 0.524 . . . . 0.0 111.892 178.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 48.0 t -100.95 106.17 18.97 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.966 176.592 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -80.82 101.03 9.12 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 120.936 0.398 . . . . 0.0 111.266 178.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 52.0 t . . . . . 0 CA--C 1.539 0.539 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -178.737 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.48 ' HD3' ' HA ' ' A' ' 29' ' ' ARG . 0.1 OUTLIER . . . . . 0 N--CA 1.441 -0.89 0 CA-C-O 122.24 1.019 . . . . 0.0 110.665 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 55.8 t -93.94 105.07 16.45 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 CA-C-N 114.134 -1.394 . . . . 0.0 111.17 -179.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 56.7 m95 -92.22 111.52 23.11 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.367 178.609 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.413 ' N ' HD12 ' A' ' 32' ' ' LEU . 5.6 mp -91.37 134.03 34.95 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 120.753 0.311 . . . . 0.0 111.003 177.612 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 14.6 tp60 -104.88 106.91 17.61 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 177.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.586 HG12 HG12 ' A' ' 41' ' ' VAL . 75.6 mt -63.46 117.42 34.16 Favored Pre-proline 0 CA--C 1.54 0.566 0 CA-C-O 120.602 0.239 . . . . 0.0 111.408 -179.702 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.555 ' HG2' ' OG1' ' A' ' 38' ' ' THR . 90.1 Cg_endo -80.1 127.78 7.01 Favored 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 122.611 2.207 . . . . 0.0 113.005 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -61.31 -21.94 64.44 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 120.981 0.42 . . . . 0.0 111.675 179.275 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -64.04 -35.12 79.68 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.884 178.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.555 ' OG1' ' HG2' ' A' ' 35' ' ' PRO . 36.0 p -106.04 -52.42 2.81 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-O 121.029 0.442 . . . . 0.0 111.605 -178.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 106.56 0.64 37.25 Favored Glycine 0 CA--C 1.526 0.762 0 CA-C-N 116.189 -0.46 . . . . 0.0 112.643 -176.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 67.7 p-90 -155.81 162.79 40.42 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 120.916 0.388 . . . . 0.0 111.595 -178.438 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.586 HG12 HG12 ' A' ' 34' ' ' ILE . 12.3 p -151.81 127.85 1.84 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.452 172.647 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.417 ' HA ' ' HA ' ' A' ' 49' ' ' LYS . 12.6 pt-20 -100.89 150.21 23.08 Favored 'General case' 0 CA--C 1.536 0.405 0 O-C-N 121.925 -0.485 . . . . 0.0 111.324 -179.357 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 42.6 t -97.16 107.41 37.94 Favored Pre-proline 0 N--CA 1.468 0.429 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.813 -177.417 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.412 ' HD3' ' O ' ' A' ' 42' ' ' GLU . 41.4 Cg_exo -58.55 -14.66 21.97 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 122.364 2.043 . . . . 0.0 113.035 177.467 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -105.03 -0.3 26.92 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.807 -178.386 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 42.5 t -143.9 -2.2 0.94 Allowed 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 112.416 0.525 . . . . 0.0 112.416 -179.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 61.7 m-20 70.95 -41.17 0.5 Allowed 'General case' 0 CA--C 1.548 0.876 0 N-CA-C 114.026 1.121 . . . . 0.0 114.026 178.125 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 77.3 m -58.69 145.68 39.2 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 -172.491 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.417 ' HA ' ' HA ' ' A' ' 42' ' ' GLU . 20.4 ttmm -107.46 123.25 48.13 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.989 -178.205 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 55.1 m-85 -100.53 114.61 28.39 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 -174.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.405 HG13 ' HB3' ' A' ' 57' ' ' ALA . 93.2 t -99.15 145.24 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 CA-C-O 120.819 0.342 . . . . 0.0 111.467 176.871 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.563 ' HB2' HG21 ' A' ' 34' ' ' ILE . 54.5 tp -94.1 126.09 39.12 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 120.907 0.384 . . . . 0.0 111.735 179.84 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.457 ' HB3' ' NZ ' ' A' ' 53' ' ' LYS . 0.9 OUTLIER -61.88 122.91 16.59 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.435 178.428 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 90.07 7.65 67.76 Favored Glycine 0 CA--C 1.524 0.649 0 C-N-CA 121.417 -0.421 . . . . 0.0 113.299 -178.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 34.6 t -100.72 -173.56 2.42 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 122.364 -0.492 . . . . 0.0 111.587 178.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 48.7 mmtm -54.31 -34.73 61.6 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 113.253 0.835 . . . . 0.0 113.253 -175.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.405 ' HB3' HG13 ' A' ' 51' ' ' VAL . . . -94.19 6.77 47.56 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -176.467 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.7 t70 . . . . . 0 CA--C 1.552 1.045 0 O-C-N 122.151 -0.343 . . . . 0.0 111.302 -178.301 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 . . . . . 0 N--CA 1.468 0.464 0 CA-C-O 121.073 0.463 . . . . 0.0 112.029 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 86.1 m -122.14 135.6 54.81 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.671 176.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 57.6 mtpt -137.23 137.92 39.59 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 122.342 0.257 . . . . 0.0 111.116 -173.566 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 57.3 mt -97.45 107.34 19.89 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-O 120.966 0.412 . . . . 0.0 111.417 -179.031 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.44 HG12 ' H ' ' A' ' 13' ' ' LYS . 11.7 t -100.07 156.21 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.772 177.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -90.17 -7.8 52.75 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 -175.679 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.44 ' H ' HG12 ' A' ' 11' ' ' VAL . 16.5 ptpt -130.53 152.21 50.16 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 121.073 0.463 . . . . 0.0 111.892 -176.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 23.0 m -83.63 9.53 11.34 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -174.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 75.0 mtp180 -128.19 116.97 20.72 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 121.007 0.432 . . . . 0.0 111.759 -178.417 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 39.9 t -131.64 152.65 37.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.396 -178.619 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.472 ' HA ' ' O ' ' A' ' 30' ' ' VAL . . . -81.53 154.1 26.44 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-O 121.278 0.561 . . . . 0.0 112.404 -179.59 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.568 ' HB2' HD13 ' A' ' 32' ' ' LEU . 43.1 t . . . . . 0 N--CA 1.476 0.859 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.773 -174.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 16.5 tpt180 . . . . . 0 N--CA 1.466 0.36 0 CA-C-O 122.01 0.909 . . . . 0.0 110.246 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.472 ' O ' ' HA ' ' A' ' 17' ' ' ALA . 61.2 t -128.11 132.24 68.65 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 CA-C-N 114.456 -1.247 . . . . 0.0 109.64 -178.595 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 84.2 m95 -115.58 136.15 53.36 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 -172.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.568 HD13 ' HB2' ' A' ' 18' ' ' CYS . 8.8 mp -113.53 144.53 42.69 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.633 172.138 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.474 ' HA ' HE21 ' A' ' 33' ' ' GLN . 0.0 OUTLIER -103.92 119.84 39.77 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.272 -179.258 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.661 HG12 HG12 ' A' ' 41' ' ' VAL . 50.7 mt -75.0 114.46 35.12 Favored Pre-proline 0 CA--C 1.54 0.566 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.956 177.432 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.565 ' HG2' ' OG1' ' A' ' 38' ' ' THR . 91.3 Cg_endo -77.92 132.34 11.71 Favored 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 122.475 2.117 . . . . 0.0 112.356 178.553 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -77.32 -7.72 56.49 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 120.836 0.351 . . . . 0.0 111.341 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -68.03 -56.01 10.48 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 121.028 0.442 . . . . 0.0 110.89 172.488 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.565 ' OG1' ' HG2' ' A' ' 35' ' ' PRO . 47.9 p -80.64 -43.26 20.75 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.157 177.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 103.07 -0.19 47.86 Favored Glycine 0 CA--C 1.524 0.617 0 CA-C-N 115.56 -0.745 . . . . 0.0 112.811 -178.279 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.542 ' HB3' HG22 ' A' ' 51' ' ' VAL . 65.9 p-90 -161.2 161.24 30.84 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 -176.288 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.661 HG12 HG12 ' A' ' 34' ' ' ILE . 9.8 p -146.76 133.39 13.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.231 169.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -111.39 140.45 45.97 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -174.604 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.528 ' HB3' ' SG ' ' A' ' 48' ' ' CYS . 43.8 t -74.41 112.87 19.1 Favored Pre-proline 0 CA--C 1.537 0.452 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.623 178.516 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -58.35 -14.39 20.07 Favored 'Trans proline' 0 CA--C 1.542 0.911 0 C-N-CA 122.695 2.263 . . . . 0.0 113.404 -178.645 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -87.18 -51.35 6.03 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.705 -177.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 52.4 t -103.27 -3.7 25.29 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -178.06 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 49.8 m-20 65.76 10.67 6.99 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.115 0.566 . . . . 0.0 112.373 179.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.528 ' SG ' ' HB3' ' A' ' 43' ' ' CYS . 6.4 p -73.85 116.85 14.94 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 121.145 0.498 . . . . 0.0 111.515 179.553 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 18.3 ttmm -91.88 113.12 25.3 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.79 -177.166 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -97.38 103.34 15.26 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 120.988 0.423 . . . . 0.0 111.921 -175.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.542 HG22 ' HB3' ' A' ' 40' ' ' TRP . 78.5 t -82.55 142.87 13.04 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.662 175.397 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.512 ' HB2' HG21 ' A' ' 34' ' ' ILE . 68.6 tp -89.41 124.93 34.91 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 120.91 0.386 . . . . 0.0 111.7 178.269 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 8.5 tmtm? -71.05 122.89 20.88 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 174.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 97.19 52.54 1.46 Allowed Glycine 0 CA--C 1.526 0.732 0 N-CA-C 111.749 -0.54 . . . . 0.0 111.749 -172.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.479 ' H ' ' HB3' ' A' ' 58' ' ' ASP . 51.6 p -155.31 -178.49 7.3 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.516 0.674 . . . . 0.0 111.75 -176.341 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 32.4 ttpt -67.68 -15.23 63.54 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-N 115.322 -0.854 . . . . 0.0 112.059 179.411 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -99.99 2.34 43.4 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 121.202 0.525 . . . . 0.0 111.667 176.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.479 ' HB3' ' H ' ' A' ' 55' ' ' SER . 16.4 t70 . . . . . 0 CA--C 1.547 0.846 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.73 -177.472 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 . . . . . 0 N--CA 1.475 0.777 0 CA-C-O 121.23 0.538 . . . . 0.0 112.313 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 80.1 m -99.45 107.3 19.47 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.926 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 6.8 mtpm? -102.81 93.46 5.08 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.158 0.504 . . . . 0.0 110.372 -175.181 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.429 ' HA ' ' O ' ' A' ' 51' ' ' VAL . 62.3 mt -78.28 99.37 2.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.061 -178.666 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 35.6 m -105.67 160.24 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-N 115.753 -0.658 . . . . 0.0 112.062 -174.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -91.19 1.14 57.32 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 120.757 0.313 . . . . 0.0 111.65 178.293 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -115.62 153.39 31.36 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 120.826 0.346 . . . . 0.0 111.63 -176.15 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 42.8 m -89.35 -22.77 22.45 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 116.517 -0.311 . . . . 0.0 111.161 176.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 68.8 mtt180 -114.38 114.6 26.09 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 120.918 0.39 . . . . 0.0 111.372 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 47.2 t -124.28 138.16 54.78 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.657 -177.386 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.0 102.11 7.23 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 120.964 0.411 . . . . 0.0 111.641 178.452 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.478 ' SG ' ' HB2' ' A' ' 43' ' ' CYS . 51.5 t . . . . . 0 C--N 1.326 -0.426 0 CA-C-O 121.398 0.618 . . . . 0.0 111.629 177.652 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 1.1 mmm180 . . . . . 0 N--CA 1.44 -0.952 0 CA-C-O 123.093 1.425 . . . . 0.0 112.563 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.476 HG23 ' HB3' ' A' ' 18' ' ' CYS . 17.8 m -119.8 125.02 73.89 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 CA-C-N 112.494 -2.139 . . . . 0.0 110.959 -179.464 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 39.5 m95 -101.84 114.53 28.69 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.078 0.466 . . . . 0.0 111.182 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 10.5 mp -92.81 150.73 20.43 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.654 -179.354 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 50.8 tp60 -104.39 124.95 50.14 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.791 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.526 HG21 ' HB2' ' A' ' 52' ' ' LEU . 74.7 mt -84.21 114.47 54.76 Favored Pre-proline 0 CA--C 1.542 0.65 0 CA-C-N 116.642 -0.254 . . . . 0.0 110.381 172.391 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -84.92 143.23 9.26 Favored 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 122.704 2.269 . . . . 0.0 113.235 -177.268 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.426 ' O ' ' NZ ' ' A' ' 56' ' ' LYS . 16.4 mm-40 -69.5 -3.81 16.17 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 121.117 0.484 . . . . 0.0 111.066 171.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -65.18 -62.86 1.29 Allowed 'General case' 0 CA--C 1.543 0.683 0 CA-C-O 121.034 0.445 . . . . 0.0 110.158 169.553 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 82.0 p -91.79 -48.88 6.56 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 115.758 -0.655 . . . . 0.0 112.037 -179.006 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 100.68 1.51 55.3 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 121.309 -0.472 . . . . 0.0 112.718 -175.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 60.2 p-90 -156.53 164.78 37.81 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 122.559 0.344 . . . . 0.0 111.39 -176.495 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 13.6 p -146.93 152.0 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 174.201 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -124.18 147.51 47.95 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 113.059 0.763 . . . . 0.0 113.059 -175.016 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.478 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 18.0 t -101.53 105.24 39.32 Favored Pre-proline 0 N--CA 1.468 0.432 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.274 174.226 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -77.17 -0.33 10.49 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 122.457 2.105 . . . . 0.0 113.123 -177.02 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -90.05 -67.71 0.83 Allowed 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 116.636 -0.256 . . . . 0.0 111.507 -176.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 49.4 t -104.26 6.07 35.17 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 111.869 0.322 . . . . 0.0 111.869 178.101 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 26.6 m-20 69.06 101.35 0.06 Allowed 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 175.29 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 52.0 m -161.69 120.8 2.43 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.135 175.075 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -100.4 110.84 23.05 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 120.753 0.311 . . . . 0.0 110.812 177.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 27.9 m-85 -91.57 107.13 18.99 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 120.638 0.256 . . . . 0.0 110.456 -177.19 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.429 ' O ' ' HA ' ' A' ' 10' ' ' ILE . 90.5 t -100.4 131.4 48.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 CA-C-O 120.726 0.298 . . . . 0.0 111.741 179.646 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.526 ' HB2' HG21 ' A' ' 34' ' ' ILE . 68.0 tp -81.54 119.42 23.75 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.096 0.475 . . . . 0.0 111.934 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.42 ' HB2' HG22 ' A' ' 10' ' ' ILE . 88.0 tttt -69.0 108.23 3.45 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.868 177.103 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 119.87 -13.59 10.63 Favored Glycine 0 CA--C 1.527 0.801 0 C-N-CA 121.412 -0.423 . . . . 0.0 112.542 -175.571 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 59.6 p -81.29 -176.57 6.06 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 120.93 0.395 . . . . 0.0 111.147 178.398 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.426 ' NZ ' ' O ' ' A' ' 36' ' ' GLU . 33.7 mtmm -73.07 -20.19 61.01 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.655 -0.248 . . . . 0.0 111.612 179.073 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -71.6 -49.61 38.67 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.287 0.565 . . . . 0.0 111.321 -175.46 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.4 t70 . . . . . 0 CA--C 1.536 0.429 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.867 177.927 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.608 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.6 OUTLIER . . . . . 0 N--CA 1.493 1.676 0 CA-C-O 120.77 0.319 . . . . 0.0 111.47 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.445 ' O ' HG13 ' A' ' 3' ' ' ILE . 40.4 p -76.62 -3.09 35.94 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -177.177 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.445 HG13 ' O ' ' A' ' 2' ' ' THR . 2.6 pp 47.34 13.26 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.91 0 C-N-CA 123.826 0.85 . . . . 0.0 112.996 -172.362 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 54.6 -165.08 0.1 Allowed 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 123.786 0.835 . . . . 0.0 112.725 177.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -150.58 88.39 4.63 Favored Pre-proline 0 N--CA 1.471 0.578 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -178.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -63.08 85.77 0.12 Allowed 'Trans proline' 0 CA--C 1.542 0.922 0 C-N-CA 122.4 2.067 . . . . 0.0 112.207 175.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -87.56 96.05 10.26 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.753 -177.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 57.2 m -75.52 127.53 33.3 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.305 179.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 85.2 mttt -141.18 123.41 15.68 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 120.993 0.425 . . . . 0.0 111.32 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.522 HD12 ' N ' ' A' ' 10' ' ' ILE . 2.8 mp -88.74 119.64 36.25 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.769 -178.042 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 15.0 t -105.97 154.69 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-O 121.028 0.442 . . . . 0.0 111.245 -178.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -80.93 -37.78 28.96 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 121.048 0.451 . . . . 0.0 110.727 -177.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -101.56 162.97 12.51 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.396 176.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 50.5 m -79.97 -40.89 27.06 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -177.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 18.5 ptt-85 -86.09 118.43 25.55 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 121.458 0.647 . . . . 0.0 110.813 177.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 39.5 t -111.47 125.02 68.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.988 -172.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.95 82.23 5.15 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 120.984 0.421 . . . . 0.0 111.341 176.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.577 ' HG ' ' HG ' ' A' ' 43' ' ' CYS . 41.9 t -84.54 178.71 7.6 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.17 0.51 . . . . 0.0 111.47 -179.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.633 ' HB3' ' HA ' ' A' ' 27' ' ' HIS . 31.4 m-20 -132.96 -66.35 0.67 Allowed 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 -177.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 162.92 -146.33 11.64 Favored Glycine 0 CA--C 1.526 0.734 0 C-N-CA 120.456 -0.878 . . . . 0.0 113.441 -178.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.891 ' HA2' ' HB2' ' A' ' 46' ' ' CYS . . . -96.62 -105.44 2.25 Favored Glycine 0 N--CA 1.467 0.719 0 C-N-CA 121.337 -0.459 . . . . 0.0 112.687 179.616 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.9 mp0 -75.11 162.77 28.23 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 122.607 -0.349 . . . . 0.0 110.408 170.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -45.0 -49.7 9.16 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 121.634 -0.317 . . . . 0.0 113.774 176.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -79.78 -3.0 45.76 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -178.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 83.1 mt -113.84 49.3 1.0 Allowed 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.581 0.705 . . . . 0.0 110.724 -179.242 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 126.46 -138.54 10.75 Favored Glycine 0 CA--C 1.524 0.617 0 CA-C-N 115.347 -0.842 . . . . 0.0 112.636 174.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.638 ' N ' ' HD3' ' A' ' 28' ' ' PRO . 7.3 m80 67.92 47.3 0.39 Allowed Pre-proline 0 CA--C 1.545 0.754 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 179.166 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.638 ' HD3' ' N ' ' A' ' 27' ' ' HIS . 42.9 Cg_endo -101.74 4.3 0.54 Allowed 'Trans proline' 0 CA--C 1.545 1.046 0 C-N-CA 122.884 2.389 . . . . 0.0 113.378 175.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.532 ' HB3' ' O ' ' A' ' 28' ' ' PRO . 1.1 tmt_? 77.06 99.13 0.07 Allowed 'General case' 0 C--N 1.346 0.421 0 CA-C-O 122.185 0.993 . . . . 0.0 109.006 -172.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.1 m -131.21 131.88 63.4 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 114.652 -1.158 . . . . 0.0 111.703 178.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 49.1 m95 -105.81 114.92 29.36 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.355 -178.077 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.461 ' HB3' HG21 ' A' ' 41' ' ' VAL . 6.4 mp -107.76 133.01 52.77 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 120.837 0.351 . . . . 0.0 111.421 179.249 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 54.9 tp60 -90.03 119.88 30.76 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 121.144 0.497 . . . . 0.0 111.958 -178.1 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.562 HG21 ' HB2' ' A' ' 52' ' ' LEU . 73.1 mt -79.93 118.17 71.08 Favored Pre-proline 0 CA--C 1.54 0.589 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.999 175.102 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.692 ' HG2' HG22 ' A' ' 38' ' ' THR . 97.2 Cg_endo -83.05 121.6 3.18 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 122.325 2.016 . . . . 0.0 112.868 178.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -56.5 -16.77 6.5 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-O 121.306 0.574 . . . . 0.0 111.427 175.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -61.69 -29.17 69.92 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 115.61 -0.723 . . . . 0.0 112.026 177.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.692 HG22 ' HG2' ' A' ' 35' ' ' PRO . 12.9 t -131.16 -38.82 1.2 Allowed 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 120.679 0.276 . . . . 0.0 111.415 178.179 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 107.42 2.45 35.34 Favored Glycine 0 CA--C 1.53 0.98 0 N-CA-C 115.419 0.928 . . . . 0.0 115.419 171.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.447 ' H ' HG23 ' A' ' 38' ' ' THR . 68.1 p-90 -144.8 164.96 29.46 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 118.271 1.035 . . . . 0.0 112.972 -176.022 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.461 HG21 ' HB3' ' A' ' 32' ' ' LEU . 9.9 p -147.92 143.94 19.31 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.244 171.118 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -116.64 141.51 48.11 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 -177.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.577 ' HG ' ' HG ' ' A' ' 18' ' ' CYS . 60.5 m -110.68 109.28 57.92 Favored Pre-proline 0 N--CA 1.473 0.716 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.163 173.07 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -69.06 15.61 0.19 Allowed 'Trans proline' 0 CA--C 1.549 1.24 0 C-N-CA 123.079 2.519 . . . . 0.0 115.511 -167.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -96.13 -72.21 0.64 Allowed 'General case' 0 N--CA 1.473 0.698 0 O-C-N 121.925 -0.485 . . . . 0.0 110.919 177.024 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.891 ' HB2' ' HA2' ' A' ' 21' ' ' GLY . 43.1 t -86.94 3.8 44.23 Favored 'General case' 0 N--CA 1.475 0.822 0 O-C-N 122.218 -0.301 . . . . 0.0 111.58 169.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 56.48 31.29 18.63 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 121.379 0.609 . . . . 0.0 112.0 -178.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 61.9 m -64.95 110.93 2.62 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.123 176.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 84.2 tttt -98.62 102.38 14.1 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 121.08 0.466 . . . . 0.0 110.659 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -87.33 116.62 25.54 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.465 -175.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.465 ' O ' ' HA ' ' A' ' 10' ' ' ILE . 77.8 t -96.9 139.53 19.34 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.07 177.194 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.562 ' HB2' HG21 ' A' ' 34' ' ' ILE . 51.7 tp -77.4 131.78 38.19 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 121.221 0.534 . . . . 0.0 111.667 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -53.43 110.38 0.55 Allowed 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -179.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 85.68 2.32 86.9 Favored Glycine 0 CA--C 1.527 0.787 0 C-N-CA 121.191 -0.528 . . . . 0.0 113.821 176.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.412 ' HB2' ' HB3' ' A' ' 52' ' ' LEU . 40.8 t -70.15 174.8 5.08 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.049 0.452 . . . . 0.0 111.776 179.387 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -67.69 -23.91 65.35 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 121.075 0.464 . . . . 0.0 111.075 179.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -74.18 -18.46 60.77 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 121.045 0.45 . . . . 0.0 110.893 172.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -101.06 29.67 4.52 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-O 121.578 0.704 . . . . 0.0 110.148 177.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -93.25 13.05 22.43 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.81 -178.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.457 ' N ' HD12 ' A' ' 60' ' ' LEU . 6.3 mp -83.19 -160.67 0.43 Allowed 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.447 177.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.421 ' HB2' ' O ' ' A' ' 60' ' ' LEU . 23.6 mm-40 69.3 -75.57 0.07 Allowed 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 120.921 0.391 . . . . 0.0 110.854 -177.273 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 17.9 p-80 -164.93 142.76 6.29 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 120.898 0.38 . . . . 0.0 111.072 -179.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 25.5 m170 -79.19 178.62 7.93 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 121.444 0.64 . . . . 0.0 112.545 -176.096 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 7.3 p80 -151.17 -52.28 0.13 Allowed 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.665 -179.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 86.5 t60 61.18 2.84 0.64 Allowed 'General case' 0 N--CA 1.48 1.025 0 N-CA-C 114.77 1.396 . . . . 0.0 114.77 167.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 33.3 p80 44.6 -164.19 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.256 0 CA-C-N 118.38 0.536 . . . . 0.0 111.553 -173.032 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 25.0 p-80 . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.647 -0.692 . . . . 0.0 111.098 174.63 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.0 mtt . . . . . 0 N--CA 1.488 1.425 0 CA-C-O 121.024 0.44 . . . . 0.0 110.885 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 67.9 p -115.9 153.56 31.33 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 121.051 0.453 . . . . 0.0 111.394 178.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 60.6 mt -95.54 -26.81 4.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-O 121.203 0.525 . . . . 0.0 109.921 171.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 66.51 -76.74 0.05 OUTLIER 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.024 -178.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 62.24 103.16 0.03 OUTLIER Pre-proline 0 N--CA 1.471 0.599 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 175.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -60.03 87.83 0.07 OUTLIER 'Trans proline' 0 CA--C 1.539 0.73 0 C-N-CA 122.267 1.978 . . . . 0.0 112.337 175.181 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -43.03 124.87 3.36 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.364 0.602 . . . . 0.0 112.243 178.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 97.3 m -89.72 136.19 33.18 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.786 -179.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 45.1 tttp -127.65 116.75 20.78 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 120.636 0.255 . . . . 0.0 110.829 -175.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 44.5 mm -86.3 112.37 22.63 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-O 120.989 0.423 . . . . 0.0 111.199 -178.387 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 35.7 m -113.33 164.53 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -178.141 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -105.41 -6.3 19.65 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-O 121.057 0.456 . . . . 0.0 111.424 179.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 68.6 mmtt -120.04 144.37 47.59 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.094 0.473 . . . . 0.0 111.856 -179.015 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 34.7 m -72.83 -21.06 61.02 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.603 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 80.4 mtt-85 -102.4 111.75 24.17 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-O 121.241 0.543 . . . . 0.0 110.634 177.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 36.7 t -119.96 131.2 73.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.851 -175.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.501 ' HB2' ' CE2' ' A' ' 31' ' ' TRP . . . -74.91 139.57 43.17 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 121.122 0.487 . . . . 0.0 111.742 177.427 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 53.0 t -127.46 71.36 1.34 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.146 0.498 . . . . 0.0 110.534 177.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -69.29 -75.21 0.11 Allowed 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.723 -178.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 161.79 -176.08 38.28 Favored Glycine 0 CA--C 1.521 0.466 0 C-N-CA 120.119 -1.039 . . . . 0.0 113.975 177.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -110.61 -102.16 2.68 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 112.244 -0.342 . . . . 0.0 112.244 178.002 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 44.2 mm-40 -67.06 167.37 12.02 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 116.778 0.289 . . . . 0.0 111.403 176.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -44.04 -54.79 5.95 Favored Glycine 0 CA--C 1.53 0.972 0 N-CA-C 114.267 0.467 . . . . 0.0 114.267 -179.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.74 -29.26 70.0 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 120.969 0.414 . . . . 0.0 112.009 179.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 85.6 mt -89.9 1.27 56.42 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.285 179.184 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -76.45 107.51 2.37 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 121.165 -0.54 . . . . 0.0 113.241 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 28.1 m80 -94.85 152.12 39.46 Favored Pre-proline 0 CA--C 1.544 0.725 0 O-C-N 122.623 -0.339 . . . . 0.0 110.192 177.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_exo -52.42 -69.79 0.06 OUTLIER 'Trans proline' 0 CA--C 1.544 0.981 0 C-N-CA 122.642 2.228 . . . . 0.0 114.199 -176.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 4.4 tmt_? 179.28 92.27 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.25 0 CA-C-O 121.941 0.876 . . . . 0.0 109.56 -179.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 28.7 m -122.36 134.89 64.21 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 CA-C-N 114.846 -1.07 . . . . 0.0 111.486 178.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.501 ' CE2' ' HB2' ' A' ' 17' ' ' ALA . 15.7 m95 -116.27 127.35 54.65 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 120.787 0.327 . . . . 0.0 111.114 179.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.7 mp -92.08 151.93 20.19 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 121.179 0.514 . . . . 0.0 111.544 -178.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 27.9 tp60 -110.2 108.98 19.31 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.019 -179.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.556 HG12 HG12 ' A' ' 41' ' ' VAL . 75.8 mt -71.62 122.3 86.81 Favored Pre-proline 0 CA--C 1.542 0.641 0 CA-C-N 116.634 -0.257 . . . . 0.0 111.481 179.336 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.488 ' HG2' ' OG1' ' A' ' 38' ' ' THR . 44.7 Cg_endo -86.31 127.11 2.83 Favored 'Trans proline' 0 CA--C 1.54 0.811 0 C-N-CA 122.95 2.434 . . . . 0.0 112.709 176.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -59.22 -21.97 60.34 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 121.43 0.633 . . . . 0.0 110.792 177.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -59.11 -31.7 69.16 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 115.234 -0.893 . . . . 0.0 111.742 178.017 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.488 ' OG1' ' HG2' ' A' ' 35' ' ' PRO . 44.8 p -113.92 -47.44 2.96 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.308 0.575 . . . . 0.0 110.975 178.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.547 ' HA3' ' H ' ' A' ' 57' ' ' ALA . . . 100.2 1.08 55.84 Favored Glycine 0 CA--C 1.525 0.676 0 CA-C-N 115.874 -0.603 . . . . 0.0 112.782 -178.198 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 58.5 p-90 -155.46 162.27 40.77 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.088 0.471 . . . . 0.0 111.388 -177.1 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.556 HG12 HG12 ' A' ' 34' ' ' ILE . 14.2 p -148.67 126.45 2.95 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 CA-C-O 120.992 0.425 . . . . 0.0 110.62 172.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.422 ' HA ' ' HA ' ' A' ' 49' ' ' LYS . 16.7 pt-20 -94.39 143.01 26.77 Favored 'General case' 0 CA--C 1.535 0.398 0 O-C-N 122.124 -0.36 . . . . 0.0 111.035 179.437 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 37.0 t -71.55 130.99 86.68 Favored Pre-proline 0 N--CA 1.468 0.435 0 N-CA-C 111.825 0.305 . . . . 0.0 111.825 179.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -76.59 0.46 9.51 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 122.406 2.07 . . . . 0.0 113.077 179.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -99.87 -87.64 0.36 Allowed 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 111.687 0.254 . . . . 0.0 111.687 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 42.0 t -169.78 22.27 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 111.827 0.306 . . . . 0.0 111.827 -179.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -87.75 -88.23 0.14 Allowed 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -173.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 73.7 m -155.31 179.19 9.4 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-O 121.596 0.712 . . . . 0.0 112.627 -177.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.422 ' HA ' ' HA ' ' A' ' 42' ' ' GLU . 40.3 ttmt -111.5 120.31 41.71 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.959 174.324 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 46.2 m-85 -103.27 116.48 32.53 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 111.922 0.342 . . . . 0.0 111.922 -170.165 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 85.9 t -105.08 135.47 42.96 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 CA-C-O 120.946 0.403 . . . . 0.0 111.513 178.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.438 ' HB2' HG21 ' A' ' 34' ' ' ILE . 53.0 tp -87.44 122.16 30.81 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 121.154 0.502 . . . . 0.0 111.711 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.442 ' HD3' ' N ' ' A' ' 54' ' ' GLY . 4.2 tmtm? -67.72 127.9 34.5 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.365 179.185 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.442 ' N ' ' HD3' ' A' ' 53' ' ' LYS . . . 87.52 12.62 66.76 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 121.391 -0.433 . . . . 0.0 112.886 -175.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.7 t -110.23 -173.4 2.24 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 122.552 -0.381 . . . . 0.0 111.34 178.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 61.6 tttp -57.1 -47.76 80.26 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -176.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.547 ' H ' ' HA3' ' A' ' 39' ' ' GLY . . . -73.99 -13.91 60.95 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 112.543 0.571 . . . . 0.0 112.543 -177.42 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -72.28 84.98 1.07 Allowed 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 121.529 0.681 . . . . 0.0 111.04 -179.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -155.78 18.95 0.39 Allowed 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.777 176.139 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.6 pp -128.06 14.58 6.8 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -175.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -57.4 134.44 56.03 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 121.217 0.532 . . . . 0.0 111.739 -177.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 56.0 m80 -92.33 113.48 25.77 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.626 -177.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 54.6 m-70 -84.48 73.7 10.48 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 116.646 -0.252 . . . . 0.0 111.023 -178.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 33.9 m170 71.46 -47.86 0.67 Allowed 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.267 0.627 . . . . 0.0 112.119 -176.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 46.0 t-80 -49.59 124.67 9.91 Favored 'General case' 0 CA--C 1.539 0.558 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 -179.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 36.0 t60 -118.2 -50.86 2.45 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.478 176.289 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 85.2 t60 . . . . . 0 C--O 1.247 0.932 0 CA-C-O 118.977 -0.535 . . . . 0.0 111.408 176.356 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.7 tpt . . . . . 0 N--CA 1.489 1.499 0 N-CA-C 111.961 0.356 . . . . 0.0 111.961 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.441 ' C ' ' H ' ' A' ' 4' ' ' GLN . 3.1 m -128.68 14.29 6.46 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-O 121.003 0.43 . . . . 0.0 111.216 -178.035 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 58.3 mt 70.08 -22.9 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 123.056 0.543 . . . . 0.0 112.055 -176.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.441 ' H ' ' C ' ' A' ' 2' ' ' THR . 23.8 mt-30 63.68 16.03 9.41 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.112 0.565 . . . . 0.0 111.17 -175.281 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -153.45 52.23 0.8 Allowed Pre-proline 0 CA--C 1.544 0.732 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.411 178.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -65.91 91.23 0.25 Allowed 'Trans proline' 0 C--N 1.355 0.906 0 C-N-CA 122.296 1.997 . . . . 0.0 112.167 -177.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 62.94 17.67 10.23 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-O 122.317 1.056 . . . . 0.0 110.54 -177.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 91.0 m -123.2 110.56 15.4 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.48 -1.236 . . . . 0.0 110.003 -177.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 5.7 tmtt? -102.6 115.4 30.51 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.787 0.327 . . . . 0.0 110.819 -172.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.513 ' N ' HD12 ' A' ' 10' ' ' ILE . 2.5 mp -82.02 101.24 6.61 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.88 -177.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.41 HG21 HD11 ' A' ' 34' ' ' ILE . 35.7 m -102.67 167.93 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 CA-C-O 120.963 0.411 . . . . 0.0 111.874 -178.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -104.63 -20.61 13.6 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -176.361 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -130.33 165.0 23.42 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 121.019 0.438 . . . . 0.0 112.097 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.9 m -81.57 -37.89 26.98 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 112.67 0.619 . . . . 0.0 112.67 -174.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 28.9 tpt180 -87.27 105.23 17.09 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 122.117 -0.364 . . . . 0.0 110.642 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 58.9 t -131.05 135.03 60.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 N-CA-C 112.211 0.448 . . . . 0.0 112.211 -173.28 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -76.09 112.53 12.63 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.044 0.449 . . . . 0.0 110.237 172.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.679 ' HB2' HD13 ' A' ' 32' ' ' LEU . 58.3 m -119.46 -164.93 1.1 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.22 -174.26 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.635 ' HB3' ' CD2' ' A' ' 27' ' ' HIS . 2.4 m-20 65.73 4.58 2.94 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 175.142 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 161.08 174.36 30.83 Favored Glycine 0 CA--C 1.527 0.794 0 C-N-CA 120.281 -0.961 . . . . 0.0 113.517 175.031 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 173.72 14.8 0.02 OUTLIER Glycine 0 CA--C 1.534 1.24 0 C-N-CA 120.55 -0.833 . . . . 0.0 114.58 177.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -98.98 -152.76 0.42 Allowed 'General case' 0 CA--C 1.548 0.883 0 CA-C-N 117.693 0.746 . . . . 0.0 111.539 -178.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -43.54 -48.64 7.19 Favored Glycine 0 CA--C 1.533 1.183 0 N-CA-C 114.991 0.757 . . . . 0.0 114.991 -176.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -105.35 20.77 18.32 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 122.219 -0.577 . . . . 0.0 111.043 177.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.61 HD13 ' HD3' ' A' ' 29' ' ' ARG . 91.1 mt 59.31 23.64 12.09 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 115.663 -0.699 . . . . 0.0 112.052 -178.497 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 65.07 -101.34 0.54 Allowed Glycine 0 CA--C 1.523 0.534 0 C-N-CA 121.248 -0.501 . . . . 0.0 112.02 -176.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.635 ' CD2' ' HB3' ' A' ' 19' ' ' ASP . 0.2 OUTLIER -92.81 133.81 28.58 Favored Pre-proline 0 CA--C 1.537 0.45 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 169.982 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.516 ' O ' ' HB2' ' A' ' 29' ' ' ARG . 20.4 Cg_exo -17.49 -57.71 0.02 OUTLIER 'Trans proline' 0 CA--C 1.545 1.033 0 C-N-CA 124.979 3.786 . . . . 0.0 115.816 -165.516 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.61 ' HD3' HD13 ' A' ' 25' ' ' LEU . 23.3 tpt180 172.2 88.98 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.667 0.746 . . . . 0.0 110.024 172.354 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.404 ' HB ' ' HB2' ' A' ' 19' ' ' ASP . 27.1 t -100.47 125.98 54.16 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.759 -173.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 61.2 m95 -105.53 115.66 30.63 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 121.026 0.441 . . . . 0.0 111.418 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.679 HD13 ' HB2' ' A' ' 18' ' ' CYS . 9.0 mp -98.04 172.2 7.77 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.307 0.575 . . . . 0.0 111.678 -179.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 58.1 tp60 -137.64 116.41 12.25 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.528 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.546 HG12 HG12 ' A' ' 41' ' ' VAL . 68.4 mt -68.56 120.21 73.84 Favored Pre-proline 0 CA--C 1.539 0.539 0 CA-C-N 116.686 -0.234 . . . . 0.0 111.209 177.141 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.576 ' HG2' ' OG1' ' A' ' 38' ' ' THR . 74.0 Cg_endo -75.21 110.98 3.21 Favored 'Trans proline' 0 CA--C 1.535 0.561 0 C-N-CA 122.412 2.075 . . . . 0.0 111.67 176.539 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -54.93 -21.56 12.07 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 116.079 -0.51 . . . . 0.0 112.242 -176.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -61.14 -46.95 88.45 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-O 120.665 0.269 . . . . 0.0 111.247 173.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.576 ' OG1' ' HG2' ' A' ' 35' ' ' PRO . 29.2 p -89.03 -50.21 6.3 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 120.841 0.353 . . . . 0.0 111.521 -177.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 103.45 1.82 47.2 Favored Glycine 0 CA--C 1.527 0.792 0 C-N-CA 121.202 -0.523 . . . . 0.0 112.71 -176.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 63.6 p-90 -152.63 158.99 43.22 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 120.951 0.405 . . . . 0.0 112.006 -177.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.546 HG12 HG12 ' A' ' 34' ' ' ILE . 14.9 p -145.17 126.67 8.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-O 120.926 0.394 . . . . 0.0 110.269 174.071 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.588 ' HA ' ' HA ' ' A' ' 49' ' ' LYS . 10.5 pt-20 -103.66 152.67 21.51 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.234 0.54 . . . . 0.0 112.416 -177.2 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 6.4 t -69.61 134.13 88.55 Favored Pre-proline 0 N--CA 1.471 0.608 0 CA-C-N 115.705 -0.68 . . . . 0.0 112.174 -176.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -78.46 -5.94 15.19 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 122.739 2.292 . . . . 0.0 112.767 178.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -108.96 -93.58 0.42 Allowed 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 -179.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 48.7 t -144.46 9.9 1.42 Allowed 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 112.948 0.722 . . . . 0.0 112.948 -169.101 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -90.14 -107.39 0.09 Allowed 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 112.959 0.726 . . . . 0.0 112.959 -172.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 72.0 m -152.33 -179.74 7.82 Favored 'General case' 0 N--CA 1.477 0.902 0 O-C-N 121.692 -0.63 . . . . 0.0 112.475 -174.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.588 ' HA ' ' HA ' ' A' ' 42' ' ' GLU . 36.8 ttpt -106.74 125.64 51.26 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.291 177.051 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 36.4 m-85 -99.77 113.24 25.6 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 120.763 0.316 . . . . 0.0 111.144 -175.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 99.9 t -99.04 131.6 45.97 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 CA-C-O 121.101 0.477 . . . . 0.0 111.898 179.34 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 59.9 tp -78.11 118.15 20.08 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.543 179.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.484 ' HB2' HG23 ' A' ' 10' ' ' ILE . 47.4 tttp -74.33 151.22 39.82 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 121.124 0.488 . . . . 0.0 111.203 178.528 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.79 14.6 81.86 Favored Glycine 0 CA--C 1.527 0.799 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.07 -174.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 48.3 t -116.5 -177.48 3.19 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.2 0.524 . . . . 0.0 111.532 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 50.6 mtpt -60.52 -34.76 74.58 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.639 -179.368 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -86.18 8.89 19.24 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 -178.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -89.81 3.23 53.54 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-O 121.182 0.515 . . . . 0.0 111.859 -179.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -143.31 87.2 1.94 Allowed 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 121.442 0.639 . . . . 0.0 111.187 178.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.466 ' N ' HD12 ' A' ' 60' ' ' LEU . 5.2 mp -85.37 17.94 2.91 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.867 -178.539 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -90.37 149.01 22.47 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.193 0.52 . . . . 0.0 111.757 -179.081 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 76.2 t60 -90.26 -38.51 13.37 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.978 171.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 32.5 t-80 -171.91 100.05 0.17 Allowed 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.789 -0.642 . . . . 0.0 111.296 178.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 79.5 t60 -156.18 -80.91 0.07 Allowed 'General case' 0 CA--C 1.537 0.463 0 O-C-N 122.415 -0.178 . . . . 0.0 110.937 176.156 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 54.4 t-80 -124.51 74.98 1.36 Allowed 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 121.322 0.582 . . . . 0.0 111.792 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 34.1 m170 -88.2 -14.99 37.18 Favored 'General case' 0 CA--C 1.54 0.562 0 O-C-N 122.157 -0.339 . . . . 0.0 110.805 173.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 19.7 t-80 . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.676 -0.678 . . . . 0.0 111.113 177.028 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.456 ' HG3' ' H ' ' A' ' 3' ' ' ILE . 26.5 ptt? . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 112.176 0.436 . . . . 0.0 112.176 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.419 ' O ' HG22 ' A' ' 2' ' ' THR . 5.6 m 58.94 10.7 1.63 Allowed 'General case' 0 N--CA 1.482 1.129 0 CA-C-O 121.123 0.487 . . . . 0.0 112.206 179.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.499 HG22 ' O ' ' A' ' 3' ' ' ILE . 36.1 mt 61.87 8.14 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.024 0 C-N-CA 123.036 0.535 . . . . 0.0 111.609 -176.011 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 62.83 -71.61 0.05 Allowed 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.243 0.617 . . . . 0.0 111.868 -176.307 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 66.57 82.62 0.2 Allowed Pre-proline 0 CA--C 1.542 0.64 0 C-N-CA 123.472 0.709 . . . . 0.0 112.684 179.013 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.84 69.88 2.9 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 122.286 1.991 . . . . 0.0 111.554 173.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -67.24 117.9 9.9 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 115.868 -0.605 . . . . 0.0 112.409 -173.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 23.3 m -98.01 125.81 43.13 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.017 176.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 24.4 tptp -121.8 110.72 16.25 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 120.816 0.341 . . . . 0.0 110.558 -178.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 55.5 mt -77.19 104.41 5.13 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-O 120.909 0.385 . . . . 0.0 111.236 -177.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 34.5 m -95.06 155.75 3.25 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-O 121.067 0.461 . . . . 0.0 111.439 179.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -82.19 -37.09 26.59 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.807 -175.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 46.5 mmtm -118.94 167.18 11.98 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 121.212 0.529 . . . . 0.0 112.273 -177.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 18.6 m -68.64 -34.65 76.1 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -174.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.457 ' HA ' ' O ' ' A' ' 32' ' ' LEU . 16.6 ptt180 -98.64 135.36 40.25 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.231 0.538 . . . . 0.0 111.668 -179.27 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 48.7 t -129.34 122.96 56.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.277 -178.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -74.78 94.03 2.69 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.12 0.486 . . . . 0.0 110.678 176.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.423 ' SG ' HD13 ' A' ' 32' ' ' LEU . 85.8 m -92.24 60.46 3.7 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.93 0.395 . . . . 0.0 111.657 -176.026 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -55.4 -62.67 1.52 Allowed 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.048 177.222 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.451 ' HA2' ' SG ' ' A' ' 46' ' ' CYS . . . 162.56 -158.28 30.4 Favored Glycine 0 CA--C 1.523 0.546 0 C-N-CA 121.155 -0.545 . . . . 0.0 112.738 178.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -80.31 -105.89 0.28 Allowed Glycine 0 CA--C 1.526 0.734 0 C-N-CA 121.093 -0.575 . . . . 0.0 112.476 177.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -64.72 156.57 29.99 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 122.515 -0.403 . . . . 0.0 110.868 174.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -43.79 -54.6 5.81 Favored Glycine 0 CA--C 1.534 1.243 0 N-CA-C 114.148 0.419 . . . . 0.0 114.148 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -66.56 -22.79 66.15 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 69.6 mt -87.14 0.74 54.82 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 120.887 0.375 . . . . 0.0 111.401 -179.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -82.31 162.63 42.23 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 121.168 -0.539 . . . . 0.0 113.833 -178.173 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.471 ' HB3' ' HD2' ' A' ' 28' ' ' PRO . 61.4 m80 -99.53 165.06 15.42 Favored Pre-proline 0 CA--C 1.545 0.771 0 C-N-CA 122.901 0.48 . . . . 0.0 110.084 178.144 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.471 ' HD2' ' HB3' ' A' ' 27' ' ' HIS . 59.7 Cg_exo -38.85 -65.3 0.17 Allowed 'Trans proline' 0 C--N 1.357 1.002 0 C-N-CA 123.205 2.603 . . . . 0.0 114.329 -178.245 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.438 ' HB2' ' O ' ' A' ' 28' ' ' PRO . 21.8 tpt180 174.48 89.94 0.0 OUTLIER 'General case' 0 C--O 1.236 0.356 0 CA-C-O 121.814 0.816 . . . . 0.0 110.089 177.531 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 30.0 m -112.84 121.67 65.54 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 CA-C-N 115.062 -0.972 . . . . 0.0 112.395 -177.176 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 69.5 m95 -106.55 113.33 26.78 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.885 177.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.457 ' O ' ' HA ' ' A' ' 15' ' ' ARG . 8.1 mp -86.38 144.72 27.19 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 120.878 0.371 . . . . 0.0 110.977 179.14 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 54.2 tp60 -115.91 116.35 27.82 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.059 -177.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.434 HG12 HG12 ' A' ' 41' ' ' VAL . 61.9 mt -76.48 126.41 86.27 Favored Pre-proline 0 CA--C 1.539 0.535 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -179.065 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.555 ' HG2' ' OG1' ' A' ' 38' ' ' THR . 57.1 Cg_endo -86.78 132.45 3.43 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 122.87 2.38 . . . . 0.0 112.092 173.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -66.04 -25.62 67.14 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 121.941 -0.474 . . . . 0.0 111.492 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -54.51 -56.48 18.46 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.134 0.492 . . . . 0.0 111.37 177.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.555 ' OG1' ' HG2' ' A' ' 35' ' ' PRO . 52.4 p -76.27 -47.82 22.39 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.407 0.622 . . . . 0.0 110.055 174.473 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 99.09 1.5 57.06 Favored Glycine 0 CA--C 1.524 0.621 0 CA-C-N 115.504 -0.771 . . . . 0.0 112.672 -178.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.528 ' HB3' HG22 ' A' ' 51' ' ' VAL . 63.7 p-90 -159.3 166.83 30.38 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 122.56 0.344 . . . . 0.0 110.911 -176.026 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.434 HG12 HG12 ' A' ' 34' ' ' ILE . 12.2 p -135.37 132.69 52.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-O 121.112 0.482 . . . . 0.0 111.399 176.219 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -92.01 112.11 23.91 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 121.148 0.499 . . . . 0.0 110.818 176.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 41.0 t -71.28 110.56 7.65 Favored Pre-proline 0 N--CA 1.471 0.576 0 CA-C-N 116.187 -0.461 . . . . 0.0 112.086 -178.132 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -71.55 -11.24 27.95 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 122.632 2.221 . . . . 0.0 112.425 177.464 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.451 ' HB3' ' CE1' ' A' ' 27' ' ' HIS . 78.4 m-85 -84.56 -42.7 15.21 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 115.956 -0.566 . . . . 0.0 112.007 -176.323 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.451 ' SG ' ' HA2' ' A' ' 20' ' ' GLY . 84.5 m -131.92 8.08 4.42 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 -178.013 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 57.7 78.26 0.24 Allowed 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 176.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 91.2 m -152.46 147.31 26.1 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.944 177.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -99.63 106.47 18.43 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 120.651 0.262 . . . . 0.0 111.091 178.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -91.74 111.69 23.32 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.55 0.214 . . . . 0.0 110.615 178.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.528 HG22 ' HB3' ' A' ' 40' ' ' TRP . 97.9 t -97.51 135.61 31.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-O 121.023 0.439 . . . . 0.0 111.58 -179.623 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.408 ' HB2' HG21 ' A' ' 34' ' ' ILE . 59.0 tp -75.42 130.95 39.8 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 116.171 -0.468 . . . . 0.0 112.029 -178.182 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 51.7 tttm -58.91 102.5 0.12 Allowed 'General case' 0 CA--C 1.542 0.645 0 CA-C-O 121.114 0.483 . . . . 0.0 111.443 174.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 117.6 -7.06 15.92 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 121.362 -0.447 . . . . 0.0 112.538 -176.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 12.4 t -65.81 151.92 45.55 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 177.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.47 -7.39 47.12 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 120.905 0.383 . . . . 0.0 111.477 174.062 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -72.19 -27.33 62.49 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 121.174 0.511 . . . . 0.0 110.402 170.066 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -85.43 -177.73 6.53 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.711 175.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 59.42 79.42 0.23 Allowed 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.333 0.587 . . . . 0.0 111.314 -179.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.5 ' N ' HD12 ' A' ' 60' ' ' LEU . 5.1 mp -79.35 3.08 19.3 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.903 -174.21 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -75.97 99.14 4.46 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-O 120.785 0.326 . . . . 0.0 110.139 178.195 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -95.98 9.29 41.21 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 -173.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 79.1 t60 -71.63 -15.34 62.24 Favored 'General case' 0 N--CA 1.471 0.599 0 O-C-N 121.602 -0.686 . . . . 0.0 110.028 173.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 45.2 m80 -69.56 96.36 0.92 Allowed 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.058 173.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 57.1 m-70 -88.15 -63.13 1.35 Allowed 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 121.031 0.443 . . . . 0.0 110.542 176.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 28.8 p80 -125.34 22.01 7.84 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 121.278 0.561 . . . . 0.0 110.571 179.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 75.0 t60 . . . . . 0 C--O 1.251 1.164 0 CA-C-O 118.201 -0.904 . . . . 0.0 110.338 -179.299 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.55 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.434 0 CA-C-O 120.707 0.289 . . . . 0.0 111.305 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.431 HG22 ' N ' ' A' ' 3' ' ' ILE . 27.7 m -109.86 159.56 17.11 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 120.748 0.309 . . . . 0.0 111.002 -178.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.431 ' N ' HG22 ' A' ' 2' ' ' THR . 15.2 tt -69.94 13.96 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.208 0 CA-C-O 121.163 0.506 . . . . 0.0 112.282 177.402 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.418 ' H ' ' C ' ' A' ' 2' ' ' THR . 22.3 tm0? 63.25 92.76 0.06 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.739 0.815 . . . . 0.0 111.959 -179.203 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.404 ' N ' ' HD3' ' A' ' 6' ' ' PRO . . . -172.96 62.94 0.29 Allowed Pre-proline 0 CA--C 1.539 0.527 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.411 177.364 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.404 ' HD3' ' N ' ' A' ' 5' ' ' ALA . 5.5 Cg_exo -79.58 29.98 0.48 Allowed 'Trans proline' 0 CA--C 1.537 0.654 0 C-N-CA 123.25 2.633 . . . . 0.0 113.455 -175.018 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -75.35 75.79 2.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.197 0.522 . . . . 0.0 110.639 -179.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 66.5 m -98.39 141.78 30.83 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.786 -177.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 55.1 tptt -133.87 114.76 13.68 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.879 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 52.4 mt -88.64 105.34 15.63 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 CA-C-O 120.727 0.298 . . . . 0.0 111.013 -177.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.461 HG12 ' H ' ' A' ' 13' ' ' LYS . 2.4 t -102.67 147.79 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-O 120.884 0.373 . . . . 0.0 111.271 -176.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -89.23 -4.46 58.19 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 121.075 0.464 . . . . 0.0 111.183 -178.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.461 ' H ' HG12 ' A' ' 11' ' ' VAL . 67.5 mttm -131.89 152.25 51.17 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.051 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 21.1 m -80.39 -6.83 58.66 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 120.837 0.351 . . . . 0.0 111.611 179.076 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -95.16 114.64 26.46 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 120.942 0.401 . . . . 0.0 110.961 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 70.7 t -125.46 135.08 65.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 N-CA-C 113.056 0.762 . . . . 0.0 113.056 -171.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -104.37 110.3 22.49 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.525 173.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 66.2 m -107.85 177.66 4.75 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 122.515 0.326 . . . . 0.0 111.28 179.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.618 ' HB3' ' HA ' ' A' ' 27' ' ' HIS . 8.2 m-20 -127.06 66.0 1.29 Allowed 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 121.563 0.697 . . . . 0.0 112.621 178.236 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -174.22 120.05 0.77 Allowed Glycine 0 CA--C 1.527 0.82 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.343 176.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 149.37 -51.99 0.53 Allowed Glycine 0 CA--C 1.533 1.198 0 C-N-CA 119.827 -1.178 . . . . 0.0 115.78 177.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.418 ' HG3' HG12 ' A' ' 30' ' ' VAL . 78.7 mt-10 -94.93 169.19 10.31 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 113.191 0.811 . . . . 0.0 113.191 -170.597 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 40.58 -97.5 0.01 OUTLIER Glycine 0 CA--C 1.534 1.227 0 CA-C-N 115.523 -0.762 . . . . 0.0 114.582 -173.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -89.13 17.17 6.16 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 117.132 0.466 . . . . 0.0 111.507 178.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.6 pp 50.41 5.62 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 125.457 1.503 . . . . 0.0 114.14 -178.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -125.98 101.95 0.63 Allowed Glycine 0 CA--C 1.526 0.745 0 C-N-CA 121.021 -0.609 . . . . 0.0 113.654 -175.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.618 ' HA ' ' HB3' ' A' ' 19' ' ' ASP . 13.3 m-70 56.29 52.15 6.62 Favored Pre-proline 0 CA--C 1.548 0.9 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 176.382 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.582 ' HD3' ' N ' ' A' ' 27' ' ' HIS . 44.0 Cg_endo -102.76 13.37 0.33 Allowed 'Trans proline' 0 CA--C 1.545 1.059 0 C-N-CA 123.362 2.708 . . . . 0.0 113.405 177.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 64.25 86.93 0.12 Allowed 'General case' 0 N--CA 1.446 -0.646 0 CA-C-O 122.35 1.071 . . . . 0.0 110.909 -177.423 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.418 HG12 ' HG3' ' A' ' 22' ' ' GLU . 19.0 m -109.69 154.2 11.24 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.133 0 CA-C-N 113.97 -1.468 . . . . 0.0 111.453 -178.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 49.7 m95 -124.14 114.84 20.2 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 121.243 0.544 . . . . 0.0 112.136 -175.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.45 ' N ' HD12 ' A' ' 32' ' ' LEU . 6.1 mp -105.46 167.56 9.66 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.454 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 54.2 tp60 -130.25 113.51 14.51 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.336 179.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.595 HG21 ' HB2' ' A' ' 52' ' ' LEU . 76.2 mt -63.06 120.15 58.67 Favored Pre-proline 0 CA--C 1.541 0.597 0 CA-C-O 120.684 0.278 . . . . 0.0 111.397 -179.288 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.596 ' HG2' ' OG1' ' A' ' 38' ' ' THR . 83.5 Cg_endo -79.82 113.75 3.08 Favored 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 122.262 1.975 . . . . 0.0 112.022 177.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -60.89 -15.0 25.91 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 121.115 0.483 . . . . 0.0 111.542 -179.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -68.87 -29.51 67.83 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.568 174.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.596 ' OG1' ' HG2' ' A' ' 35' ' ' PRO . 34.6 p -103.25 -54.73 2.55 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 121.205 0.526 . . . . 0.0 110.445 175.151 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 113.13 -0.19 25.39 Favored Glycine 0 CA--C 1.526 0.727 0 CA-C-N 115.8 -0.636 . . . . 0.0 113.123 179.245 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 66.1 p-90 -166.45 162.44 16.91 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -177.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.565 HG12 HG12 ' A' ' 34' ' ' ILE . 11.3 p -153.77 133.55 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.346 174.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.47 ' HA ' ' HA ' ' A' ' 49' ' ' LYS . 0.5 OUTLIER -110.94 148.87 31.56 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.062 0.458 . . . . 0.0 111.866 -178.282 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.564 ' HB3' ' HB3' ' A' ' 47' ' ' ASP . 52.3 t -84.52 108.13 13.6 Favored Pre-proline 0 N--CA 1.466 0.364 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 171.018 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -65.06 -9.41 21.55 Favored 'Trans proline' 0 CA--C 1.54 0.794 0 C-N-CA 122.742 2.295 . . . . 0.0 113.476 -172.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -87.33 -89.9 0.12 Allowed 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 120.566 0.222 . . . . 0.0 111.575 -177.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 75.7 m -152.45 82.62 1.24 Allowed 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 120.956 0.408 . . . . 0.0 111.477 179.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.564 ' HB3' ' HB3' ' A' ' 43' ' ' CYS . 9.7 t70 -149.98 -90.22 0.07 Allowed 'General case' 0 CA--C 1.548 0.889 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.184 177.038 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 30.2 p 179.8 -176.92 0.34 Allowed 'General case' 0 N--CA 1.477 0.889 0 CA-C-O 121.106 0.479 . . . . 0.0 111.422 174.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.47 ' HA ' ' HA ' ' A' ' 42' ' ' GLU . 39.5 ttmt -106.54 120.27 41.48 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 123.036 0.534 . . . . 0.0 110.693 178.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -98.72 108.24 20.88 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.081 0.467 . . . . 0.0 111.868 -173.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 99.7 t -93.75 134.39 31.59 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.243 178.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.595 ' HB2' HG21 ' A' ' 34' ' ' ILE . 51.8 tp -79.18 120.7 24.07 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 121.304 0.573 . . . . 0.0 111.649 -178.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -77.4 118.18 19.61 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.948 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 88.38 55.48 2.19 Favored Glycine 0 CA--C 1.524 0.652 0 C-N-CA 121.035 -0.603 . . . . 0.0 111.64 -173.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 25.0 t -151.03 -150.99 0.37 Allowed 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 122.898 0.479 . . . . 0.0 110.985 -175.383 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -101.65 22.72 12.33 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 -177.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -129.51 -33.26 1.89 Allowed 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 121.415 0.626 . . . . 0.0 111.097 -175.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -74.94 68.7 1.82 Allowed 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.764 178.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -99.14 29.74 3.76 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.517 -179.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.456 ' N ' HD12 ' A' ' 60' ' ' LEU . 6.1 mp -76.3 80.08 3.06 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 121.019 0.438 . . . . 0.0 111.842 -177.586 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -84.63 93.31 8.36 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 121.395 0.616 . . . . 0.0 110.873 176.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 88.6 m-70 -139.17 97.7 3.36 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.982 177.028 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 71.0 t60 -70.61 84.77 0.62 Allowed 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 121.192 0.52 . . . . 0.0 110.127 174.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.408 ' O ' ' N ' ' A' ' 66' ' ' HIS . 2.6 t-160 -69.73 151.58 45.65 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.252 179.625 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 0.507 ' O ' ' HB2' ' A' ' 66' ' ' HIS . 17.0 t60 -66.59 72.47 0.08 Allowed 'General case' 0 CA--C 1.545 0.754 0 CA-C-O 121.01 0.434 . . . . 0.0 111.297 -177.317 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.507 ' HB2' ' O ' ' A' ' 65' ' ' HIS . 41.0 t-80 161.19 -32.05 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.066 0.946 . . . . 0.0 110.173 -173.582 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 39.6 t-80 . . . . . 0 C--O 1.25 1.098 0 CA-C-O 118.916 -0.564 . . . . 0.0 111.876 -175.598 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.3 ptm . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 23.5 p -74.11 131.37 41.24 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.472 ' O ' ' HD2' ' A' ' 6' ' ' PRO . 25.1 pt -73.06 66.54 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 CA-C-O 121.979 0.895 . . . . 0.0 109.133 168.023 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -81.31 20.44 0.85 Allowed 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 115.243 -0.89 . . . . 0.0 113.249 -169.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.401 ' HB3' ' HD3' ' A' ' 6' ' ' PRO . . . -74.69 -47.22 5.29 Favored Pre-proline 0 CA--C 1.547 0.843 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 179.649 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.472 ' HD2' ' O ' ' A' ' 3' ' ' ILE . 83.6 Cg_exo -46.69 99.2 0.03 OUTLIER 'Trans proline' 0 C--N 1.36 1.16 0 C-N-CA 122.879 2.386 . . . . 0.0 114.526 -177.296 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -90.4 21.7 3.76 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 121.601 0.715 . . . . 0.0 110.574 173.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.435 ' HA ' ' O ' ' A' ' 49' ' ' LYS . 51.6 m -118.93 137.97 53.1 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 115.395 -0.821 . . . . 0.0 111.559 -172.351 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -134.92 129.9 35.03 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 120.766 0.317 . . . . 0.0 111.069 -176.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 59.9 mt -86.45 118.91 33.63 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 CA-C-O 121.079 0.466 . . . . 0.0 111.614 -179.203 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 35.3 m -109.52 163.41 6.62 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.964 176.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -92.17 -21.44 20.39 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -176.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -121.54 152.01 39.69 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 -176.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 48.7 m -70.28 -21.04 63.0 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 116.049 -0.523 . . . . 0.0 112.334 -178.315 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 80.7 mtp180 -87.6 111.83 21.66 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.148 0.499 . . . . 0.0 111.33 178.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 61.2 t -113.01 115.81 50.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.926 -177.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -95.16 115.01 26.87 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 120.695 0.283 . . . . 0.0 111.382 177.456 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.51 ' O ' HG12 ' A' ' 30' ' ' VAL . 82.8 m -113.95 127.86 56.15 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 120.927 0.394 . . . . 0.0 111.306 179.34 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.598 ' HA ' ' H ' ' A' ' 29' ' ' ARG . 4.6 m-20 -85.9 -76.65 0.33 Allowed 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 120.946 0.403 . . . . 0.0 111.232 178.384 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.456 ' HA3' ' O ' ' A' ' 25' ' ' LEU . . . 162.31 -145.54 10.86 Favored Glycine 0 CA--C 1.52 0.393 0 C-N-CA 120.05 -1.071 . . . . 0.0 113.879 179.286 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 128.85 16.56 1.98 Allowed Glycine 0 CA--C 1.528 0.846 0 CA-C-N 115.329 -0.436 . . . . 0.0 112.114 -175.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 66.2 mm-40 -83.53 -169.25 2.46 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 122.46 0.304 . . . . 0.0 111.213 175.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -44.4 -53.14 7.01 Favored Glycine 0 CA--C 1.533 1.202 0 N-CA-C 114.138 0.415 . . . . 0.0 114.138 179.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -98.44 20.36 12.84 Favored 'General case' 0 N--CA 1.473 0.706 0 O-C-N 122.359 -0.495 . . . . 0.0 111.706 177.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.456 ' O ' ' HA3' ' A' ' 20' ' ' GLY . 57.4 mt 71.85 -19.71 0.26 Allowed 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.943 0.897 . . . . 0.0 112.601 -179.609 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 91.92 -107.88 3.55 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 120.916 -0.659 . . . . 0.0 114.256 175.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 2.6 p80 -159.57 104.54 1.48 Allowed Pre-proline 0 N--CA 1.475 0.783 0 O-C-N 122.46 -0.435 . . . . 0.0 111.954 -168.172 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.495 ' O ' ' HB3' ' A' ' 29' ' ' ARG . 39.2 Cg_exo -56.22 93.54 0.05 OUTLIER 'Trans proline' 0 CA--C 1.54 0.789 0 C-N-CA 122.391 2.061 . . . . 0.0 113.132 -178.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.598 ' H ' ' HA ' ' A' ' 19' ' ' ASP . 0.0 OUTLIER 81.72 102.69 0.06 Allowed 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 122.444 1.116 . . . . 0.0 111.342 175.072 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.51 HG12 ' O ' ' A' ' 18' ' ' CYS . 11.5 p -132.02 132.98 61.22 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-N 114.153 -1.385 . . . . 0.0 109.488 166.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 59.8 m95 -100.09 132.5 45.41 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.24 0.543 . . . . 0.0 112.339 -176.084 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.429 ' N ' HD12 ' A' ' 32' ' ' LEU . 5.4 mp -115.67 160.89 19.45 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.904 177.13 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -119.55 124.78 47.24 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.496 178.263 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.521 HG21 ' HB2' ' A' ' 52' ' ' LEU . 73.7 mt -79.33 132.25 63.18 Favored Pre-proline 0 CA--C 1.545 0.768 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -178.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.559 ' HG2' ' OG1' ' A' ' 38' ' ' THR . 94.7 Cg_endo -81.95 117.33 2.9 Favored 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 122.609 2.206 . . . . 0.0 112.317 173.521 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -60.25 -33.82 72.82 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -176.107 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.489 ' O ' ' HE2' ' A' ' 56' ' ' LYS . 8.0 p-10 -62.23 -30.9 71.42 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 120.773 0.321 . . . . 0.0 111.846 -178.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.559 ' OG1' ' HG2' ' A' ' 35' ' ' PRO . 21.9 p -91.55 -48.89 6.6 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.377 0.608 . . . . 0.0 110.428 175.023 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 100.01 2.47 56.0 Favored Glycine 0 CA--C 1.524 0.614 0 CA-C-N 115.597 -0.729 . . . . 0.0 112.756 -177.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.441 ' HB3' HG22 ' A' ' 51' ' ' VAL . 65.2 p-90 -158.81 152.77 23.52 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 120.961 0.41 . . . . 0.0 111.867 -175.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.483 HG12 HG12 ' A' ' 34' ' ' ILE . 11.0 p -131.6 150.58 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.939 176.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -117.2 131.47 56.85 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 121.113 0.482 . . . . 0.0 111.154 178.164 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.417 ' SG ' ' HB3' ' A' ' 46' ' ' CYS . 49.5 t -82.67 110.49 22.63 Favored Pre-proline 0 N--CA 1.47 0.532 0 N-CA-C 111.911 0.337 . . . . 0.0 111.911 -179.176 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -58.94 -26.93 83.15 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 122.699 2.266 . . . . 0.0 113.319 -177.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -112.03 17.55 19.54 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 112.13 0.418 . . . . 0.0 112.13 -176.127 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.421 ' SG ' ' SG ' ' A' ' 48' ' ' CYS . 36.2 t -146.1 -7.17 0.56 Allowed 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 174.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 55.18 24.72 6.51 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 113.203 0.816 . . . . 0.0 113.203 178.033 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.421 ' SG ' ' SG ' ' A' ' 46' ' ' CYS . 81.3 m -102.92 138.02 40.35 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 120.812 0.339 . . . . 0.0 111.611 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.435 ' O ' ' HA ' ' A' ' 8' ' ' THR . 85.7 tttt -109.01 121.51 45.3 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 122.92 0.488 . . . . 0.0 111.149 -178.378 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -116.93 125.77 51.95 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 112.13 0.418 . . . . 0.0 112.13 -177.002 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.441 HG22 ' HB3' ' A' ' 40' ' ' TRP . 40.9 t -94.54 139.33 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.873 176.344 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.521 ' HB2' HG21 ' A' ' 34' ' ' ILE . 56.5 tp -87.13 119.12 27.03 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.407 177.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -67.67 118.59 11.15 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 121.076 0.465 . . . . 0.0 111.122 178.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 120.5 -28.51 6.21 Favored Glycine 0 CA--C 1.525 0.686 0 CA-C-N 115.992 -0.549 . . . . 0.0 112.29 -174.16 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 66.1 m -80.83 168.07 19.19 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 120.877 0.37 . . . . 0.0 111.252 178.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.489 ' HE2' ' O ' ' A' ' 37' ' ' ASP . 65.7 pttt -58.59 -25.03 62.18 Favored 'General case' 0 CA--C 1.543 0.673 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -177.206 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.72 -33.2 75.11 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.151 0.5 . . . . 0.0 111.23 176.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -77.28 -5.91 51.19 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.206 177.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.39 36.05 0.24 Allowed 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -177.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.9 pp -62.34 165.43 6.01 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 122.182 -0.324 . . . . 0.0 110.965 174.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 49.1 121.16 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.436 0 CA-C-O 121.999 0.904 . . . . 0.0 113.127 -175.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 52.0 t-80 -82.57 40.35 0.66 Allowed 'General case' 0 CA--C 1.546 0.816 0 O-C-N 121.232 -0.917 . . . . 0.0 110.615 176.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 39.3 t-80 -95.6 10.47 36.6 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.731 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 69.1 m80 71.03 134.58 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.626 0.77 . . . . 0.0 111.754 -177.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 43.7 m-70 -101.25 179.4 4.37 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 121.489 0.661 . . . . 0.0 112.509 -176.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 28.3 m170 -71.05 93.38 1.02 Allowed 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.989 -178.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 22.3 p-80 . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.719 -0.658 . . . . 0.0 112.112 -177.275 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.0 ptp . . . . . 0 N--CA 1.489 1.517 0 CA-C-O 120.921 0.391 . . . . 0.0 112.023 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 2.0 m -119.04 9.12 11.74 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.549 174.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.464 ' O ' ' HG2' ' A' ' 4' ' ' GLN . 49.0 mm 72.92 -40.16 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 123.345 0.658 . . . . 0.0 111.527 -173.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.464 ' HG2' ' O ' ' A' ' 3' ' ' ILE . 9.3 pt20 53.31 26.07 4.96 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.278 1.031 . . . . 0.0 113.07 171.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -117.09 82.96 14.49 Favored Pre-proline 0 CA--C 1.54 0.571 0 CA-C-O 120.775 0.321 . . . . 0.0 111.103 177.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.503 ' O ' ' HA ' ' A' ' 48' ' ' CYS . 62.6 Cg_endo -86.92 31.05 0.45 Allowed 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 123.076 2.518 . . . . 0.0 114.023 -173.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 51.11 103.83 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 178.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 86.8 m -85.83 115.32 23.4 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.059 175.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 73.8 mttt -121.95 98.57 6.01 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 120.995 0.426 . . . . 0.0 110.882 176.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 57.8 mt -86.21 127.75 39.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.108 -179.268 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 28.5 m -125.56 163.45 26.71 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.546 -179.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -89.15 -19.79 25.05 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 120.76 0.314 . . . . 0.0 111.515 179.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 13.6 pttm -131.84 148.08 52.52 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 121.076 0.465 . . . . 0.0 111.615 -177.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 12.2 p -68.39 -30.79 69.79 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 114.572 1.323 . . . . 0.0 114.572 -168.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 94.4 mtt180 -75.41 104.3 5.92 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 118.53 0.604 . . . . 0.0 111.512 179.065 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 36.4 t -117.88 122.37 69.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.388 -178.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -81.4 109.66 16.1 Favored 'General case' 0 CA--C 1.535 0.4 0 O-C-N 122.252 -0.28 . . . . 0.0 111.116 175.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.74 ' SG ' ' HB ' ' A' ' 30' ' ' VAL . 22.8 p -66.07 104.28 1.12 Allowed 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 121.056 0.455 . . . . 0.0 110.936 179.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -66.28 -84.99 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 115.989 -0.55 . . . . 0.0 112.469 -177.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.544 ' HA3' ' HA2' ' A' ' 26' ' ' GLY . . . 161.14 175.11 31.81 Favored Glycine 0 CA--C 1.524 0.65 0 C-N-CA 120.351 -0.928 . . . . 0.0 113.806 178.101 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -73.43 -70.6 1.21 Allowed Glycine 0 CA--C 1.523 0.564 0 C-N-CA 121.026 -0.606 . . . . 0.0 112.075 175.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -166.25 128.57 1.91 Allowed 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 122.343 0.257 . . . . 0.0 111.082 178.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 39.79 -96.06 0.01 OUTLIER Glycine 0 CA--C 1.531 1.064 0 N-CA-C 115.015 0.766 . . . . 0.0 115.015 179.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -60.39 -28.59 68.35 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.112 0.482 . . . . 0.0 112.196 -177.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 85.9 mt -95.65 23.0 6.5 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-O 120.983 0.42 . . . . 0.0 111.702 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.544 ' HA2' ' HA3' ' A' ' 20' ' ' GLY . . . -80.64 176.0 54.75 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 121.377 -0.44 . . . . 0.0 112.578 175.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 10.1 m-70 -127.87 140.35 37.92 Favored Pre-proline 0 N--CA 1.472 0.666 0 O-C-N 121.948 -0.736 . . . . 0.0 111.069 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -76.16 52.35 3.46 Favored 'Trans proline' 0 CA--C 1.546 1.103 0 C-N-CA 122.893 2.395 . . . . 0.0 113.981 -175.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.455 ' HA ' ' HD3' ' A' ' 29' ' ' ARG . 2.8 tpp180 59.74 85.75 0.1 Allowed 'General case' 0 N--CA 1.445 -0.722 0 CA-C-O 122.461 1.124 . . . . 0.0 112.612 176.534 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.74 ' HB ' ' SG ' ' A' ' 18' ' ' CYS . 48.4 t -118.45 115.08 47.04 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.066 0 CA-C-N 114.107 -1.406 . . . . 0.0 110.565 177.544 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 83.3 m95 -91.41 103.91 16.49 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 120.948 0.404 . . . . 0.0 111.291 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.539 HD21 ' HD3' ' A' ' 44' ' ' PRO . 6.2 mp -83.62 131.07 34.99 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 121.021 0.439 . . . . 0.0 111.436 179.107 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 27.1 tp60 -93.89 105.32 17.35 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.334 176.18 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.556 HG12 HG12 ' A' ' 41' ' ' VAL . 73.5 mt -64.43 124.76 86.83 Favored Pre-proline 0 CA--C 1.542 0.638 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.661 -178.359 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.565 ' HG2' ' OG1' ' A' ' 38' ' ' THR . 76.9 Cg_endo -74.19 119.24 5.72 Favored 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 122.671 2.247 . . . . 0.0 112.211 179.567 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -64.63 -17.15 63.76 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-O 121.162 0.506 . . . . 0.0 111.582 -178.021 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -64.93 -44.07 90.72 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 120.916 0.389 . . . . 0.0 111.22 175.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.565 ' OG1' ' HG2' ' A' ' 35' ' ' PRO . 31.6 p -95.92 -54.3 3.38 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 121.08 0.467 . . . . 0.0 110.99 179.545 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 110.87 1.18 28.74 Favored Glycine 0 CA--C 1.524 0.605 0 CA-C-N 115.948 -0.569 . . . . 0.0 113.494 179.006 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 62.0 p-90 -153.79 160.15 42.15 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 116.941 0.37 . . . . 0.0 111.183 -177.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.556 HG12 HG12 ' A' ' 34' ' ' ILE . 13.4 p -141.15 141.49 30.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.648 176.053 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.39 154.93 16.96 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 121.305 0.574 . . . . 0.0 111.948 -179.135 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.464 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 43.8 t -73.05 123.12 89.22 Favored Pre-proline 0 CA--C 1.537 0.449 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.603 179.305 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.539 ' HD3' HD21 ' A' ' 32' ' ' LEU . 14.9 Cg_exo -69.03 -7.71 21.59 Favored 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 122.757 2.305 . . . . 0.0 113.095 -179.501 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -98.83 -46.9 5.49 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 120.924 0.392 . . . . 0.0 111.576 -178.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 25.1 t -120.08 -91.0 0.57 Allowed 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.514 -177.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -173.91 19.11 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 179.005 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.503 ' HA ' ' O ' ' A' ' 6' ' ' PRO . 56.7 m -64.97 132.53 49.53 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 -177.33 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.452 ' NZ ' ' HB2' ' A' ' 49' ' ' LYS . 5.0 ttmp? -102.34 110.71 22.74 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 121.203 0.525 . . . . 0.0 111.572 -179.257 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 55.3 m-85 -94.76 104.35 16.26 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.447 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 56.7 t -92.13 137.3 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 CA-C-O 121.174 0.511 . . . . 0.0 112.372 -175.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 59.6 tp -98.91 130.05 45.28 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.508 178.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -64.77 143.9 57.62 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-O 120.845 0.355 . . . . 0.0 111.635 178.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 81.42 -13.89 31.95 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 121.367 -0.444 . . . . 0.0 114.081 175.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 59.9 p -84.2 179.99 7.35 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 120.935 0.398 . . . . 0.0 111.345 -178.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 62.0 mttm -63.5 -27.33 69.19 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 179.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -69.53 -27.45 65.18 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.301 0.572 . . . . 0.0 110.662 175.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -90.89 -21.91 21.17 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.769 176.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -86.49 -22.17 26.58 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 3.5 pp -74.85 170.58 15.62 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 111.857 0.317 . . . . 0.0 111.857 179.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 68.79 -59.95 0.45 Allowed 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.245 0.618 . . . . 0.0 111.472 -177.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 26.8 t60 -67.9 100.1 0.92 Allowed 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 172.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 13.6 p-80 -53.96 115.41 2.01 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-O 120.759 0.314 . . . . 0.0 111.122 -176.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 32.0 t60 -62.29 -17.19 57.95 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -172.277 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 0.552 ' O ' ' HB3' ' A' ' 66' ' ' HIS . 30.0 m-70 -53.11 128.79 28.91 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 120.93 -0.308 . . . . 0.0 111.025 175.14 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.552 ' HB3' ' O ' ' A' ' 65' ' ' HIS . 82.6 t60 81.92 91.89 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.549 -165.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 78.0 t60 . . . . . 0 C--O 1.252 1.232 0 CA-C-O 118.165 -0.921 . . . . 0.0 112.603 -178.773 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.3 ptm . . . . . 0 N--CA 1.49 1.526 0 CA-C-O 120.754 0.311 . . . . 0.0 111.685 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.413 ' C ' ' H ' ' A' ' 4' ' ' GLN . 75.2 p -127.03 -58.08 1.3 Allowed 'General case' 0 N--CA 1.475 0.808 0 O-C-N 122.04 -0.413 . . . . 0.0 111.624 176.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 63.7 mt 72.92 -22.73 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.849 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.944 -177.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.413 ' H ' ' C ' ' A' ' 2' ' ' THR . 83.4 mm-40 64.36 6.86 3.25 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.109 0.564 . . . . 0.0 111.875 -176.607 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -159.85 56.69 0.89 Allowed Pre-proline 0 CA--C 1.541 0.629 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.947 179.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -80.9 39.2 0.83 Allowed 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 122.738 2.292 . . . . 0.0 113.067 -175.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -66.62 134.94 53.34 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-O 121.561 0.696 . . . . 0.0 112.667 -174.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.42 ' OG1' ' NZ ' ' A' ' 49' ' ' LYS . 99.9 m -103.95 147.3 27.52 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.087 178.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -134.95 113.13 11.21 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 120.786 0.327 . . . . 0.0 110.684 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 53.2 mt -86.82 107.1 16.54 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-O 121.176 0.512 . . . . 0.0 111.005 -179.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.512 HG11 HG21 ' A' ' 16' ' ' VAL . 30.6 m -96.12 155.6 3.4 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-O 121.175 0.512 . . . . 0.0 112.149 -176.666 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -94.98 3.1 55.32 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.642 -176.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 62.7 pttt -135.07 155.2 51.15 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.016 179.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 59.0 m -75.87 -32.66 59.81 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -175.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.468 ' HB3' ' OE1' ' A' ' 33' ' ' GLN . 13.0 ptp180 -112.79 121.13 43.81 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 121.233 0.54 . . . . 0.0 111.469 -178.027 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.512 HG21 HG11 ' A' ' 11' ' ' VAL . 46.2 t -127.49 132.35 69.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.679 -177.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.486 ' HA ' ' O ' ' A' ' 30' ' ' VAL . . . -83.04 88.28 6.87 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 121.146 0.498 . . . . 0.0 110.718 176.065 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.462 ' SG ' ' HB3' ' A' ' 46' ' ' CYS . 43.7 t -72.24 104.03 3.55 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 -174.137 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 38.0 t70 54.04 22.14 3.3 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-O 122.093 0.949 . . . . 0.0 111.777 177.024 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -123.41 111.77 1.75 Allowed Glycine 0 CA--C 1.522 0.471 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.584 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 65.78 27.13 72.43 Favored Glycine 0 CA--C 1.53 1.025 0 C-N-CA 121.048 -0.596 . . . . 0.0 113.006 -174.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -112.04 -149.91 0.45 Allowed 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 122.709 0.404 . . . . 0.0 110.738 179.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -43.31 -47.0 6.84 Favored Glycine 0 CA--C 1.534 1.236 0 N-CA-C 114.537 0.575 . . . . 0.0 114.537 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -97.52 -3.22 40.25 Favored 'General case' 0 N--CA 1.472 0.656 0 O-C-N 122.356 -0.496 . . . . 0.0 112.034 179.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.0 pp 43.22 26.87 0.1 Allowed 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.507 1.123 . . . . 0.0 113.863 176.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -55.9 -68.02 1.91 Allowed Glycine 0 CA--C 1.526 0.759 0 N-CA-C 114.375 0.51 . . . . 0.0 114.375 -175.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.436 ' CE1' ' HB3' ' A' ' 45' ' ' TYR . 8.1 m80 -77.26 156.37 81.6 Favored Pre-proline 0 N--CA 1.472 0.649 0 O-C-N 122.374 -0.486 . . . . 0.0 110.974 -178.194 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -72.7 48.57 1.36 Allowed 'Trans proline' 0 CA--C 1.544 1.007 0 C-N-CA 123.142 2.562 . . . . 0.0 113.497 179.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 22.9 tpt180 67.37 85.97 0.14 Allowed 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 122.308 1.052 . . . . 0.0 111.426 179.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.486 ' O ' ' HA ' ' A' ' 17' ' ' ALA . 58.9 t -107.16 112.54 40.42 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 CA-C-N 114.196 -1.365 . . . . 0.0 111.322 -177.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 95.9 m95 -95.09 118.48 31.96 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.125 0.488 . . . . 0.0 111.919 -179.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.407 ' N ' HD12 ' A' ' 32' ' ' LEU . 7.1 mp -94.58 111.65 23.41 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.31 173.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.468 ' OE1' ' HB3' ' A' ' 15' ' ' ARG . 59.4 tp60 -92.43 110.08 21.48 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.83 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.517 HG21 ' HB2' ' A' ' 52' ' ' LEU . 73.5 mt -75.77 119.12 75.68 Favored Pre-proline 0 CA--C 1.543 0.676 0 CA-C-O 120.9 0.381 . . . . 0.0 111.331 179.162 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -85.5 146.35 9.57 Favored 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 122.842 2.361 . . . . 0.0 113.178 -178.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -70.9 -10.12 59.03 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 120.864 0.364 . . . . 0.0 110.848 174.357 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -62.94 -40.58 98.09 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.352 0.596 . . . . 0.0 110.836 172.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 44.3 p -108.56 -54.04 2.56 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.624 -176.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 99.61 1.12 56.51 Favored Glycine 0 CA--C 1.525 0.694 0 CA-C-N 116.092 -0.504 . . . . 0.0 112.061 -174.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 64.5 p-90 -156.86 166.93 31.99 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 122.588 0.355 . . . . 0.0 110.966 -177.308 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.415 HG12 HG12 ' A' ' 34' ' ' ILE . 11.5 p -145.11 136.58 20.34 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-O 120.895 0.379 . . . . 0.0 110.921 174.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -91.76 133.43 35.62 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.006 0.431 . . . . 0.0 110.447 177.176 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.48 ' SG ' ' HB2' ' A' ' 45' ' ' TYR . 44.5 t -103.69 105.31 47.02 Favored Pre-proline 0 N--CA 1.467 0.413 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -178.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -73.54 -2.54 12.3 Favored 'Trans proline' 0 CA--C 1.542 0.923 0 C-N-CA 122.526 2.151 . . . . 0.0 112.351 174.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.48 ' HB2' ' SG ' ' A' ' 43' ' ' CYS . 60.7 m-85 -90.74 -42.14 10.86 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.548 179.099 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.462 ' HB3' ' SG ' ' A' ' 18' ' ' CYS . 53.1 t -118.53 1.87 11.74 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -175.329 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 59.43 51.44 6.62 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 112.802 0.668 . . . . 0.0 112.802 175.234 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 87.6 m -149.04 157.6 43.53 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 120.835 0.35 . . . . 0.0 111.505 177.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.42 ' NZ ' ' OG1' ' A' ' 8' ' ' THR . 7.2 ttpm? -106.45 121.9 45.21 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 116.532 -0.303 . . . . 0.0 111.282 178.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 37.1 m-85 -99.62 119.41 38.04 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 120.663 0.268 . . . . 0.0 111.511 -179.093 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 97.3 t -101.87 139.99 21.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 CA-C-O 120.84 0.353 . . . . 0.0 111.491 177.103 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.517 ' HB2' HG21 ' A' ' 34' ' ' ILE . 60.9 tp -88.54 118.71 28.39 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 120.935 0.398 . . . . 0.0 111.919 -179.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.422 ' HE3' ' HB2' ' A' ' 53' ' ' LYS . 38.2 ttmt -63.57 133.17 53.3 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.816 178.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 90.36 -8.18 80.24 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 121.159 -0.543 . . . . 0.0 113.546 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 45.5 t -77.52 179.94 6.21 Favored 'General case' 0 N--CA 1.472 0.667 0 O-C-N 122.361 -0.493 . . . . 0.0 111.035 178.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -66.85 -27.77 67.8 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.116 0.484 . . . . 0.0 111.157 179.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -76.41 -25.38 54.43 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.444 177.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -110.94 86.96 2.42 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 121.42 0.628 . . . . 0.0 111.332 -178.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -102.67 -18.5 15.18 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.827 175.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 3.1 pp -67.49 -6.14 18.27 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 -177.274 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 54.1 tp10 -88.79 -73.44 0.5 Allowed 'General case' 0 CA--C 1.538 0.499 0 O-C-N 121.87 -0.519 . . . . 0.0 111.663 176.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 29.5 t60 -84.45 -20.0 32.47 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -177.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 28.3 t60 69.34 -15.12 0.29 Allowed 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 113.399 0.889 . . . . 0.0 113.399 176.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 -140.93 171.25 14.33 Favored 'General case' 0 N--CA 1.474 0.746 0 O-C-N 121.964 -0.46 . . . . 0.0 110.977 178.09 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 11.1 m170 -106.57 153.63 22.06 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 120.805 0.336 . . . . 0.0 110.94 175.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 38.7 m80 -78.13 -36.66 47.55 Favored 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 168.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 48.5 t-80 . . . . . 0 C--O 1.257 1.463 0 CA-C-N 114.971 -1.013 . . . . 0.0 110.454 172.897 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 70.7 mtm . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 120.982 0.42 . . . . 0.0 111.21 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 68.6 p -96.39 158.95 15.2 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.074 0.464 . . . . 0.0 111.713 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.425 ' O ' ' HG2' ' A' ' 4' ' ' GLN . 35.0 pt -75.22 9.19 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.303 173.651 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.425 ' HG2' ' O ' ' A' ' 3' ' ' ILE . 9.5 pt20 49.08 19.75 0.32 Allowed 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.85 1.26 . . . . 0.0 113.221 179.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -131.41 96.21 22.07 Favored Pre-proline 0 CA--C 1.542 0.642 0 CA-C-O 120.795 0.331 . . . . 0.0 111.482 179.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -88.04 32.77 0.4 Allowed 'Trans proline' 0 CA--C 1.541 0.859 0 C-N-CA 122.892 2.395 . . . . 0.0 113.124 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.48 ' HB3' ' SG ' ' A' ' 48' ' ' CYS . 86.4 tt0 -65.47 115.22 5.48 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 120.945 0.402 . . . . 0.0 111.794 -177.431 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 57.8 p -96.1 115.46 27.46 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 122.751 0.42 . . . . 0.0 111.771 178.177 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 65.2 mttm -99.37 100.43 11.49 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.018 0.437 . . . . 0.0 110.269 178.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.484 HG22 ' HB2' ' A' ' 53' ' ' LYS . 55.4 mt -82.19 100.47 6.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.546 -176.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 33.2 m -107.93 157.0 8.27 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 CA-C-O 121.108 0.48 . . . . 0.0 112.247 -176.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -99.74 25.31 7.34 Favored 'General case' 0 CA--C 1.548 0.896 0 CA-C-O 121.676 0.75 . . . . 0.0 110.5 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -144.1 131.48 20.91 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.071 -175.081 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.416 ' HA ' HD12 ' A' ' 34' ' ' ILE . 9.1 m -81.01 -26.71 36.24 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -178.106 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.451 ' HG2' ' OE1' ' A' ' 33' ' ' GLN . 89.2 mtt180 -100.7 92.38 5.07 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.17 0.509 . . . . 0.0 110.123 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 44.9 t -107.83 118.6 55.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-N 115.925 -0.579 . . . . 0.0 112.155 -171.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.449 ' HB2' ' CE2' ' A' ' 31' ' ' TRP . . . -84.93 100.5 11.66 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 120.751 0.31 . . . . 0.0 110.756 175.172 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.656 ' SG ' ' HB ' ' A' ' 30' ' ' VAL . 29.7 p -71.58 117.49 13.21 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 121.063 0.459 . . . . 0.0 111.769 -175.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -89.94 -75.3 0.46 Allowed 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.27 176.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 172.65 -164.68 36.94 Favored Glycine 0 CA--C 1.519 0.342 0 C-N-CA 120.579 -0.82 . . . . 0.0 113.088 -179.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -145.94 -86.45 0.07 OUTLIER Glycine 0 CA--C 1.522 0.507 0 C-N-CA 121.224 -0.512 . . . . 0.0 112.474 -179.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -72.32 163.32 28.17 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 120.666 0.269 . . . . 0.0 111.17 175.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -43.97 -54.08 6.18 Favored Glycine 0 CA--C 1.533 1.192 0 N-CA-C 114.6 0.6 . . . . 0.0 114.6 -176.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -77.51 -10.35 59.43 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 -178.035 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 64.1 mt -98.48 19.08 15.15 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 112.462 0.542 . . . . 0.0 112.462 -175.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -80.1 138.81 20.48 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 121.01 -0.614 . . . . 0.0 113.005 176.18 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 32.2 m80 -126.89 145.3 53.24 Favored Pre-proline 0 N--CA 1.472 0.67 0 O-C-N 122.444 -0.444 . . . . 0.0 110.579 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_exo -57.85 -58.15 0.92 Allowed 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 122.706 2.271 . . . . 0.0 114.183 -175.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 2.4 tmt_? 177.27 93.18 0.01 OUTLIER 'General case' 0 C--O 1.233 0.223 0 CA-C-O 121.806 0.813 . . . . 0.0 109.888 -171.391 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.656 ' HB ' ' SG ' ' A' ' 18' ' ' CYS . 55.1 t -124.54 132.69 70.97 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.022 0 CA-C-N 114.558 -1.201 . . . . 0.0 110.784 179.208 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.449 ' CE2' ' HB2' ' A' ' 17' ' ' ALA . 37.3 m95 -110.02 119.94 40.89 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-O 121.205 0.526 . . . . 0.0 112.26 -176.576 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.6 mp -100.4 163.43 12.38 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 121.303 0.573 . . . . 0.0 111.568 177.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.451 ' OE1' ' HG2' ' A' ' 15' ' ' ARG . 55.8 tp60 -131.27 114.21 14.77 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.768 -179.365 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.564 HG21 ' HB2' ' A' ' 52' ' ' LEU . 64.7 mt -69.96 121.21 82.11 Favored Pre-proline 0 CA--C 1.543 0.7 0 CA-C-O 120.863 0.363 . . . . 0.0 111.617 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.497 ' HG2' ' OG1' ' A' ' 38' ' ' THR . 65.3 Cg_endo -81.63 130.26 6.79 Favored 'Trans proline' 0 CA--C 1.544 0.976 0 C-N-CA 122.855 2.37 . . . . 0.0 113.351 -178.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 44.3 mm-40 -60.02 -18.14 44.04 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 175.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -67.92 -36.64 80.51 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 120.966 0.413 . . . . 0.0 111.49 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.497 ' OG1' ' HG2' ' A' ' 35' ' ' PRO . 43.7 p -108.36 -50.86 2.97 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.049 0.452 . . . . 0.0 111.701 -177.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 104.31 1.64 44.33 Favored Glycine 0 CA--C 1.527 0.826 0 C-N-CA 121.352 -0.452 . . . . 0.0 112.412 -174.125 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 65.3 p-90 -154.36 160.19 41.56 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 122.708 0.403 . . . . 0.0 111.418 -179.164 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.547 HG12 HG12 ' A' ' 34' ' ' ILE . 12.3 p -144.11 127.05 11.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 CA-C-O 120.9 0.381 . . . . 0.0 110.823 176.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.406 ' HG3' ' H ' ' A' ' 42' ' ' GLU . 0.4 OUTLIER -100.16 146.2 27.12 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 121.058 0.456 . . . . 0.0 111.745 -178.457 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.566 ' HB3' ' HB2' ' A' ' 47' ' ' ASP . 42.0 t -103.86 119.28 54.99 Favored Pre-proline 0 CA--C 1.536 0.415 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -65.57 -12.58 35.72 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 122.819 2.346 . . . . 0.0 112.836 178.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.54 ' HB2' ' SG ' ' A' ' 43' ' ' CYS . 95.3 m-85 -82.38 7.31 14.44 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.716 178.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.461 ' HB2' ' O ' ' A' ' 45' ' ' TYR . 76.4 m 83.2 31.24 0.08 Allowed 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.906 0.882 . . . . 0.0 112.48 175.715 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.566 ' HB2' ' HB3' ' A' ' 43' ' ' CYS . 24.4 m-20 -94.2 5.96 50.11 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 120.999 0.428 . . . . 0.0 111.005 169.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.48 ' SG ' ' HB3' ' A' ' 7' ' ' GLU . 78.4 m 66.72 -161.92 0.24 Allowed 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 175.065 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.42 ' NZ ' ' HB2' ' A' ' 49' ' ' LYS . 5.0 ttmp? -94.11 126.75 39.52 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -174.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -96.89 105.49 17.64 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 120.658 0.266 . . . . 0.0 110.87 176.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 98.7 t -91.28 132.0 36.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-O 120.798 0.333 . . . . 0.0 111.472 -179.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.564 ' HB2' HG21 ' A' ' 34' ' ' ILE . 48.6 tp -85.39 112.54 20.94 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 121.215 0.531 . . . . 0.0 111.503 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.484 ' HB2' HG22 ' A' ' 10' ' ' ILE . 10.1 tmtt? -58.35 138.74 56.27 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.468 176.095 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 67.32 42.32 90.33 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 121.153 -0.546 . . . . 0.0 112.68 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 35.2 t -143.15 -168.57 2.83 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 120.767 0.317 . . . . 0.0 111.327 -176.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -60.84 -26.13 67.14 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -178.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -94.86 -15.03 24.03 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 -179.154 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -141.79 115.07 8.84 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 121.004 0.43 . . . . 0.0 111.614 -177.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -133.33 -58.7 0.88 Allowed 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 120.976 0.417 . . . . 0.0 110.264 176.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 96.7 mt -121.85 -68.46 0.89 Allowed 'General case' 0 CA--C 1.539 0.519 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.47 175.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 52.64 -147.53 0.46 Allowed 'General case' 0 N--CA 1.474 0.748 0 CA-C-O 120.869 0.366 . . . . 0.0 111.605 173.271 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 57.7 m-70 -94.08 16.94 13.37 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 121.202 0.525 . . . . 0.0 110.443 171.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -64.59 98.22 0.25 Allowed 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.629 -178.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 34.3 p-80 -106.18 127.22 53.06 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 120.827 0.346 . . . . 0.0 111.869 -175.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 26.8 p80 -81.77 29.27 0.39 Allowed 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 116.623 -0.262 . . . . 0.0 111.621 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 14.7 t-80 66.72 123.95 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.136 0.574 . . . . 0.0 112.14 -174.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 10.8 p80 . . . . . 0 C--O 1.252 1.219 0 CA-C-O 118.774 -0.631 . . . . 0.0 111.662 176.029 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.0 mmt . . . . . 0 N--CA 1.493 1.701 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 72.6 p -96.0 137.45 35.05 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -179.24 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.542 ' H ' HD13 ' A' ' 3' ' ' ILE . 0.2 OUTLIER -80.75 -20.32 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 CA-C-O 120.86 0.362 . . . . 0.0 110.976 172.276 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 65.45 101.19 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.625 0.77 . . . . 0.0 112.505 178.131 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -110.83 93.55 17.45 Favored Pre-proline 0 N--CA 1.469 0.479 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.98 176.395 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -66.59 86.81 0.28 Allowed 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 122.725 2.284 . . . . 0.0 112.745 -179.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -73.14 -23.45 60.47 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.497 0.665 . . . . 0.0 111.439 177.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.461 HG23 HG21 ' A' ' 51' ' ' VAL . 38.7 m -84.38 104.94 14.82 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 114.725 -1.125 . . . . 0.0 110.788 -177.198 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 62.2 mttm -120.68 122.0 39.49 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 121.09 0.471 . . . . 0.0 111.198 -174.324 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.458 HD13 ' HB ' ' A' ' 51' ' ' VAL . 49.9 mm -82.89 121.87 36.55 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 CA-C-N 115.91 -0.586 . . . . 0.0 112.295 -173.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 29.5 m -130.08 149.85 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.194 178.063 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -90.42 -15.72 30.4 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 179.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -96.97 142.68 28.63 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.037 0.446 . . . . 0.0 111.695 -179.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 20.0 m -80.57 -23.06 40.18 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.576 179.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.457 ' HA ' ' O ' ' A' ' 32' ' ' LEU . 16.2 ptp180 -116.15 119.46 35.87 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 121.311 0.577 . . . . 0.0 111.178 176.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 51.4 t -118.3 142.34 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.501 -175.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -94.33 110.47 22.23 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 120.982 0.42 . . . . 0.0 111.34 178.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.52 ' SG ' HD13 ' A' ' 32' ' ' LEU . 78.3 m -86.8 95.69 9.93 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 120.865 0.364 . . . . 0.0 111.41 176.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -83.49 -80.07 0.19 Allowed 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.606 174.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.632 ' HA3' ' HA2' ' A' ' 26' ' ' GLY . . . 161.04 -179.74 36.31 Favored Glycine 0 CA--C 1.523 0.571 0 C-N-CA 120.828 -0.701 . . . . 0.0 113.435 178.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -84.07 -100.78 0.59 Allowed Glycine 0 CA--C 1.526 0.771 0 C-N-CA 121.133 -0.556 . . . . 0.0 112.272 175.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 13.5 mp0 -76.59 165.53 24.65 Favored 'General case' 0 CA--C 1.541 0.622 0 O-C-N 122.596 -0.355 . . . . 0.0 110.416 172.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -43.83 -49.39 7.54 Favored Glycine 0 CA--C 1.533 1.182 0 N-CA-C 114.228 0.451 . . . . 0.0 114.228 -179.115 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.22 -31.93 72.53 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 121.041 0.448 . . . . 0.0 111.829 179.073 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 86.0 mt -90.37 0.26 57.34 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.865 0.364 . . . . 0.0 111.429 179.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.632 ' HA2' ' HA3' ' A' ' 20' ' ' GLY . . . -78.7 165.48 51.33 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 121.442 -0.409 . . . . 0.0 113.352 179.502 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 77.4 m80 -138.63 157.55 71.84 Favored Pre-proline 0 CA--C 1.538 0.499 0 O-C-N 122.606 -0.35 . . . . 0.0 110.524 -179.23 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.485 ' O ' ' HB3' ' A' ' 29' ' ' ARG . 70.7 Cg_endo -72.2 31.5 0.27 Allowed 'Trans proline' 0 CA--C 1.544 1.019 0 C-N-CA 122.437 2.092 . . . . 0.0 114.191 -176.381 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.485 ' HB3' ' O ' ' A' ' 28' ' ' PRO . 0.4 OUTLIER 76.69 98.07 0.07 Allowed 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 122.598 1.189 . . . . 0.0 110.228 175.44 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 60.7 t -120.28 129.85 75.04 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-N 113.919 -1.492 . . . . 0.0 110.988 178.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 74.4 m95 -104.09 124.22 48.67 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.063 0.459 . . . . 0.0 112.157 -178.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.52 HD13 ' SG ' ' A' ' 18' ' ' CYS . 7.2 mp -103.07 149.88 24.15 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.94 177.197 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 27.6 tp60 -120.32 109.02 14.87 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.812 -178.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.516 HG12 HG12 ' A' ' 41' ' ' VAL . 67.8 mt -60.45 129.46 89.2 Favored Pre-proline 0 CA--C 1.543 0.678 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.743 179.497 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.563 ' HG2' ' OG1' ' A' ' 38' ' ' THR . 45.7 Cg_endo -78.61 119.21 4.39 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 122.216 1.944 . . . . 0.0 111.52 173.018 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 22.2 mp0 -56.72 -40.33 75.51 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 -171.175 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -81.13 0.77 34.76 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 112.515 0.561 . . . . 0.0 112.515 -173.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.563 ' OG1' ' HG2' ' A' ' 35' ' ' PRO . 22.6 p -107.06 -46.22 3.96 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.336 0.589 . . . . 0.0 109.823 171.139 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 100.3 0.92 55.75 Favored Glycine 0 CA--C 1.524 0.602 0 CA-C-N 115.558 -0.746 . . . . 0.0 113.212 178.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.445 ' HB3' HG22 ' A' ' 51' ' ' VAL . 67.5 p-90 -157.33 157.31 33.9 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.024 0.44 . . . . 0.0 112.118 -176.198 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.516 HG12 HG12 ' A' ' 34' ' ' ILE . 13.3 p -135.46 139.91 45.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.593 174.323 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -106.55 131.73 53.38 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.164 0.506 . . . . 0.0 111.083 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.432 ' HA ' HD21 ' A' ' 32' ' ' LEU . 47.5 t -86.23 122.04 72.44 Favored Pre-proline 0 CA--C 1.537 0.466 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.784 -177.419 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -74.71 -12.56 22.16 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 122.496 2.131 . . . . 0.0 112.84 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -99.42 -39.13 8.52 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 116.268 -0.424 . . . . 0.0 112.053 -178.291 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.425 ' HG ' ' HG ' ' A' ' 48' ' ' CYS . 46.3 t -116.8 2.62 12.88 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -177.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 54.25 25.86 6.24 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 174.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.425 ' HG ' ' HG ' ' A' ' 46' ' ' CYS . 71.0 m -95.48 144.71 25.75 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.296 177.546 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.452 ' HE3' ' HB2' ' A' ' 49' ' ' LYS . 34.9 ttmt -112.44 106.52 15.02 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-O 121.17 0.51 . . . . 0.0 111.215 -177.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 52.4 m-85 -91.24 111.16 22.53 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.51 -175.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.461 HG21 HG23 ' A' ' 8' ' ' THR . 68.9 t -94.86 132.66 38.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-O 121.031 0.443 . . . . 0.0 111.279 177.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 41.8 tp -82.29 115.8 21.52 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 121.054 0.454 . . . . 0.0 112.12 -176.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.559 ' HE3' ' N ' ' A' ' 54' ' ' GLY . 0.1 OUTLIER -67.27 112.9 4.78 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 120.973 0.415 . . . . 0.0 110.042 178.582 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.559 ' N ' ' HE3' ' A' ' 53' ' ' LYS . . . 114.14 -4.51 23.78 Favored Glycine 0 CA--C 1.523 0.592 0 C-N-CA 121.323 -0.465 . . . . 0.0 112.591 -176.433 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 47.7 t -82.01 179.92 7.64 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 121.107 0.48 . . . . 0.0 111.629 177.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 19.4 ptmt -54.93 -43.71 73.58 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -177.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.41 -22.64 66.24 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.097 0.475 . . . . 0.0 112.056 -178.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -79.97 -19.43 47.91 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.843 -178.29 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -80.92 58.72 3.5 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 121.277 0.56 . . . . 0.0 112.373 -174.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.6 pp -69.14 175.56 3.75 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 116.153 -0.476 . . . . 0.0 112.059 177.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -85.54 122.77 30.15 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-O 121.615 0.721 . . . . 0.0 112.734 -175.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 55.4 t60 -169.38 85.58 0.14 Allowed 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 115.253 -0.885 . . . . 0.0 108.974 173.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 23.8 p80 -142.87 177.31 8.43 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 113.512 0.93 . . . . 0.0 113.512 -167.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 6.5 p-80 -143.46 170.88 14.97 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 114.787 -1.097 . . . . 0.0 110.003 176.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 18.1 m80 -69.12 90.52 0.47 Allowed 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 121.17 0.51 . . . . 0.0 111.793 179.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 26.2 t-80 -95.03 -21.27 18.68 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.342 0.591 . . . . 0.0 109.625 172.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 53.9 m-70 . . . . . 0 C--O 1.251 1.164 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.398 174.862 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.593 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.0 OUTLIER . . . . . 0 N--CA 1.488 1.475 0 CA-C-O 120.725 0.297 . . . . 0.0 111.63 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.77 HG22 ' H ' ' A' ' 4' ' ' GLN . 6.6 m -123.96 136.3 54.22 Favored 'General case' 0 N--CA 1.475 0.806 0 O-C-N 122.172 -0.33 . . . . 0.0 111.138 177.656 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 10.2 tp -64.73 -20.66 27.76 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 CA-C-O 121.488 0.661 . . . . 0.0 110.576 174.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.77 ' H ' HG22 ' A' ' 2' ' ' THR . 53.1 mt-30 70.84 -84.59 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 115.068 -0.969 . . . . 0.0 112.047 177.612 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 51.79 58.22 15.9 Favored Pre-proline 0 CA--C 1.546 0.825 0 CA-C-O 120.922 0.391 . . . . 0.0 111.861 -174.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -83.1 37.97 0.7 Allowed 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 122.928 2.419 . . . . 0.0 113.305 -174.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.455 ' CD ' ' H ' ' A' ' 8' ' ' THR . 0.2 OUTLIER -124.05 -159.62 0.88 Allowed 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.192 -177.805 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.455 ' H ' ' CD ' ' A' ' 7' ' ' GLU . 77.2 m -70.9 123.52 22.2 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 121.102 0.477 . . . . 0.0 111.734 -179.609 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 23.2 tptp -121.35 101.82 7.88 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 120.873 0.368 . . . . 0.0 110.233 179.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 60.4 mt -83.43 99.89 6.48 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.065 -176.005 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 27.2 m -110.73 154.05 12.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 CA-C-O 121.009 0.433 . . . . 0.0 112.105 -175.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -87.5 14.99 7.16 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 120.787 0.327 . . . . 0.0 111.584 -178.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 58.0 pttt -132.83 143.94 49.88 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -174.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.425 ' HB3' HE22 ' A' ' 33' ' ' GLN . 54.0 m -87.92 -24.94 23.46 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 116.276 -0.42 . . . . 0.0 112.111 -178.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 75.2 mtt180 -108.71 110.19 21.54 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 121.179 0.514 . . . . 0.0 111.87 -179.146 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 50.3 t -114.01 147.21 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.064 -178.152 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.494 ' HA ' ' O ' ' A' ' 30' ' ' VAL . . . -91.18 106.71 18.7 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 121.348 0.594 . . . . 0.0 112.568 -177.361 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.682 ' SG ' HD22 ' A' ' 32' ' ' LEU . 95.9 m -85.39 -158.38 0.37 Allowed 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.633 178.72 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 9.9 t70 66.92 89.51 0.1 Allowed 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 121.21 0.528 . . . . 0.0 110.717 -175.212 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.625 ' HA2' ' O ' ' A' ' 25' ' ' LEU . . . -146.31 144.4 12.74 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 121.143 -0.551 . . . . 0.0 113.532 -178.681 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 154.63 -27.33 0.67 Allowed Glycine 0 CA--C 1.531 1.093 0 C-N-CA 120.763 -0.732 . . . . 0.0 114.463 176.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.501 ' HG2' ' N ' ' A' ' 23' ' ' GLY . 32.9 tt0 -151.69 168.43 25.04 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 117.071 0.436 . . . . 0.0 110.945 -174.71 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.501 ' N ' ' HG2' ' A' ' 22' ' ' GLU . . . -44.52 -57.37 5.15 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 121.632 -0.318 . . . . 0.0 113.748 176.086 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.54 -23.65 66.92 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 121.015 0.436 . . . . 0.0 111.89 177.422 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.625 ' O ' ' HA2' ' A' ' 20' ' ' GLY . 89.5 mt -103.88 25.86 9.36 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.975 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -82.68 51.82 4.6 Favored Glycine 0 CA--C 1.527 0.807 0 C-N-CA 120.892 -0.671 . . . . 0.0 113.668 -176.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 88.3 m-70 50.0 63.85 9.42 Favored Pre-proline 0 N--CA 1.475 0.78 0 C-N-CA 123.168 0.587 . . . . 0.0 112.404 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -59.21 -62.35 0.18 Allowed 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 122.721 2.281 . . . . 0.0 112.618 178.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 6.1 tpt180 -179.42 85.38 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.196 0 CA-C-O 121.956 0.884 . . . . 0.0 110.504 177.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.494 ' O ' ' HA ' ' A' ' 17' ' ' ALA . 60.8 t -135.71 103.81 4.12 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 CA-C-N 114.669 -1.15 . . . . 0.0 110.421 -179.238 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 85.1 m95 -94.78 124.07 38.61 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -173.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.682 HD22 ' SG ' ' A' ' 18' ' ' CYS . 11.2 mp -105.45 131.57 52.7 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.019 0.438 . . . . 0.0 110.646 171.579 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.425 HE22 ' HB3' ' A' ' 14' ' ' SER . 28.9 tp60 -92.88 115.1 27.81 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.836 -177.438 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.495 HG21 ' HB2' ' A' ' 52' ' ' LEU . 69.0 mt -66.79 118.1 51.49 Favored Pre-proline 0 CA--C 1.538 0.508 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.526 173.222 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.437 ' HG2' ' OG1' ' A' ' 38' ' ' THR . 97.6 Cg_endo -82.19 134.23 7.92 Favored 'Trans proline' 0 CA--C 1.538 0.704 0 C-N-CA 122.424 2.083 . . . . 0.0 113.045 179.445 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -58.4 -23.01 56.0 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 121.433 0.635 . . . . 0.0 110.599 174.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -62.4 -35.3 78.77 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 115.3 -0.864 . . . . 0.0 111.967 179.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.437 ' OG1' ' HG2' ' A' ' 35' ' ' PRO . 31.9 p -108.73 -48.73 3.26 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-O 121.03 0.443 . . . . 0.0 111.326 -179.058 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 101.08 -0.56 54.71 Favored Glycine 0 CA--C 1.527 0.807 0 CA-C-N 116.034 -0.53 . . . . 0.0 112.779 -177.005 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 67.5 p-90 -155.11 166.23 34.23 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 120.891 0.376 . . . . 0.0 111.821 -177.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.432 HG12 HG12 ' A' ' 34' ' ' ILE . 10.1 p -144.07 144.35 22.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 CA-C-N 116.528 -0.306 . . . . 0.0 110.912 175.459 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -105.13 141.36 36.81 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 120.834 0.349 . . . . 0.0 111.127 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.468 ' SG ' ' HB3' ' A' ' 46' ' ' CYS . 29.3 p -99.07 116.61 65.11 Favored Pre-proline 0 CA--C 1.539 0.52 0 O-C-N 122.305 -0.247 . . . . 0.0 110.935 175.043 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -70.37 16.93 0.24 Allowed 'Trans proline' 0 CA--C 1.544 0.981 0 C-N-CA 122.768 2.312 . . . . 0.0 113.642 -176.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 35.0 m-85 -117.26 -49.6 2.58 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 120.837 0.351 . . . . 0.0 111.418 176.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.468 ' HB3' ' SG ' ' A' ' 43' ' ' CYS . 13.2 t -105.13 -4.94 21.24 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -175.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 63.81 18.64 11.29 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 112.913 0.709 . . . . 0.0 112.913 177.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.442 ' SG ' ' SG ' ' A' ' 46' ' ' CYS . 34.7 m -79.8 135.27 36.44 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 120.84 0.352 . . . . 0.0 111.262 -179.748 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -99.62 95.42 6.95 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 120.915 0.388 . . . . 0.0 110.522 178.339 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.406 ' CZ ' ' HB2' ' A' ' 48' ' ' CYS . 76.0 m-85 -82.1 105.04 12.88 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.697 0.284 . . . . 0.0 111.263 -173.837 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 90.4 t -91.47 126.78 44.1 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.293 178.105 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.495 ' HB2' HG21 ' A' ' 34' ' ' ILE . 58.0 tp -73.32 112.53 9.46 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 121.175 0.512 . . . . 0.0 111.125 178.663 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 61.5 tttm -63.34 118.07 7.52 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.343 -178.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 102.25 -3.48 51.13 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 121.37 -0.443 . . . . 0.0 112.853 -174.176 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 35.2 t -90.82 -176.84 4.8 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 120.931 0.396 . . . . 0.0 111.544 178.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 54.9 mttm -72.24 -10.99 60.51 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 120.901 0.381 . . . . 0.0 111.968 -176.251 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -93.88 -0.94 55.45 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 120.967 0.413 . . . . 0.0 110.858 173.632 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.477 ' CG ' ' H ' ' A' ' 59' ' ' ALA . 24.9 t70 -126.91 -162.76 1.18 Allowed 'General case' 0 CA--C 1.549 0.924 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.858 -178.175 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.477 ' H ' ' CG ' ' A' ' 58' ' ' ASP . . . 71.83 45.11 0.44 Allowed 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.568 0.699 . . . . 0.0 110.958 -179.408 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.459 ' H ' HD12 ' A' ' 60' ' ' LEU . 5.4 mp -69.75 -20.84 63.49 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.527 -179.342 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.472 ' HB3' ' HB3' ' A' ' 64' ' ' HIS . 44.1 mt-10 -75.52 57.58 0.96 Allowed 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 121.095 0.474 . . . . 0.0 110.695 174.037 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 54.7 t-80 -65.26 -25.26 67.58 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 121.289 0.566 . . . . 0.0 110.081 -176.266 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 41.2 p-80 -81.87 -24.56 35.68 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 115.505 -0.771 . . . . 0.0 111.951 177.175 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.472 ' HB3' ' HB3' ' A' ' 61' ' ' GLU . 23.2 t-80 -114.93 104.94 12.42 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 120.772 0.32 . . . . 0.0 111.114 -174.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 26.4 m80 -98.01 -46.19 5.98 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 111.968 0.358 . . . . 0.0 111.968 -175.433 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 42.1 t-80 -70.08 98.81 1.37 Allowed 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 120.885 0.374 . . . . 0.0 110.728 175.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 12.0 p80 . . . . . 0 C--O 1.254 1.334 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -176.098 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.525 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.635 0 N-CA-C 111.811 0.3 . . . . 0.0 111.811 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 39.6 p -80.52 151.01 29.4 Favored 'General case' 0 N--CA 1.47 0.553 0 O-C-N 122.255 -0.278 . . . . 0.0 110.706 172.337 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.424 ' N ' HD12 ' A' ' 3' ' ' ILE . 2.0 mp -62.22 -25.22 37.02 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-O 121.014 0.435 . . . . 0.0 110.548 177.281 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 67.2 mm-40 59.74 80.39 0.2 Allowed 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 115.729 -0.669 . . . . 0.0 112.064 179.517 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.551 ' HB3' ' HD3' ' A' ' 6' ' ' PRO . . . -169.63 -52.49 0.0 OUTLIER Pre-proline 0 CA--C 1.547 0.859 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.988 178.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.551 ' HD3' ' HB3' ' A' ' 5' ' ' ALA . 55.1 Cg_endo -90.59 28.12 0.42 Allowed 'Trans proline' 0 C--N 1.357 1.022 0 C-N-CA 122.147 1.898 . . . . 0.0 112.994 179.522 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -92.99 87.62 5.83 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-O 121.953 0.883 . . . . 0.0 111.34 -176.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 96.2 m -126.51 148.9 49.64 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 114.752 -1.113 . . . . 0.0 110.731 -177.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.429 ' HD2' ' CE1' ' A' ' 50' ' ' TYR . 98.7 mttt -120.08 126.95 52.02 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 120.867 0.365 . . . . 0.0 110.735 -176.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.428 HG22 ' HB2' ' A' ' 53' ' ' LYS . 34.9 mm -91.83 98.84 8.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-O 121.023 0.439 . . . . 0.0 110.831 -179.179 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 34.7 m -99.15 158.0 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-O 121.407 0.623 . . . . 0.0 112.501 -174.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -91.72 -34.5 14.61 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.506 177.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -90.45 151.19 21.5 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.311 0.577 . . . . 0.0 112.479 -175.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 43.8 m -78.3 -27.51 47.31 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.331 173.48 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 71.7 mtp180 -90.42 107.2 19.0 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.618 175.175 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 55.1 t -113.97 118.59 58.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 120.999 0.428 . . . . 0.0 112.09 -175.423 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.13 103.09 7.85 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 121.057 0.456 . . . . 0.0 110.29 173.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.727 ' SG ' HD13 ' A' ' 32' ' ' LEU . 79.1 m -70.69 84.13 0.63 Allowed 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -172.329 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 40.37 66.3 0.64 Allowed 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 121.673 0.749 . . . . 0.0 112.532 176.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -157.04 151.9 23.24 Favored Glycine 0 CA--C 1.525 0.716 0 C-N-CA 119.804 -1.188 . . . . 0.0 114.59 -176.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' A' ' 27' ' ' HIS . . . -164.16 -132.47 1.35 Allowed Glycine 0 CA--C 1.524 0.601 0 N-CA-C 111.191 -0.764 . . . . 0.0 111.191 177.778 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.436 ' H ' HD12 ' A' ' 25' ' ' LEU . 32.8 mt-10 -88.65 118.81 28.58 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 122.277 -0.543 . . . . 0.0 111.523 174.55 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 39.76 -94.96 0.01 OUTLIER Glycine 0 CA--C 1.534 1.28 0 N-CA-C 115.512 0.965 . . . . 0.0 115.512 178.514 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.2 -17.84 63.93 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 -173.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.436 HD12 ' H ' ' A' ' 22' ' ' GLU . 86.0 mt -78.04 -2.91 39.51 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 -179.333 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 128.6 -130.0 6.39 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 121.481 -0.39 . . . . 0.0 112.866 178.255 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.417 ' O ' ' N ' ' A' ' 21' ' ' GLY . 6.3 m80 -84.94 156.56 60.77 Favored Pre-proline 0 N--CA 1.477 0.908 0 O-C-N 122.443 -0.445 . . . . 0.0 109.973 178.282 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -63.83 64.64 0.21 Allowed 'Trans proline' 0 CA--C 1.551 1.337 0 C-N-CA 122.894 2.396 . . . . 0.0 114.472 -178.547 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 7.9 tpt180 49.61 81.53 0.06 Allowed 'General case' 0 C--O 1.236 0.387 0 CA-C-O 122.62 1.2 . . . . 0.0 111.981 179.012 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 19.9 m -104.7 114.62 44.79 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 CA-C-N 113.658 -1.61 . . . . 0.0 112.265 -177.608 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 96.7 m95 -101.82 124.42 47.42 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.717 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.727 HD13 ' SG ' ' A' ' 18' ' ' CYS . 9.3 mp -117.49 134.1 55.23 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 121.011 0.434 . . . . 0.0 110.945 174.248 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -93.73 116.42 28.9 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.263 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.557 HG12 HG12 ' A' ' 41' ' ' VAL . 77.7 mt -61.73 123.0 75.24 Favored Pre-proline 0 CA--C 1.542 0.637 0 CA-C-O 120.891 0.377 . . . . 0.0 111.849 179.18 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.579 ' HG2' ' OG1' ' A' ' 38' ' ' THR . 76.7 Cg_endo -81.23 140.16 12.13 Favored 'Trans proline' 0 CA--C 1.544 0.983 0 C-N-CA 122.803 2.335 . . . . 0.0 112.818 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -70.64 -28.92 65.19 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 121.01 0.433 . . . . 0.0 111.746 -179.34 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -61.61 -25.01 67.08 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 179.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.579 ' OG1' ' HG2' ' A' ' 35' ' ' PRO . 47.2 p -109.84 -54.0 2.61 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-O 121.286 0.565 . . . . 0.0 111.197 176.048 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 101.05 1.34 54.78 Favored Glycine 0 CA--C 1.524 0.648 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.003 -175.247 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 54.5 p-90 -152.87 162.92 40.7 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 121.077 0.465 . . . . 0.0 111.681 -176.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.557 HG12 HG12 ' A' ' 34' ' ' ILE . 8.4 p -142.67 118.71 5.53 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 CA-C-O 120.925 0.393 . . . . 0.0 110.773 173.707 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.544 ' HA ' ' HA ' ' A' ' 49' ' ' LYS . 9.4 pt-20 -100.0 106.61 18.41 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.529 0.68 . . . . 0.0 110.112 175.701 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.843 ' HB3' ' SG ' ' A' ' 46' ' ' CYS . 44.0 t -75.83 130.91 77.51 Favored Pre-proline 0 N--CA 1.466 0.371 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -167.13 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -69.58 -15.15 37.61 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 122.571 2.181 . . . . 0.0 112.569 175.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.512 ' HD2' ' SG ' ' A' ' 43' ' ' CYS . 90.1 m-85 -85.24 -43.2 13.98 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.601 179.542 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.843 ' SG ' ' HB3' ' A' ' 43' ' ' CYS . 27.1 p -97.04 -17.77 19.81 Favored 'General case' 0 N--CA 1.478 0.925 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 -178.695 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 10.1 t70 67.96 20.06 9.25 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-O 121.123 0.487 . . . . 0.0 111.147 179.19 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 53.6 t -121.43 154.73 36.16 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 120.916 0.389 . . . . 0.0 111.616 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.544 ' HA ' ' HA ' ' A' ' 42' ' ' GLU . 17.9 ttmm -98.51 134.45 41.45 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.385 -177.37 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.429 ' CE1' ' HD2' ' A' ' 9' ' ' LYS . 72.3 m-85 -115.08 113.29 23.83 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 122.17 -0.331 . . . . 0.0 111.244 178.358 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 49.7 t -97.51 128.44 48.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 CA-C-O 121.169 0.509 . . . . 0.0 111.737 175.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.448 ' HB2' HD13 ' A' ' 34' ' ' ILE . 51.6 tp -78.6 114.02 17.15 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.029 178.024 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.428 ' HB2' HG22 ' A' ' 10' ' ' ILE . 33.9 ttpt -63.48 121.65 14.35 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.329 -179.188 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 92.1 13.57 57.39 Favored Glycine 0 CA--C 1.531 1.047 0 CA-C-N 116.14 -0.482 . . . . 0.0 113.751 -177.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 34.5 p -107.29 -166.65 1.18 Allowed 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 117.296 0.548 . . . . 0.0 111.905 -178.499 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -63.31 -20.29 65.36 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 115.927 -0.578 . . . . 0.0 111.777 177.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -94.22 -1.2 54.46 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 179.526 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -130.12 172.82 11.35 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 116.639 -0.255 . . . . 0.0 110.756 -176.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 63.22 77.51 0.32 Allowed 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 121.262 0.553 . . . . 0.0 111.11 -176.47 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 78.0 mt -65.8 -62.62 1.4 Allowed 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.571 -176.272 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.1 -25.66 63.61 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.846 178.38 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 39.0 t-80 74.21 20.81 2.6 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.431 0.692 . . . . 0.0 112.437 167.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 35.3 t-80 -80.46 -13.44 59.11 Favored 'General case' 0 CA--C 1.539 0.541 0 O-C-N 121.789 -0.569 . . . . 0.0 110.252 176.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 11.1 t-160 -79.65 92.96 5.43 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 170.211 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 21.6 p80 -86.41 143.73 27.66 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 -167.327 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 11.0 p80 -175.45 124.29 0.23 Allowed 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.131 172.058 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 40.7 m170 . . . . . 0 C--O 1.251 1.146 0 CA-C-O 118.678 -0.677 . . . . 0.0 111.432 178.623 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.7 mtm . . . . . 0 N--CA 1.494 1.756 0 CA-C-O 120.908 0.385 . . . . 0.0 111.18 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 2.9 m -78.62 24.93 0.27 Allowed 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -172.511 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.407 HG22 ' O ' ' A' ' 3' ' ' ILE . 44.5 mm 66.31 -5.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 CA-C-O 121.092 0.472 . . . . 0.0 111.399 -176.714 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 57.67 22.07 7.95 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.077 0.551 . . . . 0.0 111.918 -178.036 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -138.01 88.79 15.27 Favored Pre-proline 0 CA--C 1.534 0.34 0 CA-C-O 120.858 0.361 . . . . 0.0 111.917 -179.003 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -67.77 97.34 0.46 Allowed 'Trans proline' 0 CA--C 1.535 0.528 0 C-N-CA 122.308 2.005 . . . . 0.0 110.648 171.121 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -23.13 103.75 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 124.07 0.948 . . . . 0.0 112.523 -179.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.412 HG23 HG23 ' A' ' 51' ' ' VAL . 51.7 m -104.51 145.74 29.86 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 115.52 -0.764 . . . . 0.0 112.372 -171.47 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -129.14 114.19 16.02 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.262 176.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 55.0 mt -84.76 94.93 3.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 121.306 0.574 . . . . 0.0 110.761 -179.262 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 29.9 m -104.8 149.11 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-N 115.932 -0.576 . . . . 0.0 112.188 -174.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -75.67 -19.77 58.92 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.347 -177.204 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.438 ' NZ ' ' O ' ' A' ' 15' ' ' ARG . 13.2 ptmm? -112.08 143.04 43.75 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 116.204 -0.453 . . . . 0.0 112.171 -173.317 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.422 ' HB2' ' NE2' ' A' ' 33' ' ' GLN . 37.6 p -79.11 -38.58 35.85 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 112.724 0.639 . . . . 0.0 112.724 -178.609 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.438 ' O ' ' NZ ' ' A' ' 13' ' ' LYS . 8.9 mmt180 -78.69 127.72 32.48 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.362 0.601 . . . . 0.0 111.953 -178.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 95.3 t -143.21 124.18 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.765 -178.409 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.52 112.11 15.25 Favored 'General case' 0 CA--C 1.537 0.463 0 O-C-N 122.214 -0.303 . . . . 0.0 110.817 177.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 48.2 t -147.13 98.77 3.07 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 112.516 0.561 . . . . 0.0 112.516 -178.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.54 ' HB2' ' HB ' ' A' ' 30' ' ' VAL . 35.1 t70 -143.49 64.98 1.33 Allowed 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.744 0.783 . . . . 0.0 110.167 174.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 160.88 -172.99 37.3 Favored Glycine 0 CA--C 1.519 0.34 0 CA-C-N 115.846 -0.615 . . . . 0.0 112.043 -179.067 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -61.87 -42.58 99.76 Favored Glycine 0 CA--C 1.526 0.727 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.373 177.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -164.67 177.3 8.13 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 122.92 0.488 . . . . 0.0 109.966 176.38 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -45.41 -50.68 10.06 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 121.468 -0.396 . . . . 0.0 113.898 176.278 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -83.36 -2.2 55.18 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.161 0.505 . . . . 0.0 111.942 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.0 tt -125.69 56.04 1.41 Allowed 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 125.69 -140.37 12.16 Favored Glycine 0 CA--C 1.524 0.627 0 CA-C-N 115.341 -0.845 . . . . 0.0 112.598 178.307 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 1.6 m80 64.16 56.67 1.66 Allowed Pre-proline 0 CA--C 1.548 0.895 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 174.516 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.438 ' O ' ' HB2' ' A' ' 29' ' ' ARG . 19.4 Cg_endo -58.04 -58.2 0.87 Allowed 'Trans proline' 0 C--N 1.358 1.046 0 C-N-CA 122.212 1.941 . . . . 0.0 111.993 176.481 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.438 ' HB2' ' O ' ' A' ' 28' ' ' PRO . 10.1 tpt180 178.43 85.41 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 121.979 0.895 . . . . 0.0 110.831 170.558 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.54 ' HB ' ' HB2' ' A' ' 19' ' ' ASP . 89.9 t -137.78 117.77 15.77 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 CA-C-N 114.526 -1.216 . . . . 0.0 110.178 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 81.9 m95 -105.66 119.95 40.43 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 121.348 0.594 . . . . 0.0 112.254 -174.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.418 ' N ' HD12 ' A' ' 32' ' ' LEU . 6.9 mp -81.09 152.35 27.88 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.679 173.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.422 ' NE2' ' HB2' ' A' ' 14' ' ' SER . 25.0 tp60 -120.77 111.93 18.2 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.882 -178.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.529 HG21 ' HB2' ' A' ' 52' ' ' LEU . 61.0 mt -77.23 109.7 10.03 Favored Pre-proline 0 CA--C 1.541 0.608 0 CA-C-O 120.57 0.224 . . . . 0.0 110.397 173.431 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -86.47 156.24 9.27 Favored 'Trans proline' 0 CA--C 1.536 0.622 0 C-N-CA 122.793 2.329 . . . . 0.0 113.391 -176.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -73.79 -18.89 60.91 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.042 0.449 . . . . 0.0 110.271 174.372 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -58.02 -56.22 24.77 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-O 121.275 0.56 . . . . 0.0 110.927 174.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 44.6 p -90.48 -50.32 6.01 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.748 -179.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 99.48 1.55 56.63 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-N 116.141 -0.481 . . . . 0.0 112.415 -174.353 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.561 ' HB3' HG22 ' A' ' 51' ' ' VAL . 30.1 p-90 -158.55 170.86 21.25 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 122.656 0.382 . . . . 0.0 111.827 -177.036 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 11.2 p -141.93 144.92 24.79 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 CA-C-O 120.882 0.372 . . . . 0.0 111.039 175.289 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -104.38 137.94 41.53 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 120.875 0.369 . . . . 0.0 111.132 -178.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.665 ' SG ' ' HE2' ' A' ' 50' ' ' TYR . 68.6 m -95.13 109.59 45.48 Favored Pre-proline 0 N--CA 1.472 0.66 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.617 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -64.97 -12.03 32.6 Favored 'Trans proline' 0 CA--C 1.543 0.967 0 C-N-CA 122.495 2.13 . . . . 0.0 113.585 -178.144 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 -110.93 -62.63 1.51 Allowed 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 120.827 0.346 . . . . 0.0 111.716 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.504 ' SG ' ' SG ' ' A' ' 48' ' ' CYS . 42.8 t -73.08 -14.76 61.46 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -178.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 16.0 t70 71.96 -4.85 1.85 Allowed 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 123.342 0.657 . . . . 0.0 112.69 177.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.504 ' SG ' ' SG ' ' A' ' 46' ' ' CYS . 81.2 m -65.83 147.65 53.03 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.087 0.47 . . . . 0.0 112.198 178.035 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 59.8 tttm -118.45 104.31 10.58 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.419 178.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.665 ' HE2' ' SG ' ' A' ' 43' ' ' CYS . 97.3 m-85 -89.26 113.92 25.22 Favored 'General case' 0 N--CA 1.468 0.444 0 O-C-N 122.057 -0.402 . . . . 0.0 111.411 -174.109 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.561 HG22 ' HB3' ' A' ' 40' ' ' TRP . 80.1 t -95.69 136.56 26.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 CA-C-O 120.777 0.322 . . . . 0.0 111.435 176.014 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.529 ' HB2' HG21 ' A' ' 34' ' ' ILE . 48.7 tp -71.97 120.03 16.99 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 121.29 0.567 . . . . 0.0 111.195 178.46 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -65.78 116.88 7.43 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.518 -179.003 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 91.27 14.97 56.63 Favored Glycine 0 CA--C 1.527 0.784 0 CA-C-N 116.195 -0.457 . . . . 0.0 113.054 -176.03 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.515 ' HB3' ' HB3' ' A' ' 52' ' ' LEU . 76.9 p -91.09 -177.93 5.04 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 121.379 0.609 . . . . 0.0 111.916 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -57.42 -37.79 73.31 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.771 173.152 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -78.69 -30.78 46.25 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -176.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -82.24 -41.92 19.6 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 120.936 0.398 . . . . 0.0 111.662 179.177 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -79.6 -60.54 2.31 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -178.086 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 94.6 mt 61.85 101.0 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 122.602 0.361 . . . . 0.0 111.747 -176.032 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 53.9 mm-40 69.07 159.73 0.18 Allowed 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 121.659 0.742 . . . . 0.0 112.729 -179.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 19.1 p80 -147.22 123.22 10.73 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.901 -179.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 52.8 m80 -125.95 132.2 52.13 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -176.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 33.3 p80 -166.8 127.39 1.59 Allowed 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.825 171.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 38.6 m80 -75.81 118.24 18.4 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.309 -177.098 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 58.5 m80 67.87 -163.39 0.21 Allowed 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 122.778 0.431 . . . . 0.0 111.263 -175.5 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 10.6 p80 . . . . . 0 C--O 1.249 1.048 0 CA-C-O 119.116 -0.468 . . . . 0.0 111.95 -179.416 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.6 mmt . . . . . 0 N--CA 1.492 1.661 0 N-CA-C 111.753 0.279 . . . . 0.0 111.753 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.486 ' O ' ' HB ' ' A' ' 3' ' ' ILE . 7.0 m -85.17 -2.3 57.86 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -174.378 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.486 ' HB ' ' O ' ' A' ' 2' ' ' THR . 1.9 mp 74.4 -20.06 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 122.894 0.478 . . . . 0.0 111.892 -178.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 73.97 -52.33 0.69 Allowed 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.715 0.806 . . . . 0.0 112.706 177.035 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 60.16 69.77 1.14 Allowed Pre-proline 0 N--CA 1.473 0.697 0 CA-C-O 121.122 0.487 . . . . 0.0 111.983 -179.265 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_exo -71.72 90.35 0.72 Allowed 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 122.711 2.274 . . . . 0.0 112.688 -179.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -64.6 144.32 57.29 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 121.351 0.596 . . . . 0.0 111.956 178.346 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 67.9 p -90.38 142.99 27.18 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.126 -179.028 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.419 ' HD3' ' CD1' ' A' ' 50' ' ' TYR . 57.4 tttp -116.56 97.92 6.27 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 176.282 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.545 HG23 ' HB2' ' A' ' 53' ' ' LYS . 2.0 mp -77.03 124.0 34.63 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-O 121.153 0.502 . . . . 0.0 112.266 -172.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 30.2 m -136.35 162.4 35.7 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.003 177.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -102.17 -16.41 16.37 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 111.76 0.282 . . . . 0.0 111.76 176.569 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -106.81 142.31 36.64 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 121.125 0.488 . . . . 0.0 111.3 177.28 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 74.6 m -76.17 -6.47 51.44 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 -173.126 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 90.2 mtt180 -111.61 120.13 41.05 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 121.61 -0.681 . . . . 0.0 112.081 177.085 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 37.4 t -134.71 140.95 44.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.996 179.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -93.89 127.92 39.9 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 116.729 -0.214 . . . . 0.0 111.142 178.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.568 ' SG ' ' HB2' ' A' ' 47' ' ' ASP . 41.4 t -63.7 98.7 0.19 Allowed 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 120.873 0.368 . . . . 0.0 110.926 177.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -69.64 -52.4 26.17 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 -174.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -159.96 -145.38 4.25 Favored Glycine 0 C--O 1.223 -0.56 0 C-N-CA 119.851 -1.166 . . . . 0.0 114.998 -172.095 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 89.73 -5.03 83.77 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 121.377 -0.439 . . . . 0.0 113.19 -176.18 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.645 ' HB2' ' NE2' ' A' ' 27' ' ' HIS . 10.1 tp10 -95.39 122.36 38.02 Favored 'General case' 0 N--CA 1.469 0.485 0 O-C-N 122.457 -0.437 . . . . 0.0 110.982 -179.187 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 39.69 -90.86 0.01 OUTLIER Glycine 0 CA--C 1.531 1.078 0 O-C-N 123.379 0.424 . . . . 0.0 113.839 -178.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -80.84 31.23 0.31 Allowed 'General case' 0 CA--C 1.544 0.726 0 O-C-N 122.605 -0.35 . . . . 0.0 111.191 174.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.8 pp 48.81 39.55 14.32 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 124.675 1.19 . . . . 0.0 113.638 -179.377 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.431 ' O ' ' HB3' ' A' ' 22' ' ' GLU . . . -132.52 152.59 20.3 Favored Glycine 0 CA--C 1.534 1.261 0 C-N-CA 120.859 -0.686 . . . . 0.0 114.264 178.755 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.645 ' NE2' ' HB2' ' A' ' 22' ' ' GLU . 24.2 m80 -139.06 155.13 72.89 Favored Pre-proline 0 N--CA 1.479 0.977 0 C-N-CA 122.894 0.478 . . . . 0.0 110.988 174.055 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -69.1 -72.8 0.02 OUTLIER 'Trans proline' 0 CA--C 1.545 1.044 0 C-N-CA 122.605 2.203 . . . . 0.0 114.411 -179.431 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 3.8 tmt_? -179.08 94.64 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.156 0 CA-C-O 121.85 0.833 . . . . 0.0 110.584 -174.005 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.459 HG23 ' HB3' ' A' ' 18' ' ' CYS . 14.5 m -136.7 120.03 22.28 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.257 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.838 173.004 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 48.1 m95 -99.43 112.61 24.77 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.356 -178.527 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.438 ' N ' HD12 ' A' ' 32' ' ' LEU . 6.1 mp -90.26 132.1 35.71 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 121.118 0.485 . . . . 0.0 111.61 -179.392 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 27.3 tp60 -93.68 106.74 18.69 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.858 176.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.563 HG12 HG12 ' A' ' 41' ' ' VAL . 97.8 mt -60.73 125.35 82.68 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.026 176.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.567 ' HG2' ' OG1' ' A' ' 38' ' ' THR . 84.5 Cg_endo -76.96 105.34 2.06 Favored 'Trans proline' 0 CA--C 1.535 0.566 0 C-N-CA 122.261 1.974 . . . . 0.0 111.753 177.533 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -57.93 -19.13 27.81 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 121.299 0.571 . . . . 0.0 110.366 178.205 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -54.66 -43.53 72.47 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.503 172.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.567 ' OG1' ' HG2' ' A' ' 35' ' ' PRO . 44.1 p -97.49 -57.73 2.18 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.722 177.536 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 120.55 0.99 12.29 Favored Glycine 0 CA--C 1.529 0.926 0 CA-C-N 115.849 -0.614 . . . . 0.0 112.627 -177.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 63.9 p-90 -162.12 160.62 27.5 Favored 'General case' 0 N--CA 1.471 0.607 0 O-C-N 122.709 -0.289 . . . . 0.0 111.396 -176.248 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.563 HG12 HG12 ' A' ' 34' ' ' ILE . 11.6 p -148.4 129.91 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 CA-C-O 120.713 0.292 . . . . 0.0 110.807 173.75 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.416 ' HA ' ' HA ' ' A' ' 49' ' ' LYS . 9.6 pt-20 -90.89 140.02 30.21 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 120.913 0.387 . . . . 0.0 111.211 178.042 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 44.5 t -70.35 126.37 92.3 Favored Pre-proline 0 N--CA 1.47 0.569 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.774 -176.596 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.32 -26.16 29.92 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 122.785 2.323 . . . . 0.0 112.971 -179.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -78.36 -92.92 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 121.123 0.487 . . . . 0.0 111.016 177.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 48.0 t -172.41 81.38 0.05 Allowed 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.039 0.447 . . . . 0.0 110.305 -179.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.568 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 13.3 t70 -136.8 -95.72 0.22 Allowed 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.393 -178.06 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 90.7 m -153.62 -170.34 3.56 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 120.92 0.39 . . . . 0.0 110.674 177.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.416 ' HA ' ' HA ' ' A' ' 42' ' ' GLU . 34.8 ttpt -111.62 115.6 29.4 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 120.899 0.381 . . . . 0.0 110.632 175.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.419 ' CD1' ' HD3' ' A' ' 9' ' ' LYS . 43.4 m-85 -82.69 114.92 21.38 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.18 -171.218 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 80.9 t -109.38 123.74 65.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-O 121.314 0.578 . . . . 0.0 111.843 -176.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 46.0 tp -81.0 107.95 14.26 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.733 178.405 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.545 ' HB2' HG23 ' A' ' 10' ' ' ILE . 28.6 ttpp -65.15 147.45 53.45 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 120.907 0.384 . . . . 0.0 111.293 -179.593 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 85.95 7.89 80.07 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.446 -174.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 14.8 t -109.78 173.71 6.2 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 120.913 0.387 . . . . 0.0 111.499 179.143 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 23.5 pttm -62.81 -18.1 62.24 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-O 120.818 0.342 . . . . 0.0 111.241 175.542 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -74.0 -24.53 59.6 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.377 0.608 . . . . 0.0 110.804 174.296 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -95.56 -21.44 18.27 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.436 175.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.555 ' O ' ' HB2' ' A' ' 62' ' ' HIS . . . 71.08 102.59 0.06 Allowed 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.708 -176.503 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 83.8 mt -46.77 149.6 0.82 Allowed 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 -175.189 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 25.3 mm-40 73.42 -82.5 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.852 -170.25 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . 0.555 ' HB2' ' O ' ' A' ' 59' ' ' ALA . 8.9 t-160 52.1 28.63 5.56 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-O 120.889 0.376 . . . . 0.0 111.84 175.771 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 47.5 t-80 62.79 26.01 15.38 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 122.986 0.514 . . . . 0.0 112.235 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 33.7 m-70 -74.67 -3.92 34.19 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 121.922 -0.486 . . . . 0.0 111.665 177.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 57.3 t-80 -68.08 112.1 4.85 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 121.036 0.446 . . . . 0.0 111.575 178.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 78.9 m80 -85.19 165.69 17.18 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.436 179.239 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 53.6 t-80 . . . . . 0 C--O 1.252 1.218 0 CA-C-O 118.934 -0.555 . . . . 0.0 111.722 -175.419 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.446 ' SD ' ' C ' ' A' ' 1' ' ' MET . 0.9 OUTLIER . . . . . 0 N--CA 1.487 1.414 0 CA-C-O 120.696 0.284 . . . . 0.0 111.05 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 66.8 p -128.77 148.24 50.84 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 120.957 0.408 . . . . 0.0 111.249 176.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 62.1 mt -75.47 -23.2 16.69 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-O 121.045 0.45 . . . . 0.0 110.625 174.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 64.12 -86.1 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.262 -178.385 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 46.63 79.28 0.35 Allowed Pre-proline 0 CA--C 1.544 0.737 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 177.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.499 ' HD2' ' HD2' ' A' ' 49' ' ' LYS . 22.8 Cg_exo -64.92 76.72 0.21 Allowed 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 122.584 2.189 . . . . 0.0 112.481 176.574 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 55.66 103.27 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.255 0.622 . . . . 0.0 111.246 -175.069 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 87.4 m -100.02 124.57 45.53 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -172.526 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 44.7 mttp -122.59 109.03 13.8 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.877 177.299 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.57 HG22 ' HB2' ' A' ' 53' ' ' LYS . 15.7 mt -82.99 79.87 1.44 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-O 121.191 0.52 . . . . 0.0 109.706 177.477 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.443 HG12 ' H ' ' A' ' 13' ' ' LYS . 4.7 t -92.45 148.69 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 CA-C-O 121.036 0.445 . . . . 0.0 111.571 -172.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -78.55 -20.76 49.91 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 120.847 0.356 . . . . 0.0 111.343 -175.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.443 ' H ' HG12 ' A' ' 11' ' ' VAL . 7.0 ptpp? -108.92 148.62 30.4 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 120.895 0.379 . . . . 0.0 111.522 177.462 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.441 ' HA ' HD12 ' A' ' 34' ' ' ILE . 67.4 p -82.36 -44.01 16.7 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 112.894 0.701 . . . . 0.0 112.894 -177.198 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 49.2 mtt180 -78.59 90.54 4.54 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 121.417 0.627 . . . . 0.0 111.627 -176.052 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 47.8 t -110.53 120.65 61.83 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.29 -179.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -96.11 158.27 15.52 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 121.016 0.436 . . . . 0.0 111.867 179.41 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 51.4 t -149.42 140.9 23.33 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 120.946 0.403 . . . . 0.0 111.401 178.247 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -94.44 -59.58 1.91 Allowed 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.09 174.321 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 162.64 -146.44 11.86 Favored Glycine 0 CA--C 1.524 0.62 0 C-N-CA 120.858 -0.687 . . . . 0.0 113.216 177.355 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -133.82 -90.26 0.39 Allowed Glycine 0 CA--C 1.525 0.669 0 C-N-CA 121.429 -0.415 . . . . 0.0 112.782 -179.125 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -71.36 156.56 39.36 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 122.564 -0.374 . . . . 0.0 111.032 177.238 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -44.47 -46.27 8.61 Favored Glycine 0 CA--C 1.532 1.108 0 N-CA-C 113.671 0.229 . . . . 0.0 113.671 178.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -74.29 -24.09 59.19 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 178.362 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 83.7 mt -93.43 17.38 11.53 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 120.908 0.385 . . . . 0.0 111.777 -177.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -78.07 104.42 2.01 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 121.15 -0.547 . . . . 0.0 112.895 178.341 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.408 ' HA ' ' HD3' ' A' ' 28' ' ' PRO . 25.7 m170 -78.39 148.66 74.33 Favored Pre-proline 0 CA--C 1.542 0.662 0 O-C-N 122.63 -0.335 . . . . 0.0 110.533 178.16 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 27' ' ' HIS . 12.2 Cg_exo -72.08 49.34 1.3 Allowed 'Trans proline' 0 CA--C 1.549 1.27 0 C-N-CA 123.091 2.527 . . . . 0.0 114.112 -177.591 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.406 ' HA ' ' HD3' ' A' ' 29' ' ' ARG . 3.4 tpp180 64.13 90.72 0.08 Allowed 'General case' 0 N--CA 1.441 -0.896 0 CA-C-O 121.879 0.847 . . . . 0.0 112.19 176.514 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 31.4 m -98.35 124.75 51.64 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 CA-C-N 114.6 -1.182 . . . . 0.0 111.563 178.382 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 50.4 m95 -104.68 112.82 26.05 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 120.898 0.38 . . . . 0.0 111.302 178.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.443 ' N ' HD12 ' A' ' 32' ' ' LEU . 5.8 mp -98.87 127.99 44.94 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 121.254 0.549 . . . . 0.0 112.083 -177.399 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 22.8 tp60 -104.11 108.42 19.77 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.738 176.186 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.581 HG21 ' HB2' ' A' ' 52' ' ' LEU . 80.0 mt -67.61 121.36 78.86 Favored Pre-proline 0 CA--C 1.538 0.482 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.846 176.415 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.676 ' HG2' HG22 ' A' ' 38' ' ' THR . 72.8 Cg_endo -76.8 103.67 1.79 Allowed 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 122.147 1.898 . . . . 0.0 112.116 178.329 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -48.81 -26.67 2.52 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.068 0.547 . . . . 0.0 112.186 179.017 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -51.19 -46.19 62.07 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-N 116.144 -0.48 . . . . 0.0 112.049 175.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.676 HG22 ' HG2' ' A' ' 35' ' ' PRO . 14.9 t -104.7 -32.92 8.66 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 111.871 0.323 . . . . 0.0 111.871 -179.562 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 103.98 2.67 45.61 Favored Glycine 0 CA--C 1.533 1.217 0 N-CA-C 114.92 0.728 . . . . 0.0 114.92 174.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.492 ' H ' HG23 ' A' ' 38' ' ' THR . 58.2 p-90 -156.52 163.45 39.38 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 117.942 0.871 . . . . 0.0 112.09 -175.423 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.575 HG12 HG12 ' A' ' 34' ' ' ILE . 6.3 p -150.21 165.88 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 N-CA-C 109.873 -0.418 . . . . 0.0 109.873 174.645 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -142.6 150.82 40.82 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.256 0.551 . . . . 0.0 111.648 176.139 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.634 ' SG ' ' N ' ' A' ' 47' ' ' ASP . 28.6 p -69.99 141.37 89.33 Favored Pre-proline 0 N--CA 1.468 0.468 0 CA-C-N 115.692 -0.686 . . . . 0.0 112.663 -172.747 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 43' ' ' CYS . 18.3 Cg_exo -67.55 -27.88 38.72 Favored 'Trans proline' 0 CA--C 1.542 0.894 0 C-N-CA 122.708 2.272 . . . . 0.0 113.25 177.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -94.51 -83.62 0.34 Allowed 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 -178.688 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 49.5 t -168.14 18.47 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.953 0 CA-C-O 120.797 0.332 . . . . 0.0 111.874 -177.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.634 ' N ' ' SG ' ' A' ' 43' ' ' CYS . 2.1 m-20 -66.6 -79.17 0.05 OUTLIER 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 116.292 -0.413 . . . . 0.0 112.075 -174.431 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.435 ' SG ' ' O ' ' A' ' 47' ' ' ASP . 72.0 m -161.62 171.25 18.31 Favored 'General case' 0 N--CA 1.479 1.011 0 CA-C-O 121.516 0.674 . . . . 0.0 112.607 -177.743 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.499 ' HD2' ' HD2' ' A' ' 6' ' ' PRO . 36.1 tttp -110.65 120.29 41.94 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.692 174.416 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -108.67 115.34 29.92 Favored 'General case' 0 N--CA 1.469 0.502 0 O-C-N 121.871 -0.518 . . . . 0.0 112.23 -170.167 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 94.9 t -96.42 137.9 23.07 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.09 176.26 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.581 ' HB2' HG21 ' A' ' 34' ' ' ILE . 36.7 tp -84.35 104.77 14.65 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 121.514 0.673 . . . . 0.0 111.92 -178.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.57 ' HB2' HG22 ' A' ' 10' ' ' ILE . 47.3 tttm -62.2 128.19 34.95 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.75 178.657 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 93.33 -5.48 74.66 Favored Glycine 0 CA--C 1.529 0.943 0 CA-C-N 116.034 -0.53 . . . . 0.0 113.409 -177.348 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 44.7 t -95.46 -175.61 3.52 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 122.468 -0.431 . . . . 0.0 111.441 178.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 15.3 ptmm? -62.27 -19.97 63.79 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 120.872 0.368 . . . . 0.0 111.489 178.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -82.31 -10.79 58.97 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 112.027 0.38 . . . . 0.0 112.027 177.302 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -73.56 75.48 1.47 Allowed 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 121.674 0.749 . . . . 0.0 110.376 177.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -139.64 13.41 2.52 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.593 -179.232 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.443 HD22 ' N ' ' A' ' 60' ' ' LEU . 2.8 mm? -76.71 70.14 3.17 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.447 0.642 . . . . 0.0 110.608 178.599 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -141.79 86.27 1.98 Allowed 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.136 -178.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 40.2 p-80 -78.01 -13.88 59.72 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.049 0.452 . . . . 0.0 110.61 178.599 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 40.1 t-80 -171.19 -45.8 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.426 177.293 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 40.4 m-70 -106.92 124.65 49.93 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.36 176.282 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 5.1 t-160 -99.22 114.59 27.47 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 175.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 22.2 p80 -154.11 178.72 9.66 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 120.974 0.416 . . . . 0.0 112.113 -176.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 41.9 t60 . . . . . 0 C--O 1.249 1.077 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.822 170.934 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.3 mtt . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 120.887 0.375 . . . . 0.0 111.508 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 72.8 p -84.74 131.09 34.6 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 120.978 0.418 . . . . 0.0 111.678 179.583 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 33.6 pt -74.64 -17.94 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-O 120.699 0.285 . . . . 0.0 111.33 177.368 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 69.4 mt-30 68.69 141.59 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.377 0.671 . . . . 0.0 112.157 -179.612 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 61.61 73.91 0.54 Allowed Pre-proline 0 CA--C 1.544 0.719 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 176.383 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -77.81 65.73 8.19 Favored 'Trans proline' 0 CA--C 1.545 1.034 0 C-N-CA 122.514 2.143 . . . . 0.0 112.541 177.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -66.85 155.14 39.11 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.559 -179.23 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 69.1 m -125.03 142.02 51.75 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 122.447 0.299 . . . . 0.0 111.388 -178.266 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 25.1 mtmm -137.01 126.91 25.76 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 120.932 0.396 . . . . 0.0 111.25 177.068 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.525 ' N ' HD12 ' A' ' 10' ' ' ILE . 2.6 mp -92.67 110.78 23.46 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.494 178.578 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 33.7 m -104.35 164.31 3.78 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-O 121.228 0.537 . . . . 0.0 111.802 -177.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -96.38 -23.62 16.54 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 116.16 -0.473 . . . . 0.0 112.066 -177.218 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -120.27 151.17 39.56 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-O 120.941 0.4 . . . . 0.0 111.475 -177.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 19.9 m -68.97 -26.63 65.14 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 113.607 0.966 . . . . 0.0 113.607 -171.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 4.5 tpt180 -101.77 119.89 39.5 Favored 'General case' 0 N--CA 1.473 0.688 0 O-C-N 121.494 -0.754 . . . . 0.0 111.605 -178.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 41.0 t -129.69 141.89 45.31 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 CA-C-O 120.813 0.339 . . . . 0.0 111.322 -178.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -92.39 116.1 28.68 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.875 0.369 . . . . 0.0 111.356 177.548 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.506 ' HB3' HG23 ' A' ' 30' ' ' VAL . 40.1 t -80.26 91.45 5.62 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.282 179.411 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -69.7 -76.48 0.1 Allowed 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.55 -176.317 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 161.55 -157.71 29.42 Favored Glycine 0 CA--C 1.526 0.721 0 C-N-CA 120.058 -1.068 . . . . 0.0 114.164 179.018 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -104.0 -74.08 0.97 Allowed Glycine 0 CA--C 1.524 0.651 0 CA-C-O 121.097 0.276 . . . . 0.0 112.794 -179.697 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.465 ' H ' ' HB2' ' A' ' 25' ' ' LEU . 68.6 mm-40 -103.97 165.74 10.85 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 122.506 0.322 . . . . 0.0 111.006 176.184 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -44.09 -56.87 5.09 Favored Glycine 0 CA--C 1.53 1.002 0 N-CA-C 114.096 0.398 . . . . 0.0 114.096 179.048 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.75 -15.56 62.18 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 120.941 0.401 . . . . 0.0 112.037 -179.334 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.465 ' HB2' ' H ' ' A' ' 22' ' ' GLU . 90.1 mt -97.22 12.91 31.22 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.53 179.591 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -81.71 143.85 23.74 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 121.387 -0.435 . . . . 0.0 113.201 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 20.2 m80 -91.57 147.28 34.89 Favored Pre-proline 0 CA--C 1.539 0.533 0 O-C-N 122.655 -0.32 . . . . 0.0 111.108 -176.153 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -73.51 62.03 4.43 Favored 'Trans proline' 0 CA--C 1.545 1.026 0 C-N-CA 122.709 2.273 . . . . 0.0 113.639 -178.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.424 ' HA ' ' HD3' ' A' ' 29' ' ' ARG . 12.3 tpp180 58.6 88.07 0.07 Allowed 'General case' 0 N--CA 1.439 -0.993 0 CA-C-O 122.236 1.017 . . . . 0.0 112.733 176.063 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.506 HG23 ' HB3' ' A' ' 18' ' ' CYS . 17.4 m -119.08 116.38 50.81 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 CA-C-N 114.294 -1.321 . . . . 0.0 111.242 176.151 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 89.0 m95 -96.65 109.63 22.22 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.531 -178.633 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.7 mp -90.13 154.89 19.43 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 121.149 0.5 . . . . 0.0 111.276 177.219 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.487 ' HA ' HE21 ' A' ' 33' ' ' GLN . 0.0 OUTLIER -122.73 129.13 51.41 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.002 0.429 . . . . 0.0 111.368 178.754 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.586 HG12 HG12 ' A' ' 41' ' ' VAL . 55.0 mt -87.09 117.73 69.02 Favored Pre-proline 0 CA--C 1.537 0.447 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.146 177.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.509 ' HG2' ' OG1' ' A' ' 38' ' ' THR . 82.5 Cg_endo -79.76 123.34 5.24 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 122.179 1.919 . . . . 0.0 111.832 177.707 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.503 ' O ' ' HB2' ' A' ' 56' ' ' LYS . 13.0 pt-20 -56.23 -23.79 38.07 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 111.923 0.342 . . . . 0.0 111.923 -177.355 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -66.93 -35.62 80.39 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 178.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.509 ' OG1' ' HG2' ' A' ' 35' ' ' PRO . 39.9 p -92.29 -50.89 5.43 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 120.924 0.392 . . . . 0.0 110.775 178.723 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.511 ' HA2' ' OG ' ' A' ' 55' ' ' SER . . . 103.98 -0.03 44.91 Favored Glycine 0 CA--C 1.524 0.596 0 CA-C-N 116.073 -0.512 . . . . 0.0 112.841 -178.761 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.412 ' HA ' ' O ' ' A' ' 50' ' ' TYR . 67.7 p-90 -162.14 162.54 28.54 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 120.716 0.293 . . . . 0.0 111.327 -175.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.586 HG12 HG12 ' A' ' 34' ' ' ILE . 9.7 p -142.27 141.74 28.13 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-O 121.033 0.444 . . . . 0.0 110.73 173.479 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.47 ' O ' ' HD3' ' A' ' 44' ' ' PRO . 9.0 pt-20 -100.74 141.27 33.85 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 111.849 0.314 . . . . 0.0 111.849 -177.474 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.542 ' SG ' ' HB3' ' A' ' 47' ' ' ASP . 29.9 p -98.4 99.91 8.21 Favored Pre-proline 0 CA--C 1.54 0.56 0 CA-C-O 120.64 0.257 . . . . 0.0 110.419 170.449 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.47 ' HD3' ' O ' ' A' ' 42' ' ' GLU . 23.2 Cg_exo -65.77 -3.92 8.96 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 122.735 2.29 . . . . 0.0 113.13 -178.328 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -82.83 -76.15 0.28 Allowed 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 116.592 -0.276 . . . . 0.0 110.589 179.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 24.8 p 173.86 92.33 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.358 177.205 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.542 ' HB3' ' SG ' ' A' ' 43' ' ' CYS . 13.5 t70 -161.02 -83.03 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 116.717 -0.219 . . . . 0.0 110.969 173.538 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.502 ' N ' ' SG ' ' A' ' 43' ' ' CYS . 81.9 m -160.76 178.27 9.61 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 122.144 0.973 . . . . 0.0 113.135 -177.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 19.3 ttmm -102.48 113.58 27.05 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 114.484 -1.235 . . . . 0.0 108.754 168.384 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.419 ' HB2' HG12 ' A' ' 41' ' ' VAL . 67.7 m-85 -85.85 105.71 16.55 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 111.847 0.314 . . . . 0.0 111.847 -173.569 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 67.0 t -88.22 133.05 31.73 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 CA-C-O 120.767 0.317 . . . . 0.0 111.038 174.328 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.504 ' HB2' HG21 ' A' ' 34' ' ' ILE . 53.2 tp -98.77 131.75 44.66 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 121.359 0.6 . . . . 0.0 112.42 -175.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -68.05 141.25 56.23 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 115.811 -0.632 . . . . 0.0 111.144 176.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 70.8 10.64 68.06 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 121.271 -0.49 . . . . 0.0 113.68 179.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.511 ' OG ' ' HA2' ' A' ' 39' ' ' GLY . 29.4 t -97.57 -171.08 2.11 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 122.495 -0.415 . . . . 0.0 111.535 -179.356 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.503 ' HB2' ' O ' ' A' ' 36' ' ' GLU . 47.3 tptt -53.32 -43.97 68.05 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 120.944 0.402 . . . . 0.0 111.928 -177.744 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -82.26 2.39 32.17 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -175.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -77.02 -36.55 56.17 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 120.924 0.392 . . . . 0.0 111.659 -178.377 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -80.35 50.35 1.26 Allowed 'General case' 0 CA--C 1.543 0.676 0 CA-C-O 121.031 0.443 . . . . 0.0 112.021 -178.53 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.424 ' O ' HD12 ' A' ' 60' ' ' LEU . 2.7 pp -76.98 155.58 32.55 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.936 179.604 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 53.77 34.7 19.68 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-O 121.083 0.468 . . . . 0.0 112.235 178.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 45.8 t60 -76.95 11.83 1.61 Allowed 'General case' 0 CA--C 1.547 0.852 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.579 -178.468 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 15.0 t-80 66.04 18.38 11.01 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 122.696 0.398 . . . . 0.0 111.786 176.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 33.4 t60 -98.31 123.97 42.7 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 120.658 0.266 . . . . 0.0 111.024 -179.183 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 23.2 m170 -78.82 171.92 14.49 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 121.676 0.751 . . . . 0.0 112.44 179.696 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 29.6 p80 -147.86 19.0 1.14 Allowed 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.738 177.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 25.2 t60 . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.666 -0.683 . . . . 0.0 110.699 -177.605 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.3 mmt . . . . . 0 N--CA 1.489 1.503 0 CA-C-O 120.845 0.355 . . . . 0.0 111.329 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 21.4 p -72.55 161.45 30.77 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 121.028 0.442 . . . . 0.0 111.942 177.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 45.7 mt -72.15 -8.83 12.11 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 CA-C-O 121.479 0.657 . . . . 0.0 110.714 177.148 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 70.61 10.07 7.03 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 115.357 -0.838 . . . . 0.0 112.853 176.173 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -127.81 74.47 78.53 Favored Pre-proline 0 N--CA 1.47 0.558 0 CA-C-O 121.018 0.437 . . . . 0.0 111.621 178.089 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -96.22 94.67 0.09 OUTLIER 'Trans proline' 0 CA--C 1.542 0.923 0 C-N-CA 123.377 2.718 . . . . 0.0 113.009 177.784 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.44 6.02 25.03 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 121.506 0.669 . . . . 0.0 111.854 177.737 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 54.2 m -89.86 111.37 22.39 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.602 177.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 46.8 tptt -100.54 109.3 21.39 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.04 -172.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 58.3 mt -79.04 94.22 1.73 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 CA-C-O 121.141 0.496 . . . . 0.0 110.602 179.462 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.51 HG12 ' H ' ' A' ' 13' ' ' LYS . 3.5 t -97.89 156.84 3.55 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 CA-C-O 121.127 0.489 . . . . 0.0 111.62 -175.763 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -96.43 -4.31 41.96 Favored 'General case' 0 CA--C 1.548 0.873 0 CA-C-O 121.01 0.433 . . . . 0.0 111.909 -178.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.51 ' H ' HG12 ' A' ' 11' ' ' VAL . 50.9 mtmt -137.35 153.08 50.29 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 122.101 -0.374 . . . . 0.0 111.42 -176.753 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 77.7 p -79.06 -40.15 32.01 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.063 0.459 . . . . 0.0 111.265 177.438 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 78.2 mtm180 -75.35 94.82 3.1 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.96 176.294 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.495 HG11 ' CD1' ' A' ' 50' ' ' TYR . 47.4 t -111.35 137.86 42.17 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.34 -177.627 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -97.96 118.46 34.59 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 121.069 0.461 . . . . 0.0 111.755 -179.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 10.0 t -66.78 124.92 24.26 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.061 174.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -98.7 -73.49 0.62 Allowed 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 120.875 0.369 . . . . 0.0 110.989 178.487 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.455 ' HA3' ' HA2' ' A' ' 26' ' ' GLY . . . 160.08 -178.25 36.22 Favored Glycine 0 CA--C 1.525 0.665 0 C-N-CA 120.693 -0.765 . . . . 0.0 113.103 177.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -91.02 -93.33 1.29 Allowed Glycine 0 CA--C 1.525 0.715 0 N-CA-C 111.364 -0.695 . . . . 0.0 111.364 172.17 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -87.58 166.28 14.84 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 168.723 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -45.41 -50.63 10.1 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 120.975 -0.631 . . . . 0.0 112.927 172.41 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.42 -15.29 60.32 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 178.357 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 93.6 mt -111.51 18.95 18.64 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.053 0.454 . . . . 0.0 110.488 176.438 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.455 ' HA2' ' HA3' ' A' ' 20' ' ' GLY . . . -75.95 122.89 6.75 Favored Glycine 0 CA--C 1.526 0.736 0 CA-C-N 115.956 -0.566 . . . . 0.0 113.52 -177.073 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 27.6 m80 -92.42 120.9 67.26 Favored Pre-proline 0 CA--C 1.543 0.679 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 178.143 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -74.05 53.55 2.94 Favored 'Trans proline' 0 CA--C 1.546 1.09 0 C-N-CA 122.975 2.45 . . . . 0.0 115.116 -168.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.425 ' NE ' ' HE1' ' A' ' 31' ' ' TRP . 0.8 OUTLIER 75.16 99.13 0.07 Allowed 'General case' 0 N--CA 1.446 -0.655 0 CA-C-O 122.769 1.271 . . . . 0.0 111.779 169.726 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 25.7 m -134.32 141.09 44.55 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 113.855 -1.521 . . . . 0.0 109.774 169.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.425 ' HE1' ' NE ' ' A' ' 29' ' ' ARG . 75.7 m95 -107.25 123.55 48.46 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -171.433 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.487 ' N ' HD12 ' A' ' 32' ' ' LEU . 5.1 mp -103.44 158.65 16.2 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.615 178.052 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -123.77 109.53 13.78 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.935 0.398 . . . . 0.0 111.436 -179.002 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.501 HG12 HG12 ' A' ' 41' ' ' VAL . 64.6 mt -70.47 115.06 31.17 Favored Pre-proline 0 CA--C 1.542 0.656 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.47 178.439 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.432 ' HG2' ' OG1' ' A' ' 38' ' ' THR . 90.4 Cg_endo -80.11 145.47 17.38 Favored 'Trans proline' 0 CA--C 1.54 0.825 0 C-N-CA 122.517 2.145 . . . . 0.0 112.753 179.573 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.402 ' H ' ' CD ' ' A' ' 36' ' ' GLU . 20.9 mp0 -62.95 -29.51 70.86 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 121.105 0.479 . . . . 0.0 111.035 179.437 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -58.43 -50.28 74.25 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.497 -0.774 . . . . 0.0 112.155 -178.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.432 ' OG1' ' HG2' ' A' ' 35' ' ' PRO . 50.2 p -90.34 -49.16 6.69 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.077 0.465 . . . . 0.0 111.324 -178.267 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 98.24 0.95 58.22 Favored Glycine 0 CA--C 1.523 0.562 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.399 -176.292 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.557 ' HB3' HG22 ' A' ' 51' ' ' VAL . 68.2 p-90 -156.79 164.13 38.44 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 121.148 0.499 . . . . 0.0 112.151 -176.605 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.501 HG12 HG12 ' A' ' 34' ' ' ILE . 14.5 p -142.85 137.09 27.15 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.676 174.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -98.83 148.03 24.33 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.155 0.502 . . . . 0.0 112.139 -177.319 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.662 ' SG ' ' HE2' ' A' ' 50' ' ' TYR . 74.0 m -98.25 119.31 62.11 Favored Pre-proline 0 CA--C 1.538 0.519 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.578 171.256 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -73.13 22.44 0.32 Allowed 'Trans proline' 0 CA--C 1.541 0.861 0 C-N-CA 122.902 2.402 . . . . 0.0 114.036 -173.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -114.94 -88.7 0.57 Allowed 'General case' 0 CA--C 1.538 0.517 0 O-C-N 122.084 -0.385 . . . . 0.0 111.073 177.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 57.5 m -160.57 18.98 0.14 Allowed 'General case' 0 N--CA 1.477 0.913 0 CA-C-O 120.856 0.36 . . . . 0.0 111.331 -177.161 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.41 ' O ' ' SG ' ' A' ' 48' ' ' CYS . 2.1 m-20 -81.74 -93.5 0.05 Allowed 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 112.276 0.473 . . . . 0.0 112.276 -173.34 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.41 ' SG ' ' O ' ' A' ' 47' ' ' ASP . 72.3 m -161.38 173.33 15.09 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.553 0.692 . . . . 0.0 112.043 -176.539 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.7 ttmp? -101.47 104.77 15.71 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.269 169.041 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.662 ' HE2' ' SG ' ' A' ' 43' ' ' CYS . 95.4 m-85 -81.85 103.16 11.32 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.926 0.393 . . . . 0.0 111.767 -173.745 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.557 HG22 ' HB3' ' A' ' 40' ' ' TRP . 88.0 t -94.28 123.19 46.29 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.928 178.712 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 51.4 tp -77.88 120.41 22.72 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 116.585 -0.28 . . . . 0.0 110.978 176.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 46.8 tttp -65.71 146.06 55.25 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 121.149 0.5 . . . . 0.0 111.954 -178.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 85.11 17.45 62.86 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 121.117 -0.563 . . . . 0.0 112.549 -175.452 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.5 m -118.36 172.14 7.66 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 122.481 0.312 . . . . 0.0 110.886 -179.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -56.31 -30.08 62.09 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -178.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -75.96 -26.91 57.27 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 121.006 0.431 . . . . 0.0 112.111 179.079 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -77.69 72.48 4.23 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-O 121.549 0.69 . . . . 0.0 110.571 179.366 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -153.69 -17.86 0.14 Allowed 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -179.352 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.403 ' N ' HD12 ' A' ' 60' ' ' LEU . 7.0 mp -60.64 -73.72 0.09 Allowed 'General case' 0 CA--C 1.54 0.585 0 O-C-N 122.084 -0.385 . . . . 0.0 111.925 -178.285 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -96.42 116.35 28.91 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 120.806 0.336 . . . . 0.0 111.163 -178.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 1.7 p80 -167.95 134.25 2.03 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 120.901 0.381 . . . . 0.0 111.5 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 2.5 p-80 -138.63 -179.61 5.92 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.993 175.356 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 32.5 m170 -50.39 108.66 0.24 Allowed 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.218 0.532 . . . . 0.0 112.346 -175.361 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 37.5 m80 63.71 -88.88 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.965 177.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 85.7 m-70 -148.73 -35.14 0.2 Allowed 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 112.902 0.704 . . . . 0.0 112.902 -178.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 31.2 m170 . . . . . 0 C--O 1.251 1.169 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 -176.076 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.1 ptp . . . . . 0 N--CA 1.489 1.517 0 CA-C-O 121.02 0.438 . . . . 0.0 111.429 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 20.8 p -87.09 179.75 6.61 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.478 171.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 33.5 pt -68.81 -24.29 28.53 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-O 121.542 0.687 . . . . 0.0 109.738 169.461 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 22.5 mt-30 61.94 2.05 0.72 Allowed 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 114.938 -1.028 . . . . 0.0 113.66 174.246 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -59.47 106.6 0.76 Allowed Pre-proline 0 CA--C 1.542 0.66 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 -176.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -91.77 30.81 0.32 Allowed 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 123.259 2.64 . . . . 0.0 113.011 -179.537 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -94.17 25.38 3.8 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 121.227 0.537 . . . . 0.0 112.069 -176.486 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 69.5 m -89.18 119.65 29.86 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.292 174.141 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 55.9 tptt -109.82 106.91 16.69 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 120.656 0.265 . . . . 0.0 111.236 -173.473 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 56.2 mt -86.09 100.95 9.79 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-O 121.104 0.478 . . . . 0.0 111.351 -179.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 34.5 m -103.94 162.57 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 CA-C-O 120.951 0.405 . . . . 0.0 111.35 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -92.93 -32.46 14.55 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-O 120.887 0.375 . . . . 0.0 111.618 -178.317 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -108.16 143.31 37.11 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 120.729 0.299 . . . . 0.0 111.643 -179.277 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 41.2 t -63.01 -37.24 86.38 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 112.824 0.676 . . . . 0.0 112.824 -176.234 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 52.5 mtt85 -74.18 105.49 5.41 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.201 0.524 . . . . 0.0 111.892 178.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 48.0 t -100.95 106.17 18.97 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.966 176.592 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -80.82 101.03 9.12 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 120.936 0.398 . . . . 0.0 111.266 178.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 52.0 t -96.74 104.75 16.78 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -178.737 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -77.3 -58.86 3.04 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 121.534 0.683 . . . . 0.0 110.369 172.176 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 162.35 172.19 29.47 Favored Glycine 0 CA--C 1.523 0.573 0 C-N-CA 121.074 -0.584 . . . . 0.0 113.065 176.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -106.41 -80.74 1.35 Allowed Glycine 0 CA--C 1.524 0.618 0 N-CA-C 111.65 -0.58 . . . . 0.0 111.65 175.562 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 23.6 mm-40 -99.61 169.56 9.19 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 122.26 0.224 . . . . 0.0 110.397 172.129 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -44.51 -46.93 8.8 Favored Glycine 0 CA--C 1.535 1.317 0 N-CA-C 114.142 0.417 . . . . 0.0 114.142 178.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.21 -24.97 68.12 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -179.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 91.4 mt -106.49 16.4 24.71 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 120.689 0.28 . . . . 0.0 111.655 -179.442 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -85.07 138.24 16.42 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 120.978 -0.63 . . . . 0.0 113.044 179.447 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -154.58 152.62 26.34 Favored Pre-proline 0 N--CA 1.472 0.653 0 O-C-N 122.583 -0.363 . . . . 0.0 111.125 179.629 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_exo -38.88 -67.28 0.11 Allowed 'Trans proline' 0 C--N 1.354 0.846 0 C-N-CA 123.587 2.858 . . . . 0.0 114.587 -175.507 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.48 ' HD3' ' HA ' ' A' ' 29' ' ' ARG . 0.1 OUTLIER -177.78 91.57 0.03 OUTLIER 'General case' 0 N--CA 1.441 -0.89 0 CA-C-O 122.24 1.019 . . . . 0.0 110.665 -178.12 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 55.8 t -93.94 105.07 16.45 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 CA-C-N 114.134 -1.394 . . . . 0.0 111.17 -179.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 56.7 m95 -92.22 111.52 23.11 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.367 178.609 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.413 ' N ' HD12 ' A' ' 32' ' ' LEU . 5.6 mp -91.37 134.03 34.95 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 120.753 0.311 . . . . 0.0 111.003 177.612 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 14.6 tp60 -104.88 106.91 17.61 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 177.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.586 HG12 HG12 ' A' ' 41' ' ' VAL . 75.6 mt -63.46 117.42 34.16 Favored Pre-proline 0 CA--C 1.54 0.566 0 CA-C-O 120.602 0.239 . . . . 0.0 111.408 -179.702 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.555 ' HG2' ' OG1' ' A' ' 38' ' ' THR . 90.1 Cg_endo -80.1 127.78 7.01 Favored 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 122.611 2.207 . . . . 0.0 113.005 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -61.31 -21.94 64.44 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 120.981 0.42 . . . . 0.0 111.675 179.275 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -64.04 -35.12 79.68 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.884 178.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.555 ' OG1' ' HG2' ' A' ' 35' ' ' PRO . 36.0 p -106.04 -52.42 2.81 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-O 121.029 0.442 . . . . 0.0 111.605 -178.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 106.56 0.64 37.25 Favored Glycine 0 CA--C 1.526 0.762 0 CA-C-N 116.189 -0.46 . . . . 0.0 112.643 -176.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 67.7 p-90 -155.81 162.79 40.42 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 120.916 0.388 . . . . 0.0 111.595 -178.438 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.586 HG12 HG12 ' A' ' 34' ' ' ILE . 12.3 p -151.81 127.85 1.84 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.452 172.647 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.417 ' HA ' ' HA ' ' A' ' 49' ' ' LYS . 12.6 pt-20 -100.89 150.21 23.08 Favored 'General case' 0 CA--C 1.536 0.405 0 O-C-N 121.925 -0.485 . . . . 0.0 111.324 -179.357 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 42.6 t -97.16 107.41 37.94 Favored Pre-proline 0 N--CA 1.468 0.429 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.813 -177.417 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.412 ' HD3' ' O ' ' A' ' 42' ' ' GLU . 41.4 Cg_exo -58.55 -14.66 21.97 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 122.364 2.043 . . . . 0.0 113.035 177.467 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -105.03 -0.3 26.92 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.807 -178.386 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 42.5 t -143.9 -2.2 0.94 Allowed 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 112.416 0.525 . . . . 0.0 112.416 -179.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 61.7 m-20 70.95 -41.17 0.5 Allowed 'General case' 0 CA--C 1.548 0.876 0 N-CA-C 114.026 1.121 . . . . 0.0 114.026 178.125 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 77.3 m -58.69 145.68 39.2 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 -172.491 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.417 ' HA ' ' HA ' ' A' ' 42' ' ' GLU . 20.4 ttmm -107.46 123.25 48.13 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.989 -178.205 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 55.1 m-85 -100.53 114.61 28.39 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 -174.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.405 HG13 ' HB3' ' A' ' 57' ' ' ALA . 93.2 t -99.15 145.24 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 CA-C-O 120.819 0.342 . . . . 0.0 111.467 176.871 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.563 ' HB2' HG21 ' A' ' 34' ' ' ILE . 54.5 tp -94.1 126.09 39.12 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 120.907 0.384 . . . . 0.0 111.735 179.84 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.457 ' HB3' ' NZ ' ' A' ' 53' ' ' LYS . 0.9 OUTLIER -61.88 122.91 16.59 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.435 178.428 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 90.07 7.65 67.76 Favored Glycine 0 CA--C 1.524 0.649 0 C-N-CA 121.417 -0.421 . . . . 0.0 113.299 -178.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 34.6 t -100.72 -173.56 2.42 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 122.364 -0.492 . . . . 0.0 111.587 178.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 48.7 mmtm -54.31 -34.73 61.6 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 113.253 0.835 . . . . 0.0 113.253 -175.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.405 ' HB3' HG13 ' A' ' 51' ' ' VAL . . . -94.19 6.77 47.56 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -176.467 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -117.48 -136.31 0.35 Allowed 'General case' 0 CA--C 1.552 1.045 0 O-C-N 122.151 -0.343 . . . . 0.0 111.302 -178.301 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 64.31 17.15 10.59 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-O 121.15 0.5 . . . . 0.0 111.559 -173.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.6 pp -89.31 10.09 23.61 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 -177.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -65.78 90.51 0.12 Allowed 'General case' 0 CA--C 1.541 0.621 0 CA-C-O 121.281 0.562 . . . . 0.0 111.794 -178.574 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 71.7 m80 -97.66 -31.74 12.13 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.957 175.136 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 44.6 t60 -175.69 -35.06 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.93 174.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 33.8 m170 -63.98 92.58 0.08 Allowed 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 120.973 0.416 . . . . 0.0 110.912 175.373 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 8.1 t60 -172.09 -24.04 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.015 -178.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 11.9 p80 -150.92 149.88 30.17 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.345 179.293 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 60.8 t-80 . . . . . 0 C--O 1.249 1.076 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 176.829 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.9 ttt . . . . . 0 N--CA 1.489 1.522 0 CA-C-O 121.005 0.431 . . . . 0.0 110.697 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 5.2 m -108.14 -2.2 19.68 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -173.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.47 ' O ' HD12 ' A' ' 3' ' ' ILE . 2.1 pp 37.22 70.65 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-O 122.052 0.929 . . . . 0.0 111.833 -165.253 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -45.82 106.09 0.07 Allowed 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 114.697 -1.138 . . . . 0.0 112.033 -175.119 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.476 ' H ' ' HD2' ' A' ' 6' ' ' PRO . . . -165.72 -53.85 0.01 OUTLIER Pre-proline 0 CA--C 1.547 0.834 0 CA-C-N 116.017 -0.538 . . . . 0.0 112.222 -176.607 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.476 ' HD2' ' H ' ' A' ' 5' ' ' ALA . 68.9 Cg_endo -81.48 37.11 0.66 Allowed 'Trans proline' 0 C--N 1.358 1.073 0 C-N-CA 122.278 1.985 . . . . 0.0 113.085 -179.706 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -91.72 31.72 1.18 Allowed 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.073 0.463 . . . . 0.0 112.029 -174.265 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 86.1 m -122.14 135.6 54.81 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.671 176.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 57.6 mtpt -137.23 137.92 39.59 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 122.342 0.257 . . . . 0.0 111.116 -173.566 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 57.3 mt -97.45 107.34 19.89 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-O 120.966 0.412 . . . . 0.0 111.417 -179.031 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.44 HG12 ' H ' ' A' ' 13' ' ' LYS . 11.7 t -100.07 156.21 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.772 177.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -90.17 -7.8 52.75 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 -175.679 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.44 ' H ' HG12 ' A' ' 11' ' ' VAL . 16.5 ptpt -130.53 152.21 50.16 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 121.073 0.463 . . . . 0.0 111.892 -176.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 23.0 m -83.63 9.53 11.34 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -174.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 75.0 mtp180 -128.19 116.97 20.72 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 121.007 0.432 . . . . 0.0 111.759 -178.417 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 39.9 t -131.64 152.65 37.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.396 -178.619 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.472 ' HA ' ' O ' ' A' ' 30' ' ' VAL . . . -81.53 154.1 26.44 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-O 121.278 0.561 . . . . 0.0 112.404 -179.59 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.573 ' SG ' ' N ' ' A' ' 19' ' ' ASP . 43.1 t -136.53 -166.92 1.97 Allowed 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.773 -174.743 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.573 ' N ' ' SG ' ' A' ' 18' ' ' CYS . 15.7 t70 62.97 84.89 0.14 Allowed 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.586 0.754 . . . . 0.0 112.031 178.394 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.482 ' HA3' ' O ' ' A' ' 25' ' ' LEU . . . 160.05 160.45 10.56 Favored Glycine 0 CA--C 1.525 0.685 0 C-N-CA 121.336 -0.459 . . . . 0.0 112.217 177.609 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 167.43 35.86 0.02 OUTLIER Glycine 0 CA--C 1.531 1.045 0 C-N-CA 120.05 -1.071 . . . . 0.0 114.821 177.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -158.48 145.14 17.39 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 117.493 0.646 . . . . 0.0 110.989 174.328 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 41.04 -96.07 0.01 OUTLIER Glycine 0 CA--C 1.532 1.118 0 N-CA-C 114.293 0.477 . . . . 0.0 114.293 -174.006 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -78.45 2.26 19.48 Favored 'General case' 0 N--CA 1.473 0.675 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -178.244 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.482 ' O ' ' HA3' ' A' ' 20' ' ' GLY . 86.9 mt 64.85 13.78 8.76 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.393 0.677 . . . . 0.0 112.763 178.019 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 55.39 -118.13 9.84 Favored Glycine 0 CA--C 1.532 1.136 0 N-CA-C 113.979 0.352 . . . . 0.0 113.979 177.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 12.5 m-70 66.24 83.1 0.19 Allowed Pre-proline 0 N--CA 1.473 0.722 0 C-N-CA 123.523 0.729 . . . . 0.0 112.765 176.655 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.459 ' O ' ' HB2' ' A' ' 29' ' ' ARG . 57.3 Cg_endo -74.77 -62.36 0.04 OUTLIER 'Trans proline' 0 CA--C 1.542 0.888 0 C-N-CA 122.157 1.905 . . . . 0.0 111.594 172.412 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.459 ' HB2' ' O ' ' A' ' 28' ' ' PRO . 16.5 tpt180 176.84 83.89 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 122.01 0.909 . . . . 0.0 110.246 169.687 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.472 ' O ' ' HA ' ' A' ' 17' ' ' ALA . 61.2 t -128.11 132.24 68.65 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 CA-C-N 114.456 -1.247 . . . . 0.0 109.64 -178.595 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 84.2 m95 -115.58 136.15 53.36 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 -172.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.568 HD13 ' HB2' ' A' ' 18' ' ' CYS . 8.8 mp -113.53 144.53 42.69 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.633 172.138 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.474 ' HA ' HE21 ' A' ' 33' ' ' GLN . 0.0 OUTLIER -103.92 119.84 39.77 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.272 -179.258 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.661 HG12 HG12 ' A' ' 41' ' ' VAL . 50.7 mt -75.0 114.46 35.12 Favored Pre-proline 0 CA--C 1.54 0.566 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.956 177.432 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.565 ' HG2' ' OG1' ' A' ' 38' ' ' THR . 91.3 Cg_endo -77.92 132.34 11.71 Favored 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 122.475 2.117 . . . . 0.0 112.356 178.553 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -77.32 -7.72 56.49 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 120.836 0.351 . . . . 0.0 111.341 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -68.03 -56.01 10.48 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 121.028 0.442 . . . . 0.0 110.89 172.488 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.565 ' OG1' ' HG2' ' A' ' 35' ' ' PRO . 47.9 p -80.64 -43.26 20.75 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.157 177.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 103.07 -0.19 47.86 Favored Glycine 0 CA--C 1.524 0.617 0 CA-C-N 115.56 -0.745 . . . . 0.0 112.811 -178.279 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.542 ' HB3' HG22 ' A' ' 51' ' ' VAL . 65.9 p-90 -161.2 161.24 30.84 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 -176.288 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.661 HG12 HG12 ' A' ' 34' ' ' ILE . 9.8 p -146.76 133.39 13.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.231 169.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -111.39 140.45 45.97 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -174.604 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.528 ' HB3' ' SG ' ' A' ' 48' ' ' CYS . 43.8 t -74.41 112.87 19.1 Favored Pre-proline 0 CA--C 1.537 0.452 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.623 178.516 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -58.35 -14.39 20.07 Favored 'Trans proline' 0 CA--C 1.542 0.911 0 C-N-CA 122.695 2.263 . . . . 0.0 113.404 -178.645 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -87.18 -51.35 6.03 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.705 -177.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 52.4 t -103.27 -3.7 25.29 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -178.06 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 49.8 m-20 65.76 10.67 6.99 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.115 0.566 . . . . 0.0 112.373 179.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.528 ' SG ' ' HB3' ' A' ' 43' ' ' CYS . 6.4 p -73.85 116.85 14.94 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 121.145 0.498 . . . . 0.0 111.515 179.553 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 18.3 ttmm -91.88 113.12 25.3 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.79 -177.166 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -97.38 103.34 15.26 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 120.988 0.423 . . . . 0.0 111.921 -175.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.542 HG22 ' HB3' ' A' ' 40' ' ' TRP . 78.5 t -82.55 142.87 13.04 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.662 175.397 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.512 ' HB2' HG21 ' A' ' 34' ' ' ILE . 68.6 tp -89.41 124.93 34.91 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 120.91 0.386 . . . . 0.0 111.7 178.269 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 8.5 tmtm? -71.05 122.89 20.88 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 174.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 97.19 52.54 1.46 Allowed Glycine 0 CA--C 1.526 0.732 0 N-CA-C 111.749 -0.54 . . . . 0.0 111.749 -172.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.479 ' H ' ' HB3' ' A' ' 58' ' ' ASP . 51.6 p -155.31 -178.49 7.3 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.516 0.674 . . . . 0.0 111.75 -176.341 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 32.4 ttpt -67.68 -15.23 63.54 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-N 115.322 -0.854 . . . . 0.0 112.059 179.411 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -99.99 2.34 43.4 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 121.202 0.525 . . . . 0.0 111.667 176.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.479 ' HB3' ' H ' ' A' ' 55' ' ' SER . 16.4 t70 -119.17 176.24 5.41 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.73 -177.472 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 69.96 86.01 0.13 Allowed 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.472 0.653 . . . . 0.0 110.986 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.487 ' N ' HD12 ' A' ' 60' ' ' LEU . 5.3 mp -87.15 82.51 7.66 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.499 -174.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -62.38 -8.82 6.62 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-O 121.271 0.557 . . . . 0.0 111.836 179.199 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 30.5 p-80 -100.99 22.92 11.46 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.237 178.42 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 66.1 m-70 -140.27 145.17 36.97 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 120.899 0.38 . . . . 0.0 111.709 174.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 4.4 t60 63.25 -76.81 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 123.294 0.637 . . . . 0.0 112.462 174.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 57.4 t-80 -171.9 133.49 0.73 Allowed 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 122.54 0.336 . . . . 0.0 110.612 -179.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 7.1 p-80 -107.64 159.23 16.62 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 120.931 0.396 . . . . 0.0 111.476 179.488 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 6.5 p80 . . . . . 0 C--O 1.253 1.265 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.818 177.22 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.497 ' SD ' ' C ' ' A' ' 1' ' ' MET . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 120.765 0.316 . . . . 0.0 111.139 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 69.9 p -67.61 144.07 55.73 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 121.253 0.549 . . . . 0.0 112.477 -177.061 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 33.2 pt -93.68 -0.31 10.29 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.167 177.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 70.83 -70.57 0.15 Allowed 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.598 0.759 . . . . 0.0 111.693 -178.459 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.413 ' N ' ' HD3' ' A' ' 6' ' ' PRO . . . 55.09 62.36 7.86 Favored Pre-proline 0 N--CA 1.471 0.621 0 CA-C-O 121.088 0.47 . . . . 0.0 111.958 -176.364 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.413 ' HD3' ' N ' ' A' ' 5' ' ' ALA . 13.9 Cg_exo -68.61 94.8 0.45 Allowed 'Trans proline' 0 C--N 1.352 0.745 0 C-N-CA 122.3 2.0 . . . . 0.0 112.258 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -41.08 105.62 0.05 OUTLIER 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.313 178.224 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 80.1 m -99.45 107.3 19.47 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.926 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 6.8 mtpm? -102.81 93.46 5.08 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.158 0.504 . . . . 0.0 110.372 -175.181 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.429 ' HA ' ' O ' ' A' ' 51' ' ' VAL . 62.3 mt -78.28 99.37 2.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.061 -178.666 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 35.6 m -105.67 160.24 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-N 115.753 -0.658 . . . . 0.0 112.062 -174.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -91.19 1.14 57.32 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 120.757 0.313 . . . . 0.0 111.65 178.293 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -115.62 153.39 31.36 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 120.826 0.346 . . . . 0.0 111.63 -176.15 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 42.8 m -89.35 -22.77 22.45 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 116.517 -0.311 . . . . 0.0 111.161 176.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 68.8 mtt180 -114.38 114.6 26.09 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 120.918 0.39 . . . . 0.0 111.372 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 47.2 t -124.28 138.16 54.78 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.657 -177.386 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.0 102.11 7.23 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 120.964 0.411 . . . . 0.0 111.641 178.452 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.531 ' SG ' ' N ' ' A' ' 19' ' ' ASP . 51.5 t -78.77 173.78 12.13 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.398 0.618 . . . . 0.0 111.629 177.652 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.531 ' N ' ' SG ' ' A' ' 18' ' ' CYS . 0.7 OUTLIER -107.91 -4.6 17.8 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 115.553 -0.748 . . . . 0.0 112.886 -174.883 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.416 ' O ' HG21 ' A' ' 30' ' ' VAL . . . -124.14 138.4 11.29 Favored Glycine 0 CA--C 1.527 0.792 0 C-N-CA 120.059 -1.067 . . . . 0.0 114.125 -176.466 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -134.29 -42.84 0.13 Allowed Glycine 0 CA--C 1.527 0.814 0 C-N-CA 121.529 -0.367 . . . . 0.0 112.573 179.024 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.723 ' HB3' ' HB2' ' A' ' 25' ' ' LEU . 40.4 tt0 -169.32 159.09 8.54 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.373 0.669 . . . . 0.0 109.986 177.659 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -44.4 -55.79 5.78 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 121.655 -0.307 . . . . 0.0 113.64 176.148 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -85.5 -6.21 59.21 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 178.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.723 ' HB2' ' HB3' ' A' ' 22' ' ' GLU . 98.5 mt -115.6 48.9 1.14 Allowed 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.393 0.616 . . . . 0.0 109.925 177.687 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -71.29 128.96 16.79 Favored Glycine 0 CA--C 1.526 0.779 0 CA-C-N 115.758 -0.656 . . . . 0.0 113.633 -179.346 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.515 ' NE2' ' HB2' ' A' ' 19' ' ' ASP . 8.4 m80 52.43 60.43 13.12 Favored Pre-proline 0 CA--C 1.546 0.825 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 177.671 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.475 ' HG2' HG13 ' A' ' 30' ' ' VAL . 30.2 Cg_endo -102.03 18.11 0.25 Allowed 'Trans proline' 0 CA--C 1.542 0.916 0 C-N-CA 123.431 2.754 . . . . 0.0 113.711 179.471 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 1.1 mmm180 60.79 88.78 0.08 Allowed 'General case' 0 N--CA 1.44 -0.952 0 CA-C-O 123.093 1.425 . . . . 0.0 112.563 -174.589 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.476 HG23 ' HB3' ' A' ' 18' ' ' CYS . 17.8 m -119.8 125.02 73.89 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 CA-C-N 112.494 -2.139 . . . . 0.0 110.959 -179.464 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 39.5 m95 -101.84 114.53 28.69 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.078 0.466 . . . . 0.0 111.182 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 10.5 mp -92.81 150.73 20.43 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.654 -179.354 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 50.8 tp60 -104.39 124.95 50.14 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.791 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.526 HG21 ' HB2' ' A' ' 52' ' ' LEU . 74.7 mt -84.21 114.47 54.76 Favored Pre-proline 0 CA--C 1.542 0.65 0 CA-C-N 116.642 -0.254 . . . . 0.0 110.381 172.391 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -84.92 143.23 9.26 Favored 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 122.704 2.269 . . . . 0.0 113.235 -177.268 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.426 ' O ' ' NZ ' ' A' ' 56' ' ' LYS . 16.4 mm-40 -69.5 -3.81 16.17 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 121.117 0.484 . . . . 0.0 111.066 171.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -65.18 -62.86 1.29 Allowed 'General case' 0 CA--C 1.543 0.683 0 CA-C-O 121.034 0.445 . . . . 0.0 110.158 169.553 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 82.0 p -91.79 -48.88 6.56 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 115.758 -0.655 . . . . 0.0 112.037 -179.006 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 100.68 1.51 55.3 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 121.309 -0.472 . . . . 0.0 112.718 -175.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 60.2 p-90 -156.53 164.78 37.81 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 122.559 0.344 . . . . 0.0 111.39 -176.495 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 13.6 p -146.93 152.0 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 174.201 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -124.18 147.51 47.95 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 113.059 0.763 . . . . 0.0 113.059 -175.016 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.478 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 18.0 t -101.53 105.24 39.32 Favored Pre-proline 0 N--CA 1.468 0.432 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.274 174.226 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -77.17 -0.33 10.49 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 122.457 2.105 . . . . 0.0 113.123 -177.02 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -90.05 -67.71 0.83 Allowed 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 116.636 -0.256 . . . . 0.0 111.507 -176.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 49.4 t -104.26 6.07 35.17 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 111.869 0.322 . . . . 0.0 111.869 178.101 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 26.6 m-20 69.06 101.35 0.06 Allowed 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 175.29 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 52.0 m -161.69 120.8 2.43 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.135 175.075 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -100.4 110.84 23.05 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 120.753 0.311 . . . . 0.0 110.812 177.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 27.9 m-85 -91.57 107.13 18.99 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 120.638 0.256 . . . . 0.0 110.456 -177.19 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.429 ' O ' ' HA ' ' A' ' 10' ' ' ILE . 90.5 t -100.4 131.4 48.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 CA-C-O 120.726 0.298 . . . . 0.0 111.741 179.646 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.526 ' HB2' HG21 ' A' ' 34' ' ' ILE . 68.0 tp -81.54 119.42 23.75 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.096 0.475 . . . . 0.0 111.934 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.42 ' HB2' HG22 ' A' ' 10' ' ' ILE . 88.0 tttt -69.0 108.23 3.45 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.868 177.103 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 119.87 -13.59 10.63 Favored Glycine 0 CA--C 1.527 0.801 0 C-N-CA 121.412 -0.423 . . . . 0.0 112.542 -175.571 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 59.6 p -81.29 -176.57 6.06 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 120.93 0.395 . . . . 0.0 111.147 178.398 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.426 ' NZ ' ' O ' ' A' ' 36' ' ' GLU . 33.7 mtmm -73.07 -20.19 61.01 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.655 -0.248 . . . . 0.0 111.612 179.073 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -71.6 -49.61 38.67 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.287 0.565 . . . . 0.0 111.321 -175.46 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -75.91 -30.45 58.78 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.867 177.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.42 ' C ' ' H ' ' A' ' 61' ' ' GLU . . . -67.78 -47.52 68.93 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 179.438 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 88.8 mt 69.7 -29.5 0.18 Allowed 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.137 0.575 . . . . 0.0 112.263 -175.323 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.42 ' H ' ' C ' ' A' ' 59' ' ' ALA . 13.8 mt-10 -83.43 17.29 2.2 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 122.956 0.502 . . . . 0.0 111.288 173.763 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 34.8 p80 44.09 36.91 1.61 Allowed 'General case' 0 N--CA 1.476 0.832 0 CA-C-O 121.866 0.841 . . . . 0.0 110.547 -165.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 15.4 t60 79.04 -33.45 0.15 Allowed 'General case' 0 CA--C 1.548 0.876 0 CA-C-N 114.148 -1.387 . . . . 0.0 112.319 178.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 37.7 t60 69.2 143.77 0.05 OUTLIER 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 170.17 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 33.9 m170 -61.43 102.65 0.25 Allowed 'General case' 0 N--CA 1.477 0.883 0 O-C-N 122.006 -0.434 . . . . 0.0 111.606 177.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -96.38 -8.57 32.1 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 120.935 0.397 . . . . 0.0 111.429 174.39 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 79.5 m80 . . . . . 0 C--O 1.248 0.999 0 CA-C-O 118.522 -0.752 . . . . 0.0 111.201 176.139 . . . . . . . . 0 0 . 1 stop_ save_